Entry	Entry Name	Protein names	Gene Names	Length	Organism (ID)	Pathway	EC number	Keywords	Interacts with	Tissue specificity	Gene Ontology IDs	Post-translational modification	PubMed ID	Protein families
A0A024RBG1	NUD4B_HUMAN	Diphosphoinositol polyphosphate phosphohydrolase NUDT4B, DIPP-2B, EC 3.6.1.52 (Nucleoside diphosphate-linked moiety X motif 4B, Nudix motif 4B) (Nudix hydrolase 4B)	NUDT4B	181	9606		3.6.1.52	Cytoplasm;Hydrolase;Magnesium;Metal-binding;Reference proteome;RNA-binding			GO:0000298; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0008486; GO:0034431; GO:0034432; GO:0046872; GO:0050072; GO:0052840; GO:0052842; GO:0071543; GO:1901907; GO:1901909; GO:1901911		16710414	Nudix hydrolase family, DIPP subfamily
A0A087X1C5	CP2D7_HUMAN	Putative cytochrome P450 2D7, EC 1.14.14.1	CYP2D7	515	9606		1.14.14.1	Cytoplasm;Glycoprotein;Heme;Iron;Membrane;Metal-binding;Mitochondrion;Monooxygenase;Oxidoreductase;Reference proteome;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in brain cortex (at protein level). {ECO:0000269|PubMed:15051713}.	GO:0005506; GO:0005737; GO:0005739; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0019369; GO:0020037; GO:0042178; GO:0043231; GO:0070330		15051713; 10591208; 16169517; 17494644; 18838503	Cytochrome P450 family
A0A0B4J2F0	PIOS1_HUMAN	Protein PIGBOS1 (PIGB opposite strand protein 1)	PIGBOS1	54	9606			Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion outer membrane;Reference proteome;Transmembrane;Transmembrane helix;Unfolded protein response	Q96S66		GO:0006986; GO:0031307; GO:1900101		14702039; 16572171; 31653868	
A0A0B4J2F2	SIK1B_HUMAN	Putative serine/threonine-protein kinase SIK1B, EC 2.7.11.1 (Salt-inducible kinase 1B)	SIK1B	783	9606		2.7.11.1	ATP-binding;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Reference proteome;Serine/threonine-protein kinase;Transferase	Q9BRT9; Q68G74; Q14696; P78337; Q9NRG1; P62072		GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0042149; GO:0106310		10830953	Protein kinase superfamily, CAMK Ser/Thr protein kinase family, AMPK subfamily
A0A0C5B5G6	MOTSC_HUMAN	Mitochondrial-derived peptide MOTS-c (Mitochondrial open reading frame of the 12S rRNA-c)	MT-RNR1	16	9606			DNA-binding;Mitochondrion;Nucleus;Osteogenesis;Reference proteome;Secreted;Transcription;Transcription regulation		TISSUE SPECIFICITY: Detected in plasma (at protein level) (PubMed:25738459, PubMed:32182209). Also expressed in skeletal muscle (at protein level) (PubMed:32182209). {ECO:0000269|PubMed:25738459, ECO:0000269|PubMed:32182209}.	GO:0001649; GO:0003677; GO:0005615; GO:0005634; GO:0005739; GO:0006357; GO:0032147; GO:0033687; GO:0043610; GO:0048630; GO:0071902; GO:0072522; GO:0140297; GO:2001145		25738459; 7219534; 29096170; 29886458; 29983246; 30468456; 31081069; 31109005; 30725119; 31369811; 32182209; 31694019; 31931370; 33554779; 33473109; 26289118; 33468709	
A0A0K2S4Q6	CD3CH_HUMAN	Protein CD300H (CD300 antigen-like family member H)	CD300H	201	9606			Alternative splicing;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed on CD16+ monocytes and myeloid dendritic cells. By contrast, is not expressed on lymphocytes or granulocytes. {ECO:0000269|PubMed:26221034}.	GO:0004888; GO:0005576; GO:0005886; GO:0016021; GO:0030593		26221034; 16625196	CD300 family
A0A0U1RRE5	NBDY_HUMAN	Negative regulator of P-body association (P-body dissociating protein) (Protein NoBody)	NBDY LINC01420	68	9606			Cytoplasm;mRNA processing;Reference proteome	Q9NPI6; Q6P2E9		GO:0000932; GO:0000956; GO:0006397; GO:0010607		15772651; 27918561	
A0A5B9	TRBC2_HUMAN	T cell receptor beta constant 2	TRBC2 TCRBC2	178	9606			3D-structure;Adaptive immunity;Cell membrane;Disulfide bond;Glycoprotein;Immunity;Immunoglobulin domain;Membrane;Receptor;Reference proteome;T cell receptor;Transmembrane;Transmembrane helix			GO:0002250; GO:0003823; GO:0005886; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0016021; GO:0034987; GO:0042105; GO:0042571; GO:0042742; GO:0045087; GO:0046631; GO:0050852; GO:0050853; GO:0050871		3860845; 8650574; 12853948; 15040585; 20452950; 23524462; 24600447; 25493333; 8906788; 9586631; 16505140; 20921281; 20483993; 22195564; 21297580; 21552205; 22069376; 22431638; 24995984; 25015819; 25298532; 26018083; 26078271; 26147596; 26917722; 27183386; 27183389; 26875526; 27036003; 26758806; 27180909; 27568928	
A0AV02	S12A8_HUMAN	Solute carrier family 12 member 8 (Cation-chloride cotransporter 9)	SLC12A8 CCC9	714	9606			Alternative splicing;Chloride;Glycoprotein;Ion transport;Membrane;Potassium;Potassium transport;Reference proteome;Symport;Transmembrane;Transmembrane helix;Transport	P26367	TISSUE SPECIFICITY: Ubiquitous with very low level in normal skin. {ECO:0000269|PubMed:11863360}.	GO:0006884; GO:0015379; GO:0016021; GO:0055064; GO:0055075; GO:1902476; GO:1990573		11863360; 14702039; 17974005; 16641997; 15489334; 16297188	SLC12A transporter family
A0AV96	RBM47_HUMAN	RNA-binding protein 47 (RNA-binding motif protein 47)	RBM47	593	9606			3D-structure;Alternative splicing;Methylation;Nucleus;Reference proteome;Repeat;RNA-binding	Q5SWW7; Q6P1W5; Q9UQM7; Q8N6W0; B7ZLH0; P32243-2; P57721-2; Q9NZ81; Q9NWB1-5; Q66K41-2		GO:0002244; GO:0003723; GO:0003729; GO:0005634; GO:0016554		14702039; 15815621; 15489334; 24129315	RRM RBM47 family
A0AVF1	IFT56_HUMAN	Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26, TPR repeat protein 26)	TTC26 IFT56	554	9606			Alternative splicing;Cell projection;Cilium;Protein transport;Reference proteome;Repeat;TPR repeat;Transport			GO:0005813; GO:0005929; GO:0007224; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0061512; GO:0097542; GO:0097546; GO:0120170; GO:1905198		14702039; 12690205; 12853948; 15489334; 17974005	IFT56 family
A0AVI4	TM129_HUMAN	E3 ubiquitin-protein ligase TM129, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TM129)	TMEM129	362	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.27	Alternative splicing;Endoplasmic reticulum;Membrane;Metal-binding;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Ubl conjugation pathway;Unfolded protein response;Zinc;Zinc-finger	P04792; P02766; O76024		GO:0000209; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0016567; GO:0030433; GO:0030970; GO:0046872; GO:0061630		15815621; 15489334; 24807418	TMEM129 family
A0AVK6	E2F8_HUMAN	Transcription factor E2F8, E2F-8	E2F8	867	9606			3D-structure;Activator;Cell cycle;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	P07550; Q92870-2; P46379-2; P55212; O14645; Q96AV8; P22607; Q13643; Q14957; P06396; P01112; P42858; O14901; Q6FHY5; Q7Z412; P37840; Q9UNE7; Q12800; Q9UMX0; Q9Y649		GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0008283; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837		14702039; 15489334; 16179649; 15897886; 18194653; 18202719; 18220336; 22903062; 22802528; 23186163	E2F/DP family
A0AVT1	UBA6_HUMAN	Ubiquitin-like modifier-activating enzyme 6, Ubiquitin-activating enzyme 6, EC 6.2.1.45 (Monocyte protein 4, MOP-4) (Ubiquitin-activating enzyme E1-like protein 2, E1-L2)	UBA6 MOP4 UBE1L2	1052	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:P22314}.	6.2.1.45	Acetylation;Alternative splicing;ATP-binding;Ligase;Nucleotide-binding;Phosphoprotein;Reference proteome;Ubl conjugation pathway	Q6NT76	TISSUE SPECIFICITY: Widely expressed. Isoform 2 is predominantly expressed in testis with higher expression in adult testis than in fetal testis. {ECO:0000269|PubMed:15202508, ECO:0000269|PubMed:17597759}.	GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0032446; GO:0060996		15202508; 17597759; 14702039; 17974005; 15815621; 15489334; 17889673; 19413330; 19608861; 21269460; 23186163; 24275569; 25422469	Ubiquitin-activating E1 family
A0FGR8	ESYT2_HUMAN	Extended synaptotagmin-2, E-Syt2 (Chr2Syt)	ESYT2 FAM62B KIAA1228	921	9606			3D-structure;Alternative splicing;Calcium;Cell membrane;Endocytosis;Endoplasmic reticulum;Lipid transport;Lipid-binding;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	Q9BSJ8; A0FGR8; A0FGR9	TISSUE SPECIFICITY: Widely expressed with high level in cerebellum. {ECO:0000269|PubMed:17360437}.	GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0016020; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0045296; GO:0061817; GO:0140268		17360437; 14702039; 12690205; 10574462; 12168954; 17974005; 15489334; 11543631; 17081983; 17924679; 18691976; 18669648; 19690332; 20833364; 20068231; 21269460; 21406692; 23791178; 23186163; 24275569; 25944712; 30220461; 29469807; 27044890; 24847877; 24373768	Extended synaptotagmin family
A0FGR9	ESYT3_HUMAN	Extended synaptotagmin-3, E-Syt3 (Chr3Syt)	ESYT3 FAM62C	886	9606			Alternative splicing;Calcium;Cell membrane;Endoplasmic reticulum;Lipid transport;Lipid-binding;Membrane;Metal-binding;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	Q9BSJ8; A0FGR8	TISSUE SPECIFICITY: Widely expressed with high level in cerebellum and skin. {ECO:0000269|PubMed:17360437}.	GO:0005509; GO:0005544; GO:0005789; GO:0005887; GO:0006869; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268		17360437; 14702039; 15489334; 11543631; 23791178; 30220461; 29469807	Extended synaptotagmin family
A0JLT2	MED19_HUMAN	Mediator of RNA polymerase II transcription subunit 19 (Lung cancer metastasis-related protein 1) (Mediator complex subunit 19)	MED19 LCMR1	244	9606			3D-structure;Activator;Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	Q9NX70; Q86UW9; P62993; P50747; Q63ZY3; Q92993; Q8TAP4-4; Q14511-2; P17252; Q0D2K3; Q15047-2; Q13148; P61981; P36508		GO:0003712; GO:0005634; GO:0016592; GO:0032968; GO:0045944; GO:0051123; GO:0060261; GO:0070847		15489334; 12584197; 15175163; 17081983; 18669648; 19413330; 19369195; 20068231; 23186163	Mediator complex subunit 19 family
A0JNW5	UH1BL_HUMAN	UHRF1-binding protein 1-like (Syntaxin-6 Habc-interacting protein of 164 kDa)	UHRF1BP1L KIAA0701 SHIP164	1464	9606			Alternative splicing;Coiled coil;Cytoplasm;Endosome;Phosphoprotein;Reference proteome			GO:0005769; GO:0005829; GO:0042803; GO:0062069		15489334; 9734811; 12168954; 11230166; 17974005; 18669648; 20163565; 21406692; 23186163; 24275569	
A0JP26	POTB3_HUMAN	POTE ankyrin domain family member B3	POTEB3	581	9606			Alternative splicing;ANK repeat;Coiled coil;Reference proteome;Repeat	Q08AG9; O95995; Q9BYQ6; Q9BYR2; P26371; Q9BYQ4; Q8N5G2; Q5T6S3				15276201; 16572171; 15489334	POTE family
A0M8Q6	IGLC7_HUMAN	Immunoglobulin lambda constant 7 (Ig lambda-7 chain C region)	IGLC7	106	9606			Adaptive immunity;Cell membrane;Disulfide bond;Immunity;Immunoglobulin;Immunoglobulin domain;Membrane;Reference proteome;Secreted			GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0071735; GO:0071738; GO:0071742; GO:0071745; GO:0071753		2115572; 9074928; 10591208; 11872955; 17576170; 20176268; 22158414	
A0MZ66	SHOT1_HUMAN	Shootin-1 (Shootin1)	SHTN1 KIAA1598	631	9606			Acetylation;Alternative splicing;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Developmental protein;Direct protein sequencing;Phosphoprotein;Reference proteome	P62508; P05413; Q6PJR7; Q9Y5B8; P62508-3; Q9Y2D4; P05413; Q9Y5B8; A0MZ66-4; Q15025; Q05BL1; Q9NP64; O75936; Q12800		GO:0005737; GO:0005874; GO:0005875; GO:0006930; GO:0007265; GO:0007409; GO:0015630; GO:0019894; GO:0030027; GO:0030175; GO:0030424; GO:0030426; GO:0031252; GO:0032488; GO:0038007; GO:0042802; GO:0043204; GO:0044295; GO:0045296; GO:0045773; GO:0048471; GO:0048812; GO:0051015; GO:0060327; GO:0061163; GO:0061573; GO:2000114; GO:2001224	PTM: Phosphorylated on Ser-101 and Ser-249 by PAK1 through a CDC42- and RAC1-dependent signaling pathway, which enhances its association with F-actin retrograde flow in filopodia and lamellipodia of axonal growth cones. Phosphorylation on Ser-101 and Ser-249 is increased by netrin-1. {ECO:0000250|UniProtKB:A0MZ67}.	17030985; 14702039; 17974005; 15164054; 15489334; 10997877; 16964243; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569	Shootin family
A0PJK1	SC5AA_HUMAN	Sodium/glucose cotransporter 5, Na(+)/glucose cotransporter 5 (Solute carrier family 5 member 10)	SLC5A10 SGLT5	596	9606			Alternative splicing;Cell membrane;Glycoprotein;Ion transport;Membrane;Phosphoprotein;Reference proteome;Sodium;Sodium transport;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Seems to be exclusively expressed in kidney. {ECO:0000269|PubMed:22212718}.	GO:0005412; GO:0005886; GO:0006814; GO:0008645; GO:0015370; GO:0016021; GO:0070062		14702039; 16625196; 15489334; 19690332; 22212718	Sodium:solute symporter (SSF) (TC 2.A.21) family
A0PJY2	FEZF1_HUMAN	Fez family zinc finger protein 1 (Zinc finger protein 312B)	FEZF1 FEZ ZNF312B	475	9606			Alternative splicing;Developmental protein;Differentiation;Disease variant;DNA-binding;Hypogonadotropic hypogonadism;Kallmann syndrome;Metal-binding;Neurogenesis;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	A8MQ03; Q5TD97; Q6A162; Q07627; P60410; Q99750	TISSUE SPECIFICITY: Expressed in brain. Little or no expression in other tissues. Overexpressed specifically in gastric cancers. A 2- to 20-fold increase is found in over 50% of gastric cancer tissues. {ECO:0000269|PubMed:19318583}.	GO:0000978; GO:0001227; GO:0001764; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0007411; GO:0008285; GO:0021772; GO:0021797; GO:0043697; GO:0045666; GO:0045893; GO:0046872; GO:0050767		14702039; 12690205; 15489334; 19318583; 25192046	Krueppel C2H2-type zinc-finger protein family
A0PK00	T120B_HUMAN	Transmembrane protein 120B	TMEM120B	339	9606			3D-structure;Coiled coil;Membrane;Nucleus;Reference proteome;Transmembrane;Transmembrane helix	P20292; Q68DC2; Q6Q788; Q13520; O94778; O60238; O95273; P04233-2; P21964; Q7Z7G2; Q96BA8; Q15125; Q9Y282; O15552; Q9Y680; Q05329; P08034; Q5T7V8; Q8TDT2; Q9NZD1; Q8TED1; Q8NBQ5; P38484; P16871; Q8N5M9; Q9HDC5; P48051; O43300; O14880; Q9Y676; P15941-11; Q6IBW4-4; Q9BRK0; Q9H6H4; Q86VR2; Q6ZMZ0; Q99942; Q9NY72; Q8IVP1; Q14973; Q3KNW5; Q8NDX2-2; P54219-3; P43003; P27105; P32856-2; Q96MV1; Q8IV31; Q96AN5; Q9NUH8; Q96HE8; O15393-2; Q9Y320; Q96MV8		GO:0005637; GO:0016020; GO:0016021; GO:0045444; GO:0051291		14702039; 15489334	TMEM120 family
A0PK11	CLRN2_HUMAN	Clarin-2	CLRN2	232	9606			Cell membrane;Cell projection;Deafness;Disease variant;Glycoprotein;Hearing;Membrane;Non-syndromic deafness;Reference proteome;Transmembrane;Transmembrane helix	Q8N6S5; O00501; Q9UHP7-3; Q8TBE3; P26715; Q8N386; O14524-2; Q9Y3P8; Q8WWF3; P27105; Q8N6K0; Q9H7M9		GO:0007605; GO:0016021; GO:0032421; GO:0060088; GO:0120045		15815621; 15489334; 33496845	Clarin family
A1A4S6	RHG10_HUMAN	Rho GTPase-activating protein 10 (GTPase regulator associated with focal adhesion kinase 2) (Graf-related protein 2) (Rho-type GTPase-activating protein 10)	ARHGAP10 GRAF2	786	9606			3D-structure;Cell membrane;Cytoplasm;GTPase activation;Membrane;Phosphoprotein;Reference proteome;SH3 domain	Q6P5Z2	TISSUE SPECIFICITY: High levels of expression in heart and skeletal muscle. {ECO:0000269|PubMed:11432776}.	GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471; GO:0051056	PTM: Phosphorylated. Phosphorylated in vitro by constitutive active PKN3. {ECO:0000269|PubMed:11432776}.	11432776; 15489334	
A1A4Y4	IRGM_HUMAN	Immunity-related GTPase family M protein, EC 3.6.5.- (Immunity-related GTPase family M protein 1) (Interferon-inducible protein 1) (LPS-stimulated RAW 264.7 macrophage protein 47 homolog, LRG-47)	IRGM IFI1 IRGM1 LRG47	181	9606		3.6.5.-	Autophagy;Cell membrane;Cell projection;Cytoplasmic vesicle;Golgi apparatus;GTP-binding;Hydrolase;Immunity;Inflammatory response;Innate immunity;Membrane;Nucleotide-binding;Reference proteome	Q96CV9	TISSUE SPECIFICITY: Widely expressed (at protein level). Expressed in several tissues including colon, small bowel and peripheral blood leukocytes. {ECO:0000269|PubMed:16888103, ECO:0000269|PubMed:17554261}.	GO:0000045; GO:0000139; GO:0000421; GO:0001891; GO:0001934; GO:0003924; GO:0005525; GO:0005739; GO:0005789; GO:0005794; GO:0005829; GO:0006952; GO:0006954; GO:0010508; GO:0010800; GO:0019901; GO:0030670; GO:0031648; GO:0033138; GO:0035458; GO:0042742; GO:0042995; GO:0043254; GO:0043539; GO:0045087; GO:0050700; GO:0050821; GO:0050829; GO:0051434; GO:0060335; GO:0061635; GO:0061739; GO:0061762; GO:0070431; GO:0071222; GO:0071902; GO:0098586; GO:1901098		19266026; 15489334; 16277747; 16888103; 17554261; 19174780; 21278745	TRAFAC class dynamin-like GTPase superfamily, IRG family
A1A519	F170A_HUMAN	Protein FAM170A (Zinc finger domain-containing protein) (Zinc finger protein ZNFD)	FAM170A ZNFD	330	9606			Activator;Alternative splicing;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger		TISSUE SPECIFICITY: Expressed strongly in testis and brain and weakly in prostate, spleen, pancreas and uterus. {ECO:0000269|PubMed:20162441}.	GO:0003677; GO:0005634; GO:0006366; GO:0009566; GO:0045893; GO:0046872		20162441; 15372022; 15489334	FAM170 family
A1A5B4	ANO9_HUMAN	Anoctamin-9 (Transmembrane protein 16J) (Tumor protein p53-inducible protein 5) (p53-induced gene 5 protein)	ANO9 PIG5 TMEM16J TP53I5	782	9606			Alternative splicing;Cell membrane;Glycoprotein;Lipid metabolism;Lipid transport;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport	Q12959; Q9H8W4		GO:0005229; GO:0005254; GO:0005886; GO:0006629; GO:0006821; GO:0016021; GO:0017128; GO:0034220; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476; GO:1902939		12693554; 14702039; 16554811; 15489334; 20056604; 21642943; 22178883; 21607626; 22302790; 21984732; 22946059	Anoctamin family
A1A5C7	S22AN_HUMAN	Solute carrier family 22 member 23	SLC22A23 C6orf85	686	9606			Alternative splicing;Glycoprotein;Ion transport;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport	P60410; P26371; Q7Z3S9; Q08AM2; Q15848; P27352; Q9NWW5; O95406; Q7Z2K6; Q8IUG1; Q6FHY5; Q6UX06; P53801; O00526; Q14508		GO:0006811; GO:0016021; GO:0022857		14574404; 15489334; 14702039; 17714910	Major facilitator (TC 2.A.1) superfamily, Organic cation transporter (TC 2.A.1.19) family
A1E959	ODAM_HUMAN	Odontogenic ameloblast-associated protein (Apin)	ODAM APIN	279	9606			Biomineralization;Cytoplasm;Glycoprotein;Nucleus;Reference proteome;Secreted;Signal	Q13444-2; Q03989; O14964; Q71SY5; Q7Z3K3; O00560; P09234; Q8IWB4; O95231	TISSUE SPECIFICITY: Expressed in the junctional epithelium of healthy teeth. In periodontitis, absent in the pocket epithelium of the diseased periodontium but is detected in the gingival crevicular fluid. {ECO:0000269|PubMed:25911094}.	GO:0001934; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0010628; GO:0031214; GO:0032956; GO:0042475; GO:0043547; GO:0060054; GO:0071944; GO:0072686; GO:0099512	PTM: O-glycosylated. {ECO:0000250}.	14702039; 15489334; 14647039; 17647262; 25911094; 16959974	ODAM family
A1KXE4	F168B_HUMAN	Myelin-associated neurite-outgrowth inhibitor, Mani (p20)	FAM168B KIAA0280L MANI	195	9606			Acetylation;Alternative splicing;Cell membrane;Cell projection;Cytoplasm;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	P21549; Q03989; O95817; Q9UQM7; O75909-2; P33240; Q9H0L4; Q9H6Z9; Q92567-2; Q8WU58; P22607; O75593; Q12951-2; Q9BZE0; Q13227; P17482; Q9ULV5-2; O14901; Q6PEX3; Q14847-2; Q71SY5; Q8IXL7-2; Q8TDC0; Q14511-2; Q9BVL2; P32242; Q9HBE1-4; P78337; Q7Z3K3; Q96HA1-2; Q7Z5V6-2; P0CG20; Q9BTL3; O43251-10; Q9BQY4; Q01974; Q7Z3H4; P14678-2; P09234; Q99932-2; Q9NQB0-10; Q96A09; Q01085-2; Q08117-2; O43711; Q5T6F2; O95231; Q14119; A8MV65-2; A5D8V6; Q64LD2-2; Q96K80; Q15915	TISSUE SPECIFICITY: Expressed in the brain, within neuronal axonal fibers and associated with myelin sheets (at protein level). Expression tends to be lower in the brain of Alzheimer disease patients compared to healthy individuals (at protein level). {ECO:0000269|PubMed:20716133}.	GO:0005886; GO:0016021; GO:0030424; GO:0048471; GO:0070062	PTM: N-glycosylated. {ECO:0000250|UniProtKB:D4AEP3}.	20716133; 15489334; 19413330; 22771904; 23186163	FAM168 family
A1KZ92	PXDNL_HUMAN	Probable oxidoreductase PXDNL, EC 1.-.-.- (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1, PRM1) (Vascular peroxidase 2)	PXDNL VPO2	1463	9606		1.-.-.-	Alternative splicing;Calcium;Cell membrane;Cytoplasm;Disulfide bond;Endonuclease;Endoplasmic reticulum;Glycoprotein;Heme;Hydrolase;Immunoglobulin domain;Iron;Leucine-rich repeat;Membrane;Metal-binding;Nuclease;Oxidoreductase;Phosphoprotein;Reference proteome;Repeat;Secreted;Signal		TISSUE SPECIFICITY: the 57 kDa isoform PMR1 is the only form detected at protein levels in human cell lines (PubMed:22543864). Expressed in heart (PubMed:24253521). {ECO:0000269|PubMed:22543864, ECO:0000269|PubMed:24253521}.	GO:0004519; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0020037; GO:0042744; GO:0046872	PTM: Phosphorylation by SRC on tyrosine residues is required for targeting to polysomes. {ECO:0000269|PubMed:22543864}.	18929642; 16421571; 14702039; 12923263; 22543864; 24253521	Peroxidase family, XPO subfamily
A1L0T0	HACL2_HUMAN	2-hydroxyacyl-CoA lyase 2, EC 4.1.2.- (Acetolactate synthase-like protein) (IlvB-like protein)	ILVBL AHAS HACL2	632	9606		4.1.2.-	Endoplasmic reticulum;Fatty acid metabolism;Lipid metabolism;Lyase;Magnesium;Membrane;Metal-binding;Reference proteome;Thiamine pyrophosphate;Transmembrane;Transmembrane helix	Q8TAP6	TISSUE SPECIFICITY: Expressed in all tissues tested, with highest expression in heart, pancreas and placenta. {ECO:0000269|PubMed:28289220, ECO:0000269|PubMed:8954801}.	GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016020; GO:0016021; GO:0016829; GO:0030976; GO:0050660		8954801; 15057824; 15489334; 21269460; 25944712; 28289220	TPP enzyme family
A1L167	U2QL1_HUMAN	Ubiquitin-conjugating enzyme E2Q-like protein 1, EC 2.3.2.23 (E2Q-like ubiquitin-conjugating enzyme 1)	UBE2QL1	161	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.	2.3.2.23	ATP-binding;Chromosomal rearrangement;Nucleotide-binding;Nucleus;Reference proteome;Transferase;Ubl conjugation pathway			GO:0000209; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0061631		15489334; 24000165	Ubiquitin-conjugating enzyme family
A1L390	PKHG3_HUMAN	Pleckstrin homology domain-containing family G member 3, PH domain-containing family G member 3	PLEKHG3 KIAA0599	1219	9606			Alternative splicing;Cytoplasm;Cytoskeleton;Methylation;Phosphoprotein;Reference proteome			GO:0003779; GO:0005085; GO:0005829; GO:0030334; GO:0051056; GO:2000114		12508121; 15489334; 9455484; 18669648; 19413330; 20068231; 21406692; 23186163; 24275569; 24129315; 27555588	
A1L3X0	ELOV7_HUMAN	Elongation of very long chain fatty acids protein 7, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL7) (ELOVL fatty acid elongase 7, ELOVL FA elongase 7) (Very long chain 3-ketoacyl-CoA synthase 7) (Very long chain 3-oxoacyl-CoA synthase 7)	ELOVL7	281	9606	PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03207, ECO:0000269|PubMed:20937905, ECO:0000269|PubMed:21959040}.	2.3.1.199	3D-structure;Endoplasmic reticulum;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Membrane;Reference proteome;Transferase;Transmembrane;Transmembrane helix	Q9UHX3; Q96EV8; P54852; O75427; Q5QGT7; O75920; Q8IVJ1; P57105; Q9P0S9; Q8N2K1; P23763-3	TISSUE SPECIFICITY: Expressed in most tissues except heart and skeletal muscle. {ECO:0000269|PubMed:20937905}.	GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102756		15489334; 14702039; 17974005; 19826053; 20937905; 21959040	ELO family, ELOVL7 subfamily
A1L4H1	SRCRL_HUMAN	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D (Soluble scavenger protein with 5 SRCR domains, SSc5D)	SSC5D	1573	9606			Alternative splicing;Cytoplasm;Developmental protein;Disulfide bond;Glycoprotein;Immunity;Innate immunity;Receptor;Reference proteome;Repeat;Secreted;Signal	Q6QNY1; Q96L14; Q96EV8; Q9UPT5; Q9UPT5-1; Q96CS2; Q7Z3Y8; Q9P086; Q13503; Q9NX70; Q7Z6G3-2; P37198; Q13526; O00560; Q9Y6Y8; Q96BD8; Q15560; Q13077	TISSUE SPECIFICITY: Highly expressed in monocytes/macrophages and T-lymphocytes. Highly expressed in placenta and spleen, and also detected at lower levels in colon, and more weakly in lung, heart and kidney. {ECO:0000269|PubMed:19535143}.	GO:0001968; GO:0005044; GO:0005615; GO:0005737; GO:0006952; GO:0016020; GO:0031012; GO:0032717; GO:0042494; GO:0043236; GO:0045087; GO:0050829; GO:0050830; GO:0050840; GO:0062023		19535143; 15057824; 15489334	
A1L4K1	FSD2_HUMAN	Fibronectin type III and SPRY domain-containing protein 2 (SPRY domain-containing protein 1)	FSD2 SPRYD1	749	9606			Alternative splicing;Coiled coil;Cytoplasm;Nucleus;Reference proteome;Repeat;Sarcoplasmic reticulum	P29972; P53365; Q6ZNE5; Q9BXY8; Q00994; Q9H0E9-2; Q8TAB5; Q9P1Y5-2; Q9HC52; Q8NEF3; Q96HB5; Q8IYE0; Q8TD31-3; Q6P1J9; Q07002; P31146; P78358; Q2TBE0; O43602-2; O60941-5; Q9H0I2; P10768; O60645; O95990-3; Q9BQ89; Q3B820; Q9Y247; Q86YD7; O95363; Q06787-8; P56524-2; O14964; Q8IY31; Q7Z3B3; Q2TBA0; Q6PJG3; Q96BZ8; Q8TBB1; Q96EZ8; Q8IVT4; Q9UJV3-2; Q9Y3B7; O43482; Q96HP4; Q5JS98; Q96AL5; Q8N381; Q96PV4; Q9UGP5-2; Q6NYC8; Q14738; Q99633; Q8WWY3; P28070; Q9P2K3-2; O76064; Q9BWG6; Q9H788; Q9H788-2; Q969G3; O95295; Q9H0A9; Q9H0A9-2; Q8N8B7; Q9BT49; Q08117; Q08117-2; Q3SY00; Q5W5X9-3; P0CB47; Q14119; Q53FD0; Q96NC0; Q15973; P17024; Q9UIE0; P13682; Q9H9D4; Q86VK4; Q86VK4-3; Q8TAU3; Q9ULM2; Q7Z3I7; Q9UK33; Q9P0T4; Q96SQ5; Q5T619; P36508; Q6NX45; Q9ULD5; Q9Y2P0; Q96EG3; Q16670; Q9H6F0		GO:0005634; GO:0016529; GO:0048471		14702039; 16572171; 15489334	
A1X283	SPD2B_HUMAN	SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains)	SH3PXD2B FAD49 KIAA1295 TKS4	911	9606			Cell junction;Cell projection;Cytoplasm;Differentiation;Disease variant;Phosphoprotein;Reference proteome;Repeat;SH3 domain		TISSUE SPECIFICITY: Expressed in fibroblasts. {ECO:0000269|PubMed:20137777}.	GO:0001501; GO:0001654; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0016176; GO:0022617; GO:0030054; GO:0030154; GO:0032266; GO:0042169; GO:0042554; GO:0042995; GO:0060348; GO:0060612; GO:0071800; GO:0072657; GO:0080025	PTM: Phosphorylated in SRC-transformed cells. {ECO:0000250}.	18959745; 15372022; 10718198; 12615925; 18669648; 19807924; 19755710; 20137777; 20068231; 20609497; 21406692; 24129315	SH3PXD2 family
A1XBS5	CBAR1_HUMAN	CBY1-interacting BAR domain-containing protein 1	CIBAR1 FAM92A FAM92A1	289	9606			Alternative splicing;Cell projection;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleus;Reference proteome;Transit peptide	Q9Y3M2; Q9Y3M2; Q8NA61-2		GO:0005543; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0007007; GO:0019898; GO:0030061; GO:0035108; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0061024; GO:0097546; GO:0097749		17646714; 14702039; 17974005; 16421571; 15489334; 27528616; 30395363; 30404948	CIBAR family
A1Z1Q3	MACD2_HUMAN	ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2, EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2, EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2, EC 3.2.2.-)	MACROD2 C20orf133	425	9606		3.2.2.-; 3.5.1.-	3D-structure;Alternative splicing;DNA damage;Hydrolase;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation			GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293		14702039; 11780052; 15489334; 18655026; 21257746; 23474714; 31599159; 23474712	
A2A288	ZC12D_HUMAN	Probable ribonuclease ZC3H12D, EC 3.1.-.- (MCP-induced protein 4) (Transformed follicular lymphoma) (Zinc finger CCCH domain-containing protein 12D) (p34)	ZC3H12D C6orf95 MCPIP4 TFL	527	9606		3.1.-.-	Alternative splicing;Chromosomal rearrangement;Cytoplasm;Endonuclease;Hydrolase;Magnesium;Metal-binding;Nuclease;Nucleus;Reference proteome;Zinc;Zinc-finger		TISSUE SPECIFICITY: Expressed in normal human lymphocytes but defective in some leukemia/lymphoma cell lines. {ECO:0000269|PubMed:19531561}.	GO:0000932; GO:0003729; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0006402; GO:0030308; GO:0036464; GO:0046872; GO:0061158; GO:0090502; GO:2000134		19531561; 14702039; 14574404; 15489334; 17854321; 17210687; 18178554; 26134560	ZC3H12 family
A2A2Y4	FRMD3_HUMAN	FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1, 4.1O)	FRMD3 EPB41L4O	597	9606			Alternative splicing;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q96FZ5; O43169; Q8N5M9; Q8IXM6; Q5VZY2; Q9Y6X1; Q8N6R1; Q96G79; Q5SNT2-2; A2RU14; Q5BJF2; O95159	TISSUE SPECIFICITY: Ovary-specific. {ECO:0000269|PubMed:12601556}.	GO:0005856; GO:0008092; GO:0016021; GO:0031032		12601556; 14702039; 17974005; 15164053; 15489334; 17260017	
A2IDD5	CCD78_HUMAN	Coiled-coil domain-containing protein 78 (hsCCDC78)	CCDC78 C16orf25 JFP10	438	9606			Alternative splicing;Cell membrane;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Membrane;Reference proteome;Sarcoplasmic reticulum	Q0VD86	TISSUE SPECIFICITY: Expressed primarily in skeletal muscle. {ECO:0000269|PubMed:22818856}.	GO:0003009; GO:0005737; GO:0005814; GO:0016529; GO:0030030; GO:0042383; GO:0048471; GO:0098535; GO:0098536		14702039; 11157797; 15616553; 15489334; 22818856; 24075808	CCDC78 family
A2PYH4	HFM1_HUMAN	Probable ATP-dependent DNA helicase HFM1, EC 3.6.4.12 (SEC63 domain-containing protein 1)	HFM1 SEC3D1	1435	9606		3.6.4.12	Alternative splicing;ATP-binding;Disease variant;Helicase;Hydrolase;Meiosis;Nucleotide-binding;Premature ovarian failure;Reference proteome		TISSUE SPECIFICITY: Preferentially expressed in testis and ovary. {ECO:0000269|PubMed:17286053}.	GO:0000712; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0016887		17286053; 14702039; 16710414; 24597873	Helicase family, SKI2 subfamily
A2RRP1	NBAS_HUMAN	NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein) (Neuroblastoma-amplified sequence)	NBAS NAG	2371	9606			Acetylation;Alternative splicing;Cytoplasm;Disease variant;Dwarfism;Endoplasmic reticulum;Membrane;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport;WD repeat		TISSUE SPECIFICITY: Broadly expressed, with highest levels in heart and skeletal muscle, and lowest levels in liver, small intestine and thymus. Well expressed in retinal ganglion cells, epidermal skin cells, and leukocytes. Up-regulated together with N-myc in some neuroblastoma cell lines. {ECO:0000269|PubMed:10882752, ECO:0000269|PubMed:12706883, ECO:0000269|PubMed:20577004, ECO:0000269|PubMed:9926938}.	GO:0000149; GO:0000956; GO:0005783; GO:0005789; GO:0005829; GO:0006890; GO:0015031; GO:0016020; GO:0070939; GO:2000623		12706883; 15815621; 15489334; 9926938; 17974005; 10882752; 18669648; 18318008; 19413330; 19369418; 19690332; 19608861; 20577004; 20462495; 21269460; 21406692; 23186163; 24275569; 26073778; 26286438; 28629372; 27789416; 28576691; 30825388; 32146038	
A2RTX5	SYTC2_HUMAN	Threonine--tRNA ligase 2, cytoplasmic, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase protein 3)	TARS3 TARSL2	802	9606		6.1.1.3	Acetylation;Alternative splicing;Aminoacyl-tRNA synthetase;ATP-binding;Coiled coil;Cytoplasm;Direct protein sequencing;Ligase;Nucleotide-binding;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome	O15145; P18848; Q9BQ95; Q8TCE9; P26639; Q9BW92; Q05BL1; B2RDX5		GO:0004829; GO:0005524; GO:0005634; GO:0005737; GO:0006435		14702039; 15489334; 21269460; 22814378; 23186163; 24312579	Class-II aminoacyl-tRNA synthetase family
A2RU14	TM218_HUMAN	Transmembrane protein 218	TMEM218	115	9606			Cell projection;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q96BI3; P41181; Q13520; Q3SXY8; Q8WWH4; O15342; J3KQ12; Q9UGN4; P19397; P11912; P57739; Q8IUN9; Q6ZS10; Q7Z7G2; Q96BA8; P16410; Q9Y4D2; Q15125; Q9NXB9; Q9GZR5; P54849; Q9Y282; Q5JX71; A2A2Y4; Q8TB36; P08034; Q9NTQ9; O95452; Q8TDT2; Q9BZJ8; Q8TED1; P38484; P48051; O95279; P43628; Q5T700; Q8TAF8; Q8N112; Q9GZY8-5; Q96HJ5; Q9H2K0; Q9Y5X5-3; P12004; Q9BQ51; Q96FE7; Q53GL0; Q86VR2; Q9NR31; A0A0S2Z4U3; Q96EP9; Q3KNW5; P54219-3; Q9BZL3; Q8WWF3; Q96CE8; Q6PL24; Q9BVX2; Q6ZP80; Q6UWW9; Q8WY98; Q96B21; Q4KMG9; Q6PEY1; O15393-2; P34981; O95859; Q8WUV1; Q9H7M9		GO:0005929; GO:0016021		15489334	TMEM218 family
A2RU30	TESP1_HUMAN	Protein TESPA1 (Thymocyte-expressed positive selection-associated protein 1)	TESPA1 KIAA0748 HSPC257	521	9606			Alternative splicing;Cytoplasm;Endoplasmic reticulum;Membrane;Phosphoprotein;Reference proteome;Signalosome			GO:0005102; GO:0005737; GO:0005789; GO:0005829; GO:0008104; GO:0008180; GO:0010387; GO:0033077; GO:0033089; GO:0036398; GO:0036399; GO:0043274; GO:0050862	PTM: May be phosphorylated in response to store-operated Ca(+2) entry. {ECO:0000250}.	22561606; 9872452; 14702039; 16541075; 15489334; 19690332; 23650607; 23501103	
A2RU49	HYKK_HUMAN	Hydroxylysine kinase, 5-hydroxy-L-lysine kinase, EC 2.7.1.81 (Aminoglycoside phosphotransferase domain-containing protein 1)	HYKK AGPHD1	373	9606		2.7.1.81	Alternative splicing;Cytoplasm;Kinase;Reference proteome;Transferase			GO:0005759; GO:0006554; GO:0019202; GO:0047992		14702039; 16572171; 15489334; 22241472	Aminoglycoside phosphotransferase family
A2RUB1	MEIOC_HUMAN	Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein)	MEIOC C17orf104	952	9606			Alternative splicing;Cytoplasm;Meiosis;Nucleus;Reference proteome		TISSUE SPECIFICITY: Expressed in fetal ovaries (PubMed:26742488). Expressed in testis (PubMed:28380054). {ECO:0000269|PubMed:26742488, ECO:0000269|PubMed:28380054}.	GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192		16625196; 15489334; 14702039; 26742488; 28380054	
A2RUB6	CCD66_HUMAN	Coiled-coil domain-containing protein 66	CCDC66	948	9606			Alternative splicing;Cell projection;Cilium;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Disulfide bond;Phosphoprotein;Reference proteome		TISSUE SPECIFICITY: Widely expressed (at protein level) (PubMed:28235840). Expressed in retina, mainly in photoreceptors but also in outer plexiform and ganglion cell layers (at protein level) (PubMed:19777273). {ECO:0000269|PubMed:19777273, ECO:0000269|PubMed:28235840}.	GO:0001578; GO:0001750; GO:0001895; GO:0001917; GO:0005813; GO:0005829; GO:0005874; GO:0005929; GO:0008017; GO:0030054; GO:0034451; GO:0036064; GO:0042803; GO:0050908; GO:0060271; GO:0090543; GO:1903564		14702039; 16641997; 15489334; 18669648; 19777273; 28235840; 32453716; 21680557	
A2RUC4	TYW5_HUMAN	tRNA wybutosine-synthesizing protein 5, hTYW5, EC 1.14.11.42 (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase)	TYW5 C2orf60	315	9606	PATHWAY: tRNA modification; wybutosine-tRNA(Phe) biosynthesis. {ECO:0000269|PubMed:20739293, ECO:0000269|PubMed:20972222}.	1.14.11.42	3D-structure;Alternative splicing;Dioxygenase;Iron;Metal-binding;Oxidoreductase;Reference proteome;tRNA processing			GO:0000049; GO:0005506; GO:0005737; GO:0016706; GO:0031591; GO:0042803; GO:0102524		14702039; 15815621; 15489334; 20739293; 20972222	TYW5 family
A2RUH7	MBPHL_HUMAN	Myosin-binding protein H-like	MYBPHL	354	9606			Alternative splicing;Cytoplasm;Disulfide bond;Immunoglobulin domain;Methylation;Phosphoprotein;Reference proteome;Repeat	P27797; P55212; Q15078; P36957; Q13643; P14136; Q8WXH2; P13473-2; Q96EH3; Q8TDX7; P62826; Q05BL1	TISSUE SPECIFICITY: Expressed in heart, with higher expression in the atria. {ECO:0000269|PubMed:28778945, ECO:0000269|PubMed:31292467}.; TISSUE SPECIFICITY: [Isoform 1]: Expressed in left atrium and ventricle, arteria mammaria interna and skeletal muscle. {ECO:0000269|PubMed:31292467}.; TISSUE SPECIFICITY: [Isoform 2]: Expressed specifically en the left atrium. {ECO:0000269|PubMed:31292467}.	GO:0001701; GO:0030017; GO:0036379		16710414; 15489334; 28778945; 31292467	Immunoglobulin superfamily, MyBP family
A2VDJ0	T131L_HUMAN	Transmembrane protein 131-like	TMEM131L KIAA0922	1609	9606			Alternative splicing;Cell membrane;Cytoplasm;Endoplasmic reticulum;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Signal;Transmembrane;Transmembrane helix;Wnt signaling pathway		TISSUE SPECIFICITY: Expressed in thymocytes. {ECO:0000269|PubMed:23690469}.	GO:0005737; GO:0005783; GO:0005886; GO:0016020; GO:0016021; GO:0016055; GO:0033088; GO:0090090		11230166; 15815621; 14702039; 15489334; 10231032; 18669648; 19690332; 21269460; 23690469	TMEM131 family
A2VEC9	SSPO_HUMAN	SCO-spondin (SCO-spondin pseudogene)	SSPOP KIAA2036 SSPO	5150	9606			Alternative splicing;Calcium;Cell adhesion;Disulfide bond;EGF-like domain;Glycoprotein;Reference proteome;Repeat;Secreted;Signal			GO:0005615; GO:0007155; GO:0007399; GO:0030154; GO:0030414; GO:0031012		12853948; 17126404; 30520531; 26477546	Thrombospondin family
A3KMH1	VWA8_HUMAN	von Willebrand factor A domain-containing protein 8 (PEX7-binding protein 2, P7BP2)	VWA8 KIAA0564	1905	9606			Alternative splicing;ATP-binding;Glycoprotein;Mitochondrion;Nucleotide-binding;Peroxisome;Reference proteome;Transit peptide			GO:0005524; GO:0005737; GO:0005739; GO:0005777; GO:0016887		15057823; 15489334; 17974005; 9628581; 21269460; 24275569; 30204880	
A4D0S4	LAMB4_HUMAN	Laminin subunit beta-4 (Laminin beta-1-related protein)	LAMB4	1761	9606			Alternative splicing;Basement membrane;Cell adhesion;Coiled coil;Disulfide bond;Extracellular matrix;Glycoprotein;Laminin EGF-like domain;Reference proteome;Repeat;Secreted;Signal			GO:0005201; GO:0005576; GO:0009887; GO:0009888; GO:0016477; GO:0034446; GO:0043256; GO:0070831		12853948; 15489334; 14702039; 25787250	
A4D126	ISPD_HUMAN	D-ribitol-5-phosphate cytidylyltransferase, EC 2.7.7.40 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein, hISPD)	CRPPA ISPD	451	9606	PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:26687144, ECO:0000269|PubMed:26923585, ECO:0000269|PubMed:27130732}.	2.7.7.40	3D-structure;Alternative splicing;Congenital muscular dystrophy;Cytoplasm;Disease variant;Dystroglycanopathy;Limb-girdle muscular dystrophy;Lissencephaly;Nucleotidyltransferase;Reference proteome;Transferase		TISSUE SPECIFICITY: Ubiquitously expressed, with high expression in brain. {ECO:0000269|PubMed:22522420}.	GO:0005829; GO:0007411; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0070567		12853948; 12690205; 22522420; 26923585; 27130732; 27601598; 26687144; 23217329; 22522421; 23288328; 24120487; 23390185; 27234031	IspD/TarI cytidylyltransferase family, IspD subfamily
A4D161	F221A_HUMAN	Protein FAM221A	FAM221A C7orf46	298	9606			Alternative splicing;Reference proteome	Q49AR9; Q6NVV7; A8MQ03; G5E9A7; P49639; Q07627; Q3LI59; Q9BYQ6; Q9UBR4-2; Q6FHY5; P0DPK4; Q99471; Q8TAS3; Q7Z699; P55854; Q8TAU3				12690205; 15489334	FAM221 family
A4D1B5	GSAP_HUMAN	Gamma-secretase-activating protein, GSAP (Protein pigeon homolog) [Cleaved into: Gamma-secretase-activating protein 16 kDa C-terminal form, GSAP-16K ]	GSAP PION	854	9606			Alternative splicing;Golgi apparatus;Reference proteome	P05067	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:20811458}.	GO:0001540; GO:0005802; GO:0030162; GO:1902004	PTM: The protein is first synthesized as a holoprotein form of 98 kDa and rapidly processed into the gamma-secretase-activating protein 16 kDa C-terminal form, which constitutes the predominant form. {ECO:0000269|PubMed:20811458}.	12853948; 12690205; 15489334; 17974005; 20811458	GSAP family
A4D1E9	GTPBA_HUMAN	GTP-binding protein 10 (Protein obg homolog 2, ObgH2)	GTPBP10 OBGH2 UG0751c10	387	9606			3D-structure;Alternative splicing;Chromosome;GTP-binding;Nucleotide-binding;Nucleus;Reference proteome;Ribosome biogenesis	Q08379; Q5JR59; Q8ND90		GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254		14702039; 17974005; 12853948; 12690205; 15489334; 17054726; 21269460; 25944712	TRAFAC class OBG-HflX-like GTPase superfamily, OBG GTPase family
A4D1P6	WDR91_HUMAN	WD repeat-containing protein 91	WDR91 HSPC049	747	9606			3D-structure;Alternative splicing;Coiled coil;Endosome;Membrane;Phosphoprotein;Reference proteome;Repeat;WD repeat	P42858; Q562E7		GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022; GO:1903362		11042152; 14702039; 17974005; 12853948; 12690205; 15489334; 11230166; 16964243; 21269460; 23186163; 26783301; 27126989; 28404643	WD repeat WDR91 family
A4D1T9	PRS37_HUMAN	Probable inactive serine protease 37 (Probable inactive trypsin-X2)	PRSS37 TRYX2	235	9606			Cytoplasmic vesicle;Disulfide bond;Fertilization;Reference proteome;Secreted;Signal		TISSUE SPECIFICITY: Testis-specific (PubMed:27649891). Expressed in spermatids (at protein level) (PubMed:27649891). {ECO:0000269|PubMed:27649891}.	GO:0001669; GO:0004252; GO:0005576; GO:0005634; GO:0005737; GO:0007339; GO:0016477; GO:0043231; GO:0051604; GO:0070613; GO:1905516; GO:2000344		12690205; 15489334; 27649891	Peptidase S1 family
A4D256	CC14C_HUMAN	Dual specificity protein phosphatase CDC14C, EC 3.1.3.16, EC 3.1.3.48 (CDC14 cell division cycle 14 homolog C)	CDC14C CDC14B2 CDC14Bretro	447	9606		3.1.3.16; 3.1.3.48	Endoplasmic reticulum;Hydrolase;Membrane;Protein phosphatase;Reference proteome;Transmembrane;Transmembrane helix			GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005730; GO:0005737; GO:0005789; GO:0005813; GO:0007096; GO:0008138; GO:0016021; GO:0032467; GO:0060271; GO:0072686		12853948; 12690205; 15489334; 16201836; 18547142	Protein-tyrosine phosphatase family, Non-receptor class CDC14 subfamily
A4D2B0	MBLC1_HUMAN	Metallo-beta-lactamase domain-containing protein 1, EC 3.1.27.- (Endoribonuclease MBLAC1)	MBLAC1	266	9606		3.1.27.-	3D-structure;Cytoplasm;Hydrolase;Metal-binding;Nucleus;Reference proteome;Zinc			GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0008334; GO:0031124; GO:0046872; GO:1900087		12690205; 15489334; 21406692; 30507380	Metallo-beta-lactamase superfamily, Glyoxalase II family
A4D2B8	PM2P1_HUMAN	Putative postmeiotic segregation increased 2-like protein 1 (PMS2-related protein 2) (Postmeiotic segregation increased 2-like protein 13) (Postmeiotic segregation increased 2-like protein 6) (Postmeiotic segregation increased 2-like protein 8) (Postmeiotic segregation increased protein 3, hPMS3) (Postmeiotic segregation increased protein 8) (Putative postmeiotic segregation increased 2 pseudogene 1)	PMS2P1 PMS2L1 PMS2L13 PMS2L6 PMS2L8 PMS3 PMS8 PMSR2	440	9606			Alternative splicing;Kinase;Reference proteome;Transferase		TISSUE SPECIFICITY: Highly expressed in kidney, spleen, adrenal gland, ovary and cerebellum and to a lower extent in liver, esophagus, stomach, duodenum, colon, bladder, uterus, lung, pancreas and cerebrum. Not expressed in heart. {ECO:0000269|PubMed:10101297}.	GO:0006298; GO:0016301; GO:0016446; GO:0016887; GO:0032300; GO:0032389		8586419; 12690205; 10101297; 15489334; 7980603	DNA mismatch repair MutL/HexB family
A4GXA9	EME2_HUMAN	Probable crossover junction endonuclease EME2, EC 3.1.22.-	EME2	379	9606		3.1.22.-	Alternative splicing;DNA damage;DNA recombination;DNA repair;Endonuclease;Hydrolase;Nuclease;Nucleus;Reference proteome	Q96NY9		GO:0000712; GO:0003677; GO:0004519; GO:0006302; GO:0031297; GO:0031573; GO:0043596; GO:0048476; GO:1905347		17289582; 12693554; 11157797	EME1/MMS4 family
A4UGR9	XIRP2_HUMAN	Xin actin-binding repeat-containing protein 2 (Beta-xin) (Cardiomyopathy-associated protein 3) (Xeplin)	XIRP2 CMYA3	3374	9606			3D-structure;Actin-binding;Alternative splicing;Cell junction;Coiled coil;Phosphoprotein;Reference proteome;Repeat			GO:0003281; GO:0007015; GO:0030018; GO:0030054; GO:0045216; GO:0051015; GO:0051393; GO:0055008		14702039; 15815621; 15489334; 15454575; 17974005; 26566883	Xin family
A5D8T8	CL18A_HUMAN	C-type lectin domain family 18 member A (Mannose receptor-like protein 2)	CLEC18A MRLP2	446	9606			Alternative splicing;Disulfide bond;EGF-like domain;Endoplasmic reticulum;Endosome;Glycoprotein;Golgi apparatus;Lectin;Reference proteome;Secreted;Signal	Q6UY14-3; A8MQ03; Q15323; O76011; Q6A162; Q7Z3S9	TISSUE SPECIFICITY: Dectected in all cell lines tested and in peripheral blood cells. {ECO:0000269|PubMed:26170455}.	GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0030247	PTM: N-glycosylated. {ECO:0000269|PubMed:26170455}.	14702039; 15616553; 15489334; 26170455	
A5D8V6	VP37C_HUMAN	Vacuolar protein sorting-associated protein 37C, hVps37C (ESCRT-I complex subunit VPS37C)	VPS37C PML39	355	9606			Endosome;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport	Q4LEZ3; Q8NFV4-4; Q9NQ33; O95429; Q96CA5; Q6P1W5; Q53EZ4; O43186; Q15038; O75935-2; P35638; P35638-2; Q8WWB3; O00167-2; Q92567; A1KXE4-2; B7ZLH0; O94868-3; Q12951-2; Q96AE4-2; Q08379; Q13227; P62993; Q96CS2; A0A087WSW0; O14964; P52597; Q9BUJ2; Q12906-6; Q13351; Q7Z3Y8; Q14525; Q3LI76; Q3LI72; Q3LI70; Q3SYF9; Q3LI64; Q3LI66; Q8IUC3; Q14657; Q14847-2; Q8NDC0; Q8N6F8; Q96HA8; Q7Z3B4; Q7Z4N8; P55771; O75340; Q9UBV8; P55347; Q96I87; Q96KN3; O15496; Q58EX7; O15162; P52435; Q9H1A7; Q16633; P86480; P25788; Q9BTL3; Q93062; Q93062-3; Q6ZRY4; Q8HWS3; Q8N443; Q6NUQ1; Q9NQG5; Q01196-8; Q6FGM0; Q99961; Q8TEC5; O94875; O94875-10; O60504; Q99932-2; O75886; Q8IWL8; Q9Y6A5; Q7Z6R9; Q92734; Q9UBB9; Q01085-2; Q08117; Q08117-2; Q86WV8; Q99816; Q5T6F2; Q6NVU6; Q9NZC7-5; O00308; P98170; Q9BYJ9; Q9UDW3; Q9H0C1; G4XUV3		GO:0000813; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0048306; GO:0070062	PTM: Phosphorylated by TBK1. {ECO:0000269|PubMed:21270402}.	17974005; 16554811; 15489334; 15509564; 18005716; 17853893; 21269460; 21270402; 22405001	VPS37 family
A5D8V7	ODAD3_HUMAN	Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151)	ODAD3 CCDC151	595	9606			Alternative splicing;Cell projection;Ciliopathy;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Kartagener syndrome;Primary ciliary dyskinesia;Reference proteome	P22607; Q53GS7; P06396; P01112; O60341; O14901; Q2M2I5; Q7Z3Y8; Q5JR59-3; Q7Z6G3-2; Q96M63; Q15276; Q7Z699; O43463; Q9UBB9; Q8N3L3; Q9UMX0; Q8N6Y0; Q7Z6G3-2; Q96M63; Q9UBB9; Q8N3L3		GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0036064; GO:0036158; GO:1902017		14702039; 15057824; 15489334; 25192045; 25224326	
A5D8W1	CFA69_HUMAN	Cilia- and flagella-associated protein 69	CFAP69 C7orf63	941	9606			Alternative splicing;Cell projection;Cilium;Differentiation;Flagellum;Olfaction;Reference proteome;Sensory transduction;Spermatogenesis		TISSUE SPECIFICITY: Highly expressed in the testis, specifically in sperm (at protein level) (PubMed:29606301). Expressed in the brain, kidney, liver, lung, and intestine (PubMed:29606301). {ECO:0000269|PubMed:29606301}.	GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834		14702039; 12853948; 15489334; 29606301	
A5LHX3	PSB11_HUMAN	Proteasome subunit beta type-11, EC 3.4.25.1 (Proteasome subunit beta-5t)	PSMB11	300	9606		3.4.25.1	Cytoplasm;Hydrolase;Nucleus;Protease;Proteasome;Reference proteome;Threonine protease;Zymogen	Q9H1Y0; O14964; P78337; O75360; O43711		GO:0004175; GO:0004298; GO:0005634; GO:0005829; GO:0005839; GO:0006508; GO:0008233; GO:0010498; GO:0019774; GO:0033077; GO:0043374		17540904; 12508121	Peptidase T1B family
A5PKW4	PSD1_HUMAN	PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6, Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1)	PSD EFA6 EFA6A KIAA2011 PSD1 TYL	1024	9606			Alternative splicing;Cell membrane;Cell projection;Coiled coil;Guanine-nucleotide releasing factor;Membrane;Phosphoprotein;Reference proteome	P70398	TISSUE SPECIFICITY: Isoform 2 is expressed in the brain. {ECO:0000269|PubMed:9417912}.	GO:0005085; GO:0005543; GO:0007165; GO:0031175; GO:0032012; GO:0032154; GO:0032587; GO:0043197; GO:0098999; GO:0099092		9417912; 15164054; 15489334; 23603394	PSD family
A5PLL7	PDES1_HUMAN	Plasmanylethanolamine desaturase, EC 1.14.19.77 (Plasmanylethanolamine desaturase 1) (Transmembrane protein 189)	PEDS1 KUA PDES TMEM189	270	9606	PATHWAY: Lipid metabolism; fatty acid metabolism. {ECO:0000269|PubMed:31604315}.	1.14.19.77	Alternative splicing;Endoplasmic reticulum;Fatty acid metabolism;Lipid metabolism;Membrane;Oxidoreductase;Reference proteome;Transmembrane;Transmembrane helix	P13473-2; Q9Y371		GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0016021; GO:0016491; GO:0050207		11076860; 11280764; 14702039; 11780052; 15489334; 21269460; 31604315; 32209662	Fatty acid desaturase CarF family
A5PLN9	TPC13_HUMAN	Trafficking protein particle complex subunit 13	TRAPPC13 C5orf44	417	9606			Alternative splicing;Reference proteome	O43617; Q9Y2L5		GO:0005737; GO:0005829; GO:0006888; GO:0006901; GO:0099022; GO:1990071; GO:1990072		17974005; 14702039; 15372022; 15489334; 21453443	TRAPPC13 family
A5X5Y0	5HT3E_HUMAN	5-hydroxytryptamine receptor 3E, 5-HT3-E, 5-HT3E (Serotonin receptor 3E)	HTR3E	456	9606			Alternative splicing;Cell membrane;Disulfide bond;Glycoprotein;Ion channel;Ion transport;Ligand-gated ion channel;Membrane;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix;Transport	P46098; P46098	TISSUE SPECIFICITY: Expressed in adult colon and intestine. {ECO:0000269|PubMed:12801637, ECO:0000269|PubMed:14597179}.	GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0098662; GO:1904602		12801637; 14597179; 17392525; 19012743; 16641997; 15489334	Ligand-gated ion channel (TC 1.A.9) family, 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily, HTR3E sub-subfamily
A5YKK6	CNOT1_HUMAN	CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog, NOT1H, hNOT1)	CNOT1 CDC39 KIAA1007 NOT1 AD-005	2376	9606			3D-structure;Alternative splicing;Autism spectrum disorder;Cytoplasm;Developmental protein;Disease variant;Holoprosencephaly;Mental retardation;Nucleus;Phosphoprotein;Reference proteome;Repressor;RNA-mediated gene silencing;Transcription;Transcription regulation;Translation regulation	Q3ZCQ2; Q9UKZ1; Q9NZN8; O75175; Q9ULM6; Q96LI5; Q9UIV1; Q9UFF9; Q86TB9; Q8NDV7; Q9UPQ9; Q9HCJ0; P50616; P22893; P26651	TISSUE SPECIFICITY: Strongly expressed in brain, heart, thymus, spleen, kidney, liver, placenta and lung. Weakly expressed in skeletal muscle and colon. {ECO:0000269|PubMed:10637334}.	GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036		17974005; 15616553; 15489334; 10231032; 12168954; 10931946; 10637334; 16778766; 18377426; 19558367; 21269460; 21981923; 21984185; 21278420; 21976065; 22367759; 23186163; 26027925; 27558897; 27342281; 32354837; 22977175; 23644599; 26489469; 31006513; 31006510; 32553196	CNOT1 family
A5YM72	CRNS1_HUMAN	Carnosine synthase 1, EC 6.3.2.11 (ATP-grasp domain-containing protein 1)	CARNS1 ATPGD1 KIAA1394	827	9606		6.3.2.11	Alternative splicing;ATP-binding;Ligase;Magnesium;Manganese;Metal-binding;Nucleotide-binding;Reference proteome			GO:0005524; GO:0005829; GO:0006548; GO:0016887; GO:0035499; GO:0046872; GO:0047730; GO:0102102		10718198; 14702039; 16554811; 15489334; 20097752	
A6BM72	MEG11_HUMAN	Multiple epidermal growth factor-like domains protein 11, Multiple EGF-like domains protein 11	MEGF11 KIAA1781 UNQ1949/PRO4432	1044	9606			Alternative splicing;Cell membrane;Disulfide bond;EGF-like domain;Glycoprotein;Membrane;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	Q7Z417		GO:0010842; GO:0016021; GO:0016323; GO:0034109		11347906; 12975309; 16572171; 15489334; 17974005; 17498693	MEGF family
A6H8Y1	BDP1_HUMAN	Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150, TFIIIB150) (Transcription factor-like nuclear regulator)	BDP1 KIAA1241 KIAA1689 TFNR	2624	9606			3D-structure;Activator;Alternative splicing;Coiled coil;Deafness;Non-syndromic deafness;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation		TISSUE SPECIFICITY: Isoform 2 is highly expressed in cerebellum. {ECO:0000269|PubMed:11161782}.	GO:0000126; GO:0001156; GO:0005654; GO:0070898	PTM: Phosphorylated by CSNK2A1 during mitosis, resulting in its release from chromatin and suppression of polymerase III transcription. {ECO:0000269|PubMed:15469824}.	11040218; 11161782; 10574462; 11214970; 12168954; 17974005; 15372022; 15489334; 14702039; 11121026; 14592981; 15096501; 15469824; 16542149; 16769183; 16956891; 18669648; 24312468	
A6H8Z2	F221B_HUMAN	Protein FAM221B	FAM221B C9orf128	402	9606			Alternative splicing;Reference proteome	X5D778; Q8IYE1; A8MQ03; Q5JST6; O15499; Q5T749; Q92764; P60410; P52954; Q5TA81; Q9BRK4; Q9NRY7; Q86XT4; G5E9A7; P02545; Q7Z699				17974005; 15164053; 15489334	FAM221 family
A6NC98	CC88B_HUMAN	Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3, HkRP3)	CCDC88B BRLZ	1476	9606			Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Endoplasmic reticulum;Golgi apparatus;Membrane;Phosphoprotein;Reference proteome;Stress response	Q9BXY8; Q9NX04; Q9H257-2; Q8TD31-3; Q07002; Q2TBE0; Q9H4E7; O60941-5; Q9NQT4; Q3B820; Q96MY7; P55040; P08631-2; P09067; Q96AA8; Q63ZY3; P20700; Q03252; P25800; Q8TBB1; Q9Y5B8; Q13526; Q6NYC8; Q15311; Q9Y580; Q6NUQ1; Q9H788; Q96B97; Q9NU19; Q9Y228; Q99816; Q9BZW7; Q3SY00; Q9NRE2; Q8N3L3; O75604; Q53FD0-2	TISSUE SPECIFICITY: Expressed in endothelium (at protein level) (PubMed:21289099). Expressed in NK cells (at protein level) (PubMed:25762780). {ECO:0000269|PubMed:21289099, ECO:0000269|PubMed:25762780}.	GO:0001819; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0008017; GO:0016020; GO:0030705; GO:0031122; GO:0042102; GO:0042832; GO:0050870; GO:0051959		11230166; 12693554; 14702039; 16554811; 15489334; 19690332; 21289099; 23186163; 24275569; 25762780	CCDC88 family
A6NCS4	NKX26_HUMAN	Homeobox protein Nkx-2.6 (Homeobox protein NK-2 homolog F)	NKX2-6 NKX2F	301	9606			Activator;Developmental protein;Disease variant;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation			GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008284; GO:0021854; GO:0030154; GO:0035050; GO:0043066; GO:0043586; GO:0045944; GO:0048565; GO:0055014; GO:0055015; GO:0060037; GO:0060039		16421571; 15146197; 15649947; 25195019; 24421281; 25380965	NK-2 homeobox family
A6ND01	JUNO_HUMAN	Sperm-egg fusion protein Juno (Folate receptor 4) (Folate receptor delta, FR-delta) (IZUMO1 receptor protein JUNO)	IZUMO1R FOLR4 JUNO	250	9606			3D-structure;Alternative splicing;Cell membrane;Disulfide bond;Fertilization;Glycoprotein;GPI-anchor;Lipoprotein;Membrane;Receptor;Reference proteome;Signal	Q8IYV9-1		GO:0005576; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0031362; GO:0035036; GO:0038023	PTM: The protein is rapidly cleaved following fertilization, being only weakly detectable in zona-intact fertilized eggs at telophase II and undetectable at the pronuclear stage. Sheding is probably required to block to polyspermy and ensuring egg fusion with a single sperm. {ECO:0000250|UniProtKB:Q9EQF4}.	16554811; 24739963; 27309818; 27309808	Folate receptor family
A6ND36	FA83G_HUMAN	Protein FAM83G (Protein associated with SMAD1)	FAM83G PAWS1	823	9606			Acetylation;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome	P48729		GO:0005634; GO:0005829; GO:0007165; GO:0019901; GO:0030509	PTM: BMP signaling induces the phosphorylation of PAWS1 by BMPR1A at Ser-610, Ser-614 and Ser-616. In response to BMP phosphorylation at Ser-610 is necessary for the activation of SMAD4-independent BMP target genes such as NEDD9 and ASNS. {ECO:0000269|PubMed:24554596}.	14702039; 16625196; 15489334; 16964243; 18220336; 18669648; 21406692; 23186163; 24275569; 24554596; 26477546	FAM83 family
A6NDB9	PALM3_HUMAN	Paralemmin-3	PALM3	673	9606			ATP-binding;Cell membrane;Coiled coil;Cytoplasm;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Palmitate;Phosphoprotein;Prenylation;Reference proteome;Repeat	Q6IA17		GO:0001960; GO:0005524; GO:0005737; GO:0005886; GO:0008063; GO:0008360; GO:0032496	PTM: Palmitoylated on Cys-667 and Cys-669 and prenylated on Cys-670; which is required for membrane association. {ECO:0000250}.	15057824; 17525332; 21187075; 21406692; 23186163; 24275569	Paralemmin family
A6NDE4	RBY1B_HUMAN	RNA-binding motif protein, Y chromosome, family 1 member B	RBMY1B	496	9606			mRNA processing;mRNA splicing;Nucleus;Reference proteome;RNA-binding		TISSUE SPECIFICITY: Testis-specific.	GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0006397; GO:0007283; GO:0008380; GO:0008584; GO:0048026		12815422	
A6NDG6	PGP_HUMAN	Glycerol-3-phosphate phosphatase, G3PP, EC 3.1.3.21 (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase, AUM, EC 3.1.3.48) (Phosphoglycolate phosphatase, PGP)	PGP	321	9606		3.1.3.21; 3.1.3.48	Carbohydrate metabolism;Hydrolase;Magnesium;Metal-binding;Protein phosphatase;Reference proteome		TISSUE SPECIFICITY: Detected in all tissues including red cells, lymphocytes and cultured fibroblasts (at protein level). The highest activities occur in skeletal muscle and cardiac muscle. {ECO:0000269|PubMed:215071}.	GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0006114; GO:0006650; GO:0008967; GO:0016311; GO:0016791; GO:0035335; GO:0043136; GO:0045721; GO:0098519		15616553; 215071; 21269460; 26755581	HAD-like hydrolase superfamily, CbbY/CbbZ/Gph/YieH family
A6NDV4	TMM8B_HUMAN	Transmembrane protein 8B (Nasopharyngeal carcinoma-associated gene 6 protein) (Protein NAG-5) (Protein NGX6)	TMEM8B C9orf127 NGX6	472	9606			Alternative splicing;Cell adhesion;Cell membrane;Cytoplasm;Disulfide bond;EGF-like domain;Endoplasmic reticulum;Glycoprotein;Growth regulation;Membrane;Mitochondrion;Nucleus;Reference proteome;Transmembrane;Transmembrane helix			GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0007160; GO:0007346; GO:0009986; GO:0016021; GO:0040008	PTM: Isoform 2 is N-glycosylated. {ECO:0000269|PubMed:15498789}.	11565907; 14702039; 15164053; 15489334; 15498789; 15723283; 17641538; 17270023	TMEM8 family
A6NED2	RCCD1_HUMAN	RCC1 domain-containing protein 1	RCCD1	376	9606			3D-structure;Chromatin regulator;Chromosome;Hydroxylation;Reference proteome;Repeat	Q8N371		GO:0005694; GO:0005829; GO:0005886; GO:0006325	PTM: Specifically hydroxylated (with R stereochemistry) at C-3 of ARG-141 by KDM8. {ECO:0000269|PubMed:29563586}.	16572171; 15489334; 21269460; 24981860; 28455245; 28982940; 29563586	
A6NEM1	GG6L9_HUMAN	Golgin subfamily A member 6-like protein 9	GOLGA6L9 GOLGA6L20	432	9606			Alternative splicing;Coiled coil;Reference proteome	X5D778; Q9BRR9; Q8IXJ9; O75348; Q8N5M1; Q5T686; P46379-2; Q8TBE0; Q8N9N5-2; A8KA13; Q7RTU4; Q13895; Q9NX04; Q8WYQ4-2; P01024; Q9NPB3; Q7Z7H3; Q969G5; Q9HC52; Q8IYX3; Q96HB5; Q8IYE0; Q8N715; Q8TD31-3; Q16543; Q6P1J9; Q07002; Q9P209; Q96GE4; Q8NE01; Q2TBE0; Q9UER7; Q9H4E7; Q6IQ26; P17661; Q92608; Q92785; Q9BV47; Q96JC9; O15371; Q9H0I2; Q6NZ36-4; O95990-4; Q9BQ89; Q3B820; Q96MY7; Q9NVF7; Q9BSK4; Q4VC44; Q16595; Q8TAE8; Q8NHY3; P55040; Q9BZE0; O95872; Q00403; Q9GZV7; P02008; P56524-2; Q8WUI4-6; O14964; P09067; P17482; P31273; Q14005-2; Q9C086; Q9H1K1; Q8N9B5-2; O75564-2; Q63ZY3; Q7L273; Q6PF15; P04264; O95678; Q14657; Q96BZ8; P56470; Q8TAP4-4; P61968; Q96S90; Q8TC57; Q9Y586; O95983-2; Q8NHZ7; P55081; Q8IVT4; Q9BU76; P00540; Q9Y3B7; Q8TDC0; Q15742; Q9BU61; Q6X4W1-2; Q96HA8; Q9UBU9; Q9NPJ8-3; Q13415; Q9HBE1-4; Q9Y5E9; O43189; Q13526; Q16512; Q96PV4; Q9UGP5-2; O15160; P78424; Q6NYC8; O43741; Q99633; Q8WWY3; Q6NUJ5; Q86VV4; A6NK89; Q13671; P04808; Q9H2S5; Q15287; Q14D33; P57086; Q9BWG6; Q9H788; Q92529; Q9GZT3; Q9NSI2; Q96GM5; Q969G3; O95863; O60225-2; Q96FJ0; O00506; P51687; O43463; Q9H5I1-2; Q9BSH4; Q9Y2I9-2; Q8N8B7-2; Q15561; Q9BT49; Q5JTD0; Q08117-2; O43711; P62328; Q8N7U7-2; Q9Y228; Q9BUZ4; Q14142; Q7Z6J9; P43897; Q3SY00; Q9UJ04; Q5W5X9-3; Q99757; P29597; P57075-2; Q8N7F7; P0CB47; Q8N6Y0; O75604; Q14119; Q64LD2-2; Q05516; O43167; Q15911-2; Q6P2D0; Q8N5A5-2; Q9BRR0; Q96NC0; Q15973; Q12901; P49910; P17021; P17024; O95201; Q9UIE0; P15622-3; O43296; P17041; Q86UD4; P13682; Q86VK4-3; Q96IQ9; Q8TAU3; Q7Z4V0; Q8N0Y2-2; Q9NWS9-2; Q96JC4; Q96MX3; Q9ULM2; Q6ZNH5; Q96C55; Q9H707; Q8N988-2; Q6ZN55-2; Q96N58; Q9UK33; Q9P0T4; Q96SQ5; Q96NL3; Q9P2J8; Q5EBL2; Q9UEG4; Q5T619; Q96BR6; Q9H7X3; Q96H86; A8K8V0; Q3KQV3; P51504; Q9Y2P0; Q96EG3; Q08AG5; O43257; Q3MJ62; Q16670; PRO_0000449631 [P0DTD1]; PRO_0000449633 [P0DTD1]				16572171; 15489334	GOLGA6 family
A6NFA1	TIKI2_HUMAN	Metalloprotease TIKI2, EC 3.4.-.- (Heart, kidney and adipose-enriched transmembrane protein homolog) (TRAB domain-containing protein 2B)	TRABD2B HKAT TIKI2	517	9606		3.4.-.-	Cell membrane;Glycoprotein;Hydrolase;Membrane;Metal-binding;Metalloprotease;Protease;Reference proteome;Signal;Transmembrane;Transmembrane helix;Wnt signaling pathway	P27467		GO:0004222; GO:0005887; GO:0006508; GO:0016020; GO:0016055; GO:0017147; GO:0030178; GO:0031301; GO:0031334; GO:0046872; GO:1904808		22726442; 16710414	TIKI family
A6NFQ2	TCAF2_HUMAN	TRPM8 channel-associated factor 2 (TRP channel-associated factor 2)	TCAF2 FAM115C FAM139A	919	9606			Alternative splicing;Cell membrane;Membrane;Reference proteome;Transport		TISSUE SPECIFICITY: Isoform 2 is expressed in the prostate and in cancerous prostate samples. {ECO:0000269|PubMed:25559186}.	GO:0005886; GO:0010359; GO:0010360; GO:0030054; GO:0030335; GO:0044325; GO:0090314		14702039; 12853948; 12690205; 15489334; 12693554; 25559186	TCAF family
A6NFX1	MFS2B_HUMAN	Sphingosine-1-phosphate transporter MFSD2B (Major facilitator superfamily domain-containing protein 2B, hMfsd2b)	MFSD2B	504	9606			Cell membrane;Lipid transport;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport			GO:0005887; GO:0006869; GO:0008643; GO:0015293; GO:0046624; GO:0071702; GO:1901731		15815621; 18694395; 29045386; 29563527	Major facilitator superfamily
A6NFY7	SDHF1_HUMAN	Succinate dehydrogenase assembly factor 1, mitochondrial, SDH assembly factor 1, SDHAF1 (LYR motif-containing protein 8)	SDHAF1 LYRM8	115	9606			Chaperone;Disease variant;Mitochondrion;Primary mitochondrial disease;Reference proteome;Repeat	Q9UHD4; Q8IWL3; Q7Z3Y8; P21912	TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:19465911}.	GO:0005654; GO:0005739; GO:0005759; GO:0034553		15057824; 15489334; 25944712; 24954417; 19465911; 22995659; 26642834; 26749241	Complex I LYR family, SDHAF1 subfamily
A6NGG8	PCARE_HUMAN	Photoreceptor cilium actin regulator	PCARE C2orf71	1288	9606			3D-structure;Cell projection;Ciliopathy;Cilium;Disease variant;Lipoprotein;Myristate;Palmitate;Reference proteome;Retinitis pigmentosa;Sensory transduction;Vision		TISSUE SPECIFICITY: Specifically expressed in retina. {ECO:0000269|PubMed:20398884}.	GO:0001750; GO:0001917; GO:0005929; GO:0007601; GO:0035845; GO:0050896; GO:1903546		15815621; 14702039; 20398884; 20398886; 21412943; 28837730; 24780881	
A6NGQ2	OOEP_HUMAN	Oocyte-expressed protein homolog (KH homology domain-containing protein 2) (Oocyte- and embryo-specific protein 19, hOEP19)	OOEP C6orf156 KHDC2 OEP19	149	9606			Cytoplasm;Nucleus;Reference proteome	Q9NYB9-2; P09917; Q9NX04; Q9H0I2; Q9HAQ2; Q17RB8; Q96HA8; P14678-2; Q8N8B7-2		GO:0003723; GO:0005634; GO:0005737; GO:0005938; GO:0007015; GO:0009880; GO:0031297; GO:0032880; GO:0032991; GO:0035088; GO:0045179; GO:0045836; GO:0051293; GO:0051302; GO:0070201; GO:0106333; GO:1905168; GO:2000781		14574404; 17913455; 26537248; 25542835	KHDC1 family
A6NGU5	GGT3_HUMAN	Putative glutathione hydrolase 3 proenzyme, EC 3.4.19.13 (Gamma-glutamyltransferase 3) (Putative gamma-glutamyltranspeptidase 3, GGT 3, EC 2.3.2.2) [Cleaved into: Putative glutathione hydrolase 3 heavy chain; Putative glutathione hydrolase 3 light chain ]	GGT3P GGT3	568	9606	PATHWAY: Sulfur metabolism; glutathione metabolism. {ECO:0000250|UniProtKB:P19440}.	2.3.2.2; 3.4.19.13	Acyltransferase;Glutathione biosynthesis;Glycoprotein;Hydrolase;Membrane;Protease;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix;Zymogen			GO:0002682; GO:0005886; GO:0006750; GO:0006751; GO:0016021; GO:0031179; GO:0036374; GO:0050727; GO:0070062; GO:0102953; GO:0103068; GO:1901750	PTM: Cleaved by autocatalysis into a large and a small subunit. {ECO:0000250|UniProtKB:P19440}.	10591208; 18357469	Gamma-glutamyltransferase family
A6NHR9	SMHD1_HUMAN	Structural maintenance of chromosomes flexible hinge domain-containing protein 1, SMC hinge domain-containing protein 1, EC 3.6.1.-	SMCHD1 KIAA0650	2005	9606		3.6.1.-	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Chromosome;Direct protein sequencing;Disease variant;DNA damage;DNA repair;DNA-binding;Hydrolase;Hypogonadotropic hypogonadism;Isopeptide bond;Kallmann syndrome;Microphthalmia;Phosphoprotein;Reference proteome;Ubl conjugation	Q5T3J3		GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0009048; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0060820; GO:2000042; GO:2001034	PTM: Sumoylated with SUMO1. {ECO:0000250|UniProtKB:Q6P5D8}.	14702039; 16177791; 17974005; 9734811; 15489334; 19413330; 19608861; 21269460; 23186163; 23542155; 25294876; 24790221; 25218447; 28112733; 23143600; 24075187; 24128691; 25370034; 25256356; 27059856; 28067909; 28067911; 29748383	SMC family
A6NI15	MSGN1_HUMAN	Mesogenin-1 (Paraxial mesoderm-specific mesogenin1) (pMesogenin1, pMsgn1)	MSGN1	193	9606			Developmental protein;Differentiation;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation	Q10567-3; A0A0C4DG94; Q6PJG6; P0C7W6; P78358; O14645; Q9UPT5-1; P54257; P41134; Q02363; Q02535; P24592; Q13352; O95751; P43360; P13349; P24844-2; Q7Z6G3-2; P0C6T2; Q9UJW9; Q99081-3; P15884-3; Q96N21; Q9BXU0; Q13077; Q6PF05; Q9H0C1; O95229		GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001707; GO:0001756; GO:0003682; GO:0005634; GO:0006357; GO:0007379; GO:0030154; GO:0046983; GO:1990837		15815621	
A6NI61	MYMK_HUMAN	Protein myomaker (Myoblast fusion maker) (Transmembrane protein 226) (Transmembrane protein 8C)	MYMK TMEM226 TMEM8C	221	9606			Cell membrane;Disease variant;Golgi apparatus;Lipoprotein;Membrane;Myogenesis;Palmitate;Reference proteome;Transmembrane;Transmembrane helix			GO:0005886; GO:0005887; GO:0007517; GO:0007520; GO:0014905; GO:0030173; GO:0045026; GO:1904206	PTM: Palmitoylated at the C-terminus; palmitoylation promotes localization to the Golgi apparatus. {ECO:0000250|UniProtKB:Q9D1N4}.	15164053; 28681861; 30065953	TMEM8 family
A6NI73	LIRA5_HUMAN	Leukocyte immunoglobulin-like receptor subfamily A member 5 (CD85 antigen-like family member F) (Immunoglobulin-like transcript 11, ILT-11) (Leukocyte immunoglobulin-like receptor 9, LIR-9) (CD antigen CD85f)	LILRA5 ILT11 LILRB7 LIR9	299	9606			3D-structure;Alternative splicing;Cell membrane;Disulfide bond;Glycoprotein;Immunity;Immunoglobulin domain;Innate immunity;Membrane;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed mostly in tissues of the hematopoietic system, including bone marrow, spleen, lymph node and peripheral leukocytes. Among leukocytes, monocytes and neutrophils express the highest level. Expressed in CD14+ monocytes, but not in T-cells, B-cells or natural killer (NK) cells (at protein level). {ECO:0000269|PubMed:12393390}.	GO:0005576; GO:0005615; GO:0005886; GO:0009986; GO:0016021; GO:0019221; GO:0032396; GO:0032695; GO:0032696; GO:0032731; GO:0032733; GO:0032755; GO:0032760; GO:0043410; GO:0045087; GO:0050729; GO:0050867; GO:0051928; GO:0061098		10941842; 12393390; 15057824; 16675463	
A6NIH7	U119B_HUMAN	Protein unc-119 homolog B	UNC119B	251	9606			3D-structure;Acetylation;Cell projection;Cilium;Cilium biogenesis/degradation;Lipid-binding;Protein transport;Reference proteome;Transport			GO:0005829; GO:0005929; GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271		14702039; 16541075; 15489334; 19608861; 21269460; 22085962; 22814378; 24275569	PDE6D/unc-119 family
A6NIX2	WTIP_HUMAN	Wilms tumor protein 1-interacting protein, WT1-interacting protein	WTIP	430	9606			Cell junction;Cilium biogenesis/degradation;Cytoplasm;LIM domain;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;RNA-mediated gene silencing;Transcription;Transcription regulation;Zinc	Q9H9G7; Q14160		GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0022604; GO:0030030; GO:0035195; GO:0035331; GO:0046872; GO:2000637		15057824; 20303269; 20086015; 20616046; 21834987; 22286099	Zyxin/ajuba family
A6NJ46	NKX63_HUMAN	Homeobox protein Nkx-6.3	NKX6-3	265	9606			Alternative splicing;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation			GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001709; GO:0002067; GO:0005634; GO:0006357; GO:0030154; GO:0030857; GO:0043565; GO:0045944; GO:1990837		14702039; 16421571	
A6NJ78	MET15_HUMAN	12S rRNA N4-methylcytidine (m4C) methyltransferase, 12S rRNA m4C methyltransferase, EC 2.1.1.- (Methyltransferase 5 domain-containing protein 1) (Methyltransferase-like protein 15)	METTL15 METT5D1	407	9606		2.1.1.-	Alternative splicing;Methyltransferase;Mitochondrion;Phosphoprotein;Reference proteome;S-adenosyl-L-methionine;Transferase;Transit peptide	P55212; Q96AQ7; P33240; G5E9A7; P41091; Q9NW38; Q0VDC6; Q8IVS8; P31273; P13473-2; O60336; Q8IXL7-2; Q9HC98-4; Q9UBV8; O75360; P62826; P49591; Q99932-2; Q7Z699; Q15645; Q8N6Y0; Q08AM6		GO:0005759; GO:0070475; GO:0071424		14702039; 16554811; 15489334; 23186163; 31665743; 32371392	Methyltransferase superfamily, RsmH family
A6NK06	IRG1_HUMAN	Cis-aconitate decarboxylase, CAD, EC 4.1.1.6 (Aconitate decarboxylase) (Aconitate decarboxylase 1) (Cis-aconitic acid decarboxylase) (Immune-responsive gene 1 protein)	ACOD1 IRG1	481	9606		4.1.1.6	3D-structure;Antimicrobial;Immunity;Inflammatory response;Innate immunity;Lyase;Mitochondrion;Reference proteome		TISSUE SPECIFICITY: Expressed in LPS-tolerized macrophages (at protein level). Expressed in peripheral blood mononuclear cells (PBMCs), microglia and macrophage cells. {ECO:0000269|PubMed:23609450, ECO:0000269|PubMed:23610393}.	GO:0002760; GO:0005739; GO:0006952; GO:0006954; GO:0007566; GO:0032088; GO:0032480; GO:0034136; GO:0034144; GO:0035458; GO:0045824; GO:0047613; GO:0050728; GO:0051607; GO:0071219; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0071393; GO:0072573; GO:2000379		15057823; 23609450; 23610393	PrpD family
A6NK58	LIPT2_HUMAN	Putative lipoyltransferase 2, mitochondrial, EC 2.3.1.181 (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)	LIPT2	231	9606	PATHWAY: Protein modification; protein lipoylation via endogenous pathway; protein N(6)-(lipoyl)lysine from octanoyl-[acyl-carrier-protein]: step 1/2.	2.3.1.181	Acyltransferase;Disease variant;Ligase;Mitochondrion;Reference proteome;Transferase;Transit peptide			GO:0005739; GO:0005759; GO:0009249; GO:0016874; GO:0019752; GO:0033819; GO:0102555; GO:2000376		16554811; 28757203; 28628643	LipB family
A6NK89	RASFA_HUMAN	Ras association domain-containing protein 10	RASSF10	507	9606			Coiled coil;Cytoplasm;Cytoskeleton;Neurogenesis;Reference proteome	Q96A05; Q9Y3M2; Q8IYX3; G5E9W6; Q86XR8-3; Q8NHQ1; Q9UHF1; Q8N9N8; Q9BQ89; Q5VUB5; O95257; Q9P2W3; A6NEM1; O95751; P43360; Q9NPJ8-3; Q9H0W8; Q2TAY7; Q15561; P19429; Q05BL1; Q9BYV2; O96014	TISSUE SPECIFICITY: Expressed in brain. Tends to be down-regulated in astrocytic gliomas due to promoter methylation. Methylation occurs early in gliomagenesis and the extent of methylation parallels with higher glioma grades, so that methylation is observed in close to 70% WHO grade IV primary glioblastomas, but not in grade I astrocytomas. {ECO:0000269|PubMed:20956940}.	GO:0000922; GO:0005815; GO:0005829; GO:0007165; GO:0050769; GO:2000179		16554811; 18272789; 20956940	
A6NKB5	PCX2_HUMAN	Pecanex-like protein 2 (Pecanex homolog protein 2)	PCNX2 KIAA0435 PCNXL2	2137	9606			Alternative splicing;Glycoprotein;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q8WTS1; Q9P0S3; Q9BRI3		GO:0016021		9455477; 14702039; 16710414; 15489334; 12140758; 14507650	Pecanex family
A6NL88	SHSA7_HUMAN	Protein shisa-7 (Cystine-knot AMPAR modulating protein of 59 kDa, CKAMP59) (GABA(A) receptor auxiliary subunit Shisa7) (Protein shisa-6-like)	SHISA7	538	9606			Cell junction;Cell membrane;Glycoprotein;Membrane;Phosphoprotein;Postsynaptic cell membrane;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix			GO:0007214; GO:0007613; GO:0014069; GO:0032281; GO:0032591; GO:0035255; GO:0045211; GO:0048172; GO:0050811; GO:0097112; GO:0098839; GO:0098962; GO:0098985; GO:0099060; GO:0106040; GO:1900273; GO:1904717; GO:2000311		15057824	Shisa family
A6NMY6	AXA2L_HUMAN	Putative annexin A2-like protein (Annexin A2 pseudogene 2) (Lipocortin II pseudogene)	ANXA2P2 ANX2L2 ANX2P2 LPC2B	339	9606			Acetylation;Annexin;Basement membrane;Calcium;Calcium/phospholipid-binding;Extracellular matrix;Phosphoprotein;Reference proteome;Repeat;Secreted			GO:0001786; GO:0002020; GO:0005262; GO:0005509; GO:0005544; GO:0005546; GO:0005604; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0008092; GO:0019834; GO:0031982; GO:0042470; GO:0046790; GO:0070062		2174397; 15164053	Annexin family
A6NMZ7	CO6A6_HUMAN	Collagen alpha-6(VI) chain	COL6A6	2263	9606			Alternative splicing;Cell adhesion;Collagen;Extracellular matrix;Glycoprotein;Hydroxylation;Reference proteome;Repeat;Secreted;Signal			GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0062023	PTM: Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains. {ECO:0000250}.	18276594; 16641997; 17974005; 19159218; 24275569	Type VI collagen family
A6NNB3	IFM5_HUMAN	Interferon-induced transmembrane protein 5 (Bone-restricted interferon-induced transmembrane protein-like protein, BRIL) (Dispanin subfamily A member 1, DSPA1)	IFITM5	132	9606			Cell membrane;Developmental protein;Disease variant;Lipoprotein;Membrane;Mineral balance;Osteogenesis imperfecta;Palmitate;Reference proteome;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Detected in bone (PubMed:24058703). Detected in osteoblasts and fibroblasts (at protein level) (PubMed:24519609). Detected in bone (PubMed:24058703). Detected in osteoblasts and fibroblasts (PubMed:24519609). {ECO:0000269|PubMed:24058703, ECO:0000269|PubMed:24519609}.	GO:0001701; GO:0005829; GO:0005886; GO:0005887; GO:0030282; GO:0030500; GO:0043231; GO:0060349	PTM: Palmitoylated. {ECO:0000250|UniProtKB:O88728}.	15489334; 22863190; 22363774; 24058703; 24519609	CD225/Dispanin family
A6NNM8	TTL13_HUMAN	Tubulin polyglutamylase TTLL13, EC 6.3.2.- (Tubulin tyrosine ligase like 13) (Tubulin tyrosine ligase-like family member 13 pseudogene) (Tubulin--tyrosine ligase-like protein 13)	TTLL13 TTLL13P	815	9606		6.3.2.-	Alternative splicing;ATP-binding;Coiled coil;Ligase;Magnesium;Metal-binding;Microtubule;Nucleotide-binding;Reference proteome			GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0070740		14702039; 16572171; 15489334; 25959773	Tubulin--tyrosine ligase family
A6NNY8	UBP27_HUMAN	Ubiquitin carboxyl-terminal hydrolase 27, EC 3.4.19.12 (Deubiquitinating enzyme 27) (Ubiquitin carboxyl-terminal hydrolase 22-like) (Ubiquitin thioesterase 27) (Ubiquitin-specific-processing protease 27) (X-linked ubiquitin carboxyl-terminal hydrolase 27)	USP27X USP22L USP27	438	9606		3.4.19.12	Cytoplasm;Disease variant;Hydrolase;Immunity;Innate immunity;Mental retardation;Nucleus;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway			GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0043065; GO:0050821; GO:0051607; GO:0060340; GO:0061578; GO:0070536; GO:0071108; GO:1990380		15772651; 12838346; 25644381; 31534008; 32027733	Peptidase C19 family
A6NNZ2	TBB8B_HUMAN	Tubulin beta 8B	TUBB8B	444	9606			Cytoplasm;Cytoskeleton;GTP-binding;Isopeptide bond;Microtubule;Nucleotide-binding;Phosphoprotein;Reference proteome			GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0015630; GO:0045171; GO:0070062; GO:0072686	PTM: Some glutamate residues at the C-terminus are polyglutamylated, resulting in polyglutamate chains on the gamma-carboxyl group (PubMed:26875866). Polyglutamylation plays a key role in microtubule severing by spastin (SPAST). SPAST preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity by SPAST increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold (PubMed:26875866). Glutamylation is also involved in cilia motility (By similarity). {ECO:0000250|UniProtKB:P99024, ECO:0000269|PubMed:26875866}.; PTM: Some glutamate residues at the C-terminus are monoglycylated but not polyglycylated due to the absence of functional TTLL10 in human. Monoglycylation is mainly limited to tubulin incorporated into cilia and flagella axonemes, which is required for their stability and maintenance. Flagella glycylation controls sperm motility. Both polyglutamylation and monoglycylation can coexist on the same protein on adjacent residues, and lowering glycylation levels increases polyglutamylation, and reciprocally. {ECO:0000250|UniProtKB:P07437, ECO:0000305|PubMed:19524510}.; PTM: Phosphorylated on Ser-172 by CDK1 during the cell cycle, from metaphase to telophase, but not in interphase. This phosphorylation inhibits tubulin incorporation into microtubules. {ECO:0000269|PubMed:16371510}.	16177791; 16371510; 19524510; 26875866	Tubulin family
A6PVC2	TTLL8_HUMAN	Protein monoglycylase TTLL8, EC 6.3.2.- (Tubulin--tyrosine ligase-like protein 8)	TTLL8	850	9606		6.3.2.-	Alternative splicing;ATP-binding;Cell projection;Cilium;Cytoplasm;Cytoskeleton;Flagellum;Ligase;Magnesium;Metal-binding;Microtubule;Nucleotide-binding;Reference proteome			GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0030317; GO:0036126; GO:0046872; GO:0060271; GO:0070735; GO:0070736		10591208; 17974005	
A7E2V4	ZSWM8_HUMAN	Zinc finger SWIM domain-containing protein 8	ZSWIM8 KIAA0913	1837	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:33184234, ECO:0000269|PubMed:33184237}.		Alternative splicing;Cytoplasm;Metal-binding;Phosphoprotein;Reference proteome;Ubl conjugation pathway;Zinc;Zinc-finger			GO:0005829; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:1990756; GO:2000627		10048485; 15164054; 15489334; 14702039; 18669648; 20068231; 21269460; 23186163; 24275569; 24012004; 33184234; 33184237	ZSWIM8 family
A7E2Y1	MYH7B_HUMAN	Myosin-7B (Antigen MLAA-21) (Myosin cardiac muscle beta chain) (Myosin heavy chain 7B, cardiac muscle beta isoform) (Slow A MYH14)	MYH7B KIAA1512	1983	9606			Actin-binding;Alternative splicing;ATP-binding;Coiled coil;Membrane;Motor protein;Muscle protein;Myosin;Nucleotide-binding;Reference proteome;Thick filament	Q8NB12; Q16134; P78337; Q2TAL8; Q93062-3; Q8NB12; Q08117-2	TISSUE SPECIFICITY: Expressed in heart, skeletal muscle, testis, and all specific brain regions examined. Slightly lower expression was detected in ovary and kidney, and intermediate expression was detected in lung, pancreas, spleen and liver. {ECO:0000269|PubMed:10819331}.	GO:0003774; GO:0005524; GO:0016020; GO:0016459; GO:0032982; GO:0051015		15755502; 10819331; 14702039; 11780052; 15489334; 11919279	TRAFAC class myosin-kinesin ATPase superfamily, Myosin family
A7KAX9	RHG32_HUMAN	Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP)	ARHGAP32 GRIT KIAA0712 RICS	2087	9606			3D-structure;Alternative splicing;Cell junction;Cell projection;Cytoplasm;Endoplasmic reticulum;Endosome;Golgi apparatus;GTPase activation;Membrane;Methylation;Phosphoprotein;Reference proteome;SH3 domain;Synapse	Q9NYB9; P46108; Q86Y13; P06241; P50458; Q9BRK4; Q99750; O43639; Q08117	TISSUE SPECIFICITY: Isoform 1 and isoform 2 are highly expressed in brain and testis. Isoform 1 is also expressed in other tissues such as lung, liver and spleen. {ECO:0000269|PubMed:12446789}.	GO:0000139; GO:0001650; GO:0005096; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0005938; GO:0007264; GO:0010008; GO:0014069; GO:0015629; GO:0043197; GO:0051056; GO:1901981	PTM: Isoform 2 is phosphorylated on multiple tyrosine residues by FYN. Phosphorylated tyrosine residues undergo dephosphorylation after stimulation of NMDA receptors (By similarity). Phosphorylated in vitro by CaMK2 in the presence of calmodulin and calcium; which inhibits GAP activity (By similarity). {ECO:0000250}.	12446789; 12531901; 12819203; 17663722; 9872452; 15489334; 12788081; 12454018; 12857875; 19413330; 19690332; 21406692; 23186163; 24275569	PX domain-containing GAP family
A7MCY6	TBKB1_HUMAN	TANK-binding kinase 1-binding protein 1, TBK1-binding protein 1	TBKBP1 KIAA0775 SINTBAD	615	9606			Alternative splicing;Coiled coil;Host-virus interaction;Immunity;Innate immunity;Metal-binding;Phosphoprotein;Reference proteome;Zinc;Zinc-finger	Q9UKV8; O96018; Q14164; Q8TDY2; Q9UHD2; P17362	TISSUE SPECIFICITY: Detected in leukocytes, lung, placenta, small intestine, liver, kidney, spleen, muscle, heart, brain and at low levels in thymus. {ECO:0000269|PubMed:17568778}.	GO:0005737; GO:0007249; GO:0046872; GO:0051607; GO:0060337; GO:1902554		9872452; 15489334; 14743216; 17568778; 19413330; 19369195; 21931631; 21931555; 23186163; 24275569; 27980081	
A7MD48	SRRM4_HUMAN	Serine/arginine repetitive matrix protein 4 (Medulloblastoma antigen MU-MB-2.76) (Neural-specific serine/arginine repetitive splicing factor of 100 kDa, Neural-specific SR-related protein of 100 kDa, nSR100)	SRRM4 KIAA1853	611	9606			Differentiation;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;RNA-binding	Q02040; A0A0C4DG62; Q6PH81; Q16543; P49759-3; Q9HAZ1; Q8IZU0; Q9Y383; Q9P127; Q96EZ8; Q9BU76; P49756; Q14498; Q9Y388; Q15287; Q96IZ7; Q8TAD8; P08621; Q8IYB3; A7MD48; Q05519-2; Q01081; P61964; Q15973; Q9HBT8; Q32M78; Q15696; Q15695	TISSUE SPECIFICITY: Specifically expressed in neuronal cells (at protein level). Expressed in the cerebellum. {ECO:0000269|PubMed:12800201, ECO:0000269|PubMed:19737518}.	GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0007399; GO:0007605; GO:0008380; GO:0030154; GO:0042551; GO:0042802; GO:0043484	PTM: Phosphorylated. {ECO:0000250|UniProtKB:Q8BKA3}.	11347906; 14702039; 15489334; 12800201; 19737518; 30684677	NSR100 family
A7XYQ1	SOBP_HUMAN	Sine oculis-binding protein homolog (Jackson circler protein 1)	SOBP JXC1	873	9606			Isopeptide bond;Mental retardation;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger			GO:0005634; GO:0007605; GO:0007626; GO:0032184; GO:0042472; GO:0046872; GO:0048513; GO:0050890; GO:0090102		14574404; 14702039; 15489334; 21035105; 23086935; 28112733	SOBP family
A8CG34	P121C_HUMAN	Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2, POM121-2) (Pore membrane protein of 121 kDa C)	POM121C	1229	9606			Alternative splicing;Endoplasmic reticulum;Membrane;mRNA transport;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Translocation;Transmembrane;Transmembrane helix;Transport	Q14974		GO:0005635; GO:0005643; GO:0005654; GO:0005789; GO:0006405; GO:0006606; GO:0008139; GO:0016021; GO:0017056; GO:0031965; GO:0051028		12853948; 15489334; 17900573; 17081983; 18669648; 19690332; 20068231; 21406692; 23186163	POM121 family
A8K0Z3	WASH1_HUMAN	WASH complex subunit 1 (CXYorf1-like protein on chromosome 9) (Protein FAM39E) (WAS protein family homolog 1)	WASHC1 FAM39E WASH1	465	9606			Actin-binding;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Endosome;Isopeptide bond;Membrane;Protein transport;Reference proteome;Transport;Ubl conjugation	Q14457; Q9NV70; Q8IYI6		GO:0003779; GO:0005769; GO:0005770; GO:0005776; GO:0005814; GO:0005829; GO:0006887; GO:0010507; GO:0015031; GO:0016197; GO:0022617; GO:0030335; GO:0031274; GO:0031396; GO:0031625; GO:0031901; GO:0032456; GO:0034314; GO:0034315; GO:0042147; GO:0043014; GO:0043015; GO:0043553; GO:0055037; GO:0055038; GO:0071203	PTM: Ubiquitinated at Lys-220 via 'Lys-63'-linked ubiquitin chains by the TRIM27:MAGEL2 E3 ubiquitin ligase complex, leading to promote endosomal F-actin assembly. {ECO:0000269|PubMed:23452853}.	14702039; 15164053; 10655549; 18159949; 19922874; 19922875; 20498093; 22114305; 23452853; 24344185; 29084197	WASH1 family
A8K2U0	A2ML1_HUMAN	Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9)	A2ML1 CPAMD9	1454	9606			Alternative splicing;Bait region;Disulfide bond;Glycoprotein;Protease inhibitor;Reference proteome;Secreted;Serine protease inhibitor;Signal;Thioester bond		TISSUE SPECIFICITY: In the epidermis, expressed predominantly in the granular layer at the apical edge of keratinocytes (at protein level). Also detected in placenta, testis and thymus but not in epithelia of kidney, lung, small intestine or colon. {ECO:0000269|PubMed:16298998}.	GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0030414; GO:0052548; GO:0070062		14702039; 17974005; 16541075; 15489334; 16298998; 26121085	Protease inhibitor I39 (alpha-2-macroglobulin) family
A8K4G0	CLM7_HUMAN	CMRF35-like molecule 7, CLM-7 (CD300 antigen-like family member B) (CMRF35-A2) (Immune receptor expressed on myeloid cells 3, IREM-3) (Leukocyte mono-Ig-like receptor 5) (Triggering receptor expressed on myeloid cells 5, TREM-5) (CD antigen CD300b)	CD300LB CD300B CLM7 CMRF35A2 IREM3 LMIR5 TREM5 UNQ2530/PRO6029	201	9606			Cell membrane;Disulfide bond;Immunity;Immunoglobulin domain;Membrane;Phosphoprotein;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix	Q9UGN4; Q08708; Q496F6; A8K4G0; Q6UXZ3; Q8TDQ1	TISSUE SPECIFICITY: Expressed exclusively in myeloid lineages. {ECO:0000269|PubMed:16920917}.	GO:0002376; GO:0004888; GO:0005886; GO:0016021; GO:0042802	PTM: Phosphorylation on Tyr-188 by FYN is required for interaction with GRB2. {ECO:0000269|PubMed:16920917, ECO:0000269|PubMed:17928527}.	16920917; 12975309; 14702039; 16625196; 15489334; 12483297; 17928527	CD300 family
A8K7I4	CLCA1_HUMAN	Calcium-activated chloride channel regulator 1, EC 3.4.-.- (Calcium-activated chloride channel family member 1, hCLCA1) (Calcium-activated chloride channel protein 1, CaCC-1, hCaCC-1)	CLCA1 CACC1	914	9606		3.4.-.-	3D-structure;Autocatalytic cleavage;Calcium;Calcium transport;Cell membrane;Chloride;Direct protein sequencing;Glycoprotein;Hydrolase;Ion transport;Membrane;Metal-binding;Metalloprotease;Protease;Reference proteome;Secreted;Signal;Transport;Zinc		TISSUE SPECIFICITY: Highly expressed in small intestine and colon namely in intestinal basal crypt epithelia and goblet cells, and appendix. Weakly expressed in uterus, testis and kidney. Expressed in the airways epithelium of both asthmatic and healthy patients. Expressed in the bronchial epithelium, especially in mucus-producing goblet cells. Expressed in normal turbinate mucosa and nasal polyp. Expressed in. {ECO:0000269|PubMed:10437792, ECO:0000269|PubMed:11842292, ECO:0000269|PubMed:11956057, ECO:0000269|PubMed:16012037, ECO:0000269|PubMed:9828122}.	GO:0004222; GO:0005229; GO:0005254; GO:0005615; GO:0005886; GO:0005887; GO:0005902; GO:0006816; GO:0006821; GO:0034220; GO:0042589; GO:0046872; GO:0071456	PTM: Glycosylated. {ECO:0000269|PubMed:9828122}.; PTM: The 125-kDa product is autoproteolytically processed by the metalloprotease domain and yields to two cell-surface-associated subunits, a 90-kDa protein and a group of 37- to 41-kDa proteins. The cleavage is necessary for calcium-activated chloride channel (CaCC) activation activity. {ECO:0000269|PubMed:23112050, ECO:0000269|PubMed:9828122}.	9828122; 10437792; 14702039; 16710414; 23112050; 11445004; 11956057; 11842292; 16012037; 15696080; 15919655; 16151054; 17622767	CLCR family
A8K8P3	SFI1_HUMAN	Protein SFI1 homolog, hSFI1	SFI1 KIAA0542	1242	9606			3D-structure;Alternative splicing;Cytoplasm;Cytoskeleton;Reference proteome;Repeat	P41208; P62136; Q9UI95		GO:0005814; GO:0005829; GO:0019902		9628581; 12168954; 14702039; 10591208; 15489334; 14504268; 16956364	SFI1 family
A8K8V0	ZN785_HUMAN	Zinc finger protein 785	ZNF785	405	9606			Alternative splicing;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	Q9ULX6; Q9NPB3; Q8NA61-2; O95273; Q8NHQ1; A2ABF9; A6NEM1; Q9UJC3; Q9BVG8-5; O76013-2; P60370; P59991; Q99750; Q9UJV3-2; Q5JR59; Q5JR59-3; Q9UL42; Q16623; P32856-2; P07951-2; Q15654		GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872		14702039; 15489334; 26063658	Krueppel C2H2-type zinc-finger protein family
A8MPY1	GBRR3_HUMAN	Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor)	GABRR3	467	9606			Cell junction;Cell membrane;Chloride;Chloride channel;Disulfide bond;Glycoprotein;Ion channel;Ion transport;Membrane;Postsynaptic cell membrane;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix;Transport			GO:0004890; GO:0005230; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476; GO:1902711		16641997; 10542332	Ligand-gated ion channel (TC 1.A.9) family, Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily, GABRR3 sub-subfamily
A8MQ03	CRTP1_HUMAN	Cysteine-rich tail protein 1	CYSRT1 C9orf169	144	9606			Reference proteome	Q9NQ94; Q96HD9; O43184-4; P82987; Q6UY14-3; Q6ZMM2; P21549; P43353; P05187; Q9Y4X0-3; Q9NYG5-2; Q49AR9; P29972; P15514; Q9BRR9; Q03989; Q6HA08; Q7Z3C6-3; Q8N5M1; Q8WXX7-2; Q5T686; Q9UBV7; O95817; P46379-2; Q8TBE0; Q9UHR4; Q9HBH7; Q9BXY8; P62952; P18075; Q0VDD7-2; J3KQ12; Q6NUJ2; Q5BKX5-3; Q6P5X5; Q96LM5; Q8N865; Q13698; Q9BWT7; Q9H257-2; Q9Y2V2; Q7Z7H3; Q8NEC5; Q8N7E2; Q14781-2; Q96HB5; Q8TC90; O75909-2; Q6UXG3; Q8IVW4; Q8N6W0; Q5T4B2; Q8TCT0; P23141-3; Q8IYR0; P27918; Q9Y6H1; Q9NX63; Q9UKJ5; Q9H2X0; P07510-2; P51800-3; Q8N6F1-2; P57739; A5D8T8; Q8NE01; P26441; Q86WW8; P27658; P49747; P23786; Q9UGL9; Q02930-3; P06850; Q49AN0; P05813; P53672; P09603; P09228; Q9H4G1; Q99895; P08311; Q9UBR2; O60888-3; Q08AG9; A8MQ03; Q5SW24-3; Q5D0E6-2; Q8NFT6-2; A2VCK2; Q9NXZ2; Q9P1A6-3; Q9NW81-2; Q9NQL9; Q96EY1; Q13609; Q92608; Q92997; P42892; Q16610; Q12805; O95967; Q9NPA0; Q9H0I2; Q8TE68-2; P84090; Q92731-3; Q9NVF9; Q9NVM1; Q8N9I5; Q5T9C2-3; Q9H5Z6-2; Q7L5A3; A4D161; A6H8Z2; Q8WU58; Q8NEG0; Q86UY5; Q86YD7; Q9NW38; O95363; P48023; Q969U6; A0PJY2; Q13643; P21333-2; O60548; Q9NU39; Q6VB84; O75593; O43559; Q92765; Q9ULW2; O95995; P23769; P23771-2; Q9BWX5; Q8N6F7; P55040; Q86UU5; Q8IW92; P43220; Q9Y223-2; Q9P2W3; O95872; Q9NWQ4-1; Q13227; P28799; P09211; Q96NT3-2; P02008; A0A024R5S0; P08631-2; Q9BSH5; Q9UBP5; Q03014; Q14774; P49639; P09067; P17482; P31273; P31274; O43593; P04196; O75506; Q9H2F3; Q96MM6; P10809; Q12891; P05362; Q14773-3; Q14005-2; Q0VD86; Q9C086; Q92835-2; P01308; Q8NA54; Q9NPH2; P05107; P16144-2; P18084; Q15040; Q9ULS6; Q96SI1-2; A0JP07; Q2WGJ6; O60259; Q5T749; P35900; Q15323; Q14525; O76011; Q14533; P78385; P78386; O43790; Q07627; Q8IUG1; Q9BYS1; P60014; P60412; P60370; P60409; P60410; P60411; Q8IUC1; P59990; P59991; P60328; P60329; Q52LG2; Q3SY46; Q3LI77; Q3LI76; Q8IUB9; Q3LHN2; Q7Z4W3; Q3LI72; Q3LI70; Q3SYF9; Q9BYR9; Q6PEX3; Q9BYR8; Q9BYR6; Q9BYQ6; Q9BQ66; Q9BYR5; Q9BYR3; Q9BYR2; Q6L8G4; Q6L8H2; Q6L8H1; Q6L8G9; Q6L8G8; P26371; Q3LI64; Q3LI66; Q8IUC2; Q9BYQ4; Q9BYQ3; Q9BYQ0; Q6VAB6; Q14657; Q14847-2; Q5T7P2; Q5T7P3; Q5T751; Q5T752; Q5T753; Q5T754; Q5TA79; O14633; Q5TA81; Q5TA82; Q5TA76; Q5TA77; Q5T5A8; Q9BYE3; Q5T5B0; Q5TA78; Q5TCM9; Q96PV6; Q6DKI2; Q9BU23-2; Q8IXW0; Q8TAP4-4; P61968; Q8TBB1; Q17RB8; Q496Y0; Q6PJG9; Q8WV35; Q15345; Q8WUT4; Q9Y5Y7; O75367; O60336; Q96EZ8; Q71SY5; P08582-2; Q6FHY5; Q14CX5; Q8IVT4; Q5JXC2; Q13064; Q16540; Q9NQ50; Q9NZV6; Q8N339; Q13330; P48039; Q9BW11; P50539-3; Q86VE0; Q16795; Q9BU61; P49821; Q92692-2; Q9NQS3-2; Q9Y3R4; Q8WWR8-2; Q969G9; P48645; P0DPK4; Q86UR1-2; P48146; Q9NQX5; P16860; Q9Y639-1; Q6NSM0; Q92570; Q96L73-2; Q96HA8; Q9HB63; Q9Y5Y2; Q7Z417; Q8IXM7; Q7RTU3; O14581; Q8NHW6; P32242; Q99572; Q9HBE1-4; Q92824-2; O76083-2; Q9UHJ9-5; Q9HCN3; Q8N4B1-4; A2BDE7; P78337; Q99697-2; Q13563; Q16512; O15496; Q494U1-3; Q9Y342; P28340; Q12837; P62140; Q7Z5V6-2; P01298; P14222; P54646; O43741; P04070; O75360; Q8WWY3; A6NJB7-2; Q53SZ7; Q9NV39; P0CG20; P41222; Q8WUK0; P15151; Q2TAL8; Q9Y2K5; Q8TBN0; Q12967-6; Q9BTL3; O60896; Q9Y272; Q9NW64; P10745; Q6P9E2; Q8IYK8; O15211; P49796-4; Q9H310-3; Q9BSD3; Q9H0F5; Q86WX3; Q6P087; Q6UXX9-2; Q86UD0; Q8IYX7; Q14162; Q9BWG6; Q13214-2; Q9C0C4; Q96B97; Q8TEC5; Q9NUL5-4; Q6ZSJ9; Q9UP95; Q86YT5; Q9UHI7-3; Q9H1K4; Q6ZT89-3; Q8N370; Q92911; Q9NP91; O75093; Q92922; Q96GM5; Q969G3; P49901; Q9H4F8-2; Q8NCR6; Q53HV7-2; P14678-2; P09234; Q96RF0; A1A5D2; O14512; Q86W54-2; A0A024R4B0; Q5T0L3; Q6RVD6; Q9Y4P9-2; Q9UQ90; Q9HCB6; Q8IUH8; O43609; Q969W0; P31213; O75716; Q9BX59; Q13207; O95947; Q9Y4C2-2; Q15560; Q8N8B7-2; Q9NQB0-10; Q96A09; Q96N21; Q96LM6; Q8NA69; Q7Z6R9; P01137; Q9BT49; Q9Y584; Q08117-2; O76062; Q8WUU8; Q15025; Q96KP6; Q07912-2; Q8IZW8; Q8WVR3; Q9NSU2-1; Q8IWZ5; Q3SY00; O14817; Q5W5X9-3; P49638; P29597; O94888; Q8IV45; Q70EL1-9; Q9BRU9; Q6EMK4; O95231; A8MV65-2; Q8IW00; Q2TAL6; B2RUY7; Q64LD2-2; Q9Y5W5; O96014; P19544-6; P07947; P25490; P24278; Q9P1Z0; Q8WYQ9; Q8WTX9; A2RRC6; Q15915; O75800; Q15973; P49910; Q14584; Q9P2F9; Q9Y3S2; Q9H9D4; Q96IQ9; Q8TAU3; Q96HQ0; Q7Z4V0; Q8NDP4; Q8IYI8; Q8N8Z8; Q9NWS9-2; Q6ZNH5; Q9H707; Q86XF7; Q9UK33; Q9P0T4; Q96SQ5; Q5T619; Q96BR6; Q8IZ20; Q9H7X3; Q96H86; Q96BV0; Q8N393; Q9Y2P0; Q96EG3; Q8N446; O43257; Q9BUG6; Q96EJ4		GO:0042802; GO:0070062		15164053; 15489334; 17081983	CYSRT1 family
A8MQ27	NEU1B_HUMAN	E3 ubiquitin-protein ligase NEURL1B, EC 2.3.2.27 (Neuralized-2, NEUR2) (Neuralized-like protein 1B) (Neuralized-like protein 3) (RING-type E3 ubiquitin transferase NEURL1B)	NEURL1B NEURL3	555	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.27	Alternative splicing;Cytoplasm;Metal-binding;Notch signaling pathway;Phosphoprotein;Reference proteome;Repeat;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger		TISSUE SPECIFICITY: Highest expression in brain, prostate and small intestine. In the brain the levels are higher in fetal than in adult stage. In the adult brain the highest levels are detected in the olfactory system, cerebellar cortex, optic nerve and the frontal lobe. {ECO:0000269|PubMed:19723503}.	GO:0005769; GO:0005829; GO:0007219; GO:0015629; GO:0046872; GO:0061630; GO:0070086		19723503; 15372022; 24275569	
A8MT69	CENPX_HUMAN	Centromere protein X, CENP-X (FANCM-associated histone fold protein 2) (FANCM-interacting histone fold protein 2) (Fanconi anemia-associated polypeptide of 10 kDa) (Retinoic acid-inducible gene D9 protein homolog) (Stimulated by retinoic acid gene 13 protein homolog)	CENPX FAAP10 MHF2 STRA13	81	9606			3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;DNA damage;DNA repair;DNA-binding;Kinetochore;Mitosis;Nucleus;Reference proteome	Q8N2Z9; Q04864; Q9BYV2; Q9BYV2		GO:0000712; GO:0000776; GO:0000785; GO:0003677; GO:0005654; GO:0031297; GO:0031398; GO:0036297; GO:0043240; GO:0051301; GO:0051382; GO:0071821		16625196; 15489334; 19620631; 20347428; 20347429; 22304917; 22814378; 24522885	CENP-X/MHF2 family
A8MTA8	F166B_HUMAN	Protein FAM166B	FAM166B	275	9606			Alternative splicing;Reference proteome	Q9NYB9-2; Q8N5M1; Q8N4L8; O95833; O95872; Q86YW7; Q3LI66; P06239-3; Q96PV6; O15481; Q6PF18; Q8TDC0; Q92569; Q16633; Q2TAL8; Q93062-3; P40937; Q96A09; Q7Z6R9; O43711; Q9H0E2				15164053; 15489334	UPF0605 family
A8MTJ3	GNAT3_HUMAN	Guanine nucleotide-binding protein G(t) subunit alpha-3 (Gustducin alpha-3 chain)	GNAT3	354	9606			Cytoplasm;GTP-binding;Lipoprotein;Magnesium;Metal-binding;Myristate;Nucleotide-binding;Reference proteome;Transducer		TISSUE SPECIFICITY: Expressed in taste buds (sensory organs of clustered epithelial cells) of the circumvallate and foliate papillae of the tongue at protein level. Expressed in enteroendocrine L cells of the gut. Detected also in spermatozoa. {ECO:0000269|PubMed:16728727, ECO:0000269|PubMed:17021831, ECO:0000269|PubMed:17724332, ECO:0000269|PubMed:8015379}.	GO:0001580; GO:0001664; GO:0001669; GO:0001750; GO:0001917; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0005930; GO:0007188; GO:0016324; GO:0031683; GO:0032991; GO:0035094; GO:0046872; GO:0050916; GO:0050917	PTM: Potential N-myristoylation may anchor alpha-subunit to the inner surface of plasma membrane. {ECO:0000250}.	12853948; 12690205; 15489334; 8015379; 11917125; 16728727; 17021831; 17724330; 17724332	G-alpha family, G(i/o/t/z) subfamily
A8MTQ0	NOTO_HUMAN	Homeobox protein notochord	NOTO	251	9606			Developmental protein;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation	X5D778; P41238; O95817; Q8N9N5-2; P20290-2; Q96HB5; Q96LK0; Q13111; Q53HC9; Q6ZN32; Q8IZU0; O60548; O75593; Q8IVS8; P61978-2; Q96PC2; O76011; Q3SYF9; Q6L8G9; Q3LI64; Q5SW96; Q7Z4F1; Q9Y5V3; O14770-4; Q9H2Z4; Q8WWB5; Q12837; P0C264; Q5W5X9-3; P0CB47; PRO_0000449627 [P0DTD1]; PRO_0000449631 [P0DTD1]; PRO_0000449633 [P0DTD1]		GO:0000785; GO:0000978; GO:0000981; GO:0001947; GO:0005634; GO:0006357; GO:0007417; GO:0009880; GO:0009953; GO:0030182; GO:0030903; GO:0044458; GO:1902017; GO:1990837		14702039; 15815621	
A8MTZ0	BBIP1_HUMAN	BBSome-interacting protein 1 (BBSome-interacting protein of 10 kDa)	BBIP1 BBIP10 NCRNA00081	92	9606			3D-structure;Alternative splicing;Bardet-Biedl syndrome;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Cytoplasm;Obesity;Protein transport;Reference proteome;Transport	Q96RK4		GO:0005737; GO:0005829; GO:0015031; GO:0034464; GO:0042755; GO:0060170; GO:0060271; GO:0097500		14702039; 15164054; 15489334; 24026985	BBIP10 family
A8MU46	SMTL1_HUMAN	Smoothelin-like protein 1	SMTNL1	494	9606			Calmodulin-binding;Coiled coil;Cytoplasm;Muscle protein;Nucleus;Phosphoprotein;Reference proteome		TISSUE SPECIFICITY: Expressed in striated muscles, specifically in type 2a fibers (at protein level). {ECO:0000269|PubMed:18310078, ECO:0000269|PubMed:20634291}.	GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0005815; GO:0008157; GO:0009410; GO:0014823; GO:0018105; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0042310; GO:0043292; GO:0043621; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718	PTM: Maximal phosphorylation of Ser-336 correlates with maximal relaxation of aorta in response to acetylcholine. {ECO:0000250}.	16554811; 18310078; 20634291	Smoothelin family
A8MUP2	CSKMT_HUMAN	Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial, CS-KMT, EC 2.1.1.- (Methyltransferase-like protein 12, mitochondrial)	CSKMT METTL12	240	9606		2.1.1.-	Methyltransferase;Mitochondrion;Reference proteome;S-adenosyl-L-methionine;Transferase;Transit peptide	Q9NP55; Q8IUC1; Q52LG2; Q3LI70; O75716; Q96M29		GO:0005739; GO:0006479; GO:0016278; GO:0016279; GO:0018023; GO:0018026; GO:0018027		14702039; 16554811; 15489334; 25023281; 28391595; 28887308	Methyltransferase superfamily
A8MV65	VGLL3_HUMAN	Transcription cofactor vestigial-like protein 3, Vgl-3	VGLL3	326	9606			Alternative splicing;Isopeptide bond;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	Q6NVV7; Q5T4B2; Q9BYD5; Q99895; A8MQ03; Q86UW9; Q9NQ30; A1KXE4-2; O43559; A0A024R8L2; O14964; Q0VD86; Q5T749; Q07627; P60409; P60410; P60411; Q8IUC1; P59990; P59991; P60328; Q52LG2; Q3LI76; Q8IUB9; Q3LHN2; Q3LI70; Q3SYF9; Q9BYR8; Q9BYR6; Q9BYQ6; Q9BYR5; Q6L8G4; Q6L8G9; Q3LI64; Q3LI66; Q9BYQ4; Q9BYQ3; Q9BYQ0; Q14847-2; Q96PV6; Q99750; Q8TDS5; Q92824-2; P78337; Q99697-2; O15496; Q7Z3K3; Q16633; Q93062-3; Q9BVN2; Q92922; Q9H4F8-2; Q96SF7; P28347-2; Q15562-2; Q99594; Q15561; Q96LM6; Q8IWZ5; Q86WV8; O14817; Q6NVU6	TISSUE SPECIFICITY: Enriched in placenta. {ECO:0000269|PubMed:12376544}.	GO:0005634; GO:0006357		16641997; 15489334; 12376544; 28112733	Vestigial family
A8MVW5	HECA2_HUMAN	HEPACAM family member 2 (Mitotic kinetics regulator)	HEPACAM2 MIKI UNQ305/PRO346	462	9606			ADP-ribosylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Disulfide bond;Glycoprotein;Golgi apparatus;Immunoglobulin domain;Membrane;Mitosis;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:19358830}.	GO:0000139; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0007098; GO:0016021; GO:0030496; GO:0043231; GO:0051301; GO:0072686	PTM: Poly-ADP-ribosylated (PARsylated) by tankyrase TNKS during late G2 and prophase, leading to translocation to mitotic centrosomes.; PTM: N-glycosylated. {ECO:0000269|PubMed:19358830, ECO:0000269|PubMed:22864114}.	12975309; 14702039; 12853948; 15489334; 19358830; 22864114; 16959974; 21248752	
A8MW95	BECN2_HUMAN	Beclin-2 (Beclin-1 autophagy-related pseudogene 1) (Beclin-1-like protein 1)	BECN2 BECN1L1 BECN1P1	431	9606			3D-structure;Autophagy;Coiled coil;Cytoplasm;Reference proteome	Q5JY77	TISSUE SPECIFICITY: Present in fetal and adult brain (at protein level). {ECO:0000269|PubMed:23954414}.	GO:0000045; GO:0000407; GO:0006914; GO:0006995; GO:0008333; GO:0034271; GO:0034272; GO:0042593; GO:0044877; GO:0045324; GO:1990172		23954414; 16710414; 28218432	Beclin family
A8MW99	MEI4_HUMAN	Meiosis-specific protein MEI4	MEI4	385	9606			Chromosome;DNA recombination;Meiosis;Reference proteome	Q63HM1; O95429; Q9UFG5; Q9NX04; Q9NP86; P55273; Q13111; Q96FN4; Q9H4G1; Q8WZ74; P04053; P63241; O75344; P62993; Q9H2F3; P46940; Q8TCE9; Q8N5G2; Q8WXB1; Q9UH92-3; Q96QG7; Q9ULV0-2; Q9NPG2; Q9Y5B8; Q9UJX0; Q15102; Q96FC7; Q9H4M7-2; O15160; Q9Y2K5; Q9UL33-2; Q8IWR1; Q8WW01; Q96PN8; Q8N6Y0; O14972		GO:0000800; GO:0006310; GO:0007129; GO:0007283; GO:0042138; GO:0048477		14574404; 31704776	MEI4L family
A8MWX3	WASH4_HUMAN	Putative WAS protein family homolog 4 (Protein FAM39CP)	WASH4P FAM39CP	477	9606			Actin-binding;Endosome;Membrane;Reference proteome;Transport			GO:0003779; GO:0005769; GO:0005829; GO:0006887; GO:0016197; GO:0031901; GO:0032456; GO:0034314; GO:0034315; GO:0042147; GO:0043014; GO:0043015; GO:0055037; GO:0055038; GO:0071203		15616553; 10655549; 18159949	WASH1 family
A8MXD5	GRCR1_HUMAN	Glutaredoxin domain-containing cysteine-rich protein 1	GRXCR1 DFNB25	290	9606			Cell projection;Cilium;Deafness;Disease variant;Hearing;Non-syndromic deafness;Reference proteome	P13196; P40123; Q0VD86; Q9NRD5; Q9NQX0; O00560; Q86XE0; Q8IYF3-3	TISSUE SPECIFICITY: Expressed at low levels in adult lung, brain and duodenum with moderate levels in testis. Highly expressed in fetal cochlea. {ECO:0000269|PubMed:20137778}.	GO:0005902; GO:0007605; GO:0032420; GO:0042491; GO:0048563; GO:0060091; GO:0060118; GO:0060119; GO:0060122; GO:0097573		15815621; 20137778; 20137774	GRXCR1 family
A8MXV4	NUD19_HUMAN	Acyl-coenzyme A diphosphatase NUDT19, EC 3.6.1.- (Nucleoside diphosphate-linked moiety X motif 19, Nudix motif 19)	NUDT19	375	9606		3.6.1.-	Hydrolase;Magnesium;Manganese;Metal-binding;Peroxisome;Reference proteome			GO:0000287; GO:0005782; GO:0005829; GO:0009062; GO:0010945; GO:0015938; GO:0036114; GO:0044580; GO:0106399; GO:1901289; GO:1902858; GO:2001294		15057824; 21269460; 23186163; 25944712	Nudix hydrolase family
A8MYU2	KCNU1_HUMAN	Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3)	KCNU1 KCNMA3 KCNMC1 SLO3	1149	9606			3D-structure;Cell membrane;Ion channel;Ion transport;Membrane;Potassium;Potassium channel;Potassium transport;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel		TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:9452476}.	GO:0005244; GO:0005267; GO:0005886; GO:0016021; GO:0022414; GO:0034765		16421571; 9452476; 23129643	Potassium channel family, Calcium-activated (TC 1.A.1.3) subfamily, KCa5.1/KCNU1 sub-subfamily
A8MZ59	LEUTX_HUMAN	Paired-like homeodomain transcription factor LEUTX (Leucine-twenty homeobox) (Paired-like homeobox transcription factor LEUTX, PRD-LIKE homeobox transcription factor LEUTX)	LEUTX	198	9606			Alternative initiation;DNA-binding;Homeobox;Nucleus;Reference proteome	Q9NRZ5; Q9NVV5-2; P41181; Q92482; P07306; Q86Z23; O95674; Q96MX0; Q96DZ9-2; O95406; Q8TBE1; Q07325; P54852; O75355-2; Q8N5W8; O75084; O14653; P43628; O43561-2; Q9BQC6; P11836; Q9H115; Q9ULP0-2; Q6UX06; P60201-2; P54315; A5D903; Q8WWT9; Q8IWU4; Q96JW4; P02808; P02787; Q5BJH2-2; Q9BVK8; Q14656; Q8TBM7; Q9H2L4; Q5BJF2; P30536; Q5BVD1; P49638; Q9H1C4; O75379; O95159; O15015		GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357		15057824; 17963489; 27578796; 30479355	Paired homeobox family
A8TX70	CO6A5_HUMAN	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)	COL6A5 COL29A1 VWA4	2615	9606			Alternative splicing;Cell adhesion;Collagen;Extracellular matrix;Glycoprotein;Hydroxylation;Reference proteome;Repeat;Secreted;Signal		TISSUE SPECIFICITY: Expressed in skin, followed by lung, small intestine, colon and testis. In skin, it is expressed in the epidermis with strongest staining in suprabasal viable layers. In ATOD patients, it is absent in the most differentiated upper spinous and granular layers (at protein level). {ECO:0000269|PubMed:17850181}.	GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0030198; GO:0062023	PTM: Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains. {ECO:0000250}.	17850181; 18276594; 16641997; 14702039	Type VI collagen family
A9UHW6	MI4GD_HUMAN	MIF4G domain-containing protein (SLBP-interacting protein 1, hSLIP1)	MIF4GD SLIP1	222	9606			Alternative splicing;Cytoplasm;Nucleus;Reference proteome;Translation regulation	Q9NUU7; Q9UMR2; O75821; Q8IV48; P56524; O14964; A9UHW6; P01106; Q5VU43; Q14493; PRO_0000037314 [P0C6X7]; P29972; Q8N5M1; Q8IYR0; Q9Y6H1; P53673; O43310-2; Q9NUU7; Q9UMR2; O75821; Q9H0I2; Q9BQ89; A0A0S2Z4Q4; O14964; Q13064; Q96HA8		GO:0002191; GO:0003723; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006446; GO:0008022; GO:0008494; GO:0042802; GO:0062073		18025107; 14702039; 16625196; 15489334; 21269460	MIF4GD family
A9YTQ3	AHRR_HUMAN	Aryl hydrocarbon receptor repressor, AhR repressor, AhRR (Class E basic helix-loop-helix protein 77, bHLHe77)	AHRR BHLHE77 KIAA1234	701	9606			3D-structure;Alternative splicing;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation		TISSUE SPECIFICITY: Highly expressed in testis, lung, ovary, spleen and pancreas. Highly expressed in mononuclear cells (MNCs) from umbilical cord blood. Isoform 3 is highly expressed in lung, kidney, spleen and thymus. Down-regulated malignant tissue from different anatomical origins, including colon, breast, lung, stomach, cervix, and ovary. {ECO:0000269|PubMed:11835227, ECO:0000269|PubMed:14672759, ECO:0000269|PubMed:18172554}.	GO:0000785; GO:0000976; GO:0000981; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006805; GO:0034751; GO:0046983		11835227; 10574462; 15372022; 15489334; 14672759; 17980155; 17890447; 18172554; 15474075; 16084889; 17559847; 25218447; 28112733; 28904176	
B0I1T2	MYO1G_HUMAN	Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2, mHag HA-2 ]	MYO1G HA2	1018	9606			Acetylation;Actin-binding;Adaptive immunity;Alternative splicing;ATP-binding;Calmodulin-binding;Cell membrane;Cell projection;Direct protein sequencing;Immunity;Lipid-binding;Membrane;Motor protein;Myosin;Nucleotide-binding;Reference proteome		TISSUE SPECIFICITY: Specifically expressed in hematopoietic cells. {ECO:0000269|PubMed:11544309, ECO:0000269|PubMed:20071333}.	GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0031256; GO:0031589; GO:0031982; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117		12853948; 11544309; 7539551; 15489334; 19968988; 20071333; 25944712	TRAFAC class myosin-kinesin ATPase superfamily, Myosin family
B0L3A2	DEAR_HUMAN	Dual endothelin-1/angiotensin II receptor, Dear (Dual endothelin-1/VEGFsp receptor, DEspR protein) (FBXW7 antisense RNA 1)	FBXW7-AS1 DEAR DEspR	85	9606			Cell membrane;Membrane;Receptor;Reference proteome;RNA editing;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in kidney (PubMed:17446437). Expressed in endothelial cells (PubMed:24465725). {ECO:0000269|PubMed:17446437, ECO:0000269|PubMed:24465725}.	GO:0004962; GO:0005886; GO:0016021; GO:0038084; GO:0038085; GO:0086100	PTM: N-glycosylated. {ECO:0000269|PubMed:27301377}.	17446437; 15815621; 24465725; 27301377; 33853558	
B0YJ81	HACD1_HUMAN	Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1, EC 4.2.1.134 (3-hydroxyacyl-CoA dehydratase 1, HACD1) (Cementum-attachment protein, CAP) (Protein-tyrosine phosphatase-like member A)	HACD1 PTPLA	288	9606	PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:18554506}.	4.2.1.134	Alternative splicing;Developmental protein;Endoplasmic reticulum;Fatty acid biosynthesis;Fatty acid metabolism;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Lyase;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	Q7Z7G2; Q13651; Q96K19-5; Q9NZ01; Q9BVX2	TISSUE SPECIFICITY: Isoform 1 is highly expressed in the myocardium, and to a lesser extent in skeletal and smooth muscular tissues including those from stomach, jejunum, and bladder. Also detected in gingival fibroblasts, periodontal ligament cells, osteoblasts and cementoblasts (PubMed:11054553, PubMed:22067203). Isoform 2 is specifically expressed by cementoblasts but also detected in periodontal ligament cells, heart, liver and kidney (at protein level) (PubMed:22067203). {ECO:0000269|PubMed:11054553, ECO:0000269|PubMed:22067203}.	GO:0005783; GO:0005789; GO:0010811; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0035338; GO:0042761; GO:0046848; GO:0065003; GO:0071529; GO:0080023; GO:0102158; GO:0102343; GO:0102344; GO:0102345	PTM: N-glycosylated. {ECO:0000269|PubMed:23933735}.	11054553; 10644438; 22067203; 15164054; 15489334; 18554506; 18669648; 23933735; 25263524	Very long-chain fatty acids dehydratase HACD family
B1AK53	ESPN_HUMAN	Espin (Autosomal recessive deafness type 36 protein) (Ectoplasmic specialization protein)	ESPN DFNB36 LP2654	854	9606			Actin-binding;Alternative splicing;ANK repeat;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Deafness;Disease variant;Hearing;Non-syndromic deafness;Phosphoprotein;Reference proteome;Repeat;Retinitis pigmentosa;Usher syndrome			GO:0005737; GO:0005902; GO:0005903; GO:0007605; GO:0017124; GO:0030034; GO:0031941; GO:0032420; GO:0032426; GO:0051015; GO:0051017		11230166; 15498874; 16710414; 15286153; 15930085; 28281779; 29572253	
B1AL88	NALF1_HUMAN	NALCN channel auxiliary factor 1 (Transmembrane protein FAM155A)	NALF1 FAM155A NLF-1	458	9606			3D-structure;Cell membrane;Disulfide bond;Glycoprotein;Membrane;Reference proteome;Transmembrane;Transmembrane helix			GO:0005886; GO:0016021; GO:0098703		14702039; 15057823; 15489334; 32494638; 32698188; 33203861	NALF family
B2RTY4	MYO9A_HUMAN	Unconventional myosin-IXa (Unconventional myosin-9a)	MYO9A MYR7	2548	9606			Actin-binding;Alternative splicing;ATP-binding;Cell junction;Cell projection;Coiled coil;Congenital myasthenic syndrome;Cytoplasm;Disease variant;GTPase activation;Membrane;Metal-binding;Motor protein;Myosin;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Synapse;Transmembrane;Transmembrane helix;Zinc;Zinc-finger		TISSUE SPECIFICITY: Found to be expressed in testis and placenta and at lower levels in all the examined tissues with the exception of liver (PubMed:10409426). Isoform 5: Found in leukocytes but not in brain, retina or testis (PubMed:10409426). {ECO:0000269|PubMed:10409426}.	GO:0003774; GO:0003779; GO:0005096; GO:0005524; GO:0005829; GO:0007601; GO:0016021; GO:0016461; GO:0034329; GO:0035556; GO:0043547; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0051056; GO:0150011	PTM: Phosphorylated by ALPK1 following monosodium urate monohydrate (MSU)-induced inflammation. {ECO:0000269|PubMed:27169898}.	10409426; 16572171; 15489334; 9819351; 8022818; 16204458; 17974005; 14702039; 18669648; 21269460; 23186163; 24275569; 27169898; 27259756; 26752647; 30237576	TRAFAC class myosin-kinesin ATPase superfamily, Myosin family
B2RUY7	VWC2L_HUMAN	von Willebrand factor C domain-containing protein 2-like (Brorin-like)	VWC2L	222	9606			Alternative splicing;Cell junction;Developmental protein;Reference proteome;Repeat;Secreted;Signal;Synapse	Q8WW18; Q6P5X5; Q6PRD7; Q9UGL9; P42830; A8MQ03; Q30KQ8; Q9NWN3; Q13643; P49639; P60410; Q8IUC1; Q3LHN2; Q5T7P2; Q5T751; Q5TA76; Q5TCM9; Q6FHY5; Q92570; P32242; P57078-2; A0A024R4B0; Q8IWZ5; Q06418; P17024		GO:0005615; GO:0030514; GO:0032281; GO:0045202; GO:0045666		19852960; 15815621; 15489334	
B2RUZ4	SMIM1_HUMAN	Small integral membrane protein 1 (Vel blood group antigen)	SMIM1	78	9606			Acetylation;Blood group antigen;Cell membrane;Direct protein sequencing;Disulfide bond;Membrane;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix	Q68DC2; Q13520; Q8WWH4; Q9BXK5; Q13323; P04233-2; Q8N5K1; P21964; Q96BA8; P49447; Q15125; Q9Y282; Q8TBP5; Q5JX71; Q96KR6; O15552; Q8TBE3; P48165; O95377; Q6Y1H2; Q7Z5P4; P32942; Q8N5M9; P43628; Q8TAF8; Q7Z4F1; Q9HCJ2; Q9GZY8-5; Q6ZSS7; P15941-11; Q9Y3Q0; Q8N183; P15151; Q9H6H4; Q8NC24; Q86VR2; Q9NR31; Q9NY72; A0A0S2Z4U3; Q9Y286; Q3KNW5; P54219-3; Q86WA9; Q86WV6; Q16623; Q96DZ7; Q6P9G4; Q96B21; Q9NW97; Q4KMG9; Q8N661; O15393-2; Q9Y320; Q96MV8	TISSUE SPECIFICITY: Highly expressed in the bone marrow and expressed at lower levels in non-hematopoietic tissues. Highly expressed in erythroleukemia cell lines. Up-regulated in CD34+ hematopoietic progenitors cultured toward red blood cells. {ECO:0000269|PubMed:23563606}.	GO:0005886; GO:0009986; GO:0016021; GO:0042803		16710414; 15489334; 23505126; 18669648; 23563606; 23563608; 24275569; 26452714	SMIM1 family
B2RXF5	ZBT42_HUMAN	Zinc finger and BTB domain-containing protein 42	ZBTB42	422	9606			Cytoplasm;Disease variant;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	Q49AR9; Q9NWX5; Q7Z3C6-3; P51451; Q9NX04; Q9NP86; Q8NEC5; Q68D86; Q86X02; Q96AQ7; Q9BW66; O95833; Q49AN0; P56545-3; Q8IXW7; P55040; Q08379; Q96NT3-2; Q9H2F3; O75031; Q63ZY3; Q7L273; Q6A162; Q96A72; P28482; Q99750; Q9UJV3-2; Q13064; Q8WY64; O43639; Q9UHB4; Q9BVI4; Q9UMX2-2; Q9UJX0; P32242; Q13526; O60733; O15160; O75771; Q96RF0; Q9NZD8; Q9UL33-2; Q6AZZ1; Q5W5X9-3; P57075-2; Q8N6Y0; Q05516; O15156-2; Q9Y3S2	TISSUE SPECIFICITY: Expressed in skeletal muscle (at protein level). {ECO:0000269|PubMed:21193930}.	GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006357; GO:0007517; GO:0046872		12508121; 15489334; 21193930; 25055871	Krueppel C2H2-type zinc-finger protein family, ZBTB18 subfamily
B2RXH2	KDM4E_HUMAN	Lysine-specific demethylase 4E, EC 1.14.11.66 (KDM4D-like protein) (Lysine-specific demethylase 4D-like) ([histone H3]-trimethyl-L-lysine(9) demethylase 4E)	KDM4E KDM4DL	506	9606		1.14.11.66	3D-structure;Chromatin regulator;Dioxygenase;Iron;Metal-binding;Nucleus;Oxidoreductase;Reference proteome;Transcription;Transcription regulation;Zinc			GO:0005634; GO:0006338; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0140684		16554811; 15489334; 21914792	JHDM3 histone demethylase family
B3KU38	IQIP1_HUMAN	IQCJ-SCHIP1 readthrough transcript protein	IQCJ-SCHIP1	563	9606			Alternative splicing;Cell projection;Coiled coil;Cytoplasm;Phosphoprotein;Reference proteome		TISSUE SPECIFICITY: Highly expressed in brain and to a lower extent in heart and kidney. {ECO:0000269|PubMed:17045569}.	GO:0005737; GO:0005886; GO:0030054; GO:0035332; GO:0043194; GO:0051494		17045569; 14702039; 16641997; 23186163; 25950943	
B6A8C7	TARM1_HUMAN	T-cell-interacting, activating receptor on myeloid cells protein 1 (OSCAR-like transcript-2 protein, OLT-2)	TARM1	271	9606			Adaptive immunity;Alternative splicing;Cell membrane;Disulfide bond;Glycoprotein;Immunity;Immunoglobulin domain;Innate immunity;Membrane;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in fetal and adult liver, lung, testis, thymus and spleen. Expressed in blood neutrophils. {ECO:0000269|PubMed:26311901}.	GO:0002250; GO:0005886; GO:0016021; GO:0034987; GO:0035579; GO:0045087; GO:0070821; GO:2000515	PTM: N-glycosylated. {ECO:0000269|PubMed:26311901}.	14702039; 15057824; 26311901	
B7U540	KCJ18_HUMAN	Inward rectifier potassium channel 18 (Inward rectifier K(+) channel Kir2.6) (Potassium channel, inwardly rectifying subfamily J member 18)	KCNJ18	433	9606			Cell membrane;Disease variant;Ion channel;Ion transport;Membrane;Phosphoprotein;Potassium;Potassium transport;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel	P50402; P63252	TISSUE SPECIFICITY: Specifically expressed in skeletal muscle. {ECO:0000269|PubMed:20074522}.	GO:0005242; GO:0005886; GO:0016021; GO:0034765; GO:1990573	PTM: Probably phosphorylated by PKC; decreases single-channel open probability. {ECO:0000269|PubMed:20074522}.	20074522; 27008341; 16625196; 21665951; 25885757; 27178871	Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ12 subfamily
B7Z8K6	TRDC_HUMAN	T cell receptor delta constant	TRDC	153	9606			3D-structure;Adaptive immunity;Cell membrane;Disulfide bond;Glycoprotein;Immunity;Membrane;Receptor;Reference proteome;T cell receptor;Transmembrane;Transmembrane helix			GO:0002250; GO:0003823; GO:0005886; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0016021; GO:0034987; GO:0042106; GO:0042571; GO:0042742; GO:0045087; GO:0046629; GO:0050852; GO:0050853; GO:0050871		3413078; 14702039; 12508121; 23348415; 24387714; 24600447; 25674089; 28920588; 11459064	
B7ZAQ6	GPHRA_HUMAN	Golgi pH regulator A (Protein GPR89A) (Putative MAPK-activating protein PM01) (Putative NF-kappa-B-activating protein 90)	GPR89A GPHRA GPR89 SH120 CGI-13 UNQ192/PRO218	455	9606			Alternative splicing;Glycoprotein;Golgi apparatus;Ion channel;Ion transport;Membrane;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel		TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:18794847}.	GO:0000139; GO:0008308; GO:0015031; GO:0016021; GO:0030217; GO:0030660; GO:0032580; GO:0034765; GO:0043123; GO:0051452		10810093; 24722188; 12975309; 12761501; 14702039; 16710414; 15489334; 18794847; 19135895	Golgi pH regulator (TC 1.A.38) family
C4AMC7	WASH3_HUMAN	Putative WAS protein family homolog 3 (Protein FAM39DP)	WASH3P FAM39DP	463	9606			Actin-binding;Cell projection;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Endosome;Isopeptide bond;Membrane;Reference proteome;Transport;Ubl conjugation			GO:0003779; GO:0005769; GO:0005776; GO:0005814; GO:0005829; GO:0006622; GO:0006887; GO:0007032; GO:0016197; GO:0030027; GO:0030175; GO:0031901; GO:0032456; GO:0034314; GO:0034315; GO:0042147; GO:0043014; GO:0043015; GO:0045022; GO:0055037; GO:0055038; GO:0071203		16572171; 15489334; 10655549; 18159949; 20175130; 20498093	WASH1 family
C9JE40	PATL2_HUMAN	Protein PAT1 homolog 2 (PAT1-like protein 2) (Protein PAT1 homolog a, Pat1a, hPat1a)	PATL2	543	9606			Cytoplasm;Disease variant;Nucleus;Reference proteome;RNA-binding		TISSUE SPECIFICITY: Highly expressed in oocytes. {ECO:0000269|PubMed:28965849}.	GO:0000290; GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0017148; GO:0033962		16572171; 20584987; 28965844; 28965849	PAT1 family
C9JLW8	MCRI1_HUMAN	Mapk-regulated corepressor-interacting protein 1 (Granulin-2) (Protein FAM195B)	MCRIP1 FAM195B GRAN2	97	9606			Acetylation;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome			GO:0005634; GO:0005737; GO:0010494; GO:0010717	PTM: Phosphorylation by MAPK3/1 (ERK1/2) regulates MCRIP1 binding to CTBP(s) (PubMed:25728771). {ECO:0000269|PubMed:25728771}.	14702039; 16625196; 18669648; 19608861; 20068231; 21406692; 24275569; 26184334; 25728771	MCRIP family
C9JR72	KBTBD_HUMAN	Kelch repeat and BTB domain-containing protein 13	KBTBD13	458	9606	PATHWAY: Protein modification; protein ubiquitination.		Cytoplasm;Disease variant;Kelch repeat;Nemaline myopathy;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway		TISSUE SPECIFICITY: Expressed in skeletal muscle. {ECO:0000269|PubMed:21109227}.	GO:0005829; GO:0007015; GO:0014728; GO:0016567; GO:0051015; GO:0090076	PTM: Autoubiquitinated. {ECO:0000269|PubMed:22542517}.	16572171; 22542517; 21109227	
C9JRZ8	AK1BF_HUMAN	Aldo-keto reductase family 1 member B15, EC 1.1.1.-, EC 1.1.1.300, EC 1.1.1.54 (Estradiol 17-beta-dehydrogenase AKR1B15) (Farnesol dehydrogenase, EC 1.1.1.216) (Testosterone 17beta-dehydrogenase, EC 1.1.1.64)	AKR1B15	316	9606		1.1.1.-; 1.1.1.216; 1.1.1.300; 1.1.1.54; 1.1.1.64	Acetylation;Alternative splicing;Cytoplasm;Lipid metabolism;Mitochondrion;NADP;Oxidoreductase;Reference proteome	Q12933	TISSUE SPECIFICITY: Widely expressed. Expressed at highest levels in steroid-sensitive tissues, such as placenta, testis and adipose tissue. {ECO:0000269|PubMed:25577493}.	GO:0004032; GO:0004303; GO:0005739; GO:0005759; GO:0005829; GO:0006703; GO:0016616; GO:0047045; GO:0047655; GO:0047886; GO:0052650; GO:0072582		21276782; 12853948; 25577493; 26222439	Aldo/keto reductase family
D3W0D1	KLRF2_HUMAN	Killer cell lectin-like receptor subfamily F member 2, Lectin-like receptor F2 (Activating coreceptor NKp65)	KLRF2	207	9606			3D-structure;Cell membrane;Disulfide bond;Glycoprotein;Lectin;Membrane;Receptor;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix			GO:0001819; GO:0005887; GO:0030246; GO:0042803; GO:0043320	PTM: N-glycosylated. {ECO:0000269|PubMed:20194751}.	20194751; 16541075; 23803857	
D6RGH6	MCIN_HUMAN	Multicilin (Multiciliate differentiation and DNA synthesis-associated cell cycle protein, McIdas protein) (Protein Idas)	MCIDAS IDAS MCI MCIN	385	9606			3D-structure;Activator;Cell cycle;Ciliopathy;Cilium biogenesis/degradation;Coiled coil;Disease variant;Nucleus;Primary ciliary dyskinesia;Reference proteome;Transcription;Transcription regulation	Q13895; O75496; D6RGH6; Q8N8B7-2; O43167		GO:0003713; GO:0005634; GO:0007049; GO:0007346; GO:0008156; GO:0016604; GO:0030174; GO:0042802; GO:0044458; GO:0045786; GO:0045944; GO:0060271; GO:0098534; GO:1902017; GO:1903251		21543332; 15372022; 24064211; 25048963	Geminin family
G2XKQ0	SUMO5_HUMAN	Small ubiquitin-related modifier 5, SUMO-5 (SUMO1 pseudogene 1) (Ubiquitin-like 2) (Ubiquitin-like 6)	SUMO1P1 SUMO5 UBL2 UBL6	101	9606			3D-structure;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation;Ubl conjugation pathway	A0A0S2Z4M1; O15169; Q96B23; P61024; Q8WWZ3; P62508; Q9BPY3; Q8TCP9; O75344; Q53SE7; P07910; Q9BYQ4; Q96JM7; Q5TA79; Q5TA82; Q8NDC0; Q15742; O75928; Q01826; Q9Y6X0; P35711; P63165; Q12933; P36406; Q9UBT2; P63279; Q7KZS0; Q9HCK0; Q15916; O60232; B2R8Y4; Q59GP6	TISSUE SPECIFICITY: High expression levels in testes and peripheral blood leukocyte (PubMed:27211601). Expressed also in lung, placenta, liver, spleen and thymus (PubMed:27211601). {ECO:0000269|PubMed:27211601}.	GO:0005634; GO:0008134; GO:0016925; GO:0030578; GO:0031386; GO:0042802; GO:0044389	PTM: Cleavage of precursor form is necessary for function. {ECO:0000250|UniProtKB:P63165}.; PTM: Autosumoylated at Lys-18. {ECO:0000269|PubMed:27211601}.	27211601; 11780052; 30675988	Ubiquitin family, SUMO subfamily
H0YL14	TM250_HUMAN	Transmembrane protein 250 (Herpes virus UL25-binding protein)	TMEM250 C9orf69	139	9606			Cell cycle;Cytoplasm;Host-virus interaction;Membrane;Nucleus;Reference proteome;Transmembrane;Transmembrane helix	D3YP88		GO:0003924; GO:0005634; GO:0005654; GO:0005737; GO:0005940; GO:0008284; GO:0015630; GO:0016021; GO:0031105; GO:0032153; GO:0034613; GO:0048524; GO:0060090; GO:0060271; GO:0061640		15164053; 15489334; 21667337	
K7EJ46	SIM22_HUMAN	Small integral membrane protein 22 (Cancer-associated small integral membrane open reading frame 1)	SMIM22 CASIMO1	83	9606			Alternative splicing;Endosome;Membrane;Reference proteome;Transmembrane;Transmembrane helix			GO:0005770; GO:0016021; GO:0030335; GO:0032956; GO:0042127; GO:0051726; GO:0140042		29765154; 15616553; 15489334	
K9M1U5	IFNL4_HUMAN	Interferon lambda-4, IFN-lambda-4	IFNL4	179	9606			Alternative splicing;Antiviral defense;Cytokine;Cytoplasm;Reference proteome;Secreted;Signal			GO:0005102; GO:0005125; GO:0005615; GO:0005737; GO:0007260; GO:0038196; GO:0045087; GO:0050778; GO:0051607; GO:0098586		23291588; 15057824	Lambda interferon family
M0R2J8	DCDC1_HUMAN	Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein)	DCDC1 DCDC5 KIAA1493	1783	9606			Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Lectin;Microtubule;Mitosis;Reference proteome;Repeat			GO:0005737; GO:0005874; GO:0007049; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412		12820024; 14702039; 16554811; 22159412	
O00115	DNS2A_HUMAN	Deoxyribonuclease-2-alpha, EC 3.1.22.1 (Acid DNase) (Deoxyribonuclease II alpha, DNase II alpha) (Lysosomal DNase II) (R31240_2)	DNASE2 DNASE2A DNL2	360	9606		3.1.22.1	Alternative splicing;Apoptosis;Developmental protein;Disulfide bond;Endonuclease;Glycoprotein;Hydrolase;Lysosome;Nuclease;Reference proteome;Signal			GO:0003677; GO:0004531; GO:0005764; GO:0006259; GO:0006309; GO:0030218; GO:0050776; GO:0070062	PTM: Glycosylated. Mutations that eliminate N-glycosylation sites reduce activity, but enzymatic deglycosylation has no effect. {ECO:0000269|PubMed:11906178, ECO:0000269|PubMed:12558498, ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:19159218}.	9924608; 9647784; 9714827; 9812984; 9446563; 14702039; 15057824; 15489334; 11906178; 12558498; 12594037; 12754519; 19159218; 24275569; 25944712	DNase II family
O00116	ADAS_HUMAN	Alkyldihydroxyacetonephosphate synthase, peroxisomal, Alkyl-DHAP synthase, EC 2.5.1.26 (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)	AGPS AAG5	658	9606	PATHWAY: Glycerolipid metabolism; ether lipid biosynthesis.	2.5.1.26	Acetylation;Cataract;Disease variant;Dwarfism;FAD;Flavoprotein;Lipid biosynthesis;Lipid metabolism;Membrane;Peroxisome;Phosphoprotein;Reference proteome;Rhizomelic chondrodysplasia punctata;Transferase;Transit peptide	Q9BQQ3		GO:0005730; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0016491; GO:0071949		9187299; 14702039; 15489334; 8399344; 18669648; 19608861; 21269460; 23186163; 24275569; 25944712; 9553082; 11152660; 21990100	FAD-binding oxidoreductase/transferase type 4 family
O00124	UBXN8_HUMAN	UBX domain-containing protein 8 (Reproduction 8 protein, Rep-8 protein) (UBX domain-containing protein 6)	UBXN8 D8S2298E REP8 UBXD6	270	9606			Alternative splicing;Endoplasmic reticulum;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	Q13520; P14136; P48165; Q7Z5P4; Q6FHY5; O15173; Q9NUH8; P55072	TISSUE SPECIFICITY: Expressed abundantly in ovary and testis, and weakly in all other tissues tested.	GO:0000151; GO:0005654; GO:0005730; GO:0005783; GO:0007338; GO:0030176; GO:0030433; GO:0030674; GO:0043130		9027507; 15489334; 18669648; 20068231; 21949850	
O00139	KIF2A_HUMAN	Kinesin-like protein KIF2A (Kinesin-2, hK2)	KIF2A KIF2 KNS2	706	9606			3D-structure;Acetylation;Alternative splicing;ATP-binding;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Developmental protein;Differentiation;Disease variant;Lissencephaly;Microtubule;Mitosis;Motor protein;Neurogenesis;Nucleotide-binding;Phosphoprotein;Reference proteome	Q8NE31; Q659C4; Q96EL3; P25791-3; Q8TAP4-4; Q96EL3; Q7Z699		GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0120103		9177777; 14702039; 17974005; 15372022; 15489334; 15843429; 17538014; 18411309; 19351716; 19690332; 21269460; 23186163; 23603762	TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, MCAK/KIF2 subfamily
O00141	SGK1_HUMAN	Serine/threonine-protein kinase Sgk1, EC 2.7.11.1 (Serum/glucocorticoid-regulated kinase 1)	SGK1 SGK	431	9606		2.7.11.1	3D-structure;Alternative promoter usage;Alternative splicing;Apoptosis;ATP-binding;Cell membrane;Cytoplasm;Disulfide bond;Endoplasmic reticulum;Kinase;Membrane;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Stress response;Transferase;Ubl conjugation	O15182; Q969L2; Q9ULP0-2; P49815; Q80UE6	TISSUE SPECIFICITY: Expressed in most tissues with highest levels in the pancreas, followed by placenta, kidney and lung. Isoform 2 is strongly expressed in brain and pancreas, weaker in heart, placenta, lung, liver and skeletal muscle. {ECO:0000269|PubMed:10548550, ECO:0000269|PubMed:18753299}.	GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045	PTM: Regulated by phosphorylation. Activated by phosphorylation on Ser-422 by mTORC2, transforming it into a substrate for PDPK1 which phosphorylates it on Thr-256. Phosphorylation on Ser-397 and Ser-401 are also essential for its activity. Phosphorylation on Ser-78 by MAPK7 is required for growth factor-induced cell cycle progression. {ECO:0000269|PubMed:10191262, ECO:0000269|PubMed:11096081, ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:18925875, ECO:0000269|PubMed:19068477, ECO:0000269|PubMed:20338997}.; PTM: Ubiquitinated by NEDD4L; which promotes proteasomal degradation. Ubiquitinated by SYVN1 at the endoplasmic reticulum; which promotes rapid proteasomal degradation and maintains a high turnover rate in resting cells. Isoform 2 shows enhanced stability. {ECO:0000269|PubMed:15576372}.	9114008; 9722955; 18753299; 14702039; 14574404; 15489334; 10548550; 10191262; 10884438; 11254654; 11096081; 11410590; 11154281; 11696533; 12590200; 12397388; 14623317; 12650886; 12761204; 12911626; 12631736; 12634932; 15044175; 14706641; 15319523; 15234985; 15040001; 15496163; 15888551; 15845389; 15737648; 16036218; 15733869; 15576372; 16443776; 16982696; 17202226; 17382906; 18005662; 18304449; 18925875; 18691976; 18334630; 19068477; 19447520; 19756449; 19369195; 20511718; 20338997; 20730100; 20068231; 21865597; 12649597; 16460280; 20919962; 20530112; 17965184; 17344846	Protein kinase superfamily, AGC Ser/Thr protein kinase family
O00142	KITM_HUMAN	Thymidine kinase 2, mitochondrial, EC 2.7.1.21 (2'-deoxyuridine kinase TK2, EC 2.7.1.74) (Deoxycytidine kinase TK2, EC 2.7.1.-) (Mt-TK)	TK2	265	9606		2.7.1.-; 2.7.1.21; 2.7.1.74	Alternative splicing;ATP-binding;Direct protein sequencing;Disease variant;DNA synthesis;Kinase;Mitochondrion;Nucleotide-binding;Primary mitochondrial disease;Progressive external ophthalmoplegia;Reference proteome;Transferase;Transit peptide		TISSUE SPECIFICITY: Predominantly expressed in liver, pancreas, muscle, and brain. {ECO:0000269|PubMed:9079672}.	GO:0004137; GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006139; GO:0019136; GO:0019206; GO:0043097; GO:0046092; GO:0046104; GO:0071897		9079672; 9989599; 20843780; 14702039; 15616553; 25944712; 11687801; 12391347; 15639197; 15907288; 21937588; 25446393	DCK/DGK family
O00144	FZD9_HUMAN	Frizzled-9, Fz-9, hFz9 (FzE6) (CD antigen CD349)	FZD9 FZD3	591	9606			Cell membrane;Developmental protein;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Signal;Transducer;Transmembrane;Transmembrane helix;Ubl conjugation;Wnt signaling pathway		TISSUE SPECIFICITY: Expressed predominantly in adult and fetal brain, testis, eye, skeletal muscle and kidney. Moderately expressed in pancreas, thyroid, adrenal cortex, small intestine and stomach. Detected in fetal liver and kidney. Expressed in neural progenitor cells (PubMed:27509850). {ECO:0000269|PubMed:27509850}.	GO:0001503; GO:0001836; GO:0004930; GO:0005737; GO:0005789; GO:0005794; GO:0005886; GO:0007399; GO:0007405; GO:0007611; GO:0009986; GO:0016021; GO:0017147; GO:0030183; GO:0030501; GO:0031527; GO:0031966; GO:0042803; GO:0042813; GO:0043065; GO:0043524; GO:0046982; GO:0048471; GO:0051480; GO:0051726; GO:0051902; GO:0060070; GO:0060546; GO:0090263; GO:0098794; GO:0098978; GO:0099173; GO:0099566; GO:1901029; GO:1904393; GO:1904394; GO:1990523; GO:2000179	PTM: Ubiquitinated by ZNRF3, leading to its degradation by the proteasome. {ECO:0000250}.	9147651; 12853948; 9707618; 27509850	G-protein coupled receptor Fz/Smo family
O00148	DX39A_HUMAN	ATP-dependent RNA helicase DDX39A, EC 3.6.4.13 (DEAD box protein 39) (Nuclear RNA helicase URH49)	DDX39A DDX39	427	9606		3.6.4.13	Acetylation;Alternative splicing;ATP-binding;Cytoplasm;Helicase;Hydrolase;Isopeptide bond;mRNA processing;mRNA splicing;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;RNA-binding;Ubl conjugation	Q9Y3Y2-3; O00148; Q13838; P04792; P42858; P78317; P82979; P21673; P54274; Q7KZS0; O76024; H0YHG0	TISSUE SPECIFICITY: Detected in testis, and at lower levels in brain, kidney, lung, thymus, spleen and salivary gland. {ECO:0000269|PubMed:15047853}.	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0016887; GO:0042802		17548965; 14702039; 15057824; 15489334; 14667819; 15047853; 16478985; 17196963; 18669648; 19413330; 19608861; 20068231; 21269460; 21859714; 22223895; 23186163; 23652018; 25218447; 28112733	DEAD box helicase family, DECD subfamily
O00151	PDLI1_HUMAN	PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36)	PDLIM1 CLIM1 CLP36	329	9606			3D-structure;Acetylation;Cytoplasm;Cytoskeleton;Direct protein sequencing;LIM domain;Metal-binding;Phosphoprotein;Reference proteome;Zinc	O43707; P14136	TISSUE SPECIFICITY: Strongly expressed in the heart and skeletal muscle, moderately expressed in the spleen, small intestine, colon, placenta, and lung. A lower level expression is seen in liver, thymus, kidney, prostate and pancreas and is not found in the brain, testis, ovary, and peripheral blood leukocytes.	GO:0001666; GO:0001725; GO:0003713; GO:0003779; GO:0005667; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0006357; GO:0006979; GO:0007507; GO:0010761; GO:0030011; GO:0030018; GO:0030036; GO:0030950; GO:0031941; GO:0043149; GO:0046872; GO:0051371; GO:0061061; GO:0098641		10022510; 11110697; 14702039; 15164054; 15489334; 12665801; 10861853; 10753915; 15144186; 15592455; 17924679; 18088087; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569	
O00154	BACH_HUMAN	Cytosolic acyl coenzyme A thioester hydrolase, EC 3.1.2.2 (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase, BACH, hBACH) (CTE-IIa, CTE-II) (Long chain acyl-CoA thioester hydrolase)	ACOT7 BACH	380	9606	PATHWAY: Lipid metabolism; fatty acid metabolism. {ECO:0000305|PubMed:10578051}.	3.1.2.2	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Fatty acid metabolism;Hydrolase;Lipid metabolism;Mitochondrion;Reference proteome;Repeat;Serine esterase	Q01484; Q13554; Q9HCK8; Q13618; Q06787; V9HW27; P43360; Q9NVV9; Q9UMX0; Q9UMX0-2; Q8WYK0; O95429; Q13554-3; Q15038; P32321; Q9H0I2; P43357; P43360; Q14863; Q9H0A9-2; Q9NVV9; Q9UMX0; Q9UHD9; Q04323-2; Q7Z4V0	TISSUE SPECIFICITY: Isoform 4 is expressed exclusively in brain. {ECO:0000269|PubMed:12435388}.	GO:0000062; GO:0005654; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0015937; GO:0016290; GO:0036042; GO:0036114; GO:0036116; GO:0042803; GO:0047617; GO:0051792; GO:0052689; GO:0070062; GO:0102991; GO:1900535		10578051; 12435388; 14702039; 16710414; 15489334; 19608861; 21269460	
O00155	GPR25_HUMAN	Probable G-protein coupled receptor 25	GPR25	361	9606			Cell membrane;G-protein coupled receptor;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	Q13520; P27449; O15342; Q8NFU1; Q9P003; Q96BA8; Q68CJ9; Q969F0; Q9UJ14; P08034; Q70UQ0-4; Q8N6L0; Q5T700; Q6N075; Q8N4V1; Q58DX5; Q8ND90; Q9HD89; Q9UBD6; Q3SXP7; O60669; Q7Z769; Q96BD0; P27105; Q96Q45-2; Q9NWD8; Q4KMG9; Q86W33-2; O95859; O95292; Q53XM7		GO:0004930; GO:0005886; GO:0005887; GO:0007186		9020062; 15489334	G-protein coupled receptor 1 family
O00159	MYO1C_HUMAN	Unconventional myosin-Ic (Myosin I beta, MMI-beta, MMIb)	MYO1C	1063	9606			3D-structure;Acetylation;Actin-binding;Alternative splicing;ATP-binding;Calmodulin-binding;Cell membrane;Cell projection;Cytoplasm;Cytoplasmic vesicle;Direct protein sequencing;Membrane;Methylation;Motor protein;mRNA transport;Myosin;Nuclear pore complex;Nucleotide-binding;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Translocation;Transport			GO:0000146; GO:0001726; GO:0005102; GO:0005516; GO:0005524; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0006338; GO:0006612; GO:0007015; GO:0008022; GO:0009925; GO:0015629; GO:0016020; GO:0016328; GO:0016461; GO:0016604; GO:0030050; GO:0030335; GO:0030659; GO:0031267; GO:0031941; GO:0031982; GO:0035066; GO:0038089; GO:0045121; GO:0045335; GO:0045943; GO:0045944; GO:0045945; GO:0051015; GO:0051028; GO:0060171; GO:0070062; GO:0071346; GO:0090314; GO:0110016; GO:1900078; GO:1900748; GO:2000810	PTM: Isoform 2 contains a N-acetylmethionine at position 1.	9119401; 14702039; 16625196; 15489334; 16133118; 16877530; 16603771; 18669648; 20068231; 21269460; 22736583; 22814378; 23186163; 24275569; 25944712; 24636949	TRAFAC class myosin-kinesin ATPase superfamily, Myosin family
O00160	MYO1F_HUMAN	Unconventional myosin-If (Myosin-Ie)	MYO1F	1098	9606			Actin-binding;ATP-binding;Calmodulin-binding;Deafness;Disease variant;Motor protein;Myosin;Non-syndromic deafness;Nucleotide-binding;Phosphoprotein;Reference proteome;SH3 domain	Q7L5A3; Q9BWG6; P78314-3		GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016461; GO:0030050; GO:0031982; GO:0051015		11804589; 14702039; 15057824; 15489334; 9119401; 19367720; 22938506	TRAFAC class myosin-kinesin ATPase superfamily, Myosin family
O00161	SNP23_HUMAN	Synaptosomal-associated protein 23, SNAP-23 (Vesicle-membrane fusion protein SNAP-23)	SNAP23	211	9606			3D-structure;Acetylation;Alternative splicing;Cell junction;Cell membrane;Coiled coil;Direct protein sequencing;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Protein transport;Reference proteome;Repeat;Synapse;Synaptosome;Transport	P54920; Q9H115; O75558; Q15836; Q8IUH5	TISSUE SPECIFICITY: Ubiquitous. Highest levels where found in placenta.	GO:0002553; GO:0005484; GO:0005654; GO:0005737; GO:0005739; GO:0005886; GO:0005912; GO:0005925; GO:0006887; GO:0006892; GO:0006903; GO:0006906; GO:0015031; GO:0016082; GO:0019905; GO:0030670; GO:0031201; GO:0031629; GO:0035579; GO:0042581; GO:0042582; GO:0043005; GO:0061025; GO:0070062; GO:0070821; GO:0098793		8663154; 9070898; 11354632; 15489334; 12665801; 12130530; 18669648; 19413330; 20068231; 21269460; 21044946; 21406692; 22223895; 22814378; 23186163; 24275569; 25944712; 28882895; 12556468	SNAP-25 family
O00165	HAX1_HUMAN	HCLS1-associated protein X-1 (HS1-associating protein X-1, HAX-1) (HS1-binding protein 1, HSP1BP-1)	HAX1 HS1BP1	279	9606			Acetylation;Alternative splicing;Cell membrane;Cytoplasm;Cytoplasmic vesicle;Direct protein sequencing;Disease variant;Endoplasmic reticulum;Membrane;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Sarcoplasmic reticulum	P03372; Q14451; P42858; P01583; Q92993; Q8TAP4-4; Q9BRX2; Q9H4B6; Q15047-2; Q9ULQ1; Q8NHX9; P61981; Q68871	TISSUE SPECIFICITY: Ubiquitous. Up-regulated in oral cancers. {ECO:0000269|PubMed:17545607, ECO:0000269|PubMed:9058808}.	GO:0000932; GO:0005635; GO:0005667; GO:0005739; GO:0005741; GO:0005758; GO:0005783; GO:0005938; GO:0014068; GO:0015629; GO:0016324; GO:0016529; GO:0019966; GO:0030027; GO:0030136; GO:0030833; GO:0030854; GO:0031965; GO:0033138; GO:0042981; GO:0043066; GO:0045944; GO:0047485; GO:0050731; GO:0051897; GO:0071345; GO:1903146; GO:1903214; GO:2000251	PTM: Proteolytically cleaved by caspase-3 during apoptosis. {ECO:0000269|PubMed:18319618}.	9058808; 18472110; 14702039; 16710414; 15489334; 10760273; 15339924; 16857965; 17545607; 17241641; 17187068; 18337561; 18319618; 18971376; 20171186; 21269460; 20665473; 23164465; 24188827; 23186163; 24275569; 25298122; 25944712; 26997484; 19796188; 20220065	HAX1 family
O00167	EYA2_HUMAN	Eyes absent homolog 2, EC 3.1.3.48	EYA2 EAB1	538	9606		3.1.3.48	3D-structure;Activator;Alternative splicing;Chromatin regulator;Cytoplasm;Developmental protein;DNA damage;DNA repair;Hydrolase;Magnesium;Metal-binding;Nucleus;Protein phosphatase;Reference proteome;Transcription;Transcription regulation	Q15475; Q15475; O95817; Q8NEC5; Q07002; Q86UW9; Q9H596; Q9H0I2; Q7L5A3; O14964; Q8NA54; P56470; Q71SY5; Q9HBE1-4; P55771; Q13526; Q7Z3K3; P48378; Q15475; P09234; Q9NZD8; P51687; Q8WW24; Q96M29; Q92734; Q08117-2; Q9BUZ4; O75865-2; Q96PN8; A5D8V6	TISSUE SPECIFICITY: Highest expression in muscle with lower levels in kidney, placenta, pancreas, brain and heart. {ECO:0000269|PubMed:9195991}.	GO:0000287; GO:0004725; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006325; GO:0007501; GO:0014706; GO:0016576; GO:0030154; GO:0045739; GO:0048856; GO:0097192; GO:0097345; GO:2001240		9195991; 9020840; 11780052; 15489334; 9049631; 9887327; 10906137; 12500905; 19497856; 21706047; 19351884; 19858093; 23435380	HAD-like hydrolase superfamily, EYA family
O00168	PLM_HUMAN	Phospholemman (FXYD domain-containing ion transport regulator 1) (Sodium/potassium-transporting ATPase subunit FXYD1)	FXYD1 PLM	92	9606			3D-structure;Cell membrane;Glutathionylation;Ion transport;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Potassium;Potassium transport;Reference proteome;Signal;Sodium;Sodium transport;Sodium/potassium transport;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Highest expression in skeletal muscle and heart. Moderate levels in brain, placenta, lung, liver, pancreas, uterus, bladder, prostate, small intestine and colon with mucosal lining. Very low levels in kidney, colon and small intestine without mucosa, prostate without endothelial lining, spleen, and testis. {ECO:0000269|PubMed:9169143}.	GO:0005254; GO:0005886; GO:0005887; GO:0005890; GO:0005901; GO:0006813; GO:0006814; GO:0006821; GO:0006936; GO:0008016; GO:0010734; GO:0014704; GO:0016324; GO:0017080; GO:0030315; GO:0042383; GO:0044325; GO:0086036; GO:1903278; GO:2000649	PTM: Major plasma membrane substrate for cAMP-dependent protein kinase (PKA) and protein kinase C (PKC) in several different tissues (By similarity). Phosphorylated in response to insulin and adrenergic stimulation (By similarity). Phosphorylation at Ser-88 stimulates sodium/potassium-transporting ATPase activity while the unphosphorylated form inhibits sodium/potassium-transporting ATPase activity (By similarity). Phosphorylation increases tetramerization, decreases binding to ATP1A1 and reduces inhibition of ATP1A1 activity (By similarity). Phosphorylation at Ser-83 leads to greatly reduced interaction with ATP1A1, ATP1A2 and ATP1A3 (By similarity). May be phosphorylated by DMPK (PubMed:10811636). {ECO:0000250|UniProtKB:O08589, ECO:0000250|UniProtKB:P56513, ECO:0000269|PubMed:10811636}.; PTM: Palmitoylation increases half-life and stability and is enhanced upon phosphorylation at Ser-88 by PKA. {ECO:0000269|PubMed:21868384}.	9169143; 10950925; 14702039; 15489334; 10811636; 16597826; 21868384; 17511473	FXYD family
O00170	AIP_HUMAN	AH receptor-interacting protein, AIP (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2, XAP-2) (Immunophilin homolog ARA9)	AIP XAP2	330	9606			3D-structure;Cushing syndrome;Cytoplasm;Phosphoprotein;Reference proteome;Repeat;TPR repeat	P00533; P08238; Q92985; O00408	TISSUE SPECIFICITY: Widely expressed. Higher levels seen in the heart, placenta and skeletal muscle. Not expressed in the liver.	GO:0003713; GO:0003755; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0010738; GO:0016020; GO:0017162; GO:0022417; GO:0034751; GO:0036004; GO:0051082; GO:0051344		8972861; 9111057; 16728643; 17244780; 21753072; 16554811; 15489334; 15592455; 17341560; 17299063; 19366855; 23186163; 23300914; 17360484; 18410548; 21269460	
O00175	CCL24_HUMAN	C-C motif chemokine 24 (CK-beta-6) (Eosinophil chemotactic protein 2, Eotaxin-2) (Myeloid progenitor inhibitory factor 2, MPIF-2) (Small-inducible cytokine A24)	CCL24 MPIF2 SCYA24	119	9606			3D-structure;Chemotaxis;Cytokine;Direct protein sequencing;Disulfide bond;Glycoprotein;Inflammatory response;Reference proteome;Secreted;Signal	P13501; O14625	TISSUE SPECIFICITY: Activated monocytes and activated T lymphocytes. {ECO:0000269|PubMed:9104803}.	GO:0001938; GO:0002548; GO:0005615; GO:0006935; GO:0006954; GO:0006955; GO:0007010; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0008360; GO:0030335; GO:0030593; GO:0030838; GO:0031728; GO:0043547; GO:0045766; GO:0048018; GO:0048020; GO:0048245; GO:0048247; GO:0050729; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:2000418	PTM: N-glycosylated. {ECO:0000269|PubMed:9104803}.	9104803; 9365122; 14702039; 12853948; 15489334; 15340161; 10913244	Intercrine beta (chemokine CC) family
O00180	KCNK1_HUMAN	Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1)	KCNK1 HOHO1 KCNO1 TWIK1	336	9606			3D-structure;Cell junction;Cell membrane;Cell projection;Cytoplasmic vesicle;Disulfide bond;Endosome;Glycoprotein;Ion channel;Ion transport;Isopeptide bond;Membrane;Phosphoprotein;Potassium;Potassium channel;Potassium transport;Reference proteome;Synapse;Transmembrane;Transmembrane helix;Transport;Ubl conjugation	Q13520; O14735; Q96BA8; Q9Y282; O00180; P27105; P63165; Q8IV31; Q9NUH8	TISSUE SPECIFICITY: Detected in bronchial epithelial cells (PubMed:21964404). Detected in heart left atrium and left ventricle (PubMed:17478540). Detected in cardiac myocytes (at protein level) (PubMed:21653227). Widely expressed with high levels in heart, brain and kidney, and lower levels in colon, ovary, placenta, lung and liver (PubMed:8605869, PubMed:9362344). Highly expressed in cerebellum, and detected at lower levels in amygdala, caudate nucleus, brain cortex, hippocampus, putamen, substantia nigra, thalamus, dorsal root ganglion, spinal cord, pituitary, heart, kidney, lung, placenta, pancreas, stomach, small intestine, uterus and prostate (PubMed:11165377). Detected in right and left heart ventricle and atrium, and in heart Purkinje fibers (PubMed:17478540). Detected in bronchial epithelial cells (PubMed:21964404). {ECO:0000269|PubMed:11165377, ECO:0000269|PubMed:17478540, ECO:0000269|PubMed:21653227, ECO:0000269|PubMed:21964404, ECO:0000269|PubMed:8605869, ECO:0000269|PubMed:9362344}.	GO:0005242; GO:0005267; GO:0005272; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0016324; GO:0022841; GO:0030322; GO:0030425; GO:0031526; GO:0034705; GO:0035094; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0055037; GO:0060075; GO:0071805; GO:0097060; GO:1902937	PTM: Sumoylation is controversial. Sumoylated by UBE2I (PubMed:15820677). Not sumoylated when expressed in xenopus oocytes or mammalian cells (PubMed:17693262). Sumoylation inactivates the channel, but does not interfere with expression at the cell membrane (PubMed:15820677). Sumoylation of a single subunit is sufficient to silence the dimeric channel (PubMed:20498050, PubMed:23169818). Sumoylation of KCNK1 is sufficient to silence heterodimeric channels formed by KCNK1 and KCNK3 or KCNK9 (PubMed:23169818). Desumoylated by SENP1; this activates the channel (PubMed:15820677, PubMed:20498050, PubMed:23169818). Desumoylated by SENP1; this strongly increases halothane-mediated activation of heterodimeric channels formed with KCNK9 (PubMed:23169818). SENP1 treatment has no effect (PubMed:17693262). {ECO:0000269|PubMed:15820677, ECO:0000269|PubMed:17693262, ECO:0000269|PubMed:20498050, ECO:0000269|PubMed:23169818}.	8605869; 9462864; 9362344; 16710414; 15489334; 8978667; 11165377; 15820677; 17693262; 17478540; 19959478; 20498050; 21653227; 21964404; 22814378; 22431633; 23169818; 25530075; 25001086; 25339226; 22282804	Two pore domain potassium channel (TC 1.A.1.8) family
O00182	LEG9_HUMAN	Galectin-9, Gal-9 (Ecalectin) (Tumor antigen HOM-HD-21)	LGALS9	355	9606			3D-structure;Alternative splicing;Chemotaxis;Cytoplasm;Immunity;Lectin;Nucleus;Reference proteome;Repeat;Secreted	Q15038	TISSUE SPECIFICITY: Peripheral blood leukocytes and lymphatic tissues. Expressed in lung, liver, breast and kidney with higher levels in tumor endothelial cells than normal endothelium (at protein level) (PubMed:24333696). Expressed in trophoblast cells in decidua and placenta in pregnancy (at protein level) (PubMed:23242525, PubMed:25578313). Isoform 2 is the most abundant isoform expressed in endothelial cells (PubMed:24333696). Upon endothelial cell activation isoform 2 expression decreases while expression of isoform 3 and isoform 5 increases (PubMed:24333696). Isoform 4 decreases in pathological pregnancy (PubMed:23242525). {ECO:0000269|PubMed:23242525, ECO:0000269|PubMed:24333696, ECO:0000269|PubMed:25578313}.	GO:0002519; GO:0005534; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006935; GO:0006954; GO:0007565; GO:0010628; GO:0010629; GO:0016936; GO:0019899; GO:0030246; GO:0032496; GO:0032682; GO:0032689; GO:0032720; GO:0032729; GO:0032731; GO:0032733; GO:0032735; GO:0032736; GO:0032753; GO:0032755; GO:0032757; GO:0032760; GO:0032834; GO:0038066; GO:0043123; GO:0043305; GO:0045953; GO:0046007; GO:0046598; GO:0048030; GO:0051092; GO:0060135; GO:0062023; GO:0070241; GO:0070371; GO:0070374; GO:0070555; GO:0071346; GO:0071636; GO:0071639; GO:0098586; GO:1901224; GO:2000510; GO:2000562; GO:2000563; GO:2000670; GO:2001190; GO:2001200; GO:2001269		9045665; 9642261; 16625196; 15489334; 16116184; 16286920; 20209097; 21670307; 23242525; 23817958; 23408620; 24786365; 24333696; 24465902; 25578313; 25754930; 18005988; 18977853; 20861009	
O00186	STXB3_HUMAN	Syntaxin-binding protein 3 (Platelet Sec1 protein, PSP) (Protein unc-18 homolog 3, Unc18-3) (Protein unc-18 homolog C, Unc-18C)	STXBP3	592	9606			Cell membrane;Cytoplasm;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport		TISSUE SPECIFICITY: Megakaryocytes and platelets.	GO:0001678; GO:0005829; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0007420; GO:0016192; GO:0016323; GO:0016324; GO:0017075; GO:0019905; GO:0022615; GO:0030073; GO:0030141; GO:0031091; GO:0032868; GO:0042581; GO:0043312; GO:0044877; GO:0045335; GO:0045955; GO:0046325; GO:0070062; GO:0070527; GO:0070820; GO:0071346; GO:0098793	PTM: Phosphorylated by PKC in platelets in response to thrombin stimulation; phosphorylation inhibits binding to STX4. {ECO:0000269|PubMed:10194441}.	8824310; 10194441; 14702039; 16710414; 15489334; 21269460; 24275569	STXBP/unc-18/SEC1 family
O00187	MASP2_HUMAN	Mannan-binding lectin serine protease 2, EC 3.4.21.104 (MBL-associated serine protease 2) (Mannose-binding protein-associated serine protease 2, MASP-2) [Cleaved into: Mannan-binding lectin serine protease 2 A chain; Mannan-binding lectin serine protease 2 B chain ]	MASP2	686	9606		3.4.21.104	3D-structure;Alternative splicing;Autocatalytic cleavage;Calcium;Complement pathway;Direct protein sequencing;Disease variant;Disulfide bond;EGF-like domain;Hydrolase;Hydroxylation;Immunity;Innate immunity;Metal-binding;Protease;Reference proteome;Repeat;Secreted;Serine protease;Signal;Sushi	P11226; P05155; PRO_0000042699 [P0C0L5]; P48740-1; P48740-2; P48740-3; O00187-2; P11226; P11226	TISSUE SPECIFICITY: Plasma.	GO:0001855; GO:0001867; GO:0002752; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0006958; GO:0008233; GO:0009897; GO:0042802; GO:0048306; GO:0070062; GO:1903028; GO:1905370	PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains. {ECO:0000250}.; PTM: Activated by cleavage after Arg-444. The uncleaved zymogen is inactive towards synthetic substrates, but has sufficient activity to effect autocatalytic cleavage.	9087411; 10330290; 10092804; 14702039; 16710414; 8618346; 11426320; 10946292; 15117939; 15364579; 16040602; 12904520; 16029433; 17252003; 25930971	Peptidase S1 family
O00189	AP4M1_HUMAN	AP-4 complex subunit mu-1 (AP-4 adaptor complex mu subunit) (Adaptor-related protein complex 4 subunit mu-1) (Mu subunit of AP-4) (Mu-adaptin-related protein 2, mu-ARP2) (Mu4-adaptin, mu4)	AP4M1 MUARP2	453	9606			3D-structure;Endosome;Golgi apparatus;Hereditary spastic paraplegia;Membrane;Neurodegeneration;Protein transport;Reference proteome;Transport	P49354; Q96K76; Q96K76-3	TISSUE SPECIFICITY: Ubiquitous. Highly expressed in testis and lowly expressed in brain and lung. {ECO:0000269|PubMed:9013859}.	GO:0000045; GO:0005769; GO:0005802; GO:0005829; GO:0006605; GO:0006622; GO:0006886; GO:0006892; GO:0006895; GO:0008104; GO:0008320; GO:0016192; GO:0019904; GO:0030124; GO:0030131; GO:0031410; GO:0031904; GO:0032588; GO:0070062; GO:0090160; GO:1903361		9013859; 10436028; 11139587; 15489334; 10066790; 19559397; 11802162; 26544806; 29180427; 32073997; 20230749	Adaptor complexes medium subunit family
O00192	ARVC_HUMAN	Armadillo repeat protein deleted in velo-cardio-facial syndrome	ARVCF	962	9606			Alternative splicing;Cell adhesion;Cell junction;Coiled coil;Methylation;Phosphoprotein;Reference proteome;Repeat		TISSUE SPECIFICITY: Found in all the examined tissues including heart, brain, liver and kidney. Found at low level in lung. Expressed in dermal connective tissue, salivary gland duct and in the corneal layer (at protein level) (PubMed:30479852). Expressed in arrector pili muscle (at protein level) (PubMed:29034528). {ECO:0000269|PubMed:29034528, ECO:0000269|PubMed:30479852}.	GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0016339; GO:0045296; GO:0098609		9126485; 10591208; 18669648; 19706687; 19690332; 20068231; 23186163; 24275569; 25009281; 29034528; 30479852	Beta-catenin family
O00194	RB27B_HUMAN	Ras-related protein Rab-27B, EC 3.6.5.2 (C25KG)	RAB27B	218	9606		3.6.5.2	3D-structure;Acetylation;Direct protein sequencing;Disulfide bond;Endosome;GTP-binding;Hydrolase;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Prenylation;Reference proteome	Q03135; P49366; Q9H8Y8; Q9BV36; Q8NFW9; Q9Y2J0-2; Q9UNE2; Q8TDW5; Q8TDW5-2	TISSUE SPECIFICITY: Expressed primarily in testis.	GO:0003924; GO:0003925; GO:0005525; GO:0005770; GO:0005795; GO:0005886; GO:0016324; GO:0019003; GO:0019904; GO:0030140; GO:0030141; GO:0031088; GO:0031489; GO:0032402; GO:0032585; GO:0042470; GO:0042589; GO:0045921; GO:0048488; GO:0070062; GO:0071985; GO:0098993; GO:0099641; GO:1904115		9066979; 11178108; 14702039; 15489334; 2507536; 21269460; 21775604; 25944712; 30771381	Small GTPase superfamily, Rab family
O00198	HRK_HUMAN	Activator of apoptosis harakiri (BH3-interacting domain-containing protein 3) (Neuronal death protein DP5)	HRK BID3	91	9606			3D-structure;Apoptosis;Membrane;Mitochondrion;Reference proteome;Transmembrane;Transmembrane helix	Q07817-1; Q07021		GO:0005739; GO:0006915; GO:0016021; GO:0031334; GO:0043065; GO:0090200		9130713; 16541075; 15031724; 21731739	
O00203	AP3B1_HUMAN	AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain)	AP3B1 ADTB3A	1094	9606			Albinism;Alternative splicing;Cytoplasmic vesicle;Disease variant;Golgi apparatus;Hermansky-Pudlak syndrome;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport	A0A0S2Z5Q7; P46379-2; O14645; P42858; Q5S007; Q96CV9; P37840; Q12955; Q9Y496	TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:9151686, ECO:0000269|PubMed:9182526}.	GO:0000902; GO:0002224; GO:0002244; GO:0003016; GO:0005739; GO:0005765; GO:0005769; GO:0005794; GO:0006464; GO:0006622; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016020; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0035654; GO:0042789; GO:0045202; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0090152; GO:0098773; GO:1903232; GO:1904115	PTM: Phosphorylated on serine residues. {ECO:0000269|PubMed:9182526}.; PTM: Pyrophosphorylation by 5-diphosphoinositol pentakisphosphate (5-IP7) impairs interaction with KIF3A (PubMed:19934039). Serine pyrophosphorylation is achieved by Mg(2+)-dependent, but enzyme independent transfer of a beta-phosphate from a inositol pyrophosphate to a pre-phosphorylated serine residue (PubMed:19934039). {ECO:0000269|PubMed:19934039}.	9151686; 9182526; 17974005; 15372022; 15489334; 17081983; 18088087; 18669648; 19413330; 20068231; 21406692; 23186163; 25944712; 19934039; 10024875; 21269460	Adaptor complexes large subunit family
O00204	ST2B1_HUMAN	Sulfotransferase 2B1, EC 2.8.2.2 (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1, ST2B1)	SULT2B1 HSST2	365	9606		2.8.2.2	3D-structure;Alternative splicing;Cytoplasm;Disease variant;Endoplasmic reticulum;Ichthyosis;Lipid metabolism;Microsome;Nucleus;Phosphoprotein;Reference proteome;Steroid metabolism;Transferase	P14621; Q96D03; Q96Q35; Q96Q35-2; Q9P2G9-2; O43900; Q04864-2; O76094; P50225; O43704; Q6IMI6; Q6ZNH5	TISSUE SPECIFICITY: Expressed in the stratum granulosum-stratum corneum junction in the skin (at protein level) (PubMed:28575648). Expressed highly in placenta, prostate and trachea and lower expression in the small intestine and lung (PubMed:9799594). {ECO:0000269|PubMed:28575648, ECO:0000269|PubMed:9799594}.	GO:0003676; GO:0004027; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0008146; GO:0008202; GO:0008203; GO:0008285; GO:0015485; GO:0043231; GO:0045606; GO:0050294; GO:0050427; GO:0051923; GO:0070062; GO:1990239	PTM: Phosphorylated. {ECO:0000269|PubMed:16855051}.	9799594; 15057824; 15489334; 12145317; 16855051; 19589875; 21855633; 12923182; 28575648	Sulfotransferase 1 family
O00206	TLR4_HUMAN	Toll-like receptor 4 (hToll) (CD antigen CD284)	TLR4	839	9606			3D-structure;Age-related macular degeneration;Alternative splicing;Cell membrane;Cell projection;Direct protein sequencing;Disulfide bond;Endosome;Glycoprotein;Immunity;Inflammatory response;Innate immunity;Leucine-rich repeat;Membrane;NAD;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	Q96A54; Q9Y6Y9; P11226; Q99836; Q9NPH5; O15389; O43699-3; Q9Y336; Q86XR7; P58753; O00206; Q9Y2C9; P24821; Q9Y6Y9; P49278	TISSUE SPECIFICITY: Highly expressed in placenta, spleen and peripheral blood leukocytes (PubMed:9435236, PubMed:9237759). Detected in monocytes, macrophages, dendritic cells and several types of T-cells (PubMed:9237759, PubMed:27022195). {ECO:0000269|PubMed:27022195, ECO:0000269|PubMed:9237759, ECO:0000269|PubMed:9435236}.	GO:0001530; GO:0001540; GO:0001726; GO:0001875; GO:0001891; GO:0002218; GO:0002224; GO:0002246; GO:0002322; GO:0002537; GO:0002730; GO:0002755; GO:0004888; GO:0005102; GO:0005737; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0006909; GO:0006954; GO:0006955; GO:0007252; GO:0009897; GO:0009986; GO:0010008; GO:0010572; GO:0010628; GO:0014002; GO:0014911; GO:0016046; GO:0030890; GO:0031226; GO:0031663; GO:0032496; GO:0032497; GO:0032689; GO:0032700; GO:0032707; GO:0032715; GO:0032720; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032732; GO:0032733; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034142; GO:0035666; GO:0036120; GO:0038023; GO:0042088; GO:0042116; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043406; GO:0045087; GO:0045348; GO:0045429; GO:0045671; GO:0045944; GO:0046330; GO:0046696; GO:0046982; GO:0048471; GO:0048661; GO:0050135; GO:0050729; GO:0050829; GO:0051092; GO:0051770; GO:0060729; GO:0060907; GO:0061809; GO:0070373; GO:0070374; GO:0070430; GO:0070434; GO:0071222; GO:0071223; GO:0071260; GO:0071346; GO:0120163; GO:0140052; GO:1900017; GO:1900227; GO:1901224; GO:1903223; GO:1903428; GO:1903974; GO:1904466; GO:1904646; GO:2000343	PTM: N-glycosylated. Glycosylation of Asn-526 and Asn-575 seems to be necessary for the expression of TLR4 on the cell surface and the LPS-response. Likewise, mutants lacking two or more of the other N-glycosylation sites were deficient in interaction with LPS. {ECO:0000269|PubMed:11706042, ECO:0000269|PubMed:17803912, ECO:0000269|PubMed:19252480, ECO:0000269|PubMed:22363519}.; PTM: Phosphorylated on tyrosine residues by LYN after binding lipopolysaccharide. {ECO:0000250|UniProtKB:Q9QUK6}.	9237759; 9435236; 11104518; 10835634; 18810425; 19924287; 14702039; 15164053; 15489334; 15340161; 11081518; 11274165; 11706042; 14519765; 15356101; 15809303; 16622205; 17098818; 17478729; 20865800; 21393102; 20037584; 20711192; 21602844; 23880187; 23569230; 25736436; 27022195; 29038465; 28334607; 30573680; 17803912; 19252480; 22363519; 11514453; 15829498; 25787250	Toll-like receptor family
O00212	RHOD_HUMAN	Rho-related GTP-binding protein RhoD (Rho-related protein HP1, RhoHP1)	RHOD ARHD	210	9606			3D-structure;Cell membrane;Endosome;GTP-binding;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Prenylation;Reference proteome		TISSUE SPECIFICITY: Heart, placenta, liver, skeletal muscle, and pancreas and, with weaker intensity, in several other tissues.	GO:0000139; GO:0003924; GO:0005085; GO:0005525; GO:0005741; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0010008; GO:0016477; GO:0019901; GO:0030032; GO:0030335; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0045785; GO:0048041; GO:0051017; GO:0051056		9116026; 16554811; 15489334; 12577064; 17064668; 18669648; 23087206; 23454120; 24102721	Small GTPase superfamily, Rho family
O00213	APBB1_HUMAN	Amyloid beta precursor protein binding family B member 1 (Amyloid-beta A4 precursor protein-binding family B member 1) (Protein Fe65)	APBB1 FE65 RIR	710	9606			3D-structure;Acetylation;Activator;Alternative splicing;Apoptosis;Cell membrane;Cell projection;Chromatin regulator;Cytoplasm;DNA damage;Membrane;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	P05067; P05067-4; P62330; P00533; P04626; Q07954; Q02563; P05067; Q86YB2; Q8NFZ0; Q92993; O15116; Q14141; Q99720-4; O95416	TISSUE SPECIFICITY: Highly expressed in brain; strongly reduced in post-mortem elderly subjects with Alzheimer disease. {ECO:0000269|PubMed:19343227}.; TISSUE SPECIFICITY: [Isoform 4]: Expressed preferentially in the brain. {ECO:0000269|PubMed:21824145}.	GO:0000122; GO:0001540; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005886; GO:0006325; GO:0006355; GO:0006915; GO:0006939; GO:0006974; GO:0007165; GO:0007409; GO:0016607; GO:0030027; GO:0030426; GO:0031625; GO:0042393; GO:0043065; GO:0043967; GO:0045202; GO:0045893; GO:0045944; GO:0050714; GO:0050750; GO:0070064; GO:1902807	PTM: Phosphorylation at Ser-610 by SGK1 promotes its localization to the nucleus (By similarity). Phosphorylated following nuclear translocation (PubMed:15031292, PubMed:18922798). Phosphorylation at Tyr-547 by ABL1 enhances transcriptional activation activity and reduces the affinity for RASD1/DEXRAS1 (PubMed:15031292, PubMed:18922798). {ECO:0000250|UniProtKB:P46933, ECO:0000269|PubMed:15031292, ECO:0000269|PubMed:18922798}.; PTM: Acetylation at Lys-204 and Lys-701 by KAT5 promotes its transcription activator activity. {ECO:0000269|PubMed:33938178}.; PTM: Polyubiquitination by RNF157 leads to degradation by the proteasome (PubMed:25342469). {ECO:0000269|PubMed:25342469}.	8894693; 9799084; 21824145; 14702039; 17974005; 16554811; 15489334; 15031292; 17512906; 18468999; 18922798; 19234442; 19343227; 25342469; 33938178; 17686488; 18833287; 18550529	
O00214	LEG8_HUMAN	Galectin-8, Gal-8 (Po66 carbohydrate-binding protein, Po66-CBP) (Prostate carcinoma tumor antigen 1, PCTA-1)	LGALS8	317	9606			3D-structure;Alternative splicing;Autophagy;Cytoplasm;Cytoplasmic vesicle;Lectin;Reference proteome;Repeat	P13798; Q13137; Q9UJV3-2; Q86VP1; Q15583; P36406; O76024; P0DTC2; Q13137; P27797; P36957; Q9UJV3-2; Q96RE7; Q8TDX7; Q6NSM0; Q86VP1; Q969T9	TISSUE SPECIFICITY: Ubiquitous. Selective expression by prostate carcinomas versus normal prostate and benign prostatic hypertrophy.	GO:0005178; GO:0005615; GO:0005737; GO:0005829; GO:0016020; GO:0030246; GO:0031410; GO:0098586; GO:0098792; GO:1904977		8692978; 10980616; 16710414; 15489334; 19268462; 22246324; 28077878; 21288902	
O00217	NDUS8_HUMAN	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial, EC 7.1.1.2 (Complex I-23kD, CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)	NDUFS8	210	9606		7.1.1.2	3D-structure;4Fe-4S;Disease variant;Electron transport;Iron;Iron-sulfur;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;NAD;Oxidoreductase;Primary mitochondrial disease;Reference proteome;Repeat;Respiratory chain;Transit peptide;Translocase;Transport;Ubiquinone		TISSUE SPECIFICITY: Expressed in all tissues with the highest level in heart and skeletal muscle and the lowest level in lung. {ECO:0000269|PubMed:9666055}.	GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006979; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0046872; GO:0051539		9116042; 9666055; 14702039; 15489334; 12611891; 21269460; 24275569; 25944712; 31536960; 9837812; 15159508; 16142472; 22499348	Complex I 23 kDa subunit family
O00219	HYAS3_HUMAN	Hyaluronan synthase 3, EC 2.4.1.212 (Hyaluronate synthase 3) (Hyaluronic acid synthase 3, HA synthase 3)	HAS3	553	9606	PATHWAY: Glycan biosynthesis; hyaluronan biosynthesis. {ECO:0000269|PubMed:23303191}.	2.4.1.212	Alternative splicing;Cell membrane;Endosome;Glycoprotein;Glycosyltransferase;Golgi apparatus;Membrane;Reference proteome;Transferase;Transmembrane;Transmembrane helix	Q92839; Q92819; O00219; O95236-2; Q96FZ5; Q8TAF8; Q8N912; P60201-2; O43759-2		GO:0005634; GO:0005794; GO:0005886; GO:0005887; GO:0005975; GO:0016021; GO:0030213; GO:0036117; GO:0042802; GO:0045226; GO:0045893; GO:0050501; GO:0085029; GO:1900106	PTM: O-GlcNAcylation increases the hyaluronan synthase activity, HAS3 stability and its plasma membrane residence. The concentration of UDP-GlcNAc controls the level of O-GlcNAc modification. {ECO:0000269|PubMed:26883802}.	14702039; 15616553; 15489334; 9083017; 23303191; 25795779; 26883802; 30394292	NodC/HAS family
O00220	TR10A_HUMAN	Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1, TRAIL receptor 1, TRAIL-R1) (CD antigen CD261)	TNFRSF10A APO2 DR4 TRAILR1	468	9606			3D-structure;Apoptosis;Cell membrane;Cytoplasm;Disulfide bond;Glycoprotein;Membrane;Methylation;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	Q96P48; Q14790; Q08380; P50591	TISSUE SPECIFICITY: Widely expressed. High levels are found in spleen, peripheral blood leukocytes, small intestine and thymus, but also in K-562 erythroleukemia cells, MCF-7 breast carcinoma cells and activated T-cells.	GO:0002020; GO:0005035; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0007250; GO:0008625; GO:0009986; GO:0016021; GO:0036462; GO:0038023; GO:0042802; GO:0043065; GO:0045121; GO:0045569; GO:0071260; GO:0097191	PTM: Palmitoylated (PubMed:19090789). Palmitoylation of TNFRSF10A is required for its association with lipid rafts, oligomerization and function in TRAIL-induced cell death (PubMed:19090789). Palmitoylated by ZDHHC3 (Probable). {ECO:0000269|PubMed:19090789, ECO:0000305|PubMed:22240897}.	9082980; 14702039; 16421571; 15489334; 9430227; 17081983; 18165900; 18846110; 19090789; 20068231; 22240897; 23498957; 23186163; 24129315; 26457518	
O00221	IKBE_HUMAN	NF-kappa-B inhibitor epsilon, NF-kappa-BIE (I-kappa-B-epsilon, IkB-E, IkB-epsilon, IkappaBepsilon)	NFKBIE IKBE	500	9606			ANK repeat;Cytoplasm;Phosphoprotein;Reference proteome;Repeat	Q8IWZ3; Q9UPN7; O75170; Q04864	TISSUE SPECIFICITY: Highly expressed in spleen, testis and lung, followed by kidney, pancreas, heart, placenta and brain. Also expressed in granulocytes and macrophages.	GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0042994	PTM: Serine phosphorylated; followed by proteasome-dependent degradation.	9135156; 14574404; 9315679; 23186163	NF-kappa-B inhibitor family
O00222	GRM8_HUMAN	Metabotropic glutamate receptor 8, mGluR8	GRM8 GPRC1H MGLUR8	908	9606			3D-structure;Alternative splicing;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Isopeptide bond;Membrane;Receptor;Reference proteome;Sensory transduction;Signal;Transducer;Transmembrane;Transmembrane helix;Ubl conjugation			GO:0001640; GO:0001642; GO:0004930; GO:0005886; GO:0005887; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966		9299241; 9473604; 10216218; 12853948; 15489334	G-protein coupled receptor 3 family
O00230	CORT_HUMAN	Cortistatin [Cleaved into: Cortistatin-29; Cortistatin-17 ]	CORT UNQ307/PRO350	105	9606			3D-structure;Cleavage on pair of basic residues;Disulfide bond;Hormone;Reference proteome;Secreted;Signal	PRO_0000000092 [P05067]	TISSUE SPECIFICITY: Expressed in a subset of GABAergic cells in the cortex and hippocampus.	GO:0000712; GO:0001664; GO:0003682; GO:0005184; GO:0005576; GO:0005615; GO:0007193; GO:0007268; GO:0031297; GO:0043240; GO:0045202; GO:0071821		9125122; 9205124; 16710414; 15489334; 12975309	Somatostatin family
O00231	PSD11_HUMAN	26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5)	PSMD11	422	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Proteasome;Reference proteome;Ubl conjugation	P61201; O43741; Q96LA8	TISSUE SPECIFICITY: Highly expressed in embryonic stem cells (ESCs). Expression decreases as ESCs differentiate. {ECO:0000269|PubMed:22972301}.	GO:0000502; GO:0005198; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0034774; GO:0043161; GO:0043248; GO:0048863; GO:1904813	PTM: Phosphorylated by AMPK. {ECO:0000269|PubMed:19616115}.	9119060; 9426256; 14702039; 15489334; 12665801; 1317798; 17323924; 18669648; 19413330; 19616115; 21269460; 22223895; 22972301; 22814378; 23186163; 24275569; 25772364; 28112733; 27428775; 27342858	Proteasome subunit S9 family
O00232	PSD12_HUMAN	26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55)	PSMD12	456	9606			3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Isopeptide bond;Mental retardation;Proteasome;Reference proteome;Ubl conjugation	P55036		GO:0000502; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0008541; GO:0016020; GO:0022624; GO:0031595; GO:0034774; GO:0043161; GO:0070062; GO:1904813		9426256; 14702039; 16625196; 15489334; 12665801; 1317798; 14654843; 17323924; 19413330; 19608861; 21269460; 24275569; 25218447; 25114211; 25772364; 26030138; 28132691; 28112733; 27428775; 27342858	Proteasome subunit p55 family
O00233	PSMD9_HUMAN	26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27)	PSMD9	223	9606			Alternative splicing;Chaperone;Phosphoprotein;Reference proteome	Q9UHI8; O43865; Q8N9N5; Q96JN2-2; Q5SZL2-5; P0DML2; P09651-2; P08887-2; P03952; P06858; Q6FHY5; Q9NZQ3; P17980; P62333; P62263; P15923-1; Q12933; Q9HCM9; Q8IWZ5	TISSUE SPECIFICITY: Expressed in all tissues tested, highly expressed in liver and kidney.	GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0006511; GO:0032024; GO:0043425; GO:0045893; GO:0046676; GO:0070682		9653651; 14702039; 16712791; 16541075; 15489334; 19490896; 24275569; 21269460	Proteasome subunit p27 family
O00237	RN103_HUMAN	E3 ubiquitin-protein ligase RNF103, EC 2.3.2.27 (KF-1, hKF-1) (RING finger protein 103) (RING-type E3 ubiquitin transferase RNF103) (Zinc finger protein 103 homolog, Zfp-103)	RNF103 ZFP103	685	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.27	Endoplasmic reticulum;Membrane;Metal-binding;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Ubl conjugation pathway;Zinc;Zinc-finger		TISSUE SPECIFICITY: Highly expressed in the normal cerebellum but not in the cerebral cortex. {ECO:0000269|PubMed:9070305}.	GO:0004842; GO:0005783; GO:0005789; GO:0007417; GO:0016021; GO:0016567; GO:0030433; GO:0044322; GO:0046872; GO:0061630; GO:1904380		9070305; 14702039; 15815621; 15489334; 10500182; 18675248	
O00238	BMR1B_HUMAN	Bone morphogenetic protein receptor type-1B, BMP type-1B receptor, BMPR-1B, EC 2.7.11.30 (CD antigen CDw293)	BMPR1B	502	9606		2.7.11.30	3D-structure;Alternative splicing;ATP-binding;Cell membrane;Chondrogenesis;Disease variant;Disulfide bond;Dwarfism;Kinase;Magnesium;Manganese;Membrane;Metal-binding;Nucleotide-binding;Receptor;Reference proteome;Serine/threonine-protein kinase;Signal;Transferase;Transmembrane;Transmembrane helix	P12643; P43026		GO:0001502; GO:0001550; GO:0001649; GO:0001654; GO:0002063; GO:0004674; GO:0004675; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0006954; GO:0009953; GO:0016021; GO:0019211; GO:0030166; GO:0030501; GO:0030509; GO:0031290; GO:0032332; GO:0036122; GO:0042698; GO:0043235; GO:0043539; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0060041; GO:0060350; GO:0061036; GO:0071363; GO:0071773; GO:0098821; GO:1902043; GO:1902731; GO:1990712	PTM: Autophosphorylated. {ECO:0000250|UniProtKB:P36898}.	9178898; 10051328; 14702039; 15815621; 15489334; 24098149; 33308444; 14523231; 15805157; 16957682; 17344846; 24129431; 25758993; 26105076	Protein kinase superfamily, TKL Ser/Thr protein kinase family, TGFB receptor subfamily
O00241	SIRB1_HUMAN	Signal-regulatory protein beta-1, SIRP-beta-1 (CD172 antigen-like family member B) (CD antigen CD172b)	SIRPB1	398	9606			3D-structure;Alternative splicing;Cell membrane;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	O43914; P02654; Q9NP55; O75553; P50222; Q9NWB1-5; Q93062	TISSUE SPECIFICITY: Detected in monocytes and dendritic cells. {ECO:0000269|PubMed:10604985}.	GO:0005886; GO:0005887; GO:0007165; GO:0007166; GO:0009986; GO:0030667; GO:0050766; GO:0050870	PTM: N-glycosylated. {ECO:0000269|PubMed:10604985, ECO:0000269|PubMed:16335952}.	9062191; 14702039; 11780052; 15489334; 10940905; 10604985; 16081415; 16335952; 18657508	
O00244	ATOX1_HUMAN	Copper transport protein ATOX1 (Metal transport protein ATX1)	ATOX1 HAH1	68	9606			3D-structure;Acetylation;Chaperone;Copper;Copper transport;Ion transport;Metal-binding;Phosphoprotein;Reference proteome;Transport	P35670; O43822; P49747; Q9NWS6; O95749; Q8N987	TISSUE SPECIFICITY: Ubiquitous.	GO:0005507; GO:0005829; GO:0006825; GO:0006878; GO:0006979; GO:0016530; GO:0016531; GO:0032767; GO:1903136		9083055; 12594858; 14702039; 15489334; 19608861; 21269460; 21667063; 23186163; 24275569; 10966647; 19453293; 31283225	ATX1 family
O00253	AGRP_HUMAN	Agouti-related protein	AGRP AGRT ART	132	9606			3D-structure;Disease variant;Disulfide bond;Golgi apparatus;Knottin;Obesity;Reference proteome;Secreted;Signal		TISSUE SPECIFICITY: Expressed primarily in the adrenal gland, subthalamic nucleus, and hypothalamus, with a lower level of expression occurring in testis, lung, and kidney.	GO:0005102; GO:0005184; GO:0005615; GO:0005796; GO:0007218; GO:0007623; GO:0007631; GO:0008343; GO:0009755; GO:0031779; GO:0032868; GO:0042755; GO:0043025; GO:0048571; GO:0060135; GO:0060259; GO:0070996; GO:2000253		9119224; 9311920; 11602360; 11326303; 15489334; 9724530; 9892020; 11145747; 17185225; 16384863; 17041250; 10371151; 11747427; 12056887; 12213871; 15927146	
O00254	PAR3_HUMAN	Proteinase-activated receptor 3, PAR-3 (Coagulation factor II receptor-like 2) (Thrombin receptor-like 2)	F2RL2 PAR3	374	9606			Alternative splicing;Blood coagulation;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Hemostasis;Membrane;Receptor;Reference proteome;Signal;Transducer;Transmembrane;Transmembrane helix	P16333	TISSUE SPECIFICITY: Highest expression in the megakaryocytes of the bone marrow, lower in mature megakaryocytes, in platelets and in a variety of other tissues such as heart and gut. {ECO:0000269|PubMed:9614115}.	GO:0004435; GO:0004930; GO:0005576; GO:0005886; GO:0005887; GO:0007596; GO:0009611; GO:0015057; GO:0016324; GO:0030168; GO:0032991; GO:0035025; GO:0051482	PTM: A proteolytic cleavage generates a new N-terminus that functions as a tethered ligand.	9087410; 14702039; 17974005; 15372022; 15489334; 9614115; 10079109; 16458856	G-protein coupled receptor 1 family
O00255	MEN1_HUMAN	Menin	MEN1 SCG2	615	9606			3D-structure;Alternative splicing;Chromatin regulator;Disease variant;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	O14757; Q9BXW9; P35579; PRO_0000030311 [P19838]; P61964; P17535; Q03164; P35579; PRO_0000030311 [P19838]; PRO_0000030322 [Q00653]; Q04206; Q05982	TISSUE SPECIFICITY: Ubiquitous.	GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000781; GO:0000785; GO:0000976; GO:0001933; GO:0002076; GO:0003309; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005788; GO:0005829; GO:0006281; GO:0006325; GO:0006357; GO:0006974; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010812; GO:0016363; GO:0017053; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043433; GO:0044665; GO:0045668; GO:0045736; GO:0045786; GO:0045892; GO:0045944; GO:0046329; GO:0046697; GO:0047485; GO:0050680; GO:0051219; GO:0051568; GO:0051974; GO:0061469; GO:0070412; GO:0071333; GO:0071339; GO:0071375; GO:0071559; GO:1902807		9103196; 16554811; 17555499; 15489334; 9989505; 11526476; 11274402; 12874027; 12837246; 15374998; 14992727; 15199122; 17500065; 17525332; 18669648; 20068231; 23186163; 25305204; 24275569; 22936661; 22327296; 9215689; 9215690; 9241276; 9463336; 9683585; 9792884; 9843042; 9820618; 9671267; 10660339; 9506756; 9709921; 9709976; 9709985; 9740255; 9747036; 9832038; 10617276; 10229909; 10576763; 10647896; 9888389; 10090472; 10534569; 10993647; 11034102; 10849016; 10664520; 10664521; 11102994; 10634381; 11134142; 11241849; 12112656; 12417605; 12050235; 12016470; 12699448; 12791038; 12652570; 14686752; 12746426; 15205994; 15730416; 15714081; 17555500; 19413330; 19690332	
O00257	CBX4_HUMAN	E3 SUMO-protein ligase CBX4, EC 2.3.2.- (Chromobox protein homolog 4) (Polycomb 2 homolog, Pc2, hPc2)	CBX4	560	9606	PATHWAY: Protein modification; protein sumoylation.	2.3.2.-	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway	P35226; Q9HC52; Q13363; Q16665; Q99496; P63165; P31946; A6NKF2; P35226; P55212; P06307; P28329-3; P68400; P67870; P22607; P06396; O00291; P30519; P13473-2; Q9BYE7; O75400-2; P62826; Q99496; P19474; P62258; P63104	TISSUE SPECIFICITY: Ubiquitous.	GO:0000122; GO:0000976; GO:0003682; GO:0003714; GO:0003727; GO:0005634; GO:0005654; GO:0006325; GO:0016604; GO:0016607; GO:0019789; GO:0019899; GO:0031519; GO:0032183; GO:0035064; GO:0035102; GO:0043066; GO:0045892; GO:0051219; GO:0061665	PTM: Phosphorylated on Thr-497 by HIPK2 upon DNA damage. This phosphorylation stimulates E3 SUMO-protein ligase activity and promotes sumoylation on Lys-494, as well as sumoylation of other target proteins, such as HNRNPK. {ECO:0000269|PubMed:12679040, ECO:0000269|PubMed:15592428, ECO:0000269|PubMed:17018294}.	9315667; 19266028; 16625196; 15489334; 9199346; 12101246; 12167701; 12679040; 15592428; 16061479; 17018294; 18669648; 18927235; 19636380; 19608861; 21282530; 22467880; 22825850; 23186163; 24275569; 25218447; 25772364; 25755297; 27211601; 28842558; 28112733	
O00258	GET1_HUMAN	Guided entry of tail-anchored proteins factor 1 (Congenital heart disease 5 protein) (Tail-anchored protein insertion receptor WRB) (Tryptophan-rich basic protein)	GET1 CHD5 WRB	174	9606			3D-structure;Alternative splicing;Coiled coil;Endoplasmic reticulum;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q8WTS1; P02652; Q9BQE5; P29972; P49069; Q8NHW4; Q8IX05; P19397; P51798; P21964; Q5RI15; Q9UKR5; P30519; Q9BUP3-3; Q8N138; Q5VZY2; P43378; Q8IV61; Q5QGT7; Q8N6R1; Q9BZV2; Q7Z769; P30825; Q969W0; P32856-2; Q9NZ01; P02786; Q96DZ7; Q69YG0		GO:0005634; GO:0005783; GO:0005789; GO:0016021; GO:0043529; GO:0045048; GO:0050821; GO:0071816		9544840; 14702039; 10830953; 15489334; 21444755; 23041287; 24392163; 27226539; 31417168; 32187542; 32910895	WRB/GET1 family
O00264	PGRC1_HUMAN	Membrane-associated progesterone receptor component 1, mPR (Dap1) (IZA)	PGRMC1 HPR6.6 PGRMC	195	9606			3D-structure;Alternative splicing;Direct protein sequencing;Endoplasmic reticulum;Iron;Lipid-binding;Membrane;Metal-binding;Microsome;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Receptor;Reference proteome;Steroid-binding;Transmembrane;Transmembrane helix	Q13323; P49069; Q9H6E4; O76071; Q8NES8; P34910-2; P22830; O43681; Q8NBJ4; Q8N6L0; Q9UJ90; O15173; P16435; Q96EQ0; Q9NQZ8; P00181	TISSUE SPECIFICITY: Widely expressed, with highest expression in liver and kidney. Expressed by endometrial glands and stroma (at protein level) (PubMed:23793472). {ECO:0000269|PubMed:23793472}.	GO:0001540; GO:0005496; GO:0005741; GO:0005783; GO:0005886; GO:0005887; GO:0006783; GO:0007411; GO:0007613; GO:0008306; GO:0012505; GO:0016020; GO:0020037; GO:0030868; GO:0035579; GO:0042803; GO:0043005; GO:0043025; GO:0044297; GO:0045202; GO:0046872; GO:0099563; GO:1903078; GO:1905809		9705155; 14702039; 15772651; 15489334; 11697142; 17081983; 17487921; 17924679; 19367720; 18088087; 18691976; 18669648; 18318008; 19413330; 19369195; 19690332; 20068231; 21269460; 21730960; 21406692; 22292588; 23763432; 23186163; 24275569; 23793472; 25675345; 25944712; 27599036; 28396637; 28559337; 28007569; 26988023	Cytochrome b5 family, MAPR subfamily
O00267	SPT5H_HUMAN	Transcription elongation factor SPT5, hSPT5 (DRB sensitivity-inducing factor 160 kDa subunit, DSIF p160) (DRB sensitivity-inducing factor large subunit, DSIF large subunit) (Tat-cotransactivator 1 protein, Tat-CT1 protein)	SUPT5H SPT5 SPT5H	1087	9606			3D-structure;Acetylation;Activator;Alternative splicing;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	P50613; Q13526; P24928; P62937; P63272; P54274; Q5EP34; G3MZY8; A5PJW8	TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10075709, ECO:0000269|PubMed:8975720}.	GO:0000122; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006368; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982; GO:1900364	PTM: Methylated by PRMT1/HRMT1L2 and PRMT5/SKB1. Methylation negatively regulates interaction with P-TEFb and RNA polymerase II. {ECO:0000269|PubMed:12718890}.; PTM: Phosphorylated by CDK7 and CDK9. Phosphorylation by P-TEFb alleviates transcriptional pausing and can stimulate transcriptional elongation from the HIV-1 LTR. P-TEFb dependent phosphorylation is stimulated by the HIV-1 Tat protein. Phosphorylation may also stimulate interaction with PIN1. Bulk phosphorylation occurs predominantly in mitosis. {ECO:0000269|PubMed:10757782, ECO:0000269|PubMed:11112772, ECO:0000269|PubMed:11145967, ECO:0000269|PubMed:11575923, ECO:0000269|PubMed:11809800, ECO:0000269|PubMed:15564463, ECO:0000269|PubMed:16327805, ECO:0000269|PubMed:9199507}.	8975720; 9199507; 9450929; 9514752; 15489334; 9857195; 10199401; 10393184; 10421630; 10075709; 10454543; 10912001; 10757782; 11145967; 11112772; 11553615; 11575923; 11809800; 11940650; 12653964; 12718890; 12612062; 15380072; 15564463; 14701750; 15060154; 15136722; 16214896; 17081983; 16327805; 17924679; 18669648; 19413330; 20068231; 21269460; 23186163; 23652018; 24275569; 25218447; 25755297; 28112733; 19860741	SPT5 family
O00268	TAF4_HUMAN	Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit, TAF(II)130, TAFII-130, TAFII130) (Transcription initiation factor TFIID 135 kDa subunit, TAF(II)135, TAFII-135, TAFII135)	TAF4 TAF2C TAF2C1 TAF4A TAFII130 TAFII135	1085	9606			3D-structure;Direct protein sequencing;Host-virus interaction;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	O43889; Q9NS37; Q16514-1		GO:0000785; GO:0001541; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006468; GO:0017162; GO:0032991; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043966; GO:0045893; GO:0046982; GO:0051123; GO:0060261; GO:0071339		9192867; 11780052; 8942982; 8647434; 10373431; 12601814; 15960975; 15735663; 19690332; 23186163; 24129315; 10594036; 17483474; 33795473	TAF4 family
O00270	GPR31_HUMAN	12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor, 12-(S)-HETE receptor, 12-HETER (G-protein coupled receptor 31) (GPR31/12-HETER)	GPR31	319	9606			Cell membrane;G-protein coupled receptor;Glycoprotein;Lipid metabolism;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix			GO:0002237; GO:0002931; GO:0004930; GO:0005886; GO:0005887; GO:0006629; GO:0007186; GO:0010447; GO:0045125; GO:0050544; GO:0050728; GO:0050778		9205127; 14574404; 15489334; 21712392; 26965684; 28619714; 29227475; 31119277	G-protein coupled receptor 1 family
O00273	DFFA_HUMAN	DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit, DFF-45) (Inhibitor of CAD, ICAD)	DFFA DFF1 DFF45 H13	331	9606			3D-structure;Acetylation;Alternative splicing;Apoptosis;Cytoplasm;Direct protein sequencing;Phosphoprotein;Reference proteome	O76075; P04792; O54788		GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006309; GO:0019904; GO:0032076; GO:0032991; GO:0042981; GO:0043065; GO:0044183; GO:0060703; GO:0061077; GO:0070242; GO:1900118; GO:1902511	PTM: Caspase-3 cleaves DFF45 at 2 sites to generate an active factor.	9108473; 10409614; 10497265; 14702039; 16710414; 15489334; 16964243; 17525332; 18669648; 19413330; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 11371636	
O00287	RFXAP_HUMAN	Regulatory factor X-associated protein, RFX-associated protein (RFX DNA-binding complex 36 kDa subunit)	RFXAP	272	9606			3D-structure;Direct protein sequencing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;SCID;Ubl conjugation	P48382; O14593	TISSUE SPECIFICITY: Ubiquitous.	GO:0003677; GO:0005634; GO:0006357; GO:0016607; GO:0045944; GO:0090575	PTM: Phosphorylated.	9118943; 14702039; 15057823; 15489334; 10072068; 28112733; 20732328	
O00291	HIP1_HUMAN	Huntingtin-interacting protein 1, HIP-1 (Huntingtin-interacting protein I, HIP-I)	HIP1	1037	9606			3D-structure;Actin-binding;Activator;Alternative splicing;Apoptosis;Chromosomal rearrangement;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Differentiation;Endocytosis;Membrane;Neurodegeneration;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	Q9Y614; Q96MA6; Q9Y303-2; Q9H0Y0; Q14032; Q9NSI6-4; Q8WZ55; Q13901; Q3SXR2; Q5JTY5; O00257-3; P42773; Q96M91; P09496-2; P02458-1; Q9UKG9-2; P35222; Q9NUQ9; Q15038; Q9BPU6; Q08426; Q96KS9; Q92567-2; Q8IZU1; Q06547-3; Q9UI32; Q49A26-4; Q96EW2-2; P42858; Q9UK76; Q8N5Z5; Q8N4N3-2; Q9H2C1; Q99732; Q8TBB1; Q16609; Q8IYG6; P34949-2; Q15742-2; Q8NDH3-5; P36639-4; Q6N063-2; Q8NCQ7-2; Q8WUD1-2; P54727; Q09028; Q04864; P47804-3; Q15382; Q8N5U6; Q9NS64; P22307-3; Q15393; Q9BZQ2; Q86US8; Q13573; Q8N0X7; Q5W111-2; Q96BD6; O60506-4; Q9BSW7; O15273; Q15560; Q8N8B7-2; Q96A09; P54274-2; O43548; Q9P2T0; Q9NQ88; P36406; Q9P1Q0-4; Q8NA23-2; O43829; Q8IWT0-2; Q53FD0-2; Q9EPV5; Q9CR95	TISSUE SPECIFICITY: Ubiquitously expressed with the highest level in brain. Expression is up-regulated in prostate and colon cancer. {ECO:0000269|PubMed:12163454, ECO:0000269|PubMed:9140394, ECO:0000269|PubMed:9147654}.	GO:0005154; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0006897; GO:0006915; GO:0006919; GO:0007015; GO:0016020; GO:0030100; GO:0030136; GO:0030154; GO:0030276; GO:0030665; GO:0031234; GO:0032051; GO:0032266; GO:0035091; GO:0035254; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0051897; GO:0072583; GO:0080025; GO:0097190; GO:0098793; GO:0098794; GO:0098888; GO:0098890; GO:0098978; GO:0099637; GO:2000588		14702039; 12853948; 15489334; 11788820; 9140394; 9147654; 9616134; 11007801; 11063258; 11532990; 11517213; 11577110; 11889126; 12163454; 14732715; 15533940; 16027218; 18790740; 20068231; 21269460; 24275569; 25944712; 17257618; 18155047	SLA2 family
O00292	LFTY2_HUMAN	Left-right determination factor 2 (Endometrial bleeding-associated factor) (Left-right determination factor A) (Protein lefty-2) (Protein lefty-A) (Transforming growth factor beta-4, TGF-beta-4)	LEFTY2 EBAF LEFTA LEFTYA TGFB4 PSEC0024	366	9606			Alternative splicing;Cytokine;Developmental protein;Disease variant;Disulfide bond;Glycoprotein;Growth factor;Heterotaxy;Reference proteome;Secreted;Signal		TISSUE SPECIFICITY: Mesenchymal cells of the endometrial stroma.	GO:0005125; GO:0005160; GO:0005576; GO:0005615; GO:0008083; GO:0010862; GO:0030509; GO:0031093; GO:0060395; GO:0062023	PTM: The processing of the protein may also occur at the second R-X-X-R site located at AA 132-135. Processing appears to be regulated in a cell-type specific manner.	9153275; 10053005; 14702039; 16303743; 16710414; 15489334	TGF-beta family
O00294	TULP1_HUMAN	Tubby-related protein 1 (Tubby-like protein 1)	TULP1 TUBL1	542	9606			3D-structure;Alternative splicing;Cell junction;Cell membrane;Cytoplasm;Disease variant;Leber congenital amaurosis;Membrane;Phagocytosis;Reference proteome;Retinitis pigmentosa;Secreted;Sensory transduction;Synapse;Vision	P16333	TISSUE SPECIFICITY: Retina-specific.	GO:0001750; GO:0001895; GO:0001917; GO:0005546; GO:0005576; GO:0005829; GO:0005886; GO:0005929; GO:0006910; GO:0007601; GO:0016358; GO:0042462; GO:0042995; GO:0043679; GO:0045202; GO:0045494; GO:0050766; GO:0050908; GO:0051015; GO:0060041; GO:0061512; GO:1903546		9096357; 9462751; 14574404; 15489334; 16303976; 19837063; 9660588; 9462750; 15024725; 15557452; 17620573; 17962469	TUB family
O00299	CLIC1_HUMAN	Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27, NCC27) (Regulatory nuclear chloride ion channel protein, hRNCC)	CLIC1 G6 NCC27	241	9606			3D-structure;Acetylation;Cell membrane;Chloride;Chloride channel;Cytoplasm;Direct protein sequencing;Disulfide bond;Glutathionylation;Ion channel;Ion transport;Membrane;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel	O15116; Q6FHY5; Q5HYW2; O75832; Q4KMQ1-2	TISSUE SPECIFICITY: Expression is prominent in heart, placenta, liver, kidney and pancreas. {ECO:0000269|PubMed:10793131}.	GO:0005244; GO:0005254; GO:0005615; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005886; GO:0005903; GO:0006749; GO:0006821; GO:0007165; GO:0016020; GO:0031965; GO:0031982; GO:0034707; GO:0034765; GO:0045296; GO:0045669; GO:0048471; GO:0051726; GO:0051881; GO:0070062; GO:0070527; GO:0072562	PTM: Hydrogen peroxide treatment causes a conformation change, leading to dimerization and formation of an intramolecular disulfide bond between Cys-24 and Cys-59.	9139710; 10191309; 10384126; 14656967; 14574404; 15489334; 10834939; 11195932; 10793131; 11940526; 11978800; 12163479; 12681486; 18850721; 19413330; 19608861; 21269460; 22223895; 22814378; 23186163; 24275569; 25944712; 11551966; 14613939	Chloride channel CLIC family
O00300	TR11B_HUMAN	Tumor necrosis factor receptor superfamily member 11B (Osteoclastogenesis inhibitory factor) (Osteoprotegerin)	TNFRSF11B OCIF OPG	401	9606			3D-structure;Apoptosis;Direct protein sequencing;Disease variant;Disulfide bond;Glycoprotein;Receptor;Reference proteome;Repeat;Secreted;Signal	P42858; P49768-2; O14788	TISSUE SPECIFICITY: Highly expressed in adult lung, heart, kidney, liver, spleen, thymus, prostate, ovary, small intestine, thyroid, lymph node, trachea, adrenal gland, testis, and bone marrow. Detected at very low levels in brain, placenta and skeletal muscle. Highly expressed in fetal kidney, liver and lung.	GO:0001501; GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0006915; GO:0007165; GO:0007584; GO:0009410; GO:0030198; GO:0031012; GO:0032026; GO:0038023; GO:0042489; GO:0043235; GO:0043627; GO:0045671; GO:0045779; GO:0046685	PTM: N-glycosylated. Contains sialic acid residues. {ECO:0000269|PubMed:22664871}.; PTM: The N-terminus is blocked.	9108485; 9492069; 9688283; 14702039; 16421571; 15489334; 9571159; 15340161; 12110935; 9168977; 9603945; 9478964; 11505389; 22664871; 12189164	
O00303	EIF3F_HUMAN	Eukaryotic translation initiation factor 3 subunit F, eIF3f (Deubiquitinating enzyme eIF3f, EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47)	EIF3F EIF3S5	357	9606		3.4.19.12	3D-structure;Acetylation;Cytoplasm;Disease variant;Hydrolase;Initiation factor;Mental retardation;Phosphoprotein;Protease;Protein biosynthesis;Reference proteome;Thiol protease;Ubl conjugation pathway	O95994; P54253; P46379-2; Q8TAB5; Q7Z4U5-3; P55212; Q96HB5; A0A1B0GWI1; P21127; P08123; P99999; G5E9A7; O14645; P55884; O00303; O15372; Q7L2H7; A0A0C4DGQ7; Q8WU58; Q969P5; Q53GS7; O14964; P04792; O43464; Q8WXH2; O60333-2; O14901; P13473-2; Q9H000; O15457; Q969H8; Q9NP98; P35240-4; Q7Z3B4; Q9BVL2; Q9BYU1; Q16512; Q7Z3K3; P78424; O75400-2; P60891; P47224; Q13671; Q14D33; Q9Y371; Q7Z699; P51687; Q13148; Q9Y5J6; Q14119; O76024; A0A1U9X8X8; Q9Q2G4; P11223; P59594		GO:0001732; GO:0003743; GO:0004843; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0016579; GO:0031369; GO:0033290; GO:0042802; GO:0070122; GO:0071541; GO:0075522; GO:0140492	PTM: Phosphorylation is enhanced upon serum stimulation. Phosphorylated during apoptosis by caspase-processed CDK11. {ECO:0000269|PubMed:12446680, ECO:0000269|PubMed:17322308}.	9341143; 14702039; 15489334; 12446680; 16286006; 15703437; 16766523; 17581632; 17322308; 18669648; 19690332; 19608861; 20068067; 18599441; 21124883; 20068231; 21269460; 21406692; 23186163; 24275569; 25849773; 25944712; 27462815; 16322461; 30409806	EIF-3 subunit F family
O00305	CACB4_HUMAN	Voltage-dependent L-type calcium channel subunit beta-4, CAB4 (Calcium channel voltage-dependent subunit beta 4)	CACNB4 CACNLB4	520	9606			3D-structure;Alternative splicing;Calcium;Calcium channel;Calcium transport;Disease variant;Epilepsy;Ion channel;Ion transport;Methylation;Phosphoprotein;Reference proteome;SH3 domain;Transport;Voltage-gated channel	Q68D86; P56545-3; Q5JST6; P21579	TISSUE SPECIFICITY: Expressed predominantly in the cerebellum and kidney.	GO:0005245; GO:0005829; GO:0005886; GO:0005891; GO:0007268; GO:0007528; GO:0009898; GO:0045202; GO:1901385		9254841; 11880487; 17618603; 14702039; 15815621; 15489334; 9628818; 10762541; 19807924; 16385006	Calcium channel beta subunit family
O00308	WWP2_HUMAN	NEDD4-like E3 ubiquitin-protein ligase WWP2, EC 2.3.2.26 (Atrophin-1-interacting protein 2, AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2)	WWP2	870	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:19274063, ECO:0000269|PubMed:19651900}.	2.3.2.26	3D-structure;Alternative splicing;Host-virus interaction;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transferase;Ubl conjugation;Ubl conjugation pathway	P78563; Q8N8A2; Q8N5I2; Q96B67; Q86V38; P48643; Q9NWW5; P07339; Q14203-5; G5E9A7; P50570-2; Q14204; Q8N7B9-2; Q15884; Q7L5A3; Q96D16; Q8TAE8; Q8NHY3; Q86UU5; P07686; Q9BUJ2; O43464; P42858; Q8IZ03; Q8WXH2; Q92876; Q3B8N2; Q99732; Q71SY5; Q9HBE1-4; Q9NR12; O43933; Q01860; P54646; O60260-5; P60891; Q9Y272; Q9Y3C5; Q9BVN2; Q15599; Q15796; P84022; O15105; Q96GM5; Q99954; P37840; P14678-2; P09234; Q5TAL4; Q13148; O14773; Q9BUZ4; P22314; Q96LR5; Q969T4; Q9HAC8; A5D8V6; P61964; O76024; O43516; A0A0S2Z5X4; Q8WU02	TISSUE SPECIFICITY: Detected in heart, throughout the brain, placenta, lung, liver, muscle, kidney and pancreas. Also detected in spleen and peripheral blood leukocytes. {ECO:0000269|PubMed:19274063, ECO:0000269|PubMed:9647693}.	GO:0000122; GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006464; GO:0006858; GO:0008134; GO:0010629; GO:0016020; GO:0016567; GO:0032410; GO:0034765; GO:0042391; GO:0043161; GO:0043433; GO:0045732; GO:0045746; GO:0045892; GO:0045944; GO:0046718; GO:0051224; GO:0051865; GO:0061629; GO:0061630; GO:0070062; GO:0070534; GO:1901016	PTM: Autoubiquitinated. Ubiquitinated by the SCF(FBXL15) complex, leading to its degradation by the proteasome. {ECO:0000269|PubMed:19343052, ECO:0000269|PubMed:21572392}.	9169421; 14702039; 15616553; 15489334; 9647693; 12167593; 12450395; 11748237; 16964243; 17719543; 19274063; 19343052; 19651900; 20858735; 21269460; 21572392; 21191027; 21406692; 23236378; 22315426; 23186163; 26457515	
O00311	CDC7_HUMAN	Cell division cycle 7-related protein kinase, CDC7-related kinase, HsCdc7, huCdc7, EC 2.7.11.1	CDC7 CDC7L1	574	9606		2.7.11.1	3D-structure;Alternative splicing;ATP-binding;Cell cycle;Cell division;Isopeptide bond;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	Q8N9N5-2; Q13137; Q9UBU7; Q9UBU7-1; P51114-2; Q9UKD1; Q08379; Q9NYA3; Q6NT76; P42858; Q13422-7; Q9UKT9; Q9H2S9; Q9Y250; Q9BTE3; Q6FHY5; Q5JR59-3; Q14140; O75886; P55061; P14373; O94972; Q2TAA8; P0CW01; Q9Y6T4; Q96DT7-3; Q9HCK0; Q8NAP8		GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0072686; GO:0106310		9250678; 9573348; 9405610; 16710414; 15489334; 10373557; 12065429; 15668232; 17062569; 19413330; 19369195; 23186163; 28112733; 17344846	Protein kinase superfamily, Ser/Thr protein kinase family, CDC7 subfamily
O00322	UPK1A_HUMAN	Uroplakin-1a, UP1a (Tetraspanin-21, Tspan-21) (Uroplakin Ia, UPIa, UPKa)	UPK1A TSPAN21	258	9606			Alternative splicing;Disulfide bond;Glycoprotein;Membrane;Reference proteome;Transmembrane;Transmembrane helix	P35247; P08191	TISSUE SPECIFICITY: High expression restricted to ureteric urothelium (most superficial cells); low expression in prostate. Expression in normal urothelial cells is lost in culture. Some expression in tumor cell lines derived from urothelial malignancies. {ECO:0000269|PubMed:15913809, ECO:0000269|PubMed:9846985}.	GO:0005783; GO:0005886; GO:0005887; GO:0009986; GO:0016021; GO:0030855; GO:0032991; GO:0070062; GO:0120001		15057824; 15489334; 15913809; 9846985	Tetraspanin (TM4SF) family
O00327	BMAL1_HUMAN	Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5, bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3)	ARNTL BHLHE5 BMAL1 MOP3 PASD3	626	9606			3D-structure;Acetylation;Activator;Alternative splicing;Biological rhythms;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	O15516; D0VY79; O14977; O15516; Q96HY7; Q99814; Q99743; Q8WVT3; Q9H0C1	TISSUE SPECIFICITY: Hair follicles (at protein level). Highly expressed in the adult brain, skeletal muscle and heart. {ECO:0000269|PubMed:24005054}.	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0034751; GO:0042634; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:0120163; GO:0140297; GO:1901985; GO:1990513; GO:1990837; GO:2000074; GO:2000323; GO:2000772; GO:2001016	PTM: Ubiquitinated, leading to its proteasomal degradation (PubMed:24728990). Deubiquitinated by USP9X (PubMed:29626158). {ECO:0000269|PubMed:24728990, ECO:0000269|PubMed:29626158}.; PTM: O-glycosylated; contains O-GlcNAc. O-glycosylation by OGT prevents protein degradation by inhibiting ubiquitination. It also stabilizes the CLOCK-ARNTL/BMAL1 heterodimer thereby increasing CLOCK-ARNTL/BMAL1-mediated transcription of genes in the negative loop of the circadian clock such as PER1/2/3 and CRY1/2. {ECO:0000250|UniProtKB:Q9WTL8}.; PTM: Acetylated on Lys-538 by CLOCK during the repression phase of the circadian cycle. Acetylation facilitates recruitment of CRY1 protein and initiates the repression phase of the circadian cycle. Acetylated at Lys-538 by KAT5 during the activation phase of the cycle, leading to recruitment of the positive transcription elongation factor b (P-TEFb) and BRD4, followed by productive elongation of circadian transcripts. Deacetylated by SIRT1, which may result in decreased protein stability. {ECO:0000250|UniProtKB:Q9WTL8}.; PTM: Phosphorylated upon dimerization with CLOCK. Phosphorylation enhances the transcriptional activity, alters the subcellular localization and decreases the stability of the CLOCK-ARNTL/BMAL1 heterodimer by promoting its degradation. Phosphorylation shows circadian variations in the liver with a peak between CT10 to CT14. Phosphorylation at Ser-90 by CK2 is essential for its nuclear localization, its interaction with CLOCK and controls CLOCK nuclear entry (By similarity). Dephosphorylation at Ser-78 is important for dimerization with CLOCK and transcriptional activity (PubMed:23229515). {ECO:0000250|UniProtKB:Q9WTL8, ECO:0000269|PubMed:23229515}.; PTM: Sumoylated on Lys-259 upon dimerization with CLOCK. Predominantly conjugated to poly-SUMO2/3 rather than SUMO1 and the level of these conjugates undergo rhythmic variation, peaking at CT9-CT12. Sumoylation localizes it exclusively to the PML body and promotes its ubiquitination in the PML body, ubiquitin-dependent proteasomal degradation and the transcriptional activity of the CLOCK-ARNTL/BMAL1 heterodimer. {ECO:0000250|UniProtKB:Q9WTL8}.; PTM: Undergoes lysosome-mediated degradation in a time-dependent manner in the liver. {ECO:0000250|UniProtKB:Q9WTL8}.	9144434; 9079689; 9576906; 14702039; 16554811; 15489334; 9616112; 11441146; 12738229; 14645221; 16474406; 18587630; 21960634; 23576606; 23955654; 23785138; 23303907; 24385426; 24005054; 24728990; 23916625; 25936801; 28985504; 28112733; 28903391; 29626158; 30530698; 34545347; 23229515	
O00329	PK3CD_HUMAN	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, PI3-kinase subunit delta, PI3K-delta, PI3Kdelta, PtdIns-3-kinase subunit delta, EC 2.7.1.137, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta, PtdIns-3-kinase subunit p110-delta, p110delta)	PIK3CD	1044	9606	PATHWAY: Phospholipid metabolism; phosphatidylinositol phosphate biosynthesis. {ECO:0000305|PubMed:15135396, ECO:0000305|PubMed:9113989}.	2.7.1.137; 2.7.1.153	3D-structure;Adaptive immunity;Alternative splicing;ATP-binding;Chemotaxis;Cytoplasm;Differentiation;Direct protein sequencing;Disease variant;Immunity;Inflammatory response;Innate immunity;Kinase;Lipid metabolism;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase	P01112; P27986; P27986-2; Q92569; P01112	TISSUE SPECIFICITY: In humans, the highest levels of expression are seen in peripheral blood mononuclear cells, spleen, and thymus, and low levels of expression in testes, uterus, colon, and small intestine but not in other tissues examined including prostate, heart, brain, and liver (PubMed:9235916). Isoform 2 is expressed in normal thymus, lung and spleen tissues, and is detected at low levels in normal lysates from colon and ovarian biopsies, at elevated levels in lysates from colorectal tumors and is abundantly expressed in some ovarian tumors (at protein level). Both isoform 1 and isoform 2 are widely expressed. Isoform 1 is expressed predominantly in leukocytes. {ECO:0000269|PubMed:22020336, ECO:0000269|PubMed:9235916}.	GO:0001779; GO:0001819; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006468; GO:0006954; GO:0006955; GO:0007165; GO:0010595; GO:0010628; GO:0010818; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030101; GO:0030183; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278	PTM: Autophosphorylation on Ser-1039 results in the almost complete inactivation of the lipid kinase activity. {ECO:0000269|PubMed:10064595}.	9113989; 9235916; 22020336; 16710414; 15489334; 15135396; 10064595; 19369195; 20081091; 17290298; 20940048; 23186163; 24136356; 29180244; 30040974; 30336224	PI3/PI4-kinase family
O00330	ODPX_HUMAN	Pyruvate dehydrogenase protein X component, mitochondrial (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (E3-binding protein, E3BP) (Lipoyl-containing pyruvate dehydrogenase complex component X) (proX)	PDHX PDX1	501	9606			3D-structure;Acetylation;Alternative splicing;Lipoyl;Mitochondrion;Phosphoprotein;Reference proteome;Transit peptide	Q6RW13; Q9UHD4; P09622; Q9Y6E7		GO:0005739; GO:0005759; GO:0005967; GO:0006086; GO:0016746; GO:0045254; GO:0061732	PTM: Delipoylated at Lys-97 by SIRT4, delipoylation decreases the PHD complex activity. {ECO:0000269|PubMed:25525879}.	9242632; 9399911; 9467010; 14702039; 16554811; 15489334; 9110174; 14638692; 20160912; 19608861; 20385101; 21269460; 25525879; 24275569; 25944712; 16263718; 16442803; 20361979	2-oxoacid dehydrogenase family
O00337	S28A1_HUMAN	Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1, CNT 1, hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1)	SLC28A1 CNT1	649	9606			Alternative splicing;Cell membrane;Disease variant;Glycoprotein;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Expressed in kidney. {ECO:0000269|PubMed:9124315}.	GO:0005337; GO:0005345; GO:0005415; GO:0005829; GO:0005886; GO:0005887; GO:0006139; GO:0015212; GO:0015213; GO:0015293; GO:0015389; GO:0015855; GO:0015858; GO:0015861; GO:0015862; GO:0016020; GO:0016607; GO:0031526; GO:0045117; GO:0072531; GO:1901474; GO:1901642; GO:1904823		9124315; 14702039; 16572171; 15489334; 10455109; 21998139; 24275569; 30658162; 30847922	Concentrative nucleoside transporter (CNT) (TC 2.A.41) family
O00338	ST1C2_HUMAN	Sulfotransferase 1C2, ST1C2, EC 2.8.2.1 (Sulfotransferase 1C1, SULT1C#1) (humSULTC2)	SULT1C2 SULT1C1	296	9606		2.8.2.1	3D-structure;Alternative splicing;Cytoplasm;Lysosome;Phosphoprotein;Reference proteome;Transferase	Q9BSI4	TISSUE SPECIFICITY: Found in adult stomach, kidney and thyroid gland, and in fetal kidney and liver.	GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923		9169148; 9635888; 9852044; 10481272; 10783263; 14702039; 15815621; 15489334; 16804942	Sulfotransferase 1 family
O00339	MATN2_HUMAN	Matrilin-2	MATN2 UNQ193/PRO219	956	9606			Alternative splicing;Coiled coil;Disulfide bond;EGF-like domain;Glycoprotein;Reference proteome;Repeat;Secreted;Signal	O15265; O00555; O68704		GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0062023		11124542; 12975309; 14702039; 17974005; 16421571; 15489334; 9083061	
O00341	EAA5_HUMAN	Excitatory amino acid transporter 5 (Retinal glutamate transporter) (Solute carrier family 1 member 7)	SLC1A7 EAAT5	560	9606			Alternative splicing;Glycoprotein;Membrane;Reference proteome;Symport;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Expressed primarily in retina. Detectable in liver, heart, muscle and brain.	GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0006811; GO:0006835; GO:0006836; GO:0015175; GO:0015501; GO:0015813; GO:0016021; GO:0098793; GO:0098810		9108121; 16710414; 15489334; 16959974	Dicarboxylate/amino acid:cation symporter (DAACS) (TC 2.A.23) family, SLC1A7 subfamily
O00358	FOXE1_HUMAN	Forkhead box protein E1 (Forkhead box protein E2) (Forkhead-related protein FKHL15) (HFKH4) (HNF-3/fork head-like protein 5, HFKL5) (Thyroid transcription factor 2, TTF-2)	FOXE1 FKHL15 FOXE2 TITF2 TTF2	373	9606			Congenital hypothyroidism;Disease variant;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	P19419	TISSUE SPECIFICITY: Detected in adult brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, heart, colon, small intestine testis and thymus. Expression was strongest in heart and pancreas.	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0006590; GO:0009653; GO:0016477; GO:0030154; GO:0030878; GO:0031069; GO:0043565; GO:0045892; GO:0045893; GO:0048538; GO:0048562; GO:0060022; GO:0060023; GO:0060465; GO:1904888; GO:1990837	PTM: Phosphorylated. {ECO:0000250}.	9052737; 9169137; 10403172; 15164053; 9697705; 21177256; 25381600; 12165566; 16882747; 20094846; 20484477; 24219130	
O00370	LORF2_HUMAN	LINE-1 retrotransposable element ORF2 protein, ORF2p [Includes: Reverse transcriptase, EC 2.7.7.49; Endonuclease, EC 3.1.21.- ]		1275	9606		2.7.7.49; 3.1.21.-	3D-structure;DNA recombination;Endonuclease;Hydrolase;Magnesium;Metal-binding;Multifunctional enzyme;Nuclease;Nucleotidyltransferase;Reference proteome;RNA-directed DNA polymerase;Transferase			GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305		9140393; 7516468; 8945517	
O00391	QSOX1_HUMAN	Sulfhydryl oxidase 1, hQSOX, EC 1.8.3.2 (Quiescin Q6)	QSOX1 QSCN6 UNQ2520/PRO6013	747	9606		1.8.3.2	3D-structure;Alternative splicing;Disulfide bond;FAD;Flavoprotein;Glycoprotein;Golgi apparatus;Membrane;Oxidoreductase;Phosphoprotein;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in heart, placenta, lung, liver, skeletal muscle, pancreas and very weakly in brain and kidney. {ECO:0000269|PubMed:10708601, ECO:0000269|Ref.8}.	GO:0000139; GO:0003756; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0006457; GO:0016242; GO:0016971; GO:0030173; GO:0031093; GO:0035580; GO:0043231; GO:0045171; GO:0070062; GO:0071949; GO:0085029; GO:1904724	PTM: N-glycosylated (PubMed:17331072, PubMed:29757379). O-glycosylated on Thr and Ser residues (PubMed:29757379). {ECO:0000269|PubMed:17331072, ECO:0000269|PubMed:29757379}.	9878249; 16806532; 12975309; 16710414; 15489334; 10708601; 12176051; 16335952; 17331072; 18393449; 19139490; 26091039; 23704371; 25944712; 26819240; 29757379; 30367560; 20211621; 22801504; 23867277	Quiescin-sulfhydryl oxidase (QSOX) family
O00400	ACATN_HUMAN	Acetyl-coenzyme A transporter 1, AT-1, Acetyl-CoA transporter 1 (Solute carrier family 33 member 1)	SLC33A1 ACATN AT1	549	9606			Cataract;Deafness;Disease variant;Endoplasmic reticulum;Glycoprotein;Hereditary spastic paraplegia;Membrane;Neurodegeneration;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Ubiquitous. Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. With strongest signals in pancreas. {ECO:0000269|PubMed:9096318}.	GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395		9096318; 14702039; 15489334; 23186163; 25402622; 25944712; 16959974; 19061983; 22243965	SLC33A transporter family
O00401	WASL_HUMAN	Neural Wiskott-Aldrich syndrome protein, N-WASP	WASL	505	9606			3D-structure;Acetylation;Actin-binding;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Methylation;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	Q9NYB9-2; Q8IWW6-4; O15145; P59998; P60953; Q99828; Q6XZF7-1; P62993; A0A0S2Z4D7; P16333; P16333-1; E7ERP6; O43639; Q9UNF0; Q9UKS6; O96013; Q13882; Q9H4E5; O76064; O00560; Q9Y5X1; O94875-10; O60504-2; Q15642-2; P57075-2; Q8TF42; O43516; Q8TF74; P68135; P61157; P0DJ88; Q8X482; Q8R511		GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0006900; GO:0008154; GO:0009617; GO:0015629; GO:0016050; GO:0030027; GO:0030041; GO:0030048; GO:0030050; GO:0030478; GO:0030666; GO:0030695; GO:0031410; GO:0031503; GO:0032880; GO:0045944; GO:0051301; GO:0051491; GO:0051653; GO:0060997; GO:0065003; GO:0070062; GO:1903526; GO:2000370; GO:2000402; GO:2000601	PTM: Phosphorylation at Ser-242, Tyr-256, Ser-484 and Ser-485 enhances actin polymerization activity. {ECO:0000269|PubMed:16257963}.	9322739; 12853948; 15489334; 9422512; 9582270; 10491394; 16257963; 16234328; 16767080; 17015620; 18669648; 19413330; 19487689; 19767742; 19366662; 20068231; 21269460; 21406692; 22223895; 22814378; 24129315; 29887380; 16531231; 22847007; 22921828; 24332715	
O00408	PDE2A_HUMAN	cGMP-dependent 3',5'-cyclic phosphodiesterase, EC 3.1.4.17 (Cyclic GMP-stimulated phosphodiesterase, CGS-PDE, cGSPDE)	PDE2A	941	9606		3.1.4.17	3D-structure;Alternative splicing;cAMP;Cell membrane;cGMP;cGMP-binding;Cytoplasm;Disease variant;Hydrolase;Lipoprotein;Membrane;Mental retardation;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Mitochondrion outer membrane;Myristate;Nucleotide-binding;Palmitate;Reference proteome;Repeat;Zinc	O00170; O00408-1	TISSUE SPECIFICITY: Widely expressed (PubMed:9210593, PubMed:29392776). Expressed in brain, with high expression observed in the corpus striatum (PubMed:29392776). Also expressed in heart, placenta, lung, skeletal muscle, kidney and pancreas (PubMed:9210593, PubMed:29392776). {ECO:0000269|PubMed:29392776, ECO:0000269|PubMed:9210593}.	GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004114; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:1904613		9210593; 14702039; 16554811; 19632989; 19369195; 20213681; 24705027; 28463107; 29392776; 32467598; 32196122; 15938621; 19828435; 23899287	Cyclic nucleotide phosphodiesterase family, PDE2 subfamily
O00409	FOXN3_HUMAN	Forkhead box protein N3 (Checkpoint suppressor 1)	FOXN3 C14orf116 CHES1	490	9606			3D-structure;Alternative splicing;Cell cycle;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	Q13573		GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006355; GO:0007095; GO:0008022; GO:0045892; GO:0097094		9154802; 12508121; 15489334; 16102918; 19690332; 21406692	
O00410	IPO5_HUMAN	Importin-5, Imp5 (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5, RanBP5)	IPO5 KPNB3 RANBP5	1097	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Host-virus interaction;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	Q96AP0; O95166; Q9H0R8; P60520; Q9GZQ8; Q9BXW4; P18124; PRO_0000037576 [P27958]; P42858		GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005730; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0016020; GO:0031267; GO:0042307; GO:0045736; GO:0061608; GO:0071230		9114010; 9271386; 14702039; 15057823; 15489334; 9687515; 17081983; 16704975; 18691976; 18669648; 19413330; 19690332; 20068231; 21269460; 22223895; 22730302; 22814378; 23541588; 23186163; 25944712; 29475951	Importin beta family, Importin beta-3 subfamily
O00411	RPOM_HUMAN	DNA-directed RNA polymerase, mitochondrial, MtRPOL, EC 2.7.7.6	POLRMT	1230	9606		2.7.7.6	3D-structure;DNA-directed RNA polymerase;Mitochondrion;Nucleotidyltransferase;Reference proteome;Transcription;Transferase;Transit peptide	P52815; Q96QE5		GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006390; GO:0032991; GO:0034245; GO:0042645; GO:0043565		9097968; 15057824; 12068295; 21269460; 21278163; 23283301; 25944712; 29445193; 31226201; 29149603	Phage and mitochondrial RNA polymerase family
O00418	EF2K_HUMAN	Eukaryotic elongation factor 2 kinase, eEF-2 kinase, eEF-2K, EC 2.7.11.20 (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)	EEF2K	725	9606		2.7.11.20	3D-structure;Acetylation;ATP-binding;Calcium;Calmodulin-binding;Kinase;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase			GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637	PTM: Autophosphorylated at multiple residues, Thr-348 being the major site. Phosphorylated by AMP-activated protein kinase AMPK at Ser-398 leading to EEF2K activation and protein synthesis inhibition. Phosphorylated by TRPM7 at Ser-78 resulting in improved protein stability, higher EE2F phosphorylated and subsequently reduced rate of protein synthesis. Phosphorylation by other kinases such as CDK1 and MAPK13 at Ser-359 or RPS6KA1 and RPS6KB1 at Ser-366 instead decrease EEF2K activity and promote protein synthesis. {ECO:0000269|PubMed:11015200, ECO:0000269|PubMed:11500363, ECO:0000269|PubMed:11500364, ECO:0000269|PubMed:14709557, ECO:0000269|PubMed:18337751, ECO:0000269|PubMed:21112387, ECO:0000269|PubMed:22216903}.	9144159; 15616553; 15489334; 11015200; 11500363; 11500364; 15144186; 14709557; 17081983; 16964243; 18337751; 18669648; 19413330; 19690332; 20068231; 21269460; 21112387; 21406692; 22216903; 22223895; 23186163; 24275569; 17344846	Protein kinase superfamily, Alpha-type protein kinase family
O00421	CCRL2_HUMAN	C-C chemokine receptor-like 2 (Chemokine receptor CCR11) (Chemokine receptor X) (Putative MCP-1 chemokine receptor)	CCRL2 CCR11 CCR6 CKRX CRAM HCR	344	9606			Alternative splicing;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	Q8WVX3-2	TISSUE SPECIFICITY: Expressed abundantly in immunal tissues such as spleen, fetal liver, lymph node and bone marrow. Strong expression also in lung and heart. Expressed in almost all hematopoietic cells including monocytes, macrophages, PMNs, T-cells (both CD4+ and CD8+), monocyte-derived iDCs, NK cells, and CD34+ progenitor cells. B-cells expressed isoform 1 but not isoform 2. Up-regulated on synovial neutrophils of rheumatoid arthritis patients. {ECO:0000269|PubMed:11828366, ECO:0000269|PubMed:15188357, ECO:0000269|PubMed:18397265, ECO:0000269|PubMed:9473515}.	GO:0004950; GO:0005737; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0042379; GO:0048020; GO:0060326		9473515; 14702039; 16641997; 15489334; 11828366; 15188357; 18397265; 20002784	G-protein coupled receptor 1 family
O00422	SAP18_HUMAN	Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (2HOR0202) (Cell growth-inhibiting gene 38 protein) (Sin3-associated polypeptide p18)	SAP18 GIG38	153	9606			3D-structure;Acetylation;Alternative initiation;Cytoplasm;Isopeptide bond;mRNA processing;mRNA splicing;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	Q9H4E7; Q13547; Q0VD86; Q96HA8; Q9H307; Q14498; Q14498-3	TISSUE SPECIFICITY: Ubiquitous.	GO:0000118; GO:0000381; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0043065; GO:0045892; GO:0048025; GO:0061574		9150135; 14702039; 15057823; 15489334; 12665594; 16314458; 19413330; 20966198; 21269460; 22203037; 25218447; 25772364; 25755297; 28112733; 17002296	SAP18 family
O00423	EMAL1_HUMAN	Echinoderm microtubule-associated protein-like 1, EMAP-1, HuEMAP-1	EML1 EMAP1 EMAPL EMAPL1	815	9606			3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Epilepsy;Lissencephaly;Mental retardation;Microtubule;Phosphoprotein;Reference proteome;Repeat;WD repeat	P55212; P51114; Q9H9L3; P13473-2; P31948	TISSUE SPECIFICITY: Ubiquitous; expressed in most tissues with the exception of thymus and peripheral blood lymphocytes. {ECO:0000269|PubMed:10521658}.	GO:0000226; GO:0002244; GO:0005509; GO:0005829; GO:0005874; GO:0005875; GO:0007052; GO:0007405; GO:0007420; GO:0008017; GO:0015631; GO:0048471; GO:0097431; GO:1990023		9226380; 15489334; 10521658; 24275569; 25740311; 24859200; 28556411; 24706829	WD repeat EMAP family
O00425	IF2B3_HUMAN	Insulin-like growth factor 2 mRNA-binding protein 3, IGF2 mRNA-binding protein 3, IMP-3 (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer, hKOC) (VICKZ family member 3)	IGF2BP3 IMP3 KOC1 VICKZ3	579	9606			3D-structure;Alternative splicing;Cytoplasm;Isopeptide bond;mRNA transport;Nucleus;Phosphoprotein;Reference proteome;Repeat;RNA-binding;Translation regulation;Transport;Ubl conjugation	Q15365; Q13148	TISSUE SPECIFICITY: Expressed in fetal liver, fetal lung, fetal kidney, fetal thymus, fetal placenta, fetal follicles of ovary and gonocytes of testis, growing oocytes, spermatogonia and semen (at protein level). Expressed in cervix adenocarcinoma, in testicular, pancreatic and renal-cell carcinomas (at protein level). Expressed ubiquitously during fetal development at 8 and 14 weeks of gestation. Expressed in ovary, testis, brain, placenta, pancreatic cancer tissues and pancreatic cancer cell lines. {ECO:0000269|PubMed:10525192, ECO:0000269|PubMed:12161597, ECO:0000269|PubMed:15644775, ECO:0000269|PubMed:16049158, ECO:0000269|PubMed:16814207, ECO:0000269|PubMed:17192788, ECO:0000269|PubMed:9178771, ECO:0000269|PubMed:9891060}.	GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0007399; GO:0009653; GO:0010468; GO:0010494; GO:0017148; GO:0045182; GO:0048027; GO:0051028; GO:0051252; GO:0070934; GO:1990247		9178771; 17974005; 12853948; 15489334; 10525192; 9891060; 11465943; 12161597; 12921532; 15601260; 15644775; 16049158; 16541107; 16814207; 17192788; 17289661; 18669648; 19690332; 20080952; 21269460; 21406692; 23640942; 23186163; 25218447; 25944712; 28112733; 29476152	RRM IMP/VICKZ family
O00429	DNM1L_HUMAN	Dynamin-1-like protein, EC 3.6.5.5 (Dnm1p/Vps1p-like protein, DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less, Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV, HdynIV) (Dynamin-related protein 1)	DNM1L DLP1 DRP1	736	9606		3.6.5.5	3D-structure;Acetylation;Alternative splicing;Biological rhythms;Cell junction;Coated pit;Cytoplasm;Cytoplasmic vesicle;Disease variant;Endocytosis;Glycoprotein;Golgi apparatus;GTP-binding;Hydrolase;Isopeptide bond;Lipid-binding;Membrane;Mitochondrion;Mitochondrion outer membrane;Necrosis;Nucleotide-binding;Peroxisome;Phosphoprotein;Reference proteome;S-nitrosylation;Synapse;Ubl conjugation	Q9NVI7; Q9NVI7-2; O00429; P03372; Q9Y3D6; Q5S007; Q9GZY8; Q9NQG6; Q96C03; Q9Y512; Q14160; O00429-3; Q5S007; Q8N7X4; O95563; P21980-2; O43257; O00429-4	TISSUE SPECIFICITY: Ubiquitously expressed with highest levels found in skeletal muscles, heart, kidney and brain. Isoform 1 is brain-specific. Isoform 2 and isoform 3 are predominantly expressed in testis and skeletal muscles respectively. Isoform 4 is weakly expressed in brain, heart and kidney. Isoform 5 is dominantly expressed in liver, heart and kidney. Isoform 6 is expressed in neurons. {ECO:0000269|PubMed:10749171, ECO:0000269|PubMed:9422767, ECO:0000269|PubMed:9570752, ECO:0000269|PubMed:9731200, ECO:0000269|PubMed:9786947}.	GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0065003; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244	PTM: Phosphorylation/dephosphorylation events on two sites near the GED domain regulate mitochondrial fission (PubMed:17301055, PubMed:17553808, PubMed:18695047, PubMed:18838687, PubMed:23283981, PubMed:29478834). Phosphorylation on Ser-637 by CAMK1 and PKA inhibits the GTPase activity, leading to a defect in mitochondrial fission promoting mitochondrial elongation (PubMed:17553808, PubMed:18695047, PubMed:23283981, PubMed:29478834). Dephosphorylated on this site by PPP3CA which promotes mitochondrial fission (PubMed:18838687). Phosphorylation on Ser-616 by CDK1 and PINK1 activates the GTPase activity and promotes mitochondrial fission (PubMed:18838687, PubMed:32484300, PubMed:21822277). Phosphorylated in a circadian manner at Ser-637 (PubMed:29478834). {ECO:0000269|PubMed:17301055, ECO:0000269|PubMed:17553808, ECO:0000269|PubMed:18695047, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:21822277, ECO:0000269|PubMed:23283981, ECO:0000269|PubMed:29478834, ECO:0000269|PubMed:32484300}.; PTM: Sumoylated on various lysine residues within the B domain, probably by MUL1. Sumoylation positively regulates mitochondrial fission. Desumoylated by SENP5 during G2/M transition of mitosis. Appears to be linked to its catalytic activity. {ECO:0000269|PubMed:19407830, ECO:0000269|PubMed:19411255, ECO:0000269|PubMed:19638400}.; PTM: S-nitrosylation increases DNM1L dimerization, mitochondrial fission and causes neuronal damage. {ECO:0000269|PubMed:19342591}.; PTM: Ubiquitination by MARCHF5 affects mitochondrial morphology. {ECO:0000269|PubMed:16874301, ECO:0000269|PubMed:16936636}.; PTM: O-GlcNAcylation augments the level of the GTP-bound active form of DNM1L and induces translocation from the cytoplasm to mitochondria in cardiomyocytes. It also decreases phosphorylation at Ser-637 (By similarity). {ECO:0000250|UniProtKB:O35303}.	9348079; 9731200; 9570752; 10749171; 14702039; 16541075; 15489334; 9422767; 9472031; 9786947; 9915810; 11514614; 12499366; 12618434; 15208300; 16874301; 16936636; 17015472; 17301055; 17553808; 17606867; 17460227; 18695047; 18088087; 18669648; 18838687; 19413330; 19407830; 19638400; 19411255; 19690332; 19342591; 20688057; 20068231; 21269460; 21508961; 21701560; 21822277; 21406692; 22265414; 22223895; 23921378; 23186163; 23283981; 23792689; 24275569; 26122121; 23530241; 29478834; 32484300; 23584531; 23977156; 29899447; 26604000; 27145208; 26992161; 27301544; 27328748; 28969390	TRAFAC class dynamin-like GTPase superfamily, Dynamin/Fzo/YdjA family
O00442	RTCA_HUMAN	RNA 3'-terminal phosphate cyclase, RNA cyclase, RNA-3'-phosphate cyclase, EC 6.5.1.4 (RNA terminal phosphate cyclase domain-containing protein 1, RTC domain-containing protein 1)	RTCA RPC RPC1 RTC1 RTCD1	366	9606		6.5.1.4	Alternative splicing;ATP-binding;Direct protein sequencing;Ligase;Nucleotide-binding;Nucleus;Reference proteome	P32243-2	TISSUE SPECIFICITY: Ubiquitous.	GO:0003723; GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396		9184239; 16710414; 15489334; 2199762; 21269460	RNA 3'-terminal cyclase family, Type 1 subfamily
O00443	P3C2A_HUMAN	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha, PI3K-C2-alpha, PtdIns-3-kinase C2 subunit alpha, EC 2.7.1.137, EC 2.7.1.153, EC 2.7.1.154 (Phosphoinositide 3-kinase-C2-alpha)	PIK3C2A	1686	9606		2.7.1.137; 2.7.1.153; 2.7.1.154	3D-structure;Acetylation;Alternative splicing;ATP-binding;Cataract;Cell membrane;Cytoplasm;Cytoplasmic vesicle;Disease variant;Dwarfism;Endocytosis;Exocytosis;Golgi apparatus;Kinase;Lipid metabolism;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase		TISSUE SPECIFICITY: Expressed in columnar and transitional epithelia, mononuclear cells, smooth muscle cells, and endothelial cells lining capillaries and small venules (at protein level). Ubiquitously expressed, with highest levels in heart, placenta and ovary, and lowest levels in the kidney. Detected at low levels in islets of Langerhans from type 2 diabetes mellitus individuals. {ECO:0000269|PubMed:14563213, ECO:0000269|PubMed:21127054, ECO:0000269|PubMed:9337861}.	GO:0005524; GO:0005654; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0006887; GO:0006897; GO:0007173; GO:0008286; GO:0010508; GO:0014065; GO:0014829; GO:0016020; GO:0016303; GO:0016477; GO:0030136; GO:0030276; GO:0031982; GO:0035004; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0046854; GO:0046934; GO:0048008; GO:0048015; GO:0048268; GO:0052742; GO:0052812; GO:0061024; GO:0070062; GO:0090050	PTM: Phosphorylated upon insulin stimulation; which may lead to enzyme activation (By similarity). Phosphorylated on Ser-259 during mitosis and upon UV irradiation; which does not change enzymatic activity but leads to proteasomal degradation. Ser-259 phosphorylation may be mediated by CDK1 or JNK, depending on the physiological state of the cell. {ECO:0000250|UniProtKB:Q61194, ECO:0000269|PubMed:11606566, ECO:0000269|PubMed:12719431}.	9337861; 14702039; 16554811; 15489334; 10766823; 10805725; 11606566; 11239472; 14563213; 12719431; 16215232; 18691976; 18669648; 19413330; 19369195; 19690332; 21081650; 20068231; 21269460; 21127054; 17371240; 21406692; 23186163; 24275569; 31034465; 17038310	PI3/PI4-kinase family
O00444	PLK4_HUMAN	Serine/threonine-protein kinase PLK4, EC 2.7.11.21 (Polo-like kinase 4, PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak)	PLK4 SAK STK18	970	9606		2.7.11.21	3D-structure;Acetylation;Alternative splicing;ATP-binding;Cytoplasm;Cytoskeleton;Dwarfism;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	P36575; Q9Y297; Q9NX04; O94986; O94986-3; Q8TEP8; Q8TEP8-3; P59910; Q9H8V3; Q14241; O95995; Q9H4L5; P07237; O00444; P31947; Q96R06; Q15468; Q96A09; Q9UBB9; Q9BYV2; O15060		GO:0000278; GO:0000922; GO:0001741; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0007099; GO:0032154; GO:0032465; GO:0042802; GO:0046601; GO:0060271; GO:0060707; GO:0098535; GO:0098536; GO:0106310; GO:0120098; GO:0120099	PTM: Acetylation by KAT2A and KAT2B impairs kinase activity by shifting the kinase to an inactive conformation. {ECO:0000269|PubMed:27796307}.; PTM: Ubiquitinated; leading to its degradation by the proteasome. {ECO:0000250}.; PTM: Tyrosine-phosphorylated by TEC. {ECO:0000269|PubMed:11489907}.	11489907; 14702039; 15489334; 8260651; 1311287; 16326102; 16244668; 15967108; 17681131; 18239451; 18691976; 18669648; 19164942; 19454482; 19369195; 21059844; 20852615; 22020124; 21725316; 23186163; 25344692; 27246242; 27796307; 30804208; 32433990; 17344846	Protein kinase superfamily, Ser/Thr protein kinase family, CDC5/Polo subfamily
O00445	SYT5_HUMAN	Synaptotagmin-5 (Synaptotagmin V, SytV)	SYT5	386	9606			3D-structure;Alternative splicing;Calcium;Cell junction;Cytoplasmic vesicle;Endosome;Membrane;Metal-binding;Reference proteome;Repeat;Synapse;Transmembrane;Transmembrane helix			GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0043025; GO:0046982; GO:0048471; GO:0048488; GO:0048791; GO:0055038; GO:0070382; GO:0071277; GO:0099066; GO:1990769		9177789; 14702039; 15057824; 15489334; 27793683	Synaptotagmin family
O00451	GFRA2_HUMAN	GDNF family receptor alpha-2, GDNF receptor alpha-2, GDNFR-alpha-2, GFR-alpha-2 (GDNF receptor beta, GDNFR-beta) (Neurturin receptor alpha, NRTNR-alpha, NTNR-alpha) (RET ligand 2) (TGF-beta-related neurotrophic factor receptor 2)	GFRA2 GDNFRB RETL2 TRNR2	464	9606			3D-structure;Alternative splicing;Cell membrane;Glycoprotein;GPI-anchor;Lipoprotein;Membrane;Receptor;Reference proteome;Signal		TISSUE SPECIFICITY: Isoform 1 is found in both brain and placenta.	GO:0005886; GO:0007169; GO:0007399; GO:0009897; GO:0016167; GO:0019898; GO:0031225; GO:0038023; GO:0043235		9182803; 9259272; 9177201; 16421571; 15489334; 23333276	GDNFR family
O00453	LST1_HUMAN	Leukocyte-specific transcript 1 protein (Protein B144)	LST1 B144	97	9606			Alternative splicing;Cell shape;Golgi apparatus;Immunity;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in lung, tonsil, thymus, placenta, kidney, fetal spleen, fetal liver and brain. {ECO:0000269|PubMed:7590964, ECO:0000269|PubMed:9367684}.	GO:0000139; GO:0000902; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006955; GO:0008360; GO:0009653; GO:0016021; GO:0016358; GO:0050672		7590964; 9367684; 10706707; 14656967; 14574404; 15489334; 16362817; 11478849; 24275569; 25944712	LST1 family
O00459	P85B_HUMAN	Phosphatidylinositol 3-kinase regulatory subunit beta, PI3-kinase regulatory subunit beta, PI3K regulatory subunit beta, PtdIns-3-kinase regulatory subunit beta (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta, PI3-kinase subunit p85-beta, PtdIns-3-kinase regulatory subunit p85-beta)	PIK3R2	728	9606			3D-structure;Disease variant;Phosphoprotein;Protein transport;Reference proteome;Repeat;SH2 domain;SH3 domain;Stress response;Transport;Ubl conjugation	P10275; P22681; P46108; G5E9A7; Q8WWB3; P00533; P04626; P21860; Q13480; Q08379; P62993; P42858; Q9UKT9; P10721; P19012; P35900; O76015; P08581; Q96HT8; P42338; Q6NUQ1; Q7Z699; P36406; P03496; Q82506		GO:0001678; GO:0001784; GO:0005634; GO:0005829; GO:0005942; GO:0005943; GO:0006955; GO:0008286; GO:0010506; GO:0014065; GO:0015031; GO:0019903; GO:0030183; GO:0030217; GO:0030971; GO:0032869; GO:0034976; GO:0042307; GO:0043409; GO:0043551; GO:0045944; GO:0046854; GO:0046935; GO:0046982	PTM: Phosphorylated in response to signaling from activated receptor-type protein kinases (PubMed:19690332, PubMed:20068231). Dephosphorylated by PTPRJ (PubMed:18348712). Dephosphorylated at Tyr-655 by PTPN13. Phosphorylation of Tyr-655 impairs while its dephosphorylation promotes interaction with FBXL2 and SCF(FBXL2)-mediated polyubiquitination (PubMed:23604317). {ECO:0000269|PubMed:18348712, ECO:0000269|PubMed:23604317}.; PTM: Ubiquitinated. Polyubiquitination by the SCF(FBXL2) complex probably promotes proteasomal degradation of PIK3R2. {ECO:0000303|PubMed:23604317}.	1314371; 9582025; 15057824; 15489334; 9178760; 9600074; 15102829; 18348712; 18669648; 19369195; 19690332; 20068231; 21269460; 23186163; 23604317; 23745724; 22729224; 25944712; 28903391; 26520804; 26860062	PI3K p85 subunit family
O00461	GOLI4_HUMAN	Golgi integral membrane protein 4 (Golgi integral membrane protein, cis, GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa, Golgi phosphoprotein of 130 kDa)	GOLIM4 GIMPC GOLPH4 GPP130	696	9606			Coiled coil;Endosome;Glycoprotein;Golgi apparatus;Lipoprotein;Membrane;Myristate;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix;Transport			GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0016021; GO:0030133; GO:0030139; GO:0032580	PTM: Phosphorylated probably by c-AMP-dependent kinases in its lumenal part. {ECO:0000269|PubMed:9201717}.; PTM: O-glycosylated; modified by sialic acid residues. {ECO:0000250}.; PTM: N-glycosylated; N-glycans are probably of the complex type and modified by sialic acid residues. {ECO:0000269|PubMed:9201717}.	9201717; 11598199; 15331763; 17081983; 21269460; 24275569; 25255805; 16959974	GOLIM4 family
O00462	MANBA_HUMAN	Beta-mannosidase, EC 3.2.1.25 (Lysosomal beta A mannosidase) (Mannanase, Mannase)	MANBA MANB1	879	9606	PATHWAY: Glycan metabolism; N-glycan degradation. {ECO:0000269|PubMed:12890191, ECO:0000269|PubMed:30552791}.	3.2.1.25	Disulfide bond;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Reference proteome;Signal		TISSUE SPECIFICITY: Ubiquitous. Detected in pancreas, kidney and placenta, ands at lower levels in liver, lung, brain, heart and muscle. {ECO:0000269|PubMed:9384606}.	GO:0004567; GO:0005537; GO:0005886; GO:0006464; GO:0006516; GO:0009313; GO:0035577; GO:0043202		9384606; 15489334; 12890191; 16904924; 18565776; 30552791	Glycosyl hydrolase 2 family
O00463	TRAF5_HUMAN	TNF receptor-associated factor 5 (RING finger protein 84)	TRAF5 RNF84	557	9606			3D-structure;Alternative splicing;Apoptosis;Coiled coil;Cytoplasm;Metal-binding;Reference proteome;Repeat;Zinc;Zinc-finger	Q52MB2; Q16543; Q96Q77; Q16206-2; Q8IZU1; Q9NVF7; O95995; Q9H8Y8; Q86YM7; O75031; P13473-2; P61968; Q8TBB1; Q6FHY5; Q13287; Q96HA8; Q5BJF6-2; O14832; O75928-2; Q4G0R1; Q9NRD5; P25786; P54725; P78317; O00560; P55735; P55735-3; P50453; Q7Z699; Q07955; P31948; P63165; Q9NVV9; Q9BT49; Q92956; Q12933; Q13114; O00463; Q9Y4K3; P62699; Q6FIF0; Q8N720	TISSUE SPECIFICITY: Expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood.	GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0046330; GO:0048255; GO:0051091; GO:0051092; GO:0070534; GO:0097400		9511754; 14702039; 16710414; 15489334; 9177772; 11384837; 11607847; 9162022; 9153189; 9275204; 8999898; 9774977; 9718306; 9488716; 9642260; 10809768; 9774460; 10764746; 10880535; 10908663; 15121867; 19690332	TNF receptor-associated factor family, A subfamily
O00468	AGRIN_HUMAN	Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment, C90; Agrin C-terminal 22 kDa fragment, C22 ]	AGRN AGRIN	2068	9606			Alternative splicing;Calcium;Cell junction;Cell membrane;Congenital myasthenic syndrome;Developmental protein;Differentiation;Disease variant;Disulfide bond;EGF-like domain;Extracellular matrix;Glycoprotein;Heparan sulfate;Laminin EGF-like domain;Membrane;Phosphoprotein;Proteoglycan;Reference proteome;Repeat;Secreted;Signal;Synapse;Transmembrane;Transmembrane helix	O15265; Q8N9W6-4; Q9Y5V3; Q96N21	TISSUE SPECIFICITY: Expressed in basement membranes of lung and kidney. Muscle- and neuron-specific isoforms are found. Isoforms (y+) with the 4 AA insert and (z+8) isoforms with the 8 AA insert are all neuron-specific. Isoforms (z+11) are found in both neuronal and non-neuronal tissues. {ECO:0000269|PubMed:16487930, ECO:0000269|PubMed:20551380, ECO:0000269|PubMed:9652404}.	GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0009887; GO:0009888; GO:0016021; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062	PTM: Contains heparan and chondroitin sulfate chains and alpha-dystroglycan as well as N-linked and O-linked oligosaccharides. Glycosaminoglycans (GAGs), present in the N-terminal 110 kDa fragment, are required for induction of filopodia in hippocampal neurons. The first cluster (Gly/Ser-rich) for GAG attachment contains heparan sulfate (HS) chains and the second cluster (Ser/Thr-rich), contains chondroitin sulfate (CS) chains. Heparin and heparin sulfate binding in the G3 domain is independent of calcium ions. Binds heparin with a stoichiometry of 2:1. Binds sialic acid with a stoichiometry of 1:1 and binding requires calcium ions (By similarity). {ECO:0000250}.; PTM: At synaptic junctions, cleaved at two conserved sites, alpha and beta, by neurotrypsin. Cleavage at the alpha-site produces the agrin N-terminal 110-kDa subunit and the agrin C-terminal 110-kDa subunit. Further cleavage of agrin C-terminal 110-kDa subunit at the beta site produces the C-terminal fragments, agrin C-terminal 90 kDa fragment and agrin C-terminal 22 kDa fragment. Excessive cleavage at the beta-site releases large amounts of the agrin C-terminal 22 kDa fragment leading to destabilization at the neuromuscular junction (NMJ).	16710414; 9652404; 9151673; 15489334; 11161480; 16487930; 19159218; 20551380; 21969364; 22683512; 19631309; 22205389; 24951643	
O00469	PLOD2_HUMAN	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2, EC 1.14.11.4 (Lysyl hydroxylase 2, LH2)	PLOD2	737	9606		1.14.11.4	Alternative splicing;Dioxygenase;Disease variant;Endoplasmic reticulum;Glycoprotein;Iron;Membrane;Metal-binding;Osteogenesis imperfecta;Oxidoreductase;Phosphoprotein;Reference proteome;Signal;Vitamin C		TISSUE SPECIFICITY: Highly expressed in pancreas and muscle. Isoform 1 and isoform 2 are expressed in the majority of the examined cell types. Isoform 2 is specifically expressed in skin, lung, dura and aorta. {ECO:0000269|PubMed:10372558}.	GO:0001666; GO:0005506; GO:0005783; GO:0005789; GO:0006464; GO:0008475; GO:0017185; GO:0030867; GO:0031418; GO:0046947; GO:0070062		9054364; 14702039; 16641997; 10372558; 15489334; 18088087; 19159218; 21269460; 12881513; 15523624; 22689593; 29983323	
O00470	MEIS1_HUMAN	Homeobox protein Meis1	MEIS1	390	9606			3D-structure;Activator;Alternative splicing;Developmental protein;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription	P16220; P14921; P40424; P31314	TISSUE SPECIFICITY: Expressed at low level in normal immunohepatopoietic tissues, including the fetal liver. Expressed in a subset of myeloid leukemia cell lines, with the highest expression seen in those with a megakaryocytic-erythroid phenotype. Also expressed at high levels in the cerebellum.	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005667; GO:0006357; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0045638; GO:0045665; GO:0045944; GO:0060216		9226379; 15815621; 15489334; 12609849; 17081983; 19799567; 23186163; 26550823; 28473536; 19620614	TALE/MEIS homeobox family
O00471	EXOC5_HUMAN	Exocyst complex component 5 (Exocyst complex component Sec10, hSec10)	EXOC5 SEC10 SEC10L1	708	9606			Acetylation;Coiled coil;Cytoplasm;Exocytosis;Phosphoprotein;Protein transport;Reference proteome;Transport	A0AVN2; Q99728; P23560-2; Q5PSV4; Q8TAB5; Q68D86; P02511; P53674; Q05D60; Q3B7T1-5; Q6FHV6; Q8TAG9; Q9Y2D4; P02671-2; Q96NE9; P04406; Q8N4P3; A0A0S2Z4Q4; O14964; P42858; Q9NWB7; Q9BVG8-5; Q9BQD3; P43357; P43360; P00973; P00973-2; D3DTS7; A0A0S2Z528; Q13882; Q9ULZ3; P61106; P20338; P61018; P37840; Q96E40; Q7Z699; Q9UNE7; Q13148; Q96FV9; O14787; Q86WV8; Q6PF05-3; Q8N3L3; P83876; O75604; O76024	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9119050}.	GO:0000145; GO:0000281; GO:0001736; GO:0005737; GO:0005829; GO:0006887; GO:0006892; GO:0006893; GO:0006904; GO:0015031; GO:0030496; GO:0031267; GO:0047485; GO:0072659; GO:0090148; GO:0090522; GO:1904019; GO:1905515		9119050; 14702039; 15489334; 18756269; 18691976; 21269460; 22814378; 23186163; 25944712	SEC10 family
O00472	ELL2_HUMAN	RNA polymerase II elongation factor ELL2	ELL2	640	9606			3D-structure;Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	P07550; Q8TAX5; Q92870-2; P54253; P55212; P28329-3; Q96JC9; Q8IYI6; P22607; P21333-2; Q14957; P06396; P30519; P13473-2; Q8N2W9; O43741; O75400-2; P49810; P62826; Q9Y371; P37840; Q9UMX0		GO:0000791; GO:0000987; GO:0005654; GO:0006368; GO:0008023; GO:0032968; GO:0042795	PTM: Ubiquitinated by SIAH1, leading to its degradation by the proteasome. Interaction with AFF4 stabilizes ELL2 and prevents ELL2 ubiquitination. {ECO:0000269|PubMed:22483617}.	9108030; 14702039; 15372022; 15489334; 11418481; 12446457; 18691976; 18669648; 20471948; 20159561; 20068231; 22195968; 21406692; 22483617; 22895430; 23251033	ELL/occludin family
O00476	NPT4_HUMAN	Sodium-dependent phosphate transport protein 4 (Na(+)/PI cotransporter 4) (Sodium/phosphate cotransporter 4) (Solute carrier family 17 member 3)	SLC17A3 NPT4	420	9606			Alternative splicing;Cell membrane;Endoplasmic reticulum;Glycoprotein;Ion transport;Membrane;Reference proteome;Sodium;Sodium transport;Symport;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Expressed in the liver and kidney. It is detected in proximal tubules in renal cortex as well as some tubules and glomeruli, with highest expression at the apical side of proximal tubules (at protein level). {ECO:0000269|PubMed:20810651, ECO:0000269|PubMed:9149941}.	GO:0005436; GO:0005737; GO:0005764; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006817; GO:0006820; GO:0008308; GO:0008514; GO:0015136; GO:0015143; GO:0015562; GO:0015711; GO:0015739; GO:0015747; GO:0015760; GO:0016021; GO:0016324; GO:0019534; GO:0022857; GO:0031526; GO:0034220; GO:0042910; GO:0046415; GO:0048471; GO:1990961		9149941; 14702039; 14574404; 15489334; 15505377; 20810651	Major facilitator superfamily, Sodium/anion cotransporter family
O00478	BT3A3_HUMAN	Butyrophilin subfamily 3 member A3	BTN3A3 BTF3	584	9606			3D-structure;Adaptive immunity;Alternative splicing;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunity;Immunoglobulin domain;Membrane;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Detected in peripheral blood mononuclear cells and in T-cells (at protein level). Detected in spleen and lymphocytes. {ECO:0000269|PubMed:20610803}.	GO:0001817; GO:0002456; GO:0005102; GO:0005886; GO:0009897; GO:0016020; GO:0016021; GO:0050852	PTM: N-glycosylated. {ECO:0000269|PubMed:19349973, ECO:0000269|PubMed:20610803}.	9149941; 14702039; 14574404; 15489334; 15340161; 19349973; 20610803; 21918970; 22767497; 24275569; 22846996	Immunoglobulin superfamily, BTN/MOG family
O00481	BT3A1_HUMAN	Butyrophilin subfamily 3 member A1 (CD antigen CD277)	BTN3A1 BTF5	513	9606			3D-structure;Adaptive immunity;Alternative splicing;Cell membrane;Disulfide bond;Glycoprotein;Immunity;Immunoglobulin domain;Membrane;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	P78410; G5E9A7; O60437; P04155; O60437	TISSUE SPECIFICITY: Detected on T-cells, natural killer cells, dendritic cells and macrophages (at protein level). Ubiquitous. Highly expressed in heart, pancreas and lung, Moderately expressed in placenta, liver and muscle. {ECO:0000269|PubMed:20610803, ECO:0000269|PubMed:21113407, ECO:0000269|PubMed:21918970, ECO:0000269|PubMed:9149941}.	GO:0001817; GO:0001819; GO:0002250; GO:0005102; GO:0005886; GO:0009897; GO:0016021; GO:0032729; GO:0050798; GO:0050852	PTM: N-glycosylated. {ECO:0000269|PubMed:20610803, ECO:0000269|PubMed:22846996}.	9382921; 9149941; 14702039; 14574404; 15489334; 20610803; 21113407; 21918970; 22767497; 22846996	Immunoglobulin superfamily, BTN/MOG family
O00482	NR5A2_HUMAN	Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor, hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1, LRH-1)	NR5A2 B1F CPF FTF	541	9606			3D-structure;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Lipid-binding;Metal-binding;Nucleus;Receptor;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	O60869; P35222; Q15596; Q15466; Q6P1K8; Q92786	TISSUE SPECIFICITY: Abundantly expressed in pancreas, less in liver, very low levels in heart and lung. Expressed in the Hep-G2 cell line. Isoform 1 and isoform 2 seem to be present in fetal and adult liver and Hep-G2 cells.	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008206; GO:0008270; GO:0009755; GO:0009792; GO:0009888; GO:0030855; GO:0042127; GO:0042592; GO:0042632; GO:0043565; GO:0045070; GO:0045893; GO:0045944; GO:0061113; GO:0090575; GO:0097720; GO:1990830; GO:1990837	PTM: Sumoylated by SUMO1 at Lys-270 during the hepatic acute phase response, leading to promote interaction with GPS2 and prevent N-Cor corepressor complex dissociation. {ECO:0000269|PubMed:20159957}.	9786908; 10359768; 11595170; 14702039; 16710414; 15489334; 9858833; 20159957; 15707893; 16289203; 15723037; 15897460	Nuclear hormone receptor family, NR5 subfamily
O00483	NDUA4_HUMAN	Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ, CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit)	NDUFA4	81	9606			3D-structure;Acetylation;Electron transport;Leigh syndrome;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport	Q92782-2		GO:0005739; GO:0005743; GO:0005747; GO:0005751; GO:0006120; GO:0006123; GO:0008137; GO:0031966; GO:0044877; GO:0045333; GO:1904960		9352085; 12690205; 15489334; 12611891; 21269460; 22902835; 23746447; 23186163; 24275569; 25944712; 31536960; 30030519	Complex IV NDUFA4 subunit family
O00487	PSDE_HUMAN	26S proteasome non-ATPase regulatory subunit 14, EC 3.4.19.- (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1)	PSMD14 POH1	310	9606		3.4.19.-	3D-structure;Direct protein sequencing;DNA damage;DNA repair;Hydrolase;Metal-binding;Metalloprotease;Phosphoprotein;Protease;Proteasome;Reference proteome;Ubl conjugation pathway;Zinc	Q9C005; Q8IZU0; P42858; P50222; P51665	TISSUE SPECIFICITY: Widely expressed. Highest levels in heart and skeletal muscle. {ECO:0000269|PubMed:9374539}.	GO:0000502; GO:0000724; GO:0004843; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0034774; GO:0043161; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0061578; GO:0070122; GO:0070536; GO:0070628; GO:0140492; GO:1904813		9374539; 14702039; 15489334; 1317798; 17323924; 17693683; 19214193; 19349277; 19690332; 21269460; 22909820; 23186163; 24275569; 27428775; 27342858	Peptidase M67A family, PSMD14 subfamily
O00488	ZN593_HUMAN	Zinc finger protein 593 (Zinc finger protein T86)	ZNF593 ZT86	134	9606			3D-structure;DNA-binding;Metal-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	Q96D03; Q8TBB1; Q9NRD5	TISSUE SPECIFICITY: Ubiquitous. Detected in spleen, prostate, testis, small intestine, colon and to a minor level in thymus and peripheral blood leukocytes.	GO:0003677; GO:0005654; GO:0005730; GO:0008270; GO:0045944; GO:1903026		14702039; 16710414; 15489334; 9115366; 12429849; 17081983; 18669648; 19690332; 20068231; 21406692; 23186163; 18287285	ZNF593/BUD20 C2H2-type zinc-finger protein family
O00499	BIN1_HUMAN	Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1)	BIN1 AMPHL	593	9606			3D-structure;Acetylation;Alternative splicing;Cell membrane;Coiled coil;Cytoplasm;Developmental protein;Differentiation;Disease variant;Endocytosis;Endosome;Host-virus interaction;Membrane;Nucleus;Phosphoprotein;Reference proteome;SH3 domain	O00499; Q9UBW5; Q9Y2H0; P09467; Q13496; Q8NFH8; Q8TB24; O95219; Q13426; PRO_0000037576 [P27958]; PRO_0000037551 [Q9WMX2]; P10636-7; P10636-8; PRO_0000037576 [P27958]; P01106; P01106	TISSUE SPECIFICITY: Ubiquitous. Highest expression in the brain and muscle (PubMed:9182667). Expressed in oligodendrocytes (PubMed:27488240). Isoform IIA is expressed only in the brain, where it is detected in the gray matter, but not in the white matter (PubMed:27488240). Isoform BIN1 is widely expressed with highest expression in skeletal muscle. {ECO:0000269|PubMed:10903846, ECO:0000269|PubMed:27488240, ECO:0000269|PubMed:9182667}.	GO:0000122; GO:0002020; GO:0005543; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0006997; GO:0007010; GO:0008021; GO:0008333; GO:0010564; GO:0015629; GO:0016020; GO:0019828; GO:0030018; GO:0030276; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0031674; GO:0031982; GO:0033268; GO:0033292; GO:0042802; GO:0043065; GO:0043194; GO:0043196; GO:0043547; GO:0043679; GO:0044300; GO:0045664; GO:0045807; GO:0048156; GO:0048488; GO:0048711; GO:0051015; GO:0051020; GO:0051087; GO:0051647; GO:0060987; GO:0060988; GO:0070063; GO:0086091; GO:0090571; GO:0098850; GO:0098978; GO:1901380; GO:1902430; GO:1902960; GO:1903946; GO:1904878	PTM: Phosphorylated by protein kinase C. {ECO:0000250}.	9195986; 9182667; 8782822; 9603201; 9223448; 9395479; 17974005; 15815621; 9418903; 10903846; 12668730; 17081983; 16530520; 17676042; 19367720; 18669648; 19413330; 19690332; 20068231; 22814378; 23186163; 24275569; 24755653; 27179792; 27488240; 28893863; 20142620; 25260562; 29950440	
O00501	CLD5_HUMAN	Claudin-5 (Transmembrane protein deleted in VCFS, TMDVCF)	CLDN5 AWAL TMVCF	218	9606			Cell junction;Cell membrane;Membrane;Reference proteome;Tight junction;Transmembrane;Transmembrane helix	P29972; Q6UX41-6; Q9P0B6; A0PK11; Q9BT09; Q9Y5Q5; P40313; Q07325; Q8NBI2; P52803; Q08426; Q9UKR5; Q7Z2K6; P02724; O43561-2; Q8TAF8; P30301; Q04941; Q96GM1; Q01453; Q9NS64; P11686; Q13326; Q969S0; Q9BZL3; Q9NZ01; P02787; Q5BJH2-2; Q9NV12; Q9P0S9; Q6ZP80; Q8WZ59; Q9H0R3; O60636; O95183; Q9Y548		GO:0003151; GO:0005198; GO:0005886; GO:0005911; GO:0005923; GO:0007043; GO:0007155; GO:0007179; GO:0007612; GO:0008284; GO:0010628; GO:0010629; GO:0016021; GO:0016327; GO:0016328; GO:0016338; GO:0016525; GO:0030054; GO:0030336; GO:0032092; GO:0033270; GO:0035633; GO:0042552; GO:0042802; GO:0043116; GO:0043220; GO:0045471; GO:0060021; GO:0060325; GO:0070160; GO:0070830; GO:0120192; GO:1903142; GO:1903348; GO:1990963		9192844; 15461802; 14702039; 10591208; 15489334	Claudin family
O00505	IMA4_HUMAN	Importin subunit alpha-4 (Importin alpha Q2, Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma)	KPNA3 QIP2	521	9606			Acetylation;Cytoplasm;Host-virus interaction;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport;Viral penetration into host nucleus;Virus entry into host cell	Q9GZX7; X5D778; B3KTP4; Q8TBE0; Q15059-2; Q68D86; P46527; Q6ZMK1-3; Q9NR30; P19447; Q92731-3; Q7L5A3; Q86YD7; P02792; Q13322-4; Q96MH2; P07910; P42858; Q92993; Q14974; Q8NA19-2; P45984; Q9NZL9; Q13330; Q9HAN9; Q9UKX7; Q9BUI4; P43351; Q96P16; Q8WWX8; Q8WWX8-3; Q96LM6; Q96KP6; Q9Y5U2; Q2YD98; O43167; Q8TBK6; Q6PEW1; P36508; Q96H86; Q9BRL8; K9N643; P03427	TISSUE SPECIFICITY: Ubiquitous. Highest levels in heart and skeletal muscle.	GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0006607; GO:0008022; GO:0008139; GO:0042564; GO:0043657; GO:0046718; GO:0061608; GO:0065003; GO:0075732		9154134; 9395085; 9435235; 14702039; 15057823; 15489334; 12740372; 17081983; 18669648; 18318008; 19413330; 19690332; 20554775; 20068231; 21269460; 21406692; 23186163; 24275569; 26382858	Importin alpha family
O00506	STK25_HUMAN	Serine/threonine-protein kinase 25, EC 2.7.11.1 (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1, SOK-1, Ste20/oxidant stress response kinase 1)	STK25 SOK1 YSK1	426	9606		2.7.11.1	3D-structure;Alternative splicing;ATP-binding;Cytoplasm;Golgi apparatus;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase	Q9Y376; O95273; Q8NHQ1; Q08379; A6NEM1; Q8IYA8; Q9BUL8; O43815; P14373; P63104; Q62839	TISSUE SPECIFICITY: Ubiquitously expressed. Highest levels are found in testis, large intestine, brain and stomach followed by heart and lung.	GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005794; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168; GO:0106310		8887545; 9160885; 14702039; 15815621; 15489334; 15037601; 18782753; 21269460	Protein kinase superfamily, STE Ser/Thr protein kinase family, STE20 subfamily
O00507	USP9Y_HUMAN	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y, EC 3.4.19.12 (Deubiquitinating enzyme FAF-Y) (Fat facets protein-related, Y-linked) (Ubiquitin thioesterase FAF-Y) (Ubiquitin-specific protease 9, Y chromosome) (Ubiquitin-specific-processing protease FAF-Y)	USP9Y DFFRY	2555	9606		3.4.19.12	Alternative splicing;Cytoplasm;Hydrolase;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway		TISSUE SPECIFICITY: Widely expressed in embryonic and adult tissues.	GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007179; GO:0007283; GO:0008234; GO:0016477; GO:0016579; GO:0030509; GO:0070410		8922996; 9381176; 9384609; 12815422; 10581029; 14759258; 19246359	Peptidase C19 family
O00512	BCL9_HUMAN	B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, Bcl-9 (Protein legless homolog)	BCL9	1426	9606			3D-structure;Acetylation;Chromosomal rearrangement;Methylation;Nucleus;Phosphoprotein;Proto-oncogene;Reference proteome;Wnt signaling pathway	Q6P1J9; P35222; Q9Y3Y4; Q9BRQ0; P18824; Q9V9W8	TISSUE SPECIFICITY: Detected at low levels in thymus, prostate, testis, ovary and small intestine, and at lower levels in spleen, colon and blood.	GO:0003713; GO:0005654; GO:0005801; GO:0008013; GO:0014908; GO:0035019; GO:0035914; GO:0045944; GO:0060070; GO:1990907		9490669; 16710414; 11955446; 17525332; 18669648; 19413330; 19690332; 20068231; 21406692; 23186163; 24275569; 17052462; 18498752	BCL9 family
O00519	FAAH1_HUMAN	Fatty-acid amide hydrolase 1, EC 3.5.1.99 (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase, EC 3.1.1.-) (Oleamide hydrolase 1)	FAAH FAAH1	579	9606		3.1.1.-; 3.5.1.99	Cytoplasm;Cytoskeleton;Direct protein sequencing;Hydrolase;Lipid degradation;Lipid metabolism;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	Q7Z3S9	TISSUE SPECIFICITY: Highly expressed in the brain, small intestine, pancreas, skeletal muscle and testis. Also expressed in the kidney, liver, lung, placenta and prostate. {ECO:0000269|PubMed:17015445}.	GO:0004040; GO:0005543; GO:0005789; GO:0005856; GO:0009062; GO:0016021; GO:0017064; GO:0019369; GO:0031090; GO:0042802; GO:0045907; GO:0047372; GO:0052651; GO:0102077; GO:0103073		9122178; 9878243; 16710414; 15489334; 12665801; 17015445; 21049984; 19926788; 24275569; 12060782; 15254019; 16972078; 16959974; 23556448	Amidase family
O00522	KRIT1_HUMAN	Krev interaction trapped protein 1, Krev interaction trapped 1 (Cerebral cavernous malformations 1 protein)	KRIT1 CCM1	736	9606			3D-structure;Alternative splicing;Angiogenesis;ANK repeat;Cell junction;Cell membrane;Cytoplasm;Cytoskeleton;Disease variant;Membrane;Reference proteome;Repeat	Q9BSQ5; Q9BSQ5-1; Q9ULI3; O14713; P61086	TISSUE SPECIFICITY: Low levels in brain. Very weak expression found in heart and muscle. {ECO:0000269|PubMed:9285558}.	GO:0001525; GO:0001937; GO:0003158; GO:0005546; GO:0005615; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0007264; GO:0008017; GO:0010596; GO:0016525; GO:0030695; GO:0033622; GO:0045454; GO:0045765; GO:2000114; GO:2000352		9285558; 11161791; 11161805; 12172908; 14702039; 12853948; 15489334; 11342228; 11741838; 11854171; 17916086; 20332120; 20668652; 20616044; 21633110; 26417067; 22577140; 23007647; 23317506; 26458359	
O00526	UPK2_HUMAN	Uroplakin-2, UP2 (Uroplakin II, UPII)	UPK2	184	9606			Cell membrane;Cleavage on pair of basic residues;Glycoprotein;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix	Q86Y34; Q86WK6; P07307-3; O75787; J3KQ12; Q6UXG8-3; P04233-2; O95471; Q6ZS10; Q9BXN2-6; P12314; P12318-2; P55899; Q8TBE3; Q99795; P05981; Q9NQX7-3; Q8N6L0; P43628; Q8N743; Q9H400; P60201-2; Q96K19-5; A1A5C7-2; Q0VAQ4; Q8TAV4; Q9BVX2; O15393-2; O14788; O43557; Q5BVD1; Q8WWF5	TISSUE SPECIFICITY: Expressed in ureter. {ECO:0000269|PubMed:9846985}.	GO:0005887; GO:0016324; GO:0030855; GO:0070062		9846985; 12792753; 15489334	Uroplakin-2 family
O00533	NCHL1_HUMAN	Neural cell adhesion molecule L1-like protein (Close homolog of L1) [Cleaved into: Processed neural cell adhesion molecule L1-like protein ]	CHL1 CALL	1208	9606			Alternative splicing;Cell adhesion;Cell membrane;Developmental protein;Differentiation;Disulfide bond;Extracellular matrix;Glycoprotein;Immunoglobulin domain;Membrane;Neurogenesis;Phosphoprotein;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in the fetal and adult brain as well as in Schwann cell culture. Also detected in adult peripheral tissues. {ECO:0000269|PubMed:9799093}.	GO:0001764; GO:0002020; GO:0005886; GO:0007155; GO:0007165; GO:0007411; GO:0008344; GO:0016021; GO:0030425; GO:0035640; GO:0043524; GO:0045177; GO:0050890; GO:0070062	PTM: Cleavage by metalloprotease ADAM8 in the extracellular part generates 2 soluble forms (125 kDa and 165 kDa) in vitro and is inhibited by metalloprotease inhibitors (By similarity). Cleaved by BACE1 (By similarity). {ECO:0000250|UniProtKB:P70232}.; PTM: N-glycosylated. Contains N-linked oligosaccharides with a sulfated carbohydrate structure type HNK-1 (SO4-3-GlcUABeta1,3GalBeta1,4GlcNAc) (By similarity). {ECO:0000250}.; PTM: O-glycosylated. {ECO:0000250}.	9799093; 16641997; 15489334; 16335952; 16959974	Immunoglobulin superfamily, L1/neurofascin/NgCAM family
O00541	PESC_HUMAN	Pescadillo homolog	PES1	588	9606			3D-structure;Acetylation;Alternative splicing;Chromosome;Isopeptide bond;Nucleus;Reference proteome;Ribosome biogenesis;rRNA processing;Ubl conjugation	P54253; Q14137; Q08050; P42858; Q9GZL7	TISSUE SPECIFICITY: Significant levels are detected in a variety of cancer cell lines, including glioblastoma, breast carcinoma, colon carcinoma and cervical carcinoma cells. Levels are abnormally elevated in malignant tumors of astrocytic origin.	GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006364; GO:0008283; GO:0016020; GO:0030687; GO:0042273; GO:0043021; GO:0051726; GO:0070545	PTM: Sumoylated.	8985183; 15461802; 10591208; 15489334; 11071894; 12022229; 12429849; 16043514; 16738141; 17353269; 17189298; 18669648; 19608861; 21269460; 22814378; 25114211; 28112733; 25825154	Pescadillo family
O00548	DLL1_HUMAN	Delta-like protein 1 (Drosophila Delta homolog 1, Delta1, H-Delta-1)	DLL1 UNQ146/PRO172	723	9606			3D-structure;Alternative splicing;Autism spectrum disorder;Cell junction;Cell membrane;Developmental protein;Differentiation;Disulfide bond;EGF-like domain;Epilepsy;Glycoprotein;Isopeptide bond;Membrane;Mental retardation;Notch signaling pathway;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix;Ubl conjugation		TISSUE SPECIFICITY: Expressed in heart and pancreas, with lower expression in brain and muscle and almost no expression in placenta, lung, liver and kidney.	GO:0001709; GO:0001756; GO:0001757; GO:0001947; GO:0002315; GO:0003323; GO:0005112; GO:0005509; GO:0005576; GO:0005886; GO:0005887; GO:0005912; GO:0007219; GO:0007368; GO:0007386; GO:0008217; GO:0008284; GO:0008285; GO:0009954; GO:0010628; GO:0014002; GO:0014807; GO:0016324; GO:0021510; GO:0021688; GO:0021693; GO:0030097; GO:0030154; GO:0030155; GO:0030857; GO:0030957; GO:0031410; GO:0032693; GO:0034351; GO:0035265; GO:0040008; GO:0045121; GO:0045596; GO:0045605; GO:0045608; GO:0045638; GO:0045662; GO:0045665; GO:0045746; GO:0045747; GO:0045807; GO:0045944; GO:0046331; GO:0048630; GO:0048631; GO:0048633; GO:0048665; GO:0048839; GO:0050767; GO:0051302; GO:0060041; GO:0060042; GO:0060853; GO:0070986; GO:0072006; GO:0072014; GO:0072070; GO:0072583; GO:0097009; GO:0097102; GO:0097110; GO:0097150; GO:0098773; GO:1900746; GO:1903672; GO:2000726	PTM: Ubiquitinated by MIB (MIB1 or MIB2), leading to its endocytosis and subsequent degradation (By similarity). Ubiquitinated; promotes recycling back to the plasma membrane and confers a strong affinity for NOTCH1. Multi-ubiquitination of LYS-613 by MIB1 promotes both cis and trans-interaction with NOTCH1, as well as activation of Notch signaling. Ubiquitinated by NEURL1B (By similarity). {ECO:0000250|UniProtKB:P10041, ECO:0000250|UniProtKB:Q61483}.; PTM: Phosphorylated in a membrane association-dependent manner. Phosphorylation at Ser-697 requires the presence of Ser-694, whereas phosphorylation at Ser-694 occurs independently of the other site. Phosphorylation is required for full ligand activity in vitro and affects surface presentation, ectodomain shedding, and endocytosis. {ECO:0000250|UniProtKB:Q61483}.; PTM: O-fucosylated. Can be elongated to a disaccharide by MFNG. {ECO:0000250|UniProtKB:P97677}.	10079256; 10688816; 19906316; 12975309; 14702039; 14574404; 11006133; 11581320; 15509766; 24025447; 29856955; 31353024	
O00555	CAC1A_HUMAN	Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I, BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)	CACNA1A CACH4 CACN3 CACNL1A4	2506	9606			3D-structure;Alternative splicing;Calcium;Calcium channel;Calcium transport;Cell membrane;Disease variant;Disulfide bond;Epilepsy;Glycoprotein;Ion channel;Ion transport;Membrane;Metal-binding;Neurodegeneration;Phosphoprotein;Reference proteome;Repeat;Spinocerebellar ataxia;Transmembrane;Transmembrane helix;Transport;Triplet repeat expansion;Voltage-gated channel	Q8IZP0; O94910; Q86SJ2; Q7Z5H3; P67870; O75953; P28799; P15822; Q8N2S1; O00339; O75095; Q7Z7M0; Q9UHX1; Q8IXT5; O95153; Q9BVA1; P22695; P49750	TISSUE SPECIFICITY: Brain specific; mainly found in cerebellum, cerebral cortex, thalamus and hypothalamus. Expressed in the small cell lung carcinoma cell line SCC-9. No expression in heart, kidney, liver or muscle. Purkinje cells contain predominantly P-type VSCC, the Q-type being a prominent calcium current in cerebellar granule cells. {ECO:0000269|PubMed:1335101}.	GO:0001540; GO:0005245; GO:0005634; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0007204; GO:0007268; GO:0008219; GO:0008331; GO:0016021; GO:0019905; GO:0034765; GO:0042995; GO:0043025; GO:0045202; GO:0046872; GO:0050804; GO:0070509; GO:0070588; GO:1904645; GO:1904646		10049321; 8898206; 8988170; 10753886; 15057824; 7823133; 1335101; 8525433; 11865310; 18400181; 9345107; 9302278; 10987655; 10408532; 10408533; 11409427; 11176968; 11439943; 11723274; 12420090; 15293273; 15032980; 15173248; 14718690; 16866717; 16325861; 18400034; 18602318; 19232643; 19429006; 20682717; 20129625; 21696515; 24836863; 26716990; 27476654; 27250579; 29053796; 28900389; 28742085; 33798445	Calcium channel alpha-1 subunit (TC 1.A.1.11) family, CACNA1A subfamily
O00559	RCAS1_HUMAN	Receptor-binding cancer antigen expressed on SiSo cells (Cancer-associated surface antigen RCAS1) (Estrogen receptor-binding fragment-associated gene 9 protein)	EBAG9 RCAS1	213	9606			Alternative splicing;Apoptosis;Coiled coil;Golgi apparatus;Membrane;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix	Q9ULC5; Q9BQE5; Q12983; Q9BXR6; Q9H5X1; Q6UXB4; Q9NWW5; A0A0C4DFN3; Q8N912; Q8NH19; Q9P0S3; Q9Y5Y5; O60831; Q96HR9-2; Q9BRI3; P78382; Q96G79; Q969S0; Q16623; P32856-2; Q13277; Q6UX40; Q6ZUI0; Q9Y228; Q9P0L0; O95292	TISSUE SPECIFICITY: Widely expressed. Expressed in ovary, testis, prostate, thymus, muscle and heart, but not in small intestine, colon, lymph nodes, or peripherical blood lymphocytes. The protein is not detected in any of the above organs.	GO:0000139; GO:0001558; GO:0016021; GO:0016505; GO:0030141		10426319; 9418891; 14702039; 16421571; 15489334; 12054692; 12138241; 12672804; 15144186; 15592455; 17081983; 18088087; 18691976; 18669648; 19369195; 19690332; 20068231; 21406692; 22814378; 23186163; 24275569	
O00560	SDCB1_HUMAN	Syntenin-1 (Melanoma differentiation-associated protein 9, MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18, TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)	SDCBP MDA9 SYCL	298	9606			3D-structure;Acetylation;Alternative splicing;Cell junction;Cell membrane;Cytoplasm;Cytoskeleton;Direct protein sequencing;Endoplasmic reticulum;Lipid-binding;Membrane;Nucleus;Phosphoprotein;Reference proteome;Repeat;Secreted	Q9NYB9; Q7Z3H0-1; Q8N2N9-4; Q6AI12; Q92688; Q96GX9; P53365; Q15041; P54253; Q5TBC7; Q8N7W2-2; Q9H3H3; Q9H3H3-3; Q9NX04; O14523; Q9NP86; A2RRN7; Q9ULU8-4; Q13137; P51636; O75828; Q68D86; Q9BWC9; P32320; P49427; Q9H5V8; O14735; P55273; Q53EZ4; Q6P2H3-3; Q9UFW8; Q9UKJ5; Q9HD42; P49760; P49761; Q96DZ9; Q96DZ9-2; P13073; Q86WV2; O43186; P02489; Q5HYN5; P0DMU9; Q8NHU0; Q6NSH3; P56545-3; Q9GZU7; Q9NTM9; Q6ZMK1-3; P32321; Q9H773; Q13838; Q96Q80; Q14565; G5E9A7; P50570; Q14919; Q96EV8; P63172; Q96JC9; Q8WWZ3; Q8N9N8; P63241; Q9GZV4; Q15717; Q9NT22; Q8TC92; Q96C92-2; A1L162; Q9NPD3; Q13158; Q9NWS6; Q9BPY3; Q8IZU1; Q8IZU0; Q13643; Q5TD97; Q8NFF5; O15409; Q6NZ44; P02792; O75084; Q7L5D6; O95749; Q5VSY0; Q9Y3E0; Q8N954; Q8N954-2; A8MXD5; O15499; Q2KHT4-3; A0A024RA76; V9HW60; V9HW40; Q96MH2; Q5VTY9; Q6NT76; O15347; P07910; Q9NSC5; Q8IX15-3; P49639; P31268; P00492; O75506; O75031; P42858; O60921; Q02535; P24592; Q8IYA8; Q13422; Q01344; Q8NBZ0; Q9H079; O95259; P63252; Q719H9; Q8NC69; Q7L273; Q5VWX1; O60333-2; Q53G59; O95198; P02533; Q8IUG1; Q9BYS1; P60409; P26371; O43679; P07195; O95751; O95214; P05162; P62312; Q8IV03; Q9NQ48; Q13257; P45984; Q9UPY8; O95460-2; O95983; Q9NPJ6; P50221; Q6FHY5; A0A0C4DFN3; Q9UJV3-2; Q9H8M7; Q9UHC7; Q9BU76; Q13875-3; Q9Y605; Q96HT8; Q5JR59; Q5JR59-3; Q8WY64; O15049; O95544; Q9UJ70; Q9UJ70-2; Q9H115; Q7Z6G3-2; Q15223; Q6ZUT1; Q6ZUT1-2; Q7Z3S9; P49902; P0CE72; A1E959; Q96CV9; Q92882; P61457; P49585; Q5VU43; Q5VU43-2; O76083-2; P50479; Q13113; Q99471; Q8IXK0; Q9UIL8; Q8WWB5; Q8ND90; Q9UL42; P52435; Q9Y2Y1; Q8NAV1; O75400-2; Q9NZ81; P49720; P62333; Q9UL46; O43586; Q03393; Q9UHX1; Q53H96; Q53GL6; Q14498; Q96HR9; Q96HR9-2; Q04864; Q9NPQ8-4; Q9Y3C5; P13489; Q9HAT0; Q8TA86; P49247; P35268; Q96P16-3; Q9NS64; P62854; P31350; Q15050; Q17RB0; Q16799-3; Q59EK9; Q59EK9-3; P04271; Q8WXD2; Q9UN30-2; O00560; Q8WYJ6; Q9UH03; Q01105; Q01105-2; Q8WV19; Q8IUQ4; Q9BRV3; P51531; P51531-2; P37840; P09012; Q13596; Q5MJ09; Q7Z699; P12931; Q8N9Q2; Q05519; Q05519-2; P84103; Q16629; A1L4H1; O43805; P53999; O43704; O43759-2; Q16563; Q8N2H4; O43680; P15884-3; P48775; Q969V4; Q12800; Q9NWX6; Q96CG3; Q3LXA3; Q08117; Q7Z6W1; Q86X19; Q8WW34; Q8WW34-2; O95379; Q5GJ75; O95271; O00463; P14373; Q13049; O00635; Q9BYV2; Q15645; Q86WV8; Q15631; A5PKU2; P0CG47; P49459; P61086; Q712K3; O95292; Q9Y3C0; O00401; O76024; O95070; O43829; Q96BR9; Q8TBK6; Q9NP64; Q9H0C1; Q6P1L6; Q8NCK3; Q6AZW8; Q9H5H4; Q9UGI0; Q3MJ62; P59637	TISSUE SPECIFICITY: Expressed in lung cancers, including adenocarcinoma, squamous cell carcinoma and small-cell carcinoma (at protein level) (PubMed:25893292). Widely expressed. Expressed in fetal kidney, liver, lung and brain. In adult highest expression in heart and placenta. {ECO:0000269|PubMed:25893292}.	GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0044877; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046875; GO:0046982; GO:0047485; GO:0050839; GO:0070062; GO:0072562; GO:0099054; GO:1903543; GO:1903553; GO:1903561	PTM: Phosphorylated on tyrosine residues.	9391086; 9511750; 14702039; 16421571; 15489334; 9883737; 10230395; 10770943; 11152476; 11432873; 11179419; 11498591; 12643545; 17081065; 19413330; 21269460; 22660413; 23186163; 24275569; 26032692; 25219541; 26539120; 25893292; 26291527; 12679023; 12842047; 15081807; 16533050; 27386966	
O00562	PITM1_HUMAN	Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1, PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2, NIR-2)	PITPNM1 DRES9 NIR2 PITPNM	1244	9606			Alternative splicing;Calcium;Cytoplasm;Endoplasmic reticulum;Golgi apparatus;Lipid droplet;Membrane;Metal-binding;Methylation;Phosphoprotein;Protein transport;Reference proteome;Transport	Q12800	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10022914}.	GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0043231; GO:0044297; GO:0070300	PTM: Phosphorylated on multiple sites by CDK1 at the onset of mitosis. Phosphorylation facilitates dissociation from the Golgi complex and is required for interaction with PLK1.; PTM: Phosphorylated on threonine residues upon treatment with oleic acid.; PTM: Phosphorylated on tyrosine residues by PTK2B.	9680295; 10022914; 15627748; 16554811; 15489334; 10531358; 12225667; 11909959; 15125835; 15545272; 15723057; 22822086; 23186163; 24275569	PtdIns transfer protein family, PI transfer class IIA subfamily
O00566	MPP10_HUMAN	U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10)	MPHOSPH10 MPP10	681	9606			3D-structure;Acetylation;Chromosome;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;rRNA processing;Ubl conjugation	Q13895; Q9UI47-2; Q9NV31; Q96G21; Q9UBU8-2; P62136		GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006364; GO:0006396; GO:0008380; GO:0032040; GO:0034457	PTM: Phosphorylated in M (mitotic) phase.	8885239; 9450966; 15489334; 12429849; 12655004; 17081983; 18669648; 19690332; 19608861; 20068231; 21406692; 23186163; 24275569; 25218447; 25755297; 28112733	MPP10 family
O00567	NOP56_HUMAN	Nucleolar protein 56 (Nucleolar protein 5A)	NOP56 NOL5A	594	9606			3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Neurodegeneration;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Spinocerebellar ataxia;Ubl conjugation	Q9H190		GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226		9372940; 11780052; 15489334; 12429849; 12417735; 12777385; 15574333; 17081983; 17487921; 17636026; 18691976; 18669648; 19413330; 19620283; 19690332; 20068231; 21683323; 21269460; 21406692; 23186163; 24275569; 24129315; 25772364; 25755297; 28112733	NOP5/NOP56 family
O00571	DDX3X_HUMAN	ATP-dependent RNA helicase DDX3X, EC 3.6.4.13 (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform, DBX) (Helicase-like protein 2, HLP2)	DDX3X DBX DDX3	662	9606		3.6.4.13	3D-structure;Acetylation;Alternative splicing;Apoptosis;ATP-binding;Cell membrane;Cell projection;Chromosome partition;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease variant;DNA-binding;Helicase;Host-virus interaction;Hydrolase;Immunity;Inflammasome;Innate immunity;Isopeptide bond;Membrane;Mental retardation;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;RNA-binding;Transcription;Transcription regulation;Translation regulation;Ubl conjugation	Q8TF63; O95786; P05198; P55884; Q99613; Q04637; Q14164; Q7Z434; Q6P582; Q15003; Q9UBU9; P11940; Q13148; Q03403; P68467; P14240; P03427; P04608; Q923J1; P68466; PRO_0000037517 [P26664]; PRO_0000037566 [P27958]; PRO_0000037559 [Q5EG65]; Q99IB8; PRO_0000037541 [Q9WMX2]	TISSUE SPECIFICITY: Widely expressed (PubMed:15294876). In testis, expressed in spermatids (PubMed:15294876). Expressed in epidermis and liver (at protein level) (PubMed:16818630, PubMed:16301996). {ECO:0000269|PubMed:15294876, ECO:0000269|PubMed:16301996, ECO:0000269|PubMed:16818630}.	GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031053; GO:0031252; GO:0031333; GO:0031369; GO:0031954; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1901985; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243	PTM: Phosphorylated by TBK1; the phosphorylation is required for the synergistic induction of IFNB mediated by TBK1 and DDX3X (PubMed:18583960). Phosphorylated by IKBKE at Ser-102 after ssRNA viral infection; enhances the induction of INFB promoter by IRF3 (PubMed:18583960, PubMed:23478265). The cytoplasmic form is highly phosphorylated in the G1/S phase of the cell cycle and much less at G2/M (PubMed:22034099). Phosphorylation by CSNK1E may inhibit RNA-stimulated ATPase activity (PubMed:29222110). {ECO:0000269|PubMed:18583960, ECO:0000269|PubMed:22034099, ECO:0000269|PubMed:23478265, ECO:0000269|PubMed:29222110}.; PTM: Upon stimulation of death receptors, including TNFRSF10B, recruited to receptors and cleaved by caspases. Proteolytic fragments remain associated with the receptors. This cleavage presumably inactivates DDX3X anti-apoptotic function. {ECO:0000269|PubMed:18846110}.	10329544; 9381176; 14702039; 15772651; 15489334; 10859333; 14654843; 15507209; 15294876; 15592455; 16818630; 16301996; 17357160; 17095540; 18846110; 18583960; 18636090; 18632687; 18596238; 18628297; 17667941; 18264132; 18669648; 19029303; 19608861; 20127681; 20375222; 20837705; 21170385; 20657822; 20068231; 21269460; 21589879; 21730191; 21406692; 21883093; 22034099; 22223895; 22323517; 22872150; 23186163; 23478265; 23413191; 24275569; 24129315; 25218447; 26100019; 26030138; 25944712; 27546789; 27105836; 27736973; 27980081; 28733330; 28112733; 28842590; 29062139; 28128295; 30341167; 30131165; 29222110; 29899501; 30256975; 31575075; 17401195; 17631897; 19913487; 31300642; 16959974; 26235985	DEAD box helicase family, DDX3/DED1 subfamily
O00574	CXCR6_HUMAN	C-X-C chemokine receptor type 6, CXC-R6, CXCR-6 (CDw186) (G-protein coupled receptor STRL33) (G-protein coupled receptor bonzo) (CD antigen CD186)	CXCR6 BONZO STRL33 TYMSTR	342	9606			Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in lymphoid tissues and activated T cells.	GO:0004930; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0015026; GO:0016493; GO:0016494; GO:0019079; GO:0019722; GO:0019957; GO:0060326		9230441; 9166430; 9285716; 15489334	G-protein coupled receptor 1 family
O00584	RNT2_HUMAN	Ribonuclease T2, EC 4.6.1.19 (Ribonuclease 6)	RNASET2 RNASE6PL	256	9606		4.6.1.19	3D-structure;Alternative splicing;Disease variant;Disulfide bond;Endonuclease;Endoplasmic reticulum;Glycoprotein;Hydrolase;Immunity;Innate immunity;Lyase;Lysosome;Mitochondrion;Nuclease;Reference proteome;Secreted;Signal		TISSUE SPECIFICITY: Ubiquitous. Higher expression levels observed in the temporal lobe and fetal brain. {ECO:0000269|PubMed:19525954}.	GO:0003723; GO:0004521; GO:0004540; GO:0005576; GO:0005615; GO:0005758; GO:0005764; GO:0005788; GO:0006401; GO:0033897; GO:0035578; GO:0043202; GO:0045087; GO:0070062		9192857; 11821951; 14702039; 14574404; 15489334; 15809705; 16620762; 19525954; 21269460; 21199949; 25944712; 28730546; 30385512; 30184494; 31778653; 22735700	RNase T2 family
O00585	CCL21_HUMAN	C-C motif chemokine 21 (6Ckine) (Beta-chemokine exodus-2) (Secondary lymphoid-tissue chemokine, SLC) (Small-inducible cytokine A21)	CCL21 SCYA21 UNQ784/PRO1600	134	9606			3D-structure;Chemotaxis;Cytokine;Direct protein sequencing;Disulfide bond;Inflammatory response;Reference proteome;Secreted;Signal	Q99616; Q92583; Q9Y258; Q9NRJ3; P13501; P02778; P48061; O95715; Q07325; Q8WXH2; Q5XKR4; P02776; P10720; Q6UX40; Q5BVD1	TISSUE SPECIFICITY: Highly expressed in high endothelial venules of lymph nodes, spleen and appendix. Intermediate levels found in small intestine, thyroid gland and trachea. Low level expression in thymus, bone marrow, liver, and pancreas. Also found in tonsil, fetal heart and fetal spleen.	GO:0001768; GO:0001771; GO:0001954; GO:0002407; GO:0002548; GO:0002606; GO:0005576; GO:0005615; GO:0006954; GO:0006955; GO:0007186; GO:0007267; GO:0008009; GO:0010560; GO:0010820; GO:0030593; GO:0030838; GO:0031274; GO:0031295; GO:0031529; GO:0031640; GO:0031732; GO:0033630; GO:0034695; GO:0035759; GO:0038116; GO:0042379; GO:0043123; GO:0043547; GO:0043552; GO:0045860; GO:0046330; GO:0048020; GO:0048245; GO:0048247; GO:0048260; GO:0048469; GO:0050921; GO:0051209; GO:0051491; GO:0051897; GO:0060326; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0090023; GO:0090630; GO:0097026; GO:1903237; GO:1990869; GO:2000147; GO:2000406; GO:2000529; GO:2000548; GO:2000669		9235955; 9257816; 9300671; 9419363; 12975309; 14702039; 15489334; 9507024; 14978162; 23341447; 27044744; 22221265	Intercrine beta (chemokine CC) family
O00587	MFNG_HUMAN	Beta-1,3-N-acetylglucosaminyltransferase manic fringe, EC 2.4.1.222 (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)	MFNG	321	9606		2.4.1.222	Alternative splicing;Developmental protein;Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Manganese;Membrane;Metal-binding;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix			GO:0001825; GO:0002315; GO:0005615; GO:0007389; GO:0008375; GO:0008593; GO:0030173; GO:0032092; GO:0033829; GO:0045747; GO:0046872		9187150; 15461802; 14702039; 10591208; 15489334; 10935626	Glycosyltransferase 31 family
O00590	ACKR2_HUMAN	Atypical chemokine receptor 2 (C-C chemokine receptor D6) (Chemokine receptor CCR-10) (Chemokine receptor CCR-9) (Chemokine-binding protein 2) (Chemokine-binding protein D6)	ACKR2 CCBP2 CCR10 CMKBR9 D6	384	9606			Cell membrane;Disulfide bond;Endosome;G-protein coupled receptor;Glycoprotein;Inflammatory response;Membrane;Phosphoprotein;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	P52803; P48165; P11836; Q0D2K0; Q9NTJ5; Q9UKG4; Q9NRX6	TISSUE SPECIFICITY: Found in endothelial cells lining afferent lymphatics in dermis and lymph nodes. Also found in lymph nodes subcapsular and medullary sinuses, tonsillar lymphatic sinuses and lymphatics in mucosa and submucosa of small and large intestine and appendix. Also found in some malignant vascular tumors. Expressed at high levels in Kaposi sarcoma-related pathologies. Expressed on apoptotic neutrophils (at protein level). Expressed primarily in placenta and fetal liver, and found at very low levels in the lung and lymph node. {ECO:0000269|PubMed:11238036, ECO:0000269|PubMed:22651933, ECO:0000269|PubMed:23479571}.	GO:0004950; GO:0005044; GO:0005654; GO:0005769; GO:0005829; GO:0005884; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0031965; GO:0035556; GO:0043231; GO:0055037; GO:0060326	PTM: Phosphorylated on serine residues in the C-terminal cytoplasmic tail. {ECO:0000269|PubMed:18201974}.	9364936; 9405404; 14702039; 15489334; 11238036; 18201974; 20373092; 22651933; 22698181; 23356288; 23479571; 23125030; 22939232; 23633677	G-protein coupled receptor 1 family, Atypical chemokine receptor subfamily
O00591	GBRP_HUMAN	Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi)	GABRP	440	9606			Cell junction;Cell membrane;Chloride;Chloride channel;Disulfide bond;Glycoprotein;Ion channel;Ion transport;Membrane;Postsynaptic cell membrane;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Most abundant in the uterus, also expressed in lung, thymus and prostate.	GO:0004890; GO:0005230; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:1902476; GO:1902711		9182563; 14702039; 15489334; 16959974	Ligand-gated ion channel (TC 1.A.9) family, Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily, GABRP sub-subfamily
O00592	PODXL_HUMAN	Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1, PC, PCLP-1)	PODXL PCLP PCLP1	558	9606			Alternative splicing;Cell adhesion;Cell membrane;Cell projection;Direct protein sequencing;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Signal;Transmembrane;Transmembrane helix	P46940; Q96EQ0; Q9UHD9	TISSUE SPECIFICITY: Glomerular epithelium cell (podocyte).	GO:0001726; GO:0005615; GO:0005730; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007162; GO:0016324; GO:0016477; GO:0022408; GO:0030027; GO:0030175; GO:0030335; GO:0031528; GO:0032534; GO:0033634; GO:0034451; GO:0036057; GO:0043231; GO:0045121; GO:0070062; GO:0072015; GO:0072175	PTM: N- and O-linked glycosylated. Sialoglycoprotein (By similarity). {ECO:0000250}.	9188463; 12853948; 12690205; 15489334; 12504081; 17616675; 18456258; 18669648; 20068231; 21269460; 21406692; 25944712	Podocalyxin family
O00602	FCN1_HUMAN	Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)	FCN1 FCNM	326	9606			3D-structure;Calcium;Cell membrane;Collagen;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunity;Innate immunity;Lectin;Membrane;Metal-binding;Reference proteome;Repeat;Secreted;Signal	P02741; P26022; Q2TS39; O15552; P26022; P02769; PRO_0000000214 [P9WQP3]; P9WQP1	TISSUE SPECIFICITY: Peripheral blood leukocytes, monocytes and granulocytes. Also detected in spleen, lung, and thymus, may be due to the presence of tissue macrophages or trapped blood in these tissues. Not detected on lymphocytes. {ECO:0000269|PubMed:20400674}.	GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1903028; GO:1904813; GO:1905370		8573080; 14702039; 15164053; 15489334; 8947836; 15340161; 21037097; 20400674; 17148457; 17897951; 20032467; 16959974	Ficolin lectin family
O00622	CCN1_HUMAN	CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10, IBP-10, IGF-binding protein 10, IGFBP-10) (Protein CYR61) (Protein GIG1)	CCN1 CYR61 GIG1 IGFBP10	381	9606			3D-structure;Cell adhesion;Chemotaxis;Disulfide bond;Growth factor binding;Heparin-binding;Phosphoprotein;Reference proteome;Secreted;Signal	O60906; Q9UHD9		GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005576; GO:0005788; GO:0006935; GO:0007155; GO:0007165; GO:0008201; GO:0010518; GO:0010811; GO:0019838; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0031012; GO:0033690; GO:0043065; GO:0043066; GO:0043280; GO:0044319; GO:0045669; GO:0045860; GO:0045944; GO:0050840; GO:0060413; GO:0060548; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0062023; GO:0070372; GO:0072593; GO:2000304		9135077; 9536281; 10852911; 11810026; 15489334; 11584015; 9446626; 10446209; 10821835; 11287419; 26091039	CCN family
O00623	PEX12_HUMAN	Peroxisome assembly protein 12 (Peroxin-12) (Peroxisome assembly factor 3, PAF-3)	PEX12 PAF3	359	9606			Disease variant;Membrane;Metal-binding;Peroxisome;Peroxisome biogenesis disorder;Reference proteome;Transmembrane;Transmembrane helix;Zellweger syndrome;Zinc;Zinc-finger	Q9ULC5; Q15848; Q12982; Q8WVV5; Q6UWT4; P78369; Q4VAQ0; Q9BQA9; Q96LL9; Q7Z2K6; Q7L5A8; Q14318; Q9H0Q3; P29033; Q9Y5U9; Q9P0N8; A0A0C4DFN3; Q16617; Q8IXM6; P40855; P50542; P54315; P43378; Q8N0V3; Q96IW7; P60059; Q9NRQ5; P10124; Q9UNK0; C9JKN6; P17152; Q9H0R3; Q9NSU2-1; P49638		GO:0004842; GO:0005777; GO:0005778; GO:0005779; GO:0005829; GO:0006513; GO:0006625; GO:0007031; GO:0008022; GO:0008270; GO:0016558; GO:1990429		9090384; 9632816; 14702039; 15489334; 10704444; 11390669; 10562279; 19105186	Pex2/pex10/pex12 family
O00625	PIR_HUMAN	Pirin, EC 1.13.11.24 (Probable quercetin 2,3-dioxygenase PIR, Probable quercetinase)	PIR	290	9606	PATHWAY: Flavonoid metabolism; quercetin degradation. {ECO:0000305|PubMed:15951572}.	1.13.11.24	3D-structure;Cytoplasm;Dioxygenase;Iron;Metal-binding;Nucleus;Oxidoreductase;Reference proteome;Transcription;Transcription regulation		TISSUE SPECIFICITY: Highly expressed in a subset of melanomas. Detected at very low levels in most tissues (at protein level). Expressed in all tissues, with highest level of expression in heart and liver. {ECO:0000269|PubMed:20089166, ECO:0000269|PubMed:9079676}.	GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007586; GO:0008127; GO:0030224; GO:0046872		9079676; 15489334; 10362352; 15951572; 17288615; 20089166; 19766747; 20010624; 21269460; 22814378; 14573596; 20711196; 23716661	Pirin family
O00626	CCL22_HUMAN	C-C motif chemokine 22 (CC chemokine STCP-1) (MDC(1-69)) (Macrophage-derived chemokine) (Small-inducible cytokine A22) (Stimulated T-cell chemotactic protein 1) [Cleaved into: MDC(3-69); MDC(5-69); MDC(7-69) ]	CCL22 MDC SCYA22 A-152E5.1	93	9606			Chemotaxis;Cytokine;Direct protein sequencing;Disulfide bond;Reference proteome;Secreted;Signal	Q13520	TISSUE SPECIFICITY: Highly expressed in macrophage and in monocyte-derived dendritic cells, and thymus. Also found in lymph node, appendix, activated monocytes, resting and activated macrophages. Lower expression in lung and spleen. Very weak expression in small intestine. In lymph node expressed in a mature subset of Langerhans' cells (CD1a+ and CD83+). Expressed in Langerhans' cell histiocytosis but not in dermatopathic lymphadenopathy. Expressed in atopic dermatitis, allergic contact dermatitis skin, and psoriasis, in both the epidermis and dermis. {ECO:0000269|PubMed:11241286}.	GO:0002548; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0006955; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0009615; GO:0030593; GO:0031640; GO:0043547; GO:0048020; GO:0048247; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356	PTM: The N-terminal processed forms MDC(3-69), MDC(5-69) and MDC(7-69) are produced by proteolytic cleavage after secretion from monocyte derived dendrocytes. {ECO:0000269|PubMed:11241286}.	9312138; 9151897; 14702039; 10493829; 15616553; 15489334; 9430724; 11241286	Intercrine beta (chemokine CC) family
O00628	PEX7_HUMAN	Peroxisomal targeting signal 2 receptor, PTS2 receptor (Peroxin-7)	PEX7 PTS2R	323	9606			Alternative splicing;Cataract;Cytoplasm;Deafness;Disease variant;Ichthyosis;Peroxisome;Peroxisome biogenesis disorder;Protein transport;Reference proteome;Repeat;Retinitis pigmentosa;Rhizomelic chondrodysplasia punctata;Transport;WD repeat	O75925; Q8WXF7; Q96EL1; Q99932-2; Q9UNE7	TISSUE SPECIFICITY: Ubiquitous. Highest expression in pancreas, skeletal muscle and heart.	GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803		9090383; 9090381; 10673331; 14574404; 15489334; 30204880; 12522768	WD repeat peroxin-7 family
O00629	IMA3_HUMAN	Importin subunit alpha-3 (Importin alpha Q1, Qip1) (Karyopherin subunit alpha-4)	KPNA4 QIP1	521	9606			3D-structure;Acetylation;Cytoplasm;Host-virus interaction;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	Q9H2P0; P51816; Q05D32; Q6ZMK1; Q9Y222; Q9Y247; Q8NCD3; P07910; Q9H2F3; Q92993; P35968; Q14974; Q9NZL9; Q9ULH7; Q13330; P01106; Q53F19; O75376; Q9Y618; Q16236; P52952; Q9UKX7; Q9Y263; Q96PX9; P46063; Q9H040; Q13148; Q9ULW0; Q6R2W3; Q8NF64; Q9HCE3; Q5FWF4; PRO_0000042447 [P04585]; Q8K4J6; K9N643; P31345; P03070	TISSUE SPECIFICITY: Highly expressed in testis, ovary, small intestine, heart, skeletal muscle, lung and pancreas, but barely detectable in kidney, thymus, colon and peripheral blood leukocytes.	GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0031965; GO:0042564; GO:0061608		9168958; 9395085; 14702039; 15489334; 12610148; 14654843; 18669648; 19413330; 19690332; 20068231; 21269460; 21454664; 22814378; 23186163; 23864635; 23984714; 24275569; 29370303	Importin alpha family
O00631	SARCO_HUMAN	Sarcolipin	SLN	31	9606			3D-structure;Endoplasmic reticulum;Membrane;Reference proteome;Sarcoplasmic reticulum;Transmembrane;Transmembrane helix	Q8N6L0; Q8N205; Q9BSE2		GO:0004857; GO:0006816; GO:0016021; GO:0016529; GO:0033017; GO:0043086; GO:0043242; GO:0051117; GO:0051924; GO:0070296; GO:0090281; GO:0120162; GO:1901020; GO:1901077; GO:1901877; GO:1901881; GO:1901894; GO:1901895		9367679; 14702039; 15489334; 9575189; 28890335; 11781085	Sarcolipin family
O00635	TRI38_HUMAN	E3 ubiquitin-protein ligase TRIM38, EC 2.3.2.27 (RING finger protein 15) (Tripartite motif-containing protein 38) (Zinc finger protein RoRet)	TRIM38 RNF15 RORET	465	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:23056470}.; PATHWAY: Protein modification; protein sumoylation. {ECO:0000250|UniProtKB:Q5SZ99}.	2.3.2.27	Cytoplasm;Immunity;Innate immunity;Metal-binding;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	P54253; Q13895; Q53SE7; Q6FG85; Q9H8Y8; P34931; P54652; P11142; Q8N3F0; Q8N2W9; P25789; P40937; P78317; O00560; P61764; Q15560; Q9UJ04; Q7KZS0; Q96H86	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9149941}.	GO:0000209; GO:0003713; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032648; GO:0032880; GO:0042803; GO:0043123; GO:0043161; GO:0045070; GO:0045087; GO:0046596; GO:0046598; GO:0050687; GO:0051091; GO:0051092; GO:0061630; GO:0070936		9149941; 14702039; 15489334; 21269460; 23056470; 24275569; 24434549	
O00712	NFIB_HUMAN	Nuclear factor 1 B-type, NF1-B, Nuclear factor 1/B (CCAAT-box-binding transcription factor, CTF) (Nuclear factor I/B, NF-I/B, NFI-B) (TGGCA-binding protein)	NFIB	420	9606			Activator;Alternative splicing;Disease variant;DNA replication;DNA-binding;Mental retardation;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	P08651		GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0002062; GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0007420; GO:0009617; GO:0010001; GO:0021740; GO:0021960; GO:0030902; GO:0043392; GO:0044300; GO:0045893; GO:0045944; GO:0060486; GO:0060509; GO:0060510; GO:0060662; GO:0060689; GO:0061141; GO:0071679; GO:0140416; GO:1902894; GO:1990837; GO:2000791; GO:2000795		9484777; 9099724; 14702039; 17974005; 15164053; 15489334; 7590749; 18669648; 20068231; 23186163; 24275569; 31375868; 30388402	CTF/NF-I family
O00716	E2F3_HUMAN	Transcription factor E2F3, E2F-3	E2F3 KIAA0075	465	9606			Activator;Alternative splicing;Cell cycle;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation	Q9NRZ9; Q96JM7; P06400		GO:0000082; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0006606; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0070345; GO:0090575; GO:1905461; GO:1990837		8246996; 17974005; 14574404; 7584044; 15716352	E2F/DP family
O00743	PPP6_HUMAN	Serine/threonine-protein phosphatase 6 catalytic subunit, PP6C, EC 3.1.3.16 [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed ]	PPP6C PPP6	305	9606		3.1.3.16	Acetylation;Alternative splicing;Cell cycle;Cytoplasm;Direct protein sequencing;Hydrolase;Immunity;Innate immunity;Manganese;Metal-binding;Mitochondrion;Protein phosphatase;Reference proteome	O15084; P78318; O43318; Q9UPN7; O75170; Q5H9R7; O75663; Q08AM6	TISSUE SPECIFICITY: Ubiquitously expressed in all tissues tested with highest expression levels in testis, heart, kidney, brain, stomach, liver and skeletal muscle and lowest in placenta, lung colon and spleen. {ECO:0000269|PubMed:16769727, ECO:0000269|PubMed:9013334}.	GO:0000082; GO:0004722; GO:0005654; GO:0005739; GO:0005829; GO:0006470; GO:0045087; GO:0046872; GO:0048208		9013334; 10227379; 14702039; 15164053; 15489334; 9647778; 16769727; 17079228; 17568194; 18186651; 21269460; 22814378; 24275569; 27335426; 29053956; 32753499; 32474700	PPP phosphatase family, PP-6 (PP-V) subfamily
O00744	WN10B_HUMAN	Protein Wnt-10b (Protein Wnt-12)	WNT10B WNT12	389	9606			Alternative splicing;Developmental protein;Disease variant;Disulfide bond;Extracellular matrix;Glycoprotein;Lipoprotein;Phosphoprotein;Reference proteome;Secreted;Signal;Wnt signaling pathway	P05067	TISSUE SPECIFICITY: Detected in most adult tissues. Highest levels were found in heart and skeletal muscle. Low levels are found in brain.	GO:0000086; GO:0000122; GO:0002062; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0006629; GO:0007224; GO:0008284; GO:0010971; GO:0014835; GO:0030182; GO:0030501; GO:0030858; GO:0032434; GO:0043065; GO:0045165; GO:0045599; GO:0045669; GO:0045899; GO:0048018; GO:0048641; GO:0048741; GO:0050680; GO:0050821; GO:0050909; GO:0051091; GO:0051885; GO:0060070; GO:0060346; GO:0061196; GO:0071300; GO:0071320; GO:0071374; GO:0071425; GO:0090263; GO:0120163	PTM: Palmitoleoylation is required for efficient binding to frizzled receptors. Depalmitoleoylation leads to Wnt signaling pathway inhibition. {ECO:0000250|UniProtKB:P27467, ECO:0000250|UniProtKB:P56704}.	9284937; 11713588; 14702039; 16541075; 15489334; 9121776; 9441749; 18669648; 21447090; 26902720; 16477437; 18515319; 27321946	Wnt family
O00746	NDKM_HUMAN	Nucleoside diphosphate kinase, mitochondrial, NDK, NDP kinase, mitochondrial, EC 2.7.4.6 (Nucleoside diphosphate kinase D, NDPKD) (nm23-H4)	NME4 NM23D	187	9606		2.7.4.6	3D-structure;Alternative splicing;ATP-binding;Direct protein sequencing;Kinase;Lipid transport;Lipid-binding;Magnesium;Membrane;Metal-binding;Mitochondrion;Nucleotide metabolism;Nucleotide-binding;Reference proteome;Transferase;Transit peptide;Transport	Q9NYB9-2; P01019; Q9H6L4; Q8N5M1; P54253; Q8WUW1; Q9NWQ9; Q9NX04; Q9NPB3; Q9NP86; Q68D86; Q2TAC2-2; P55273; Q8IYR0; Q99828; Q96Q77; Q9UHD4; Q86UW9; P02042; Q8WUI4-6; O75031; P42858; P03952; P61968; P06858; Q13064; P40692; P15531; P22392; Q9Y5B8; P61970; Q9UBU9; Q9BY11; O15160; P20618; P37840; Q9NZD8; Q9UMX1; Q13148; O14656-2; P0DI81-3; Q15645; Q96PN8; Q6DKK2; Q9BZL1; P40337-2; Q05516	TISSUE SPECIFICITY: Widely distributed. Found at very high levels in prostate, heart, liver, small intestine, and skeletal muscle tissues, and in low amounts in the brain and in blood leukocytes.	GO:0004550; GO:0005524; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006183; GO:0006228; GO:0006241; GO:0006869; GO:0009116; GO:0046872; GO:1901612		9099850; 11157797; 15616553; 15489334; 17028143; 18635542; 23150663; 24970086; 10799505	NDK family
O00748	EST2_HUMAN	Cocaine esterase, EC 3.1.1.84 (Carboxylesterase 2, CE-2, hCE-2, EC 3.1.1.1) (Methylumbelliferyl-acetate deacetylase 2, EC 3.1.1.56)	CES2 ICE	559	9606		3.1.1.1; 3.1.1.56; 3.1.1.84	Alternative initiation;Alternative splicing;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Hydrolase;Lipid metabolism;Pyrrolidone carboxylic acid;Reference proteome;Serine esterase;Signal		TISSUE SPECIFICITY: Preferentially expressed in intestine with moderate expression in liver. Within the intestine, highest expression is found in small intestine with lower expression in colon and rectum. {ECO:0000269|PubMed:9144407}.	GO:0005783; GO:0005788; GO:0006693; GO:0009056; GO:0043231; GO:0047374; GO:0052689; GO:0080030	PTM: Glycosylated. {ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:9169443}.	9144407; 9169443; 14702039; 17974005; 15616553; 15489334; 19159218; 21049984; 22446793; 28677105; 21269460; 24275569; 12721789; 15618752	Type-B carboxylesterase/lipase family
O00750	P3C2B_HUMAN	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, PI3K-C2-beta, PtdIns-3-kinase C2 subunit beta, EC 2.7.1.137, EC 2.7.1.154 (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)	PIK3C2B	1634	9606		2.7.1.137; 2.7.1.154	ATP-binding;Cell membrane;Cytoplasm;Endoplasmic reticulum;Kinase;Lipid metabolism;Membrane;Microsome;Nucleotide-binding;Nucleus;Reference proteome;Transferase	P00533; P04626; P62993; P16333; P14373; P63104	TISSUE SPECIFICITY: Expressed in columnar and transitional epithelia, mononuclear cells, and ganglion cells (at protein level). Widely expressed, with highest levels in thymus and placenta and lowest in peripheral blood, skeletal muscle and kidney. {ECO:0000269|PubMed:14563213, ECO:0000269|PubMed:9144573}.	GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0046854; GO:0048015; GO:0052742		9144573; 9830063; 16710414; 10805725; 11533253; 14563213; 18669648	PI3/PI4-kinase family
O00754	MA2B1_HUMAN	Lysosomal alpha-mannosidase, Laman, EC 3.2.1.24 (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide ]	MAN2B1 LAMAN MANB	1011	9606		3.2.1.24	Alternative splicing;Direct protein sequencing;Disease variant;Disulfide bond;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Metal-binding;Reference proteome;Signal;Zinc;Zymogen			GO:0004559; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006013; GO:0006464; GO:0006517; GO:0030246; GO:0035578; GO:0043202; GO:0043231; GO:0046872; GO:0070062	PTM: First processed into 3 peptides of 70 kDa, 42 kDa (D) and 13/15 kDa (E). The 70 kDa peptide is further processed into three peptides (A, B and C). The A, B and C peptides are disulfide-linked.; PTM: Heavily glycosylated. {ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:19159218}.	8166692; 9158146; 9192839; 15057824; 15489334; 8910458; 7832746; 12754519; 19159218; 21269460; 24275569; 25944712; 9758606; 9915946; 12718372; 15712269; 22161967	Glycosyl hydrolase 38 family
O00755	WNT7A_HUMAN	Protein Wnt-7a	WNT7A	349	9606			3D-structure;Developmental protein;Disease variant;Disulfide bond;Extracellular matrix;Glycoprotein;Lipoprotein;Reference proteome;Secreted;Signal;Wnt signaling pathway	P55212; P22607; P06396; P13473-2; Q9UMX0; Q9Y5W5; Q9Z0J1	TISSUE SPECIFICITY: Expression is restricted to placenta, kidney, testis, uterus, fetal lung, and fetal and adult brain.	GO:0000578; GO:0001502; GO:0001525; GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007269; GO:0007409; GO:0007548; GO:0009953; GO:0009986; GO:0010595; GO:0010628; GO:0014719; GO:0014834; GO:0021707; GO:0021846; GO:0022009; GO:0030010; GO:0030182; GO:0030666; GO:0031012; GO:0031133; GO:0032270; GO:0032355; GO:0035019; GO:0035115; GO:0035116; GO:0035313; GO:0036465; GO:0042733; GO:0043066; GO:0043627; GO:0045165; GO:0045167; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048103; GO:0048864; GO:0050768; GO:0051965; GO:0060054; GO:0060066; GO:0060070; GO:0060071; GO:0060997; GO:0061038; GO:0062009; GO:0070062; GO:0070307; GO:0071560; GO:0098685; GO:0098793; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:1904861; GO:1904891; GO:1905386; GO:1905606; GO:2000300; GO:2000463	PTM: Palmitoleoylation is required for efficient binding to frizzled receptors. Depalmitoleoylation leads to Wnt signaling pathway inhibition. {ECO:0000250|UniProtKB:P27467, ECO:0000250|UniProtKB:P56704}.	9161407; 8893824; 15489334; 8168088; 26902720; 30026314; 25731175; 16826533; 17431918; 20949531; 21271649; 27638328	Wnt family
O00757	F16P2_HUMAN	Fructose-1,6-bisphosphatase isozyme 2, FBPase 2, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)	FBP2	339	9606	PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.	3.1.3.11	3D-structure;Allosteric enzyme;Calcium;Carbohydrate metabolism;Cell junction;Cytoplasm;Gluconeogenesis;Hydrolase;Magnesium;Metal-binding;Nucleus;Phosphoprotein;Reference proteome	P09467; O00757; P04792; O60333-2; O60260-5; P60891	TISSUE SPECIFICITY: Expressed in skeletal muscle (at protein level). {ECO:0000269|PubMed:12507293}.	GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872; GO:0070062		9678974; 15164053; 15489334; 12507293; 16213487; 17350621; 18214967; 19626708; 22120740; 24086250	FBPase class 1 family
O00762	UBE2C_HUMAN	Ubiquitin-conjugating enzyme E2 C, EC 2.3.2.23 ((E3-independent) E2 ubiquitin-conjugating enzyme C, EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UbcH10) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C)	UBE2C UBCH10	179	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000269|PubMed:18485873}.	2.3.2.23; 2.3.2.24	3D-structure;Acetylation;Alternative splicing;ATP-binding;Cell cycle;Cell division;Mitosis;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway	P62879; Q13164		GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0005886; GO:0006511; GO:0010458; GO:0010994; GO:0016567; GO:0030071; GO:0031145; GO:0031536; GO:0044389; GO:0051301; GO:0061630; GO:0061631; GO:0070936; GO:0070979; GO:1904668	PTM: Autoubiquitinated by the APC/C complex, leading to its degradation by the proteasome. Its degradation plays a central role in APC/C regulation, allowing cyclin-A accumulation before S phase entry. APC/C substrates inhibit the autoubiquitination of UBE2C/UBCH10 but not its E2 function, hence APC/C remaining active until its substrates have been destroyed. {ECO:0000269|PubMed:15558010}.	9122200; 11780052; 15489334; 15558010; 17588522; 18485873; 19413330; 19820702; 19822757; 20061386; 21269460; 21406692; 23186163; 11927573; 27259151	Ubiquitin-conjugating enzyme family
O00763	ACACB_HUMAN	Acetyl-CoA carboxylase 2, EC 6.4.1.2 (ACC-beta)	ACACB ACC2 ACCB	2458	9606	PATHWAY: Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. {ECO:0000269|PubMed:19900410, ECO:0000269|PubMed:26976583}.	6.4.1.2	3D-structure;Allosteric enzyme;Alternative splicing;ATP-binding;Biotin;Fatty acid biosynthesis;Fatty acid metabolism;Ligase;Lipid biosynthesis;Lipid metabolism;Magnesium;Manganese;Metal-binding;Mitochondrion;Multifunctional enzyme;Nucleotide-binding;Phosphoprotein;Reference proteome;Transit peptide	O00763; P50747; Q9CQ20	TISSUE SPECIFICITY: Widely expressed with highest levels in heart, skeletal muscle, liver, adipose tissue, mammary gland, adrenal gland and colon (PubMed:9099716). Isoform 3 is expressed in skeletal muscle, adipose tissue and liver (at protein level) (PubMed:19190759). Isoform 3 is detected at high levels in adipose tissue with lower levels in heart, liver, skeletal muscle and testis (PubMed:19190759). {ECO:0000269|PubMed:19190759, ECO:0000269|PubMed:9099716}.	GO:0003989; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006084; GO:0006633; GO:0009374; GO:0009410; GO:0010629; GO:0010884; GO:0010906; GO:0014070; GO:0031667; GO:0031999; GO:0042802; GO:0043086; GO:0046872; GO:0051289; GO:0060421; GO:0097009; GO:2001295	PTM: The biotin cofactor is covalently attached to the central biotinyl-binding domain and is required for the catalytic activity. {ECO:0000305|PubMed:18247344}.; PTM: Phosphorylation at Ser-222 by AMPK inactivates the enzyme (PubMed:12488245). Required for the maintenance of skeletal muscle lipid and glucose homeostasis (By similarity). {ECO:0000250|UniProtKB:E9Q4Z2, ECO:0000269|PubMed:12488245}.	9099716; 16854592; 16541075; 8670171; 10677481; 12488245; 18669648; 19236960; 19190759; 20457939; 20952656; 24275569; 17876819; 18247344; 19390150; 19900410; 26976583; 18772397	
O00764	PDXK_HUMAN	Pyridoxal kinase, EC 2.7.1.35 (Pyridoxine kinase)	PDXK C21orf124 C21orf97 PKH PNK PRED79	312	9606	PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage; pyridoxal 5'-phosphate from pyridoxal: step 1/1. {ECO:0000269|PubMed:31187503, ECO:0000305|PubMed:17766369}.; PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage; pyridoxine 5'-phosphate from pyridoxine: step 1/1. {ECO:0000305|PubMed:17766369}.; PATHWAY: Cofactor metabolism; pyridoxal 5'-phosphate salvage; pyridoxamine 5'-phosphate from pyridoxamine: step 1/1. {ECO:0000305|PubMed:17766369}.	2.7.1.35	3D-structure;Acetylation;Alternative splicing;ATP-binding;Charcot-Marie-Tooth disease;Cobalt;Cytoplasm;Disease variant;Kinase;Magnesium;Manganese;Metal-binding;Neurodegeneration;Neuropathy;Nucleotide-binding;Phosphoprotein;Reference proteome;Sodium;Transferase;Zinc		TISSUE SPECIFICITY: Ubiquitous (PubMed:9099727, PubMed:31187503). Highly expressed in testis (PubMed:9099727). {ECO:0000269|PubMed:31187503, ECO:0000269|PubMed:9099727}.; TISSUE SPECIFICITY: [Isoform 3]: In adult testis and spermatozoa. {ECO:0000269|PubMed:15154080}.	GO:0000287; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0008478; GO:0009443; GO:0030170; GO:0030955; GO:0031402; GO:0031403; GO:0034774; GO:0035580; GO:0042803; GO:0070062		9099727; 15154080; 10830953; 15489334; 10987144; 18691976; 19369195; 21269460; 23186163; 24275569; 28716709; 16600635; 17766369; 19351586; 22879864; 31187503	Pyridoxine kinase family
O00767	SCD_HUMAN	Stearoyl-CoA desaturase, hSCD1, EC 1.14.19.1 (Acyl-CoA desaturase) (Delta(9)-desaturase, Delta-9 desaturase) (Fatty acid desaturase)	SCD FADS5 SCD1 SCDOS	359	9606		1.14.19.1	3D-structure;Direct protein sequencing;Endoplasmic reticulum;Fatty acid biosynthesis;Fatty acid metabolism;Iron;Lipid biosynthesis;Lipid metabolism;Membrane;Metal-binding;Oxidoreductase;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	Q13520; Q9UJ71; P20138; Q9HA82; Q2HXU8-2; Q96BA8; P49447; Q9BQA9; Q9Y282; P08034; Q8TDT2; O15529; Q8TED1; Q7Z5P4; Q8N5M9; P48051; Q9NX47; Q8NI22; Q5SR56; O14880; Q9H2K0; P15151; Q9BRK0; Q86VR2; Q99942; Q9NY72; Q9BY50; Q3KNW5; Q8TBB6; Q9NPE6; P27105; Q9NPL8; Q96MV1; Q3MIR4; O15393-2; Q9Y320; Q3ZAQ7; A0A142I5B9	TISSUE SPECIFICITY: Detected in fetal liver, lung and brain. Highly expressed in adult adipose tissue, and at lower levels in adult brain and lung. {ECO:0000269|PubMed:15907797}.	GO:0004768; GO:0005506; GO:0005730; GO:0005783; GO:0005789; GO:0006636; GO:0016020; GO:0016021; GO:0016491; GO:0030176; GO:0032896; GO:0070542; GO:0120162; GO:1903966		10229681; 14702039; 15164054; 15489334; 11415448; 19892738; 7909540; 15907797; 15610069; 18691976; 18669648; 18765284; 21269460; 21406692; 23186163; 26098317	Fatty acid desaturase type 1 family
O14490	DLGP1_HUMAN	Disks large-associated protein 1, DAP-1 (Guanylate kinase-associated protein, hGKAP) (PSD-95/SAP90-binding protein 1) (SAP90/PSD-95-associated protein 1, SAPAP1)	DLGAP1 DAP1 GKAP	977	9606			3D-structure;Alternative splicing;Cell junction;Cell membrane;Membrane;Phosphoprotein;Reference proteome;Synapse	P78352; P62993; P16333; Q62696	TISSUE SPECIFICITY: Expressed in brain.	GO:0005886; GO:0007268; GO:0014069; GO:0044877; GO:0060090; GO:0098962; GO:0098978; GO:0099572		9286858; 9024696; 14702039; 16177791; 15489334	SAPAP family
O14492	SH2B2_HUMAN	SH2B adapter protein 2 (Adapter protein with pleckstrin homology and Src homology 2 domains) (SH2 and PH domain-containing adapter protein APS)	SH2B2 APS	632	9606			3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Membrane;Phosphoprotein;Reference proteome;SH2 domain	P22681; Q9NWX5; P49759-3; P49761; Q9UII6; Q9H5Z6-2; Q86YD7; P08631-2; Q9UBH0; Q8TAP4-4; Q9H213; Q96EZ8; Q9HB20; Q9NRW1; Q08117-2; Q9H1K6; O75604; Q96IQ9; Q8TAU3	TISSUE SPECIFICITY: Expressed in spleen, prostate, testis, uterus, small intestine and skeletal muscle. Among hematopoietic cell lines, expressed exclusively in B-cells. Not expressed in most tumor cell lines. {ECO:0000269|PubMed:9233773, ECO:0000269|PubMed:9989826}.	GO:0005068; GO:0005737; GO:0005829; GO:0005886; GO:0008286; GO:0035556; GO:0035591; GO:0042169; GO:0050851; GO:0050853	PTM: Tyrosine phosphorylated by JAK2, KIT and other kinases activated by B-cell receptor in response to stimulation with cytokines, IL3, IL5, PDGF, IGF1, IGF2, CSF2/GM-CSF and cross-linking of the B-cell receptor complex. {ECO:0000250|UniProtKB:Q9JID9, ECO:0000269|PubMed:10374881, ECO:0000269|PubMed:9233773, ECO:0000269|PubMed:9989826}.	9233773; 12853948; 10374881; 9989826; 12400014; 16129412; 15378031	SH2B adapter family
O14493	CLD4_HUMAN	Claudin-4 (Clostridium perfringens enterotoxin receptor, CPE-R, CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein)	CLDN4 CPER CPETR1 WBSCR8	209	9606			3D-structure;Cell junction;Cell membrane;Chloride;Chloride channel;Disulfide bond;Ion channel;Ion transport;Membrane;Phosphoprotein;Reference proteome;Tight junction;Transmembrane;Transmembrane helix;Transport;Williams-Beuren syndrome	Q13520; Q3SXY8; Q86T13; Q5JX71; O15552; P48165; Q8NBJ4; Q7Z5P4; P32942; Q5SR56; Q8N9I0; Q96Q45-2; Q4KMG9; Q8IWR1; Q5TGU0		GO:0004888; GO:0005198; GO:0005254; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0006821; GO:0007155; GO:0007565; GO:0007623; GO:0009925; GO:0016324; GO:0016327; GO:0016328; GO:0016338; GO:0022604; GO:0030335; GO:0032570; GO:0034707; GO:0042802; GO:0061436; GO:0070160; GO:0070293; GO:0070830; GO:0090303; GO:1905050	PTM: Phosphorylated. Phosphorylation by EPHA2 is stimulated by EFNA1 and alters interaction with TJP1. {ECO:0000269|PubMed:16236711}.	9334247; 15489334; 16236711; 20375010; 21269460; 27647526	Claudin family
O14494	PLPP1_HUMAN	Phospholipid phosphatase 1, EC 3.1.3.-, EC 3.1.3.106, EC 3.1.3.4, EC 3.1.3.81 (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a, PAP-2a, PAP2a)	PLPP1 LPP1 PPAP2A	284	9606	PATHWAY: Lipid metabolism; phospholipid metabolism. {ECO:0000269|PubMed:10962286, ECO:0000269|PubMed:9305923, ECO:0000269|PubMed:9607309, ECO:0000269|PubMed:9705349}.	3.1.3.-; 3.1.3.106; 3.1.3.4; 3.1.3.81	Alternative splicing;Cell membrane;Glycoprotein;Hydrolase;Lipid metabolism;Membrane;Reference proteome;Transmembrane;Transmembrane helix	P05067; Q9UQM7; P29466-3; P48730-2; O15529; P17612; P49768-2; Q8WWF3; Q15583	TISSUE SPECIFICITY: Widely expressed with highest expression found in prostate (PubMed:9305923). Found to be down-regulated in colon adenocarcinomas (PubMed:9570154). {ECO:0000269|PubMed:9305923, ECO:0000269|PubMed:9570154}.; TISSUE SPECIFICITY: [Isoform 1]: Predominant in kidney, lung, placenta and liver. {ECO:0000269|PubMed:9570154}.; TISSUE SPECIFICITY: [Isoform 2]: Predominant in heart and pancreas. {ECO:0000269|PubMed:9570154}.	GO:0000810; GO:0005886; GO:0005887; GO:0005901; GO:0006644; GO:0006670; GO:0006672; GO:0007165; GO:0007205; GO:0008195; GO:0008285; GO:0016020; GO:0016324; GO:0019216; GO:0030148; GO:0030518; GO:0030521; GO:0042392; GO:0042577; GO:0045121; GO:0046839; GO:0070062; GO:0106235	PTM: N-glycosylated (PubMed:9305923, PubMed:10962286). N-linked sugars are of the complex type. N-glycosylation is not required for the phosphatase activity (By similarity). {ECO:0000250|UniProtKB:Q61469, ECO:0000269|PubMed:10962286, ECO:0000269|PubMed:9305923}.	9305923; 9570154; 9468526; 9705349; 15372022; 15489334; 9607309; 10962286; 14527693; 12909631; 15461590; 17005594; 17379599	PA-phosphatase related phosphoesterase family
O14495	PLPP3_HUMAN	Phospholipid phosphatase 3, EC 3.1.3.-, EC 3.1.3.4 (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b, PAP-2b, PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein, VCIP)	PLPP3 LPP3 PPAP2B	311	9606	PATHWAY: Lipid metabolism; phospholipid metabolism. {ECO:0000269|PubMed:27694435, ECO:0000269|PubMed:9607309, ECO:0000269|PubMed:9705349}.	3.1.3.-; 3.1.3.4	Cell membrane;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Hydrolase;Lipid metabolism;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	O60716	TISSUE SPECIFICITY: Ubiquitously expressed (PubMed:9305923, PubMed:12660161). Highly expressed in heart and placenta (PubMed:9305923). {ECO:0000269|PubMed:12660161, ECO:0000269|PubMed:9305923}.	GO:0000139; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0016020; GO:0016021; GO:0016323; GO:0030111; GO:0030148; GO:0033116; GO:0033631; GO:0034109; GO:0042392; GO:0042577; GO:0044328; GO:0044329; GO:0044330; GO:0045121; GO:0046839; GO:0050821; GO:0051091; GO:0060070; GO:0070971; GO:0106235	PTM: N-glycosylated (PubMed:9705349). Contains high-mannose oligosaccharides (PubMed:9705349). {ECO:0000269|PubMed:9705349}.	9305923; 9705349; 12660161; 9110174; 14702039; 15489334; 9607309; 14527693; 14725715; 16099422; 17005594; 18215144; 18691976; 18669648; 20123964; 21569306; 21406692; 23591818; 27694435	PA-phosphatase related phosphoesterase family
O14497	ARI1A_HUMAN	AT-rich interactive domain-containing protein 1A, ARID domain-containing protein 1A (B120) (BRG1-associated factor 250, BAF250) (BRG1-associated factor 250a, BAF250A) (Osa homolog 1, hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)	ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1	2285	9606			3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Direct protein sequencing;DNA-binding;Mental retardation;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	Q14526; P51531; P51532; P11388	TISSUE SPECIFICITY: Highly expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon, and PBL, and at a much lower level in heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas. {ECO:0000269|PubMed:11073988, ECO:0000269|PubMed:11318604, ECO:0000269|PubMed:12200431}.	GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0030520; GO:0030521; GO:0035060; GO:0042766; GO:0042921; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819		11073988; 16710414; 12200431; 11734557; 10757798; 9434167; 11318604; 8804307; 11780067; 11988099; 17081983; 16964243; 17525332; 18220336; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22426308; 22814378; 23186163; 24275569; 24129315; 12672490; 12665591; 15170388; 18765789; 22952240; 26601204; 26614907; 14722072; 21248752; 22009941; 23906836	
O14503	BHE40_HUMAN	Class E basic helix-loop-helix protein 40, bHLHe40 (Class B basic helix-loop-helix protein 2, bHLHb2) (Differentially expressed in chondrocytes protein 1, DEC1) (Enhancer-of-split and hairy-related protein 2, SHARP-2) (Stimulated by retinoic acid gene 13 protein)	BHLHE40 BHLHB2 DEC1 SHARP2 STRA13	412	9606			Biological rhythms;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	C9JG97; Q16613; P54253; Q13895; O75909; Q6NVV7; P10606; Q03060-25; O75553; Q15038; Q92997; Q08426; Q86UY5; Q8NEA9; Q86YR5-3; Q96G42; Q8IUG1; Q8IUB9; Q3LI72; Q3SYF9; A1A580; Q3LI64; Q3LI66; Q8IUC2; Q71RC2-6; Q14847-2; Q8TAP4-4; Q9Y5V3; Q96EZ8; Q9GZZ1; Q9HC98-4; Q9BVI4; P18545; Q99471; O43189; Q96CS7; P78424; Q13131; P86480; Q9Y4B4; Q9NWB1-5; Q86U06; Q86U06-2; Q93062; Q6ZRY4; O94955; Q9H4E5; Q01974; P19793; Q8WU79; Q8NB12; O94964-4; O60248; B7ZLI8; Q96A09; Q08117; Q08117-2; Q14106; P04637; Q5W5X9; Q9NX01; P63279; Q70EL1-9; Q08AM6; O95231; P19544-6; Q15911-2; P0C206	TISSUE SPECIFICITY: Expressed in cartilage, spleen, intestine, lung, and to a lesser extent in heart, brain, liver, muscle and stomach.	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007623; GO:0009952; GO:0016604; GO:0019904; GO:0032922; GO:0042752; GO:0042803; GO:0043153; GO:0043425; GO:0043426; GO:0043433; GO:0045892; GO:0046982; GO:0050767; GO:0061629; GO:0070888; GO:1990837	PTM: Ubiquitinated; which may lead to proteasomal degradation. {ECO:0000269|PubMed:11278694}.; PTM: Sumoylation inhibits its ubiquitination and promotes its negative regulation of the CLOCK-ARNTL/BMAL1 heterodimer transcriptional activator activity. {ECO:0000269|PubMed:11278694, ECO:0000269|PubMed:21829689}.	9240428; 11226878; 15489334; 11278694; 12397359; 14672706; 15193144; 15560782; 18411297; 19786558; 21829689; 23186163; 25218447; 25114211; 25772364; 25755297; 28797635; 28112733; 30012868	
O14508	SOCS2_HUMAN	Suppressor of cytokine signaling 2, SOCS-2 (Cytokine-inducible SH2 protein 2, CIS-2) (STAT-induced STAT inhibitor 2, SSI-2)	SOCS2 CIS2 SSI2 STATI2	198	9606	PATHWAY: Protein modification; protein ubiquitination.		3D-structure;Growth regulation;Isopeptide bond;Phosphoprotein;Reference proteome;SH2 domain;Signal transduction inhibitor;Ubl conjugation;Ubl conjugation pathway	Q93034; Q15369; P19235; P10721; O75716; P40337-2; P07947	TISSUE SPECIFICITY: High expression in heart, placenta, lung, kidney and prostate. Predominantly expressed in pulmonary epithelia cells, specifically type II pneumocytes. {ECO:0000269|PubMed:31578312, ECO:0000269|PubMed:9266833}.	GO:0001558; GO:0005131; GO:0005159; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0007595; GO:0008269; GO:0009966; GO:0016567; GO:0032355; GO:0032870; GO:0035556; GO:0040015; GO:0043066; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060749	PTM: Ubiquitinated; mediated by AREL1 and leading to its subsequent proteasomal degradation (PubMed:31578312). Ubiquitination is dependent on its phosphorylation at Ser-52, by PKC (PubMed:31578312). Ubiquitination is stimulated by LPS (By similarity). {ECO:0000250|UniProtKB:O35717, ECO:0000269|PubMed:31578312}.; PTM: Phosphorylation at Ser-52 by PKC facilitates its ubiquitination and proteosomal degradation. {ECO:0000269|PubMed:31578312}.	9266833; 9344848; 9727029; 14702039; 15489334; 10512686; 21269460; 23401859; 23186163; 31578312; 16675548	
O14511	NRG2_HUMAN	Pro-neuregulin-2, membrane-bound isoform, Pro-NRG2 [Cleaved into: Neuregulin-2, NRG-2 (Divergent of neuregulin-1, DON-1) (Neural- and thymus-derived activator for ERBB kinases, NTAK) ]	NRG2 NTAK	850	9606			Alternative splicing;Cell membrane;Disulfide bond;EGF-like domain;Glycoprotein;Growth factor;Immunoglobulin domain;Membrane;Reference proteome;Secreted;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Restricted to the cerebellum in the adult.	GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0007165; GO:0007399; GO:0008083; GO:0016021; GO:0035556; GO:0048513	PTM: Proteolytic cleavage close to the plasma membrane on the external face leads to the release of the soluble growth factor form. {ECO:0000250}.; PTM: Extensive glycosylation precedes the proteolytic cleavage. {ECO:0000250}.	9348101; 9199335; 10369162; 10867024	Neuregulin family
O14512	SOCS7_HUMAN	Suppressor of cytokine signaling 7, SOCS-7 (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4, NAP-4)	SOCS7 NAP4 SOCS6	581	9606	PATHWAY: Protein modification; protein ubiquitination.		Alternative splicing;Cell membrane;Cytoplasm;Growth regulation;Membrane;Nucleus;Reference proteome;SH2 domain;Signal transduction inhibitor;Ubl conjugation pathway	Q8IZP0; A8MQ03; Q96B26; Q8NHY3; P62993; Q9UJY1; Q96PV6; Q99750; Q8IVT2; O43639; Q6X4W1-2; O94875-10; O60504; Q63HR2; P07947; Q14141	TISSUE SPECIFICITY: Expressed in brain and leukocytes. Also in fetal lung fibroblasts and fetal brain. {ECO:0000269|PubMed:9344857}.	GO:0005634; GO:0005829; GO:0005886; GO:0005942; GO:0009968; GO:0016567; GO:0017124; GO:0035556; GO:0040008; GO:0046854; GO:0046935		9344857; 16625196; 15489334; 10969179; 15242778; 15677474; 16127460; 17803907	
O14514	AGRB1_HUMAN	Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40, Vstat40; Vasculostatin-120, Vstat120 ]	ADGRB1 BAI1	1584	9606			Cell junction;Cell membrane;Cell projection;Disulfide bond;G-protein coupled receptor;Glycoprotein;Immunity;Innate immunity;Membrane;Myogenesis;Neurogenesis;Phagocytosis;Phosphoprotein;Receptor;Reference proteome;Repeat;Secreted;Signal;Synapse;Transducer;Transmembrane;Transmembrane helix;Ubl conjugation	Q92556-1	TISSUE SPECIFICITY: Expressed in brain (at protein level) (PubMed:12074842, PubMed:12507886). Expressed on mononuclear phagocytes and monocyte-derived macrophages in the gastric mucosa (at protein level) (PubMed:24509909). Expressed in normal pancreatic tissue but not in pancreatic tumor tissue (PubMed:11875720). Reduced or no expression is observed in some glioblastomas (PubMed:12507886). {ECO:0000269|PubMed:11875720, ECO:0000269|PubMed:12074842, ECO:0000269|PubMed:12507886, ECO:0000269|PubMed:24509909}.	GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428	PTM: Proteolytically cleaved to produce vasculostatin-40 and vasculostatin-120 (PubMed:15782143, PubMed:22333914, PubMed:22330140). Vasculostatin-40 is the major form and is produced through proteolytic cleavage by MMP14 between residues 321 and 329 with cleavage likely to be between Ser-326 and Leu-327 (PubMed:22330140). {ECO:0000269|PubMed:15782143, ECO:0000269|PubMed:22330140, ECO:0000269|PubMed:22333914}.; PTM: Ubiquitinated. {ECO:0000269|PubMed:23782696}.	9393972; 16421571; 9647739; 9790924; 10343108; 10748157; 11875720; 12074842; 12507886; 15782143; 19176395; 22333914; 22330140; 23782696; 23595754; 23186163; 24509909; 26710850; 26838550	G-protein coupled receptor 2 family, LN-TM7 subfamily
O14519	CDKA1_HUMAN	Cyclin-dependent kinase 2-associated protein 1, CDK2-associated protein 1 (Deleted in oral cancer 1, DOC-1) (Putative oral cancer suppressor)	CDK2AP1 CDKAP1 DOC1	115	9606			3D-structure;Alternative splicing;Cell cycle;Disulfide bond;Phosphoprotein;Reference proteome;Tumor suppressor	Q8N5M1; Q9H257-2; Q96JN2-2; P22607; Q96HT8; Q96HA8; Q9NRD5; Q9NZD8; A0A024R8A9		GO:0001934; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006261; GO:0007049; GO:0048471; GO:0070182	PTM: Phosphorylated in vitro by IKBKE at Ser-46. {ECO:0000269|PubMed:22427660}.	9331572; 9506968; 16541075; 15489334; 14985111; 22427660	CDK2AP family
O14520	AQP7_HUMAN	Aquaporin-7, AQP-7 (Aquaglyceroporin-7) (Aquaporin adipose, AQPap) (Aquaporin-7-like)	AQP7 AQP7L AQP9	342	9606			3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Cytoplasmic vesicle;Lipid droplet;Membrane;Phosphoprotein;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	O60240	TISSUE SPECIFICITY: Detected in the sperm head (at protein level) (PubMed:28042826). Detected in white adipose tissue (PubMed:9405233). {ECO:0000269|PubMed:28042826, ECO:0000269|PubMed:9405233}.	GO:0005737; GO:0005811; GO:0005886; GO:0005887; GO:0005911; GO:0005938; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016323; GO:0030659		9405233; 11952783; 14702039; 15164053; 15489334; 28042826; 27832861; 30423801; 30420639; 17566090	MIP/aquaporin (TC 1.A.8) family
O14521	DHSD_HUMAN	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial, CybS (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit)	SDHD SDH4	159	9606	PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle.		Alternative splicing;Disease variant;Electron transport;Heme;Iron;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Primary mitochondrial disease;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Transport;Tricarboxylic acid cycle	Q6NTF9-3		GO:0005739; GO:0005740; GO:0005743; GO:0005749; GO:0006099; GO:0006121; GO:0009055; GO:0016021; GO:0020037; GO:0042776; GO:0046872; GO:0048039		9533030; 10482792; 16303743; 16554811; 15489334; 21269460; 24275569; 25944712; 11156372; 10657297; 11343322; 11391796; 11391798; 11526495; 12007193; 14500403; 12000816; 12696072; 15328326; 15032977; 17804857; 18678321; 18987736; 24367056; 26008905	CybS family
O14522	PTPRT_HUMAN	Receptor-type tyrosine-protein phosphatase T, R-PTP-T, EC 3.1.3.48 (Receptor-type tyrosine-protein phosphatase rho, RPTP-rho)	PTPRT KIAA0283	1441	9606		3.1.3.48	3D-structure;Alternative splicing;Disulfide bond;Glycoprotein;Hydrolase;Immunoglobulin domain;Membrane;Phosphoprotein;Protein phosphatase;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	P62993; Q16849; Q99K10; Q69ZK9; Q9CS84; Q6P9K9	TISSUE SPECIFICITY: Expressed in colon, lung, heart and testis, as well as in fetal and adult brain. Not detected in muscle and peripheral blood leukocytes. {ECO:0000269|PubMed:15155950}.	GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264		9602027; 9179496; 11780052; 15489334; 11423001; 11814386; 19167335; 15155950; 18987736; 24123876	Protein-tyrosine phosphatase family, Receptor class 2B subfamily
O14523	C2C2L_HUMAN	Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like, C2CD2-like) (Transmembrane protein 24)	C2CD2L KIAA0285 TMEM24 DLNB23	706	9606			3D-structure;Alternative splicing;Cell membrane;Endoplasmic reticulum;Lipid transport;Lipid-binding;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport	Q86WK6; Q13520; Q3SXY8; Q13323; P11912; Q9H9P2; Q8N5K1; P58418; P49682; Q15125; Q9NYP7; Q9Y282; P48165; P08034; P31937; P26951; O95214; Q6N075; P15941-11; P35372-10; Q13113; Q9BRK0; Q9H6H4; O00560; Q3KNW5; P54219-3; Q9NUH8; Q7Z7N9; Q9NWD8; Q8N661; Q6PEY1; Q9P0T7; O15393-2; Q9Y320; Q96MV8		GO:0005789; GO:0005886; GO:0008526; GO:0016021; GO:0032541; GO:0035091; GO:0035774; GO:0043559; GO:0140268	PTM: Phosphorylation at the C-terminus acidifies the protein and leads to disassociation from the acidic cell membrane. Reassociates with the cell membrane upon dephosphorylation. {ECO:0000269|PubMed:28209843}.	15489334; 9179496; 12168954; 18669648; 19413330; 19690332; 23186163; 28209843	
O14524	NEMP1_HUMAN	Nuclear envelope integral membrane protein 1	NEMP1 KIAA0286 TMEM194 TMEM194A	444	9606			Alternative splicing;Glycoprotein;Membrane;Nucleus;Phosphoprotein;Reference proteome;Signal;Transmembrane;Transmembrane helix	Q15848; Q96PS8; P07306; Q6PL45-2; P01031; P60033; Q9BXN2-6; A0PK11; Q8TBE1; P29400-2; Q07325; Q96IV6; Q9NPR9; Q02747; Q9Y5U4; P54315; Q5QGT7; Q14162; Q8N6R1; Q86Y82; Q9Y6G1; Q8NBD8; Q69YG0; Q8N661; Q5BJF2; Q71RG4; Q86UF1; Q5BVD1; O75841; Q15836		GO:0005635; GO:0005637; GO:0016021; GO:0071763	PTM: Phosphorylation may regulate its interaction with RAN-GTP. {ECO:0000250|UniProtKB:Q6ZQE4}.	9179496; 12168954; 14702039; 17974005; 15489334; 18691976; 18669648; 24275569	NEMP family
O14525	ASTN1_HUMAN	Astrotactin-1	ASTN1 ASTN KIAA0289	1302	9606			Alternative splicing;Cell adhesion;Cell membrane;Cytoplasmic vesicle;Disulfide bond;EGF-like domain;Endosome;Glycoprotein;Membrane;Methylation;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	Q96D03; Q14145		GO:0001764; GO:0005768; GO:0007158; GO:0007626; GO:0009897; GO:0016021; GO:0030136; GO:0043204		9179496; 14702039; 16710414; 15489334	Astrotactin family
O14526	FCHO1_HUMAN	F-BAR domain only protein 1	FCHO1 KIAA0290	889	9606			Alternative splicing;Coated pit;Coiled coil;Disease variant;Endocytosis;Membrane;Phosphoprotein;Reference proteome	Q9NQT4; Q8TCE9; Q13882; A7BFV9	TISSUE SPECIFICITY: Predominantly expressed in lymphoid cells. {ECO:0000269|PubMed:30822429}.	GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0035612; GO:0048268; GO:0050852; GO:0050870; GO:0072583		9179496; 14702039; 15057824; 15489334; 17617719; 19690332; 20448150; 22484487; 23186163; 30822429; 32098969; 32312977	FCHO family
O14529	CUX2_HUMAN	Homeobox protein cut-like 2 (Homeobox protein cux-2)	CUX2 CUTL2 KIAA0293	1486	9606			3D-structure;Coiled coil;Disease variant;DNA-binding;Epilepsy;Homeobox;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	Q93009		GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007614; GO:0010628; GO:0043565; GO:0050775; GO:0050890; GO:0051965; GO:0061003; GO:0070062; GO:0071310; GO:1990837; GO:2000463		9179496; 12168954; 16541075; 15489334; 18669648; 29630738; 29795476	CUT homeobox family
O14530	TXND9_HUMAN	Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4)	TXNDC9 APACD	226	9606			Alternative splicing;Cytoplasm;Cytoskeleton;Nucleus;Phosphoprotein;Reference proteome	Q6P1W5; Q6ZUJ4; P0C7W6; Q8TAP6; Q9H9E3; Q8WWB3; Q96B26; Q99689; O14901; Q9Y250; P43360; Q15528-2; P52815; P15173; Q9BYU1; Q9NRD5; Q8ND90; Q8N6V9; P14373; Q8N720		GO:0000226; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0030496; GO:0045296		14702039; 19054851; 15815621; 15489334; 16415341; 18669648; 19690332; 20068231; 21269460; 21406692; 23186163	
O14531	DPYL4_HUMAN	Dihydropyrimidinase-related protein 4, DRP-4 (Collapsin response mediator protein 3, CRMP-3) (UNC33-like phosphoprotein 4, ULIP-4)	DPYSL4 CRMP3 ULIP4	572	9606			3D-structure;Cytoplasm;Direct protein sequencing;Phosphoprotein;Reference proteome	P28799-2; O60333-2; P17612; Q93062; Q7Z699; P37173; Q15645; O76024		GO:0005829; GO:0007399; GO:0016810; GO:0031005; GO:0070997; GO:0097485		15164054; 15489334; 9652388; 25358863	Metallo-dependent hydrolases superfamily, Hydantoinase/dihydropyrimidinase family
O14543	SOCS3_HUMAN	Suppressor of cytokine signaling 3, SOCS-3 (Cytokine-inducible SH2 protein 3, CIS-3) (STAT-induced STAT inhibitor 3, SSI-3)	SOCS3 CIS3 SSI3	225	9606	PATHWAY: Protein modification; protein ubiquitination.		Growth regulation;Pharmaceutical;Phosphoprotein;Reference proteome;SH2 domain;Signal transduction inhibitor;Ubl conjugation pathway	P51451; Q13480; Q8N8K9; P10721; Q66K74; I6L996; O95863; P42681; P07947	TISSUE SPECIFICITY: Widely expressed with high expression in heart, placenta, skeletal muscle, peripheral blood leukocytes, fetal and adult lung, and fetal liver and kidney. Lower levels in thymus.	GO:0001784; GO:0004860; GO:0005829; GO:0005942; GO:0007259; GO:0016567; GO:0035556; GO:0040008; GO:0042532; GO:0043066; GO:0045597; GO:0046426; GO:0046627; GO:0046854; GO:0046935; GO:0050728; GO:0060670; GO:0060674; GO:0060707; GO:0060708; GO:1990830	PTM: Phosphorylated on tyrosine residues after stimulation by the cytokines, IL-2, EPO or IGF1.	9266833; 9344848; 11071852; 15489334; 10421843; 12027890; 14559241; 15070676; 15601820; 16685656; 16410555; 23019338	
O14544	SOCS6_HUMAN	Suppressor of cytokine signaling 6, SOCS-6 (Cytokine-inducible SH2 protein 4, CIS-4) (Suppressor of cytokine signaling 4, SOCS-4)	SOCS6 CIS4 SOCS4	535	9606	PATHWAY: Protein modification; protein ubiquitination.		3D-structure;Growth regulation;Reference proteome;SH2 domain;Signal transduction inhibitor;Ubl conjugation pathway	P10275; Q9NX04; O75460-2; P22607; Q0VDC6; Q13480; P06396; P54652; P10721; P08581; O60260-5; P49591; Q13148; P42681; Q9UMX0; P46937		GO:0001772; GO:0005737; GO:0005829; GO:0005942; GO:0006952; GO:0007259; GO:0009968; GO:0010498; GO:0016567; GO:0035556; GO:0040008; GO:0046854; GO:0046935; GO:0050868		9344848; 15489334; 15526160; 21030588	
O14556	G3PT_HUMAN	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific, EC 1.2.1.12 (Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2, GAPDH-2) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase)	GAPDHS GAPD2 GAPDH2 GAPDS HSD-35 HSD35	408	9606	PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 1/5.	1.2.1.12	3D-structure;Cytoplasm;Glycolysis;NAD;Oxidoreductase;Reference proteome	Q96E35	TISSUE SPECIFICITY: Testis specific.	GO:0004365; GO:0005634; GO:0005829; GO:0006006; GO:0006096; GO:0030317; GO:0045821; GO:0050661; GO:0051287		10714828; 14702039; 15057824; 15489334; 16820410; 18298375; 21269272	Glyceraldehyde-3-phosphate dehydrogenase family
O14558	HSPB6_HUMAN	Heat shock protein beta-6, HspB6 (Heat shock 20 kDa-like protein p20)	HSPB6	160	9606			3D-structure;Chaperone;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Secreted;Stress response			GO:0005212; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0042803; GO:0045766; GO:0051082; GO:0051087; GO:0061077	PTM: The N-terminus is blocked. {ECO:0000269|PubMed:8195168}.; PTM: Phosphorylated at Ser-16 by PKA and probably PKD1K; required to protect cardiomyocytes from apoptosis. {ECO:0000250|UniProtKB:P97541, ECO:0000250|UniProtKB:Q5EBG6, ECO:0000305|PubMed:26443497}.	14702039; 15057824; 15489334; 8195168; 19845507; 14717697; 19464326; 19568960; 19777375; 20843828; 21641913; 21334344; 22794279; 22002549; 22427880; 23948568; 24275569; 26098708; 26443497; 27717639; 24382496; 18790732	Small heat shock protein (HSP20) family
O14559	RHG33_HUMAN	Rho GTPase-activating protein 33 (Rho-type GTPase-activating protein 33) (Sorting nexin-26) (Tc10/CDC42 GTPase-activating protein)	ARHGAP33 SNX26 TCGAP	1287	9606			Alternative splicing;GTPase activation;Methylation;Phosphoprotein;Protein transport;Reference proteome;SH3 domain;Transport	P06241		GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0015031; GO:0019901; GO:0032991; GO:0035091		14702039; 15057824; 17974005; 15489334; 20873783; 21406692	PX domain-containing GAP family
O14561	ACPM_HUMAN	Acyl carrier protein, mitochondrial, ACP (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)	NDUFAB1	156	9606			3D-structure;Acetylation;Direct protein sequencing;Electron transport;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Mitochondrion;Phosphopantetheine;Phosphoprotein;Reference proteome;Respiratory chain;Transit peptide;Transport	Q08043; Q96PG8; Q5H9J7; Q8N4L8; P26441; Q9BSK4; Q13643; Q53EP0-3; Q9BQA5; Q7L273; P25791-3; Q8TBB1; Q6PF18; Q86UR1-2; Q16656-4; Q96HA8; O43482; Q969H6; Q96I34; P17980; Q9GZT3; Q9NVV9; O43711; Q96NM4-3; Q08AM6; P17023; Q86VK4-3; Q3KNS6-3		GO:0000035; GO:0000036; GO:0005504; GO:0005509; GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006633; GO:0009060; GO:0009249; GO:0016226; GO:0031966; GO:0032981; GO:0042776; GO:1990229		9878551; 14702039; 10493829; 15489334; 19892738; 12611891; 21269460; 23157686; 24275569; 25944712; 27499296; 27626371; 30215512; 28892042	Acyl carrier protein (ACP) family
O14569	C56D2_HUMAN	Transmembrane reductase CYB561D2, EC 7.2.1.3 (Cytochrome b561 domain-containing protein 2) (Putative tumor suppressor protein 101F6)	CYB561D2 101F6 LUCA12.2	222	9606		7.2.1.3	Cytoplasmic vesicle;Direct protein sequencing;Electron transport;Endoplasmic reticulum;Heme;Iron;Membrane;Metal-binding;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport	Q3SXY8; P11912; O95471; Q86T13; O75208; Q96BA8; Q9Y282; Q5JX71; Q8TED1; P27815-4; O15173; P54829; Q96TC7; P54219-3; Q9BRI3; Q6P9G4; Q96B21		GO:0005783; GO:0005789; GO:0016021; GO:0016491; GO:0020037; GO:0030659; GO:0031982; GO:0046872; GO:0140571; GO:0140575; GO:0140576		14702039; 16641997; 15489334; 19892738; 11085536; 19734123; 23641721; 23235316	
O14576	DC1I1_HUMAN	Cytoplasmic dynein 1 intermediate chain 1 (Cytoplasmic dynein intermediate chain 1) (Dynein intermediate chain 1, cytosolic, DH IC-1)	DYNC1I1 DNCI1 DNCIC1	645	9606			Acetylation;Alternative splicing;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Dynein;Kinetochore;Microtubule;Motor protein;Phosphoprotein;Reference proteome;Repeat;Transport;WD repeat	Q8TD16; Q9CZA6; P05067; Q14203-5; Q9GZQ8; P00491; P04271; Q13501; P43405-2; Q9BVJ6; Q9UBQ0-2; P05067		GO:0000776; GO:0000922; GO:0003774; GO:0003777; GO:0005634; GO:0005737; GO:0005829; GO:0005868; GO:0005874; GO:0007018; GO:0008017; GO:0010970; GO:0030507; GO:0031982; GO:0036464; GO:0045503; GO:0045504; GO:0047496; GO:0048471; GO:0055037		10049579; 14702039; 12853948; 15489334; 19229290; 19690332; 27502274; 21248752	Dynein intermediate chain family
O14578	CTRO_HUMAN	Citron Rho-interacting kinase, CRIK, EC 2.7.11.1 (Serine/threonine-protein kinase 21)	CIT CRIK KIAA0949 STK21	2027	9606		2.7.11.1	Acetylation;Alternative splicing;ATP-binding;Cell cycle;Cell division;Coiled coil;Cytoplasm;Developmental protein;Differentiation;Disease variant;Kinase;Metal-binding;Mitosis;Neurogenesis;Nucleotide-binding;Phosphoprotein;Primary microcephaly;Reference proteome;Serine/threonine-protein kinase;SH3-binding;Transferase;Zinc;Zinc-finger			GO:0000086; GO:0000278; GO:0000281; GO:0001223; GO:0001889; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007030; GO:0008064; GO:0016020; GO:0017124; GO:0018107; GO:0019901; GO:0030165; GO:0030291; GO:0030496; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035331; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110; GO:0106310		15983625; 10231032; 16541075; 16431929; 16236794; 17488780; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21457715; 21406692; 22814378; 23186163; 27453578; 27453579; 27503289; 27519304; 17344846	Protein kinase superfamily, AGC Ser/Thr protein kinase family
O14579	COPE_HUMAN	Coatomer subunit epsilon (Epsilon-coat protein, Epsilon-COP)	COPE	308	9606			3D-structure;Alternative splicing;Cytoplasm;Cytoplasmic vesicle;Direct protein sequencing;ER-Golgi transport;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transport;Ubl conjugation	Q9UKI2; Q5JST6		GO:0000139; GO:0005198; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030133; GO:0099612	PTM: Phosphorylated by PKA.; PTM: Polyubiquitinated by RCHY1 in the presence of androgen, leading to proteasomal degradation. {ECO:0000269|PubMed:17721809}.	10469566; 11230166; 14702039; 15057824; 15489334; 18691976; 17721809; 18669648; 21269460; 23186163; 24275569; 25944712	COPE family
O14593	RFXK_HUMAN	DNA-binding protein RFXANK (Ankyrin repeat family A protein 1) (Regulatory factor X subunit B, RFX-B) (Regulatory factor X-associated ankyrin-containing protein)	RFXANK ANKRA1 RFXB	260	9606			3D-structure;Activator;Alternative splicing;ANK repeat;Cytoplasm;Direct protein sequencing;Disease variant;DNA-binding;Nucleus;Reference proteome;Repeat;SCID;Transcription;Transcription regulation	P48382; Q2KHR2; O00287	TISSUE SPECIFICITY: Ubiquitous.	GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007265; GO:0010468; GO:0042826; GO:0045171; GO:0045944; GO:0090575	PTM: Phosphorylated by RAF1. {ECO:0000250|UniProtKB:Q9Z205}.	9806546; 10072068; 11042152; 15057824; 15489334; 20732328; 25752541; 22649097; 10725724	
O14594	NCAN_HUMAN	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3 NEUR	1321	9606			Calcium;Cell adhesion;Disulfide bond;EGF-like domain;Glycoprotein;Hyaluronic acid;Immunoglobulin domain;Lectin;Proteoglycan;Reference proteome;Repeat;Secreted;Signal;Sushi		TISSUE SPECIFICITY: Brain.	GO:0001501; GO:0005509; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0043202	PTM: O-glycosylated. {ECO:0000269|PubMed:23234360}.	9795216; 15057824; 23234360	Aggrecan/versican proteoglycan family
O14595	CTDS2_HUMAN	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2, EC 3.1.3.16 (Nuclear LIM interactor-interacting factor 2, NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2, SCP2)	CTDSP2 NIF2 OS4 SCP2	271	9606		3.1.3.16	3D-structure;Hydrolase;Magnesium;Metal-binding;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome	P10275; Q99618; P80188; O15049; Q15797; P14079	TISSUE SPECIFICITY: Expression is restricted to non-neuronal tissues. Highest expression in pancreas and lowest in liver. {ECO:0000269|PubMed:15681389}.	GO:0001933; GO:0004721; GO:0005654; GO:0006470; GO:0008420; GO:0046872; GO:2000134		9315096; 12721286; 14702039; 15489334; 15681389; 23186163; 18058037	
O14607	UTY_HUMAN	Histone demethylase UTY, EC 1.14.11.68 (Ubiquitously-transcribed TPR protein on the Y chromosome) (Ubiquitously-transcribed Y chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase UTY)	UTY KDM6C	1347	9606		1.14.11.68	3D-structure;Alternative splicing;Chromatin regulator;Dioxygenase;Direct protein sequencing;Iron;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Zinc			GO:0000978; GO:0005654; GO:0006325; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0044666; GO:0046872; GO:0071557; GO:0071558		9381176; 14702039; 12815422; 12665801; 24798337	UTX family
O14610	GBGT2_HUMAN	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 (G gamma-C) (G-gamma-8) (G-gamma-9) (Guanine nucleotide binding protein gamma transducing activity polypeptide 2)	GNGT2 GNG8 GNG9 GNGT8	69	9606			Cell membrane;Lipoprotein;Membrane;Methylation;Prenylation;Reference proteome;Transducer		TISSUE SPECIFICITY: Retinal cones.	GO:0003924; GO:0005834; GO:0007186; GO:0007602; GO:0031681		9286705; 11714923; 14702039; 15489334	G protein gamma family
O14613	BORG1_HUMAN	Cdc42 effector protein 2 (Binder of Rho GTPases 1)	CDC42EP2 BORG1 CEP2	210	9606			Acetylation;Cell shape;Cytoplasm;Cytoskeleton;Membrane;Phosphoprotein;Reference proteome	Q9UNA1; Q9UNA1-2; Q9NQ75-2; P60953; P10606; Q14511-2; Q9Y5B8; Q9NRD5	TISSUE SPECIFICITY: Highly expressed in the heart. Weakly expressed in the pancreas and liver. {ECO:0000269|PubMed:10490598}.	GO:0001515; GO:0005096; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007015; GO:0007266; GO:0008360; GO:0012505; GO:0015630; GO:0016020; GO:0030036; GO:0030838; GO:0031267; GO:0031274; GO:0031334; GO:0045335; GO:0071346		9253601; 10490598; 11035016; 14702039; 15489334; 11584266; 18691976; 20068231; 22814378; 23186163	BORG/CEP family
O14617	AP3D1_HUMAN	AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin)	AP3D1 PRO0039	1153	9606			3D-structure;Acetylation;Albinism;Alternative splicing;Coiled coil;Cytoplasm;Golgi apparatus;Hermansky-Pudlak syndrome;Membrane;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport		TISSUE SPECIFICITY: Present in all adult tissues examined with the highest levels in skeletal muscle, heart, pancreas and testis. {ECO:0000269|PubMed:9151686}.	GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0016183; GO:0016192; GO:0030123; GO:0032438; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:1903232; GO:1904115		9303295; 9151686; 15057824; 15489334; 15598649; 17081983; 18088087; 18669648; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25808614; 26744459	Adaptor complexes large subunit family
O14618	CCS_HUMAN	Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone)	CCS	274	9606			3D-structure;Chaperone;Copper;Cytoplasm;Disulfide bond;Isopeptide bond;Metal-binding;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc	Q9NWV4; P00441; P98170	TISSUE SPECIFICITY: Ubiquitous.	GO:0005507; GO:0005634; GO:0005737; GO:0005829; GO:0006801; GO:0015035; GO:0015680; GO:0019430; GO:0034599; GO:0045296; GO:0051353	PTM: Ubiquitinion by XIAP/BIRC4 leads to enhancement of its chaperone activity toward its physiologic target, SOD1, rather than proteasomal degradation. XIAP/BIRC4 preferentially ubiquitinates at Lys-241. {ECO:0000269|PubMed:20154138}.	9295278; 21269460; 24275569; 23625804; 15489334; 9726962; 15736924; 20595380; 20154138; 22508683; 10677207	Cu-Zn superoxide dismutase family
O14625	CXL11_HUMAN	C-X-C motif chemokine 11 (Beta-R1) (H174) (Interferon gamma-inducible protein 9, IP-9) (Interferon-inducible T-cell alpha chemoattractant, I-TAC) (Small-inducible cytokine B11)	CXCL11 ITAC SCYB11 SCYB9B	94	9606			3D-structure;Chemotaxis;Citrullination;Cytokine;Direct protein sequencing;Disulfide bond;Inflammatory response;Reference proteome;Secreted;Signal	Q99616; O00175; Q9Y258; P13501; P48061; O95715; P27487; Q5JR59; P02776; P10720; P98066	TISSUE SPECIFICITY: High levels in peripheral blood leukocytes, pancreas and liver astrocytes. Moderate levels in thymus, spleen and lung. Low levels in placenta, prostate and small intestine. Also found in epidermal basal layer keratinocytes in skin disorders.	GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007189; GO:0007267; GO:0008009; GO:0008201; GO:0010818; GO:0030593; GO:0031640; GO:0042127; GO:0045236; GO:0048248; GO:0051281; GO:0061844; GO:0070098; GO:0071222		8798467; 9370294; 9625760; 10233762; 10386863; 10395932; 15489334; 9730616; 18645041; 27044744; 15273303	Intercrine alpha (chemokine CxC) family
O14627	CDX4_HUMAN	Homeobox protein CDX-4 (Caudal-type homeobox protein 4)	CDX4	284	9606			Developmental protein;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation	Q8N9N5-7; P61024; P25800; P25791; Q13131; P54646; O43741		GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0003700; GO:0005634; GO:0006357; GO:0009887; GO:0009948; GO:0030154; GO:0045944; GO:0060711; GO:1990837		15772651; 15489334	Caudal homeobox family
O14628	ZN195_HUMAN	Zinc finger protein 195	ZNF195 ZNFP104	629	9606			Acetylation;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		TISSUE SPECIFICITY: Expressed in adult heart, brain, placenta, skeletal muscle and pancreas, and in fetal lung, kidney and brain. There is little expression in adult lung, liver and kidney.	GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0008270		9344677; 14702039; 17974005; 16554811; 15489334; 19608861; 25218447; 28112733	Krueppel C2H2-type zinc-finger protein family
O14633	LCE2B_HUMAN	Late cornified envelope protein 2B (Late envelope protein 10) (Skin-specific protein Xp5) (Small proline-rich-like epidermal differentiation complex protein 1B)	LCE2B LEP10 SPRL1B XP5	110	9606			Keratinization;Reference proteome	Q6UY14-3; Q9UGL9; A8MQ03; Q96LJ7; P28799; Q96NT3-2; P49639; Q07627; Q8IUG1; Q9BYS1; P60409; P60410; P60411; P59990; P59991; P60328; Q9BYP8; Q9BYR9; Q6PEX3; Q9BYR8; Q9BYR6; Q9BQ66; Q9BYR5; Q9BYR3; Q9BYR2; Q701N4; Q6L8G8; P26371; Q3LI66; Q9BYQ4; Q9BYQ3; Q9BYQ0; Q5T7P2; Q5T7P3; Q5T751; Q5T752; Q5T753; Q5T754; Q5TA79; O14633; Q5TA81; Q5TA82; Q5TA76; Q9BYE3; Q5TA78; Q5TCM9; Q99750; Q92692-2; P0DPK4; Q92570; P32242; O15496; Q9NRY6; Q9NRQ2; Q9UGC6; O76081-6; P78317; Q7Z698; O43610; P01137; Q8IWZ5; O14817; Q96EJ4	TISSUE SPECIFICITY: Skin-specific. Expression was readily detected in adult trunk skin, adult arm skin, fetal skin, penal skin, vulva, esophagus and tongue. Not expressed in the cervix, rectum, lung, colon, or placenta. {ECO:0000269|PubMed:15854049, ECO:0000269|PubMed:9344646}.	GO:0008544; GO:0031424; GO:0042802		9344646; 16710414; 15854049	LCE family
O14638	ENPP3_HUMAN	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3, E-NPP 3, NPP3 (Phosphodiesterase I beta, PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) [Includes: Alkaline phosphodiesterase I, EC 3.1.4.1; Nucleotide pyrophosphatase, NPPase, EC 3.6.1.9 (Nucleotide diphosphatase) ]	ENPP3 PDNP3	875	9606		3.1.4.1; 3.6.1.9	3D-structure;Calcium;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Hydrolase;Membrane;Metal-binding;Reference proteome;Repeat;Secreted;Signal-anchor;Transmembrane;Transmembrane helix;Zinc		TISSUE SPECIFICITY: Detected on bile ducts in liver, and in blood serum (at protein level) (PubMed:15072822). Detected in prostate and uterus (PubMed:9344668). Detected on basophils, but not neutrophils (PubMed:11342463). {ECO:0000269|PubMed:11342463, ECO:0000269|PubMed:15072822, ECO:0000269|PubMed:9344668}.	GO:0002276; GO:0003676; GO:0004528; GO:0005509; GO:0006220; GO:0006796; GO:0008270; GO:0009143; GO:0009897; GO:0016021; GO:0016324; GO:0033007; GO:0035529; GO:0036218; GO:0046034; GO:0047429; GO:0048471; GO:0050728; GO:0055062; GO:0070062; GO:0070667	PTM: N-glycosylated. N-glycosylation is necessary for normal transport to the cell membrane, but is not the apical targeting signal. {ECO:0000250|UniProtKB:P97675}.	9344668; 17974005; 14574404; 11342463; 15072822; 15031605; 29717535	Nucleotide pyrophosphatase/phosphodiesterase family
O14639	ABLM1_HUMAN	Actin-binding LIM protein 1, abLIM-1 (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin)	ABLIM1 ABLIM KIAA0059 LIMAB1	778	9606			Actin-binding;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Isopeptide bond;LIM domain;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc	Q9H257; O95751; Q2TAC2-2; Q14192; O75031	TISSUE SPECIFICITY: Detected in liver, heart, skeletal muscle, brain and retina, where it is concentrated in the inner segment and in the outer plexiform layers. {ECO:0000269|PubMed:9245787}.	GO:0001725; GO:0003779; GO:0005737; GO:0007010; GO:0007601; GO:0009887; GO:0015629; GO:0030027; GO:0030032; GO:0046872; GO:0051015; GO:0060271		9245787; 7584044; 12168954; 14702039; 17974005; 15164054; 15489334; 15144186; 15592455; 17194709; 17525332; 18088087; 18669648; 19413330; 19690332; 20068231; 21406692; 23186163; 24275569; 28112733	
O14640	DVL1_HUMAN	Segment polarity protein dishevelled homolog DVL-1, Dishevelled-1 (DSH homolog 1)	DVL1	695	9606			3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Cytoplasmic vesicle;Developmental protein;Dwarfism;Membrane;Phosphoprotein;Reference proteome;Ubl conjugation;Wnt signaling pathway	P25054; P49674; O14640; Q92997; Q6P3W7; Q96EB6; Q14186; Q9GZV5; O70239; Q9EQC9; Q5S007		GO:0001505; GO:0001934; GO:0005109; GO:0005829; GO:0005874; GO:0006355; GO:0006469; GO:0007269; GO:0007411; GO:0007528; GO:0008013; GO:0010976; GO:0014069; GO:0016328; GO:0019899; GO:0019901; GO:0021915; GO:0022007; GO:0030136; GO:0030426; GO:0031122; GO:0031267; GO:0031410; GO:0032091; GO:0032436; GO:0032880; GO:0034504; GO:0035176; GO:0035372; GO:0035556; GO:0035567; GO:0042802; GO:0043005; GO:0043025; GO:0043113; GO:0043197; GO:0045202; GO:0045944; GO:0048668; GO:0048675; GO:0048813; GO:0050808; GO:0050821; GO:0060070; GO:0060071; GO:0060134; GO:0060997; GO:0071340; GO:0090103; GO:0090179; GO:0098685; GO:0098793; GO:0098978; GO:0099054; GO:0150012; GO:1905386; GO:1990909; GO:2000300; GO:2000463	PTM: Ubiquitinated; undergoes both 'Lys-48'-linked ubiquitination, leading to its subsequent degradation by the ubiquitin-proteasome pathway, and 'Lys-63'-linked ubiquitination. The interaction with INVS is required for ubiquitination. Deubiquitinated by CYLD, which acts on 'Lys-63'-linked ubiquitin chains (By similarity). {ECO:0000250}.	9192851; 16710414; 11742073; 14750955; 15454084; 15852005; 21044957; 25557784; 25817016; 25817014; 25805136; 26126266; 27214281	DSH family
O14641	DVL2_HUMAN	Segment polarity protein dishevelled homolog DVL-2, Dishevelled-2 (DSH homolog 2)	DVL2	736	9606			3D-structure;Cell membrane;Cytoplasm;Cytoplasmic vesicle;Developmental protein;Membrane;Nucleus;Phosphoprotein;Reference proteome;Wnt signaling pathway	P25054; O15169; P28329-3; Q5R2U3; P49674; Q9NYF0; Q155Q3; O14641; P22607; P01112; Q5S007; P53350; P57078; Q96CG3; Q08117-2; P04637; Q14134; Q96RL1; Q9GZV5; P49910; Q9Z101; A2A5Z6		GO:0001843; GO:0001934; GO:0003151; GO:0005109; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0007379; GO:0007507; GO:0016235; GO:0016328; GO:0016604; GO:0019901; GO:0019904; GO:0022007; GO:0030674; GO:0031267; GO:0031410; GO:0034613; GO:0035556; GO:0035567; GO:0042802; GO:0043507; GO:0043547; GO:0043621; GO:0044340; GO:0045177; GO:0045334; GO:0045944; GO:0051091; GO:0060070; GO:0060071; GO:0061098; GO:0090103; GO:0090179; GO:0150012	PTM: Phosphorylated by CSNK1D (PubMed:21422228, PubMed:9192851). WNT3A induces DVL2 phosphorylation by CSNK1E and MARK kinases (PubMed:25805136). {ECO:0000269|PubMed:21422228, ECO:0000269|PubMed:25805136, ECO:0000269|PubMed:9192851}.	9192851; 15489334; 11742073; 15262978; 19690332; 20068231; 21422228; 21406692; 22610794; 23186163; 23708998; 24275569; 25557784; 25805136; 27214281; 19252499; 21248752	DSH family
O14645	IDLC_HUMAN	Axonemal dynein light intermediate polypeptide 1 (Inner dynein arm light chain, axonemal) (hp28)	DNALI1	258	9606			Alternative splicing;Cell projection;Cilium;Coiled coil;Cytoplasm;Dynein;Flagellum;Motor protein;Reference proteome	Q96MA6; Q99996-3; P13196; Q6LES2; P13928; O00203; P05067; Q96DX5-3; Q96FT7-4; P15313; P54687-4; Q14457; Q9NNX6-10; Q7Z7K6; Q8WUX9; Q9UJU6; Q8WTU0; A0A024RCP2; Q86TI2-2; Q14117; A0AVK6; O00303; Q9UBQ5; Q6NXG1; Q6NXG1-3; Q49AJ0-4; Q9NSA1; P06241-3; Q06547-3; Q9BRX5; Q96IJ6; P42858; P80217-2; Q8NA54; Q13352; Q9UIH9; Q13887; Q6DKI2; Q9BV99; Q9BRK4; Q8N6F8; A6NI15; P02795; Q96FW1; Q6GQQ9-2; Q9ULW8; Q9BPZ3; P57054; Q6ZMI0-5; Q96LA8; P47736; Q96EN9; P47804-3; Q96EP0; Q8IUQ4; Q96GM5; Q7Z6I5; Q9BZK7; Q3YBR2; Q8WTV1; Q8IUR5-4; Q12888; Q86WV8; Q6PID6; P49459; P58304; Q9BRX9; Q86U90; Q96JL9-2; Q96MN9-2; Q2QGD7; B7Z3E8	TISSUE SPECIFICITY: Expressed in many tissues. A smaller 0.9 kb and a larger 2.5 kb transcripts were detected at the highest level in the testis, at medium levels in the prostate, heart, liver, lung and pancreas, at low levels in the ovary, skeletal muscle and small intestine. Not detected in spleen, colon epithelium, thymus or peripheral blood leukocytes. The 0.9 kb transcript is expressed at a 20-fold higher level than the 2.5 kb transcript in the testis. Expressed in spermatozoa and airway epithelial cells (at protein level) (PubMed:31178125). {ECO:0000269|PubMed:31178125}.	GO:0005737; GO:0005929; GO:0005930; GO:0030175; GO:0030286; GO:0031514; GO:0036126; GO:0045504; GO:0097546; GO:0097729; GO:0120293		9284741; 14702039; 17974005; 16710414; 15489334; 27120127; 33139725; 16959974; 31178125	Inner dynein arm light chain family
O14646	CHD1_HUMAN	Chromodomain-helicase-DNA-binding protein 1, CHD-1, EC 3.6.4.12 (ATP-dependent helicase CHD1)	CHD1	1710	9606		3.6.4.12	3D-structure;Alternative splicing;ATP-binding;Chromatin regulator;Cytoplasm;Disease variant;DNA-binding;Helicase;Hydrolase;Mental retardation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	O60341-1; B2BUF1; P28799; O76024	TISSUE SPECIFICITY: Expressed in many tissues including in the brain, where the highest level of expression is found in the cerebellum and basal ganglia. {ECO:0000269|PubMed:28866611}.	GO:0000228; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0016887; GO:0035064; GO:0043923; GO:0140658		9326634; 15372022; 15489334; 16263726; 17081983; 16964243; 17433364; 18042460; 18691976; 18669648; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 28866611; 16372014	SNF2/RAD54 helicase family
O14647	CHD2_HUMAN	Chromodomain-helicase-DNA-binding protein 2, CHD-2, EC 3.6.4.12 (ATP-dependent helicase CHD2)	CHD2	1828	9606		3.6.4.12	Alternative splicing;ATP-binding;Chromatin regulator;Disease variant;DNA-binding;Epilepsy;Helicase;Hydrolase;Myogenesis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	Q8N7W2-2; Q9UJV3-2; Q969V4; Q9NVV9; Q8WV44; Q8IYF1; Q6FHY5; Q9BYV2; Q8TD17		GO:0000978; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0007517; GO:0016887; GO:0042393; GO:0140658		9326634; 16572171; 15489334; 17974005; 18691976; 18669648; 20068231; 21406692; 23186163; 24275569; 23708187; 25356899; 33798445	SNF2/RAD54 helicase family
O14649	KCNK3_HUMAN	Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1, Two pore K(+) channel KT3.1)	KCNK3 TASK TASK1	394	9606			3D-structure;Cell membrane;Disease variant;Glycoprotein;Ion channel;Ion transport;Membrane;Potassium;Potassium channel;Potassium transport;Reference proteome;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Widespread expression in adult. Strongest expression in pancreas and placenta. Lower expression in brain, lung, prostate, heart, kidney, uterus, small intestine and colon.	GO:0005216; GO:0005252; GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0007268; GO:0007420; GO:0008022; GO:0009410; GO:0022841; GO:0030322; GO:0034220; GO:0044548; GO:0045202; GO:0051481; GO:0071294; GO:0071456; GO:0071805; GO:0090102		9312005; 10748056; 15815621; 10321245; 11680614; 23169818; 23883380	Two pore domain potassium channel (TC 1.A.1.8) family
O14653	GOSR2_HUMAN	Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin)	GOSR2 GS27	212	9606			3D-structure;Acetylation;Alternative splicing;Coiled coil;Direct protein sequencing;Disease variant;Endoplasmic reticulum;Epilepsy;Golgi apparatus;Membrane;Neurodegeneration;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	Q13520; Q3SXY8; O15155; P62952; Q96BA8; P49447; Q53TN4; Q15125; Q9GZR5; Q9NYP7; Q8TBP5; Q5JX71; Q969F0; Q0D2H9; Q08AF8; Q8TDT2; O15529; Q8TED1; P31937; Q7Z5P4; Q9Y5U9; Q8N5M9; Q8N6L0; A8MZ59; Q9H400; Q5T0T0; Q9GZY8-5; Q5SR56; Q6N075; Q8N4V1; Q96FA3; Q86VR2; Q7Z5B4-5; Q6ZMZ0; Q14973; Q3KNW5; Q9NPE6; Q16623; Q12846; Q13190; O43752; Q96MV1; Q96DZ7; Q8N6Q1; Q96A25; Q9BVX2; Q6UW68; Q53FP2		GO:0000139; GO:0000149; GO:0005484; GO:0005789; GO:0005794; GO:0006891; GO:0006906; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0031201; GO:0031902; GO:0033116		9349823; 10198168; 14702039; 16625196; 15489334; 18843296; 21549339	GOSR2 family
O14654	IRS4_HUMAN	Insulin receptor substrate 4, IRS-4 (160 kDa phosphotyrosine protein, py160) (Phosphoprotein of 160 kDa, pp160)	IRS4	1257	9606			Cell membrane;Congenital hypothyroidism;Direct protein sequencing;Disease variant;Membrane;Phosphoprotein;Reference proteome;Repeat;Transducer	P46108; P00533; Q9H492; Q15185	TISSUE SPECIFICITY: Expressed in myoblasts. Expressed in liver and hepatocellular carcinoma. {ECO:0000269|PubMed:12639902, ECO:0000269|PubMed:17408801}.	GO:0005158; GO:0005829; GO:0005886; GO:0007165; GO:0008286; GO:0043548	PTM: Phosphorylated on tyrosine residues in response to both insulin and IGF1 signaling. Phosphorylated on Tyr-921 in response to FGF2 signaling. Phosphorylation of Tyr-921 is required for GRB2, phospholipase C-gamma and phosphatidylinositol 3-kinase interaction. {ECO:0000269|PubMed:15316024, ECO:0000269|PubMed:9261155, ECO:0000269|PubMed:9553137}.	9261155; 15772651; 9553137; 9614078; 10531310; 10594015; 11316748; 11912194; 12639902; 15316024; 15331607; 15870689; 17408801; 19413330; 16959974; 30061370	
O14656	TOR1A_HUMAN	Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A, EC 3.6.4.-) (Torsin family 1 member A)	TOR1A DQ2 DYT1 TA TORA	332	9606		3.6.4.-	3D-structure;Alternative splicing;ATP-binding;Cell junction;Cell projection;Chaperone;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Disease variant;Dystonia;Endoplasmic reticulum;Glycoprotein;Hydrolase;Membrane;Nucleotide-binding;Nucleus;Reference proteome;Signal;Synapse	Q6PCB6; P05067; Q96FT7-4; Q9UNS2; P22692; P60409; Q99750; Q5JTV8; Q8NFQ8; Q6PCB6; P63010-2; P05067; Q9UII2; Q5JTY5; Q9UJX2; Q53EZ4; Q96FZ7; Q92478; P35222; Q9NR90-2; Q9UHI6; Q14154; Q9H147; O75616; Q9UI08-2; Q6PIV2; Q9H4A5; P0C0S5; Q6DN90-2; Q8NA54; Q92993; Q8IUB9; A2RU56; Q8TDB4; P41218; Q9Y605; O43196-2; O00746; Q96CV9-2; Q99497; Q13113; P27986-2; P12273; O75626-3; P57729; Q96QF0-7; Q9BY12-3; Q15019-3; Q9NQ40; Q12824; Q05C28; Q7Z6I5; O75558; P21980-2; Q9BUZ4; Q9NX07-2	TISSUE SPECIFICITY: Widely expressed. Highest levels in kidney and liver. In the brain, high levels found in the dopaminergic neurons of the substantia nigra pars compacta, as well as in the neocortex, hippocampus and cerebellum. Also highly expressed in the spinal cord. {ECO:0000269|PubMed:10640617, ECO:0000269|PubMed:14970196, ECO:0000269|PubMed:15147511}.	GO:0000338; GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0005829; GO:0005856; GO:0006979; GO:0006996; GO:0006998; GO:0007155; GO:0008021; GO:0008092; GO:0016020; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0042406; GO:0042802; GO:0043231; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051082; GO:0051085; GO:0051584; GO:0051787; GO:0061077; GO:0070062; GO:0071712; GO:0071763; GO:0140662; GO:1900244; GO:2000008	PTM: N-glycosylated. {ECO:0000269|PubMed:10871631, ECO:0000269|PubMed:15147511, ECO:0000269|PubMed:17037984}.	9288096; 14702039; 15164053; 15489334; 10871631; 10640617; 15147511; 14970196; 15505207; 15767459; 16361107; 17037984; 17428918; 18167355; 18827015; 19535332; 19339278; 20169475; 20015956; 21269460; 21102408; 23569223; 25944712; 29053766; 27490483; 11523564; 18477710; 19955557; 24930953; 26940431; 28516161; 30244176	ClpA/ClpB family, Torsin subfamily
O14657	TOR1B_HUMAN	Torsin-1B (Torsin ATPase-1B, EC 3.6.4.-) (Torsin family 1 member B)	TOR1B DQ1 FKSG18	336	9606		3.6.4.-	ATP-binding;Chaperone;Endoplasmic reticulum;Glycoprotein;Hydrolase;Membrane;Nucleotide-binding;Nucleus;Reference proteome;Signal		TISSUE SPECIFICITY: Widely expressed with low levels in brain. {ECO:0000269|PubMed:15147511}.	GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0006986; GO:0007029; GO:0016887; GO:0019894; GO:0031965; GO:0034504; GO:0042802; GO:0051085; GO:0070062; GO:0071763	PTM: N-glycosylated. {ECO:0000269|PubMed:15147511}.	15164053; 15489334; 9288096; 15147511; 20015956; 21269460; 23569223; 24275647	ClpA/ClpB family, Torsin subfamily
O14662	STX16_HUMAN	Syntaxin-16, Syn16	STX16	325	9606			Alternative splicing;Coiled coil;Cytoplasm;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	P50222; Q9H115; Q12846; O95183; P05067; P42858; Q9H115; O95721; Q16623; P32856-2; Q12846; O75379; O95183; Q9NRW7	TISSUE SPECIFICITY: Ubiquitous.	GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0031201; GO:0031985; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161		9587053; 9464276; 11780052; 15489334; 14561710; 15800843; 18195106; 28626000	Syntaxin family
O14669	TMG2_HUMAN	Transmembrane gamma-carboxyglutamic acid protein 2 (Proline-rich gamma-carboxyglutamic acid protein 2, Proline-rich Gla protein 2)	PRRG2 PRGP2 TMG2	202	9606			Cell membrane;Disulfide bond;Gamma-carboxyglutamic acid;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix	Q96PU5; P46937	TISSUE SPECIFICITY: Widely expressed with highest levels in kidney (PubMed:23873930). Also highly expressed in the thyroid (PubMed:9256434, PubMed:23873930). {ECO:0000269|PubMed:23873930, ECO:0000269|PubMed:9256434}.	GO:0005509; GO:0005615; GO:0005886; GO:0005887	PTM: Gamma-carboxyglutamate residues are formed by vitamin K dependent carboxylation. These residues are essential for the binding of calcium. {ECO:0000255|PROSITE-ProRule:PRU00463, ECO:0000269|PubMed:17502622}.	9256434; 17502622; 23873930	
O14672	ADA10_HUMAN	Disintegrin and metalloproteinase domain-containing protein 10, ADAM 10, EC 3.4.24.81 (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)	ADAM10 KUZ MADM	748	9606		3.4.24.81	3D-structure;Alternative splicing;Alzheimer disease;Amyloidosis;Cell junction;Cell membrane;Cell projection;Cleavage on pair of basic residues;Cytoplasm;Cytoplasmic vesicle;Direct protein sequencing;Disease variant;Disulfide bond;Glycoprotein;Golgi apparatus;Hydrolase;Membrane;Metal-binding;Metalloprotease;Neurodegeneration;Notch signaling pathway;Phosphoprotein;Protease;Reference proteome;SH3-binding;Signal;Transmembrane;Transmembrane helix;Zinc;Zymogen	P00519; P05067; P56817; P60033; P21926; P06241; Q13588; O75791; P62993; P08631; P06239; Q9BY11; Q9UNF0; Q9UKS6; Q99961; Q96RF0; P12931; O95859; Q8NG11; O95858; Q86UF1; P62079; P07947; P60033; O95859	TISSUE SPECIFICITY: Expressed in the brain (at protein level) (PubMed:23676497). Expressed in spleen, lymph node, thymus, peripheral blood leukocyte, bone marrow, cartilage, chondrocytes and fetal liver (PubMed:11511685, PubMed:9016778). {ECO:0000269|PubMed:11511685, ECO:0000269|PubMed:23676497, ECO:0000269|PubMed:9016778}.	GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005102; GO:0005178; GO:0005634; GO:0005737; GO:0005788; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0005925; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007229; GO:0007267; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0017124; GO:0019901; GO:0022617; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0035579; GO:0042117; GO:0042803; GO:0042987; GO:0043231; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070062; GO:0070821; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945	PTM: The precursor is cleaved by furin and PCSK7. {ECO:0000250|UniProtKB:Q10741}.	9305925; 8694785; 16572171; 14702039; 9016778; 12475894; 11477090; 11511685; 11786905; 16239146; 16263699; 17557115; 19114711; 19159218; 19349973; 20164177; 20592283; 20624979; 21269460; 21288900; 23676497; 23186163; 24275569; 24990881; 26091039; 25944712; 26686862; 26876177; 26668317; 30463011; 29430990; 30312582; 19608551; 21618342; 23666529; 24055016; 29224781	
O14678	ABCD4_HUMAN	Lysosomal cobalamin transporter ABCD4, EC 7.6.2.8 (ATP-binding cassette sub-family D member 4) (PMP70-related protein, P70R) (Peroxisomal membrane protein 1-like, PXMP1-L) (Peroxisomal membrane protein 69, PMP69)	ABCD4 PXMP1L	606	9606		7.6.2.8	3D-structure;ATP-binding;Disease variant;Endoplasmic reticulum;Lysosome;Membrane;Nucleotide-binding;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport	O14678; Q9NUN5	TISSUE SPECIFICITY: Ubiquitous.	GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016021; GO:0042626; GO:0042760; GO:0043190; GO:0055085; GO:1990830		9266848; 9599016; 9302272; 14702039; 25535791; 27456980; 15489334; 22922874; 28572511; 33845046; 12111378; 23141461; 31467407	ABC transporter superfamily, ABCD family, Peroxisomal fatty acyl CoA transporter (TC 3.A.1.203) subfamily
O14681	EI24_HUMAN	Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein)	EI24 PIG8	340	9606			Acetylation;Alternative splicing;Apoptosis;Autophagy;Cytoplasm;Disease variant;Endoplasmic reticulum;Membrane;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	Q12982; O15173; Q9UI14; Q6PL24; Q9NUH8		GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0016236; GO:0030308; GO:0031965; GO:0061676		9305847; 14702039; 15489334; 11753653; 17081983; 18691976; 18669648; 19690332; 20068231; 21269460; 21154811; 22814378; 23186163; 24275569	EI24 family
O14682	ENC1_HUMAN	Ectoderm-neural cortex protein 1, ENC-1 (Kelch-like protein 37) (Nuclear matrix protein NRP/B) (p53-induced gene 10 protein)	ENC1 KLHL37 NRPB PIG10	589	9606			Actin-binding;Alternative splicing;Cytoplasm;Cytoskeleton;Developmental protein;Kelch repeat;Nucleus;Reference proteome;Repeat;Ubl conjugation		TISSUE SPECIFICITY: Detected in fetal brain tissue, moderate expression in fetal heart, lung and kidney. Highly expressed in adult brain, particularly high in the hippocampus and amygdala, and spinal chord. Detectable in adult pancreas. May be down-regulated in neuroblastoma tumors.	GO:0000785; GO:0003779; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005856; GO:0007399; GO:0010499; GO:0010976; GO:0016363; GO:0016567; GO:0017148; GO:0031463; GO:0043025	PTM: Ubiquitinated by E3 ubiquitin ligase complex formed by CUL3 and RBX1 and probably targeted for proteasome-independent degradation. Quinone-induced oxidative stress increases its ubiquitination. {ECO:0000269|PubMed:15983046}.	9305847; 9683534; 9566959; 14702039; 15372022; 15489334; 15983046; 19424503; 19690332	
O14684	PTGES_HUMAN	Prostaglandin E synthase, EC 5.3.99.3 (Glutathione peroxidase PTGES, EC 1.11.1.-) (Glutathione transferase PTGES, EC 2.5.1.18) (Microsomal glutathione S-transferase 1-like 1, MGST1-L1) (Microsomal prostaglandin E synthase 1, MPGES-1) (p53-induced gene 12 protein)	PTGES MGST1L1 MPGES1 PGES PIG12	152	9606	PATHWAY: Lipid metabolism; prostaglandin biosynthesis. {ECO:0000269|PubMed:10869354}.	1.11.1.-; 2.5.1.18; 5.3.99.3	3D-structure;Cytoplasm;Fatty acid biosynthesis;Fatty acid metabolism;Isomerase;Lipid biosynthesis;Lipid metabolism;Membrane;Oxidoreductase;Prostaglandin biosynthesis;Prostaglandin metabolism;Reference proteome;Transferase;Transmembrane;Transmembrane helix	O15155; Q8WVX3-2; Q08426; Q8WWP7; Q96F15; Q04941; Q96IW7; Q8N6R1; Q9NRQ5; Q96HH6; Q9H0R3; Q6PI78; Q15836; O75379; O95292; O95070		GO:0001516; GO:0004364; GO:0004602; GO:0004667; GO:0005641; GO:0005789; GO:0006693; GO:0007165; GO:0008285; GO:0016020; GO:0016021; GO:0019233; GO:0031620; GO:0032308; GO:0043295; GO:0048471; GO:0050220; GO:0050727		9305847; 10377395; 10760517; 14702039; 15164053; 15489334; 10869354; 12244105; 12460774; 16439136; 21269460; 12672824; 27684486; 26755582; 18682561; 23431194	MAPEG family
O14686	KMT2D_HUMAN	Histone-lysine N-methyltransferase 2D, Lysine N-methyltransferase 2D, EC 2.1.1.364 (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)	KMT2D ALR MLL2 MLL4	5537	9606		2.1.1.364	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Coiled coil;Disease variant;Isopeptide bond;Mental retardation;Metal-binding;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	P10275; Q9UBL3-3; P03372; P61964	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.	GO:0000976; GO:0001555; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0008284; GO:0031507; GO:0033148; GO:0035097; GO:0042393; GO:0042800; GO:0043627; GO:0044648; GO:0044666; GO:0045944; GO:0046872; GO:0048477; GO:0051568; GO:0080182; GO:0097692; GO:1904837		9247308; 16541075; 12482968; 17081983; 16603732; 17021013; 17500065; 17851529; 17525332; 17761849; 18220336; 18669648; 19413330; 19690332; 19608861; 20068231; 21406692; 23186163; 23508102; 24275569; 24129315; 25218447; 28112733; 25561738; 22665483; 22266653; 20711175; 21671394; 21607748; 21280141; 21658225; 22126750; 23913813; 24739679; 23320472	Class V-like SAM-binding methyltransferase superfamily, Histone-lysine methyltransferase family, TRX/MLL subfamily
O14713	ITBP1_HUMAN	Integrin beta-1-binding protein 1 (Integrin cytoplasmic domain-associated protein 1, ICAP-1)	ITGB1BP1 ICAP1	200	9606			3D-structure;Alternative splicing;Angiogenesis;Biomineralization;Cell adhesion;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Differentiation;Membrane;Mitogen;Notch signaling pathway;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	P54253; P09622; Q6PIW4; O00522; Q15669; P37840; P00441; P22392	TISSUE SPECIFICITY: Expressed in endothelial cells and fibroblasts (at protein level). Ubiquitously expressed. Expressed in intestine, colon, testis, ovary, thymus, spleen and prostate. {ECO:0000269|PubMed:9281591, ECO:0000269|PubMed:9867804}.	GO:0001726; GO:0002043; GO:0005092; GO:0005178; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006469; GO:0006933; GO:0007160; GO:0007219; GO:0007229; GO:0008284; GO:0008285; GO:0010595; GO:0010764; GO:0016020; GO:0016477; GO:0016604; GO:0019901; GO:0030027; GO:0030154; GO:0031214; GO:0032091; GO:0032148; GO:0033622; GO:0033628; GO:0034451; GO:0035148; GO:0035556; GO:0035924; GO:0043087; GO:0043113; GO:0044344; GO:0045747; GO:0045944; GO:0048471; GO:0051451; GO:0051496; GO:0051781; GO:0051894; GO:0051895; GO:0051897; GO:0070373; GO:0071944; GO:0072659; GO:0090051; GO:0090314; GO:0090315; GO:0097746; GO:1900025; GO:2001044	PTM: Phosphorylation at Thr-38 seems to enhance integrin alpha5beta1-mediated cell adhesion. The degree of phosphorylation is regulated by integrin-dependent cell-matrix interaction. {ECO:0000269|PubMed:9281591, ECO:0000269|PubMed:9813144, ECO:0000269|PubMed:9867804}.	9281591; 9867804; 15815621; 15489334; 9813144; 11741838; 11854171; 11741908; 11919189; 11807099; 12473654; 14759258; 15703214; 17916086; 20616313; 21768292; 23186163	
O14717	TRDMT_HUMAN	tRNA (cytosine(38)-C(5))-methyltransferase, EC 2.1.1.204 (DNA (cytosine-5)-methyltransferase-like protein 2, Dnmt2) (DNA methyltransferase homolog HsaIIP, DNA MTase homolog HsaIIP, M.HsaIIP) (PuMet)	TRDMT1 DNMT2	391	9606		2.1.1.204	3D-structure;Alternative splicing;Cytoplasm;Methyltransferase;Reference proteome;RNA-binding;S-adenosyl-L-methionine;Transferase;tRNA processing		TISSUE SPECIFICITY: Ubiquitous. Higher expression in testis, ovary and thymus and at much lower levels in spleen, prostate, colon, small intestine, and peripheral blood leukocytes.	GO:0001975; GO:0003723; GO:0005654; GO:0005737; GO:0006400; GO:0008175; GO:0016428; GO:0030488; GO:0036416		9425235; 9599025; 9592134; 15164054; 15489334; 11551826; 16424344; 11139614	Class I-like SAM-binding methyltransferase superfamily, C5-methyltransferase family
O14727	APAF_HUMAN	Apoptotic protease-activating factor 1, APAF-1	APAF1 KIAA0413	1248	9606			3D-structure;Alternative splicing;Apoptosis;ATP-binding;Calcium;Cytoplasm;Direct protein sequencing;Nucleotide-binding;Reference proteome;Repeat;WD repeat	P55211; P99999; P62136; P62258	TISSUE SPECIFICITY: Ubiquitous. Highest levels of expression in adult spleen and peripheral blood leukocytes, and in fetal brain, kidney and lung. Isoform 1 is expressed in heart, kidney and liver.	GO:0000166; GO:0001666; GO:0001822; GO:0001843; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0006915; GO:0006919; GO:0007399; GO:0007568; GO:0007584; GO:0008635; GO:0008656; GO:0010659; GO:0030154; GO:0030900; GO:0031072; GO:0032991; GO:0034774; GO:0042802; GO:0042981; GO:0043065; GO:0043293; GO:0043531; GO:0051402; GO:0070059; GO:0070062; GO:0071560; GO:0072432; GO:0097193; GO:0097202; GO:1902510; GO:1904813; GO:2001235		9267021; 10441496; 10364241; 10393175; 12804598; 9455477; 12168954; 15489334; 9651578; 11389439; 15262985; 17244527; 21371431; 25716227; 31498791; 10543941; 10578182	
O14730	RIOK3_HUMAN	Serine/threonine-protein kinase RIO3, EC 2.7.11.1 (RIO kinase 3) (sudD homolog)	RIOK3 SUDD	519	9606		2.7.11.1	Alternative splicing;Antiviral defense;ATP-binding;Cytoplasm;Immunity;Innate immunity;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Ribosome biogenesis;Serine/threonine-protein kinase;Transferase	Q92851; Q92851-7; Q9BYX4; Q14653; Q9UHD2	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9602165}.	GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:0106310; GO:1990786	PTM: Autophosphorylated (in vitro). {ECO:0000269|PubMed:19557502}.	9602165; 16177791; 15489334; 18669648; 19557502; 21269460; 22072790; 22418843; 23186163; 24807708; 25865883; 17344846	Protein kinase superfamily, RIO-type Ser/Thr kinase family
O14732	IMPA2_HUMAN	Inositol monophosphatase 2, IMP 2, IMPase 2, EC 3.1.3.25 (Inositol-1(or 4)-monophosphatase 2) (Myo-inositol monophosphatase A2)	IMPA2 IMP.18P	288	9606	PATHWAY: Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2.	3.1.3.25	3D-structure;Alternative splicing;Cytoplasm;Hydrolase;Magnesium;Metal-binding;Reference proteome	P29218; P29218-3; Q8N4M1-3; Q8TBC4		GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006796; GO:0007165; GO:0008934; GO:0010226; GO:0042803; GO:0046854; GO:0046855; GO:0046872; GO:0052832; GO:0052833		9322233; 10822345; 15489334; 15504365; 17068342; 21269460; 17340635	Inositol monophosphatase superfamily
O14733	MP2K7_HUMAN	Dual specificity mitogen-activated protein kinase kinase 7, MAP kinase kinase 7, MAPKK 7, EC 2.7.12.2 (JNK-activating kinase 2) (MAPK/ERK kinase 7, MEK 7) (Stress-activated protein kinase kinase 4, SAPK kinase 4, SAPKK-4, SAPKK4) (c-Jun N-terminal kinase kinase 2, JNK kinase 2, JNKK 2)	MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4	419	9606		2.7.12.2	3D-structure;Acetylation;Alternative splicing;Apoptosis;ATP-binding;Coiled coil;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Stress response;Transferase;Tyrosine-protein kinase	O15519-1; O75293; P08238; Q5S007; O43318; Q9UQF2; P45983	TISSUE SPECIFICITY: Ubiquitous; with highest level of expression in skeletal muscle. Isoform 3 is found at low levels in placenta, fetal liver, and skeletal muscle. {ECO:0000269|PubMed:16442502, ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930}.	GO:0000165; GO:0000287; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0008022; GO:0008545; GO:0009408; GO:0009411; GO:0019899; GO:0019901; GO:0019903; GO:0031435; GO:0032212; GO:0034612; GO:0038095; GO:0043507; GO:0043525; GO:0045893; GO:0046330; GO:0051403; GO:0051973; GO:0070374; GO:0072709; GO:0090398; GO:0106310; GO:1904355	PTM: Activated by phosphorylation on Ser-271 and Thr-275 by MAP kinase kinase kinases (MAP3Ks). {ECO:0000250}.	9372971; 9312068; 9535930; 16442502; 14702039; 15489334; 9207092; 10490659; 11104681; 12189133; 15866172; 18286207; 17496909; 19413330; 20801953; 21278800; 21333379; 22814378; 23186163; 28111074; 17344846	Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase subfamily
O14734	ACOT8_HUMAN	Acyl-coenzyme A thioesterase 8, Acyl-CoA thioesterase 8, EC 3.1.2.1, EC 3.1.2.11, EC 3.1.2.2, EC 3.1.2.3, EC 3.1.2.5 (Choloyl-coenzyme A thioesterase, EC 3.1.2.27) (HIV-Nef-associated acyl-CoA thioesterase) (Peroxisomal acyl-CoA thioesterase 2, PTE-2) (Peroxisomal acyl-coenzyme A thioester hydrolase 1, PTE-1) (Peroxisomal long-chain acyl-CoA thioesterase 1) (Thioesterase II, hACTE-III, hACTEIII, hTE)	ACOT8 ACTEIII PTE1	319	9606	PATHWAY: Lipid metabolism; fatty acid metabolism. {ECO:0000305|PubMed:10944470, ECO:0000305|PubMed:9299485}.	3.1.2.1; 3.1.2.11; 3.1.2.2; 3.1.2.27; 3.1.2.3; 3.1.2.5	Fatty acid metabolism;Host-virus interaction;Hydrolase;Lipid metabolism;Peroxisome;Peroxisome biogenesis;Reference proteome;Serine esterase	Q7Z4N8; P50542; Q04864; Q04864-2; P04601	TISSUE SPECIFICITY: Detected in a T-cell line (at protein level). Ubiquitous (PubMed:9153233, PubMed:9299485). {ECO:0000269|PubMed:9153233, ECO:0000269|PubMed:9299485}.	GO:0003986; GO:0004778; GO:0005782; GO:0005829; GO:0006637; GO:0006699; GO:0009062; GO:0016289; GO:0016290; GO:0016559; GO:0033540; GO:0033882; GO:0036109; GO:0043649; GO:0044466; GO:0045225; GO:0047603; GO:0047617; GO:0047994; GO:0052689; GO:0052815; GO:0102991		9299485; 9153233; 10092594; 11780052; 15489334; 10944470; 15194431; 11755680; 21269460; 25944712	C/M/P thioester hydrolase family
O14735	CDIPT_HUMAN	CDP-diacylglycerol--inositol 3-phosphatidyltransferase, EC 2.7.8.11 (Phosphatidylinositol synthase, PI synthase, PtdIns synthase)	CDIPT PIS PIS1	213	9606		2.7.8.11	Alternative splicing;Cell membrane;Endoplasmic reticulum;Lipid biosynthesis;Lipid metabolism;Magnesium;Manganese;Membrane;Phospholipid biosynthesis;Phospholipid metabolism;Reference proteome;Transferase;Transmembrane;Transmembrane helix	P41181; Q13520; Q3SXY8; O15342; Q8WZ55; P11912; Q99675; Q8N5K1; Q7Z7G2; P49447; P00387; Q6PI48; Q15125; Q9Y282; P34910-2; Q5JX71; P12318-2; O15552; Q9Y680; P08034; Q8NBJ4; Q96P66; Q8TDV0; Q8TDT2; Q8TED1; Q7Z5P4; Q9Y5U9; P24592; Q8N5M9; O00180; P43628; Q8TBB1; Q9GZY8-5; O14880; Q96JA4; Q9H2K0; Q2M2E3; P60201-2; Q8NC24; Q86VR2; Q6ZMZ0; O95197; Q8N9R8; O00560; Q96PQ1; Q3KNW5; O60669; P30825; Q96MV1; Q9Y320; Q86WB7-2; Q3ZAQ7	TISSUE SPECIFICITY: Detected in placenta (at protein level). Widely expressed. Higher expression in adult liver and skeletal muscle, slightly lower levels seen in pancreas, kidney, lung, placenta, brain, heart, leukocyte, colon, small intestine, ovary, testis, prostate, thymus and spleen. In fetus, expressed in kidney, liver, lung and brain. {ECO:0000269|PubMed:8110188}.	GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341		9407135; 14702039; 15616553; 15489334; 8110188; 21269460	CDP-alcohol phosphatidyltransferase class-I family
O14737	PDCD5_HUMAN	Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19, Protein TFAR19)	PDCD5 TFAR19	125	9606			3D-structure;Acetylation;Alternative splicing;Apoptosis;Direct protein sequencing;Phosphoprotein;Reference proteome	Q9NRD5; Q9NS91; Q9UPQ4-2	TISSUE SPECIFICITY: Widely expressed. Highest levels in heart, testis, kidney, pituitary gland, adrenal gland and placenta.	GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008201; GO:0008285; GO:0010628; GO:0010698; GO:0043065; GO:0043280; GO:0048487; GO:0070062; GO:0071560; GO:0090200; GO:1903638; GO:1903645		9920759; 14702039; 15057824; 15489334; 12665801; 17081983; 18669648; 18318008; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 19358820	PDCD5 family
O14744	ANM5_HUMAN	Protein arginine N-methyltransferase 5, PRMT5, EC 2.1.1.320 (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog, SKB1 homolog, SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed ]	PRMT5 HRMT1L5 IBP72 JBP1 SKB1	637	9606		2.1.1.320	3D-structure;Acetylation;Alternative splicing;Biological rhythms;Chromatin regulator;Chromosome;Cytoplasm;Direct protein sequencing;Golgi apparatus;Methyltransferase;Nucleus;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase	P01019; Q8WUW1; Q9NX04; Q08289; P78371; Q16543; Q8N8U2; P54105; P21964-2; Q9NQ92; Q16526; Q9Y6K1; Q01094; Q08426; P38919; Q14241; O15197-2; Q6ZV65; P01100; O95995; P62993; Q8TE85; Q9BX10; P62805; P31269; Q00613; Q63ZY3; P03952; Q8TBB1; P06858; Q86UQ8-1; Q96HA8; Q8WVJ2; P24928; O14744; Q86U06; Q9BRS2; O75044; Q96RU7; P31930; P40337-2; Q9BQA1; P63104; Q96E35; Q91XC0; P03418; Q6ZV65-2	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9556550}.	GO:0000387; GO:0000785; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0007088; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0045596; GO:0046982; GO:0048026; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:0097421; GO:1901796; GO:1904992		9556550; 9843966; 10531356; 14702039; 19054851; 12508121; 15489334; 21917714; 12665801; 12411503; 15737618; 16087681; 10734105; 11152681; 11747828; 12101096; 12718890; 15485929; 17184735; 17709427; 18984161; 18404153; 19011621; 19413330; 20421892; 20159986; 20810653; 21269460; 21081503; 21258366; 22269951; 22223895; 22814378; 25284789; 25092918; 26700805; 33376131; 23071334	Class I-like SAM-binding methyltransferase superfamily, Protein arginine N-methyltransferase family
O14745	NHRF1_HUMAN	Na(+)/H(+) exchange regulatory cofactor NHE-RF1, NHERF-1 (Ezrin-radixin-moesin-binding phosphoprotein 50, EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)	SLC9A3R1 NHERF NHERF1	358	9606			3D-structure;Acetylation;Alternative splicing;Cell membrane;Cell projection;Cytoplasm;Direct protein sequencing;Disease variant;Membrane;Phosphoprotein;Reference proteome;Repeat;Wnt signaling pathway	Q9BYF1; P07550; Q92624; P13569; P29762; Q9Y2H0-1; P15311; P26038; P35240-1; P47900; P09619; O60346; O60346-2; Q6ZVD8; P60484; O14745; Q9R0W0; P26043	TISSUE SPECIFICITY: Detected in liver, kidney, pancreas, prostate, spleen, small intestine and placenta, in particular in the syncytiotrophoblast. {ECO:0000269|PubMed:9096337, ECO:0000269|PubMed:9314537}.	GO:0001726; GO:0002009; GO:0003096; GO:0005102; GO:0005737; GO:0005902; GO:0007009; GO:0007097; GO:0007191; GO:0007605; GO:0008013; GO:0008285; GO:0008360; GO:0008361; GO:0010642; GO:0012505; GO:0014067; GO:0015185; GO:0015629; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0019902; GO:0022612; GO:0030033; GO:0030036; GO:0030165; GO:0030175; GO:0030336; GO:0030643; GO:0031526; GO:0031528; GO:0031698; GO:0031799; GO:0031800; GO:0031982; GO:0032415; GO:0032416; GO:0032426; GO:0032782; GO:0034635; GO:0034767; GO:0042802; GO:0043495; GO:0043621; GO:0044782; GO:0044877; GO:0045121; GO:0045159; GO:0045198; GO:0045199; GO:0045859; GO:0045930; GO:0047485; GO:0048471; GO:0050780; GO:0051683; GO:0051898; GO:0051939; GO:0060088; GO:0060158; GO:0065003; GO:0070062; GO:0070293; GO:0070373; GO:0070851; GO:0071944; GO:0072659; GO:0090090; GO:0090660; GO:0097225; GO:0097291; GO:0098739; GO:0098797; GO:0150104; GO:1903402; GO:2001244	PTM: Phosphorylated on serine residues. {ECO:0000269|PubMed:9314537}.	9314537; 9430655; 14702039; 16625196; 15489334; 12665801; 9096337; 10499588; 11684085; 11285285; 11956211; 12004055; 12080081; 12193606; 12403779; 12154080; 12145337; 12444018; 12444019; 12830000; 12471024; 17081983; 17924679; 18220336; 19367720; 18088087; 18669648; 19413330; 19555689; 19690332; 20068231; 21269460; 21406692; 22223895; 22506049; 22814378; 23186163; 24275569; 25944712; 34189428; 11304524; 11352585; 11882663; 15020681; 16615918; 18784102	
O14746	TERT_HUMAN	Telomerase reverse transcriptase, EC 2.7.7.49 (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2, TP2)	TERT EST2 TCS1 TRT	1132	9606		2.7.7.49	3D-structure;Alternative splicing;Chromosome;Cytoplasm;Disease variant;DNA-binding;Dyskeratosis congenita;Magnesium;Metal-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;RNA-directed DNA polymerase;Telomere;Transferase;Ubl conjugation	P35222; Q9BVP2; P06748; Q96BK5; P29590-5; Q9Y265; P51532; O14746; O14773-1; Q92900; P03126	TISSUE SPECIFICITY: Expressed at a high level in thymocyte subpopulations, at an intermediate level in tonsil T-lymphocytes, and at a low to undetectable level in peripheral blood T-lymphocytes. {ECO:0000269|PubMed:8676067, ECO:0000269|PubMed:9389643}.	GO:0000049; GO:0000333; GO:0000723; GO:0000781; GO:0000783; GO:0001172; GO:0001223; GO:0003677; GO:0003720; GO:0003721; GO:0003723; GO:0003964; GO:0003968; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005829; GO:0005886; GO:0006278; GO:0007004; GO:0007005; GO:0008022; GO:0010629; GO:0016605; GO:0016607; GO:0022616; GO:0030177; GO:0030422; GO:0031379; GO:0031647; GO:0032092; GO:0042162; GO:0042635; GO:0042645; GO:0042802; GO:0042803; GO:0043524; GO:0045766; GO:0046326; GO:0046686; GO:0046872; GO:0047485; GO:0051000; GO:0051087; GO:0062103; GO:0070034; GO:0070200; GO:0071456; GO:0071897; GO:0090399; GO:0098680; GO:1900087; GO:1902895; GO:1903620; GO:1903704; GO:1903799; GO:1904707; GO:1904751; GO:1904754; GO:1990572; GO:2000352; GO:2000648; GO:2000773; GO:2001240	PTM: Phosphorylation at Tyr-707 under oxidative stress leads to translocation of TERT to the cytoplasm and reduces its antiapoptotic activity. Dephosphorylated by SHP2/PTPN11 leading to nuclear retention. Phosphorylation at Ser-227 by the AKT pathway promotes nuclear location. Phosphorylation at the G2/M phase at Ser-457 by DYRK2 promotes ubiquitination by the EDVP complex and degradation. {ECO:0000269|PubMed:12808100, ECO:0000269|PubMed:18829466, ECO:0000269|PubMed:22366458, ECO:0000269|PubMed:23362280}.; PTM: Ubiquitinated by the EDVP complex, a E3 ligase complex following phosphorylation at Ser-457 by DYRK2. Ubiquitinated leads to proteasomal degradation. {ECO:0000269|PubMed:23362280}.; PTM: (Microbial infection) In case of infection by HIV-1, the EDVP complex is hijacked by HIV-1 via interaction between HIV-1 Vpr and DCAF1/VPRBP, leading to ubiquitination and degradation. {ECO:0000269|PubMed:23362280}.	9288757; 9252327; 10333526; 12869302; 14654914; 15372022; 8676067; 9389643; 9443919; 11029039; 11274138; 12808100; 15044100; 14963003; 15138842; 15371412; 15082768; 15805468; 15857955; 17026956; 17548608; 18082603; 17296728; 17264120; 18829466; 19188162; 19567472; 19571879; 19777057; 19179534; 20351177; 21846770; 22226966; 22366458; 23362280; 23612978; 23348503; 29490055; 16323248; 29695869; 15885610; 15814878; 16247010; 16890917; 16332973; 16627250; 16990594; 17785587; 17392301; 17460043; 18042801; 19760749; 19147845; 21436073; 21602826; 21483807; 22512499; 31355908	Reverse transcriptase family, Telomerase subfamily
O14756	H17B6_HUMAN	17-beta-hydroxysteroid dehydrogenase type 6, 17-beta-HSD 6, 17-beta-HSD6, EC 1.1.1.105, EC 1.1.1.209, EC 1.1.1.239, EC 1.1.1.53, EC 1.1.1.62 (3-alpha->beta-hydroxysteroid epimerase, 3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 6)	HSD17B6 RODH SDR9C6	317	9606		1.1.1.105; 1.1.1.209; 1.1.1.239; 1.1.1.53; 1.1.1.62	Endoplasmic reticulum;Endosome;Glycoprotein;Lipid metabolism;Membrane;Microsome;NAD;Oxidoreductase;Reference proteome;Signal;Steroid metabolism		TISSUE SPECIFICITY: Detected in liver and prostate (at protein level). Detected in adult liver, lung, brain, placenta, prostate, adrenal gland, testis, mammary gland, spleen, spinal cord and uterus. Detected in caudate nucleus, and at lower levels in amygdala, corpus callosum, hippocampus, substantia nigra and thalamus. Detected in fetal lung, liver and brain. {ECO:0000269|PubMed:10896656, ECO:0000269|PubMed:9188497}.	GO:0003824; GO:0004745; GO:0005783; GO:0006702; GO:0006710; GO:0009055; GO:0016491; GO:0031901; GO:0044594; GO:0047023; GO:0047024; GO:0047035; GO:0047044; GO:0047045; GO:0062175; GO:0072582		9188497; 10896656; 15489334; 11360992; 11513953; 24275569	Short-chain dehydrogenases/reductases (SDR) family
O14757	CHK1_HUMAN	Serine/threonine-protein kinase Chk1, EC 2.7.11.1 (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1)	CHEK1 CHK1	476	9606		2.7.11.1	3D-structure;Alternative splicing;ATP-binding;Cell cycle;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Isopeptide bond;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	P38398; P30307; Q9HAW4; Q9UJM3; P08238; O00255; Q06609; P06400; Q9HCE7-2; Q9UNS1; P61981	TISSUE SPECIFICITY: Expressed ubiquitously with the most abundant expression in thymus, testis, small intestine and colon. {ECO:0000269|PubMed:9278511, ECO:0000269|PubMed:9382850}.	GO:0000077; GO:0000086; GO:0000785; GO:0000794; GO:0001833; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0005829; GO:0006260; GO:0006281; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006997; GO:0007095; GO:0010569; GO:0010767; GO:0018107; GO:0019904; GO:0032991; GO:0035402; GO:0035556; GO:0042127; GO:0043231; GO:0044818; GO:0045787; GO:0045815; GO:0045839; GO:0046602; GO:0070317; GO:0071260; GO:0071313; GO:0090399; GO:0106310; GO:1901796; GO:1902742; GO:2000279; GO:2000615	PTM: Phosphorylated by ATR in a RAD17-dependent manner in response to ultraviolet irradiation and inhibition of DNA replication. Phosphorylated by ATM in response to ionizing irradiation. ATM and ATR can both phosphorylate Ser-317 and Ser-345 and this results in enhanced kinase activity. Phosphorylation at Ser-345 induces a change in the conformation of the protein, activates the kinase activity and is a prerequisite for interaction with FBXO6 and subsequent ubiquitination at Lys-436. Phosphorylation at Ser-345 also increases binding to 14-3-3 proteins and promotes nuclear retention. Conversely, dephosphorylation at Ser-345 by PPM1D may contribute to exit from checkpoint mediated cell cycle arrest. Phosphorylation at Ser-280 by AKT1/PKB, may promote mono and/or diubiquitination. Also phosphorylated at undefined residues during mitotic arrest, resulting in decreased activity. {ECO:0000269|PubMed:10859164, ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12446774, ECO:0000269|PubMed:12588868, ECO:0000269|PubMed:12660173, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676925, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:14657349, ECO:0000269|PubMed:14681223, ECO:0000269|PubMed:14988723, ECO:0000269|PubMed:15650047, ECO:0000269|PubMed:15707391, ECO:0000269|PubMed:15870257, ECO:0000269|PubMed:19716789}.; PTM: Ubiquitinated. Mono or diubiquitination promotes nuclear exclusion (By similarity). The activated form (phosphorylated on Ser-345) is polyubiquitinated at Lys-436 by some SCF-type E3 ubiquitin ligase complex containing FBXO6 promoting its degradation. Ubiquitination and degradation are required to terminate the checkpoint and ensure that activated CHEK1 does not accumulate as cells progress through S phase, when replication forks encounter transient impediments during normal DNA replication. 'Lys-63'-mediated ubiquitination by TRAF4 at Lys-132 activates cell cycle arrest and activation of DNA repair (PubMed:32357935). {ECO:0000250, ECO:0000269|PubMed:10859164, ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12446774, ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676925, ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:14681223, ECO:0000269|PubMed:14988723, ECO:0000269|PubMed:15650047, ECO:0000269|PubMed:15707391, ECO:0000269|PubMed:15870257, ECO:0000269|PubMed:19716789}.; PTM: Proteolytically cleaved at the C-terminus by SPRTN during normal DNA replication, thereby promoting CHEK1 removal from chromatin and activating the protein kinase activity. {ECO:0000269|PubMed:31316063}.	9278511; 9382850; 10717241; 22184239; 14702039; 19054851; 16554811; 15489334; 10673501; 10859164; 11535615; 11390642; 11821419; 12446774; 11836499; 12399544; 12676583; 12660173; 14681206; 12588868; 12676925; 12676962; 12759351; 12766152; 14559997; 12955071; 14657349; 14988723; 14681223; 15311285; 15707391; 15710331; 15870257; 15659650; 15798197; 15665856; 15650047; 16511572; 16963448; 17380128; 17296736; 17525332; 18510930; 18728393; 18451105; 18691976; 18317453; 18669648; 19413330; 19223857; 19716789; 19369195; 19734889; 19330022; 19690332; 20090422; 20068231; 21269460; 21406692; 23186163; 31316063; 33108758; 32357935; 10761933; 12244092; 15974586; 17344846	Protein kinase superfamily, CAMK Ser/Thr protein kinase family, NIM1 subfamily
O14763	TR10B_HUMAN	Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2) (CD antigen CD262)	TNFRSF10B DR5 KILLER TRAILR2 TRICK2 ZTNFR9 UNQ160/PRO186	440	9606			3D-structure;Alternative splicing;Apoptosis;Direct protein sequencing;Disulfide bond;Glycoprotein;Membrane;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	Q12797-6; P15941-11; P50591; Q96MV8	TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues; very highly expressed in tumor cell lines such as HeLaS3, K-562, HL-60, SW480, A-549 and G-361; highly expressed in heart, peripheral blood lymphocytes, liver, pancreas, spleen, thymus, prostate, ovary, uterus, placenta, testis, esophagus, stomach and throughout the intestinal tract; not detectable in brain.	GO:0002357; GO:0005886; GO:0006915; GO:0007166; GO:0007250; GO:0008625; GO:0009986; GO:0016021; GO:0034976; GO:0036462; GO:0036463; GO:0038023; GO:0042981; GO:0043065; GO:0043123; GO:0045569; GO:0070059; GO:0071260	PTM: (Microbial infection) Glycosylated on Arg residue by S.typhimurium protein Ssek3. {ECO:0000269|PubMed:30902834}.	9285725; 9311998; 9373179; 9430227; 9325248; 9326928; 9242610; 9242611; 10072170; 12975309; 17974005; 16421571; 15489334; 14759258; 15322075; 18846110; 23498957; 30902834; 10549288; 10542098; 23555243	
O14764	GBRD_HUMAN	Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta)	GABRD	452	9606			Cell junction;Cell membrane;Chloride;Chloride channel;Disease variant;Disulfide bond;Epilepsy;Glycoprotein;Ion channel;Ion transport;Membrane;Phosphoprotein;Postsynaptic cell membrane;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix;Transport	Q99750; Q7Z3S9; Q9UMX0; Q9UMX0-2		GO:0004890; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030424; GO:0030425; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043025; GO:0045202; GO:0050877; GO:0098982; GO:0099055; GO:1902476; GO:1902711; GO:1904315		16710414; 15489334; 15115768; 27864847; 27932480	Ligand-gated ion channel (TC 1.A.9) family, Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily, GABRD sub-subfamily
O14770	MEIS2_HUMAN	Homeobox protein Meis2 (Meis1-related protein 1)	MEIS2 MRG1	477	9606			3D-structure;Activator;Alternative splicing;Cytoplasm;Developmental protein;Disease variant;DNA-binding;Homeobox;Mental retardation;Nucleus;Reference proteome;Transcription;Transcription regulation	Q5TZZ9; Q6P1W5; A0A1B0GWI1; Q9UJX0; P03363; P31314; P18825; Q9BQD7; Q9NP55; Q16568; A0A1B0GWI1; P78358; Q96C01; Q92567-2; P24592; Q13352; P60410; Q8IUC1; Q3LHN2; Q3LI70; Q3LI64; Q3LI66; P59942; P17568; A8MTQ0; Q9BVL2; O43482; P40424; Q9BYU1; Q16633; P78424; Q13882; Q9BVN2; P09683; Q8NCR6; Q13207; Q9Y5J6; Q8IWZ5; Q99990; D3DTS7	TISSUE SPECIFICITY: Expressed in various tissues. Expressed at high level in the lymphoid organs of hematopoietic tissues. Also expressed in some regions of the brain, such as the putamen.	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003677; GO:0005634; GO:0006357; GO:0007420; GO:0008134; GO:0008284; GO:0008542; GO:0009612; GO:0009880; GO:0009887; GO:0031016; GO:0043565; GO:0045638; GO:0045931; GO:0045944; GO:0048471; GO:0070848; GO:0110024; GO:1990837		10764806; 14702039; 16572171; 15489334; 9383298; 11279116; 20523026; 20553494; 19559479; 21746878; 23186163; 24678003; 26550823; 25712757; 27225850	TALE/MEIS homeobox family
O14771	ZN213_HUMAN	Zinc finger protein 213 (Putative transcription factor CR53) (Zinc finger protein with KRAB and SCAN domains 21)	ZNF213 ZKSCAN21	459	9606			Alternative splicing;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	Q96G04; Q96EF6; P61968; Q8TBB1; O60437; P57086; Q9Y5A6	TISSUE SPECIFICITY: Widely expressed with highest levels in testis. {ECO:0000269|PubMed:10023065}.	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872		10023065; 14702039; 15616553; 15489334	Krueppel C2H2-type zinc-finger protein family
O14772	FPGT_HUMAN	Fucose-1-phosphate guanylyltransferase, EC 2.7.7.30 (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase)	FPGT GFPP	607	9606		2.7.7.30	Alternative splicing;Cytoplasm;GTP-binding;Nucleotide-binding;Nucleotidyltransferase;Reference proteome;Transferase		TISSUE SPECIFICITY: Expressed in many tissues.	GO:0003824; GO:0005525; GO:0005737; GO:0005829; GO:0006004; GO:0047341		9804772; 14702039; 16710414; 15489334	
O14773	TPP1_HUMAN	Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)	TPP1 CLN2 GIG1 UNQ267/PRO304	563	9606		3.4.14.9	3D-structure;Alternative splicing;Autocatalytic cleavage;Calcium;Direct protein sequencing;Disease variant;Disulfide bond;Epilepsy;Glycoprotein;Hydrolase;Lysosome;Metal-binding;Neurodegeneration;Neuronal ceroid lipofuscinosis;Protease;Reference proteome;Serine protease;Signal;Spinocerebellar ataxia;Zymogen	Q9NWX5-2; Q53EZ4; Q9NSE2; Q9UKA2; Q6P3S6; Q96FW1; Q96D59; Q9BUZ4; P45974-2; O00308; Q8NAP3; E5LBV4; Q2NKJ3-1; Q9H668; O14746	TISSUE SPECIFICITY: Detected in all tissues examined with highest levels in heart and placenta and relatively similar levels in other tissues.	GO:0004175; GO:0004252; GO:0005764; GO:0005794; GO:0006508; GO:0006629; GO:0007040; GO:0007399; GO:0007417; GO:0008233; GO:0008236; GO:0008240; GO:0030163; GO:0030855; GO:0035727; GO:0042277; GO:0042470; GO:0043171; GO:0043202; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070062; GO:0070198; GO:0120146; GO:1905146	PTM: Activated by autocatalytic proteolytical processing upon acidification (PubMed:11054422, PubMed:19038966, PubMed:19038967). N-glycosylation is required for processing and activity (PubMed:19038966, PubMed:19038967). {ECO:0000269|PubMed:11054422, ECO:0000269|PubMed:19038966, ECO:0000269|PubMed:19038967}.	9295267; 9653647; 12975309; 15489334; 11054422; 12643545; 12754519; 10477428; 17081065; 17237713; 19941651; 19159218; 21269460; 24275569; 25944712; 19038966; 19038967; 10330339; 10665500; 11339651; 11241479; 11589012; 11462245; 12376936; 12414822; 12698559; 14736728; 19201763; 20340139; 22612257; 21990111; 23418007	
O14775	GNB5_HUMAN	Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)	GNB5	395	9606			3D-structure;Alternative splicing;Disease variant;Membrane;Mental retardation;Reference proteome;Repeat;Transducer;WD repeat		TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9606987}.	GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0007165; GO:0007186; GO:0007212; GO:0030159; GO:0031682; GO:0036367; GO:0043547; GO:0051087; GO:0098793; GO:1901386; GO:1902773; GO:1990603		9606987; 11230166; 14702039; 15489334; 10521509; 10339615; 27523599; 27677260	WD repeat G protein beta family
O14776	TCRG1_HUMAN	Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150)	TCERG1 CA150 TAF2S	1098	9606			3D-structure;Activator;Alternative splicing;Coiled coil;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	Q99728; P42858; O14776	TISSUE SPECIFICITY: Detected in brain neurons. {ECO:0000269|PubMed:11172033}.	GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063		9315662; 15489334; 10908677; 11604498; 11172033; 15485897; 21269460; 23186163; 24129315; 25218447; 25772364; 25755297; 28112733; 17060612	
O14777	NDC80_HUMAN	Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1, HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC)	NDC80 HEC HEC1 KNTC2	642	9606			3D-structure;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome	Q9Y2J4; P18848; P48047; Q9Y5K8; Q8TC20-4; Q9P1Z2; Q8TD31-3; P51946; O75909; Q9H211; Q9H3R5; Q96MT8-3; Q9UBC2-3; Q8IYI6; Q8IZT9; Q08379; Q96CS2; O14964; O75146-2; Q8IY31; Q9BVG8-5; Q6P597; Q7Z3Y8; P04259; O95678; Q8TBB1; Q9NPJ6; P55081; O14777; Q9GZM8; Q9BZD4; Q96KQ4; Q6ZNE9; Q86XK3; Q96ES7; Q9HBM1; O75558; Q9UBB9; Q6I9Y2; Q15025; Q05BL1; Q13625-3; P33981-1; P40222; Q8N6Y0; Q8N1B4; Q9Y3C0; Q8N720; O95229		GO:0000070; GO:0000132; GO:0000278; GO:0000775; GO:0000776; GO:0000940; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0007094; GO:0008315; GO:0008608; GO:0016020; GO:0030332; GO:0031262; GO:0031617; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483; GO:1905342	PTM: Phosphorylation begins in S phase of the cell cycle and peaks in mitosis. Phosphorylated by NEK2. Also phosphorylated by AURKA and AURKB. {ECO:0000269|PubMed:12386167, ECO:0000269|PubMed:14602875, ECO:0000269|PubMed:30409912}.; PTM: Acetylated at Lys-53 and Lys-59 by KAT5 during mitosis, promoting robust kinetochore-microtubule attachment (PubMed:30409912). Deacetylated by SIRT1 (PubMed:30409912). {ECO:0000269|PubMed:30409912}.	9315664; 15489334; 9295362; 10409732; 10779342; 12386167; 12351790; 14654001; 15235793; 15062103; 15239953; 15133482; 14699129; 14978040; 14602875; 15502821; 15964272; 15961401; 15824131; 15548592; 15713649; 16732327; 20068231; 21269460; 23085020; 22581055; 23891108; 23186163; 25743205; 27156448; 30409912	NDC80/HEC1 family
O14782	KIF3C_HUMAN	Kinesin-like protein KIF3C	KIF3C	793	9606			3D-structure;ATP-binding;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Microtubule;Motor protein;Nucleotide-binding;Reference proteome	Q9NRI5; P23508; Q9UBB9		GO:0003774; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0072384; GO:0097542		9480755; 9446808; 15815621; 15489334; 26138355	TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, Kinesin II subfamily
O14786	NRP1_HUMAN	Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304)	NRP1 NRP VEGF165R	923	9606			3D-structure;Alternative splicing;Angiogenesis;Calcium;Cell membrane;Cytoplasm;Developmental protein;Differentiation;Direct protein sequencing;Disulfide bond;Glycoprotein;Heparan sulfate;Heparin-binding;Host-virus interaction;Membrane;Metal-binding;Mitochondrion;Neurogenesis;Phosphoprotein;Proteoglycan;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix	P21333; P08648; P35968; P15692; P0DTC2; P15692-4	TISSUE SPECIFICITY: [Isoform 1]: The expression of isoforms 1 and 2 does not seem to overlap. Expressed by the blood vessels of different tissues. In the developing embryo it is found predominantly in the nervous system. In adult tissues, it is highly expressed in heart and placenta; moderately in lung, liver, skeletal muscle, kidney and pancreas; and low in adult brain (PubMed:10688880, PubMed:9529250). Expressed in olfactory epithelium (at protein level) (PubMed:33082293). Expressed in the central nervous system, including olfactory related regions such as the olfactory tubercles and paraolfactory gyri (PubMed:33082293). {ECO:0000269|PubMed:10688880, ECO:0000269|PubMed:33082293, ECO:0000269|PubMed:9529250}.; TISSUE SPECIFICITY: [Isoform 2]: The expression of isoforms 1 and 2 does not seem to overlap. Found in liver hepatocytes, kidney distal and proximal tubules. {ECO:0000269|PubMed:10688880}.	GO:0001525; GO:0001569; GO:0001764; GO:0001938; GO:0002040; GO:0002042; GO:0002116; GO:0003148; GO:0005021; GO:0005096; GO:0005615; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0005925; GO:0006930; GO:0007165; GO:0007229; GO:0007267; GO:0007411; GO:0007413; GO:0008201; GO:0009887; GO:0010595; GO:0014911; GO:0015026; GO:0017154; GO:0019838; GO:0019901; GO:0019955; GO:0021612; GO:0021637; GO:0021649; GO:0021675; GO:0021785; GO:0021828; GO:0030424; GO:0031290; GO:0031410; GO:0031532; GO:0031966; GO:0032489; GO:0034446; GO:0035729; GO:0035767; GO:0035924; GO:0036486; GO:0038085; GO:0038189; GO:0038190; GO:0042327; GO:0043005; GO:0043235; GO:0043524; GO:0043542; GO:0045766; GO:0046718; GO:0046872; GO:0048008; GO:0048010; GO:0048012; GO:0048842; GO:0048843; GO:0048844; GO:0048846; GO:0050731; GO:0050918; GO:0051491; GO:0051496; GO:0051894; GO:0060301; GO:0060385; GO:0060627; GO:0060666; GO:0060978; GO:0060982; GO:0061299; GO:0061441; GO:0061549; GO:0061551; GO:0070374; GO:0071526; GO:0071679; GO:0090050; GO:0090259; GO:0097102; GO:0097374; GO:0097443; GO:0097475; GO:0097490; GO:0097491; GO:0098978; GO:0099055; GO:0099173; GO:0150018; GO:0150020; GO:1900026; GO:1901166; GO:1901998; GO:1902285; GO:1902287; GO:1902336; GO:1902378; GO:1902946; GO:1903375; GO:1904835; GO:1905040; GO:2000251; GO:2001237		9288753; 9529250; 10688880; 17974005; 15164054; 15489334; 10520995; 10748121; 16335952; 16763549; 19159218; 19805273; 24275569; 26503042; 26789244; 30623799; 33000221; 33082293; 12517344; 17989695; 33082294	Neuropilin family
O14787	TNPO2_HUMAN	Transportin-2 (Karyopherin beta-2b)	TNPO2	897	9606			Acetylation;Alternative splicing;Cytoplasm;Nucleus;Protein transport;Reference proteome;Repeat;Transport	Q96GX9; Q6P1W5; Q13557; O00471; V9HW27; O95198; P15531; Q96PV4; P54274; Q8N7W2-2; Q96CA5; Q13867; Q86WS4; Q13554-3; Q13555-5; P78358; P07954; Q9C0B1-2; Q9BTY2; P30793; O15499; Q9BS75; Q9UH77; Q92876; O95678; Q8IUC2; P32243-2; Q9UKS6; Q9NR12; Q96BK5; P78424; Q9NR22; P32322; P62826; Q8IUH3-3; Q9NQG5; Q9UJW9; Q15637-4; Q13207; Q8TBB0; Q9BZR9; A0A0C4DGF1; Q53FD0-2		GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0031267; GO:0061608		9298975; 15057824; 15489334; 19608861; 21269460; 23033978	Importin beta family, Importin beta-2 subfamily
O14788	TNF11_HUMAN	Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor, ODF) (Osteoprotegerin ligand, OPGL) (Receptor activator of nuclear factor kappa-B ligand, RANKL) (TNF-related activation-induced cytokine, TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form ]	TNFSF11 OPGL RANKL TRANCE	317	9606			3D-structure;Alternative splicing;Cell membrane;Cytokine;Cytoplasm;Developmental protein;Differentiation;Disease variant;Glycoprotein;Membrane;Osteopetrosis;Receptor;Reference proteome;Secreted;Signal-anchor;Transmembrane;Transmembrane helix	Q6UX06; P98066; O00300; O00526; Q9Y6Q6	TISSUE SPECIFICITY: Highest in the peripheral lymph nodes, weak in spleen, peripheral blood Leukocytes, bone marrow, heart, placenta, skeletal muscle, stomach and thyroid.	GO:0001503; GO:0002158; GO:0002548; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006955; GO:0010628; GO:0019221; GO:0019722; GO:0030316; GO:0032813; GO:0033209; GO:0033598; GO:0034112; GO:0036035; GO:0038001; GO:0042802; GO:0043123; GO:0043406; GO:0044691; GO:0045453; GO:0045672; GO:0045780; GO:0045944; GO:0046330; GO:0050870; GO:0051091; GO:0051092; GO:0051466; GO:0051897; GO:0055074; GO:0060749; GO:0070371; GO:0071812; GO:0071847; GO:0071848; GO:1902533; GO:1904616; GO:1990830; GO:2001206	PTM: The soluble form of isoform 1 derives from the membrane form by proteolytic processing (By similarity). The cleavage may be catalyzed by ADAM17. {ECO:0000250}.	9367155; 9568710; 10708588; 15489334; 9312132; 22664871; 17632511	Tumor necrosis factor family
O14791	APOL1_HUMAN	Apolipoprotein L1 (Apolipoprotein L, Apo-L, ApoL) (Apolipoprotein L-I, ApoL-I)	APOL1 APOL	398	9606			3D-structure;Alternative splicing;Cholesterol metabolism;Direct protein sequencing;Disease variant;Glycoprotein;HDL;Lipid metabolism;Lipid transport;Phosphoprotein;Reference proteome;Secreted;Signal;Steroid metabolism;Sterol metabolism;Transport	Q9UJX2; Q8IXL6	TISSUE SPECIFICITY: Plasma. Found on APOA-I-containing high density lipoprotein (HDL3). Expressed in pancreas, lung, prostate, liver, placenta and spleen.	GO:0005254; GO:0005576; GO:0005615; GO:0005788; GO:0006869; GO:0008203; GO:0008289; GO:0031224; GO:0034361; GO:0034364; GO:0042157; GO:0045087; GO:0051838; GO:0072562; GO:1902476	PTM: Phosphorylated by FAM20C in the extracellular medium. {ECO:0000269|PubMed:26091039}.	9325276; 11290834; 11374903; 11944986; 14702039; 10591208; 15489334; 16335952; 24275569; 26091039; 16959974; 20635188; 20647424	Apolipoprotein L family
O14792	HS3S1_HUMAN	Heparan sulfate glucosamine 3-O-sulfotransferase 1, EC 2.8.2.23 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1, 3-OST-1, Heparan sulfate 3-O-sulfotransferase 1, h3-OST-1)	HS3ST1 3OST 3OST1	307	9606		2.8.2.23	3D-structure;Disulfide bond;Glycoprotein;Golgi apparatus;Reference proteome;Signal;Transferase		TISSUE SPECIFICITY: Highly expressed in the brain and kidney and weakly expressed in the heart, lung and placenta. {ECO:0000269|PubMed:9988767}.	GO:0005796; GO:0006024; GO:0008146; GO:0008467		9346953; 14702039; 15489334; 8900198; 9988768; 9988767	Sulfotransferase 1 family
O14793	GDF8_HUMAN	Growth/differentiation factor 8, GDF-8 (Myostatin)	MSTN GDF8	375	9606			3D-structure;Cleavage on pair of basic residues;Cytokine;Disulfide bond;Glycoprotein;Growth factor;Heparin-binding;Reference proteome;Secreted;Signal	Q13705; P13497; P09958; O14793; Q96NZ8; PRO_0000033950 [O14793]		GO:0005102; GO:0005125; GO:0005615; GO:0005737; GO:0007179; GO:0007517; GO:0008083; GO:0008201; GO:0009408; GO:0009629; GO:0010592; GO:0010759; GO:0010862; GO:0014732; GO:0014741; GO:0014839; GO:0014850; GO:0022602; GO:0033574; GO:0033673; GO:0042802; GO:0042803; GO:0043627; GO:0045471; GO:0045662; GO:0045893; GO:0046627; GO:0046716; GO:0048632; GO:0051602; GO:0051898; GO:0060395; GO:0071549; GO:1902723; GO:1902725; GO:2000818	PTM: Synthesized as large precursor molecule that undergoes proteolytic cleavage to generate an N-terminal propeptide and a disulfide linked C-terminal dimer, which is the biologically active molecule. The circulating form consists of a latent complex of the C-terminal dimer and other proteins, including its propeptide, which maintain the C-terminal dimer in a latent, inactive state. Ligand activation requires additional cleavage of the prodomain by a tolloid-like metalloproteinase. {ECO:0000250|UniProtKB:O08689}.	9356471; 9843994; 17186467; 15489334; 12595574; 15215484; 17878677; 27625211; 28257634	TGF-beta family
O14795	UN13B_HUMAN	Protein unc-13 homolog B (Munc13-2, munc13)	UNC13B UNC13	1591	9606			Alternative splicing;Calcium;Cell junction;Cell membrane;Coiled coil;Cytoplasm;Exocytosis;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Synapse;Zinc;Zinc-finger		TISSUE SPECIFICITY: Expressed in kidney cortical epithelial cells and brain. {ECO:0000269|PubMed:9607201}.	GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007528; GO:0010808; GO:0016020; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030672; GO:0030742; GO:0031267; GO:0031594; GO:0035249; GO:0042734; GO:0043065; GO:0043195; GO:0048786; GO:0050714; GO:0060478; GO:0061789; GO:0071333; GO:0097151; GO:0098831; GO:0099011; GO:0099525		9607201; 15164053; 15489334; 10233166; 18669648; 20068231; 23186163; 24275569; 16959974	Unc-13 family
O14796	SH21B_HUMAN	SH2 domain-containing protein 1B (EWS/FLI1-activated transcript 2, EAT-2)	SH2D1B EAT2	132	9606			3D-structure;Adaptive immunity;Alternative splicing;Immunity;Innate immunity;Phosphoprotein;Reference proteome;SH2 domain	O95994; P10275; P51451; Q9BZW8; Q9UIB8; Q96D03; P01100; Q13480; P10721; O15481; Q6FHY5; P08581; Q8NI38; Q8TAK6; P19174; P16885; Q96DU3; P12931; Q99081-3; Q07912-2; Q9BYV2; Q53HF2; O76024		GO:0002250; GO:0002366; GO:0002717; GO:0005829; GO:0030674; GO:0045087; GO:0045089		11689425; 12115647; 14702039; 16710414; 15489334; 9000139; 21219180; 24687958	
O14798	TR10C_HUMAN	Tumor necrosis factor receptor superfamily member 10C (Antagonist decoy receptor for TRAIL/Apo-2L) (Decoy TRAIL receptor without death domain) (Decoy receptor 1, DcR1) (Lymphocyte inhibitor of TRAIL) (TNF-related apoptosis-inducing ligand receptor 3, TRAIL receptor 3, TRAIL-R3) (TRAIL receptor without an intracellular domain) (CD antigen CD263)	TNFRSF10C DCR1 LIT TRAILR3 TRID UNQ321/PRO366	259	9606			Apoptosis;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;GPI-anchor;Lipoprotein;Membrane;Receptor;Reference proteome;Repeat;Signal	Q13520; Q3SXY8; Q8WWH4; P11912; O75208; Q96BA8; P00387; Q96KC8; Q9Y282; Q5JX71; Q8TDT2; O60883; P48051; O95279; P10620; Q9Y676; Q13113; O43765; O14863; P27105; Q96A49; Q96B21; Q96HE8	TISSUE SPECIFICITY: Higher expression in normal tissues than in tumor cell lines. Highly expressed in peripheral blood lymphocytes, spleen, skeletal muscle, placenta, lung and heart.	GO:0004888; GO:0005886; GO:0009986; GO:0031225; GO:0036462; GO:0043065; GO:0045569	PTM: N-glycosylated and O-glycosylated.	9325248; 9314565; 9242610; 9242611; 9373179; 9551946; 12975309; 16421571; 15489334; 15340161	
O14802	RPC1_HUMAN	DNA-directed RNA polymerase III subunit RPC1, RNA polymerase III subunit C1, EC 2.7.7.6 (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit, RPC155) (RNA polymerase III subunit C160)	POLR3A	1390	9606		2.7.7.6	3D-structure;Acetylation;Antiviral defense;Disease variant;DNA-directed RNA polymerase;Immunity;Innate immunity;Leukodystrophy;Magnesium;Metal-binding;Nucleotidyltransferase;Nucleus;Reference proteome;Transcription;Transferase;Zinc		TISSUE SPECIFICITY: Expressed in the brain, in the cortex and the white matter (at protein level). {ECO:0000269|PubMed:21855841}.	GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0016020; GO:0032728; GO:0045087; GO:0046872; GO:0051607		9331371; 15164054; 15489334; 12384934; 12391170; 19631370; 19609254; 19608861; 21269460; 21855841; 22036171; 23355746; 23694757; 27612211; 30414627; 30450527; 30323018	RNA polymerase beta' chain family
O14807	RASM_HUMAN	Ras-related protein M-Ras, EC 3.6.5.2 (Ras-related protein R-Ras3)	MRAS RRAS3	208	9606		3.6.5.2	Alternative splicing;Cell membrane;Disease variant;GTP-binding;Hydrolase;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Prenylation;Reference proteome		TISSUE SPECIFICITY: Expression highly restricted to the brain and heart.	GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003; GO:0030036; GO:0030742; GO:1990830		9400994; 10477695; 14702039; 15489334; 16641997; 16630891; 28289718; 31173466	Small GTPase superfamily, Ras family
O14810	CPLX1_HUMAN	Complexin-1 (Complexin I, CPX I) (Synaphin-2)	CPLX1	134	9606			3D-structure;Cell junction;Cell projection;Coiled coil;Cytoplasm;Disease variant;Epilepsy;Exocytosis;Neurotransmitter transport;Reference proteome;Synapse;Transport	P60880-2	TISSUE SPECIFICITY: Nervous system. In hippocampus and cerebellum, expressed mainly by inhibitory neurons. Overexpressed in substantia nigra from patients with Parkinson disease. {ECO:0000269|PubMed:11483314, ECO:0000269|PubMed:15526345, ECO:0000269|PubMed:9853440}.	GO:0000149; GO:0005326; GO:0005829; GO:0006887; GO:0007268; GO:0016079; GO:0017157; GO:0019905; GO:0030073; GO:0031201; GO:0031630; GO:0043195; GO:0043204; GO:0044305; GO:0046928; GO:0070554; GO:0098685; GO:0098794; GO:0098967; GO:0098978		7553862; 24722188; 21697133; 14702039; 15815621; 15489334; 9853440; 11483314; 15526345; 26539891; 28422131; 21785414	Complexin/synaphin family
O14813	PHX2A_HUMAN	Paired mesoderm homeobox protein 2A (ARIX1 homeodomain protein) (Aristaless homeobox protein homolog) (Paired-like homeobox 2A)	PHOX2A ARIX PMX2A	284	9606			Activator;Disease variant;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation	P50570-2; O43464; P41219		GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0003357; GO:0003700; GO:0005634; GO:0006357; GO:0021523; GO:0021623; GO:0021642; GO:0021703; GO:0030901; GO:0043576; GO:0045944; GO:0048484; GO:0048485; GO:0071542; GO:1990837		8661014; 14702039; 15489334; 11600883; 14566559	Paired homeobox family
O14815	CAN9_HUMAN	Calpain-9, EC 3.4.22.- (Digestive tract-specific calpain) (New calpain 4, nCL-4) (Protein CG36)	CAPN9 NCL4	690	9606		3.4.22.-	3D-structure;Alternative splicing;Calcium;Hydrolase;Metal-binding;Protease;Reference proteome;Repeat;Thiol protease		TISSUE SPECIFICITY: Expressed predominantly in stomach.	GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007586		9524069; 10835488; 16710414; 17157313	Peptidase C2 family
O14817	TSN4_HUMAN	Tetraspanin-4, Tspan-4 (Novel antigen 2, NAG-2) (Transmembrane 4 superfamily member 7)	TSPAN4 NAG2 TM4SF7	238	9606			Glycoprotein;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q8NEC5; Q9H2X0; Q9UHP7-3; Q02930-3; A8MQ03; Q9H8M9; A0A0C3SFZ9; O43559; Q9Y223-2; P28799; Q96NT3-2; P49639; P60410; Q9BYQ6; Q9BYR2; Q3LI66; Q9BYQ4; Q9BYQ3; Q5T7P2; O14633; Q5TA82; Q5TA76; Q5T5A8; Q9BYE3; Q5TA78; Q8N386; Q99750; Q13064; Q7Z3S9; P0DPK4; Q92570; P32242; A2BDE7; Q9NRQ2; O95470; Q8WW24; Q96A25; A8MV65-2	TISSUE SPECIFICITY: Expressed in multiple tissues but is absent in brain, lymphoid cells, and platelets.	GO:0003823; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0031982; GO:0065003		9360996; 9714763; 14702039; 15489334; 19159218; 16959974	Tetraspanin (TM4SF) family
O14818	PSA7_HUMAN	Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7 HSPC	248	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Glycoprotein;Host-virus interaction;Nucleus;Phosphoprotein;Proteasome;Reference proteome	Q19T08; Q7L775; P42858; P25786; P25787; P25788; P25789; P28066; P60900; O14818; P49720; Q5VVQ6		GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0042802; GO:0043161; GO:0070062; GO:0098794	PTM: Phosphorylation by ABL1 or ABL2 leads to an inhibition of proteasomal activity and cell cycle transition blocks. {ECO:0000269|PubMed:16678104}.	8764072; 11042152; 14702039; 11780052; 15489334; 8610016; 10748218; 11389899; 11713272; 11574696; 12119296; 12181345; 14550573; 15244466; 14759258; 14998988; 15987638; 16251969; 16678104; 17323924; 18202793; 19362550; 19734229; 19442227; 19608861; 21269460; 24275569; 25944712; 27176742; 26133119; 25599644; 27428775; 27342858; 27493187; 34711951; 23033978	Peptidase T1A family
O14827	RGRF2_HUMAN	Ras-specific guanine nucleotide-releasing factor 2, Ras-GRF2 (Ras guanine nucleotide exchange factor 2)	RASGRF2 GRF2	1237	9606			Calcium;Calmodulin-binding;Cell membrane;Coiled coil;Cytoplasm;Endoplasmic reticulum;Guanine-nucleotide releasing factor;Membrane;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation		TISSUE SPECIFICITY: Widely expressed with higher expression in brain, followed by heart, lung, pancreas and kidney. Detected in placenta. Expressed in brain and lung (at protein level). {ECO:0000269|PubMed:10373510, ECO:0000269|PubMed:11856323}.	GO:0005085; GO:0005516; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0007265; GO:0034976; GO:0035023; GO:0043547; GO:0051056; GO:0060291; GO:2000310	PTM: Phosphorylated by CDK5; down-regulates RASGRF2-mediated RAC1 activation. {ECO:0000269|PubMed:15128856}.; PTM: Ubiquitinated upon interaction with Ras. Ubiquitination leads to degradation through the 26S proteasome (By similarity). {ECO:0000250}.	10373510; 11856323; 15489334; 12176907; 15128856; 14749369; 21406692; 16959974	
O14828	SCAM3_HUMAN	Secretory carrier-associated membrane protein 3, Secretory carrier membrane protein 3	SCAMP3 C1orf3 PROPIN1	347	9606			Alternative splicing;Isopeptide bond;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport;Ubl conjugation		TISSUE SPECIFICITY: Widely expressed, with highest expression in heart and skeletal muscle.	GO:0006892; GO:0015031; GO:0016021; GO:0031625; GO:0032588; GO:0043231; GO:0055038; GO:0070062	PTM: Monoubiquitinated.	9331372; 9378760; 16710414; 15489334; 15144186; 15592455; 18669648; 19158374; 19690332; 20068231; 21269460; 21406692; 23418353; 23186163; 24275569; 25114211; 25944712	SCAMP family
O14829	PPE1_HUMAN	Serine/threonine-protein phosphatase with EF-hands 1, PPEF-1, EC 3.1.3.16 (Protein phosphatase with EF calcium-binding domain, PPEF) (Serine/threonine-protein phosphatase 7, PP7)	PPEF1 PPEF PPP7C	653	9606		3.1.3.16	Alternative splicing;Calcium;Hydrolase;Magnesium;Manganese;Metal-binding;Protein phosphatase;Reference proteome;Repeat	O43865; P62158; P27797; P36957; Q8TDX7; P62204	TISSUE SPECIFICITY: Detected in retina and retinal derived Y-79 retinoblastoma cells. Also found in fetal brain.	GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0030145; GO:0050906		9326663; 9215685; 9430683; 14702039; 15772651; 15489334; 14759258	PPP phosphatase family
O14830	PPE2_HUMAN	Serine/threonine-protein phosphatase with EF-hands 2, PPEF-2, EC 3.1.3.16	PPEF2	753	9606		3.1.3.16	Alternative splicing;Calcium;Cell projection;Cilium;Cytoplasm;Hydrolase;Manganese;Metal-binding;Protein phosphatase;Reference proteome;Repeat;Sensory transduction;Vision	P62204	TISSUE SPECIFICITY: Retinal specific.	GO:0001750; GO:0001917; GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0007601; GO:0010801; GO:0030145; GO:0030544; GO:0031435; GO:0043405; GO:0043409; GO:0043506; GO:0050906; GO:0051879		9326663; 15815621	PPP phosphatase family
O14832	PAHX_HUMAN	Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)	PHYH PAHX	338	9606	PATHWAY: Lipid metabolism; fatty acid metabolism.	1.14.11.18	3D-structure;Alternative splicing;Cataract;Deafness;Dioxygenase;Disease variant;Ichthyosis;Iron;Metal-binding;Oxidoreductase;Peroxisome;Peroxisome biogenesis disorder;Phosphoprotein;Reference proteome;Retinitis pigmentosa;Transit peptide;Vitamin C	Q6PCB6; Q96FT7-4; Q8N865; Q9UJX2; Q9UNS2; Q8IUI8; Q3B7T1; P29323-3; Q8IZU0; A5PKX9; Q9Y2M5; Q9UPM6; P43364; Q9UDY8-2; Q6GQQ9-2; O75925; Q9ULX5; O00463; Q86UV6-2	TISSUE SPECIFICITY: Expressed in liver, kidney, and T-cells, but not in spleen, brain, heart, lung and skeletal muscle.	GO:0001561; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731		9326939; 9326940; 10051602; 10767344; 15164054; 15489334; 10686344; 10744784; 12031666; 12923223; 24275569; 25944712; 16186124; 14974078; 10709665; 27535533	PhyH family
O14836	TR13B_HUMAN	Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267)	TNFRSF13B TACI	293	9606			3D-structure;Adaptive immunity;Alternative splicing;Disease variant;Disulfide bond;Glycoprotein;Immunity;Membrane;Receptor;Reference proteome;Repeat;Signal-anchor;Transmembrane;Transmembrane helix	Q99836; O43765; Q9Y275; O43765	TISSUE SPECIFICITY: Highly expressed in spleen, thymus, small intestine and peripheral blood leukocytes. Expressed in resting B-cells and activated T-cells, but not in resting T-cells.	GO:0001782; GO:0002244; GO:0002250; GO:0005886; GO:0005887; GO:0007166; GO:0030889; GO:0038023		9311921; 14702039; 15489334; 10956646; 10973284; 10880535; 15542592; 16007086; 21248752	
O14841	OPLA_HUMAN	5-oxoprolinase, EC 3.5.2.9 (5-oxo-L-prolinase, 5-OPase) (Pyroglutamase)	OPLAH	1288	9606		3.5.2.9	ATP-binding;Hydrolase;Nucleotide-binding;Phosphoprotein;Reference proteome	O14841; P78424; Q9H3S4		GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802		14993790; 15489334; 17974005; 21269460; 21651516; 23186163; 24275569	Oxoprolinase family
O14842	FFAR1_HUMAN	Free fatty acid receptor 1 (G-protein coupled receptor 40)	FFAR1 GPR40	300	9606			3D-structure;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Lipid-binding;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Detected in brain and pancreas. Detected in pancreatic beta cells. {ECO:0000269|PubMed:12496284, ECO:0000269|PubMed:16289108}.	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007204; GO:0008289; GO:0030073; GO:0032024; GO:0032691; GO:0042593; GO:0045125; GO:0051928; GO:0070542		9344866; 15489334; 12496284; 16289108; 17699519; 19068482; 21570468; 23809162; 24130766; 24742677; 25043059; 29695780	G-protein coupled receptor 1 family
O14843	FFAR3_HUMAN	Free fatty acid receptor 3 (G-protein coupled receptor 41)	FFAR3 GPR41	346	9606			Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Immunity;Inflammatory response;Lipid-binding;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	P11912; P21964; Q4LDR2; P52803; Q9Y2W7; O43561-2; Q16873; Q9NRX5; Q8IVJ1; Q9Y6I9; Q96B49; Q9NSU2-1; Q9H1C4; Q9Y548	TISSUE SPECIFICITY: Highest level in adipose tissue, and lower expression across all tissues tested. Expressed in sympathetic ganglia. {ECO:0000269|PubMed:12496283, ECO:0000269|PubMed:21518883}.	GO:0002385; GO:0002720; GO:0002879; GO:0004930; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007193; GO:0008289; GO:0014061; GO:0032722; GO:0045776; GO:0046626; GO:0046885; GO:0071398; GO:0090276		9344866; 15057824; 15489334; 12496283; 12711604; 18801738; 19630535; 21518883; 23066016	G-protein coupled receptor 1 family
O14862	AIM2_HUMAN	Interferon-inducible protein AIM2 (Absent in melanoma 2)	AIM2	343	9606			3D-structure;Apoptosis;Cytoplasm;DNA-binding;Immunity;Inflammatory response;Innate immunity;Nucleus;Reference proteome;Tumor suppressor	O14862; Q9ULZ3	TISSUE SPECIFICITY: Expressed in spleen, small intestine, peripheral blood leukocytes, and testis. {ECO:0000269|PubMed:9242382}.	GO:0002218; GO:0002221; GO:0002230; GO:0003690; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006954; GO:0006955; GO:0032088; GO:0032731; GO:0033209; GO:0035458; GO:0042802; GO:0044546; GO:0045087; GO:0050729; GO:0051092; GO:0051607; GO:0070269; GO:0071466; GO:0097169; GO:1904270; GO:2001056		9242382; 14702039; 16710414; 15489334; 15582594; 16432157; 17726700; 19158679; 19158676; 19158675; 20566831; 22046441; 22869553; 22801494; 24531343; 22483801	HIN-200 family
O14863	ZNT4_HUMAN	Zinc transporter 4, ZnT-4 (Solute carrier family 30 member 4)	SLC30A4 ZNT4	429	9606			Endosome;Ion transport;Lysosome;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport;Zinc;Zinc transport	Q8WVV5; Q9NWW5; Q96DZ9-2; O75084; Q9Y5U9; O95214; P42857; I3L0A0; Q8N6R1; Q6XR72; Q9BRI3; Q99726; Q9NV29; Q9H2L4; P01375; O14798; Q96EC8; Q99376		GO:0005385; GO:0005737; GO:0005765; GO:0005770; GO:0005886; GO:0009636; GO:0010043; GO:0016021; GO:0031902; GO:0055069; GO:0061088; GO:0071577		9354792; 14702039; 15489334; 17349999	Cation diffusion facilitator (CDF) transporter (TC 2.A.4) family, SLC30A subfamily
O14867	BACH1_HUMAN	Transcription regulator protein BACH1 (BTB and CNC homolog 1) (HA2303)	BACH1	736	9606			3D-structure;Activator;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	P15336; P35638; O75444; Q9Y5Q3; Q9ULX9; O15525; O60260-5; P40337-2; Q9DGW5		GO:0000083; GO:0000117; GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006355; GO:0006357; GO:0020037; GO:0061418; GO:0090575	PTM: Ubiquitinated by the SCF(FBXL17) complex, leading to its degradation by the proteasome. {ECO:0000269|PubMed:24035498}.	9544839; 9479503; 14702039; 10830953; 15489334; 16964243; 18669648; 23186163; 24035498	BZIP family, CNC subfamily
O14874	BCKD_HUMAN	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial, EC 2.7.11.4 (Branched-chain alpha-ketoacid dehydrogenase kinase, BCKD-kinase, BCKDHKIN)	BCKDK	412	9606		2.7.11.4	Acetylation;Alternative splicing;ATP-binding;Autism;Autism spectrum disorder;Disease variant;Epilepsy;Kinase;Mental retardation;Mitochondrion;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase;Transit peptide	P02549; P40763; PRO_0000037548 [Q9WMX2]; Q8WUW1	TISSUE SPECIFICITY: Ubiquitous.	GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0005947; GO:0006468; GO:0009063; GO:0009083; GO:0010906; GO:0016301; GO:0016310; GO:0045763; GO:0047323	PTM: Autophosphorylated. {ECO:0000269|PubMed:24449431}.	14702039; 15616553; 15489334; 17081983; 18220336; 18691976; 19608861; 20068231; 21406692; 23186163; 24275569; 25944712; 22956686; 24449431	PDK/BCKDK protein kinase family
O14879	IFIT3_HUMAN	Interferon-induced protein with tetratricopeptide repeats 3, IFIT-3 (CIG49) (ISG-60) (Interferon-induced 60 kDa protein, IFI-60K) (Interferon-induced protein with tetratricopeptide repeats 4, IFIT-4) (Retinoic acid-induced gene G protein, P60, RIG-G)	IFIT3 CIG-49 IFI60 IFIT4 ISG60	490	9606			3D-structure;Antiviral defense;Cytoplasm;Immunity;Innate immunity;Mitochondrion;Phosphoprotein;Reference proteome;Repeat;TPR repeat	Q16543; Q92905; Q05D60; Q0P5U8; Q96CS2; P09914; Q5T764; P09913; Q8IZ03; O14879; Q8IXX5; P09493-10; P06753; Q5VU62	TISSUE SPECIFICITY: Expression significantly higher in peripheral blood mononuclear cells (PBMCs) and monocytes from systemic lupus erythematosus (SLE) patients than in those from healthy individuals (at protein level). Spleen, lung, leukocytes, lymph nodes, placenta, bone marrow and fetal liver. {ECO:0000269|PubMed:18706081}.	GO:0003723; GO:0005737; GO:0005739; GO:0005829; GO:0008285; GO:0009615; GO:0035457; GO:0042802; GO:0043066; GO:0045087; GO:0051607		9391139; 9828129; 15489334; 17050680; 18706081; 18691976; 18669648; 20686046; 20068231; 21269460; 21190939; 21813773; 20950130; 21642987; 24275569	IFIT family
O14880	MGST3_HUMAN	Microsomal glutathione S-transferase 3, Microsomal GST-3 (Glutathione peroxidase MGST3, EC 1.11.1.-) (LTC4 synthase MGST3, EC 4.4.1.20) (Microsomal glutathione S-transferase III, Microsomal GST-III)	MGST3	152	9606		1.11.1.-; 4.4.1.20	Endoplasmic reticulum;Lipid metabolism;Lipoprotein;Lyase;Membrane;Microsome;Oxidoreductase;Palmitate;Reference proteome;Transferase;Transmembrane;Transmembrane helix	Q9NRZ5; Q6RW13-2; P05090; Q9BQE5; P29972; Q96PS8; Q92482; Q15041; Q8N6S5; O15155; O95393; Q96F05; Q06432; P24863; O14735; P58418; Q96DZ9-2; Q96BA8; Q9BQA9; Q9UKR5; Q96IV6; Q9BWH2; Q9H0Q3; Q8WWP7; Q96F15; Q8TDT2; Q8TED1; Q14416; P30519; P11215; Q68G75; Q9UBY5; Q7Z4F1; O14880; P30301; Q6IN84; Q9H2K0; Q99519; Q9NZG7; Q16617; Q8N912; Q8IXM6; P42857; O75459; P26678; P60201-2; Q04941; Q5VZY2; Q59EV6; O00767; Q9NY72; O75396; P43003; P22732; P78382; Q9NUM3; P30825; Q9NRQ5; Q5SQN1; Q6UX34; Q13277; O15400; Q9UNK0; Q8N2H4; Q00059; P02786; Q6UX40; Q9BVC6; A0PK00; Q9NV12; Q8NBD8; Q9H2L4; Q8N661; Q9Y320; O95859; O60636; Q86UF1; Q5BVD1; Q9Y5Z9; Q53HI1; Q15836; O75379; O95070; O95159	TISSUE SPECIFICITY: Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. {ECO:0000269|PubMed:9278457}.	GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0016020; GO:0016021; GO:0016740; GO:0019370; GO:0042802; GO:0043231		9278457; 14702039; 16710414; 15489334; 21269460; 21044946; 24275569; 25944712	MAPEG family
O14893	GEMI2_HUMAN	Gem-associated protein 2, Gemin-2 (Component of gems 2) (Survival of motor neuron protein-interacting protein 1, SMN-interacting protein 1)	GEMIN2 SIP1	280	9606			3D-structure;Alternative initiation;Alternative splicing;Cytoplasm;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome	Q8N7W2-2; P28358; Q0VD86; O60684; P50221; P26367; P20618; O95059; Q16637; Q16637-2; P62306; Q9NZD8		GO:0000245; GO:0000375; GO:0000387; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0032797; GO:0034719; GO:0097504; GO:1905215		9323129; 11943600; 10909848; 14702039; 15489334; 10500148; 11714716; 16314521; 17178713; 18984161; 18691976; 18669648; 19413330; 21269460; 23022347; 24275569; 26092730; 21816274; 22607171; 31799625	Gemin-2 family
O14894	T4S5_HUMAN	Transmembrane 4 L6 family member 5 (Tetraspan transmembrane protein L6H)	TM4SF5	197	9606			Cell cycle;Cell membrane;Glycoprotein;Lysosome;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q86WK6	TISSUE SPECIFICITY: Intestine. Overexpressed in pancreatic cancers.	GO:0005765; GO:0005886; GO:0005887; GO:0007049; GO:0016021; GO:0034618; GO:2000045		9479038; 15489334; 20399237; 30956113	L6 tetraspanin family
O14896	IRF6_HUMAN	Interferon regulatory factor 6, IRF-6	IRF6	467	9606			Alternative splicing;Cytoplasm;Differentiation;Disease variant;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	Q02556	TISSUE SPECIFICITY: Expressed in normal mammary epithelial cells. Expression is reduced or absent in breast carcinomas. {ECO:0000269|PubMed:16049006}.	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0008285; GO:0030054; GO:0030216; GO:0043565; GO:0043616; GO:0045893; GO:0045944; GO:0048468; GO:0060021; GO:0060173; GO:0060644; GO:0070062; GO:1904888; GO:1990837	PTM: Phosphorylated. Phosphorylation status depends on the cell cycle and is a signal for ubiquitination and proteasome-mediated degradation. {ECO:0000269|PubMed:16049006, ECO:0000269|PubMed:18212048}.	14702039; 16710414; 15489334; 16049006; 18212048; 21269460; 12219090; 12920575; 14640121; 14618417; 15300989; 15317890; 17122170; 18478600; 19036739; 20803643; 21082654; 25691407	IRF family
O14901	KLF11_HUMAN	Krueppel-like factor 11 (Transforming growth factor-beta-inducible early growth response protein 2, TGFB-inducible early growth response protein 2, TIEG-2)	KLF11 FKLF TIEG2	512	9606			Activator;Alternative splicing;Apoptosis;Diabetes mellitus;Disease variant;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	Q96MA6; Q99996-3; Q9NP70; Q6ZTN6-2; Q6LES2; P13928; P05067; Q92624; O94778; Q52LW3-2; Q9Y2Y0; Q8WXK3; Q9Y575-3; Q96DX5-3; Q96FT7-4; Q9UII2; P15313; Q8TBE0; O75934; P54687-4; P06276; Q14457; Q96LC9; Q969J3; Q6PJG6; Q8WUW1; Q9H0W9-3; Q8IVU9; O95503; A0A1B0GWI1; Q9NNX6-10; Q9HCU0; Q9UJX2; Q7Z7K6; Q53EZ4; Q8NHQ1; Q8WUX9; Q6PJW8-3; Q96JB2-2; Q96MW5; Q8NE08; P13073; P24310; Q9BSW2; Q96SW2; Q8IUI8; P53672; Q7L576; Q9NUQ9; Q9UJU6; O75935-2; Q8WTU0; Q14154; Q9UBP4; A0A024RCP2; Q86TI2-2; Q14117; Q9BPU6; Q9H410; A0AVK6; H3BUJ7; Q5JVL4; O00303; Q9UBQ5; Q9Y262; Q969X5; Q6NXG1; Q6NXG1-3; Q6P1L5; Q49AJ0-4; A1KXE4-2; O15287; Q8WVX9; Q9NSA1; Q5TD97; Q9BQS8-2; P06241-3; Q06547-2; Q06547-3; F2Z2M7; P15976-2; Q9BRX5; Q9NS71; Q96IJ6; P51674; Q9H9Y4; Q93077; Q6NXT2; Q96CS2; Q68CZ6; Q99871; P42858; Q8NDH6-2; P80217-2; Q8IY31-2; Q8IY31-3; P08833; P22692; Q14005-2; Q0VD86; Q86VI3; Q8NA54; Q13352; Q96I82; A1A512; Q6ZU52; Q8IV33; Q9BVG8-5; Q6P597; Q9UIH9; P57682; Q13887; Q9Y2M5; Q9UH77; Q96NJ5; Q8N1A0; Q14525; Q15012; Q92615; Q6DKI2; Q96JB6; Q9BV99; Q96LR2; Q9BRK4; Q9UDY8-2; P27338; Q13503; Q14696; Q8N6F8; Q9NYP9; Q9HBH9-2; Q9Y605; Q96HT8; P02795; Q8WY64; I6L9F6; Q8IXH7; Q13562; Q13952-2; Q6PHZ7; Q9NXX6-2; Q7Z3B4; A5D8V7; O43482; Q9BZF3-6; Q96FW1; Q6GQQ9-2; Q9NUU6; Q9ULW8; Q9BPZ3; Q9BR81; P22061-2; O15534; Q99471; Q8IXK0-5; Q9BUL5; P57054; P55347; Q6P1J6-2; Q58EX7-2; Q6P1K2; Q8N490-3; Q6ZMI0-5; P30154-2; A0A0C4DFM3; P35998; Q96QF0-7; P47736; Q15293; Q96EN9; P47804-3; Q9UGC6; Q96EP0; Q15349; P51812; O75676-2; Q9BY12-3; Q96GM5; Q96H20; Q8N0X2-4; Q7Z6I5; Q8IXS7; Q14765; Q9NRP7; O75558; Q8N4C7; P61764; A1L190; O75528; O60907-2; Q9BZK7; Q3YBR2; O15273; Q8N4U5; Q86WV5; Q9BXU0; Q8WTV1; Q8WUU8; Q8IUR5-4; Q12888; Q86WT6-2; Q96A04; Q86WV8; Q99598; O60636; Q6PF05; Q6PID6; O14530; P49459; Q9H347; Q8IYU4; Q16851; Q9NYH9; P45880; P08670; Q9H270; Q8NEZ2; P58304; Q9BRX9; Q86U90; O43829; Q8IWT0-2; Q9H4I2-2; Q96JL9-2; Q9UL40; Q96MN9-2; Q8NBB4-2; O95229; Q2QGD7; A0A384NQ31; B7Z3E8	TISSUE SPECIFICITY: Ubiquitous. Higher expression in erythroid cells. {ECO:0000269|PubMed:10207080}.	GO:0000083; GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006357; GO:0006915; GO:0008285; GO:0016604; GO:0043065; GO:0046872; GO:1901653; GO:1990837		9748269; 10207080; 11087666; 14702039; 15815621; 15489334; 16131492; 23186163; 15774581	Sp1 C2H2-type zinc-finger protein family
O14904	WNT9A_HUMAN	Protein Wnt-9a (Protein Wnt-14)	WNT9A WNT14	365	9606			Developmental protein;Disulfide bond;Extracellular matrix;Glycoprotein;Lipoprotein;Reference proteome;Secreted;Signal;Wnt signaling pathway	O43829		GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0008285; GO:0030182; GO:0032331; GO:0045165; GO:0048018; GO:0060070; GO:0061072; GO:0061303; GO:0071300; GO:0072498	PTM: Palmitoleoylation is required for efficient binding to frizzled receptors. Depalmitoleoylation leads to Wnt signaling pathway inhibition. {ECO:0000250|UniProtKB:P27467, ECO:0000250|UniProtKB:P56704}.	11414706; 16710414; 15489334; 9441749; 26902720	Wnt family
O14905	WNT9B_HUMAN	Protein Wnt-9b (Protein Wnt-14b) (Protein Wnt-15)	WNT9B WNT14B WNT15 UNQ6973/PRO21956	357	9606			Developmental protein;Disulfide bond;Extracellular matrix;Glycoprotein;Lipoprotein;Reference proteome;Secreted;Signal;Wnt signaling pathway		TISSUE SPECIFICITY: Moderately expressed in fetal kidney and adult kidney. Also found in brain.	GO:0001658; GO:0001701; GO:0001932; GO:0003339; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0009267; GO:0009786; GO:0030182; GO:0030539; GO:0032526; GO:0035150; GO:0039706; GO:0043085; GO:0045165; GO:0048018; GO:0048701; GO:0060021; GO:0060070; GO:0060071; GO:0061038; GO:0061303; GO:0071300; GO:0072003; GO:0072038; GO:0072044; GO:0072046; GO:0072174; GO:0072181; GO:1902455; GO:1904948; GO:1905438	PTM: Palmitoleoylation is required for efficient binding to frizzled receptors. Depalmitoleoylation leads to Wnt signaling pathway inhibition. {ECO:0000250|UniProtKB:P27467, ECO:0000250|UniProtKB:P56704}.	11604992; 12975309; 16625196; 9441749; 20093360; 26902720; 27214281	Wnt family
O14907	TX1B3_HUMAN	Tax1-binding protein 3 (Glutaminase-interacting protein 3) (Tax interaction protein 1, TIP-1) (Tax-interacting protein 1)	TAX1BP3 TIP1	124	9606			3D-structure;Acetylation;Cell membrane;Cytoplasm;Membrane;Nucleus;Phosphoprotein;Reference proteome;Wnt signaling pathway	Q96D59; P03126	TISSUE SPECIFICITY: Ubiquitous. Detected in brain, heart, kidney, lung, small intestine and skeletal muscle. Detected in various cell lines including HeLa. Weakly expressed in peripheral blood leukocytes. {ECO:0000269|PubMed:10940294, ECO:0000269|PubMed:16855024, ECO:0000269|PubMed:25645515}.	GO:0001650; GO:0005737; GO:0005829; GO:0005886; GO:0007266; GO:0008013; GO:0008022; GO:0008285; GO:0015629; GO:0016055; GO:0030178; GO:0043231; GO:0070062; GO:0090630; GO:2000009		9482110; 10673275; 11163757; 14702039; 15489334; 10940294; 16855024; 18669648; 20068231; 21269460; 21139582; 22223895; 22814378; 23186163; 19685007; 19635485; 21417405; 21787750; 25645515	
O14908	GIPC1_HUMAN	PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2, TIP-2)	GIPC1 C19orf3 GIPC RGS19IP1	333	9606			Alternative splicing;Congenital muscular dystrophy;Cytoplasm;Dystroglycanopathy;Membrane;Phosphoprotein;Reference proteome	Q9HB19; Q03167; P17643; Q8NC06-3; Q9NP61; Q8TBE0; P20849; Q6NZ36-4; Q96GL9; Q06547-2; Q7LGA3-3; Q14005-2; P57682; Q9Y2M5; Q15759; Q9Y266; Q6P4D5-2; Q8WZ73-3; Q969K3; P48443; Q8N488; Q9BY12-3; Q86SQ7-2; Q2NKQ1-4; O75558; O15273; O60830; Q5VYS8-5; Q9H9P5-5; Q96EF9; Q8WUU4; Q8N0Y2-2	TISSUE SPECIFICITY: Widely expressed (PubMed:9770488). Expressed in skeletal muscle (at protein level) (PubMed:32413282). {ECO:0000269|PubMed:32413282, ECO:0000269|PubMed:9770488}.	GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005938; GO:0006605; GO:0007186; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0045296; GO:0048023; GO:0048167; GO:0070062; GO:0098685; GO:0098761; GO:0098978; GO:2000300		9770488; 14702039; 15057824; 15489334; 9482110; 21269460; 21406692; 23186163; 24275569; 32413282	GIPC family
O14910	LIN7A_HUMAN	Protein lin-7 homolog A, Lin-7A, hLin-7 (Mammalian lin-seven protein 1, MALS-1) (Tax interaction protein 33, TIP-33) (Vertebrate lin-7 homolog 1, Veli-1)	LIN7A MALS1 VELI1	233	9606			Cell junction;Cell membrane;Exocytosis;Membrane;Postsynaptic cell membrane;Protein transport;Reference proteome;Synapse;Tight junction;Transport	O14936; O14936-4; Q9H2X0; Q16610; Q8IZU0; Q08379; Q99750; Q14168-2; Q14168-4; Q13368; Q5T2T1; Q7Z3S9; Q8N3R9; Q9NZW5; Q15942	TISSUE SPECIFICITY: Expressed in brain, testis, kidney, placenta and liver. {ECO:0000269|PubMed:11311936}.	GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0015031; GO:0016323; GO:0045199; GO:0045202; GO:0048489; GO:0048839; GO:0065003; GO:0070062; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361		9753324; 10341223; 14702039; 15489334; 9482110; 11311936; 12967566; 17237226	Lin-7 family
O14917	PCD17_HUMAN	Protocadherin-17 (Protocadherin-68)	PCDH17 PCDH68 PCH68	1159	9606			3D-structure;Alternative splicing;Calcium;Cell adhesion;Cell membrane;Glycoprotein;Membrane;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	Q9Y3Q8; Q8IY57-5		GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030534; GO:0050805; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099560; GO:1904071; GO:2000807		14702039; 15057823; 15489334; 17978184	
O14920	IKKB_HUMAN	Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B-kinase beta, IKK-B, IKK-beta, IkBKB, EC 2.7.11.10 (I-kappa-B kinase 2, IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta, NFKBIKB) (Serine/threonine protein kinase IKBKB, EC 2.7.11.1)	IKBKB IKKB	756	9606		2.7.11.1; 2.7.11.10	3D-structure;Acetylation;Alternative splicing;ATP-binding;Cytoplasm;Direct protein sequencing;Disease variant;Host-virus interaction;Hydroxylation;Isopeptide bond;Kinase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;S-nitrosylation;SCID;Serine/threonine-protein kinase;Transferase;Ubl conjugation	O14965; Q16543; O15111; O14920; Q9Y6K9; Q14145; Q99558; O43318; Q9Y6Q9; P19838; P25963; P67775; Q04206; P23396; Q9UGK3; Q9UKE5; P04637; Q92574; P03230; P0DTC9; P03409; P24772; Q5D1E7; Q8WXH2	TISSUE SPECIFICITY: Highly expressed in heart, placenta, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis and peripheral blood.	GO:0002223; GO:0002479; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0008384; GO:0008385; GO:0009615; GO:0009898; GO:0010803; GO:0018105; GO:0019901; GO:0030866; GO:0033209; GO:0035509; GO:0035631; GO:0038095; GO:0042325; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0045121; GO:0045893; GO:0045944; GO:0046982; GO:0050852; GO:0051092; GO:0051403; GO:0070498; GO:0071356; GO:0072659; GO:0097110; GO:0106310; GO:1903140; GO:1903347; GO:1990459	PTM: Upon cytokine stimulation, phosphorylated on Ser-177 and Ser-181 by MEKK1 and/or MAP3K14/NIK as well as TBK1 and PRKCZ; which enhances activity. Once activated, autophosphorylates on the C-terminal serine cluster; which decreases activity and prevents prolonged activation of the inflammatory response. Phosphorylated by the IKK-related kinases TBK1 and IKBKE, which is associated with reduced CHUK/IKKA and IKBKB activity and NF-kappa-B-dependent gene transcription. Dephosphorylated at Ser-177 and Ser-181 by PPM1A and PPM1B. {ECO:0000269|PubMed:10022904, ECO:0000269|PubMed:10195894, ECO:0000269|PubMed:10783893, ECO:0000269|PubMed:16207722}.; PTM: (Microbial infection) Acetylation of Thr-180 by Yersinia YopJ prevents phosphorylation and activation, thus blocking the I-kappa-B pathway. {ECO:0000269|PubMed:16728640, ECO:0000269|PubMed:17116858}.; PTM: Ubiquitinated. Monoubiquitination involves TRIM21 that leads to inhibition of Tax-induced NF-kappa-B signaling. According to PubMed:19675099, 'Ser-163' does not serve as a monoubiquitination site. According to PubMed:16267042, ubiquitination on 'Ser-163' modulates phosphorylation on C-terminal serine residues. {ECO:0000269|PubMed:16267042, ECO:0000269|PubMed:19675099}.; PTM: (Microbial infection) Monoubiquitination by TRIM21 is disrupted by Yersinia YopJ. {ECO:0000269|PubMed:19675099}.; PTM: Hydroxylated by PHD1/EGLN2, loss of hydroxylation under hypoxic conditions results in activation of NF-kappa-B. {ECO:0000269|PubMed:17114296}.	9346484; 9346485; 9813230; 9763654; 14702039; 16421571; 15489334; 17116858; 9819420; 9751059; 10356400; 10022904; 10195894; 10848580; 10783893; 11297557; 12133833; 11971985; 12612076; 15084260; 14739303; 15456791; 15173580; 15184672; 15951441; 16207722; 16267042; 16177806; 17114296; 16728640; 16497931; 17287217; 17684021; 17213322; 10712233; 18626576; 18691976; 18669648; 19413330; 19716809; 18930133; 19369195; 19690332; 20434986; 19675099; 20410276; 20797629; 20068231; 21269460; 21138416; 23091055; 23453969; 23776175; 23186163; 23090968; 24369075; 24275569; 25326418; 26334375; 25944712; 26296658; 26101251; 27426725; 29748387; 30337470; 31434731; 32935379; 18462684; 16959974; 17344846	Protein kinase superfamily, Ser/Thr protein kinase family, I-kappa-B kinase subfamily
O14924	RGS12_HUMAN	Regulator of G-protein signaling 12, RGS12	RGS12	1447	9606			3D-structure;Alternative splicing;Cell junction;Cell projection;Cytoplasm;GTPase activation;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Signal transduction inhibitor;Synapse;Transcription;Ubl conjugation	Q8IYS1	TISSUE SPECIFICITY: Isoform 3 is brain specific.	GO:0000794; GO:0003924; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0016363; GO:0030425; GO:0030695; GO:0045202		10869340; 9651375; 14702039; 15815621; 15489334; 12024043; 17525332; 18434541; 24129315; 28112733	
O14925	TIM23_HUMAN	Mitochondrial import inner membrane translocase subunit Tim23	TIMM23 TIM23	209	9606			Membrane;Mitochondrion;Mitochondrion inner membrane;Protein transport;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport	Q13520; Q96BA8; Q15125; Q96KR6; Q14802-3; Q6ZVE7; Q7Z5P4; Q8N5M9; P13473-2; Q6P5S7; Q9NY72; Q9Y371; O60669; O60830; Q9BVV7; Q96MV1; Q9NUH8; Q8N661; Q6PEY1; P19075		GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0006626; GO:0006886; GO:0008320; GO:0030150; GO:0031305		10339406; 15164054; 15489334; 15044455; 23263864; 25997101; 25944712	Tim17/Tim22/Tim23 family
O14926	FSCN2_HUMAN	Fascin-2 (Retinal fascin)	FSCN2	492	9606			Actin-binding;Alternative splicing;Cell projection;Cytoplasm;Cytoskeleton;Reference proteome;Retinitis pigmentosa	Q92993; Q8TAP4-4; P17252; Q15047-2; P61981	TISSUE SPECIFICITY: Localized specifically in the outer and inner segments of the photoreceptor cells in the retina.	GO:0003779; GO:0005737; GO:0007163; GO:0007601; GO:0009653; GO:0015629; GO:0016477; GO:0030036; GO:0030674; GO:0032420; GO:0042462; GO:0051015; GO:0051017		10234509; 10783262; 16625196; 15489334; 10892848; 11527955	Fascin family
O14929	HAT1_HUMAN	Histone acetyltransferase type B catalytic subunit, EC 2.3.1.48 (Histone acetyltransferase 1)	HAT1 KAT1	419	9606		2.3.1.48	3D-structure;Acetylation;Acyltransferase;Alternative splicing;Cytoplasm;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transferase	P62805; Q5T7N3; P50222; Q6FHY5; Q5VZ52; Q09028; Q04864; Q04864-2; Q16533; Q9H5V9; P15884; Q96N21; Q13829; Q96RU7; Q8NAM6; P12520; P50222		GO:0000781; GO:0000785; GO:0004402; GO:0005634; GO:0005654; GO:0005739; GO:0006323; GO:0006335; GO:0006336; GO:0006475; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043967	PTM: Phosphorylated by AMPK at Ser-190; phosphorylation increases HAT1 activity. {ECO:0000269|PubMed:28143904}.	9427644; 15815621; 15489334; 11585814; 12841681; 19413330; 20148353; 20953179; 21269460; 22223895; 23653357; 23186163; 28143904; 31695772; 31278053; 32081014; 31812350; 22615379; 16959974	HAT1 family
O14931	NCTR3_HUMAN	Natural cytotoxicity triggering receptor 3 (Activating natural killer receptor p30) (Natural killer cell p30-related protein, NK-p30, NKp30) (CD antigen CD337)	NCR3 1C7 LY117	201	9606			3D-structure;Alternative splicing;Cell membrane;Disulfide bond;Glycoprotein;Immunity;Immunoglobulin domain;Membrane;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix	P46379; Q5JX71; P17931; O14931; Q68D85; P46379-1; P46379-2; P17931	TISSUE SPECIFICITY: Selectively expressed by all resting and activated NK cells and weakly expressed in spleen. {ECO:0000269|PubMed:10562324, ECO:0000269|Ref.2}.	GO:0002429; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0008037; GO:0030101; GO:0042802; GO:0045954		10562324; 10202016; 8824804; 14656967; 14574404; 15489334; 15784725; 18055229; 17208487; 18852879; 19528259; 21422170; 21444796	Natural cytotoxicity receptor (NCR) family
O14933	UB2L6_HUMAN	Ubiquitin/ISG15-conjugating enzyme E2 L6, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme L6) (Retinoic acid-induced gene B protein, RIG-B) (UbcH8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6)	UBE2L6 UBCH8	153	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.	2.3.2.23	3D-structure;Alternative splicing;Direct protein sequencing;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway	O95376; Q8N9I9; P62879; Q99732; Q17RB8; O15344; Q9BYM8; Q7Z419; Q6ZMZ0; Q9NWF9; Q9BVG3; Q9BZR9; Q99PZ6; Q8CJB9	TISSUE SPECIFICITY: Present in natural killer cells (at protein level). {ECO:0000269|PubMed:16709802}.	GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006464; GO:0006511; GO:0031625; GO:0032020; GO:0042296; GO:0043130; GO:0061631	PTM: ISGylated. {ECO:0000269|PubMed:16428300}.	10894956; 14702039; 16554811; 15489334; 9153201; 15131269; 11237715; 16428300; 16427630; 16709802; 20508617; 21269460; 24275569; 19928833	Ubiquitin-conjugating enzyme family
O14936	CSKP_HUMAN	Peripheral plasma membrane protein CASK, hCASK, EC 2.7.11.1 (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog)	CASK LIN2	926	9606		2.7.11.1	3D-structure;Alternative splicing;ATP-binding;Calmodulin-binding;Cell membrane;Cytoplasm;Disease variant;Kinase;Membrane;Mental retardation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Serine/threonine-protein kinase;SH3 domain;Transferase	Q8WXD9; Q12929; P41134; O14910; Q9Y2J0; P34741; Q9H788; Q13425; Q13009; Q63373; Q8WXD9; Q9H1P6; O14910; Q9HAP6; Q9UH92-3; Q9HB63; Q9H788	TISSUE SPECIFICITY: Ubiquitous. Expression is significantly greater in brain relative to kidney, lung, and liver and in fetal brain and kidney relative to lung and liver. {ECO:0000269|PubMed:11003712}.	GO:0001953; GO:0004385; GO:0004674; GO:0004712; GO:0005102; GO:0005516; GO:0005524; GO:0005604; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007155; GO:0010839; GO:0015629; GO:0016323; GO:0016363; GO:0031982; GO:0034613; GO:0042043; GO:0042734; GO:0045944; GO:0046928; GO:0060170; GO:0061045; GO:0070509; GO:0090280; GO:0090288; GO:0098685; GO:0106310; GO:2000300		9660868; 15772651; 15489334; 11003712; 19012874; 23186163; 24275569; 9546224; 18423203; 17344846; 19165920; 19200522; 19377476; 23662938	Protein kinase superfamily, CAMK Ser/Thr protein kinase family, CaMK subfamily; MAGUK family
O14939	PLD2_HUMAN	Phospholipase D2, PLD 2, hPLD2, EC 3.1.4.4 (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2)	PLD2	933	9606		3.1.4.4	3D-structure;Alternative splicing;Cell membrane;Hydrolase;Lipid degradation;Lipid metabolism;Lipoprotein;Membrane;Phosphoprotein;Reference proteome;Repeat	P05067; P23528; P62993; P15153; P13051-2	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9582313}.	GO:0004630; GO:0005789; GO:0005886; GO:0006654; GO:0007010; GO:0007264; GO:0016042; GO:0035091; GO:0036465; GO:0038096; GO:0048017; GO:0048870; GO:0070290; GO:0098793	PTM: Phosphorylated by FGR. {ECO:0000250|UniProtKB:P70498}.	9761774; 9582313; 16625196; 15489334; 11032811; 23186163; 16959974	Phospholipase D family
O14944	EREG_HUMAN	Proepiregulin [Cleaved into: Epiregulin, EPR ]	EREG	169	9606			3D-structure;Angiogenesis;Cell membrane;Developmental protein;Differentiation;Disulfide bond;EGF-like domain;Glycoprotein;Growth factor;Membrane;Mitogen;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix	Q07325; P00533; Q5J8X5; Q9NZG7; Q6UX06	TISSUE SPECIFICITY: In normal adults, expressed predominantly in the placenta and peripheral blood leukocytes. High levels were detected in carcinomas of the bladder, lung, kidney and colon. {ECO:0000269|PubMed:9337852}.	GO:0001525; GO:0001550; GO:0001556; GO:0001819; GO:0005154; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0007143; GO:0007173; GO:0007267; GO:0008083; GO:0008284; GO:0008285; GO:0009299; GO:0009653; GO:0009887; GO:0019221; GO:0030216; GO:0030297; GO:0030669; GO:0030728; GO:0032755; GO:0038134; GO:0038135; GO:0038138; GO:0042060; GO:0042327; GO:0042700; GO:0043434; GO:0043616; GO:0045089; GO:0045740; GO:0045741; GO:0045840; GO:0045860; GO:0045892; GO:0048018; GO:0048146; GO:0048160; GO:0048661; GO:0050680; GO:0051151; GO:0051781		9337852; 14702039; 15489334; 9419975; 14572630; 24631357; 16959974	
O14948	TFEC_HUMAN	Transcription factor EC, TFE-C (Class E basic helix-loop-helix protein 34, bHLHe34) (Transcription factor EC-like, hTFEC-L)	TFEC BHLHE34 TCFEC TFECL	347	9606			Activator;Alternative splicing;DNA-binding;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation	Q9H1M4; Q9H115; Q9UBY5; Q9NRQ5	TISSUE SPECIFICITY: Expressed moderately in spleen, kidney, bone marrow, small intestine and leukocytes. Expressed weakly in testis, trachea and colon. {ECO:0000269|PubMed:11467950, ECO:0000269|PubMed:15118077}.	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0034605; GO:0045944; GO:0046983; GO:1990837		9256061; 14702039; 17974005; 12690205; 15489334; 15118077; 11467950; 16959974	MiT/TFE family
O14949	QCR8_HUMAN	Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C)	UQCRQ	82	9606			3D-structure;Acetylation;Direct protein sequencing;Disease variant;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport			GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0021539; GO:0021548; GO:0021680; GO:0021766; GO:0021794; GO:0021854; GO:0021860; GO:0030901; GO:0045333		15489334; 8592474; 21269460; 23186163; 25944712; 28844695; 18439546	UQCRQ/QCR8 family
O14950	ML12B_HUMAN	Myosin regulatory light chain 12B (MLC-2A, MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa, MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)	MYL12B MRLC2 MYLC2B	172	9606			Calcium;Metal-binding;Motor protein;Muscle protein;Myosin;Phosphoprotein;Reference proteome;Repeat	P60709; P35749; Q6X4W1-2	TISSUE SPECIFICITY: Ubiquitously expressed in various hematopoietic cells. {ECO:0000269|PubMed:11436981, ECO:0000269|PubMed:18480596}.	GO:0001725; GO:0005509; GO:0005737; GO:0005829; GO:0005903; GO:0005938; GO:0008360; GO:0016460; GO:0030016; GO:0030018; GO:0032036; GO:0045177; GO:0070062	PTM: Phosphorylation increases the actin-activated myosin ATPase activity and thereby regulates the contractile activity. It is required to generate the driving force in the migration of the cells but not necessary for localization of myosin-2 at the leading edge. Phosphorylation is reduced following epigallocatechin-3-O-gallate treatment. {ECO:0000269|PubMed:11942626, ECO:0000269|PubMed:12429016, ECO:0000269|PubMed:15946647, ECO:0000269|PubMed:17126281}.	11942626; 11436981; 14702039; 15489334; 10965042; 12429016; 12589046; 15946647; 17126281; 18480596; 24275569	
O14957	QCR10_HUMAN	Cytochrome b-c1 complex subunit 10 (Complex III subunit 10) (Complex III subunit XI) (Ubiquinol-cytochrome c reductase complex 6.4 kDa protein)	UQCR11 UQCR	56	9606			3D-structure;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport			GO:0005743; GO:0005750; GO:0006091; GO:0006122; GO:0009055; GO:0045333		9161705; 14702039; 15057824; 15489334; 28844695	UQCR11/QCR10 family
O14958	CASQ2_HUMAN	Calsequestrin-2 (Calsequestrin, cardiac muscle isoform)	CASQ2	399	9606			3D-structure;Alternative splicing;Calcium;Disease variant;Glycoprotein;Metal-binding;Muscle protein;Phosphoprotein;Reference proteome;Sarcoplasmic reticulum;Signal	Q13895		GO:0002027; GO:0005509; GO:0005513; GO:0005737; GO:0006874; GO:0006941; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016529; GO:0030018; GO:0033017; GO:0033018; GO:0034704; GO:0042803; GO:0043267; GO:0048306; GO:0051208; GO:0051258; GO:0051279; GO:0060048; GO:0060306; GO:0060315; GO:0071313; GO:0086029; GO:0140314; GO:1901017	PTM: Phosphorylation in the C-terminus, probably by CK2, moderately increases calcium buffering capacity. {ECO:0000269|PubMed:21416293}.; PTM: N-glycosylated. {ECO:0000269|PubMed:15485681}.	14702039; 16710414; 15489334; 18669648; 21416293; 17881003; 11704930; 14571276; 15485681; 16908766; 18399795; 27157848	Calsequestrin family
O14960	LECT2_HUMAN	Leukocyte cell-derived chemotaxin-2, LECT-2, hLECT2	LECT2	151	9606			3D-structure;Chemotaxis;Cytoplasm;Disulfide bond;Metal-binding;Reference proteome;Secreted;Signal;Zinc	O14960	TISSUE SPECIFICITY: Highly expressed in adult and fetal liver and weakly in testis. Not expressed in bone marrow. {ECO:0000269|PubMed:9524238, ECO:0000269|PubMed:9832057}.	GO:0001501; GO:0005615; GO:0005737; GO:0005829; GO:0006935; GO:0042802; GO:0043231; GO:0046872		9524238; 9545637; 9832057; 14702039; 15372022; 15489334; 8877413; 20103838; 27334921	LECT2/MIM-1 family
O14964	HGS_HUMAN	Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110)	HGS HRS	777	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Endosome;Membrane;Metal-binding;Phosphoprotein;Protein transport;Reference proteome;Transport;Ubl conjugation;Zinc;Zinc-finger	Q9NYB9; Q8WXI4-2; Q08043; P18825; Q9ULX6; Q3KP44; Q9BQD7; P53365; Q9H6L4; Q8WXK4-2; Q86V38; Q96PG8; O75934; Q13515; Q6AI39; P78537; Q96GS4; Q9H5F2; Q6P1W5; Q96LM9; Q3SXR2; Q8IW40; A0A1B0GWI1; P30281; Q01850; P40199; Q53EZ4; Q8IYX8-2; Q96MT8-3; Q76N32-2; Q96MW5; O43186; P33240; Q9H0L4; Q9P2B4; Q6BCY4-2; Q15038; Q9H410; Q86UW9; Q8WWB3; Q5JST6; Q9UHF1; O00303; Q86VI1; O00471; Q9UPT5; O00167-2; Q6J272; Q92567-2; Q8N0U4; B7ZLH0; A0A0S2Z4A7; P35555; O94868-3; Q5HY92; Q9BVV2; Q9NU39; Q12951-2; A1L4K1; O95954; O43716; Q08379; A6NEM1; Q2TAP0; O95843; P54257; Q96CS2; P52272; Q9ULV5-2; Q96LI6; Q8NDH6-2; P05015; Q96LB3-2; Q8WYH8; Q96HW7; Q96HW7-2; Q8TEX9; Q96AA8; P0C870; Q2KHM9; Q8IV33; O43474; P13646; P02533; P19012; P08779; P05783; P08727; Q2M2I5; Q7Z3Z0; Q7Z3Y9; Q7Z3Y8; P12035; Q15323; Q14525; O76011; Q92764; O76013-2; O76014; O76015; Q6A163; Q6A162; P02538; O95678; Q01546; Q9NSB4; O43790; Q3LI72; Q6PEX3; Q8IUC3; Q14847-2; O95751; Q99732; P25800; P61968; Q9BV99; Q96LR2; O15481; Q9Y5V3; Q8NDC0; Q13503; Q15528-2; Q71SY5; Q96HR3; Q9NPJ6; O43513; Q99687-3; Q8N6F8; A9UHW6; A9UHW6-2; Q13064; Q96HT8; Q6IA69; O14777; O96000; I6L9F6; P35240-4; Q13952-2; Q13287; Q7Z3B4; P37198; Q96M63; A1E959; O43482; Q7Z4N8; Q02548; P26367; Q9UBV8; Q96KN3; O15496; Q9HDD0; P51178; Q96CS7; Q7Z3K3; Q16633; P78424; Q7Z5V6-2; Q9Y5P8; P85299-2; A5LHX3; P28070; Q9H2L5; P35250-2; Q8HWS3; P78317; Q96P16-3; Q2I0M5; Q01196-8; Q5SSQ6-2; P09683; P20132; Q9UGK8; Q9UJW9; Q12824-2; Q8NCR6; Q9UNH6; O60504; Q7Z6I5; Q9HBM1; Q8WWL2-2; O75177-5; Q92783; Q92783-1; Q92783-2; Q86UX6; Q9NZ72; O75558; P63165; O75478; O75478-2; O60806; Q8N4U5; Q969V4; Q96M29; Q92734; Q9Y5J6; Q08117-2; Q12888; Q13077; Q9BUZ4; Q9UDY6-2; Q9Y577; P36406; P14373; Q9BYV2; Q86WT6-2; Q86UV6-2; Q8N7C3; Q99816; Q99816-1; Q5T6F2; Q7KZS0; Q9UHD9; Q8IYU4; Q5T124-6; Q8N6Y0; Q70EL1-9; A8MV65-2; Q9H9H4; A5D8V6; Q8N1B4; Q2NKJ9; M0R160; A0A1U9X8X8; Q7TLC7; Q6NRD3; P03410; P14079; P0CG53; P62990; P35240-1; P35240-3	TISSUE SPECIFICITY: Ubiquitous expression in adult and fetal tissues with higher expression in testis and peripheral blood leukocytes. {ECO:0000269|PubMed:9407053, ECO:0000269|PubMed:9630564}.	GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0008285; GO:0010324; GO:0010628; GO:0010642; GO:0016197; GO:0016236; GO:0016525; GO:0019904; GO:0030948; GO:0031901; GO:0032585; GO:0033565; GO:0035091; GO:0036258; GO:0042176; GO:0043130; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0070062; GO:0072657; GO:0097013; GO:1903543	PTM: Phosphorylated on Tyr-334. A minor site of phosphorylation on Tyr-329 is detected (By similarity). Phosphorylation occurs in response to EGF, IL-2, GM-CSF and HGF. {ECO:0000250|UniProtKB:Q99LI8}.; PTM: Ubiquitinated (PubMed:25588945). Ubiquitinated by ITCH (PubMed:14602072, PubMed:24790097). {ECO:0000269|PubMed:14602072, ECO:0000269|PubMed:24790097, ECO:0000269|PubMed:25588945}.	9407053; 9630564; 10861283; 15489334; 9252367; 14602072; 12551915; 12900394; 15509564; 16159959; 15592455; 16964243; 18675823; 15772161; 18669648; 19413330; 19296456; 19608861; 20068231; 21269460; 23166352; 23236378; 23208550; 24275569; 24790097; 25588945; 16462748; 19278655; 21070952; 18987736	
O14965	AURKA_HUMAN	Aurora kinase A, EC 2.7.11.1 (Aurora 2) (Aurora/IPL1-related kinase 1, ARK-1, Aurora-related kinase 1, hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)	AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6	403	9606		2.7.11.1	3D-structure;ATP-binding;Cell cycle;Cell division;Cell projection;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Isopeptide bond;Kinase;Microtubule;Mitosis;Nucleotide-binding;Phosphoprotein;Proto-oncogene;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	Q9NWT8; O15392; P00533; P61978; Q13123; O14920; Q9NQS7; Q9NQS7-1; P04198; P06748; P53350; P23468; Q96R06; O15350; Q9ULW0; Q8VDQ8	TISSUE SPECIFICITY: Highly expressed in testis and weakly in skeletal muscle, thymus and spleen. Also highly expressed in colon, ovarian, prostate, neuroblastoma, breast and cervical cancer cell lines.	GO:0000086; GO:0000278; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005929; GO:0006468; GO:0007051; GO:0007052; GO:0007057; GO:0007100; GO:0009611; GO:0009948; GO:0010389; GO:0010629; GO:0015630; GO:0018105; GO:0019901; GO:0030496; GO:0031616; GO:0031625; GO:0031647; GO:0032091; GO:0032133; GO:0032436; GO:0032465; GO:0035174; GO:0042585; GO:0043066; GO:0043203; GO:0045120; GO:0045840; GO:0046605; GO:0046777; GO:0046982; GO:0048471; GO:0051233; GO:0051301; GO:0051642; GO:0071539; GO:0072686; GO:0072687; GO:0090141; GO:0097421; GO:0097431; GO:0106310; GO:1900195; GO:1901796; GO:1990138	PTM: Activated by phosphorylation at Thr-288; this brings about a change in the conformation of the activation segment. Phosphorylation at Thr-288 varies during the cell cycle and is highest during M phase. Autophosphorylated at Thr-288 upon TPX2 binding. Thr-288 can be phosphorylated by several kinases, including PAK and PKA. Protein phosphatase type 1 (PP1) binds AURKA and inhibits its activity by dephosphorylating Thr-288 during mitosis. Phosphorylation at Ser-342 decreases the kinase activity. PPP2CA controls degradation by dephosphorylating Ser-51 at the end of mitosis. {ECO:0000269|PubMed:11039908, ECO:0000269|PubMed:11551964, ECO:0000269|PubMed:12390251, ECO:0000269|PubMed:13678582, ECO:0000269|PubMed:14580337, ECO:0000269|PubMed:16246726, ECO:0000269|PubMed:17229885, ECO:0000269|PubMed:18662907, ECO:0000269|PubMed:19668197}.; PTM: Ubiquitinated by the E3 ubiquitin-protein ligase complex SCF(FBXL7) during mitosis, leading to its degradation by the proteasome (By similarity). Ubiquitinated by CHFR, leading to its degradation by the proteasome (By similarity). Ubiquitinated by the anaphase-promoting complex (APC), leading to its degradation by the proteasome (PubMed:10851084, PubMed:11039908). Ubiquitinated by the CUL3-KLHL18 ligase leading to its activation at the centrosome which is required for initiating mitotic entry (PubMed:23213400). Ubiquitination mediated by CUL3-KLHL18 ligase does not lead to its degradation by the proteasome (PubMed:23213400). {ECO:0000250|UniProtKB:P97477, ECO:0000269|PubMed:10851084, ECO:0000269|PubMed:11039908, ECO:0000269|PubMed:23213400}.	9153231; 9514916; 9771714; 11780052; 15489334; 9606188; 10851084; 11039908; 11551964; 12576638; 12390251; 11790771; 13678582; 14523000; 14603251; 15147269; 14990569; 26341884; 15128871; 14702041; 15966895; 16246726; 15987997; 16890155; 18056443; 17604723; 17488622; 17229885; 17726514; 17360485; 18691976; 18615013; 19812038; 19351716; 19668197; 19357306; 20643351; 20596670; 20460379; 21269460; 21225229; 14625535; 19774610; 22014574; 21242313; 23213400; 22753416; 25657325; 25986610; 27335426; 28112733; 28218735; 30538148; 12237287; 12467573; 14580337; 16337122; 17125279; 18662907; 19801554; 19140666; 19402633; 27837025; 15867347; 16011022; 16762494; 17344846; 26246606	Protein kinase superfamily, Ser/Thr protein kinase family, Aurora subfamily
O14966	RAB7L_HUMAN	Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29)	RAB29 RAB7L1	203	9606			3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Cytoskeleton;Differentiation;Golgi apparatus;GTP-binding;Lipoprotein;Membrane;Nucleotide-binding;Phosphoprotein;Prenylation;Protein transport;Reference proteome;Transport;Vacuole	O95751; Q5S007; Q04864-2; P14373; Q13049	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:24788816}.	GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0032438; GO:0039694; GO:0042110; GO:0042147; GO:0042470; GO:0043231; GO:0048471; GO:0050862; GO:0055037; GO:0070062; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1901214; GO:1901998; GO:1903441; GO:1905279	PTM: In case of Salmonella enterica serovar Typhimurium (S.Typhimurium) infection, is proteolytically cleaved between Gly-41 and Val-42 by the GtgE viral protease encoded on the Gifsy-2 lysogen bacteriophage, which therefore prevents the recruitment of RAB29 to S.Typhimurium-containing vacuoles. In contrast, no proteolytically cleavage is detected in S.Typhi-infected cells (PubMed:22042847). {ECO:0000269|PubMed:22042847}.	9284931; 14702039; 16710414; 15489334; 18669648; 20068231; 22042847; 24788816; 29212815	Small GTPase superfamily, Rab family
O14967	CLGN_HUMAN	Calmegin	CLGN	610	9606			Acetylation;Alternative splicing;Calcium;Chaperone;Disulfide bond;Endoplasmic reticulum;Membrane;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Detected in testis (at protein level). Detected in testis. {ECO:0000269|PubMed:9434179}.	GO:0005509; GO:0005783; GO:0005789; GO:0006457; GO:0007338; GO:0007339; GO:0016021; GO:0030433; GO:0044183; GO:0051082; GO:0065003		9434179; 14702039; 15489334; 17081983; 17507649; 21269460	Calreticulin family
O14972	VP26C_HUMAN	Vacuolar protein sorting-associated protein 26C (Down syndrome critical region protein 3) (Down syndrome critical region protein A)	VPS26C DCRA DSCR3 DSCRA	297	9606			Alternative splicing;Endosome;Reference proteome	Q13191; Q9NUI1; Q0VD86; Q5T3J3; O15151; A8MW99; Q6FHY5; Q16825; Q96DA2; Q96N21; P23025; Q8N720	TISSUE SPECIFICITY: Ubiquitously expressed.	GO:0005634; GO:0005768; GO:0006886; GO:0032456		9399594; 14702039; 10830953; 15489334; 28892079	VPS26 family
O14974	MYPT1_HUMAN	Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1, Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit)	PPP1R12A MBS MYPT1	1030	9606			3D-structure;Alternative splicing;ANK repeat;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease variant;Hydroxylation;Phosphoprotein;Reference proteome;Repeat	Q9UBB4; O43293; P01100; O18734	TISSUE SPECIFICITY: Expressed in striated muscles, specifically in type 2a fibers (at protein level). {ECO:0000269|PubMed:20634291}.	GO:0000278; GO:0000776; GO:0004857; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0006470; GO:0007098; GO:0007165; GO:0015629; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0035508; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0071466; GO:0071889; GO:0072357	PTM: Phosphorylated by CIT (Rho-associated kinase) (By similarity). Phosphorylated cooperatively by ROCK1 and CDC42BP on Thr-696. Phosphorylated on upon DNA damage, probably by ATM or ATR. In vitro, phosphorylation of Ser-695 by PKA and PKG appears to prevent phosphorylation of the inhibitory site Thr-696, probably mediated by PRKG1. Phosphorylation at Ser-445, Ser-472 and Ser-910 by NUAK1 promotes interaction with 14-3-3, leading to inhibit interaction with myosin light chain MLC2, preventing dephosphorylation of MLC2. May be phosphorylated at Thr-696 by DMPK; may inhibit the myosin phosphatase activity. Phosphorylated at Ser-473 by CDK1 during mitosis, creating docking sites for the POLO box domains of PLK1. Subsequently, PLK1 binds and phosphorylates PPP1R12A. {ECO:0000250, ECO:0000269|PubMed:10567269, ECO:0000269|PubMed:11283607, ECO:0000269|PubMed:11287000, ECO:0000269|PubMed:11331307, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:12773565, ECO:0000269|PubMed:15194681, ECO:0000269|PubMed:15723050, ECO:0000269|PubMed:17126281, ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:19701943, ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:20354225, ECO:0000269|PubMed:21457715}.	9286714; 14702039; 16541075; 15489334; 11342221; 19245366; 10567269; 11287000; 11067852; 11331307; 11283607; 11719507; 12873707; 12923170; 12773565; 15144186; 15194681; 15723050; 17126281; 17081983; 16417406; 17904578; 18477460; 18782776; 19367720; 18088087; 18669648; 19413330; 19131646; 19997641; 19690332; 20354225; 20634291; 20068231; 21269460; 21457715; 21406692; 22814378; 23186163; 24275569; 31883643; 19701943	
O14975	S27A2_HUMAN	Very long-chain acyl-CoA synthetase, VLACS, VLCS, EC 6.2.1.- (Arachidonate--CoA ligase, EC 6.2.1.15) (Fatty acid transport protein 2, FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase, EC 6.2.1.3) (Phytanate--CoA ligase, EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase, EC 6.2.1.7) (Very long-chain-fatty-acid-CoA ligase)	SLC27A2 ACSVL1 FACVL1 FATP2 VLACS	620	9606		6.2.1.-; 6.2.1.15; 6.2.1.24; 6.2.1.3; 6.2.1.7	Acetylation;Alternative splicing;ATP-binding;Cell membrane;Endoplasmic reticulum;Fatty acid metabolism;Ligase;Lipid metabolism;Membrane;Microsome;Nucleotide-binding;Peroxisome;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in liver, kidney, placenta and pancreas. {ECO:0000269|PubMed:10198260, ECO:0000269|PubMed:21768100, ECO:0000269|PubMed:24269233}.	GO:0001561; GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005778; GO:0005779; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006635; GO:0006699; GO:0015245; GO:0019899; GO:0030176; GO:0031957; GO:0035579; GO:0042760; GO:0044539; GO:0047676; GO:0047747; GO:0050197; GO:0070062; GO:0070251; GO:0097089		10198260; 14702039; 16572171; 15489334; 10640429; 10749848; 11980911; 18669648; 20530735; 20068231; 21269460; 21768100; 24269233; 23186163; 24275569	ATP-dependent AMP-binding enzyme family
O14976	GAK_HUMAN	Cyclin-G-associated kinase, EC 2.7.11.1	GAK	1311	9606		2.7.11.1	3D-structure;Acetylation;Alternative splicing;ATP-binding;Cell cycle;Cell junction;Cytoplasm;Golgi apparatus;Kinase;Methylation;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase	Q9NQ11; P11142; Q5S007	TISSUE SPECIFICITY: Ubiquitous. Highest in testis.	GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006898; GO:0007029; GO:0007030; GO:0007049; GO:0010977; GO:0016020; GO:0016191; GO:0030276; GO:0030332; GO:0031982; GO:0034067; GO:0043231; GO:0048471; GO:0051085; GO:0051087; GO:0072318; GO:0072583; GO:0072659; GO:0090160; GO:0098793; GO:0106310; GO:1905224		9299234; 15489334; 10625686; 18691976; 18669648; 19413330; 19369195; 19690332; 21269460; 21406692; 23186163; 24275569; 17344846	Protein kinase superfamily, Ser/Thr protein kinase family
O14977	AZIN1_HUMAN	Antizyme inhibitor 1, AZI, AZI1 (Ornithine decarboxylase antizyme inhibitor)	AZIN1 OAZI OAZIN	448	9606			3D-structure;Nucleus;Polyamine biosynthesis;Reference proteome;Ubl conjugation	O00327-8; Q9UMX2; Q9UMX2-2	TISSUE SPECIFICITY: Expressed in liver. {ECO:0000269|PubMed:9349715}.	GO:0004586; GO:0005634; GO:0005737; GO:0005829; GO:0033387; GO:0042177; GO:0042978; GO:1902269	PTM: Ubiquitinated, leading to its proteasomal degradation; a process that is reduced in presence of antizyme OAZ1. {ECO:0000269|PubMed:17900240}.	9349715; 16421571; 15489334; 17900240; 26305948	Orn/Lys/Arg decarboxylase class-II family, ODC antizyme inhibitor subfamily
O14978	ZN263_HUMAN	Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12)	ZNF263 FPM315 ZKSCAN12	683	9606			DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	P49760; P49761; Q9NWQ4; Q9NWQ4-1; Q96AA8; Q8TBB1; O60437; P57086; Q9Y4C2; Q8WV44; P49910; P10073	TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and leukocyte. {ECO:0000269|PubMed:9256059}.	GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0045944; GO:0046872; GO:1990837	PTM: Ubiquitinated, leading to proteasomal degradation. {ECO:0000269|PubMed:32051553}.	9256059; 14702039; 15616553; 15489334; 23186163; 28112733; 32051553; 32277030; 27231705	Krueppel C2H2-type zinc-finger protein family
O14979	HNRDL_HUMAN	Heterogeneous nuclear ribonucleoprotein D-like, hnRNP D-like, hnRNP DL (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1)	HNRNPDL HNRPDL JKTBP	420	9606			Acetylation;Activator;Alternative splicing;Cytoplasm;Direct protein sequencing;Disease variant;DNA-binding;Isopeptide bond;Limb-girdle muscular dystrophy;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;RNA-binding;Transcription;Transcription regulation;Ubl conjugation	Q15637; P09234; Q13148; O76024	TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and leukocytes. Expressed in myeloid leukemia, gastric adenocarcinoma, cervical carcinoma, hepatoma, fibrosarcoma, colon adenocarcinoma, epidermoid carcinoma, osteosarcoma and urinary bladder carcinoma cells. {ECO:0000269|PubMed:10072754, ECO:0000269|PubMed:9538234}.	GO:0003677; GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008143; GO:0010468; GO:0034046	PTM: Dimethylation of Arg-408 is probably of the asymmetric type.	9538234; 10072754; 11705999; 15815621; 15489334; 15190078; 9524220; 12406575; 17081983; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 23186163; 24647604; 24275569; 24129315; 28112733	
O14980	XPO1_HUMAN	Exportin-1, Exp1 (Chromosome region maintenance 1 protein homolog)	XPO1 CRM1	1071	9606			3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Host-virus interaction;mRNA transport;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;RNA-binding;Transport	O15392; Q08211; P04626; P22736; P35232; P61925; O95149; P04637; P63104; P04618; Q9WMX2	TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, liver, skeletal muscle, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and peripheral blood leukocytes. Not expressed in the kidney. {ECO:0000269|PubMed:9049309, ECO:0000269|PubMed:9368044}.	GO:0000054; GO:0000055; GO:0000056; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0010824; GO:0015030; GO:0016020; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0043231; GO:0046825; GO:0051028; GO:1990904		9049309; 9368044; 14702039; 17974005; 15815621; 15489334; 9323133; 9311922; 9837918; 10209022; 10400785; 10430904; 10358091; 11571268; 11119609; 11425870; 11932251; 12134013; 12724356; 12808100; 14612415; 15507209; 15574332; 15632073; 16103875; 16302269; 16964243; 18316374; 18691976; 18669648; 19608861; 20826784; 20147401; 20921223; 20068231; 21269460; 22022502; 21637748; 22500989; 22084111; 22275354; 22730302; 23164465; 23186163; 24275569; 25944712; 15574331	Exportin family
O14981	BTAF1_HUMAN	TATA-binding protein-associated factor 172, EC 3.6.4.- (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172, TAF-172)	BTAF1 TAF172	1849	9606		3.6.4.-	Alternative splicing;ATP-binding;Direct protein sequencing;DNA-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat			GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0016887; GO:0017025; GO:0035562; GO:0043231; GO:0045892; GO:0140658		9342322; 9488487; 14702039; 15164054; 10642510; 15509807; 21269460; 23186163	SNF2/RAD54 helicase family
O14983	AT2A1_HUMAN	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1, SERCA1, SR Ca(2+)-ATPase 1, EC 7.2.2.10 (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)	ATP2A1	1001	9606		7.2.2.10	Alternative splicing;ATP-binding;Calcium;Calcium transport;Disease variant;Disulfide bond;Endoplasmic reticulum;Ion transport;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Sarcoplasmic reticulum;Translocase;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Skeletal muscle, fast twitch muscle (type II) fibers. {ECO:0000269|PubMed:8825625}.	GO:0005388; GO:0005509; GO:0005524; GO:0005739; GO:0005789; GO:0005793; GO:0006816; GO:0006874; GO:0006942; GO:0008637; GO:0015662; GO:0016020; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031095; GO:0031448; GO:0031673; GO:0031674; GO:0032470; GO:0032471; GO:0033017; GO:0034220; GO:0034704; GO:0034976; GO:0042803; GO:0045988; GO:0048471; GO:0051561; GO:0051659; GO:0070059; GO:0070509; GO:0070588; GO:0090076; GO:0106134; GO:1901896; GO:1902082; GO:1903779; GO:1990036		8825625; 14702039; 15616553; 28890335; 10914677	Cation transport ATPase (P-type) (TC 3.A.3) family, Type IIA subfamily
O14986	PI51B_HUMAN	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta, PIP5K1-beta, PtdIns(4)P-5-kinase 1 beta, EC 2.7.1.68 (Phosphatidylinositol 4-phosphate 5-kinase type I beta, PIP5KIbeta) (Protein STM-7) (Type I phosphatidylinositol 4-phosphate 5-kinase beta)	PIP5K1B STM7	540	9606		2.7.1.68	Alternative splicing;ATP-binding;Cell membrane;Cytoplasm;Kinase;Lipid metabolism;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase		TISSUE SPECIFICITY: Detected in heart, pancreas, brain, kidney, skeletal muscle and lung. {ECO:0000269|PubMed:8955136}.	GO:0000285; GO:0001931; GO:0005524; GO:0005829; GO:0005886; GO:0006661; GO:0012505; GO:0014066; GO:0016308; GO:0046854; GO:0052810; GO:0052812		8841185; 9177790; 14702039; 15164053; 15489334; 8955136; 19369195; 23186163	
O14994	SYN3_HUMAN	Synapsin-3 (Synapsin III)	SYN3	580	9606			3D-structure;ATP-binding;Calcium;Cell junction;Cytoplasmic vesicle;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Synapse		TISSUE SPECIFICITY: Neuron specific. Detected predominantly in brain.	GO:0005524; GO:0007269; GO:0008021; GO:0014069; GO:0030672; GO:0032228; GO:0097091; GO:0098850; GO:0098978	PTM: Phosphorylation at Ser-9 dissociates synapsins from synaptic vesicles. {ECO:0000250}.	9539796; 15461802; 10591208; 15489334; 14732590	Synapsin family
O15013	ARHGA_HUMAN	Rho guanine nucleotide exchange factor 10	ARHGEF10 KIAA0294	1369	9606			Alternative splicing;Coiled coil;Disease variant;Guanine-nucleotide releasing factor;Methylation;Phosphoprotein;Reference proteome	O15066		GO:0005085; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051056; GO:0051298; GO:0051496; GO:0090307; GO:0090630	PTM: Methylated at Gln-1338 by N6AMT1. {ECO:0000269|PubMed:26797129}.	17974005; 9205841; 12168954; 16421571; 15489334; 9314494; 14508709; 18669648; 21406692; 23186163; 26797129; 24627108	
O15014	ZN609_HUMAN	Zinc finger protein 609	ZNF609 KIAA0295	1411	9606			Activator;Alternative splicing;Developmental protein;Isopeptide bond;Metal-binding;Myogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q93009	TISSUE SPECIFICITY: Isoform 1: Expressed in myoblasts and myotubes. Isoform 2: Expressed in myoblasts and myotubes, with a preference in undifferentiated myoblasts. {ECO:0000269|PubMed:28344082}.	GO:0005634; GO:0005654; GO:0006357; GO:0007517; GO:0045944; GO:0046872; GO:1990841; GO:2000291; GO:2001224		16572171; 9205841; 15489334; 17081983; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 25218447; 25921068; 28344082; 28112733	
O15015	ZN646_HUMAN	Zinc finger protein 646	ZNF646 KIAA0296	1832	9606			Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q7Z589; A8MZ59; Q99750; Q13976		GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872		9205841; 15616553; 15489334; 17081983; 23186163; 25218447; 25772364; 25755297; 28112733; 16959974	Krueppel C2H2-type zinc-finger protein family
O15018	PDZD2_HUMAN	PDZ domain-containing protein 2 (Activated in prostate cancer protein) (PDZ domain-containing protein 3) [Cleaved into: Processed PDZ domain-containing protein 2 ]	PDZD2 AIPC KIAA0300 PDZK3	2839	9606			Alternative splicing;Cell adhesion;Cytoplasm;Endoplasmic reticulum;Nucleus;Phosphoprotein;Reference proteome;Repeat;Secreted		TISSUE SPECIFICITY: Isoform 2 is expressed (at protein level) in prostate and many prostate tumors. {ECO:0000269|PubMed:11289102}.	GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0007155; GO:0034451; GO:0043231	PTM: A secreted form is produced by caspase-mediated proteolytic cleavage. {ECO:0000250}.	11289102; 9205841	
O15020	SPTN2_HUMAN	Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)	SPTBN2 KIAA0302 SCA5	2390	9606			3D-structure;Acetylation;Actin capping;Actin-binding;Alternative splicing;Cytoplasm;Cytoskeleton;Disease variant;Neurodegeneration;Phosphoprotein;Reference proteome;Repeat;Spinocerebellar ataxia		TISSUE SPECIFICITY: Highly expressed in brain, kidney, pancreas, and liver, and at lower levels in lung and placenta.	GO:0003779; GO:0005200; GO:0005543; GO:0005615; GO:0005829; GO:0005886; GO:0007416; GO:0008091; GO:0016192; GO:0016324; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099173; GO:0099189		9205841; 16554811; 9826670; 17081983; 18669648; 20068231; 21269460; 21406692; 23236289; 23186163; 23838597; 24275569; 16429157; 16959974; 22914369	Spectrin family
O15021	MAST4_HUMAN	Microtubule-associated serine/threonine-protein kinase 4, EC 2.7.11.1	MAST4 KIAA0303	2623	9606		2.7.11.1	3D-structure;Alternative splicing;ATP-binding;Cytoplasm;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase		TISSUE SPECIFICITY: Highly expressed in most normal human tissues, with an exception of in testis, small intestine, colon and peripheral blood leukocyte. {ECO:0000269|PubMed:17086981}.	GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0007010; GO:0018105; GO:0035556; GO:0106310		17086981; 15372022; 15489334; 14702039; 9205841; 22814378; 23186163; 24275569; 17344846	Protein kinase superfamily, AGC Ser/Thr protein kinase family
O15027	SC16A_HUMAN	Protein transport protein Sec16A (SEC16 homolog A, p250)	SEC16A KIAA0310 SEC16 SEC16L	2357	9606			Alternative splicing;Cytoplasm;Endoplasmic reticulum;ER-Golgi transport;Golgi apparatus;Membrane;Microsome;Phosphoprotein;Protein transport;Reference proteome;Transport	Q96N67; Q5S007; Q6ZNJ1	TISSUE SPECIFICITY: Ubiquitous. Expressed at higher levels in the pancreas. {ECO:0000269|PubMed:17192411}.	GO:0000139; GO:0005789; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0012507; GO:0021762; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070971; GO:0070973; GO:0072659		9205841; 12168954; 15164053; 17192411; 15489334; 17081983; 16964243; 17005010; 17428803; 17924679; 18691976; 18669648; 18318008; 19413330; 19638414; 19369195; 19690332; 20068231; 21269460; 21768384; 22355596; 21406692; 23186163; 24275569; 25201882; 28442536; 28067262; 29300766	SEC16 family
O15031	PLXB2_HUMAN	Plexin-B2 (MM1)	PLXNB2 KIAA0315	1838	9606			3D-structure;Cell membrane;Developmental protein;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	P08581; Q04912; Q92730; P52198; P61587		GO:0001843; GO:0001932; GO:0002116; GO:0005887; GO:0007156; GO:0007162; GO:0007405; GO:0007420; GO:0008360; GO:0009986; GO:0010976; GO:0017154; GO:0030334; GO:0043087; GO:0045727; GO:0050772; GO:0070062; GO:0071526; GO:1902287; GO:1904861; GO:2001222		9205841; 10591208; 15489334; 12183458; 12533544; 15184888; 19159218; 19349973; 21269460; 24275569	Plexin family
O15033	AREL1_HUMAN	Apoptosis-resistant E3 ubiquitin protein ligase 1, EC 2.3.2.26 (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1)	AREL1 KIAA0317	823	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:23479728, ECO:0000269|PubMed:25752577}.	2.3.2.26	3D-structure;Alternative splicing;Apoptosis;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway			GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0043161; GO:0045732; GO:0050727; GO:0061630; GO:0070979; GO:1990390	PTM: Autoubiquitinated in vitro in the presence of E2 enzyme UBE2D1/UBCH5A. {ECO:0000269|PubMed:23479728}.	9205841; 14702039; 12508121; 15489334; 23479728; 25752577; 31578312	
O15040	TCPR2_HUMAN	Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297)	TECPR2 KIAA0297 KIAA0329	1411	9606			Alternative splicing;Autophagy;Hereditary spastic paraplegia;Neurodegeneration;Reference proteome;Repeat;WD repeat	O95166; Q9H0R8; P60520; Q9BXW4	TISSUE SPECIFICITY: Detected in skin fibroblast (at protein level). {ECO:0000269|PubMed:23176824}.	GO:0005737; GO:0006914; GO:0032527		9205841; 12508121; 15489334; 18669648; 20562859; 23176824	WD repeat KIAA0329 family
O15041	SEM3E_HUMAN	Semaphorin-3E	SEMA3E KIAA0331 SEMAH	775	9606			Alternative splicing;Angiogenesis;Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Immunoglobulin domain;Neurogenesis;Reference proteome;Secreted;Signal	Q9Y4D7		GO:0001569; GO:0001755; GO:0001953; GO:0002040; GO:0005576; GO:0005615; GO:0005887; GO:0007411; GO:0008360; GO:0016525; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050808; GO:0050919; GO:0071526; GO:2000249		9205841; 14702039; 12853948; 15235037	Semaphorin family
O15042	SR140_HUMAN	U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140)	U2SURP KIAA0332 SR140	1029	9606			Acetylation;Alternative splicing;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;RNA-binding;Ubl conjugation	P98175; P52756		GO:0003723; GO:0005634; GO:0005654; GO:0006396		16641997; 15489334; 9205841; 12234937; 17081983; 18669648; 19690332; 19608861; 20858735; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25218447; 25755297; 28112733	Splicing factor SR family
O15047	SET1A_HUMAN	Histone-lysine N-methyltransferase SETD1A, EC 2.1.1.364 (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A, hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1)	SETD1A KIAA0339 KMT2F SET1 SET1A	1707	9606		2.1.1.364	3D-structure;Activator;Chromatin regulator;Chromosome;Disease variant;DNA damage;Epilepsy;Mental retardation;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;RNA-binding;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase	Q9UBL3-3; P51610; Q15291; Q93009; Q02248		GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006974; GO:0007420; GO:0008013; GO:0016607; GO:0035097; GO:0042800; GO:0044648; GO:0048188; GO:0051568; GO:0061629; GO:0080182; GO:0097692; GO:1902036; GO:1902275		9205841; 15616553; 15489334; 12670868; 16253997; 17081983; 17355966; 17998332; 18838538; 18669648; 19413330; 19690332; 21269460; 21406692; 23178126; 22843687; 23186163; 23508102; 24275569; 25561738; 29937342; 31197650; 32346159; 22665483; 22266653	Class V-like SAM-binding methyltransferase superfamily
O15049	N4BP3_HUMAN	NEDD4-binding protein 3, N4BP3	N4BP3 KIAA0341	544	9606			Cell projection;Coiled coil;Cytoplasmic vesicle;Developmental protein;Immunity;Innate immunity;Neurogenesis;Phosphoprotein;Reference proteome	Q8IYE0; Q96LX7-5; Q6P9H4; O14595; Q9H0I2; P61968; Q96HA8; P0CG20; P40937; Q9H4P4; Q9BVN2; O00560; Q9NZD8; P57075-2		GO:0007399; GO:0030424; GO:0030425; GO:0031410		9205841; 15489334; 14702039; 11717310; 15324660; 18669648; 23186163; 34880843	N4BP3 family
O15054	KDM6B_HUMAN	Lysine-specific demethylase 6B, EC 1.14.11.68 (JmjC domain-containing protein 3) (Jumonji domain-containing protein 3) (Lysine demethylase 6B) ([histone H3]-trimethyl-L-lysine(27) demethylase 6B)	KDM6B JMJD3 KIAA0346	1643	9606		1.14.11.68	3D-structure;Alternative splicing;Chromatin regulator;Dioxygenase;Disease variant;Inflammatory response;Iron;Isopeptide bond;Mental retardation;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc	P03372		GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0006954; GO:0007507; GO:0008013; GO:0010468; GO:0031490; GO:0032452; GO:0044666; GO:0045165; GO:0045446; GO:0045944; GO:0046872; GO:0048333; GO:0055007; GO:0070301; GO:0071557; GO:0071558; GO:0120162		9205841; 12168954; 16625196; 15489334; 17193924; 17825402; 17851529; 17713478; 18003914; 23186163; 28262558; 28112733; 31124279	UTX family
O15055	PER2_HUMAN	Period circadian protein homolog 2, hPER2 (Circadian clock protein PERIOD 2)	PER2 KIAA0347	1255	9606			3D-structure;Acetylation;Alternative splicing;Biological rhythms;Cytoplasm;Disease variant;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	P48730; P49674; Q14241; Q96PV6; P61968; P40692; J3QSH9; P29590; P11441	TISSUE SPECIFICITY: Widely expressed. Found in heart, brain, placenta, lung, liver, skeleatal muscle, kidney and pancreas. High levels in skeletal muscle and pancreas. Low levels in lung. Isoform 2 is expressed in keratinocytes (at protein level). {ECO:0000269|PubMed:9427249}.	GO:0000122; GO:0000976; GO:0001222; GO:0002931; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005978; GO:0006094; GO:0006631; GO:0007623; GO:0019229; GO:0019249; GO:0031397; GO:0032922; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0048471; GO:0050767; GO:0050796; GO:0050872; GO:0051726; GO:0051946; GO:0070345; GO:0070932; GO:0097167; GO:0120162; GO:2000678	PTM: Acetylated. Deacetylated by SIRT1, resulting in decreased protein stability. Deacetylated by SIRT6, preventing its degradation by the proteasome, resulting in increased protein stability. {ECO:0000250|UniProtKB:O54943}.; PTM: Phosphorylated by CSNK1E and CSNK1D. Phosphorylation results in PER2 protein degradation. May be dephosphorylated by PP1. {ECO:0000269|PubMed:11165242, ECO:0000269|PubMed:11232563}.; PTM: Ubiquitinated, leading to its proteasomal degradation. Ubiquitination may be inhibited by CRY1. {ECO:0000250|UniProtKB:O54943}.	11165242; 9205841; 15815621; 9427249; 14750904; 22274616; 24202686; 23303907; 23916625; 30530698; 11232563; 16959974	
O15056	SYNJ2_HUMAN	Synaptojanin-2, EC 3.1.3.36 (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2)	SYNJ2 KIAA0348	1496	9606		3.1.3.36	3D-structure;Alternative splicing;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Hydrolase;Lipid metabolism;Membrane;Phosphoprotein;Reference proteome;RNA-binding;Synapse	P62993; P16333; Q96B97		GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0005856; GO:0005886; GO:0006661; GO:0007420; GO:0017124; GO:0034596; GO:0042995; GO:0043813; GO:0045121; GO:0046855; GO:0046856; GO:0048471; GO:0048488; GO:0052629; GO:0061024; GO:0098793		11084340; 14574404; 11498538; 9205841; 15489334; 19690332; 21269460; 23186163; 24275569	Synaptojanin family; Inositol 1,4,5-trisphosphate 5-phosphatase family
O15060	ZBT39_HUMAN	Zinc finger and BTB domain-containing protein 39	ZBTB39 KIAA0352	712	9606			DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	P29972; O95995; Q14005-2; O60341; O00444; Q13200; P61956; P55854; Q8N8B7-2; Q8WV44; Q9BZW7		GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872		9205841; 14702039; 15489334; 8358434; 28112733	Krueppel C2H2-type zinc-finger protein family
O15061	SYNEM_HUMAN	Synemin (Desmuslin)	SYNM DMN KIAA0353 SYN	1565	9606			3D-structure;Alternative splicing;Cell junction;Coiled coil;Cytoplasm;Cytoskeleton;Intermediate filament;Methylation;Phosphoprotein;Reference proteome	Q8WZ42	TISSUE SPECIFICITY: Isoform 2 is strongly detected in adult heart, fetal skeletal muscles and fetal heart. Isoform 1 is weakly detected in fetal heart and also in fetal skeletal muscle. Isoform 1 and isoform 2 are detected in adult bladder (at protein level). The mRNA is predominantly expressed in heart and muscle with some expression in brain which may be due to tissue-specific isoforms. {ECO:0000269|PubMed:11353857, ECO:0000269|PubMed:11737198}.	GO:0005200; GO:0005882; GO:0005912; GO:0008307; GO:0017166; GO:0019215; GO:0031443; GO:0042383; GO:0043034; GO:0045104; GO:0045111; GO:0060053		11737198; 11353857; 16572171; 15489334; 9205841; 14552890; 16777071; 17081983; 18028034; 18342854; 18691976; 18669648; 20068231; 23186163; 24275569; 11454237	Intermediate filament family
O15062	ZBTB5_HUMAN	Zinc finger and BTB domain-containing protein 5	ZBTB5 KIAA0354	677	9606			DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	O95429; O43602; O43602-2; Q9NRN9; Q9UH65; O15156; O15156-2		GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872		9205841; 15489334; 19690332; 23186163; 25755297; 28112733	
O15066	KIF3B_HUMAN	Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed ]	KIF3B KIAA0359	747	9606			3D-structure;Acetylation;Alternative splicing;ATP-binding;Cell junction;Cell projection;Ciliopathy;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Microtubule;Motor protein;Nucleotide-binding;Reference proteome;Retinitis pigmentosa;Synapse	O15013; P51795; Q92845		GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0120170; GO:1904115		9205841; 14702039; 11780052; 15489334; 9506951; 18669648; 22814378; 23186163; 27072130; 32386558	TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, Kinesin II subfamily
O15067	PUR4_HUMAN	Phosphoribosylformylglycinamidine synthase, FGAM synthase, FGAMS, EC 6.3.5.3 (Formylglycinamide ribonucleotide amidotransferase, FGAR amidotransferase, FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Phosphoribosylformylglycineamide amidotransferase)	PFAS KIAA0361	1338	9606	PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5-amino-1-(5-phospho-D-ribosyl)imidazole from N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide: step 1/2. {ECO:0000305|PubMed:10548741}.	6.3.5.3	ATP-binding;Cytoplasm;Glutamine amidotransferase;Ligase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Purine biosynthesis;Reference proteome			GO:0004642; GO:0005524; GO:0005829; GO:0006177; GO:0006189; GO:0006541; GO:0009168; GO:0009410; GO:0044208; GO:0046872; GO:0070062; GO:0097065; GO:0097294		10548741; 9205841; 16625196; 15489334; 17081983; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 19413330	FGAMS family
O15068	MCF2L_HUMAN	Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein)	MCF2L KIAA0362 OST	1137	9606			Alternative splicing;Cell membrane;Coiled coil;Cytoplasm;Guanine-nucleotide releasing factor;Lipid-binding;Membrane;Phosphoprotein;Proto-oncogene;Reference proteome;SH3 domain	O76024		GO:0005085; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0012505; GO:0019898; GO:0031234; GO:0035025; GO:0035091; GO:0035556; GO:0051056		15157669; 9205841; 14702039; 15057823; 15489334	MCF2 family
O15072	ATS3_HUMAN	A disintegrin and metalloproteinase with thrombospondin motifs 3, ADAM-TS 3, ADAM-TS3, ADAMTS-3, EC 3.4.24.- (Procollagen II N-proteinase, PC II-NP) (Procollagen II amino propeptide-processing enzyme)	ADAMTS3 KIAA0366	1205	9606		3.4.24.-	Cleavage on pair of basic residues;Disease variant;Disulfide bond;Extracellular matrix;Glycoprotein;Heparin-binding;Hydrolase;Metal-binding;Metalloprotease;Protease;Reference proteome;Repeat;Secreted;Signal;Zinc;Zymogen	Q9UHD9	TISSUE SPECIFICITY: Found in cartilage and skin.	GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748	PTM: The precursor is cleaved by a furin endopeptidase. {ECO:0000250}.; PTM: Glycosylated. Can be O-fucosylated by POFUT2 on a serine or a threonine residue found within the consensus sequence C1-X(2)-(S/T)-C2-G of the TSP type-1 repeat domains where C1 and C2 are the first and second cysteine residue of the repeat, respectively. Fucosylated repeats can then be further glycosylated by the addition of a beta-1,3-glucose residue by the glucosyltransferase, B3GALTL. Fucosylation mediates the efficient secretion of ADAMTS family members. Also can be C-glycosylated with one or two mannose molecules on tryptophan residues within the consensus sequence W-X-X-W of the TPRs, and N-glycosylated. These other glycosylations can also facilitate secretion (By similarity). {ECO:0000250}.	15815621; 15489334; 11408482; 9205841; 28985353	
O15075	DCLK1_HUMAN	Serine/threonine-protein kinase DCLK1, EC 2.7.11.1 (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1)	DCLK1 DCAMKL1 DCDC3A KIAA0369	740	9606		2.7.11.1	3D-structure;Alternative splicing;ATP-binding;Developmental protein;Differentiation;Kinase;Neurogenesis;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase	Q9UJX2; Q5JST6	TISSUE SPECIFICITY: In fetal tissues, highly expressed in brain, detectable in lung and liver, but not in kidney. In adult tissues, expressed ubiquitously in the brain, detectable in the heart, liver, spleen, thymus, prostate, testis, ovary, small intestine and colon. The type A isoforms seem to be expressed predominantly in fetal brain whereas type B isoforms are expressed abundantly in both fetal and adult brain. {ECO:0000269|PubMed:10051403}.	GO:0001764; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005887; GO:0006468; GO:0007399; GO:0007417; GO:0009615; GO:0014069; GO:0016197; GO:0018105; GO:0021952; GO:0030900; GO:0035556; GO:0048675; GO:0048812; GO:0048813; GO:0106310; GO:1900181		9747029; 10036192; 9205841; 14702039; 15057823; 15489334; 10051403; 16548883; 21406692; 17344846	Protein kinase superfamily, CAMK Ser/Thr protein kinase family, CaMK subfamily
O15078	CE290_HUMAN	Centrosomal protein of 290 kDa, Cep290 (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87, CT87) (Nephrocystin-6) (Tumor antigen se2-2)	CEP290 BBS14 KIAA0373 NPHP6	2479	9606			Activator;Bardet-Biedl syndrome;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Disease variant;Joubert syndrome;Leber congenital amaurosis;Meckel syndrome;Mental retardation;Nephronophthisis;Nucleus;Obesity;Protein transport;Reference proteome;Senior-Loken syndrome;Transport;Ubl conjugation	Q9BUW7; P62158; O43303; Q9UPN4; Q5TB80; O15078; Q15051; Q86T90; Q9NRD5; Q2M1K9; P62161	TISSUE SPECIFICITY: Ubiquitous. Expressed strongly in placenta and weakly in brain. {ECO:0000269|PubMed:11149944, ECO:0000269|PubMed:16682973}.	GO:0001822; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043010; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:1905349; GO:1905515	PTM: Ubiquitinated. May undergo monoubiquitination; monoubiquitination is inhibited in response to cellular stress, such as ultraviolet light (UV) radiation or heat shock, but does not cause it displacement from centriolar satellites. {ECO:0000269|PubMed:24121310}.	16682973; 16541075; 14702039; 9205841; 11149944; 14654843; 16909394; 18950740; 18694559; 18723859; 17705300; 18327255; 20200501; 21565611; 22863007; 22940612; 22797915; 24121310; 23446637; 24051377; 23644468; 23943788; 24421332; 26166481; 25552655; 16682970; 17564974; 24816561; 28235840; 32453716; 17564967; 17617513; 20683928; 21493627; 21602930; 22425360; 26477546	
O15079	SNPH_HUMAN	Syntaphilin	SNPH KIAA0374	494	9606			Alternative splicing;Cell junction;Coiled coil;Membrane;Phosphoprotein;Reference proteome;Synapse;Synaptosome;Transmembrane;Transmembrane helix	Q9UI12; Q6NTF9-3; P23025	TISSUE SPECIFICITY: Brain specific. Found in synapses. {ECO:0000269|PubMed:10707983}.	GO:0005737; GO:0005739; GO:0005881; GO:0007269; GO:0016021; GO:0016081; GO:0017075; GO:0030182; GO:0043005; GO:0098793		10707983; 9205841; 11780052; 15489334	
O15083	ERC2_HUMAN	ERC protein 2	ERC2 KIAA0378	957	9606			Cell junction;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Phosphoprotein;Reference proteome;Synapse	P10242		GO:0007274; GO:0016082; GO:0030426; GO:0042734; GO:0048167; GO:0048786; GO:0048788; GO:0048790; GO:0098882; GO:0098978; GO:0098982		9205841; 12168954; 15489334; 12923177	
O15084	ANR28_HUMAN	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, PP6-ARS-A, Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K, PITK)	ANKRD28 KIAA0379	1053	9606			Alternative promoter usage;Alternative splicing;ANK repeat;Nucleus;Phosphoprotein;Reference proteome;Repeat	Q14185; O15371; Q8TAE8; Q0VD86; Q8TDN2; Q8IVT4; Q4G0R1; O00743; Q9UPN7; O75170; Q5H9R7; Q86Y79; Q9BT49; Q9H2K2; Q96MU7		GO:0005654; GO:0005829		9205841; 12168954; 14702039; 15489334; 16564677; 18186651; 18691976; 18669648; 19369195; 21269460; 23186163	
O15085	ARHGB_HUMAN	Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF)	ARHGEF11 KIAA0380	1522	9606			3D-structure;Alternative splicing;Coiled coil;Cytoplasm;GTPase activation;Guanine-nucleotide releasing factor;Membrane;Phosphoprotein;Reference proteome;Ubl conjugation	P46108; P16333; P61586; Q7DB74; Q96PX9; Q8BPM0	TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10026210}.	GO:0001558; GO:0001664; GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006941; GO:0007186; GO:0007266; GO:0030010; GO:0030036; GO:0045893; GO:0051056	PTM: Phosphorylated by MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14).; PTM: Ubiquitinated by the BCR(KLHL20) E3 ubiquitin ligase complex when previously phosphorylated by MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14), leading to its degradation, thereby restricting RhoA activity and facilitating growth cone spreading and neurite outgrowth. {ECO:0000269|PubMed:21670212}.	9205841; 16710414; 15489334; 10526156; 10026210; 12372594; 12183458; 10900204; 17081983; 18669648; 19690332; 20844236; 20068231; 21670212; 21406692; 23186163; 24275569; 11470431	
O15091	MRPP3_HUMAN	Mitochondrial ribonuclease P catalytic subunit, EC 3.1.26.5 (Mitochondrial ribonuclease P protein 3, Mitochondrial RNase P protein 3) (Protein only RNase P catalytic subunit)	PRORP KIAA0391 MRPP3	583	9606		3.1.26.5	3D-structure;Alternative splicing;Hydrolase;Magnesium;Manganese;Metal-binding;Mitochondrion;Nuclease;Phosphoprotein;Reference proteome;Transit peptide;tRNA processing;Zinc			GO:0001682; GO:0004526; GO:0005654; GO:0005739; GO:0005759; GO:0030678; GO:0046872; GO:0097745	PTM: Degraded by LONP1 following mitochondrial unfolded protein response, probably leading to inhibit translation in mitochondrion. {ECO:0000269|PubMed:27350246}.	9205841; 14702039; 12508121; 15489334; 18984158; 21269460; 23186163; 25944712; 27350246; 25953853	PPR family, P subfamily
O15105	SMAD7_HUMAN	Mothers against decapentaplegic homolog 7, MAD homolog 7, Mothers against DPP homolog 7 (Mothers against decapentaplegic homolog 8, MAD homolog 8, Mothers against DPP homolog 8) (SMAD family member 7, SMAD 7, Smad7, hSMAD7)	SMAD7 MADH7 MADH8	426	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc	P36896; O15169; Q92905; P62942; Q96PU5-5; Q9HCE7-1; Q9HAU4; O00308; P46937; Q99ML9	TISSUE SPECIFICITY: Ubiquitous with higher expression in the lung and vascular endothelium.	GO:0000122; GO:0000785; GO:0001650; GO:0001657; GO:0002725; GO:0003677; GO:0005518; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007179; GO:0008013; GO:0009653; GO:0010717; GO:0010719; GO:0010801; GO:0010944; GO:0017015; GO:0022409; GO:0030154; GO:0030279; GO:0030336; GO:0030509; GO:0030512; GO:0030514; GO:0031397; GO:0031398; GO:0031503; GO:0031625; GO:0032436; GO:0032925; GO:0032991; GO:0033137; GO:0034333; GO:0034616; GO:0034713; GO:0043433; GO:0046872; GO:0048185; GO:0048844; GO:0050821; GO:0051444; GO:0055010; GO:0055117; GO:0060373; GO:0060389; GO:0060394; GO:0060395; GO:0060412; GO:0070411; GO:0071144; GO:0071560; GO:0140416; GO:1902731; GO:1903043; GO:1990830; GO:2000317; GO:2000320	PTM: Phosphorylation on Ser-249 does not affect its stability, nuclear localization or inhibitory function in TGFB signaling; however it affects its ability to regulate transcription (By similarity). Phosphorylated by PDPK1. {ECO:0000250|UniProtKB:O35253, ECO:0000269|PubMed:17327236}.; PTM: Ubiquitinated by WWP1 (By similarity). Polyubiquitinated by RNF111, which is enhanced by AXIN1 and promotes proteasomal degradation (PubMed:14657019, PubMed:16601693). In response to TGF-beta, ubiquitinated by SMURF1; which promotes its degradation (PubMed:11278251). {ECO:0000250|UniProtKB:O35253, ECO:0000269|PubMed:11278251, ECO:0000269|PubMed:14657019, ECO:0000269|PubMed:16601693}.; PTM: Acetylation prevents ubiquitination and degradation mediated by SMURF1. {ECO:0000269|PubMed:12408818}.	9215638; 9256479; 9335507; 14702039; 16177791; 15489334; 9759503; 10647776; 9892009; 10708948; 10708949; 11163210; 11483516; 11278251; 12023024; 12408818; 14657019; 14718519; 14993265; 16061177; 16601693; 17327236; 16641086; 17934461	Dwarfin/SMAD family
O15111	IKKA_HUMAN	Inhibitor of nuclear factor kappa-B kinase subunit alpha, I-kappa-B kinase alpha, IKK-A, IKK-alpha, IkBKA, IkappaB kinase, EC 2.7.11.10 (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1, IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha, NFKBIKA) (Transcription factor 16, TCF-16)	CHUK IKKA TCF16	745	9606		2.7.11.10	3D-structure;Acetylation;ATP-binding;Cytoplasm;Direct protein sequencing;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase	Q16543; P46527; Q13451; P07900; O14920; Q9Y6K9; Q92985; Q99558; Q5TCX8; P01106; P19838; P25963; Q04206; Q15796; Q86VP1; P03129; Q07857; Q6TY28; Q6TY35; Q80901; Q8B5B5; P71451; Q77M19; P24772	TISSUE SPECIFICITY: Widely expressed.	GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0006955; GO:0007249; GO:0007252; GO:0008384; GO:0008385; GO:0009615; GO:0009653; GO:0009898; GO:0018105; GO:0032088; GO:0032727; GO:0033209; GO:0034614; GO:0035631; GO:0038061; GO:0042803; GO:0043123; GO:0045087; GO:0045893; GO:0045944; GO:0046982; GO:0051092; GO:0071276; GO:0071356; GO:0097110; GO:0098586; GO:1990459	PTM: Phosphorylated by MAP3K14/NIK, AKT and to a lesser extent by MEKK1, and dephosphorylated by PP2A. Autophosphorylated.; PTM: (Microbial infection) Acetylation of Thr-179 by Yersinia YopJ prevents phosphorylation and activation, thus blocking the I-kappa-B signaling pathway. {ECO:0000269|PubMed:17116858}.	9244310; 9252186; 9346484; 9813230; 15164054; 8777433; 17116858; 9751059; 9520446; 10485710; 10195894; 9819420; 10712233; 11971985; 12612076; 12789342; 15084260; 15456791; 15173580; 16177806; 17540171; 17434128; 18626576; 19088076; 19150425; 20434986; 20855622; 20961246; 20501937; 21269460; 21765415; 23091055; 23776175; 26334375; 27426725; 30341167; 30217973; 32935379; 25691407; 17344846; 18462684	Protein kinase superfamily, Ser/Thr protein kinase family, I-kappa-B kinase subfamily
O15116	LSM1_HUMAN	U6 snRNA-associated Sm-like protein LSm1 (Cancer-associated Sm-like) (Small nuclear ribonuclear CaSm)	LSM1 CASM	133	9606			Cytoplasm;mRNA processing;mRNA splicing;Phosphoprotein;Reference proteome;Ribonucleoprotein;RNA-binding	O95994; Q8TD06; O00213-2; Q5H9J7; O00299; P21964-2; A0PJW8; O15217; Q9Y333; P62310; Q9Y4Z0; P62312; P59942; Q86TB9; P28074; P28062-2; O95988		GO:0000290; GO:0000339; GO:0000375; GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016070; GO:0019827; GO:0045665; GO:0071044; GO:1990726		9230209; 10369684; 14702039; 15489334; 18172165; 23186163	SnRNP Sm proteins family
O15117	FYB1_HUMAN	FYN-binding protein 1 (Adhesion and degranulation promoting adaptor protein, ADAP) (FYB-120/130, p120/p130) (FYN-T-binding protein) (SLAP-130) (SLP-76-associated phosphoprotein)	FYB1 FYB SLAP130	783	9606			3D-structure;Acetylation;Alternative splicing;Cell junction;Coiled coil;Cytoplasm;Direct protein sequencing;Disease variant;Nucleus;Phosphoprotein;Reference proteome;Repeat;SH3 domain	P06241; Q13094; P16333; O43639; Q86WV1	TISSUE SPECIFICITY: Expressed in hematopoietic tissues such as myeloid and T-cells, spleen and thymus. Not expressed in B-cells, nor in non-lymphoid tissues.	GO:0005102; GO:0005634; GO:0005829; GO:0005886; GO:0006955; GO:0007229; GO:0008289; GO:0015629; GO:0030054; GO:0032991; GO:0044877; GO:0050852; GO:0072659	PTM: T-cell receptor ligation leads to increased tyrosine phosphorylation.	9207119; 9115214; 10747096; 14702039; 15372022; 15489334; 9755858; 9748251; 9671755; 10942756; 10856234; 15144186; 15849195; 16461356; 16980616; 18088087; 19807924; 19690332; 19608861; 23186163; 25516138; 24275569; 25876182; 27335501; 15062083	
O15118	NPC1_HUMAN	NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)	NPC1	1278	9606			3D-structure;Alternative splicing;Cholesterol metabolism;Disease variant;Disulfide bond;Endosome;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Lipid metabolism;Lipid transport;Lysosome;Membrane;Niemann-Pick disease;Receptor;Reference proteome;Signal;Steroid metabolism;Sterol metabolism;Transmembrane;Transmembrane helix;Transport	Q03135; P61916; P87666; X5HMX4; P0DTC9		GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0015248; GO:0015485; GO:0016020; GO:0016021; GO:0016242; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0033344; GO:0038023; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103	PTM: N-glycosylated. {ECO:0000269|PubMed:10821832, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19563754}.	9211849; 10425213; 11754101; 14702039; 16177791; 15489334; 9927649; 10821832; 17897319; 18772377; 19583955; 19159218; 18832164; 20674853; 21269460; 21412152; 21866103; 25855742; 25944712; 32855215; 19563754; 26771495; 27238017; 26846330; 27551080; 28784760; 9634529; 10521290; 10521297; 10480349; 11182931; 11349231; 11333381; 11545687; 11479732; 12408188; 12401890; 12554680; 12955717; 16098014; 15774455; 16126423; 16802107; 23453666	Patched family
O15119	TBX3_HUMAN	T-box transcription factor TBX3, T-box protein 3	TBX3	743	9606			3D-structure;Alternative splicing;Developmental protein;Disease variant;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	P35219; Q8N4W3; Q99471; P86480; Q08117; Q6NVU6	TISSUE SPECIFICITY: Widely expressed.	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001501; GO:0001568; GO:0001701; GO:0001708; GO:0001947; GO:0003151; GO:0003167; GO:0003205; GO:0003272; GO:0005634; GO:0006357; GO:0007417; GO:0007569; GO:0008284; GO:0008595; GO:0009887; GO:0010159; GO:0019827; GO:0021761; GO:0030539; GO:0030540; GO:0030857; GO:0030879; GO:0032275; GO:0035115; GO:0035116; GO:0035136; GO:0036302; GO:0042733; GO:0043066; GO:0043565; GO:0045662; GO:0045787; GO:0045892; GO:0045944; GO:0046884; GO:0048332; GO:0048752; GO:0051145; GO:0060021; GO:0060317; GO:0060412; GO:0060444; GO:0060596; GO:0060923; GO:0060931; GO:0061629; GO:0072105; GO:0090398; GO:1905072; GO:1905222; GO:1990837; GO:2000137; GO:2000648		10468588; 9207801; 10330342; 15489334; 12000749; 18220336; 18669648; 19413330; 22002537; 23186163; 24275569; 12005433	
O15120	PLCB_HUMAN	1-acyl-sn-glycerol-3-phosphate acyltransferase beta, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 2, 1-AGP acyltransferase 2, 1-AGPAT 2) (Lysophosphatidic acid acyltransferase beta, LPAAT-beta)	AGPAT2	278	9606	PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3.	2.3.1.51	Acyltransferase;Alternative splicing;Congenital generalized lipodystrophy;Diabetes mellitus;Disease variant;Endoplasmic reticulum;Lipid biosynthesis;Lipid metabolism;Membrane;Phospholipid biosynthesis;Phospholipid metabolism;Reference proteome;Signal;Transferase;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed predominantly in adipose tissue, pancreas and liver. {ECO:0000269|PubMed:21873652, ECO:0000269|PubMed:9242711}.	GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0005886; GO:0006644; GO:0006654; GO:0008544; GO:0009410; GO:0016021; GO:0016024; GO:0035579		9242711; 9291118; 9212163; 15164053; 15489334; 15028826; 15629135; 19075029; 21269460; 21873652; 11967537	1-acyl-sn-glycerol-3-phosphate acyltransferase family
O15121	DEGS1_HUMAN	Sphingolipid delta(4)-desaturase DES1, EC 1.14.19.17 (Cell migration-inducing gene 15 protein) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1) (Membrane lipid desaturase) (Retinol isomerase, EC 5.2.1.-)	DEGS1 DES1 MLD MIG15	323	9606		1.14.19.17; 5.2.1.-	Disease variant;Endoplasmic reticulum;Fatty acid biosynthesis;Fatty acid metabolism;Isomerase;Leukodystrophy;Lipid biosynthesis;Lipid metabolism;Lipoprotein;Membrane;Mitochondrion;Myristate;Oxidoreductase;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	Q8WVX3-2; Q9NTN9-2	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9188692}.	GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006636; GO:0009055; GO:0016020; GO:0030148; GO:0031966; GO:0035579; GO:0042284; GO:0043217; GO:0046513; GO:0050251	PTM: Myristoylation can target the enzyme to the mitochondria leading to an increase in ceramide levels. {ECO:0000269|PubMed:19647031}.	9188692; 11937514; 15489334; 18669648; 19647031; 21269460; 23143414; 25255805; 30620338; 30620337; 31186544	Fatty acid desaturase type 1 family, DEGS subfamily
O15123	ANGP2_HUMAN	Angiopoietin-2, ANG-2	ANGPT2	496	9606			3D-structure;Alternative splicing;Angiogenesis;Calcium;Coiled coil;Developmental protein;Differentiation;Disease variant;Disulfide bond;Glycoprotein;Metal-binding;Reference proteome;Secreted;Signal	Q02763; Q02763		GO:0001525; GO:0001666; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0007165; GO:0007281; GO:0009314; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0050928; GO:0060135; GO:0062023; GO:0071363; GO:0072012		9204896; 9927494; 10766762; 14702039; 16421571; 15489334; 12427764; 15284220; 19116766; 19223473; 19234476; 15893672; 16732286; 32908006	
O15126	SCAM1_HUMAN	Secretory carrier-associated membrane protein 1, Secretory carrier membrane protein 1	SCAMP1 SCAMP	338	9606			Acetylation;Alternative splicing;Endosome;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	P53367; P53365; P55212; Q05329; P13473-2; Q96E29; Q9ULP0-2; Q96AL5; P49585; O75400-2; P43378; Q9Y371; Q9NZD8; Q5VWN6-2; Q969Z0; Q8WY91; P49638; Q8NF64-2	TISSUE SPECIFICITY: Widely expressed, with highest expression in brain.	GO:0005802; GO:0005886; GO:0006887; GO:0006892; GO:0006897; GO:0015031; GO:0016021; GO:0019904; GO:0030136; GO:0030285; GO:0032588; GO:0035579; GO:0042589; GO:0055038		9378760; 9653160; 15489334; 14759258; 15840657; 19413330; 21269460; 22223895; 22814378; 23186163	SCAMP family
O15127	SCAM2_HUMAN	Secretory carrier-associated membrane protein 2, Secretory carrier membrane protein 2	SCAMP2	329	9606			Endosome;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	P21333-2; Q8IVJ1; Q96T83	TISSUE SPECIFICITY: Widely expressed.	GO:0005794; GO:0006892; GO:0015031; GO:0016021; GO:0032588; GO:0043231; GO:0055038; GO:0070062		9378760; 14702039; 15489334; 15840657; 16870614; 18088087; 19413330; 20068231; 21269460; 21406692; 23186163; 24275569; 25944712	SCAMP family
O15130	NPFF_HUMAN	Pro-FMRFamide-related neuropeptide FF (FMRFamide-related peptides) [Cleaved into: Neuropeptide SF, NPSF; Neuropeptide FF, NPFF; Neuropeptide AF, NPAF ]	NPFF	113	9606			Alternative splicing;Amidation;Cleavage on pair of basic residues;Neuropeptide;Reference proteome;Secreted;Signal	P48643; P07339; P42858; P13473-2; Q9Y371; O76024		GO:0001664; GO:0005102; GO:0005184; GO:0005576; GO:0005615; GO:0007218; GO:0007268; GO:0030425; GO:0043204; GO:0043679; GO:0060079; GO:0098794		9224703; 16541075; 15489334; 11587714	FARP (FMRFamide related peptide) family
O15131	IMA6_HUMAN	Importin subunit alpha-6 (Karyopherin subunit alpha-5)	KPNA5	539	9606			3D-structure;Cytoplasm;Host-virus interaction;Protein transport;Reference proteome;Repeat;Transport	Q9GZX7; Q92688; P46527; Q9UKX7; Q6IQ16	TISSUE SPECIFICITY: Testis.	GO:0005634; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0061608		14702039; 14574404; 15489334; 9395085; 12740372; 12610148; 17928350; 21269460; 16959974	Importin alpha family
O15143	ARC1B_HUMAN	Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC)	ARPC1B ARC41	372	9606			3D-structure;Actin-binding;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease variant;Nucleus;Reference proteome;Repeat;WD repeat	Q5ZTM4		GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005885; GO:0005925; GO:0015629; GO:0030833; GO:0032355; GO:0034314; GO:0036284; GO:0043627; GO:0044877; GO:0070062		9230079; 12853948; 15489334; 12665801; 11741539; 21269460; 28368018; 29925947	WD repeat ARPC1 family
O15144	ARPC2_HUMAN	Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit, p34-ARC)	ARPC2 ARC34 PRO2446	300	9606			3D-structure;Acetylation;Actin-binding;Cell junction;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleus;Reference proteome;Synapse;Synaptosome	Q7Z6K5-1; Q9BR76; Q16236; P18206		GO:0003779; GO:0005200; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005885; GO:0005925; GO:0010592; GO:0015629; GO:0030027; GO:0030041; GO:0030838; GO:0034314; GO:0035861; GO:0036195; GO:0043005; GO:0070062; GO:0070358; GO:0098978; GO:1900026		9230079; 8812419; 15489334; 12665801; 11741539; 19608861; 21269460; 22814378; 24275569; 25944712; 29925947; 32128961	ARPC2 family
O15145	ARPC3_HUMAN	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit, p21-ARC)	ARPC3 ARC21	178	9606			3D-structure;Acetylation;Actin-binding;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	P59998; P46092; Q68J44; Q8IZU1; Q08379; O43365; O95835-2; P48552; P14859-6; Q8NC74; Q86VR2; Q9NX95-5; A2RTX5; O00401; Q9H609; P0DTC9		GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005885; GO:0005925; GO:0015629; GO:0016020; GO:0030027; GO:0030833; GO:0034314; GO:0035861; GO:0070062; GO:0070358		9359840; 9230079; 15489334; 12665801; 11741539; 19690332; 19608861; 21269460; 24275569; 25944712; 28112733; 29925947	ARPC3 family
O15146	MUSK_HUMAN	Muscle, skeletal receptor tyrosine-protein kinase, EC 2.7.10.1 (Muscle-specific tyrosine-protein kinase receptor, MuSK, Muscle-specific kinase receptor)	MUSK	869	9606		2.7.10.1	Alternative splicing;ATP-binding;Cell junction;Cell membrane;Congenital myasthenic syndrome;Developmental protein;Differentiation;Disease variant;Disulfide bond;Glycoprotein;Immunoglobulin domain;Kinase;Magnesium;Membrane;Metal-binding;Muscle protein;Nucleotide-binding;Phosphoprotein;Postsynaptic cell membrane;Receptor;Reference proteome;Repeat;Signal;Synapse;Transferase;Transmembrane;Transmembrane helix;Tyrosine-protein kinase;Ubl conjugation	P08238		GO:0001934; GO:0004712; GO:0004713; GO:0004714; GO:0005518; GO:0005524; GO:0005887; GO:0007169; GO:0007528; GO:0007613; GO:0008582; GO:0010628; GO:0030154; GO:0031594; GO:0033674; GO:0038062; GO:0043235; GO:0045211; GO:0046777; GO:0046872; GO:0071340; GO:2000541	PTM: Ubiquitinated by PDZRN3. Ubiquitination promotes endocytosis and lysosomal degradation (By similarity). {ECO:0000250}.; PTM: Phosphorylated (By similarity). Phosphorylation is induced by AGRIN in a LRP4-dependent manner (By similarity). Autophosphorylated (PubMed:25029443). Autophosphorylation at Tyr-554 is required for interaction with DOK7 which in turn stimulates the phosphorylation and the activation of MUSK (By similarity). {ECO:0000250|UniProtKB:Q61006, ECO:0000269|PubMed:25029443}.; PTM: Neddylated. {ECO:0000269|PubMed:20596523}.	7546737; 15164053; 15489334; 20603078; 20596523; 25029443; 15496425; 17344846; 19949040; 20371544; 23326516; 25537362; 24183479; 25612909	Protein kinase superfamily, Tyr protein kinase family
O15151	MDM4_HUMAN	Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4)	MDM4 MDMX	490	9606			3D-structure;Alternative splicing;Disease variant;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	P10415; Q9NX04; Q7Z479; O95971; P48729; Q00987; Q13064; P41227; P06400; Q9Y4L5; P23297; P29034; P33763; P04271; P04637; P62837; Q93009; O14972; P61964; P62258; P61981; P63104; Q9BRR0; A0A0S2Z6X0; Q3YBA8; P03255-2	TISSUE SPECIFICITY: Expressed in all tissues tested with high levels in thymus.	GO:0000122; GO:0002039; GO:0003170; GO:0003181; GO:0003203; GO:0003281; GO:0003283; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0008285; GO:0017053; GO:0019899; GO:0030330; GO:0042177; GO:0043066; GO:0045892; GO:0050821; GO:0051726; GO:0065003; GO:0071456	PTM: Phosphorylated. Phosphorylation at Ser-367 promotes interaction with YWHAG and subsequent ubiquitination and degradation. Phosphorylation at Ser-342 also induces ubiquitination and degradation but to a lower extent. {ECO:0000269|PubMed:16163388, ECO:0000269|PubMed:16511572, ECO:0000269|PubMed:19838211}.; PTM: Ubiquitinated and degraded by MDM2. Deubiquitination by USP2 on the other hand stabilizes the MDM4 protein. {ECO:0000269|PubMed:19838211}.	9226370; 16266988; 16710414; 15489334; 12761890; 10608892; 16163388; 16511572; 19838211; 11840567; 23186163; 32300648	MDM2/MDM4 family
O15155	BET1_HUMAN	BET1 homolog, hBET1 (Golgi vesicular membrane-trafficking protein p18)	BET1	118	9606			3D-structure;Alternative splicing;Coiled coil;Endoplasmic reticulum;ER-Golgi transport;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	P29274; Q68DC2; Q13520; P07307-3; Q8WWH4; P04233-2; P11912; Q99675; Q8N5K1; O95471; Q8IUN9; Q9BUF7-2; Q96BA8; P49447; Q9BQA9; Q9GZR5; Q9Y282; Q8TBP5; Q5JX71; Q96KR6; O14653; Q8TDT2; Q8TED1; Q8N5M9; Q8N6L0; P48051; Q6UWN5; P43360; Q9GZY8-5; O14880; Q9H115; O14684; Q9H6H4; Q86VR2; Q9BXS9-3; Q8TBB6; Q8WWF3; Q16623; P61266; P32856-2; Q12846; Q8N6Q1; Q96Q45-2; Q53FP2; Q4KMG9; Q96HE8; Q9Y320; Q8N6Y0; Q86V38; Q92876		GO:0000138; GO:0000139; GO:0005484; GO:0005789; GO:0006888; GO:0015031; GO:0016020; GO:0030133; GO:0030173; GO:0031201; GO:0033116; GO:0048280		9382863; 12853948; 15489334; 17081983; 18669648; 20068231; 21269460; 21406692; 23186163; 24275569; 25944712	BET1 family
O15156	ZBT7B_HUMAN	Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox, hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog, Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK)	ZBTB7B ZBTB15 ZFP67 ZNF857B	539	9606			Acetylation;Alternative splicing;Developmental protein;Differentiation;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	P41182; P62993; Q96G21; Q15014; O43639; Q13526; P32969; Q96HL8; O60504; Q96C24; O15062; Q5JPT6; A8KA13; Q96S94-5; Q86YD7; Q96G21; O43639; Q7Z4N8; Q96B97; Q15642-2; P0CB47; B2RXF5; O15062; A6NJL1		GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001865; GO:0005654; GO:0006357; GO:0006366; GO:0007398; GO:0007595; GO:0010628; GO:0010629; GO:0031065; GO:0032740; GO:0032868; GO:0042803; GO:0042826; GO:0043372; GO:0043377; GO:0046628; GO:0046872; GO:0051141; GO:0090336; GO:0120162; GO:1990837; GO:1990845; GO:2000320; GO:2000640	PTM: Acetylated directly and specifically by EP300 (PubMed:20810990). EP300-mediated acetylation of Lys-206, Lys-212 and Lys-335 stabilizes the protein by antagonizing ubiquitin conjugation (By similarity). {ECO:0000250|UniProtKB:Q64321, ECO:0000269|PubMed:20810990}.; PTM: Ubiquitinated, leading to proteasomal degradation (PubMed:20810990). Competes with acetylation on Lys-206, Lys-212 and Lys-335 (By similarity). {ECO:0000250|UniProtKB:Q64321, ECO:0000269|PubMed:20810990}.	9370309; 14702039; 17974005; 16710414; 15489334; 18669648; 20810990; 20068231; 24275569	
O15160	RPAC1_HUMAN	DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)	POLR1C POLR1E	346	9606			3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Disease variant;DNA-directed RNA polymerase;Leukodystrophy;Nucleus;Phosphoprotein;Reference proteome;Transcription	Q6UY14-3; Q12774; Q8WXE1; Q5T686; Q6PI77; Q9NQY0; Q96CA5; Q9H2G9; O95561; Q0VAL7; Q96LM5; Q9HC52; Q8NA61-2; O75909-2; P49368; Q9UFW8; Q9BSW2; P02489; Q5JST6; A0A0A0MR80; P07954; Q8IXW7; Q6PJQ5; O95995; Q9Y5P6; Q9NYA3; A6NEM1; Q9HAV7; Q9H4Y5; Q7Z353; P31943; P17482; P35452-2; Q8IYA8; Q9UKT9; Q0VD86; Q719H9; Q8WZ19; Q9UIH9; P08727; O95678; Q01546; P59991; Q9BYR8; Q5T3J3; Q9Y250; Q9BRK4; Q9NS73-5; A8MW99; Q6FHY5; Q13064; Q6PF18; Q9Y3D9; O96000; P46934-3; Q9GZT8; P15531; O00746; Q8WWB5; Q8WUT1; P0DPB6; P62487; P52435; Q9H1A7; Q969Q6; P25786; Q5RL73; Q9UFD9; Q9UHP6; Q9BVN2; Q8IYX7; Q16637; O60504; Q9H0A9-2; O43609; Q9NZ72; Q5VWN6-2; Q86VP1; P15884; Q6ZNM6; Q9UBB9; Q08117-2; Q9BTD3; Q13829; P19237; Q9BWF2; Q14142; P14373; Q9Y3Q8; Q9H9P5-5; Q70EL1-9; P23025; O96006; B2RXF5; Q53FD0-2; Q9NU63-3; Q9NZV7; Q8IVP9; Q86TJ5; Q8N720; P0C7X2; Q9Y2P0; Q9UGI0		GO:0001054; GO:0001056; GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005736; GO:0005829; GO:0006360; GO:0046983		9540830; 9653160; 14574404; 15489334; 12391170; 15592455; 19413330; 21269460; 22223895; 22814378; 23186163; 26151409; 21131976	Archaeal Rpo3/eukaryotic RPB3 RNA polymerase subunit family
O15162	PLS1_HUMAN	Phospholipid scramblase 1, PL scramblase 1 (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease, EC 3.1.-.-) (MmTRA1b)	PLSCR1	318	9606		3.1.-.-	3D-structure;Alternative splicing;Antiviral defense;Calcium;Cell membrane;Cytoplasm;Direct protein sequencing;DNA-binding;Host cell receptor for virus entry;Host-virus interaction;Hydrolase;Lipid transport;Lipoprotein;Magnesium;Membrane;Nuclease;Nucleus;Palmitate;Phosphoprotein;Receptor;Reference proteome;Repeat;SH3-binding;Transmembrane;Transmembrane helix;Transport	P05067; A8KA13; Q8NEC5; Q9H2X0; Q16630; Q9UBR2; Q15038; Q9H4E7; Q9NQL9; Q92608; Q92731; Q92731-3; Q01844; O43559; Q9HBR3; O76003; Q9NXX0; P60412; P60411; Q9BYQ6; Q9BYR5; Q6L8G9; Q9BYQ4; Q5TA82; Q5TA78; Q6DKI2; Q8WWR8; Q7Z417; Q16625; Q15077; Q13563; Q9NZ81; P49796; Q9BWG6; Q92922; Q6RVD6; O75716; Q92734; Q8IWZ5; A5D8V6; Q8TAU3; Q96SQ5; A0A0S2Z5X4; P09022; Q8ZG77; Q56973; P69974; P61417; Q9WMX2	TISSUE SPECIFICITY: Expressed in platelets, erythrocyte membranes, lymphocytes, spleen, thymus, prostate, testis, uterus, intestine, colon, heart, placenta, lung, liver, kidney and pancreas. Not detected in brain and skeletal muscle. {ECO:0000269|PubMed:10930526, ECO:0000269|PubMed:9218461}.	GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006659; GO:0006915; GO:0006953; GO:0008270; GO:0010288; GO:0010628; GO:0016020; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0032791; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0062023; GO:0070062; GO:0070782; GO:1905820; GO:2000373	PTM: Phosphorylation at Thr-161 by PKC/PKCD increases its phospholipid scramblase activity during both cell stimulation and apoptosis (PubMed:10770950). Phosphorylated by OXSR1 in the presence of RELT. {ECO:0000269|PubMed:10770950, ECO:0000269|PubMed:22052202}.; PTM: Palmitoylation is required for its phospholipid scramblase activity (PubMed:9572851). Palmitoylation regulates its localization to the cell membrane or the nucleus; trafficking to the cell membrane is dependent upon palmitoylation whereas in the absence of palmitoylation, localizes to the nucleus (PubMed:12564925). {ECO:0000269|PubMed:12564925, ECO:0000269|PubMed:9572851}.	9218461; 9712717; 10930526; 14702039; 16641997; 15489334; 8663431; 10770950; 11390389; 9572851; 9485382; 12564925; 15308695; 16091359; 17567603; 18629440; 21269460; 21806988; 22052202; 23659204; 23590222; 24648509; 24343571; 24275569; 27206388; 26745724; 29748552; 32110987; 15611084	Phospholipid scramblase family
O15164	TIF1A_HUMAN	Transcription intermediary factor 1-alpha, TIF1-alpha, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)	TRIM24 RNF82 TIF1 TIF1A	1050	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.27	3D-structure;Alternative splicing;Bromodomain;Chromosomal rearrangement;Coiled coil;Cytoplasm;Direct protein sequencing;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Transferase;Tumor suppressor;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	P03372; P04637		GO:0000791; GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0005102; GO:0005634; GO:0005654; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796	PTM: Phosphorylated at Ser-768 by ATM kinase induces ubiquitination and degradation during DNA damage. {ECO:0000269|PubMed:24820418}.; PTM: Sumoylated. {ECO:0000250|UniProtKB:Q64127}.; PTM: Undergoes ubiquitination-mediated degradation in response to DNA damage. {ECO:0000269|PubMed:24820418}.	9115274; 10022127; 14702039; 12690205; 15489334; 10935545; 10439047; 17081983; 16322096; 18669648; 19413330; 19909775; 19556538; 19690332; 20068231; 21269460; 21406692; 22629402; 22814378; 23186163; 24275569; 24820418; 25218447; 25114211; 25772364; 25755297; 28112733; 32324863; 33724611; 21164480; 17344846	
O15165	LRAD4_HUMAN	Low-density lipoprotein receptor class A domain-containing protein 4	LDLRAD4 C18orf1	306	9606			Alternative splicing;Disulfide bond;Endosome;Membrane;Reference proteome;Signal transduction inhibitor;Transmembrane;Transmembrane helix	O43681; O43765; Q8N966	TISSUE SPECIFICITY: Expressed in lymphocytes. {ECO:0000269|PubMed:19461657}.	GO:0000139; GO:0010719; GO:0010991; GO:0016021; GO:0030336; GO:0030512; GO:0031901; GO:0043231; GO:0060394; GO:0070412		9479497; 14702039; 16177791; 15489334; 19461657; 24627487	PMEPA1 family
O15169	AXIN1_HUMAN	Axin-1 (Axis inhibition protein 1, hAxin)	AXIN1 AXIN	862	9606			3D-structure;ADP-ribosylation;Alternative splicing;Apoptosis;Cell membrane;Cytoplasm;Developmental protein;Disease variant;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;Tumor suppressor;Ubl conjugation;Wnt signaling pathway	Q5JTC6; P39687; P25054; P49407; O15169; Q13137; Q9H257-2; Q2TAC2-2; Q14194; P49674; P35222; Q5VWQ8-2; O14641; Q9UKB1; Q08379; P49840; P49841; P14923; Q6A162; Q9BQ66; Q9BYR5; Q969G2; Q99750; Q6FHY5; Q9UJV3-2; Q5JR59-3; P01106; P35813; P62136; O43586; Q6ZNA4; Q96KG9-4; O15105; Q7Z699; O75558; P63165; G2XKQ0; Q9UBB9; Q15583; Q9H2K2; P04637; Q12933; Q9C019; P14373; Q14134; O94972; Q15654; P23258; Q9H7D7; P46937; Q9HCK0; Q96K21-3; P70039; Q02248; G1T8E2; Q99ML9; O75581	TISSUE SPECIFICITY: Ubiquitously expressed.	GO:0000209; GO:0001701; GO:0001934; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0008022; GO:0009950; GO:0010800; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030159; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032147; GO:0032436; GO:0033138; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043507; GO:0043621; GO:0045599; GO:0045732; GO:0045893; GO:0046330; GO:0046332; GO:0048320; GO:0048471; GO:0051248; GO:0051443; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071514; GO:0071944; GO:0090090; GO:1990909; GO:2000060	PTM: Phosphorylation and dephosphorylation of AXIN1 regulates assembly and function of the beta-catenin complex. Phosphorylated by CK1 and GSK3B. Dephosphorylated by PPP1CA and PPP2CA. Phosphorylation by CK1 enhances binding of GSK3B to AXIN1. {ECO:0000269|PubMed:17318175, ECO:0000269|PubMed:9920888}.; PTM: ADP-ribosylated by tankyrase TNKS and TNKS2. Poly-ADP-ribosylated protein is recognized by RNF146, followed by ubiquitination at 'Lys-48' and subsequent activation of the Wnt signaling pathway. {ECO:0000269|PubMed:21383061}.; PTM: Ubiquitinated by RNF146 when poly-ADP-ribosylated, leading to its degradation and subsequent activation of the Wnt signaling pathway. Sumoylation at Lys-857 and Lys-860 prevents ubiquitination and degradation. Sumoylation is required for AXIN1-mediated JNK activation. Deubiquitinated by USP34, deubiquitinated downstream of beta-catenin stabilization step: deubiquitination is important for nuclear accumulation during Wnt signaling to positively regulate beta-catenin (CTNBB1)-mediated transcription. Ubiquitination by SIAH1 and SIAH2 induces its proteasomal degradation as part of the activation of the Wnt signaling pathway (PubMed:28546513). {ECO:0000269|PubMed:18632848, ECO:0000269|PubMed:21383061, ECO:0000269|PubMed:28546513}.	9230313; 11157797; 15616553; 15489334; 9920888; 10700176; 11336703; 12192039; 12805222; 15262978; 16773576; 16601693; 17210684; 17318175; 18632848; 18669648; 19759537; 21383061; 21478859; 21799911; 23186163; 24275569; 27098453; 28829046; 28546513; 10811618; 12554650; 12101426	
O15173	PGRC2_HUMAN	Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6)	PGRMC2 DG6 PMBP	223	9606			Alternative splicing;Endoplasmic reticulum;Lipid-binding;Membrane;Nucleus;Phosphoprotein;Receptor;Reference proteome;Steroid-binding;Transmembrane;Transmembrane helix	Q96PS8; A0A024RCD1; O95429; P01031; Q5RI15; O14569; P78329; Q6ZPD8; Q8N5I4; O14681; Q7L5A8; Q96IV6; Q9H0Q3; O43681; Q9H3K2; Q8TDV0; P11215; Q8IWB1; Q9UBY5; Q13021; Q6N075; Q9P0S3; I3L0A0; Q9Y5Y5; O00264; Q9Y342; Q01453; O76064; Q96GQ5; Q9H9B4; Q7RTY0; Q8IWU4; Q9H2H9; Q96H72; Q86UD5; O60906; Q96JF0-2; Q13277; P59542; Q9NZ01; P02787; Q6UX40; Q14656; Q96HH6; Q9BTX3; Q9H2L4; Q8N2M4; Q8N661; O60636; O00124; Q9P0L0; Q9BWQ6; Q8IVQ6; O95159; P22315	TISSUE SPECIFICITY: Expressed by endometrial glands and stroma (at protein level). {ECO:0000269|PubMed:23793472}.	GO:0003707; GO:0005496; GO:0005635; GO:0005783; GO:0012505; GO:0015232; GO:0016020; GO:0016021; GO:0020037; GO:0060612		9705155; 14702039; 15489334; 17081983; 18691976; 18669648; 18318008; 19413330; 19369195; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 23793472; 25944712; 27754849; 28111073; 28396637	Cytochrome b5 family, MAPR subfamily
O15178	TBXT_HUMAN	T-box transcription factor T (Brachyury protein) (Protein T)	TBXT T	435	9606			3D-structure;Activator;Alternative splicing;Developmental protein;Disease variant;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation		TISSUE SPECIFICITY: Detected in testis, but not in other, normal tissues. Detected in lung tumors (at protein level). {ECO:0000269|PubMed:22611028, ECO:0000269|PubMed:30237576}.	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001707; GO:0001708; GO:0001756; GO:0003007; GO:0003257; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007165; GO:0007498; GO:0008595; GO:0043433; GO:0061629; GO:0090009; GO:1990837		8963900; 14574404; 15489334; 15449172; 19801981; 22611028; 24253444; 30237576	
O15182	CETN3_HUMAN	Centrin-3	CETN3 CEN3	167	9606			Calcium;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Metal-binding;Mitosis;mRNA transport;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Translocation;Transport	O95994; P17540; P13473-2; O43679; Q8NA72; Q8NA72-3; Q15293; O00141; Q2NKQ1-4; Q9Y371; P19237		GO:0005509; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390		9256449; 15372022; 15489334; 14654843; 22307388; 23591820; 23186163; 26337392	Centrin family
O15194	CTDSL_HUMAN	CTD small phosphatase-like protein, CTDSP-like, EC 3.1.3.16 (Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3) (NIF-like protein) (Nuclear LIM interactor-interacting factor 1, NLI-interacting factor 1) (Protein YA22, hYA22) (RBSP3) (Small C-terminal domain phosphatase 3, SCP3, Small CTD phosphatase 3)	CTDSPL C3orf8 NIF1 NIFL SCP3 YA22	276	9606		3.1.3.16	3D-structure;Alternative splicing;Hydrolase;Magnesium;Metal-binding;Nucleus;Protein phosphatase;Reference proteome	Q15797; Q99618; P02686-2	TISSUE SPECIFICITY: Expression is restricted to non-neuronal tissues. {ECO:0000269|PubMed:15681389}.	GO:0001933; GO:0004721; GO:0005634; GO:0008420; GO:0046872; GO:0070062; GO:2000134		9179494; 12721286; 15051889; 16533400; 15681389; 18058037	
O15195	VILL_HUMAN	Villin-like protein	VILL	856	9606			Actin capping;Actin-binding;Alternative splicing;Calcium;Reference proteome;Repeat	Q99732; P10636; Q96CV9	TISSUE SPECIFICITY: Ubiquitously expressed in 16 tissues examined.	GO:0005200; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0051014; GO:0051015; GO:0051016		16641997; 15489334; 9179494; 29846532	Villin/gelsolin family
O15197	EPHB6_HUMAN	Ephrin type-B receptor 6 (HEP) (Tyrosine-protein kinase-defective receptor EPH-6)	EPHB6	1021	9606			3D-structure;Alternative splicing;ATP-binding;Direct protein sequencing;Glycoprotein;Membrane;Nucleotide-binding;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix	O95994; Q8WXK4-2; Q9H2G9; Q96D03; Q9UKT9; Q0VD86; P35548; Q5VT66; Q9GZT8; Q7Z3S9; P78424; O14744; Q04864; Q04864-2; Q99081-3; P15884; P15884-3; Q96M29; Q96RU7; Q9HCM9; Q9HCM9-2	TISSUE SPECIFICITY: Expressed in brain. Expressed in non invasive breast carcinoma cell lines (at protein level). Strong expression in brain and pancreas, and weak expression in other tissues, such as heart, placenta, lung, liver, skeletal muscle and kidney. Expressed in breast non invasive tumors but not in metastatic lesions. Isoform 3 is expressed in cell lines of glioblastomas, anaplastic astrocytomas, gliosarcomas and astrocytomas. Isoform 3 is not detected in normal tissues. {ECO:0000269|PubMed:18754880, ECO:0000269|PubMed:19234485, ECO:0000269|PubMed:9207182}.	GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0021952; GO:0033674; GO:0038023; GO:0043005; GO:0043235	PTM: Ligand-binding increases phosphorylation on tyrosine residues. Phosphorylation on tyrosine residues is mediated by transphosphorylation by the catalytically active EPHB1 in a ligand-independent manner. Tyrosine phosphorylation of the receptor may act as a switch on the functional transition from cell adhesion/attraction to de-adhesion/repulsion. {ECO:0000269|PubMed:11713248, ECO:0000269|PubMed:15955811}.	9207182; 12853948; 12690205; 15489334; 18425388; 15340161; 11713248; 12517763; 15955811; 18754880; 19234485; 16959974; 17344846	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily
O15198	SMAD9_HUMAN	Mothers against decapentaplegic homolog 9, MAD homolog 9, Mothers against DPP homolog 9 (Madh6) (SMAD family member 9, SMAD 9, Smad9)	SMAD9 MADH6 MADH9 SMAD8	467	9606			3D-structure;Alternative splicing;Cytoplasm;Disease variant;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Zinc	O60341; Q96LA8; Q13485; P28799; Q9Y2U8; Q13485	TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, skeletal muscle, prostate, testis, ovary and small intestine. Also expressed in fetal brain, lung and kidney.	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007179; GO:0009653; GO:0030154; GO:0030509; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144; GO:0071773; GO:1901522	PTM: Phosphorylated on serine by BMP (bone morphogenetic proteins) type 1 receptor kinase.	9205116; 15057823; 15489334; 9759503; 10647776; 10708948; 10708949; 25755279; 21898662	Dwarfin/SMAD family
O15204	ADEC1_HUMAN	ADAM DEC1, EC 3.4.24.- (A disintegrin and metalloproteinase domain-like protein decysin-1, ADAM-like protein decysin-1)	ADAMDEC1	470	9606		3.4.24.-	Alternative splicing;Disulfide bond;Glycoprotein;Hydrolase;Metal-binding;Metalloprotease;Protease;Reference proteome;Secreted;Signal;Zinc;Zymogen		TISSUE SPECIFICITY: Expressed highly in the small intestine and appendix, moderately in lymph node, mucosal lining of the colon, thymus, spleen and very weakly in the bone marrow. Predominantly expressed in dendritic cells (DC) of the germinal center. Weakly expressed in monocyte and highly expressed in macrophage. Absent in immature DC. {ECO:0000269|PubMed:14632642, ECO:0000269|PubMed:9271581}.	GO:0004222; GO:0005576; GO:0006955; GO:0007162; GO:0008270; GO:0062023		9271581; 14702039; 16421571; 15489334; 14632642; 16335952; 19139490	
O15205	UBD_HUMAN	Ubiquitin D (Diubiquitin) (Ubiquitin-like protein FAT10)	UBD FAT10	165	9606			3D-structure;Acetylation;Cytoplasm;Nucleus;Reference proteome;Repeat;Ubl conjugation pathway	Q13387; O76083-2; O60260-5; P37840; Q9H832	TISSUE SPECIFICITY: Constitutively expressed in mature dendritic cells and B-cells. Mostly expressed in the reticuloendothelial system (e.g. thymus, spleen), the gastrointestinal system, kidney, lung and prostate gland. {ECO:0000269|PubMed:12730673, ECO:0000269|PubMed:9368598}.	GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006511; GO:0016235; GO:0016567; GO:0032446; GO:0034341; GO:0034612; GO:0043011; GO:0043065; GO:0043123; GO:0070628; GO:0070842; GO:1901990	PTM: Can be acetylated. {ECO:0000269|PubMed:19033385}.	9368598; 10200259; 14574404; 15489334; 12730673; 14757770; 15831455; 16959044; 16495380; 16495226; 16707496; 16501612; 17889673; 19033385; 18574467; 19166848; 19028597; 19726511; 19437562; 19959714; 25422469	
O15209	ZBT22_HUMAN	Zinc finger and BTB domain-containing protein 22 (Protein BING1) (Zinc finger and BTB domain-containing protein 22A) (Zinc finger protein 297)	ZBTB22 BING1 ZBTB22A ZNF297	634	9606			DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	Q8IYE1; P51116; Q9H0R8; O95995; Q96EZ8; Q9Y316; Q6P2C6; Q13526; Q14498-3; Q15560; Q9P0L0; O95292; A8KA83		GO:0000785; GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0046872; GO:1990837		9545376; 14702039; 14574404; 15489334; 23186163	Krueppel C2H2-type zinc-finger protein family
O15211	RGL2_HUMAN	Ral guanine nucleotide dissociation stimulator-like 2, RalGDS-like 2 (RalGDS-like factor) (Ras-associated protein RAB2L)	RGL2 RAB2L	777	9606			Alternative splicing;Guanine-nucleotide releasing factor;Phosphoprotein;Reference proteome	Q6UY14-3; A8MQ03; Q9H8Y8; Q5T749; P60410; Q7Z3S9		GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0010667; GO:0014068; GO:0032485; GO:0043547		9545376; 11230166; 14702039; 14574404; 15489334; 8976381; 16964243; 20068231; 21160498; 23186163; 24275569	
O15212	PFD6_HUMAN	Prefoldin subunit 6 (Protein Ke2)	PFDN6 HKE2 PFD6	129	9606			3D-structure;Acetylation;Chaperone;Isopeptide bond;Reference proteome;Ubl conjugation	Q13155; Q8TD31-3; P53567; Q9UK22; P22607; Q63ZY3; Q9BVG8-5; O15481; O95983-2; Q9NQG5		GO:0001540; GO:0005737; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:0051131; GO:0101031; GO:1905907; GO:1990062		9545376; 15489334; 9630229; 19608861; 21269460; 22814378; 25114211; 28112733; 31738558	Prefoldin subunit beta family
O15217	GSTA4_HUMAN	Glutathione S-transferase A4, EC 2.5.1.18 (GST class-alpha member 4) (Glutathione S-transferase A4-4)	GSTA4	222	9606		2.5.1.18	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Reference proteome;Transferase	Q96LR7; O95995; P09210; O15217; O15116; Q96HA8	TISSUE SPECIFICITY: Expressed at a high level in brain, placenta, and skeletal muscle and much lower in lung and liver.	GO:0004364; GO:0005829; GO:0006749; GO:0006805; GO:0042802; GO:0042803		9461507; 9480897; 9587421; 9820822; 14702039; 17974005; 14574404; 15489334; 10329152; 20085333	GST superfamily, Alpha family
O15226	NKRF_HUMAN	NF-kappa-B-repressing factor, NFkB-repressing factor, NRF (Protein ITBA4)	NKRF ITBA4 NRF	690	9606			3D-structure;Alternative splicing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	P78563-4; O43143; Q96C10; O75569; O95793; Q9UL40; P0DTC9; PRO_0000449628 [P0DTD1]	TISSUE SPECIFICITY: Widely and constitutively expressed (PubMed:10562553). Expressed at lower level in colon, peripheral blood lymphocytes, lung and kidney (PubMed:10562553). {ECO:0000269|PubMed:10562553}.	GO:0000978; GO:0001228; GO:0001671; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944		10562553; 15772651; 15489334; 9224902; 12381793; 12429849; 21269460; 23186163; 24462208; 25218447; 28112733; 32179686	
O15228	GNPAT_HUMAN	Dihydroxyacetone phosphate acyltransferase, DAP-AT, DHAP-AT, EC 2.3.1.42 (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)	GNPAT DAPAT DHAPAT	680	9606	PATHWAY: Membrane lipid metabolism; glycerophospholipid metabolism.	2.3.1.42	Acetylation;Acyltransferase;Alternative splicing;Cataract;Direct protein sequencing;Disease variant;Dwarfism;Membrane;Peroxisome;Phosphoprotein;Reference proteome;Rhizomelic chondrodysplasia punctata;Transferase			GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006631; GO:0006654; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0009410; GO:0016020; GO:0016287; GO:0021587; GO:0030913; GO:0031966; GO:0042594; GO:0061024; GO:0070542		9459311; 9536089; 11237722; 14702039; 16710414; 15489334; 15687349; 19608861; 21269460; 21990100; 25944712; 11152660	GPAT/DAPAT family
O15229	KMO_HUMAN	Kynurenine 3-monooxygenase, EC 1.14.13.9 (Kynurenine 3-hydroxylase)	KMO	486	9606	PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate from L-kynurenine: step 1/3. {ECO:0000255|HAMAP-Rule:MF_03018}.	1.14.13.9	3D-structure;Alternative splicing;FAD;Flavoprotein;Glycoprotein;Membrane;Mitochondrion;Mitochondrion outer membrane;Monooxygenase;NADP;Oxidoreductase;Pyridine nucleotide biosynthesis;Reference proteome;Transmembrane;Transmembrane helix	P42858	TISSUE SPECIFICITY: Highest levels in placenta and liver. Detectable in kidney. {ECO:0000269|PubMed:9237672}.	GO:0004502; GO:0005615; GO:0005741; GO:0005829; GO:0006569; GO:0007568; GO:0009651; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1901216; GO:1903296		9237672; 10672018; 16710414; 12402501; 23575632; 26752518; 28604669; 29208702; 29429898	Aromatic-ring hydroxylase family, KMO subfamily
O15230	LAMA5_HUMAN	Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha)	LAMA5 KIAA0533 KIAA1907	3695	9606			3D-structure;Alternative splicing;Basement membrane;Cell adhesion;Coiled coil;Disulfide bond;Extracellular matrix;Glycoprotein;Laminin EGF-like domain;Reference proteome;Repeat;Secreted;Signal		TISSUE SPECIFICITY: Expressed in heart, lung, kidney, skeletal muscle, pancreas, retina and placenta. Little or no expression in brain and liver.	GO:0001658; GO:0001738; GO:0001755; GO:0001942; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005610; GO:0005615; GO:0005634; GO:0007229; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0016331; GO:0016477; GO:0030155; GO:0030324; GO:0030334; GO:0031594; GO:0034446; GO:0042127; GO:0042475; GO:0043083; GO:0043259; GO:0043260; GO:0045995; GO:0060271; GO:0060445; GO:0062023; GO:0070062; GO:0072659; GO:0098609		11821406; 11780052; 15489334; 11572484; 9628581; 9271224; 10964957; 19159218; 19690332; 21269460; 24275569	
O15231	ZN185_HUMAN	Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A)	ZNF185	689	9606			Alternative splicing;Cell junction;Cytoplasm;Cytoskeleton;LIM domain;Metal-binding;Phosphoprotein;Reference proteome;Zinc	Q9BTE6-2; Q9HC52; Q8TAP6; O75031; P25791-3; Q8WWB5; Q6ZRT6	TISSUE SPECIFICITY: Expressed in placenta, pancreas and kidney. Also expressed in prostate, testis, ovary and blood.	GO:0005737; GO:0005925; GO:0008270; GO:0015629; GO:0051015		9268636; 16799630; 14702039; 10854409; 15772651; 18088087; 19413330; 23186163; 24275569	
O15232	MATN3_HUMAN	Matrilin-3	MATN3	486	9606			Alternative splicing;Coiled coil;Disease variant;Disulfide bond;Dwarfism;EGF-like domain;Methylation;Phosphoprotein;Reference proteome;Repeat;Secreted;Signal	Q0VD86; P60410; Q7Z3S9; P13667; P15884; P15884-3	TISSUE SPECIFICITY: Expressed only in cartilaginous tissues, such as vertebrae, ribs and shoulders.	GO:0001501; GO:0005201; GO:0005509; GO:0005576; GO:0005788; GO:0030198; GO:0031012; GO:0051216; GO:0062023; GO:0120216		9799608; 15815621; 15489334; 9350998; 9287130; 15075323; 26091039; 11479597; 12736871; 12884427; 15459972; 14729835; 15121775; 15948199; 16287128; 21922596	
O15234	CASC3_HUMAN	Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein, MLN 51) (Protein barentsz, Btz)	CASC3 MLN51	703	9606			3D-structure;ADP-ribosylation;Cell projection;Coiled coil;Cytoplasm;mRNA processing;mRNA splicing;mRNA transport;Nonsense-mediated mRNA decay;Nucleus;Phosphoprotein;Reference proteome;RNA-binding;Spliceosome;Stress response;Translation regulation;Transport;Ubl conjugation	P38919; Q3LI66; P61326	TISSUE SPECIFICITY: Widely expressed. Overexpressed in breast cancers and metastasis, as well as in gastric cancers. {ECO:0000269|PubMed:12080473}.	GO:0000184; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006406; GO:0006417; GO:0008298; GO:0010494; GO:0016607; GO:0019899; GO:0030425; GO:0031625; GO:0031965; GO:0035145; GO:0042802; GO:0048471; GO:0071006; GO:2000622	PTM: ADP-ribosylated by tankyrase TNKS and TNKS2. Poly-ADP-ribosylated protein is recognized by RNF146, followed by ubiquitination. {ECO:0000269|PubMed:21478859}.; PTM: Ubiquitinated by RNF146 when poly-ADP-ribosylated, leading to its degradation. {ECO:0000269|PubMed:21478859}.	7490069; 12080473; 14702039; 16625196; 15489334; 11980659; 15166247; 16170325; 16314458; 17081983; 17652158; 17375189; 18669648; 19413330; 19369195; 19690332; 21269460; 21478859; 21406692; 23186163; 25220460; 24275569; 16923391; 16931718; 19033377; 20479275; 28502770; 29301961	CASC3 family
O15239	NDUA1_HUMAN	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Complex I-MWFE, CI-MWFE) (NADH-ubiquinone oxidoreductase MWFE subunit)	NDUFA1	70	9606			3D-structure;Disease variant;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Primarily expressed in heart and skeletal muscle.	GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776		8938439; 9224902; 15489334; 12611891; 27626371; 16959974; 17262856	Complex I NDUFA1 subunit family
O15240	VGF_HUMAN	Neurosecretory protein VGF [Cleaved into: Neuroendocrine regulatory peptide-1, NERP-1; Neuroendocrine regulatory peptide-2, NERP-2; VGF-derived peptide TLQP-21; VGF-derived peptide TLQP-62; Antimicrobial peptide VGF[554-577] ]	VGF	615	9606			3D-structure;Amidation;Antibiotic;Antimicrobial;Cleavage on pair of basic residues;Cytoplasmic vesicle;Direct protein sequencing;Growth factor;Phosphoprotein;Pyrrolidone carboxylic acid;Reference proteome;Secreted;Signal		TISSUE SPECIFICITY: Central and peripheral nervous systems, synthesized exclusively in neuronal and neuroendocrine cells. {ECO:0000269|PubMed:19194657}.	GO:0001541; GO:0002021; GO:0005179; GO:0005184; GO:0005615; GO:0005788; GO:0005794; GO:0006091; GO:0008083; GO:0009409; GO:0030073; GO:0030133; GO:0030667; GO:0031410; GO:0032868; GO:0033500; GO:0042593; GO:0042742; GO:0043005; GO:0043025; GO:0043084; GO:0043231; GO:0045202; GO:0048167; GO:0048168; GO:0051591	PTM: Multiple peptides are derived from VGF, with activities in synaptic plasticity, antidepression, penile erection, autonomic activation, and increases in energy expenditure. {ECO:0000250}.	9344675; 12853948; 15489334; 23250050; 19194657; 26091039; 28934328	
O15243	OBRG_HUMAN	Leptin receptor gene-related protein (Endospanin-1) (Leptin receptor overlapping transcript protein) (OB-R gene-related protein, OB-RGRP)	LEPROT LEPR OBR	131	9606			Endosome;Golgi apparatus;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q13520; P36382; P48357; Q8TBJ4; Q9UBD6; P30825; O43759-2; Q9BXJ8; O95807; P56557; Q9Y320; Q9Y548	TISSUE SPECIFICITY: Expressed at the highest levels in heart and placenta and at a lesser extent in lung, liver, skeletal muscle, kidney and pancreas.	GO:0000139; GO:0005102; GO:0005768; GO:0005794; GO:0010008; GO:0016021; GO:0032511; GO:0046426; GO:0060400; GO:1903955; GO:2000009		9207021; 16303743; 16710414; 15489334; 18042720; 19907080	OB-RGRP/VPS55 family
O15244	S22A2_HUMAN	Solute carrier family 22 member 2 (Organic cation transporter 2, hOCT2)	SLC22A2 OCT2	555	9606			Alternative splicing;Glycoprotein;Ion transport;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Mainly expressed in kidney. Localized at the luminal membrane and basolateral membrane of kidney distal tubule and proximal tubules. To a lower extent, expressed in neurons of the cerebral cortex and in various subcortical nuclei (at protein levels). Also detected in secretory phase endometrium; in scattered cells in the stroma. {ECO:0000269|PubMed:11912245, ECO:0000269|PubMed:17393420, ECO:0000269|PubMed:9260930, ECO:0000269|PubMed:9687576}.	GO:0005275; GO:0005326; GO:0005886; GO:0005887; GO:0006836; GO:0006919; GO:0007589; GO:0008504; GO:0010628; GO:0015101; GO:0015179; GO:0015214; GO:0015220; GO:0015562; GO:0015695; GO:0015837; GO:0015871; GO:0016020; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0061459; GO:0070062; GO:0072530; GO:0089718; GO:0090494; GO:0097638; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1902475; GO:1990962		9260930; 12089365; 14702039; 14574404; 15489334; 10942111; 9687576; 11758759; 11912245; 12538837; 15496291; 16314463; 16272756; 16006492; 15783073; 16394027; 16951202; 17072098; 16914559; 17582384; 17393420; 12142729; 17111267	Major facilitator (TC 2.A.1) superfamily, Organic cation transporter (TC 2.A.1.19) family
O15245	S22A1_HUMAN	Solute carrier family 22 member 1 (Organic cation transporter 1, hOCT1)	SLC22A1 OCT1	554	9606			Alternative splicing;Cell membrane;Glycoprotein;Ion transport;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport	Q96G23; Q9BZL3	TISSUE SPECIFICITY: Widely expressed with high level in liver. Isoform 1 and isoform 2 are expressed in liver. Isoform 1, isoform 2, isoform 3 and isoform 4 are expressed in glial cell lines. {ECO:0000269|PubMed:11388889, ECO:0000269|PubMed:9187257, ECO:0000269|PubMed:9260930}.	GO:0005277; GO:0005326; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0008504; GO:0008513; GO:0010248; GO:0015101; GO:0015214; GO:0015651; GO:0015695; GO:0015697; GO:0015874; GO:0016020; GO:0016323; GO:0016324; GO:0019534; GO:0042802; GO:0042908; GO:0042910; GO:0048241; GO:0051610; GO:0072530; GO:0090494; GO:0098793; GO:0150104; GO:1901998; GO:1990962	PTM: Phosphorylated. {ECO:0000250}.	9260930; 9187257; 11388889; 14702039; 14574404; 15489334; 9655880; 11408531; 15389554; 16263091; 16272756; 16436500; 16581093; 17635184; 24275569; 12439218; 12719534; 14697261; 15499200	Major facilitator (TC 2.A.1) superfamily, Organic cation transporter (TC 2.A.1.19) family
O15247	CLIC2_HUMAN	Chloride intracellular channel protein 2 (XAP121)	CLIC2	247	9606			3D-structure;Chloride;Chloride channel;Cytoplasm;Disease variant;Disulfide bond;Ion channel;Ion transport;Membrane;Mental retardation;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel	Q4KMQ1-2	TISSUE SPECIFICITY: Expressed in adult and fetal brain, heart, skeletal muscle, liver, lung, and spleen. Detected in adult stomach and testis. Expressed in fetal thymus and kidney. {ECO:0000269|PubMed:15147738, ECO:0000269|PubMed:22814392}.	GO:0004602; GO:0005244; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006749; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707; GO:0051099; GO:0060315; GO:1902476		9339381; 14702039; 15772651; 15489334; 12681486; 15147738; 15916532; 21269460; 22814392; 24275569; 17945253; 18186468	Chloride channel CLIC family
O15254	ACOX3_HUMAN	Peroxisomal acyl-coenzyme A oxidase 3, EC 1.3.3.6 (Branched-chain acyl-CoA oxidase, BRCACox) (Pristanoyl-CoA oxidase)	ACOX3 BRCOX PRCOX	700	9606	PATHWAY: Lipid metabolism; peroxisomal fatty acid beta-oxidation.	1.3.3.6	Acetylation;Alternative splicing;FAD;Fatty acid metabolism;Flavoprotein;Lipid metabolism;Oxidoreductase;Peroxisome;Phosphoprotein;Reference proteome			GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949		9271077; 15489334; 19369195; 22223895; 22814378; 25944712	Acyl-CoA oxidase family
O15258	RER1_HUMAN	Protein RER1	RER1	196	9606			Acetylation;Golgi apparatus;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	P57086; Q17RD7; O43516-4		GO:0005783; GO:0005793; GO:0005794; GO:0005886; GO:0006621; GO:0006890; GO:0009986; GO:0030173; GO:0033130; GO:0071340; GO:1903078		9309388; 15489334; 18691976; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 25489052; 25944712	RER1 family
O15259	NPHP1_HUMAN	Nephrocystin-1 (Juvenile nephronophthisis 1 protein)	NPHP1 NPH1	732	9606			3D-structure;Alternative splicing;Cell junction;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Differentiation;Disease variant;Joubert syndrome;Leber congenital amaurosis;Nephronophthisis;Phosphoprotein;Reference proteome;Senior-Loken syndrome;SH3 domain;Spermatogenesis;Tight junction	Q13444; Q8N157; O75161; P98161; Q14289; Q9Y265	TISSUE SPECIFICITY: Widespread expression, with highest levels in pituitary gland, spinal cord, thyroid gland, testis, skeletal muscle, lymph node and trachea. Weakly expressed in heart, kidney and pancreas. Expressed in nasal epithelial cells (at protein level) (PubMed:16308564). Expressed in the renal collecting duct (at protein level) (PubMed:18477472). {ECO:0000269|PubMed:16308564, ECO:0000269|PubMed:18477472}.	GO:0005198; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0005912; GO:0005923; GO:0005929; GO:0007165; GO:0007632; GO:0016020; GO:0030030; GO:0030036; GO:0031514; GO:0032391; GO:0048515; GO:0060041; GO:0090251; GO:0098609; GO:1903348	PTM: Phosphorylation by CK2 is required for the interaction with PACS1 and the targeting to the base region of cilia. {ECO:0000269|PubMed:16308564, ECO:0000269|PubMed:21357692}.	9361039; 9326933; 15815621; 15489334; 9856524; 12244321; 12872123; 12872122; 16308564; 15138899; 16885411; 18477472; 18633336; 20856870; 21565611; 21357692; 21633164; 26477546; 15723349; 10839884; 24746959	Nephrocystin-1 family
O15260	SURF4_HUMAN	Surfeit locus protein 4	SURF4 SURF-4	269	9606			Alternative splicing;Endoplasmic reticulum;Golgi apparatus;Membrane;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	P49257; Q86WV6; Q8VCW4		GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0010638; GO:0016021; GO:0030133; GO:0031965; GO:0032368; GO:0033116; GO:0035577; GO:0038024; GO:0042953; GO:0055088		10931946; 14702039; 15164053; 15489334; 7540914; 9740673; 15308636; 18287528; 21269460; 22814378; 25944712; 30251625; 29643117; 29251827; 32989016; 33186557; 34015269	SURF4 family
O15263	DFB4A_HUMAN	Beta-defensin 4A (Beta-defensin 2, BD-2, hBD-2) (Defensin, beta 2) (Skin-antimicrobial peptide 1, SAP1)	DEFB4A DEFB102 DEFB2 DEFB4; DEFB4B	64	9606			3D-structure;Antibiotic;Antimicrobial;Defensin;Disulfide bond;Reference proteome;Secreted;Signal		TISSUE SPECIFICITY: Expressed in the skin and respiratory tract.	GO:0005576; GO:0005615; GO:0005796; GO:0006935; GO:0006955; GO:0007186; GO:0031640; GO:0031731; GO:0042056; GO:0042742; GO:0050829; GO:0050830; GO:0060326; GO:0061844		9202117; 9831658; 10603376; 10837369; 15489334; 12010514; 20068036; 10906336; 11714914	Beta-defensin family, LAP/TAP subfamily
O15264	MK13_HUMAN	Mitogen-activated protein kinase 13, MAP kinase 13, MAPK 13, EC 2.7.11.24 (Mitogen-activated protein kinase p38 delta, MAP kinase p38 delta) (Stress-activated protein kinase 4)	MAPK13 PRKM13 SAPK4	365	9606		2.7.11.24	3D-structure;Alternative splicing;ATP-binding;Cell cycle;Kinase;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Stress response;Transcription;Transcription regulation;Transferase	P21462; Q15139; P40763	TISSUE SPECIFICITY: Expressed in testes, pancreas, small intestine, lung and kidney. Abundant in macrophages, also present in neutrophils, CD4+ T-cells, and endothelial cells. {ECO:0000269|PubMed:10201954, ECO:0000269|PubMed:9374491}.	GO:0004674; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006970; GO:0007049; GO:0018105; GO:0032755; GO:0034644; GO:0035556; GO:0050729; GO:0051403; GO:0070301; GO:0071347; GO:0072709; GO:0072740; GO:0106310; GO:1903936	PTM: Dually phosphorylated on Thr-180 and Tyr-182 by MAP2K3/MKK3, MAP2K4/MKK4, MAP2K6/MKK6 and MAP2K7/MKK7, which activates the enzyme. Dephosphorylated by dual specificity phosphatase DUSP1. {ECO:0000269|PubMed:9374491}.	9218798; 9374491; 9295308; 9207191; 10066767; 10727080; 14574404; 15489334; 9731215; 10201954; 11378392; 11500363; 11943212; 15632108; 17256148; 18006338; 18088087; 18367666; 19369195; 20478268; 20090411; 20626350; 21269460; 17344846	Protein kinase superfamily, CMGC Ser/Thr protein kinase family, MAP kinase subfamily
O15265	ATX7_HUMAN	Ataxin-7 (Spinocerebellar ataxia type 7 protein)	ATXN7 SCA7	892	9606			3D-structure;Alternative splicing;Cytoplasm;Cytoskeleton;Disease variant;Isopeptide bond;Neurodegeneration;Nucleus;Reference proteome;Spinocerebellar ataxia;Transcription;Transcription regulation;Triplet repeat expansion;Ubl conjugation	O00468; Q9P209; Q8N2S1; O00339; O75095; Q7Z7M0; Q9Y3T9; P37198; Q8IUQ4; Q9BX66; Q12962; Q9Y4A5; P02283	TISSUE SPECIFICITY: Isoform a and isoform b are expressed in CNS, but isoform a is expressed predominantly in the peripherical tissues. Isoform b is also highly expressed in the frontal lobe, skeletal muscle and spinal cord and is expressed at a lower level in the lung, lymphoblast and intestine.	GO:0000124; GO:0000226; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006282; GO:0006357; GO:0006997; GO:0007026; GO:0007601; GO:0015630; GO:0016363; GO:0016578; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893	PTM: Proteolytically cleaved. The cleavage may be involved in SCA7 degeneration: the isoform fragments may exert distinct toxic influences that could contribute to selective neurodegeneration.; PTM: Sumoylation decreases the aggregation propensity and cellular toxicity of forms with an expanded poly-Gln region but has no effect on subcellular location or interaction with components of the STAGA complex. {ECO:0000269|PubMed:19843541}.	9288099; 9425224; 14702039; 16641997; 12533095; 10441328; 11371513; 11734547; 15115762; 15932940; 16314424; 18206972; 19843541; 22100762; 28112733	Ataxin-7 family
O15266	SHOX_HUMAN	Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein)	SHOX PHOG	292	9606			Activator;Alternative splicing;Developmental protein;Disease variant;DNA-binding;Dwarfism;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation	P35711; P35712; Q9BZE0; Q9Y5R4; P78318; P52952	TISSUE SPECIFICITY: SHOXA is expressed in skeletal muscle, placenta, pancreas, heart and bone marrow fibroblast and SHOXB is highly expressed in bone marrow fibroblast followed by kidney and skeletal muscle. SHOXB is not expressed in brain, kidney, liver and lung. Highly expressed in osteogenic cells.	GO:0000785; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0043231; GO:0043565; GO:0045944; GO:1990837		9140395; 9259282; 15772651; 11030412; 11891678; 11403039; 11889214	Paired homeobox family, Bicoid subfamily
O15269	SPTC1_HUMAN	Serine palmitoyltransferase 1, EC 2.3.1.50 (Long chain base biosynthesis protein 1, LCB 1) (Serine-palmitoyl-CoA transferase 1, SPT 1, SPT1)	SPTLC1 LCB1	473	9606	PATHWAY: Lipid metabolism; sphingolipid metabolism. {ECO:0000269|PubMed:19416851}.	2.3.1.50	3D-structure;Acyltransferase;Alternative splicing;Disease variant;Endoplasmic reticulum;Lipid metabolism;Membrane;Neurodegeneration;Neuropathy;Phosphoprotein;Pyridoxal phosphate;Reference proteome;Sphingolipid metabolism;Transferase;Transmembrane;Transmembrane helix	Q8N138; Q9NUV7; Q86SG2; Q6ZR37; Q8IYM2; Q8WXH5; Q9UNE7	TISSUE SPECIFICITY: Widely expressed. Not detected in small intestine. {ECO:0000269|PubMed:17023427}.	GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0035339; GO:0046511; GO:0046512; GO:0046513; GO:1904504; GO:1904649	PTM: Phosphorylation at Tyr-164 inhibits activity and promotes cell survival. {ECO:0000269|PubMed:23629659}.	9363775; 11242114; 14702039; 15164053; 15489334; 17023427; 19416851; 20504773; 20182505; 21269460; 21994399; 23629659; 25944712; 15037712; 17060578; 16959974; 19651702; 19132419; 21618344; 22302274; 23454272; 24247255; 30420926	Class-II pyridoxal-phosphate-dependent aminotransferase family
O15270	SPTC2_HUMAN	Serine palmitoyltransferase 2, EC 2.3.1.50 (Long chain base biosynthesis protein 2, LCB 2) (Long chain base biosynthesis protein 2a, LCB2a) (Serine-palmitoyl-CoA transferase 2, SPT 2)	SPTLC2 KIAA0526 LCB2	562	9606	PATHWAY: Lipid metabolism; sphingolipid metabolism.	2.3.1.50	3D-structure;Acyltransferase;Disease variant;Endoplasmic reticulum;Lipid metabolism;Membrane;Neurodegeneration;Neuropathy;Pyridoxal phosphate;Reference proteome;Sphingolipid metabolism;Transferase;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:17023427}.	GO:0004758; GO:0005789; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504		9363775; 9628581; 12508121; 15489334; 8921873; 7506601; 17023427; 19648650; 19416851; 20920666; 21269460; 21994399; 23658386; 26573920	Class-II pyridoxal-phosphate-dependent aminotransferase family
O15273	TELT_HUMAN	Telethonin (Titin cap protein)	TCAP	167	9606			3D-structure;Cardiomyopathy;Cytoplasm;Disease variant;Limb-girdle muscular dystrophy;Phosphoprotein;Reference proteome	Q9NWX5; Q86V38; P54253; Q9H2G9; Q5BKX5-3; P55212; P45973; Q9BXL8; P28329-3; P02489; P50461; O75190-2; Q14204; P00488; P0C7A2-2; P22607; P14136; O14908-2; Q14957; P06396; O00291; Q9UKT9; Q8WXH2; O14901; Q3SYF9; P13473-2; A0A0C4DGV4; Q9NPC6; Q13153; P16284; Q9H8W4; O75400-2; P20339; P62826; Q5SSQ6-2; Q12933; Q6DKK2; Q8WZ42; Q8WZ42-3; P61086; Q9UMX0; P08670; Q9Y649	TISSUE SPECIFICITY: Heart and skeletal muscle.	GO:0001756; GO:0003009; GO:0003300; GO:0005829; GO:0007512; GO:0008307; GO:0014898; GO:0030018; GO:0030240; GO:0030241; GO:0030674; GO:0030916; GO:0031432; GO:0031674; GO:0035994; GO:0035995; GO:0036122; GO:0044325; GO:0045214; GO:0048769; GO:0050982; GO:0051373; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0065003; GO:0070080; GO:1990733		9350988; 15489334; 9645487; 10984498; 11842093; 15136035; 24860983; 16407954; 16713295; 10655062; 12507422; 16352453; 16490376; 16650785; 15582318	
O15287	FANCG_HUMAN	Fanconi anemia group G protein, Protein FACG (DNA repair protein XRCC9)	FANCG XRCC9	622	9606			3D-structure;Cytoplasm;Disease variant;DNA damage;DNA repair;Fanconi anemia;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat	Q92870-2; P54252; Q8TD31-3; P08684; G5E9A7; O15360; O15360-3; Q9NPI8; P14136; Q53GS7; P04792; Q8WXH2; O60333-2; O14901; P19404; P29474; Q9BVL2; P16284; Q13393; Q99633; P60891; P20339; Q7Z699; Q13813; P51687; Q8N8B7-2; Q8N7U7-2; P08670; O76024; Q86UD4; P14079	TISSUE SPECIFICITY: Highly expressed in testis and thymus. Found in lymphoblasts.	GO:0000785; GO:0001541; GO:0003684; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0006513; GO:0006974; GO:0007005; GO:0007286; GO:0009314; GO:0036297; GO:0043240		9256465; 9806548; 15164053; 15489334; 10373536; 12724401; 15299030; 15502827; 16116422; 18212739; 22343915; 22705371; 22266823; 11093276; 16959974; 18550849	
O15294	OGT1_HUMAN	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, EC 2.4.1.255 (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit, OGT)	OGT	1046	9606	PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:15361863, ECO:0000269|PubMed:21240259, ECO:0000269|PubMed:21285374, ECO:0000269|PubMed:23103939, ECO:0000269|PubMed:26678539}.	2.4.1.255	3D-structure;Acetylation;Alternative splicing;Apoptosis;Biological rhythms;Cell membrane;Cell projection;Chromatin regulator;Cytoplasm;Direct protein sequencing;Disease variant;Glycoprotein;Glycosyltransferase;Host-virus interaction;Lipid-binding;Membrane;Mental retardation;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Transferase;Ubl conjugation;Ubl conjugation pathway	P51610; O95644; Q9H1M0; Q8NDX5; P36873; P11464; Q04206; O95721; Q15750; E7EQS8; Q6N021; Q6N021-1; O43151; Q9UPV9; O94763; O94763-1; P09022; P63088; Q8BG87; A0A0S2Z5B5; Q9H1M0; Q9UHR5; Q8N9R8; Q15973	TISSUE SPECIFICITY: Highly expressed in pancreas and to a lesser extent in skeletal muscle, heart, brain and placenta. Present in trace amounts in lung and liver. {ECO:0000269|PubMed:9083068}.	GO:0000122; GO:0000123; GO:0000423; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016262; GO:0016485; GO:0016580; GO:0017122; GO:0030097; GO:0030336; GO:0030512; GO:0031397; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045862; GO:0045893; GO:0045944; GO:0046626; GO:0048015; GO:0051571; GO:0060544; GO:0061087; GO:0080182; GO:0097363; GO:0120162; GO:1900095; GO:1902455; GO:1902459	PTM: Ubiquitinated, leading to its proteasomal degradation. {ECO:0000269|PubMed:21285374}.; PTM: Phosphorylation on Ser-3 or Ser-4 by GSK3-beta positively regulates its activity. {ECO:0000250}.	9083068; 11773972; 17974005; 15489334; 12150998; 12670868; 18669648; 19413330; 19451179; 19073609; 19377461; 24336203; 20018852; 20018868; 20200153; 20824293; 21269460; 22121020; 21285374; 22814378; 22923583; 23353889; 23629655; 23186163; 23222540; 24995978; 24474760; 26678539; 27527864; 28742148; 30699359; 15361863; 21240259; 23103939; 26273451; 28302723; 28584052	Glycosyltransferase 41 family, O-GlcNAc transferase subfamily
O15296	LX15B_HUMAN	Polyunsaturated fatty acid lipoxygenase ALOX15B (15-lipoxygenase 2, 15-LOX-2) (Arachidonate 15-lipoxygenase B, 15-LOX-B, EC 1.13.11.33) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb, EC 1.13.11.-)	ALOX15B	676	9606	PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid biosynthesis. {ECO:0000269|PubMed:10542053}.	1.13.11.-; 1.13.11.33	3D-structure;Alternative splicing;Calcium;Cell junction;Cell membrane;Cytoplasm;Cytoskeleton;Dioxygenase;Iron;Lipid metabolism;Lipid-binding;Membrane;Metal-binding;Nucleus;Oxidoreductase;Reference proteome	Q96NT0; P78358; Q9H3M0; P10276; Q9BWF2; P19474	TISSUE SPECIFICITY: Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. {ECO:0000269|PubMed:10542053, ECO:0000269|PubMed:11350124, ECO:0000269|PubMed:9177185}.	GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006629; GO:0006644; GO:0006915; GO:0008285; GO:0008289; GO:0010744; GO:0016020; GO:0016165; GO:0016702; GO:0019369; GO:0019372; GO:0019898; GO:0030336; GO:0030850; GO:0030856; GO:0032722; GO:0034440; GO:0035360; GO:0036403; GO:0043651; GO:0045618; GO:0045786; GO:0045926; GO:0050473; GO:0051122; GO:0070062; GO:0071926; GO:1901696; GO:1990136; GO:2001303		9177185; 11350124; 11839751; 16625196; 15489334; 10542053; 10625675; 11956198; 12704195; 16112079; 17493578; 18067895; 18311922; 18755188; 22912809; 24282679; 27145229; 27435673; 32404334; 24497644	Lipoxygenase family
O15297	PPM1D_HUMAN	Protein phosphatase 1D, EC 3.1.3.16 (Protein phosphatase 2C isoform delta, PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1)	PPM1D WIP1	605	9606		3.1.3.16	Alternative splicing;Autism spectrum disorder;Cell cycle;Cytoplasm;Disease variant;Hydrolase;Magnesium;Manganese;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome	P16104; Q00987; Q13950	TISSUE SPECIFICITY: Expressed in fetal and adult brain. Also detected in fetal liver and skeletal muscle, but not in their adult counterparts. {ECO:0000269|PubMed:28343630}.	GO:0000086; GO:0004674; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006306; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0030330; GO:0031507; GO:0035970; GO:0045814; GO:0046872; GO:0051019; GO:0060260		9177166; 16625196; 15489334; 15870257; 16311512; 19690332; 21283629; 23186163; 23242139; 28343630	PP2C family
O15303	GRM6_HUMAN	Metabotropic glutamate receptor 6, mGluR6	GRM6 GPRC1F MGLUR6	877	9606			Cell membrane;Cell projection;Congenital stationary night blindness;Disease variant;Disulfide bond;Endoplasmic reticulum;G-protein coupled receptor;Glycoprotein;Golgi apparatus;Membrane;Receptor;Reference proteome;Sensory transduction;Signal;Transducer;Transmembrane;Transmembrane helix;Vision		TISSUE SPECIFICITY: Detected in melanocytes. {ECO:0000269|PubMed:23452348}.	GO:0000139; GO:0001640; GO:0004930; GO:0005789; GO:0005886; GO:0005887; GO:0007216; GO:0007268; GO:0007626; GO:0008066; GO:0009584; GO:0030425; GO:0035841; GO:0042803; GO:0045202; GO:0050908; GO:0051966; GO:0060041; GO:0090280		9215706; 15372022; 23452348; 15781871; 16959974; 17405131; 23714322	G-protein coupled receptor 3 family
O15304	SIVA_HUMAN	Apoptosis regulatory protein Siva (CD27-binding protein, CD27BP)	SIVA1 SIVA	175	9606			Alternative splicing;Apoptosis;Cytoplasm;Host-virus interaction;Metal-binding;Nucleus;Pharmaceutical;Phosphoprotein;Reference proteome;Zinc	P10415; Q07817; Q07817-1; P26842; Q9NR77; P03129; Q07817-1; P29972; Q2NKX9; Q8NEC5; Q02930-3; P49639; A0A0C4DG38; Q6PEX3; Q96HA8; Q8IYS1; Q7Z6R9; Q9NWS9-2	TISSUE SPECIFICITY: Ubiquitous. Mostly expressed in thymus, testis, ovary, prostate, small intestine and spleen and less in colon.	GO:0001618; GO:0005164; GO:0005175; GO:0005654; GO:0005737; GO:0005739; GO:0006924; GO:0008270; GO:0032088; GO:0046872; GO:0097191; GO:0097193; GO:1901030	PTM: Phosphorylated by ABL2/ARG in response to oxidative stress. {ECO:0000269|PubMed:11278261}.	9177220; 15489334; 10756043; 11278261; 11601913; 12011449; 14739602; 15034012; 15958577; 16683188; 16491128; 24275569	
O15305	PMM2_HUMAN	Phosphomannomutase 2, PMM 2, EC 5.4.2.8	PMM2	246	9606	PATHWAY: Nucleotide-sugar biosynthesis; GDP-alpha-D-mannose biosynthesis; alpha-D-mannose 1-phosphate from D-fructose 6-phosphate: step 2/2.	5.4.2.8	3D-structure;Acetylation;Alternative splicing;Congenital disorder of glycosylation;Cytoplasm;Disease variant;Isomerase;Magnesium;Metal-binding;Reference proteome	Q96HD9; Q6FHY5; Q9HBY8-2		GO:0004615; GO:0005654; GO:0005829; GO:0006013; GO:0006486; GO:0006487; GO:0009298; GO:0043025; GO:0046872		9140401; 9425221; 14702039; 15616553; 15489334; 16540464; 21269460; 22223895; 22814378; 24275569; 17850744; 10527672; 9497260; 9781039; 10066032; 10602363; 10571956; 11058895; 11058896; 10801058; 11350185; 12357336; 15844218; 17307006	Eukaryotic PMM family
O15315	RA51B_HUMAN	DNA repair protein RAD51 homolog 2, R51H2 (RAD51 homolog B, Rad51B) (RAD51-like protein 1)	RAD51B RAD51L1 REC2	384	9606			Alternative splicing;ATP-binding;Chromosomal rearrangement;DNA damage;DNA recombination;DNA repair;DNA-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	Q8IZU0; Q6FHY5; O43502; O75771; Q86UA6; Q6NVH7	TISSUE SPECIFICITY: Expressed in a wide range of tissues.	GO:0000724; GO:0001832; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0006281; GO:0006310; GO:0007131; GO:0008094; GO:0008284; GO:0010971; GO:0033063; GO:0061053	PTM: Phosphorylated on tyrosine residues by BCR-ABL. {ECO:0000269|PubMed:19657362}.	9207106; 9441753; 9512535; 12508121; 15489334; 12649198; 11751635; 11751636; 11842113; 11744692; 11842112; 12427746; 9892177; 11978964; 12441335; 14704354; 19657362; 21965664; 23108668; 23149936; 24005041; 20207730	RecA family, RAD51 subfamily
O15318	RPC7_HUMAN	DNA-directed RNA polymerase III subunit RPC7, RNA polymerase III subunit C7 (DNA-directed RNA polymerase III subunit G) (RNA polymerase III 32 kDa apha subunit, RPC32-alpha) (RNA polymerase III 32 kDa subunit, RPC32)	POLR3G	223	9606			3D-structure;Antiviral defense;Cytoplasm;DNA-directed RNA polymerase;Immunity;Innate immunity;Nucleus;Phosphoprotein;Reference proteome;Transcription	Q9BUI4; Q9H1D9	TISSUE SPECIFICITY: Barely detectable in differentiated tissues. Expressed in embryonic stem cells and in other dividing cells, such as some tumor cell lines. {ECO:0000269|PubMed:20154270, ECO:0000269|PubMed:24107381, ECO:0000269|PubMed:28494942}.	GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0008283; GO:0016604; GO:0032728; GO:0045087; GO:0045089; GO:0051607		9171375; 14702039; 15372022; 12391170; 18669648; 19631370; 19609254; 20154270; 20068231; 21358628; 21406692; 21898682; 23186163; 24107381; 26394183; 27339422; 28494942	Eukaryotic RPC7 RNA polymerase subunit family
O15327	INP4B_HUMAN	Inositol polyphosphate 4-phosphatase type II (Type II inositol 3,4-bisphosphate 4-phosphatase, EC 3.1.3.66)	INPP4B	924	9606	PATHWAY: Signal transduction; phosphatidylinositol signaling pathway. {ECO:0000250|UniProtKB:Q9QWG5}.	3.1.3.66	Alternative splicing;Hydrolase;Lipid metabolism;Reference proteome		TISSUE SPECIFICITY: Widely expressed with highest levels occurring in the skeletal muscle and heart. {ECO:0000269|PubMed:9295334}.	GO:0005737; GO:0005829; GO:0006661; GO:0007165; GO:0016316; GO:0017161; GO:0034597; GO:0043647; GO:0046855; GO:0046856; GO:0052828		9295334; 15815621; 15489334; 19647222; 24070612; 24591580	Inositol 3,4-bisphosphate 4-phosphatase family
O15342	VA0E1_HUMAN	V-type proton ATPase subunit e 1, V-ATPase subunit e 1 (V-ATPase 9.2 kDa membrane accessory protein) (V-ATPase M9.2 subunit) (Vacuolar proton pump subunit e 1)	ATP6V0E1 ATP6H ATP6V0E	81	9606			3D-structure;Glycoprotein;Hydrogen ion transport;Ion transport;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transport	P05090; O14735; Q4VAQ0; P54849; O00155; P43628; Q969L2; Q5J8X5; Q96JQ5; Q9UHE5; P35372-10; P26678; Q9BQS2-2; A2RU14; Q8TBM7; Q96EC8	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:17350184}.	GO:0005765; GO:0007035; GO:0010008; GO:0016021; GO:0016241; GO:0016787; GO:0030670; GO:0033179; GO:0042625; GO:0046961; GO:0055085; GO:1902600		9556572; 14702039; 15489334; 17350184; 33065002	V-ATPase e1/e2 subunit family
O15344	TRI18_HUMAN	E3 ubiquitin-protein ligase Midline-1, EC 2.3.2.27 (Midin) (Putative transcription factor XPRF) (RING finger protein 59) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18)	MID1 FXY RNF59 TRIM18 XPRF	667	9606		2.3.2.27	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Metal-binding;Microtubule;Phosphoprotein;Reference proteome;Repeat;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	Q13895; Q16543; Q49AN0; Q9NR20; Q08426; Q14241; O95208-2; I6L9I8; Q9Y247; Q0VDC6; Q53SE7; Q96IK5; P78318; Q9HAQ2; P50221; O15344; Q9UJV3-2; O75113; Q96DC9; Q16512; Q8WV60; Q8N8B7; P51668; P62837; P61077; Q9Y2X8; Q96LR5; Q969T4; P61086; P68036; O14933; Q9HAC8; Q5T7W0	TISSUE SPECIFICITY: In the fetus, highest expression found in kidney, followed by brain and lung. Expressed at low levels in fetal liver. In the adult, most abundant in heart, placenta and brain.	GO:0000226; GO:0005794; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0007026; GO:0007389; GO:0008017; GO:0008270; GO:0016740; GO:0019899; GO:0031625; GO:0032874; GO:0034451; GO:0035372; GO:0042802; GO:0042803; GO:0051219	PTM: Phosphorylated on serine and threonine residues. {ECO:0000269|PubMed:11806752}.	9354791; 9425238; 9722948; 11030761; 11331580; 14702039; 15489334; 10400985; 10077590; 11685209; 11806752; 17081983; 18669648; 19413330; 21406692; 22613722; 22629402; 23186163; 24275569; 16529770; 9718340; 15558842	TRIM/RBCC family
O15347	HMGB3_HUMAN	High mobility group protein B3 (High mobility group protein 2a, HMG-2a) (High mobility group protein 4, HMG-4)	HMGB3 HMG2A HMG4	200	9606			3D-structure;Acetylation;Chromosome;Cytoplasm;Disulfide bond;DNA-binding;Immunity;Innate immunity;Microphthalmia;Nucleus;Oxidation;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	P50221; Q6FHY5; Q02548; P26367; O00560; Q9NYB0	TISSUE SPECIFICITY: Expressed predominantly in placenta.	GO:0000400; GO:0003690; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0006310; GO:0006357; GO:0008301; GO:0032392; GO:0045087; GO:0045578; GO:0045638	PTM: Reduction/oxidation of cysteine residues Cys-23, Cys-45 and Cys-104 and a possible intramolecular disulfide bond involving Cys-23 and Cys-45 give rise to different redox forms with specific functional activities in various cellular compartments: 1- fully reduced HMGB3 (HMGB3C23hC45hC104h), 2- disulfide HMGB3 (HMGB3C23-C45C104h) and 3- sulfonyl HMGB3 (HMGB3C23soC45soC104so). {ECO:0000250|UniProtKB:P09429, ECO:0000305|PubMed:24531895}.	9370291; 15772651; 15489334; 21269460; 25944712; 20598277; 24993872; 24531895	HMGB family
O15350	P73_HUMAN	Tumor protein p73 (p53-like transcription factor) (p53-related protein)	TP73 P73	636	9606			3D-structure;Activator;Alternative promoter usage;Alternative splicing;Apoptosis;Cell cycle;Ciliopathy;Cytoplasm;Disease variant;DNA-binding;Host-virus interaction;Isopeptide bond;Lissencephaly;Metal-binding;Nucleus;Phosphoprotein;Primary ciliary dyskinesia;Reference proteome;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Zinc	O14965; Q09472; P38646; Q96J02; Q00987; P54278-1; Q7Z419; Q13950; Q96EB6; Q13625; Q9H3D4; O15350; P46937; Q9ESJ1; Q9UKL3; Q96J02; P46937; P03126; Q96J02; Q7Z419	TISSUE SPECIFICITY: Expressed in striatal neurons of patients with Huntington disease (at protein level). Brain, kidney, placenta, colon, heart, liver, spleen, skeletal muscle, prostate, thymus and pancreas. Highly expressed in fetal tissue. Expressed in the respiratory epithelium (PubMed:34077761). {ECO:0000269|PubMed:11753569, ECO:0000269|PubMed:16461361, ECO:0000269|PubMed:34077761}.	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001228; GO:0001822; GO:0002039; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006298; GO:0006357; GO:0006974; GO:0007049; GO:0007346; GO:0008285; GO:0008630; GO:0009410; GO:0010243; GO:0010468; GO:0019901; GO:0030054; GO:0042771; GO:0042802; GO:0043065; GO:0043231; GO:0043410; GO:0045665; GO:0045893; GO:0045944; GO:0046872; GO:0048714; GO:0051262; GO:0051726; GO:0060044; GO:0061629; GO:0097371; GO:0140297	PTM: Isoform alpha (but not isoform beta) is sumoylated on Lys-627, which potentiates proteasomal degradation but does not affect transcriptional activity. Phosphorylation by PLK1 and PLK3 inhibits the transcription regulator activity and pro-apoptotic function. {ECO:0000269|PubMed:10961991}.; PTM: Higher levels of phosphorylation seen in the brain from patients with Huntington disease.; PTM: Polyubiquitinated by RCHY1/PIRH2; leading to its degradation by the proteasome. {ECO:0000269|PubMed:19581926, ECO:0000269|PubMed:21994467}.	9288759; 9721206; 9802988; 10381648; 10362363; 11753569; 14702039; 16710414; 15489334; 10391251; 10203277; 10961991; 11706030; 11925430; 12890487; 15070730; 15558019; 16461361; 18418051; 18174154; 17535448; 18280240; 19490146; 19581926; 21994467; 24314664; 28112733; 28291250; 10449409; 34077761	P53 family
O15353	FOXN1_HUMAN	Forkhead box protein N1 (Winged-helix transcription factor nude)	FOXN1 RONU WHN	648	9606			3D-structure;Developmental protein;Differentiation;Disease variant;DNA-binding;Hypotrichosis;Nucleus;Reference proteome;Transcription;Transcription regulation	P32320; Q9UJX2; Q9NQL9; P49639; Q68G74; O60336; Q13526; Q9H0A9-2; Q08117-2; Q12933; O75865-2; Q9BXA7	TISSUE SPECIFICITY: Expressed in thymus.	GO:0000785; GO:0000976; GO:0000981; GO:0001228; GO:0001942; GO:0002360; GO:0005634; GO:0006357; GO:0006952; GO:0008544; GO:0009887; GO:0030216; GO:0030858; GO:0035878; GO:0043029; GO:0048514; GO:0051798; GO:0097535; GO:0097536; GO:1902232		9321431; 14702039; 10206641; 21507891; 25173801; 23874334; 24432845; 20978268; 28636882; 31447097; 31566583	
O15354	GPR37_HUMAN	Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1, ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor, PAELR)	GPR37	613	9606			Cell membrane;Disulfide bond;Endoplasmic reticulum;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Signal;Transducer;Transmembrane;Transmembrane helix;Ubl conjugation	P29274; D3DTF8; Q02930-3; O15540; Q5HYJ3-3; Q9UBS5; Q13639; Q5TA79; Q8IXL7-2; Q14995; Q14671; Q7Z7K5; Q969E2; P34741; P08195; Q01959; A0A024R4B0; Q9NX61; Q71RG4-4; Q9H313; O95070; Q5BJH7; P25490; Q9C0A1; Q7L8T7	TISSUE SPECIFICITY: Expressed in brain and spinal cord, and at lower levels in testis, placenta and liver, but no detectable expression observed in any other tissue. When overexpressed in cells, tends to become insoluble and unfolded. Accumulation of the unfolded protein may lead to dopaminergic neuronal death in juvenile Parkinson disease (PDJ). {ECO:0000269|PubMed:9526070}.	GO:0000151; GO:0004930; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007218; GO:0008188; GO:0008528; GO:0009986; GO:0016358; GO:0030165; GO:0030544; GO:0031072; GO:0031625; GO:0031987; GO:0036505; GO:0042277; GO:0042416; GO:0042923; GO:0043235; GO:0043410; GO:0045202; GO:0045964; GO:1903206	PTM: Ubiquitinated by PRKN in the presence of UBE2E1 and UBE2L3 in the endoplasmic reticulum. The unfolded form is specifically ubiquitinated by SYVN1, which promotes its proteasomal degradation and prevents neuronal cell death. {ECO:0000269|PubMed:17059562}.	9339362; 9526070; 9144577; 11439185; 12853948; 12690205; 15489334; 12150907; 14532270; 17059562; 23690594	G-protein coupled receptor 1 family
O15355	PPM1G_HUMAN	Protein phosphatase 1G, EC 3.1.3.16 (Protein phosphatase 1C) (Protein phosphatase 2C isoform gamma, PP2C-gamma) (Protein phosphatase magnesium-dependent 1 gamma)	PPM1G PPM1C	546	9606		3.1.3.16	Acetylation;Cytoplasm;Hydrolase;Lipoprotein;Magnesium;Manganese;Membrane;Metal-binding;Methylation;Myristate;Phosphoprotein;Protein phosphatase;Reference proteome;Repeat	P54274; P13010; P12956; P67809; P04608	TISSUE SPECIFICITY: Widely expressed. Most abundant in testis, skeletal muscle, and heart.	GO:0004722; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0016020; GO:0035970; GO:0046872; GO:0051726		9276438; 15489334; 17525332; 18669648; 19690332; 19608861; 20068231; 21269460; 21406692; 23186163; 24275569; 24129315; 25255805; 25807930	PP2C family
O15357	SHIP2_HUMAN	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2, EC 3.1.3.86 (Inositol polyphosphate phosphatase-like protein 1, INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2, SH2 domain-containing inositol phosphatase 2, SHIP-2)	INPPL1 SHIP2	1258	9606		3.1.3.86	3D-structure;Actin-binding;Alternative splicing;Cell adhesion;Cell projection;Cytoplasm;Cytoskeleton;Diabetes mellitus;Disease variant;Hydrolase;Immunity;Lipid metabolism;Membrane;Nucleus;Phosphoprotein;Reference proteome;SH2 domain;SH3-binding	P10275; P56945; P46108; Q13480; Q8IV36; Q15811-2; P08581; Q9BX66; O60504-1; A0A061I5T4; P29317	TISSUE SPECIFICITY: Widely expressed, most prominently in skeletal muscle, heart and brain. Present in platelets. Expressed in transformed myeloid cells and in primary macrophages, but not in peripheral blood monocytes. {ECO:0000269|PubMed:12676785, ECO:0000269|PubMed:12690104, ECO:0000269|PubMed:8530088, ECO:0000269|PubMed:9367831, ECO:0000269|PubMed:9660833}.	GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006006; GO:0006661; GO:0006897; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0034485; GO:0042169; GO:0046856; GO:0097178	PTM: Tyrosine phosphorylated by the members of the SRC family after exposure to a diverse array of extracellular stimuli such as insulin, growth factors such as EGF or PDGF, chemokines, integrin ligands and hypertonic and oxidative stress. May be phosphorylated upon IgG receptor FCGR2B-binding. Phosphorylated at Tyr-986 following cell attachment and spreading. Phosphorylated at Tyr-1162 following EGF signaling pathway stimulation. Phosphorylated at Thr-958 in response to PDGF. {ECO:0000269|PubMed:10194451, ECO:0000269|PubMed:11158326, ECO:0000269|PubMed:11349134, ECO:0000269|PubMed:11687594, ECO:0000269|PubMed:12235291, ECO:0000269|PubMed:12690104, ECO:0000269|PubMed:17219406, ECO:0000269|PubMed:9660833}.	8530088; 9367831; 16554811; 15489334; 9660833; 10194451; 11016922; 11349134; 11739414; 11158326; 11687594; 12235291; 12504111; 12676785; 12690104; 15592455; 17081983; 16824732; 16302969; 15668240; 15735664; 17314030; 17135240; 17219406; 12086927; 15220217; 15687335; 17557929; 18691976; 18669648; 20068231; 21269460; 20933011; 21624956; 23273569; 23186163	Inositol 1,4,5-trisphosphate 5-phosphatase family
O15360	FANCA_HUMAN	Fanconi anemia group A protein, Protein FACA	FANCA FAA FACA FANCH	1455	9606			3D-structure;Alternative splicing;Cytoplasm;Disease variant;DNA damage;DNA repair;Fanconi anemia;Nucleus;Phosphoprotein;Reference proteome	Q0VG06; Q6NZ36-1; Q9NPI8; O15287; P62993; O15287		GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0042127; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:2000348	PTM: Phosphorylation is required for the formation of the nuclear complex. Not phosphorylated in cells derived from groups A, B, C, E, F, G, and H. {ECO:0000269|PubMed:9789045}.	8896563; 9169126; 14702039; 15616553; 15489334; 9721219; 9711872; 9742112; 12724401; 9789045; 15299030; 15502827; 16116422; 17525332; 18550849; 18691976; 22343915; 22705371; 22266823; 23186163; 9399890; 9371798; 10521298; 10094191; 10210316; 9929978; 11091222; 10807541; 17924555; 18987736	
O15370	SOX12_HUMAN	Transcription factor SOX-12 (Protein SOX-22)	SOX12 SOX22	315	9606			Activator;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation		TISSUE SPECIFICITY: Expressed most abundantly in the CNS (PubMed:9215677). Expressed in the heart, pancreas, thymus, testis and ovary (PubMed:9215677). Weakly expressed in brain, placenta, lung, liver, skeletal muscle, kidney, spleen, prostate, small intestine, colon, and peripheral blood lymphocytes (PubMed:9215677). {ECO:0000269|PubMed:9215677}.	GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005654; GO:0006355; GO:0009653; GO:0021510; GO:0030154; GO:0032993; GO:0045165; GO:0045591; GO:0045944; GO:1990837		9215677; 11780052; 15489334	
O15371	EIF3D_HUMAN	Eukaryotic translation initiation factor 3 subunit D, eIF3d (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)	EIF3D EIF3S7	548	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Host-virus interaction;Initiation factor;Phosphoprotein;Protein biosynthesis;Reference proteome;RNA-binding	O15084; Q7L4P6; Q86Z20; Q2TAC2-2; Q8NHQ1; Q92997; P60228; A6NEM1; Q9NSC5; Q96ED9-2; O75031; Q9BVG8-5; Q9BRK4; Q6PF18; Q5JR59-3; Q8WV24; Q9NRD5; P62487; Q04864; P21673; Q9UBB9; P36406; P14373; Q9UGI0; Q9Q2G4		GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416		9341143; 15461802; 14702039; 10591208; 15489334; 12773399; 15703437; 16766523; 17581632; 18056426; 17322308; 18088087; 18691976; 18669648; 18599441; 19690332; 20068231; 21269460; 21406692; 25370813; 24275569; 25322666; 25682860; 26617750; 26008152; 26036682; 25849773; 27035563; 27462815; 16322461; 25787250	EIF-3 subunit D family
O15372	EIF3H_HUMAN	Eukaryotic translation initiation factor 3 subunit H, eIF3h (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)	EIF3H EIF3S3	352	9606			3D-structure;Cytoplasm;Initiation factor;Isopeptide bond;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation	Q8IZP0-5; Q9P2A4; Q9NRI5; Q9NRI5-1; P55884; B5ME19; O00303; Q7L2H7; O43639; O94875-10; O60504; Q9Q2G4		GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0008237; GO:0016020; GO:0016282; GO:0032435; GO:0033290; GO:0042788; GO:0070062; GO:0070122; GO:0071541; GO:0140492		9341143; 15489334; 16286006; 15703437; 20068067; 16766523; 17581632; 17322308; 18599441; 20068231; 21269460; 23186163; 24275569; 26100019; 25849773; 25944712; 27462815; 28112733; 16322461	EIF-3 subunit H family
O15374	MOT5_HUMAN	Monocarboxylate transporter 5, MCT 5 (Monocarboxylate transporter 4, MCT 4) (Solute carrier family 16 member 4)	SLC16A4 MCT4 MCT5	487	9606			Alternative splicing;Cell membrane;Membrane;Reference proteome;Symport;Transmembrane;Transmembrane helix;Transport	Q9BRK0; Q96Q45-2		GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020; GO:0016021		9425115; 14702039; 16710414; 15489334	Major facilitator superfamily, Monocarboxylate porter (TC 2.A.1.13) family
O15379	HDAC3_HUMAN	Histone deacetylase 3, HD3, EC 3.5.1.98 (Protein deacetylase HDAC3, EC 3.5.1.-) (Protein deacylase HDAC3, EC 3.5.1.-) (RPD3-2) (SMAP45)	HDAC3	428	9606		3.5.1.-; 3.5.1.98	3D-structure;Alternative splicing;Biological rhythms;Chromatin regulator;Cytoplasm;Host-virus interaction;Hydrolase;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	O43823; Q9ULX6; Q9UKG1; P24385; P23771; Q13227; O60341; Q969R5; P43356; Q9UIS9; P01106; O75376; Q9Y618; Q15466; P48552; P00558; P00558-1; P60510; Q15022; P08393; Q60974; Q8CBD1; P12504	TISSUE SPECIFICITY: Widely expressed.	GO:0000118; GO:0000122; GO:0001222; GO:0001934; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006325; GO:0006357; GO:0006476; GO:0017053; GO:0019899; GO:0030332; GO:0031398; GO:0031647; GO:0032008; GO:0032922; GO:0033558; GO:0042307; GO:0042752; GO:0042826; GO:0043066; GO:0045892; GO:0045944; GO:0046329; GO:0051059; GO:0051225; GO:0071498; GO:0072686; GO:0120162; GO:0140297; GO:0160008; GO:0160009; GO:0160010	PTM: Sumoylated in vitro. {ECO:0000269|PubMed:12032081}.	9464271; 9346952; 9501169; 10051405; 15489334; 15572445; 11006275; 10669754; 10655483; 10860984; 11466315; 11533236; 11861901; 12032081; 10809664; 10944117; 10898795; 11931768; 12628926; 14633989; 14525983; 15297880; 15927959; 16569215; 17081983; 18417529; 18279852; 19409814; 19690332; 21030595; 21269460; 21914818; 21444723; 23911289; 23186163; 25190803; 25301942; 28497810; 28167758; 29192674; 34608293	Histone deacetylase family, HD type 1 subfamily
O15381	NVL_HUMAN	Nuclear valosin-containing protein-like, NVLp, Nuclear VCP-like protein	NVL NVL2	856	9606			3D-structure;Acetylation;Alternative splicing;ATP-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;Ubl conjugation	P54253; Q14203-5; Q01658; Q00403; Q9Y5Q9; P04792; O43464; O60333-2; P19404; P35240-4; P29474; D3DTS7; P41219; P60891; Q9Y3C5; P78317; P37840; Q13148; P09936; O76024	TISSUE SPECIFICITY: Widely expressed. Highest level of expression in heart, placenta, skeletal muscle, pancreas and retina. {ECO:0000269|PubMed:9286697}.	GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275		9286697; 14702039; 16710414; 15489334; 12429849; 15469983; 16782053; 18669648; 20068231; 21269460; 21474449; 21406692; 22226966; 23186163; 26166824; 26456651; 28112733; 28416111; 29107693; 31358741	AAA ATPase family
O15382	BCAT2_HUMAN	Branched-chain-amino-acid aminotransferase, mitochondrial, BCAT(m), EC 2.6.1.42 (Placental protein 18, PP18)	BCAT2 BCATM BCT2 ECA40	392	9606		2.6.1.42	3D-structure;Acetylation;Alternative splicing;Amino-acid biosynthesis;Aminotransferase;Branched-chain amino acid biosynthesis;Disease variant;Lipid metabolism;Mitochondrion;Pyridoxal phosphate;Reference proteome;Transferase;Transit peptide		TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11170829}.	GO:0004084; GO:0005654; GO:0005739; GO:0005759; GO:0006550; GO:0006629; GO:0009082; GO:0009098; GO:0009099; GO:0010817; GO:0050048; GO:0052654; GO:0052655; GO:0052656; GO:1990830		9165094; 11170829; 14702039; 15489334; 8702755; 19608861; 21269460; 25653144; 25944712; 11264579; 12269802; 16141215; 17050531	Class-IV pyridoxal-phosphate-dependent aminotransferase family
O15389	SIGL5_HUMAN	Sialic acid-binding Ig-like lectin 5, Siglec-5 (CD33 antigen-like 2) (Obesity-binding protein 2, OB-BP2, OB-binding protein 2) (CD antigen CD170)	SIGLEC5 CD33L2 OBBP2	551	9606			3D-structure;Cell adhesion;Disulfide bond;Glycoprotein;Immunoglobulin domain;Lectin;Membrane;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	Q9H115; Q9UHI5; O00206; Q15645; Q08AM6	TISSUE SPECIFICITY: Expressed by monocytic/myeloid lineage cells. Found at high levels in peripheral blood leukocytes, spleen, bone marrow and at lower levels in lymph node, lung, appendix, placenta, pancreas and thymus. Expressed by monocytes and neutrophils but absent from leukemic cell lines representing early stages of myelomonocytic differentiation.	GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0030667; GO:0033691; GO:0070821; GO:0101003		9731071; 10428856; 15057824; 15489334; 18022638	Immunoglobulin superfamily, SIGLEC (sialic acid binding Ig-like lectin) family
O15391	TYY2_HUMAN	Transcription factor YY2 (Yin and yang 2, YY-2) (Zinc finger protein 631)	YY2 ZNF631	372	9606			Activator;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger		TISSUE SPECIFICITY: Expressed in kidney, liver, spleen and testis but not in colon. {ECO:0000269|PubMed:15087442}.	GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0031519; GO:0043565; GO:0045944; GO:0046872; GO:1990837		15087442; 14702039; 15772651; 15489334; 16260628; 16377127; 16959974	YY transcription factor family
O15392	BIRC5_HUMAN	Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin)	BIRC5 API4 IAP4	142	9606			3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;Cytoskeleton;Kinetochore;Metal-binding;Microtubule;Mitosis;Nucleus;Phosphoprotein;Protease inhibitor;Reference proteome;Repressor;Thiol protease inhibitor;Transcription;Transcription regulation;Ubl conjugation;Zinc	Q92870-2; P05067; P05067-2; O14965; Q96GD4; Q9UQB9; Q14457; O15392; Q15834; Q53HL2; P06493; Q14203-5; Q9NR28; Q86XJ1; Q8TB36; P42858; Q9NQS7; A0A0C4DGV4; Q96CV9; Q7Z412; Q9BXM7; P62826; P37840; Q13148; P09936; O14980; Q96GD4; O15392-1; Q53HL2; Q96GD4; O15392-1; Q53HL2	TISSUE SPECIFICITY: Expressed only in fetal kidney and liver, and to lesser extent, lung and brain (PubMed:10626797). Abundantly expressed in adenocarcinoma (lung, pancreas, colon, breast, and prostate) and in high-grade lymphomas (PubMed:14741722, PubMed:16329164). Also expressed in various renal cell carcinoma cell lines (PubMed:10626797). Expressed in cochlea including the organ of Corti, the lateral wall, the interdental cells of the Limbus as well as in Schwann cells and cells of the cochlear nerve and the spiral ganglions (at protein level). Not expressed in cells of the inner and outer sulcus or the Reissner's membrane (at protein level) (PubMed:21364656, PubMed:20627126). {ECO:0000269|PubMed:10626797, ECO:0000269|PubMed:14741722, ECO:0000269|PubMed:16329164, ECO:0000269|PubMed:20627126, ECO:0000269|PubMed:21364656}.	GO:0000086; GO:0000228; GO:0000278; GO:0000281; GO:0000775; GO:0000776; GO:0001934; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005876; GO:0005881; GO:0006468; GO:0007052; GO:0007094; GO:0007605; GO:0008017; GO:0008270; GO:0008284; GO:0015630; GO:0015631; GO:0019899; GO:0030496; GO:0031021; GO:0031267; GO:0031503; GO:0031536; GO:0032133; GO:0032991; GO:0042802; GO:0042803; GO:0043027; GO:0043066; GO:0043154; GO:0045892; GO:0045931; GO:0046872; GO:0046982; GO:0050897; GO:0051087; GO:0051256; GO:0051301; GO:0051303; GO:0051726; GO:0090267; GO:1901970; GO:1902425; GO:1903490; GO:1990713	PTM: Ubiquitinated by the Cul9-RING ubiquitin-protein ligase complex, leading to its degradation. Ubiquitination is required for centrosomal targeting. {ECO:0000269|PubMed:16322459, ECO:0000269|PubMed:24793696}.; PTM: In vitro phosphorylation at Thr-117 by AURKB prevents interaction with INCENP and localization to mitotic chromosomes (PubMed:14610074). Phosphorylation at Thr-48 by CK2 is critical for its mitotic and anti-apoptotic activities (PubMed:21252625). Phosphorylation at Thr-34 by CDK15 is critical for its anti-apoptotic activity (PubMed:24866247). Phosphorylation at Ser-20 by AURKC is critical for regulation of proper chromosome alignment and segregation, and possibly cytokinesis. {ECO:0000269|PubMed:11069302, ECO:0000269|PubMed:14610074, ECO:0000269|PubMed:21252625, ECO:0000269|PubMed:24866247, ECO:0000269|PubMed:27332895}.; PTM: Acetylation at Lys-129 by CBP results in its homodimerization, while deacetylation promotes the formation of monomers which heterodimerize with XPO1/CRM1 which facilitates its nuclear export. The acetylated form represses STAT3 transactivation. The dynamic equilibrium between its acetylation and deacetylation at Lys-129 determines its interaction with XPO1/CRM1, its subsequent subcellular localization, and its ability to inhibit STAT3 transactivation. {ECO:0000269|PubMed:20826784}.	9256286; 10626797; 11084331; 14741722; 16329164; 14702039; 16625196; 15489334; 9859993; 11069302; 12773388; 14610074; 15249581; 15665297; 16344111; 16322459; 16762323; 16239925; 16427043; 16764853; 16291752; 16436504; 18329369; 17993464; 18691976; 18591255; 21364656; 20826784; 20627126; 20929775; 21252625; 21225229; 21536684; 24866247; 24793696; 25778398; 27332895; 28218735; 10949039; 10876248; 17956729; 19530738	IAP family
O15393	TMPS2_HUMAN	Transmembrane protease serine 2, EC 3.4.21.- (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain ]	TMPRSS2 PRSS10	492	9606		3.4.21.-	3D-structure;Alternative splicing;Autocatalytic cleavage;Cell membrane;Disulfide bond;Glycoprotein;Hydrolase;Membrane;Protease;Reference proteome;Secreted;Serine protease;Signal-anchor;Transmembrane;Transmembrane helix;Zymogen	Q9BYF1; P01009; Q15848; Q86W74-2; P29972; O95393; Q12982; Q12983; Q6PL45-2; Q86Z23; O14523; Q9BXR6; Q9BXN2-6; Q9NWW5; Q96FZ5; Q6PI25; Q8TBE1; Q4LDR2; Q07325; Q9BQA9; P81534; P56851; Q9UKR5; Q92520; Q96IV6; P24593; Q6ZSS7; O75425; Q9NZG7; Q9UHJ9-5; Q9Y342; P26678; P60201-2; Q04941; Q13635-3; P53801; O00767; Q96IW7; Q9Y6D0; P11686; P78382; Q9NVC3; B2RUZ4; O15400; Q9UNK0; P17152; A0PK00; Q5BJH2-2; A2RU14; Q9H0R3; Q8NBD8; Q9BU79; Q9H2L4; Q9BSE2; Q8N2M4; Q8N661; P01375; Q5BVD1; O00526; O95183; Q9BQB6; O95159	TISSUE SPECIFICITY: Expressed in several tissues that comprise large populations of epithelial cells with the highest level of transcripts measured in the prostate gland. Expressed in type II pneumocytes in the lung (at protein level). Expressed strongly in small intestine. Also expressed in colon, stomach and salivary gland. Coexpressed with ACE2 within lung type II pneumocytes, ileal absorptive enterocytes, intestinal epithelial cells, cornea, gallbladder and nasal goblet secretory cells (Ref.21). {ECO:0000269|PubMed:11169526, ECO:0000269|PubMed:20382709, ECO:0000269|PubMed:21325420, ECO:0000269|PubMed:32404436, ECO:0000269|Ref.21}.	GO:0004252; GO:0005044; GO:0005576; GO:0005654; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016540; GO:0046598; GO:0070062	PTM: Proteolytically processed; by an autocatalytic mechanism.	9325052; 11414763; 11245484; 14702039; 10830953; 15489334; 11169526; 15537383; 20382709; 21068237; 21325420; 23536651; 23966399; 24027332; 24227843; 25122198; 26018085; 32142651; 33051876; 33522642; 32327758; 32404436; 34159616; 17918732; 32867305	Peptidase S1 family
O15394	NCAM2_HUMAN	Neural cell adhesion molecule 2, N-CAM-2, NCAM-2	NCAM2 NCAM21	837	9606			3D-structure;Alternative splicing;Cell adhesion;Cell membrane;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	O15394	TISSUE SPECIFICITY: Expressed most strongly in adult and fetal brain.	GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802; GO:0043005		9226371; 14702039; 10830953; 15489334; 12754519	
O15397	IPO8_HUMAN	Importin-8, Imp8 (Ran-binding protein 8, RanBP8)	IPO8 RANBP8	1037	9606			Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transport	Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; Q15797; P84022; P19532; P19544-6; Q6ZN57; O43296; Q6NX45		GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0031267		9214382; 14702039; 16541075; 11682607; 18691976; 18669648; 19690332; 21269460; 21406692	Importin beta family
O15399	NMDE4_HUMAN	Glutamate receptor ionotropic, NMDA 2D, GluN2D (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D, NMDAR2D, NR2D)	GRIN2D GluN2D NMDAR2D	1336	9606			Calcium;Cell junction;Cell membrane;Disease variant;Disulfide bond;Epilepsy;Glycoprotein;Ion channel;Ion transport;Ligand-gated ion channel;Magnesium;Membrane;Methylation;Phosphoprotein;Postsynaptic cell membrane;Receptor;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix;Transport	Q62936		GO:0001964; GO:0004970; GO:0004972; GO:0005789; GO:0005886; GO:0005887; GO:0007420; GO:0008344; GO:0015276; GO:0016595; GO:0017146; GO:0022849; GO:0035249; GO:0038023; GO:0042165; GO:0045211; GO:0048167; GO:0048168; GO:0051930; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098686; GO:0098839; GO:0098976; GO:0098978; GO:0099061; GO:1904062; GO:1904315; GO:2000463		9489750; 15057824; 27616483; 26875626; 28126851; 28095420; 16959974; 22833210	Glutamate-gated ion channel (TC 1.A.10.1) family, NR2D/GRIN2D subfamily
O15400	STX7_HUMAN	Syntaxin-7	STX7	261	9606			Acetylation;Alternative splicing;Coiled coil;Direct protein sequencing;Endosome;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	Q68DC2; Q13520; Q3SXY8; Q9HA82; Q8N5K1; Q96BA8; Q53TN4; Q15125; Q9NYP7; Q8TBP5; Q96KR6; Q9Y680; Q8NFK1; Q8NBQ5; Q7Z5P4; Q8N5M9; Q9H400; Q8N112; Q9GZY8-5; O14880; Q6IN84; Q9ULD2-3; Q9H902; Q86VR2; Q7Z5B4-5; Q9NR31; Q14973; Q3KNW5; Q16623; P32856-2; Q12846; Q96DZ7; Q6UW68; Q24JQ0; Q0VDI3; Q96HE8; O15393-2; Q9Y320; Q9BV40; Q9H270; Q9P253; Q5T4F4	TISSUE SPECIFICITY: Highest expression is found in placenta followed by heart, skeletal muscle, kidney and brain. Low expression is found in pancreas, lung and liver.	GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076		9358037; 14574404; 15489334; 12665801; 10564279; 10692457; 11382755; 18669648; 19413330; 19690332; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 25944712	Syntaxin family
O15405	TOX3_HUMAN	TOX high mobility group box family member 3 (CAG trinucleotide repeat-containing gene F9 protein) (Trinucleotide repeat-containing gene 9 protein)	TOX3 CAGF9 TNRC9	576	9606			Activator;Alternative splicing;Apoptosis;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation		TISSUE SPECIFICITY: Expressed mainly in epithelial cells. Expressed in the central nervous system (CNS), in the ileum and within the brain in the frontal and occipital lobe. {ECO:0000269|PubMed:21172805}.	GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0031490; GO:0042803; GO:0042981; GO:0043524; GO:0045944; GO:0051219		14702039; 15616553; 9225980; 21172805	
O15409	FOXP2_HUMAN	Forkhead box protein P2 (CAG repeat protein 44) (Trinucleotide repeat-containing gene 10 protein)	FOXP2 CAGH44 TNRC10	715	9606			3D-structure;Alternative splicing;Chromosomal rearrangement;Disease variant;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	P24863; Q00526; Q13363-2; P56545; P56545-3; Q86V42; Q9H334; O15409; Q8IVH2; Q8TBB1; Q13526; O00560; Q08117; Q08117-2; Q96A04	TISSUE SPECIFICITY: Isoform 1 and isoform 6 are expressed in adult and fetal brain, caudate nucleus and lung. {ECO:0000269|PubMed:12189486}.	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0021757; GO:0021758; GO:0021987; GO:0042802; GO:0042803; GO:0043565; GO:0045892; GO:0046872		11586359; 12189486; 14702039; 12853948; 12690205; 15489334; 9225980; 12192408; 15056695; 25232744; 26647308; 30250039	
O15427	MOT4_HUMAN	Monocarboxylate transporter 4, MCT 4 (Solute carrier family 16 member 3)	SLC16A3 MCT4	465	9606			Cell membrane;Direct protein sequencing;Membrane;Phosphoprotein;Reference proteome;Symport;Transmembrane;Transmembrane helix;Transport	Q8N9N5; Q12959; Q8IZU0; P48165; Q8WUI4-6; P84074; Q86WQ0; Q9UMX0; Q9UHD9	TISSUE SPECIFICITY: Highly expressed in skeletal muscle.	GO:0003723; GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0031965; GO:0035879; GO:0098688; GO:0099061		9425115; 14702039; 15489334; 17081983; 18691976; 18669648; 20068231; 21269460; 23186163; 25944712	Major facilitator superfamily, Monocarboxylate porter (TC 2.A.1.13) family
O15431	COPT1_HUMAN	High affinity copper uptake protein 1 (Copper transporter 1, hCTR1) (Solute carrier family 31 member 1)	SLC31A1 COPT1 CTR1	190	9606			3D-structure;Cell membrane;Copper;Copper transport;Glycoprotein;Ion transport;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport	O15431		GO:0005375; GO:0005770; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0015677; GO:0042802; GO:0055037	PTM: O-Glycosylation at Thr-27 protects from proteolytic cleavage in the N-terminal extracellular domain. {ECO:0000269|PubMed:17525160}.	9207117; 14702039; 17974005; 15164053; 15489334; 11734551; 17525160; 23186163; 16501047	Copper transporter (Ctr) (TC 1.A.56) family, SLC31A subfamily
O15438	MRP3_HUMAN	ATP-binding cassette sub-family C member 3, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D, MOAT-D) (Multidrug resistance-associated protein 3)	ABCC3 CMOAT2 MLP2 MRP3	1527	9606		7.6.2.-; 7.6.2.2; 7.6.2.3	Alternative splicing;ATP-binding;Cell membrane;Glycoprotein;Lipid transport;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Translocase;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. {ECO:0000269|PubMed:10094960, ECO:0000269|PubMed:9738950}.	GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015164; GO:0015431; GO:0015432; GO:0015721; GO:0016020; GO:0016323; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0071714; GO:0071716; GO:0150104		9813153; 9738950; 9827529; 9889399; 10094960; 10359813; 16625196; 15489334; 9270026; 11581266; 15083066; 14759258; 18669648; 23186163; 24275569	ABC transporter superfamily, ABCC family, Conjugate transporter (TC 3.A.1.208) subfamily
O15439	MRP4_HUMAN	ATP-binding cassette sub-family C member 4, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B, MOAT-B) (Multidrug resistance-associated protein 4)	ABCC4 MOATB MRP4	1325	9606		7.6.2.-; 7.6.2.2; 7.6.2.3	Alternative splicing;ATP-binding;Cell membrane;Glycoprotein;Lipid transport;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Translocase;Transmembrane;Transmembrane helix;Transport	Q00013	TISSUE SPECIFICITY: Widely expressed, with particularly high levels in prostate, but is barely detectable in liver. sinusoidal membrane of hepatocytes.	GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104	PTM: N-glycosylated; leading to substrate-selective effects on its transport activity. {ECO:0000269|PubMed:26721430}.	9661885; 12105214; 14702039; 15057823; 15489334; 9270026; 11106685; 11856762; 12883481; 12523936; 12835412; 15364914; 15454390; 16282361; 17344354; 17959747; 17081983; 18669648; 19690332; 20068231; 21269460; 22411990; 23186163; 18300232; 26721430; 20547088	ABC transporter superfamily, ABCC family, Conjugate transporter (TC 3.A.1.208) subfamily
O15440	MRP5_HUMAN	ATP-binding cassette sub-family C member 5, EC 7.6.2.-, EC 7.6.2.2 (Multi-specific organic anion transporter C, MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11)	ABCC5 MRP5	1437	9606		7.6.2.-; 7.6.2.2	Alternative splicing;ATP-binding;Cell membrane;Endosome;Glycoprotein;Golgi apparatus;Membrane;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Translocase;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: [Isoform 3]: Predominant isoform in retinal pigment epithelium, bladder, and stomach. {ECO:0000269|PubMed:17521428}.; TISSUE SPECIFICITY: Ubiquitously expressed, but levels in brain and muscle are especially high (PubMed:9827529, PubMed:10438534, PubMed:15501592). All isoforms are equally expressed in retina (PubMed:17521428). {ECO:0000269|PubMed:10438534, ECO:0000269|PubMed:15501592, ECO:0000269|PubMed:17521428, ECO:0000269|PubMed:9827529}.	GO:0005524; GO:0005796; GO:0005886; GO:0005887; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0150104		9827529; 10438534; 10721709; 10840050; 17521428; 16641997; 15489334; 9325169; 9270026; 10893247; 12435799; 12695538; 12637526; 15501592; 15899835; 17229149; 18669648; 20068231; 23186163; 24836561; 26515061; 25964343	ABC transporter superfamily, ABCC family, Conjugate transporter (TC 3.A.1.208) subfamily
O15444	CCL25_HUMAN	C-C motif chemokine 25 (Chemokine TECK) (Small-inducible cytokine A25) (Thymus-expressed chemokine)	CCL25 SCYA25 TECK	150	9606			Alternative splicing;Chemotaxis;Cytokine;Disulfide bond;Inflammatory response;Reference proteome;Secreted;Signal	Q92583; P13501; P48061; P02776; P10720	TISSUE SPECIFICITY: Specifically expressed by thymic dendritic cells. High levels in thymus and small intestine.	GO:0001954; GO:0002548; GO:0005179; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0006955; GO:0007166; GO:0007186; GO:0008009; GO:0030593; GO:0031640; GO:0031735; GO:0042379; GO:0043547; GO:0048020; GO:0048247; GO:0060326; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:1903237		9285413; 14702039; 15057824; 15489334; 10229797; 23341447	Intercrine beta (chemokine CC) family
O15446	RPA34_HUMAN	DNA-directed RNA polymerase I subunit RPA34 (A34.5) (Antisense to ERCC-1 protein, ASE-1) (CD3-epsilon-associated protein, CD3E-associated protein) (DNA-directed RNA polymerase I subunit G) (RNA polymerase I-associated factor PAF49)	POLR1G ASE1 CAST CD3EAP PAF49	510	9606			3D-structure;Acetylation;Alternative splicing;Chromosome;DNA-directed RNA polymerase;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Ubl conjugation			GO:0000120; GO:0001650; GO:0003723; GO:0003899; GO:0005654; GO:0005694; GO:0005730; GO:0005736; GO:0005739; GO:0005829; GO:0006360; GO:0007169; GO:0009303	PTM: Isoform 2 undergoes tyrosine phosphorylation upon T-cell receptor (TCR) stimulation. This phosphorylation has not been confirmed by other groups.; PTM: Isoform 1 is phosphorylated on tyrosine residues in initiation-competent Pol I-beta complexes but not in Pol I-alpha complexes.	9426281; 10373416; 15489334; 17081983; 16809778; 17525332; 18669648; 19413330; 19690332; 20068231; 21406692; 22814378; 23186163; 24275569; 25218447; 25114211; 25772364; 25755297; 28112733	Eukaryotic RPA34 RNA polymerase subunit family
O15455	TLR3_HUMAN	Toll-like receptor 3 (CD antigen CD283)	TLR3	904	9606			3D-structure;Alternative splicing;Direct protein sequencing;Disease variant;Disulfide bond;Endoplasmic reticulum;Endosome;Glycoprotein;Immunity;Inflammatory response;Innate immunity;Leucine-rich repeat;Membrane;Phosphoprotein;Receptor;Reference proteome;Repeat;RNA-binding;Signal;Transmembrane;Transmembrane helix	P27986; O15455	TISSUE SPECIFICITY: Expressed at high level in placenta and pancreas. Also detected in CD11c+ immature dendritic cells. Only expressed in dendritic cells and not in other leukocytes, including monocyte precursors. TLR3 is the TLR that is expressed most strongly in the brain, especially in astrocytes, glia, and neurons. {ECO:0000269|PubMed:17085778}.	GO:0000139; GO:0001774; GO:0002730; GO:0002756; GO:0003725; GO:0003953; GO:0004888; GO:0005615; GO:0005737; GO:0005765; GO:0005769; GO:0005789; GO:0005887; GO:0006972; GO:0007165; GO:0007250; GO:0007252; GO:0007254; GO:0008584; GO:0009597; GO:0010008; GO:0010628; GO:0016020; GO:0031012; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034123; GO:0034138; GO:0034346; GO:0035458; GO:0036020; GO:0038023; GO:0042742; GO:0042802; GO:0043065; GO:0043123; GO:0043330; GO:0043331; GO:0045087; GO:0045671; GO:0045766; GO:0045944; GO:0046330; GO:0050729; GO:0051092; GO:0051607; GO:0071260; GO:0071346; GO:0071360; GO:0071466; GO:0097191; GO:0097527; GO:0098586; GO:1901224	PTM: Heavily N-glycosylated, except on that part of the surface of the ectodomain that is involved in ligand binding. {ECO:0000269|PubMed:15961631, ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22579623}.; PTM: TLR3 signaling requires a proteolytic cleavage mediated by cathepsins CTSB and CTSH, the cleavage occurs between amino acids 252 and 346. The cleaved form of TLR3 is the predominant form found in endosomes. {ECO:0000269|PubMed:22611194}.	9435236; 17085778; 18810425; 14702039; 15815621; 15489334; 15340161; 12471095; 12539043; 16144834; 16858407; 16720699; 17178723; 18172197; 19159218; 22611194; 25736436; 16043704; 15961631; 22579623; 33432245; 17872438; 18753640; 22174453; 32972995	Toll-like receptor family
O15457	MSH4_HUMAN	MutS protein homolog 4, hMSH4	MSH4	936	9606			ATP-binding;Chromosome;DNA-binding;Meiosis;Nucleotide-binding;Reference proteome	O00303; O43196	TISSUE SPECIFICITY: Testis and ovary specific.	GO:0000795; GO:0001541; GO:0003677; GO:0003690; GO:0005524; GO:0005634; GO:0005694; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0030983		9299235; 16710414; 15489334; 18669648	DNA mismatch repair MutS family
O15460	P4HA2_HUMAN	Prolyl 4-hydroxylase subunit alpha-2, 4-PH alpha-2, EC 1.14.11.2 (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)	P4HA2 UNQ290/PRO330	535	9606		1.14.11.2	3D-structure;Alternative splicing;Dioxygenase;Disease variant;Endoplasmic reticulum;Glycoprotein;Iron;Metal-binding;Oxidoreductase;Reference proteome;Signal;TPR repeat;Vitamin C	P50570-2; Q13643	TISSUE SPECIFICITY: Expressed in the heart, placenta, lung and pancreas. {ECO:0000269|PubMed:9211872}.	GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0018401; GO:0031418; GO:0043231		9211872; 11606192; 12975309; 15489334; 7753822; 21269460; 25741866	P4HA family
O15466	SIA8E_HUMAN	Alpha-2,8-sialyltransferase 8E, EC 2.4.99.- (Sialyltransferase 8E, SIAT8-E) (Sialyltransferase St8Sia V, ST8SiaV)	ST8SIA5 SIAT8E	376	9606	PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:9199191}.	2.4.99.-	Alternative splicing;Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Lipid metabolism;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	Q92624	TISSUE SPECIFICITY: [Isoform 1]: Expressed in fetal and adult brain, adult heart and skeletal muscle. {ECO:0000269|PubMed:9199191}.; TISSUE SPECIFICITY: [Isoform 2]: Expressed in fetal and adult brain, not detected in adult heart and skeletal muscle. {ECO:0000269|PubMed:9199191}.	GO:0000139; GO:0003828; GO:0005975; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009311; GO:0016021		9199191; 14702039; 16177791; 15489334	Glycosyltransferase 29 family
O15467	CCL16_HUMAN	C-C motif chemokine 16 (Chemokine CC-4, HCC-4) (Chemokine LEC) (IL-10-inducible chemokine) (LCC-1) (Liver-expressed chemokine) (Lymphocyte and monocyte chemoattractant, LMC) (Monotactin-1, MTN-1) (NCC-4) (Small-inducible cytokine A16)	CCL16 ILINCK NCC4 SCYA16	120	9606			3D-structure;Chemotaxis;Cytokine;Direct protein sequencing;Disulfide bond;Inflammatory response;Reference proteome;Secreted;Signal	P13501; Q9UHD9	TISSUE SPECIFICITY: Mainly expressed in liver, also found in spleen and thymus. Highly expressed in LPS- and IFN-gamma-activated monocytes, weakly in some lymphocytes, including natural killer cells, gamma-delta T-cells, and some T-cell clones.	GO:0002548; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007154; GO:0007186; GO:0007267; GO:0008009; GO:0030593; GO:0042056; GO:0043547; GO:0048020; GO:0048247; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356		9596672; 9545580; 10213461; 9642106; 10235110; 10671294; 15489334	Intercrine beta (chemokine CC) family
O15479	MAGB2_HUMAN	Melanoma-associated antigen B2 (Cancer/testis antigen 3.2, CT3.2) (DSS-AHC critical interval MAGE superfamily 6, DAM6) (MAGE XP-2 antigen) (MAGE-B2 antigen)	MAGEB2	319	9606			Phosphoprotein;Reference proteome;Tumor antigen;Ubl conjugation pathway	Q99856; Q96S94-5; Q96D03; Q9BQ95; P35637; Q96KN7; Q99757; O96006	TISSUE SPECIFICITY: Expressed in testis and placenta, and in a significant fraction of tumors of various histologic types.	GO:0000122; GO:0005634		8535061; 9441743; 9538511; 15772651; 15489334; 18669648; 20864041; 21269460; 23186163	
O15481	MAGB4_HUMAN	Melanoma-associated antigen B4 (MAGE-B4 antigen)	MAGEB4	346	9606			Cytoplasm;Reference proteome;Tumor antigen	Q4LEZ3; Q8WXI4-2; Q99856; P78537; Q96JN2-2; Q49A88-3; Q92997; Q96AZ1; Q96C01; A8MTA8-2; Q96RJ6; Q9BTI6; Q8N9W4-2; Q9NW75-2; O75409; O14964; Q8IYA8; Q63ZY3; O76015; Q9BRK4; P43361; Q13503; Q14696; Q9HD90; O15212; Q9NRD5; Q13464; Q59EK9; Q59EK9-3; O14796; Q96FV9; A1L306; P14927; Q8N6Y0; Q9UHP3; O43379; Q9BYN7; Q9UGI0	TISSUE SPECIFICITY: Expressed in testis.	GO:0000122; GO:0005634; GO:0005737		9441743; 14702039; 15772651; 15489334	
O15484	CAN5_HUMAN	Calpain-5, EC 3.4.22.- (Calpain htra-3) (New calpain 3, nCL-3)	CAPN5 NCL3	640	9606		3.4.22.-	3D-structure;Disease variant;Hydrolase;Protease;Reference proteome;Thiol protease		TISSUE SPECIFICITY: Expressed in many tissues. Strong expression in the photoreceptor cells of the retina, with a punctate pattern of labeling over the nuclei and inner segments with less expression along the other segments and outer plexiform layer. {ECO:0000269|PubMed:23055945}.	GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0045202; GO:0070062		9367857; 15489334; 9339374; 23055945	Peptidase C2 family
O15488	GLYG2_HUMAN	Glycogenin-2, GN-2, GN2, EC 2.4.1.186	GYG2	501	9606	PATHWAY: Glycan biosynthesis; glycogen biosynthesis. {ECO:0000269|PubMed:9346895, ECO:0000269|PubMed:9857012}.	2.4.1.186	3D-structure;Alternative splicing;Glycogen biosynthesis;Glycoprotein;Manganese;Metal-binding;Phosphoprotein;Reference proteome;Transferase		TISSUE SPECIFICITY: Detected in liver (at protein level) (PubMed:9857012). Expressed preferentially in liver, heart, and pancreas (PubMed:9346895). {ECO:0000269|PubMed:9346895, ECO:0000269|PubMed:9857012}.	GO:0005737; GO:0005829; GO:0005978; GO:0008466; GO:0016757; GO:0046872; GO:0102751	PTM: Self-glycosylated by the transfer of glucose residues from UDP-glucose to itself, forming an alpha-1,4-glycan of around 10 residues attached to Tyr-228. {ECO:0000269|PubMed:9857012}.	9346895; 10721716; 15772651; 15489334; 9857012; 11840567; 24275569; 21248752	Glycosyltransferase 8 family, Glycogenin subfamily
O15492	RGS16_HUMAN	Regulator of G-protein signaling 16, RGS16 (A28-RGS14P) (Retinal-specific RGS, RGS-r, hRGS-r) (Retinally abundant regulator of G-protein signaling)	RGS16 RGSR	202	9606			3D-structure;GTPase activation;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Reference proteome;Signal transduction inhibitor		TISSUE SPECIFICITY: Abundantly expressed in retina with lower levels of expression in most other tissues.	GO:0003924; GO:0005096; GO:0005516; GO:0005737; GO:0005886; GO:0007186; GO:0007601; GO:0008277; GO:0009968; GO:0031224; GO:0043547	PTM: Palmitoylated on Cys-2 and/or Cys-12. {ECO:0000250|UniProtKB:P97428}.; PTM: Phosphorylated. Phosphorylation at Tyr-168 by EGFR enhances GTPase accelerating (GAP) activity toward GNAI1. {ECO:0000269|PubMed:11602604}.	9223279; 9469939; 14702039; 16710414; 15489334; 11602604; 18434541	
O15496	PA2GX_HUMAN	Group 10 secretory phospholipase A2, EC 3.1.1.4 (Group X secretory phospholipase A2, GX sPLA2, sPLA2-X) (Phosphatidylcholine 2-acylhydrolase 10)	PLA2G10	165	9606		3.1.1.4	3D-structure;Calcium;Cleavage on pair of basic residues;Cytoplasmic vesicle;Disulfide bond;Glycoprotein;Hydrolase;Lipid metabolism;Lysosome;Metal-binding;Phospholipid metabolism;Reference proteome;Secreted;Signal	P21549; P29972; Q03989; P54253; O95817; Q9BXY8; Q6P1W5; Q8NEC5; Q96HB5; Q02930-3; A8MQ03; Q8WU58; O75593; Q9BWX5; Q9Y223-2; O14964; P31273; O43593; Q9ULV5-2; Q0VD86; Q5T749; Q8IUC1; Q6PEX3; Q5T7P2; Q5T751; Q5TA79; O14633; Q5TA82; P21145; O60336; Q86UR1-2; Q96HA8; P32242; P78337; Q15319; Q7Z5V6-2; Q01974; P09234; Q99932-2; Q7Z699; O75716; O95947; Q92734; O43711; A8MV65-2; A5D8V6; Q96K80	TISSUE SPECIFICITY: Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon (PubMed:9188469). Expressed in neuronal fibers in dorsal root ganglia and in peripheral tissues including stomach, white adipose tissue and prostate (at protein level) (PubMed:21266581). {ECO:0000269|PubMed:21266581, ECO:0000269|PubMed:9188469}.	GO:0001516; GO:0001669; GO:0002532; GO:0003847; GO:0004620; GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0006644; GO:0006658; GO:0007411; GO:0009566; GO:0010744; GO:0010884; GO:0019369; GO:0031069; GO:0032270; GO:0032308; GO:0034374; GO:0034638; GO:0036335; GO:0042116; GO:0042632; GO:0043030; GO:0043249; GO:0043433; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0047498; GO:0050482; GO:0050728; GO:0051607; GO:0051977; GO:0062234; GO:0090238; GO:0090370; GO:1900016; GO:1990830; GO:2000344		9188469; 15616553; 15489334; 11694541; 12021277; 12359733; 16962371; 16146426; 21266581; 12161451	Phospholipase A2 family
O15498	YKT6_HUMAN	Synaptobrevin homolog YKT6, EC 2.3.1.-	YKT6	198	9606		2.3.1.-	3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Cytoplasmic vesicle;ER-Golgi transport;Golgi apparatus;Lipoprotein;Membrane;Methylation;Palmitate;Phosphoprotein;Prenylation;Protein transport;Reference proteome;Transferase;Transport			GO:0000139; GO:0005484; GO:0005737; GO:0005739; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005887; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0019706; GO:0030133; GO:0030659; GO:0031201; GO:0033116; GO:0042147; GO:0043025; GO:0045296; GO:0097440; GO:0097441	PTM: Palmitoylated; catalyzes its own palmitoylation. Palmitoylation is required for Golgi targeting. {ECO:0000269|PubMed:15044687, ECO:0000269|PubMed:15479160}.; PTM: Farnesylation is required for Golgi targeting.	9211930; 14702039; 12853948; 15489334; 15479160; 14742712; 15215310; 15044687; 20068231; 21269460; 23186163	Synaptobrevin family
O15499	GSC2_HUMAN	Homeobox protein goosecoid-2, GSC-2 (Homeobox protein goosecoid-like, GSC-L)	GSC2 GSCL	205	9606			DNA-binding;Homeobox;Nucleus;Reference proteome	P05187; P08758; Q12797-6; Q8N1M1-5; Q12982; Q8N9M1-2; Q13901; P27797; P55273; Q9H5X1; P27658; O75575-2; P68400; Q9Y463; Q9H6Z9; P63241; Q16134; A6H8Z2; O75344; Q8NCW6-2; O75603; Q6ZYL4; Q9H1H1; P43080; P33402; Q6NT76; Q2M1V0; O15550; Q2WGJ6; O76011; P26371; Q5T5B0; Q8WV07; Q9UI95; P45984; Q9Y4F3; Q9UJV3-2; Q9UBU8-2; Q96EL3; Q9Y3D9; Q9Y5B8; Q9UNF0; Q08493-2; O43741; Q96BW5; Q9H7N4; O00560; Q9BVW5; O14787-2; Q969E8; Q712K3; Q3SXR9; Q13426; P62699; Q8N0Y2-2; Q96SQ5	TISSUE SPECIFICITY: Detected in adult testis and pituitary, and in 9-10 week fetal tissue (thorax). Probably expressed in other tissues at low levels.	GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0009653; GO:0043565; GO:1990837		9441739; 9150167	Paired homeobox family, Bicoid subfamily
O15503	INSI1_HUMAN	Insulin-induced gene 1 protein, INSIG-1	INSIG1	277	9606			3D-structure;Alternative splicing;Cholesterol metabolism;Direct protein sequencing;Endoplasmic reticulum;Isopeptide bond;Lipid metabolism;Lipid-binding;Membrane;Phosphoprotein;Reference proteome;Steroid metabolism;Sterol metabolism;Transmembrane;Transmembrane helix;Ubl conjugation	Q9UKV5; Q13520; Q96Q45-2; P00180; P00181; P00347	TISSUE SPECIFICITY: Expressed in all tissues tested with highest expression in the liver. {ECO:0000269|PubMed:12202038}.	GO:0005783; GO:0005789; GO:0006641; GO:0006695; GO:0008142; GO:0010894; GO:0016126; GO:0032869; GO:0032933; GO:0032937; GO:0036315; GO:0036316; GO:0042472; GO:0042474; GO:0042632; GO:0045599; GO:0045717; GO:0060021; GO:0060363; GO:0070862; GO:1901303	PTM: Phosphorylation at Ser-207 by PCK1 reduces binding to oxysterol, disrupting the interaction between INSIG1 and SCAP, thereby promoting nuclear translocation of SREBP proteins (SREBF1/SREBP1 or SREBF2/SREBP2) and subsequent transcription of downstream lipogenesis-related genes. {ECO:0000269|PubMed:32322062}.; PTM: Ubiquitinated by AMFR/gp78 in response to sterol deprivation, leading to its degradation: when the SCAP-SREBP complex becomes dissociated from INSIG1, INSIG1 is then ubiquitinated and degraded in proteasomes (PubMed:16399501, PubMed:17043353). Although ubiquitination is required for rapid INSIG1 degradation, it is not required for release of the SCAP-SREBP complex (PubMed:16399501). Ubiquitinated by RNF139 (PubMed:20068067). {ECO:0000269|PubMed:16399501, ECO:0000269|PubMed:17043353, ECO:0000269|PubMed:20068067}.	9268630; 12202038; 14702039; 12690205; 15489334; 12535518; 14660594; 15899885; 16168377; 16399501; 17043353; 16606821; 20068067; 22143767; 28604676; 29184177; 28849786; 29374057; 32322062; 23481256	INSIG family
O15504	NUP42_HUMAN	Nucleoporin NUP42 (NLP-1) (NUP42 homolog) (Nucleoporin hCG1) (Nucleoporin-42) (Nucleoporin-like protein 2)	NUP42 CG1 NUPL2	423	9606			3D-structure;Alternative splicing;Glycoprotein;Membrane;Metal-binding;mRNA transport;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Translocation;Transport;Zinc;Zinc-finger	O76011	TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:10358091}.	GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006611; GO:0006913; GO:0031965; GO:0046872; GO:0051028	PTM: O-glycosylated. {ECO:0000269|PubMed:10358091}.	9450185; 14702039; 12690205; 15489334; 10228171; 10610322; 10358091; 12228227; 16000379; 18669648; 20068231; 23186163	
O15511	ARPC5_HUMAN	Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit, p16-ARC)	ARPC5 ARC16	151	9606			3D-structure;Acetylation;Actin-binding;Alternative splicing;Cell projection;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleus;Reference proteome;Ubl conjugation			GO:0003779; GO:0005200; GO:0005576; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005885; GO:0005925; GO:0014909; GO:0015629; GO:0016477; GO:0021769; GO:0030011; GO:0030027; GO:0030036; GO:0030426; GO:0030833; GO:0034314; GO:0034774; GO:0035861; GO:0051639; GO:0061842; GO:0070062; GO:0097581; GO:1904813	PTM: Polyubiquitinated by RNF128 with 'Lys-63'-linked chains, leading to proteasomal degradation. {ECO:0000269|PubMed:22016387}.	9230079; 9359840; 16710414; 15489334; 12665801; 11741539; 21269460; 22016387; 22814378; 24275569; 25944712; 29925947	ARPC5 family
O15514	RPB4_HUMAN	DNA-directed RNA polymerase II subunit RPB4, RNA polymerase II subunit B4 (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit, RPB16)	POLR2D	142	9606			3D-structure;DNA-directed RNA polymerase;Nucleus;Reference proteome;Transcription	P62875		GO:0000166; GO:0000288; GO:0000932; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006366; GO:0006367; GO:0016607; GO:0031369; GO:0031990; GO:0034402; GO:0045948		9528765; 15489334; 9852112; 21269460; 16282592	Eukaryotic RPB4 RNA polymerase subunit family
O15516	CLOCK_HUMAN	Circadian locomoter output cycles protein kaput, hCLOCK, EC 2.3.1.48 (Class E basic helix-loop-helix protein 8, bHLHe8)	CLOCK BHLHE8 KIAA0334	846	9606		2.3.1.48	3D-structure;Activator;Acyltransferase;Biological rhythms;Cytoplasm;DNA damage;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Ubl conjugation	O00327; O00327-8; Q8WYA1-3	TISSUE SPECIFICITY: Hair follicles (at protein level). Expressed in all tissues examined including spleen, thymus, prostate, testis, ovary, small intestine, colon, leukocytes, heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Highest levels in testis and skeletal muscle. Low levels in thymus, lung and liver. Expressed in all brain regions with highest levels in cerebellum. Highly expressed in the suprachiasmatic nucleus (SCN). {ECO:0000269|PubMed:10198158, ECO:0000269|PubMed:24005054}.	GO:0000077; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005829; GO:0006355; GO:0006357; GO:0006473; GO:0007165; GO:0007283; GO:0007623; GO:0009648; GO:0031490; GO:0032922; GO:0033391; GO:0042634; GO:0042752; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050729; GO:0050796; GO:0051092; GO:0051775; GO:0070888; GO:0071479; GO:1990513; GO:1990837; GO:2000074; GO:2000323	PTM: Ubiquitinated, leading to its proteasomal degradation. {ECO:0000250|UniProtKB:O08785}.; PTM: O-glycosylated; contains O-GlcNAc. O-glycosylation by OGT prevents protein degradation by inhibiting ubiquitination. It also stabilizes the CLOCK-ARNTL/BMAL1 heterodimer thereby increasing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER1/2/3 and CRY1/2. {ECO:0000250|UniProtKB:O08785}.; PTM: Phosphorylation is dependent on the CLOCK-ARNTL/BMAL1 heterodimer formation. Phosphorylation enhances the transcriptional activity, alters the subcellular localization and decreases the stability of the heterodimer by promoting its degradation. Phosphorylation shows circadian variations in the liver. May be phosphorylated by CSNK1D and CKSN1E. {ECO:0000269|PubMed:24235147}.; PTM: Sumoylation enhances its transcriptional activity and interaction with ESR1, resulting in up-regulation of ESR1 activity. Estrogen stimulates sumoylation. Desumoylation by SENP1 negatively regulates its transcriptional activity. Sumoylation stimulates cell proliferation and increases the proportion of S phase cells in breast cancer cell lines. {ECO:0000269|PubMed:23160374}.; PTM: Undergoes lysosome-mediated degradation in a time-dependent manner in the liver. {ECO:0000250|UniProtKB:O08785}.	10198158; 9205841; 14702039; 15489334; 11441146; 14645221; 16474406; 18587630; 20861012; 21613214; 21980503; 21659603; 21960634; 22284746; 23576606; 24235147; 23785138; 23160374; 23303907; 24005054; 24275569; 23916625; 25936801; 28985504; 28903391; 30530698; 23229515	
O15519	CFLAR_HUMAN	CASP8 and FADD-like apoptosis regulator (Caspase homolog, CASH) (Caspase-eight-related protein, Casper) (Caspase-like apoptosis regulatory protein, CLARP) (Cellular FLICE-like inhibitory protein, c-FLIP) (FADD-like antiapoptotic molecule 1, FLAME-1) (Inhibitor of FLICE, I-FLICE) (MACH-related inducer of toxicity, MRIT) (Usurpin) [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12 ]	CFLAR CASH CASP8AP1 CLARP MRIT	480	9606			3D-structure;Alternative splicing;Apoptosis;Host-virus interaction;Reference proteome;Repeat	Q92851; Q14790; Q13077; Q14790; Q14790-2; Q02750; O14733; Q92851-4	TISSUE SPECIFICITY: Widely expressed. Higher expression in skeletal muscle, pancreas, heart, kidney, placenta, and peripheral blood leukocytes. Also detected in diverse cell lines. Isoform 8 is predominantly expressed in testis and skeletal muscle.	GO:0002020; GO:0005123; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0007519; GO:0008047; GO:0010667; GO:0010976; GO:0014732; GO:0014842; GO:0014866; GO:0031264; GO:0031265; GO:0032869; GO:0033574; GO:0042060; GO:0043066; GO:0043123; GO:0043403; GO:0044877; GO:0045121; GO:0051092; GO:0060544; GO:0070374; GO:0071364; GO:0071392; GO:0071456; GO:0071549; GO:0071732; GO:0072126; GO:0097153; GO:0097199; GO:0097200; GO:0097342; GO:1901740; GO:1902042; GO:1903055; GO:1903427; GO:1903845; GO:1903944; GO:2000347; GO:2001237	PTM: Proteolytically processed by CASP8 generating subunit p43 and p12. {ECO:0000269|PubMed:9228018}.	9208847; 9326610; 9217161; 9228018; 9211860; 9289491; 9380701; 10200473; 11161814; 14702039; 15815621; 15489334; 9880531; 10227994; 12727877; 14759258	Peptidase C14A family
O15520	FGF10_HUMAN	Fibroblast growth factor 10, FGF-10 (Keratinocyte growth factor 2)	FGF10	208	9606			3D-structure;Disease variant;Ectodermal dysplasia;Glycoprotein;Growth factor;Lacrimo-auriculo-dento-digital syndrome;Reference proteome;Secreted;Signal	P21802; Q8N9Q2; Q9NVV9		GO:0000132; GO:0001525; GO:0001656; GO:0001759; GO:0001823; GO:0001934; GO:0001974; GO:0003338; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007368; GO:0007431; GO:0008083; GO:0008201; GO:0008284; GO:0008285; GO:0008543; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010628; GO:0010634; GO:0010838; GO:0021983; GO:0030154; GO:0030334; GO:0030538; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0031532; GO:0032355; GO:0032496; GO:0032781; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0042056; GO:0042060; GO:0042246; GO:0042475; GO:0042693; GO:0043410; GO:0045596; GO:0045739; GO:0045747; GO:0045944; GO:0046579; GO:0046877; GO:0048146; GO:0048536; GO:0048538; GO:0048557; GO:0048754; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050731; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060054; GO:0060173; GO:0060174; GO:0060428; GO:0060430; GO:0060436; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0090263; GO:1900087; GO:2001240		9287324; 15489334; 15806171; 16597617; 20094046; 12591959; 15654336; 16630169; 16501574	Heparin-binding growth factors family
O15522	NKX28_HUMAN	Homeobox protein Nkx-2.8 (Homeobox protein NK-2 homolog H)	NKX2-8 NKX-2.8 NKX2G NKX2H	239	9606			Developmental protein;DNA-binding;Homeobox;Nucleus;Reference proteome			GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003690; GO:0003700; GO:0005634; GO:0006351; GO:0006357; GO:0006366; GO:0007409; GO:0030154; GO:0030324; GO:0043565; GO:0045944; GO:0050680; GO:1990837		9446603; 14702039; 15489334	NK-2 homeobox family
O15523	DDX3Y_HUMAN	ATP-dependent RNA helicase DDX3Y, EC 3.6.4.13 (DEAD box protein 3, Y-chromosomal)	DDX3Y DBY	660	9606		3.6.4.13	Acetylation;Alternative splicing;ATP-binding;Cytoplasm;DNA-binding;Helicase;Hydrolase;Isopeptide bond;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;RNA-binding;Ubl conjugation		TISSUE SPECIFICITY: Widely expressed at the mRNA level, with highest levels in testis (PubMed:9381176). Testis-specific (at protein level). Expressed predominantly in spermatogonia, but occasionally detected in some pre-leptotene/leptotene spermatocytes (PubMed:15294876). {ECO:0000269|PubMed:15294876, ECO:0000269|PubMed:9381176}.	GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007276; GO:0016020; GO:0016887; GO:0030154; GO:0043186		9381176; 12815422; 14702039; 15489334; 15383328; 15294876; 21269460	DEAD box helicase family, DDX3/DED1 subfamily
O15524	SOCS1_HUMAN	Suppressor of cytokine signaling 1, SOCS-1 (JAK-binding protein, JAB) (STAT-induced STAT inhibitor 1, SSI-1) (Tec-interacting protein 3, TIP-3)	SOCS1 SSI1 TIP3	211	9606	PATHWAY: Protein modification; protein ubiquitination.		Cytoplasmic vesicle;Disease variant;Growth regulation;Nucleus;Reference proteome;SH2 domain;Signal transduction inhibitor;Ubl conjugation pathway	Q8N668; Q15369; P04626; Q04206; Q99961; Q77YG1	TISSUE SPECIFICITY: Expressed in all tissues with high expression in spleen, small intestine and peripheral blood leukocytes.	GO:0001817; GO:0001932; GO:0004860; GO:0005159; GO:0005654; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0010533; GO:0016567; GO:0019210; GO:0019221; GO:0019901; GO:0031410; GO:0035556; GO:0036464; GO:0040008; GO:0042532; GO:0043372; GO:0043377; GO:0045444; GO:0045591; GO:0046426; GO:0046627; GO:0046854; GO:0046935; GO:0060334; GO:0071230		9266833; 9341160; 9202125; 10512686; 9202126; 9727029; 11278610; 11313480; 11553846; 12470648; 11835308; 16410555; 12163497; 23401859; 32853638; 32499645; 33087723	SOCS1 family
O15525	MAFG_HUMAN	Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF)	MAFG	162	9606			Acetylation;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	O14867; Q9BYV9; Q9NR55; Q9ULX9; O15525; Q14494; Q14494-2; Q16236; Q9Y4A8; Q16649; P0C746	TISSUE SPECIFICITY: Highly expressed in skeletal muscle. Also expressed in heart and brain.	GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030534; GO:0030641; GO:0042127; GO:0042802; GO:0045604; GO:0046982; GO:0090575; GO:1990837	PTM: Acetylated in erythroid cells by CREB-binding protein (CBP). Acetylation augments the DNA-binding activity of NFE2, but has no effect on binding NFE2. {ECO:0000269|PubMed:11154691}.; PTM: Sumoylation at Lys-14 is required for active transcriptional repression. {ECO:0000250|UniProtKB:O54790}.	9195958; 9166829; 9286713; 9150357; 15489334; 8932385; 9421508; 11154691; 20068231; 23186163; 25218447; 25114211; 25772364; 25755297; 28112733	BZIP family, Maf subfamily
O15527	OGG1_HUMAN	N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase, EC 3.2.2.-; DNA-(apurinic or apyrimidinic site) lyase, AP lyase, EC 4.2.99.18 ]	OGG1 MMH MUTM OGH1	345	9606		3.2.2.-; 4.2.99.18	3D-structure;Alternative splicing;DNA damage;DNA repair;Glycosidase;Hydrolase;Lyase;Mitochondrion;Multifunctional enzyme;Nucleus;Reference proteome		TISSUE SPECIFICITY: Ubiquitous.	GO:0002526; GO:0003684; GO:0004519; GO:0005634; GO:0005654; GO:0005759; GO:0005829; GO:0006284; GO:0006285; GO:0006355; GO:0006974; GO:0006979; GO:0007568; GO:0008017; GO:0008534; GO:0009314; GO:0009410; GO:0009416; GO:0016363; GO:0016607; GO:0032355; GO:0032357; GO:0032991; GO:0033683; GO:0034039; GO:0043066; GO:0045007; GO:0045008; GO:0045471; GO:0051593; GO:0071276; GO:0140078; GO:1901291		9187114; 9207108; 9223306; 9223305; 9197244; 9190902; 9348312; 9321410; 10449904; 10233168; 14702039; 16641997; 15489334; 10775435; 17148573; 10706276; 11902834; 12578369; 12592398; 15610848; 17114185; 9765618; 9662341; 10497264; 10908322; 12509224	Type-1 OGG1 family
O15528	CP27B_HUMAN	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, EC 1.14.15.18 (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase, VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1)	CYP27B1 CYP1ALPHA CYP27B	508	9606	PATHWAY: Hormone biosynthesis; vitamin D biosynthesis. {ECO:0000269|PubMed:9486994}.	1.14.15.18	Disease variant;Heme;Iron;Lipid metabolism;Membrane;Metal-binding;Mitochondrion;Monooxygenase;Oxidoreductase;Reference proteome;Transit peptide		TISSUE SPECIFICITY: Kidney. {ECO:0000269|PubMed:9428799, ECO:0000269|PubMed:9486994}.	GO:0004498; GO:0005506; GO:0005737; GO:0005739; GO:0005741; GO:0006766; GO:0006816; GO:0008285; GO:0010956; GO:0010980; GO:0020037; GO:0030282; GO:0030308; GO:0030500; GO:0032496; GO:0033280; GO:0034341; GO:0036378; GO:0042359; GO:0042369; GO:0043627; GO:0045618; GO:0046697; GO:0055074; GO:0062185; GO:0070314; GO:0070564		9428799; 9344864; 9415400; 12496369; 14702039; 15489334; 10518789; 22862690; 9486994; 9837822; 10320521; 10566658; 12050193	Cytochrome P450 family
O15529	GPR42_HUMAN	G-protein coupled receptor 42	GPR42 GPR42P	346	9606			Cell membrane;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	Q15848; P20292; Q86W74-2; P05090; Q9HD20-3; P51164; Q99437; P27449; Q12983; Q8WVV5; Q9P0B6; Q8NHW4; Q08708; P11912; Q9UHP7-3; P21964; Q4LDR2; Q07325; Q8N682; P52803; P54849; Q7Z2K6; Q92520; Q14802-3; Q9H0Q3; P29033; O14653; O60883; P04921; Q9Y5U9; P24593; Q01638-2; P11215; Q9HDC5; Q09470; Q96E93; O43561-2; O95214; Q8TAF8; Q9UIQ6-2; Q16873; Q6N075; Q6ZSS7; O43451; P11836; Q9NX14; Q9NZG7; Q8IXM6; P42857; P09466; P60201-2; O14494; Q01453; P54315; Q9NS64; Q5QGT7; Q96GQ5; O00767; Q9NRX5; Q8N6R1; A2A2V5; Q9BRI3; Q99726; Q8IWU4; Q6ICL7; Q9H2H9; Q9NVC3; Q9NP94; Q8IVJ1; Q96JW4; Q9NRQ5; Q9BZL3; P02808; P0DN84; Q9UNK0; Q9H7V2; O43759-2; Q9Y6I9; P02787; P48230; P55061; Q9NV12; Q9BVK8; Q6ZP80; Q96HH6; Q96Q45-2; Q8WW34-2; Q9NWH2; E9PQX1; Q3MIR4; Q9H2L4; Q6PI78; Q9NSU2-1; Q5TGU0; A5PKU2; O95070; Q9Y548; Q9BWQ6; Q9BSR8; Q96EC8; O95159		GO:0004930; GO:0005887; GO:0007186		9344866; 15057824; 12496283; 19630535	G-protein coupled receptor 1 family
O15530	PDPK1_HUMAN	3-phosphoinositide-dependent protein kinase 1, hPDK1, EC 2.7.11.1	PDPK1 PDK1	556	9606		2.7.11.1	3D-structure;Acetylation;Activator;Alternative splicing;ATP-binding;Cell junction;Cell membrane;Cytoplasm;Direct protein sequencing;Kinase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Ubl conjugation	P31749; Q00005; O75385; P54252; P42858; Q8WXH2; Q8IUH5	TISSUE SPECIFICITY: Appears to be expressed ubiquitously. The Tyr-9 phosphorylated form is markedly increased in diseased tissue compared with normal tissue from lung, liver, colon and breast. {ECO:0000269|PubMed:18024423}.	GO:0003323; GO:0004674; GO:0004676; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0030036; GO:0030512; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043274; GO:0043304; GO:0043536; GO:0045766; GO:0046777; GO:0051281; GO:0071364; GO:0097191; GO:0106310; GO:1903078; GO:1903672; GO:1905564; GO:2000352	PTM: Phosphorylation on Ser-241 in the activation loop is required for full activity. PDPK1 itself can autophosphorylate Ser-241, leading to its own activation. Autophosphorylation is inhibited by the apoptotic C-terminus cleavage product of PKN2 (By similarity). Tyr-9 phosphorylation is critical for stabilization of both PDPK1 and the PDPK1/SRC complex via HSP90-mediated protection of PDPK1 degradation. Angiotensin II stimulates the tyrosine phosphorylation of PDPK1 in vascular smooth muscle in a calcium- and SRC-dependent manner. Phosphorylated on Tyr-9, Tyr-373 and Tyr-376 by INSR in response to insulin. Palmitate negatively regulates autophosphorylation at Ser-241 and palmitate-induced phosphorylation at Ser-529 and Ser-501 by PKC/PRKCQ negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylation at Thr-354 by MELK partially inhibits kinase activity, the inhibition is cooperatively enhanced by phosphorylation at Ser-394 and Ser-398 by MAP3K5. {ECO:0000250, ECO:0000269|PubMed:10455013, ECO:0000269|PubMed:11481331, ECO:0000269|PubMed:14585963, ECO:0000269|PubMed:15743829, ECO:0000269|PubMed:16314505, ECO:0000269|PubMed:16780920, ECO:0000269|PubMed:22544756, ECO:0000269|Ref.8}.; PTM: Autophosphorylated; autophosphorylation is inhibited by the apoptotic C-terminus cleavage product of PKN2. {ECO:0000250}.; PTM: Monoubiquitinated in the kinase domain, deubiquitinated by USP4.	9094314; 9368760; 9445477; 15616553; 15489334; 9637919; 9768361; 9707564; 9445476; 10455013; 10364160; 10480933; 10995762; 11481331; 12177059; 12167717; 14585963; 14604990; 15210700; 10226025; 15209375; 16207722; 16251192; 15743829; 16314505; 16780920; 17327236; 17371830; 18835241; 18616680; 18802401; 18024423; 19591923; 19276999; 19690332; 22544756; 22347420; 24275569; 12169624; 15741170; 15772071; 20978239; 22999883	Protein kinase superfamily, AGC Ser/Thr protein kinase family, PDPK1 subfamily
O15533	TPSN_HUMAN	Tapasin, TPN, TPSN (NGS-17) (TAP-associated protein) (TAP-binding protein)	TAPBP NGS17 TAPA	448	9606			3D-structure;Alternative splicing;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Glycoprotein;Immunoglobulin domain;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix	P01892; Q03518; Q03519; P0C739; Q77CE4	TISSUE SPECIFICITY: Neutrophils, mostly in fully differentiated cells.	GO:0000139; GO:0002397; GO:0002398; GO:0002502; GO:0003823; GO:0005783; GO:0005789; GO:0006890; GO:0006955; GO:0010468; GO:0015433; GO:0016021; GO:0019885; GO:0030670; GO:0033116; GO:0042288; GO:0042605; GO:0042824; GO:0046978; GO:0046979; GO:0050776; GO:0050823; GO:0051082; GO:0061635; GO:0061779; GO:0062061; GO:0065003; GO:0071556		9238042; 9271576; 9521053; 9545376; 9802609; 10088603; 14668790; 20600451; 14574404; 15489334; 10382748; 10636848; 12582157; 19159218; 21269460; 21263072; 22638925; 25944712; 26611325; 19119025; 12149238	
O15534	PER1_HUMAN	Period circadian protein homolog 1, hPER1 (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui)	PER1 KIAA0482 PER RIGUI	1290	9606			Alternative splicing;Biological rhythms;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	Q92870-2; P46379-2; Q8WUW1; P55212; Q99832; P29692-2; P41091; O75460-2; P22607; Q0VDC6; P14136; Q14957; P28799; P06396; P01112; P54652; P04792; Q8WXH2; O60333-2; O14901; O60356; P07237; P60201-2; O75400-2; P60891; P62826; P49591; Q9P1I4; Q9UMX0; O76024; Q9R194	TISSUE SPECIFICITY: Widely expressed. Expressed in hair follicles (at protein level).Found in heart, brain, placenta, lung, liver, skeletal muscle, pancreas, kidney, spleen, thymus, prostate, testis, ovary and small intestine. Highest level in skeletal muscle. {ECO:0000269|PubMed:14750904, ECO:0000269|PubMed:24005054, ECO:0000269|PubMed:9333243, ECO:0000269|PubMed:9427249}.	GO:0000122; GO:0000976; GO:0000978; GO:0001222; GO:0002028; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007623; GO:0009649; GO:0010608; GO:0019900; GO:0031490; GO:0031625; GO:0032922; GO:0042634; GO:0042752; GO:0043124; GO:0043153; GO:0043966; GO:0043967; GO:0045892; GO:0045944; GO:0046329; GO:0051591; GO:0070888; GO:0070932; GO:0097167; GO:0140297; GO:1900015; GO:1900744; GO:2000323	PTM: Phosphorylated on serine residues by CSNK1D, CSNK1E and probably also by CSNK1G2. Phosphorylation by CSNK1D or CSNK1E promotes nuclear location of PER proteins as well as ubiquitination and subsequent degradation. May be dephosphorylated by PP1. {ECO:0000269|PubMed:15917222}.; PTM: Ubiquitinated; requires phosphorylation by CSNK1E and interaction with BTRC and FBXW11. Deubiquitinated by USP2 (By similarity). {ECO:0000250|UniProtKB:O35973, ECO:0000269|PubMed:15917222}.	9323128; 9333243; 10940553; 10857746; 9455484; 14702039; 16625196; 15489334; 9427249; 10790862; 11165242; 14750904; 15917222; 17081983; 17525332; 18669648; 19413330; 19690332; 20068231; 23186163; 23303907; 24005054; 23916625; 30530698; 16959974; 27717682	
O15535	ZSC9_HUMAN	Zinc finger and SCAN domain-containing protein 9 (Cell proliferation-inducing gene 12 protein) (PRD51) (Zinc finger protein 193)	ZSCAN9 ZNF193 PIG12	394	9606			Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q9NX04; Q96EF6; Q14192; P55040; P14136; P28799; O43464; P42858; Q8WXH2; Q92993; O60333-2; Q8TAP4-4; Q9H213; P07196; P62937-2; P17252; P60891; Q15047-2; Q7Z699; P78362; O76024; P61981; Q9NWS9; Q9NWS9-2; P10073; Q3MJ62		GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837		9244436; 14702039; 14574404; 15489334; 28112733; 24658003	Krueppel C2H2-type zinc-finger protein family
O15537	XLRS1_HUMAN	Retinoschisin (X-linked juvenile retinoschisis protein)	RS1 XLRS1	224	9606			3D-structure;Cell adhesion;Cell membrane;Disease variant;Disulfide bond;Lipid-binding;Membrane;Reference proteome;Secreted;Sensory transduction;Signal;Vision		TISSUE SPECIFICITY: Restricted to the retina (at protein level) (PubMed:10915776). Detected in the inner segment of the photoreceptors, the inner nuclear layer, the inner plexiform layer and the ganglion cell layer (at protein level). At the macula, expressed in both the outer and inner nuclear layers and in the inner plexiform layer (at protein level) (PubMed:10915776). Detected in retina (PubMed:9326935). Detected only within the photoreceptor cell layer, most prominently within the inner segments of the photoreceptors (PubMed:10915776). Undetectable in the inner plexiform layers and the inner nuclear layer (PubMed:10915776). {ECO:0000269|PubMed:10915776, ECO:0000269|PubMed:9326935}.	GO:0001654; GO:0001786; GO:0001917; GO:0005615; GO:0007155; GO:0007601; GO:0010842; GO:0016062; GO:0019897; GO:0043325; GO:0051260; GO:0098984		9326935; 15772651; 17286855; 10915776; 15644328; 19849666; 27798099; 26812435; 27114531; 9760195; 10079181; 10450864; 10234514; 10220153; 10533068; 17304551; 17631851; 17615541; 19093009	
O15540	FABP7_HUMAN	Fatty acid-binding protein, brain (Brain lipid-binding protein, BLBP) (Brain-type fatty acid-binding protein, B-FABP) (Fatty acid-binding protein 7) (Mammary-derived growth inhibitor related)	FABP7 BLBP FABPB MRG	132	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Lipid-binding;Reference proteome;Transport	G5E9A7; O15354; P28799; P28799-2; O60333-2; D3DTS7; Q9Y3C5; Q7Z699; O76024	TISSUE SPECIFICITY: Expressed in brain and other neural tissues.	GO:0005504; GO:0005634; GO:0005829; GO:0007399; GO:0008285; GO:0008289; GO:0015908; GO:0050673		9375786; 9591779; 14702039; 17974005; 14574404; 15489334; 10854433; 12479569	Calycin superfamily, Fatty-acid binding protein (FABP) family
O15541	R113A_HUMAN	E3 ubiquitin-protein ligase RNF113A, EC 2.3.2.27 (Cwc24 homolog) (RING finger protein 113A) (Zinc finger protein 183)	RNF113A RNF113 ZNF183	343	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:28978524, ECO:0000269|PubMed:29144457}.	2.3.2.27	3D-structure;Acetylation;DNA damage;DNA repair;Metal-binding;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	Q13123; Q13435; O75643	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9224902}.	GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0006281; GO:0016567; GO:0016607; GO:0018276; GO:0034247; GO:0046872; GO:0061630; GO:0070100; GO:0071005		9224902; 14702039; 15772651; 15489334; 17081983; 17487921; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22365833; 23186163; 24275569; 25612912; 28978524; 29144457; 29361316; 29360106	
O15547	P2RX6_HUMAN	P2X purinoceptor 6, P2X6 (ATP receptor) (P2XM) (Purinergic receptor) (Purinergic receptor P2X-like 1)	P2RX6 P2RXL1 P2X6	441	9606			Alternative splicing;Disulfide bond;Glycoprotein;Ion channel;Ion transport;Ligand-gated ion channel;Membrane;Phosphoprotein;Receptor;Reference proteome;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Expressed predominantly in skeletal muscle.	GO:0001614; GO:0004888; GO:0004931; GO:0005524; GO:0005639; GO:0005737; GO:0005886; GO:0005887; GO:0006936; GO:0007165; GO:0014069; GO:0015267; GO:0030054; GO:0033198; GO:0043025; GO:0043197; GO:0043235; GO:0044877; GO:0098688; GO:0098978; GO:0099060	PTM: N-glycosylated. {ECO:0000269|PubMed:15657042}.	9242461; 15461802; 10591208; 15489334; 12112843; 15657042	P2X receptor family
O15550	KDM6A_HUMAN	Lysine-specific demethylase 6A, EC 1.14.11.68 (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)	KDM6A UTX	1401	9606		1.14.11.68	3D-structure;Chromatin regulator;Dioxygenase;Iron;Mental retardation;Metal-binding;Methylation;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Zinc	O15499; Q6FHY5; P61964		GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0051568; GO:0071557; GO:0071558		9381176; 15772651; 15489334; 17500065; 17851529; 17713478; 18003914; 17761849; 19413330; 19690332; 22197486; 23186163; 22002947; 16959974; 21828135	UTX family
O15551	CLD3_HUMAN	Claudin-3 (Clostridium perfringens enterotoxin receptor 2, CPE-R 2, CPE-receptor 2) (Rat ventral prostate.1 protein homolog, hRVP1)	CLDN3 C7orf1 CPETR2	220	9606			Cell junction;Cell membrane;Membrane;Phosphoprotein;Reference proteome;Tight junction;Transmembrane;Transmembrane helix;Williams-Beuren syndrome			GO:0001666; GO:0001934; GO:0003382; GO:0004888; GO:0005198; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0007155; GO:0008285; GO:0010628; GO:0010629; GO:0014045; GO:0016021; GO:0016327; GO:0016328; GO:0016338; GO:0022604; GO:0030335; GO:0030336; GO:0031532; GO:0032991; GO:0034331; GO:0035633; GO:0042802; GO:0043296; GO:0045471; GO:0061045; GO:0070160; GO:0070830; GO:0090303; GO:0090559; GO:0150111; GO:1901890; GO:1903348; GO:1905050		9441748; 9334247; 15489334; 24275569	Claudin family
O15552	FFAR2_HUMAN	Free fatty acid receptor 2 (G-protein coupled receptor 43)	FFAR2 FFA2 GPCR43 GPR43	330	9606			Cell membrane;G-protein coupled receptor;Glycoprotein;Immunity;Inflammatory response;Lipid-binding;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	Q9NRZ5; Q6RW13-2; P20292; P05090; Q9HD20-3; P27449; O95393; Q12983; Q8WVV5; Q96F05; Q8WVX3-2; Q06432; P27352; Q9P0B6; P27701; O14735; Q9BXR6; Q99675; O14493; Q8NHS1; Q8NC01; Q96DZ9-2; Q96FZ5; O95406; P29400-2; Q07325; Q8NBI2; Q9BUN8; P56851; P54849; Q9UKR5; O75063; Q92520; Q96IV6; PRO_0000009136 [O00602]; Q9Y3D6; Q14802-3; Q9H0Q3; O75084; Q8N3T1; P29033; O60883; Q02747; P02724; Q01628; P04264; Q86UP2-3; Q15012; O43561-2; O95214; Q8TAF8; Q9UBY5; Q13021; Q6N075; Q5J8X5; Q9UHE5; Q0D2K0; Q16617; Q8IXM6; P42857; Q8NH19; Q9Y5Y5; P60201-2; Q01453; P54315; Q9NS64; Q5QGT7; Q96GQ5; Q9NTJ5; O95968; Q9Y6D0; Q9BRI3; Q969S0; Q9NQQ7-3; Q7Z769; Q9H2H9; Q9NUM3; Q8IVJ1; Q0VAQ4; Q9NRQ5; B2RUZ4; P0DN84; Q9UNK0; Q9H7V2; Q9Y6I9; P48230; P17152; A0PK00; Q7Z5S9; Q9BVK8; Q969S6; Q8WW34-2; E9PQX1; Q9H2L4; Q8N2M4; Q5BJF2; P01375; Q5TGU0; Q5BVD1; Q53HI1; O75841; O95070; Q9BWQ6; Q96EC8	TISSUE SPECIFICITY: Expressed at relatively high levels in peripheral blood leukocytes and, to lesser extent, in spleen. {ECO:0000269|PubMed:12496283, ECO:0000269|PubMed:12684041}.	GO:0002232; GO:0002385; GO:0002673; GO:0002720; GO:0002752; GO:0002879; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008289; GO:0019915; GO:0032722; GO:0032757; GO:0042593; GO:0042995; GO:0045444; GO:0071398; GO:0090276		9344866; 15057824; 15489334; 12684041; 12496283; 12711604; 18801738; 20837008; 21037097; 21216233; 23066016; 23589301	G-protein coupled receptor 1 family
O15553	MEFV_HUMAN	Pyrin (Marenostrin)	MEFV MEF TRIM20	781	9606			3D-structure;Actin-binding;Alternative splicing;Amyloidosis;Cell projection;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Disease variant;Immunity;Inflammatory response;Innate immunity;Metal-binding;Microtubule;Nucleus;Phosphoprotein;Reference proteome;Zinc;Zinc-finger	P29466; O15553; O43586; Q9ULZ3; P29466	TISSUE SPECIFICITY: Expressed in peripheral blood leukocytes, particularly in mature granulocytes and to a lesser extent in monocytes but not in lymphocytes. Detected in spleen, lung and muscle, probably as a result of leukocyte infiltration in these tissues. Not expressed in thymus, prostate, testis, ovary, small intestine, colon, heart, brain, placenta, liver, kidney, pancreas. Expression detected in several myeloid leukemic, colon cancer, and prostate cancer cell lines. {ECO:0000269|PubMed:10666224, ECO:0000269|PubMed:10807793, ECO:0000269|PubMed:11115844}.	GO:0001726; GO:0002221; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005829; GO:0005874; GO:0005875; GO:0006954; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0030027; GO:0031410; GO:0032651; GO:0032691; GO:0032695; GO:0032731; GO:0034341; GO:0042802; GO:0045087; GO:0050728; GO:0061630; GO:0061702; GO:0070269; GO:0071641; GO:1900016; GO:1900226; GO:1904270; GO:2001056	PTM: Cleaved by CASP1 (Probable). The N-terminal cleavage product localizes to the nucleus as a filamentous network and to the cytoplasm, interacts more strongly with RELA and NFKBIA than the full-length protein, enhances the nuclear localization of RELA and induces NFKBIA proteolysis. The C-terminal cleavage product localizes to the cytoplasm (Probable). {ECO:0000305|PubMed:18577712}.; PTM: Phosphorylation at Ser-242 is required for the interaction with 14-3-3 proteins and down-regulation of pyrin pro-inflammatory activity. {ECO:0000269|PubMed:27030597}.; PTM: Degraded along with the delivery of its substrates to autolysosomal compartments (at protein level). {ECO:0000269|PubMed:26347139}.	9288758; 11115844; 15489334; 9288094; 11470495; 10807793; 10666224; 11468188; 11498534; 14595024; 12384939; 16037825; 16785446; 17431422; 17964261; 18577712; 19109554; 19584923; 26347139; 19729025; 9668175; 10024914; 10090880; 10364520; 10234504; 10612841; 10737995; 10854105; 10842288; 10787449; 11464238; 12124996; 14679589; 15024744; 16378925; 16730661; 23031807; 23505238; 24929125; 27030597; 28835462	
O15554	KCNN4_HUMAN	Intermediate conductance calcium-activated potassium channel protein 4, SK4, SKCa 4, SKCa4 (IKCa1, IK1) (KCa3.1) (KCa4) (Putative Gardos channel)	KCNN4 IK1 IKCA1 KCA4 SK4	427	9606			3D-structure;Calmodulin-binding;Cell membrane;Disease variant;Hereditary hemolytic anemia;Immunity;Ion channel;Ion transport;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport	Q13323; P62158; P13569; Q8TBE1; Q14802-3; Q8TDT2; Q9NRX4; Q01453; Q9BRI3; P61266	TISSUE SPECIFICITY: Widely expressed in non-excitable tissues.	GO:0002376; GO:0005267; GO:0005516; GO:0005829; GO:0005886; GO:0006811; GO:0006813; GO:0006816; GO:0006884; GO:0006952; GO:0008076; GO:0015269; GO:0016286; GO:0019903; GO:0022894; GO:0030322; GO:0031982; GO:0043005; GO:0043025; GO:0045332; GO:0046541; GO:0050714; GO:0050862; GO:0071805; GO:1901381	PTM: Phosphorylation at His-358 by NDKB activates the channel, and conversely it's dephosphorylation by PHPT1 inhibits the channel. {ECO:0000269|PubMed:17157250}.	9380751; 9326665; 9407042; 9693050; 10961988; 15489334; 10026195; 11425865; 15831468; 17157250; 18796614; 22814378; 24591580; 26178367; 26148990; 26198474	Potassium channel KCNN family, KCa3.1/KCNN4 subfamily
O42043	ENK18_HUMAN	Endogenous retrovirus group K member 18 Env polyprotein (Envelope polyprotein) (HERV-K(C1a) envelope protein) (HERV-K110 envelope protein) (HERV-K18 envelope protein) (HERV-K18 superantigen) (HERV-K_1q23.3 provirus ancestral Env polyprotein) (IDDMK1,2 22 envelope protein) (IDDMK1,2 22 superantigen) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]	ERVK-18	560	9606			Cell membrane;Cleavage on pair of basic residues;Disulfide bond;ERV;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Transposable element;Viral envelope protein;Virion		TISSUE SPECIFICITY: Expressed at higher level in the thymus. Expressed at lower level in peripheral blood lymphocytes.	GO:0005198; GO:0005886; GO:0016021	PTM: Specific enzymatic cleavages in vivo yield the mature SU and TM proteins. {ECO:0000250}.	10516026; 11672541; 9244304; 9778243; 10496080; 11672540; 11982593; 11841850; 11776384; 14988274; 12629516	Beta type-B retroviral envelope protein family, HERV class-II K(HML-2) env subfamily
O43143	DHX15_HUMAN	ATP-dependent RNA helicase DHX15, EC 3.6.4.13 (ATP-dependent RNA helicase #46) (DEAH box protein 15) (Splicing factor Prp43, hPrp43)	DHX15 DBP1 DDX15	795	9606		3.6.4.13	3D-structure;Acetylation;ATP-binding;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;mRNA processing;mRNA splicing;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;RNA-binding;Ubl conjugation	Q8N302; Q9P1Y5-2; P51114-2; O95872; O95678; O15226; Q96RS6-1; P98175; Q96I25; P52756; Q15428; Q8IWZ8; A0A0S2Z6H0; Q8N5A5; Q8N5A5-2; Q91WS2-1	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9388478}.	GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0016887; GO:0043123; GO:0043279; GO:0051607; GO:0140374		9388478; 12458796; 15489334; 14654843; 15146077; 19432882; 19103666; 19608861; 21269460; 22002106; 23186163; 24990078; 24275569; 24782566; 28112733; 34161762; 28580923; 30728453; 32179686	DEAD box helicase family, DEAH subfamily, DDX15/PRP43 sub-subfamily
O43147	SGSM2_HUMAN	Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)	SGSM2 KIAA0397 RUTBC1	1006	9606			Alternative splicing;Cytoplasm;GTPase activation;Phosphoprotein;Reference proteome		TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:17509819}.	GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630		17509819; 9455477; 12168954; 14702039; 16625196; 15489334; 21808068; 26620560	RUTBC family
O43148	MCES_HUMAN	mRNA cap guanine-N7 methyltransferase, EC 2.1.1.56 (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase, hCMT1, hMet, hcm1p)	RNMT KIAA0398	476	9606		2.1.1.56	3D-structure;Alternative splicing;Methyltransferase;mRNA capping;mRNA processing;Nucleus;Phosphoprotein;Reference proteome;RNA-binding;S-adenosyl-L-methionine;Transferase	Q96IK5; P52292; O60684; Q9HB20; Q9BTL3	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9705270, ECO:0000269|PubMed:9790902}.	GO:0001650; GO:0003723; GO:0004482; GO:0005634; GO:0005654; GO:0005845; GO:0006370; GO:0031533; GO:0043235; GO:1990830		9790902; 9705270; 10589710; 9455477; 15489334; 10347220; 11114884; 15767670; 21269460; 22099306; 27422871	Class I-like SAM-binding methyltransferase superfamily, mRNA cap 0 methyltransferase family
O43149	ZZEF1_HUMAN	Zinc finger ZZ-type and EF-hand domain-containing protein 1	ZZEF1 KIAA0399	2961	9606			Acetylation;Activator;Alternative splicing;Lipoprotein;Metal-binding;Myristate;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		TISSUE SPECIFICITY: Expressed at low levels in cerebellum. {ECO:0000269|PubMed:15519529}.	GO:0003713; GO:0005509; GO:0008270; GO:0035064; GO:0070577		9455477; 12168954; 14702039; 16625196; 15489334; 15519529; 16964243; 18669648; 19413330; 19690332; 19608861; 20213681; 20068231; 21269460; 23186163; 24223779; 24275569; 33227311	
O43150	ASAP2_HUMAN	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3, PAG3) (Pyk2 C-terminus-associated protein, PAP)	ASAP2 DDEF2 KIAA0400	1006	9606			Alternative splicing;ANK repeat;Cell membrane;Coiled coil;Cytoplasm;Golgi apparatus;GTPase activation;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Repeat;SH3 domain;Zinc	P46108; P62993; P19174; Q96B97; P0CG48; Q5JPT6; P70039	TISSUE SPECIFICITY: Detected in heart, brain, placenta, kidney, monocytes and pancreas. {ECO:0000269|PubMed:10022920}.	GO:0005096; GO:0005886; GO:0032580; GO:0043547; GO:0046872	PTM: Phosphorylated on tyrosine residues by SRC and PTK2B. {ECO:0000269|PubMed:10022920}.	9455477; 15489334; 10022920; 10749932; 11304556; 17081983; 18088087; 18669648; 20068231; 21406692; 23186163	
O43151	TET3_HUMAN	Methylcytosine dioxygenase TET3, EC 1.14.11.n2	TET3 KIAA0401	1795	9606		1.14.11.n2	3D-structure;Alternative splicing;Chromatin regulator;Chromosome;Cytoplasm;Developmental protein;Dioxygenase;Disease variant;DNA-binding;Iron;Isopeptide bond;Mental retardation;Metal-binding;Nucleus;Oxidoreductase;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	O15294	TISSUE SPECIFICITY: Expressed in colon, muscle, adrenal gland and peripheral blood lymphocytes. {ECO:0000269|PubMed:12646957}.	GO:0001939; GO:0001940; GO:0005634; GO:0005694; GO:0005737; GO:0006211; GO:0006325; GO:0006493; GO:0008270; GO:0008327; GO:0044727; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0080182		23217707; 15815621; 15489334; 9455477; 12646957; 23353889; 23222540; 25218447; 28112733; 29276034; 31928709	TET family
O43155	FLRT2_HUMAN	Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2)	FLRT2 KIAA0405 UNQ232/PRO265	660	9606			Cell adhesion;Cell junction;Cell membrane;Developmental protein;Direct protein sequencing;Disulfide bond;Endoplasmic reticulum;Extracellular matrix;Glycoprotein;Leucine-rich repeat;Membrane;Microsome;Reference proteome;Repeat;Secreted;Signal;Synapse;Synaptosome;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in pancreas, skeletal muscle, brain, and heart. {ECO:0000269|PubMed:10644439}.	GO:0003007; GO:0005104; GO:0005615; GO:0005789; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007411; GO:0008543; GO:0030674; GO:0031012; GO:0043005; GO:0045202; GO:0045499; GO:0051965; GO:0061343; GO:0070062; GO:0071711; GO:2001222	PTM: N-glycosylated. {ECO:0000269|PubMed:10644439, ECO:0000269|PubMed:19159218}.; PTM: Proteolytic cleavage in the juxtamembrane region gives rise to a soluble ectodomain. Cleavage is probably effected by a metalloprotease. {ECO:0000250|UniProtKB:Q8BLU0}.	10644439; 9455477; 12975309; 15489334; 15340161; 19159218	
O43156	TTI1_HUMAN	TELO2-interacting protein 1 homolog (Protein SMG10)	TTI1 KIAA0406 SMG10	1089	9606			3D-structure;Cytoplasm;Phosphoprotein;Reference proteome;Ubl conjugation	Q13315; Q13535; Q9UK97; Q9Y4R8	TISSUE SPECIFICITY: Widely expressed.	GO:0005634; GO:0005737; GO:0006338; GO:0031931; GO:0031932; GO:0032006; GO:0050821; GO:0070209; GO:0110078; GO:2000003	PTM: Phosphorylated at Ser-828 by CK2 following growth factor deprivation, leading to its subsequent ubiquitination by the SCF(FBXO9) complex. Phosphorylation by CK2 only takes place when TELO2 is bound to mTORC1, not mTORC2; leading to selective ubiquitination of mTORC1-associated protein. {ECO:0000269|PubMed:23263282}.; PTM: Ubiquitinated by the SCF(FBXO9) complex following phosphorylation by CK2 in response to growth factor deprivation, leading to its degradation by the proteasome. Only mTORC1-associated protein is ubiquitinated and degraded, leading to selective inactivation of mTORC1 to restrain cell growth and protein translation, while mTORC2 is activated due to the relief of feedback inhibition by mTORC1. {ECO:0000269|PubMed:23263282}.	9455477; 20427287; 11780052; 15489334; 17081983; 18691976; 20810650; 20801936; 20371770; 20068231; 21269460; 23186163; 23263282; 26812014	Tti1 family
O43157	PLXB1_HUMAN	Plexin-B1 (Semaphorin receptor SEP)	PLXNB1 KIAA0407 PLXN5 SEP	2135	9606			3D-structure;Alternative splicing;Cell membrane;Coiled coil;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix	P08581; Q04912; Q92730; P52198; P61587; Q92730; Q92854-1	TISSUE SPECIFICITY: Highly expressed in fetal kidney, and at slightly lower levels in fetal brain, lung and liver. {ECO:0000269|PubMed:8570614}.	GO:0002116; GO:0004888; GO:0005096; GO:0005576; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0014068; GO:0016477; GO:0017154; GO:0030215; GO:0030334; GO:0032794; GO:0033689; GO:0035556; GO:0043087; GO:0043547; GO:0043931; GO:0048812; GO:0050772; GO:0051493; GO:0071526; GO:1900220; GO:1902287; GO:1904862	PTM: Phosphorylated on tyrosine residues by ERBB2 and MET upon SEMA4D binding. {ECO:0000269|PubMed:10520995, ECO:0000269|PubMed:15210733}.; PTM: Proteolytic processing favors heterodimerization with PLXNB2 and SEMA4D binding. {ECO:0000269|PubMed:12533544}.	9455477; 10520995; 8570614; 15489334; 11035813; 12198496; 12196628; 12533544; 12730235; 15210733; 15184888; 16335952; 19159218; 19349973; 24275569; 17916560; 18411422; 18275816; 19843518; 20877282; 21912513; 16959974	Plexin family
O43159	RRP8_HUMAN	Ribosomal RNA-processing protein 8, EC 2.1.1.- (Cerebral protein 1) (Nucleomethylin)	RRP8 KIAA0409 NML hucep-1	456	9606		2.1.1.-	3D-structure;Chromatin regulator;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repressor;rRNA processing;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase	Q92997; Q6FHY5; Q9NRD5; Q96EB6; O43463		GO:0000183; GO:0003723; GO:0005654; GO:0005677; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0008757; GO:0031062; GO:0031065; GO:0032259; GO:0033553; GO:0035064; GO:0042149; GO:0045786; GO:0045892; GO:0046015; GO:0061773; GO:0072332; GO:0097009; GO:1903450		9455477; 15489334; 12429849; 11790298; 17081983; 18669648; 19413330; 19690332; 20068231; 23186163; 24275569; 18485871	Methyltransferase superfamily, RRP8 family
O43164	PJA2_HUMAN	E3 ubiquitin-protein ligase Praja-2, Praja2, EC 2.3.2.27 (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2)	PJA2 KIAA0438 RNF131	708	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.27	Acetylation;Alternative splicing;Cell junction;Cell membrane;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Golgi apparatus;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Synapse;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger			GO:0000139; GO:0004842; GO:0005737; GO:0005789; GO:0005886; GO:0006954; GO:0007616; GO:0010738; GO:0014069; GO:0016567; GO:0034137; GO:0034236; GO:0034237; GO:0035329; GO:0043030; GO:0045087; GO:0045111; GO:0046330; GO:0046872; GO:1900745		9455477; 14702039; 15372022; 15489334; 17974005; 12036302; 17081983; 18669648; 19690332; 20068231; 21423175; 21406692; 23186163; 24275569; 28471450	
O43166	SI1L1_HUMAN	Signal-induced proliferation-associated 1-like protein 1, SIPA1-like protein 1 (High-risk human papilloma viruses E6 oncoproteins targeted protein 1, E6-targeted protein 1)	SIPA1L1 E6TP1 KIAA0440	1804	9606			Alternative splicing;Cell junction;Coiled coil;Cytoplasm;Cytoskeleton;GTPase activation;Methylation;Phosphoprotein;Reference proteome;Synapse;Synaptosome;Ubl conjugation	P78352	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9858596}.	GO:0005096; GO:0005737; GO:0005886; GO:0014069; GO:0015629; GO:0031532; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0048814; GO:0050770; GO:0051056; GO:0061001; GO:0090630	PTM: Ubiquitinated and degraded by the SCF(BTRC) following phosphorylation by PLK2. {ECO:0000250}.; PTM: Phosphorylated at Ser-1349 by CDK5, creating a docking site for the POLO box domains of PLK2. Subsequently, PLK2 binds and phosphorylates SIPA1L1, leading to ubiquitination and degradation by the proteasome (By similarity). {ECO:0000250}.	9858596; 9455477; 12168954; 14702039; 12508121; 17081983; 18094260; 18220336; 18691976; 18669648; 19413330; 19690332; 20068231; 21406692; 23186163; 24275569; 16959974	
O43167	ZBT24_HUMAN	Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450)	ZBTB24 KIAA0441 ZNF450	697	9606			Alternative splicing;Disease variant;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	Q9BYV9; Q9H165-2; Q9H2G9; Q96LM5; O95273; P32320; Q8NHQ1; Q8TAP6; Q8NEL9-2; Q92997; A0A0C3SFZ9; Q96IK5; A6NEM1; Q6NT76; Q9UIH9; O00505; Q6A162; P60370; P60371; P60409; P60410; P60411; Q9BYR9; Q9BYR5; P26371; O95751; Q68G74; Q8TBB1; Q8N456; D6RGH6; Q99750; Q9UJV3-2; Q5VU43-2; Q8IXK0; Q9NRD5; Q7Z3K3; P78424; Q53GL6; P98175; Q9Y2D8; Q08117; Q08117-2; Q9BTD3; Q12933; O94972; Q8WV44; Q9Y3Q8; Q9BZW7; Q9H2G4; O43298; Q96BR9; Q96C00; O95789-4; Q8TF50; Q9UID6; Q9NQZ8; Q15937; Q3KQV3; Q96EG3; Q9UGI0; G5E9A7; P28799; P42858; O60333-2; O60260-5; Q9Y3C5; P37840; Q7Z699; Q13148; Q86WV8; O76024	TISSUE SPECIFICITY: Widely expressed, with highest levels in naive B-cells. {ECO:0000269|PubMed:21596365}.	GO:0000978; GO:0002244; GO:0003700; GO:0005634; GO:0006357; GO:0046872		9455477; 12168954; 14574404; 15489334; 31839203; 21596365	Krueppel C2H2-type zinc-finger protein family
O43169	CYB5B_HUMAN	Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform)	CYB5B CYB5M OMB5	150	9606			3D-structure;Acetylation;Electron transport;Heme;Iron;Membrane;Metal-binding;Methylation;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport	Q8IVF2-3; Q13520; Q13323; O60238; Q6UXG8-3; P20138; P11912; Q99675; O95471; Q7Z7G2; Q15125; Q5JX71; Q96KR6; Q8TBE3; A2A2Y4; O95377; Q8TDT2; Q9P2J2-2; O95279; P43628; Q5T0T0; Q9GZY8-5; Q5SR56; Q5TF39; Q6N075; P15941-11; Q8N183; Q13113; Q96KR7; Q5VZY2; Q9H6H4; Q86VR2; Q5VUM1; Q3KNW5; Q9NUM3; P27105; Q16623; P21579; Q8IV31; Q96Q45-2; Q53FP2; Q96HV5; Q8N661; PRO_0000045601 [Q99IB8]		GO:0005741; GO:0006805; GO:0006809; GO:0006979; GO:0008047; GO:0016020; GO:0016021; GO:0020037; GO:0043231; GO:0046872; GO:1903958		14702039; 15616553; 15489334; 18669648; 19608861; 21269460; 22814378; 23186163; 24275569; 24129315; 25944712	Cytochrome b5 family
O43172	PRP4_HUMAN	U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog, hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)	PRPF4 PRP4	522	9606			3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Disease variant;mRNA processing;mRNA splicing;Nucleus;Reference proteome;Repeat;Retinitis pigmentosa;Spliceosome;WD repeat	Q92917; O43447		GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0015030; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0071005; GO:0097525		9257651; 9404889; 9328476; 15164053; 15489334; 9000057; 16723661; 19608861; 21269460; 26030138; 12875835; 26912367; 28781166; 24419317; 25383878	
O43173	SIA8C_HUMAN	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase, EC 2.4.99.- (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sialyltransferase 8C, SIAT8-C) (Sialyltransferase St8Sia III, ST8SiaIII)	ST8SIA3 SIAT8C	380	9606	PATHWAY: Protein modification; protein glycosylation. {ECO:0000305|PubMed:10766765, ECO:0000305|PubMed:26192331}.	2.4.99.-	3D-structure;Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	O43173	TISSUE SPECIFICITY: Expressed in fetal and adult brain and fetal liver. {ECO:0000269|PubMed:9826427}.	GO:0000139; GO:0001574; GO:0003828; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009100; GO:0009311; GO:0016021; GO:0033691; GO:0042802; GO:1990743		9826427; 10766765; 14702039; 15489334; 26192331	Glycosyltransferase 29 family
O43174	CP26A_HUMAN	Cytochrome P450 26A1, EC 1.14.13.- (Cytochrome P450 retinoic acid-inactivating 1, Cytochrome P450RAI, hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome)	CYP26A1 CYP26 P450RAI1	497	9606		1.14.13.-	Alternative splicing;Endoplasmic reticulum;Heme;Iron;Lipid metabolism;Membrane;Metal-binding;Microsome;Monooxygenase;Oxidoreductase;Reference proteome		TISSUE SPECIFICITY: Expressed in most fetal and adult tissues with highest levels in adult liver, heart, pituitary gland, adrenal gland, placenta and regions of the brain (PubMed:9826557). Expressed at high levels in lung, pancreas, skin and uterus (at protein level) (PubMed:22020119). Lower expression level is detected in spleen, kidney, intestine and adipose tissue (at protein level) (PubMed:22020119). {ECO:0000269|PubMed:22020119, ECO:0000269|PubMed:9826557}.	GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006766; GO:0006805; GO:0008401; GO:0016125; GO:0016491; GO:0016709; GO:0019825; GO:0020037; GO:0032526; GO:0033189; GO:0034653; GO:0042573; GO:0048387; GO:0062182; GO:0062183		9228017; 9716180; 14702039; 15164054; 9826557; 22020119; 26937021	Cytochrome P450 family
O43175	SERA_HUMAN	D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)	PHGDH PGDH3	533	9606	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 1/3.	1.1.1.37; 1.1.1.399; 1.1.1.95	3D-structure;Acetylation;Amino-acid biosynthesis;Direct protein sequencing;Disease variant;Isopeptide bond;NAD;Oxidoreductase;Phosphoprotein;Reference proteome;Serine biosynthesis;Ubl conjugation			GO:0004617; GO:0005829; GO:0006541; GO:0006544; GO:0006564; GO:0006566; GO:0007420; GO:0009055; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0030060; GO:0031175; GO:0051287; GO:0070062; GO:0070314		10713460; 11055895; 14702039; 16710414; 15489334; 11751922; 14654843; 16949628; 18378410; 18669648; 21269460; 23186163; 24275569; 25114211; 25406093; 25944712; 19235232; 24836451	D-isomer specific 2-hydroxyacid dehydrogenase family
O43181	NDUS4_HUMAN	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa, CI-18 kDa) (Complex I-AQDQ, CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)	NDUFS4	175	9606			3D-structure;Disease variant;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transit peptide;Transport			GO:0001932; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007420; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0045333; GO:0048146; GO:0051591; GO:0072593		9463323; 15489334; 11181577; 12616398; 12611891; 19107570; 20433953; 21269460; 25944712; 27626371; 31206022; 10944442; 15975579; 19364667	Complex I NDUFS4 subunit family
O43182	RHG06_HUMAN	Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1)	ARHGAP6 RHOGAP6	974	9606			Alternative splicing;Cytoplasm;GTPase activation;Phosphoprotein;Reference proteome;SH3-binding		TISSUE SPECIFICITY: Highly expressed in kidney, heart and skeletal muscle followed by retina, lymphoblast, placenta, lung, brain, pancreas and liver.	GO:0005096; GO:0005737; GO:0005829; GO:0005884; GO:0007202; GO:0007266; GO:0010518; GO:0015629; GO:0016004; GO:0017124; GO:0030041; GO:0043274; GO:0043547; GO:0048041; GO:0051056; GO:0051497; GO:0051895		10699171; 9417914; 15489334; 18088087; 21269460; 23186163	
O43184	ADA12_HUMAN	Disintegrin and metalloproteinase domain-containing protein 12, ADAM 12, EC 3.4.24.- (Meltrin-alpha)	ADAM12 MLTN UNQ346/PRO545	909	9606		3.4.24.-	Alternative splicing;Cell adhesion;Cell membrane;Cleavage on pair of basic residues;Disulfide bond;EGF-like domain;Glycoprotein;Hydrolase;Membrane;Metal-binding;Metalloprotease;Phosphoprotein;Protease;Reference proteome;Secreted;SH3-binding;Signal;Transmembrane;Transmembrane helix;Zinc;Zymogen	Q8N157; P08631; P07948; P12931; O95633; Q6UY14-3; A8MQ03; Q9NQ30; Q5TD97; Q96NT3-2; P49639; P78385; Q07627; Q8IUG1; P60410; P59991; Q9BYR8; Q9BYR7; Q9BQ66; Q6L8G9; P26371; Q3LI66; Q9BYQ4; Q9BYQ0; Q5TCM9; O60336; P0DPK4; P32242; Q6P9E2; Q16348; O43609; Q9C004; Q7Z6R9	TISSUE SPECIFICITY: Isoform 1 is expressed in placenta and skeletal, cardiac, and smooth muscle. Isoform 2 seems to be expressed only in placenta or in embryo and fetus. Both forms were expressed in some tumor cells lines. Not detected in brain, lung, liver, kidney or pancreas.	GO:0004222; GO:0005576; GO:0005654; GO:0005886; GO:0007155; GO:0007520; GO:0008237; GO:0016021; GO:0017124; GO:0045766; GO:0046872	PTM: The precursor is cleaved by a furin endopeptidase. {ECO:0000250}.	9417060; 12975309; 15164054; 15489334; 9642263; 10831617; 12615925; 15574124; 18621736; 16959974; 21618342	
O43186	CRX_HUMAN	Cone-rod homeobox protein	CRX CORD2	299	9606			Activator;Cone-rod dystrophy;Developmental protein;Differentiation;Disease variant;DNA-binding;Homeobox;Leber congenital amaurosis;Neurogenesis;Nucleus;Reference proteome;Retinitis pigmentosa;Sensory transduction;Transcription;Transcription regulation;Vision	Q9NRN7; Q9NYB9; K7EM05; O95376; O94817; Q8N8Y2; P54253; Q9H503-2; A0A0S2Z5G4; B4DE54; Q8N9N5-2; Q8N9N5-7; Q8IYS8; Q9UFG5; Q9NX04; Q9BV19; Q96LT7; P35219; P24863; P42773; Q8IYR0; Q9UI47-2; Q14154; P63241; Q6NZ36-4; O75593; O75603; Q9BZE0; Q96NT3; P13807; A0A024R8L2; O14964; P35680; Q86VF2-5; P78412; Q63ZY3; Q5THT1; Q71RC2-6; P17931; P0CW20; Q8TBB1; Q17RB8; Q8TC57; Q9BUN1; Q6P2C6; Q9NP98; Q969S2; Q13952-2; Q9Y221; P34130; O95007; Q9UJX0; Q7Z2X4; P0CW24; Q7Z3K3; Q96T49; O43741; P0CG20; P25786; P40306; Q2TAL8; Q9BQY4; A1L4F5; Q01974; Q9UBE0; O00560; Q9UDX3; P84022; Q8IYB5-2; Q8WU79; Q53HV7; P56693; O95416; P41225; P35711; P35711-4; Q9NZD8; O75716; Q9UMX1; P51687; Q5T011-5; O95947; Q9NQB0-10; O43247-2; Q92734; Q08117; Q08117-2; O43711; Q63HR2; Q14CS0; O94888; A5D8V6; Q96K80; Q15915; Q6P088; A0A0S2Z6P0; P03410	TISSUE SPECIFICITY: Retina.	GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007399; GO:0007601; GO:0009887; GO:0016922; GO:0030154; GO:0043522; GO:0045944; GO:0050896; GO:0061629; GO:0090575; GO:1990837		9390563; 15057824; 15489334; 17286855; 10625658; 10887186; 15028672; 9427255; 9792858; 9931337; 11139241; 16959974; 18682808; 20513135; 21602930; 27535533	Paired homeobox family
O43187	IRAK2_HUMAN	Interleukin-1 receptor-associated kinase-like 2, IRAK-2	IRAK2	625	9606			3D-structure;ATP-binding;Nucleotide-binding;Phosphoprotein;Reference proteome	P10398; Q9NWZ3; P46977; Q13148; P58753; Q9H0E2; Q9Y4K3; Q5D1E8; P68467; Q6PDS3	TISSUE SPECIFICITY: Expressed in spleen, thymus, prostate, lung, liver, skeletal muscle, kidney, pancreas and peripheral blood leukocytes. {ECO:0000269|PubMed:9374458}.	GO:0001959; GO:0002755; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006954; GO:0007249; GO:0010008; GO:0019221; GO:0031663; GO:0032088; GO:0035556; GO:0042803; GO:0046982; GO:0051092; GO:0070498; GO:0070555		14702039; 15489334; 9374458; 10383454; 23186163; 24275569; 20485341; 17344846	Protein kinase superfamily, TKL Ser/Thr protein kinase family, Pelle subfamily
O43189	PHF1_HUMAN	PHD finger protein 1, Protein PHF1, hPHF1 (Polycomb-like protein 1, hPCl1)	PHF1 PCL1	567	9606			3D-structure;Alternative splicing;Chromatin regulator;Chromosomal rearrangement;Cytoplasm;Cytoskeleton;DNA damage;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	Q9NYB9-2; Q03989; Q96B67; Q9ULK2; Q5T686; Q6PI77; O14503; Q96CA5; Q8N9W6-4; Q9H6J7-2; Q13137; Q9NRI5-2; Q92782-2; Q5JST6; Q15910; Q14192; P53539; A6NEM1; Q92917; Q9BPX1; Q0VD86; Q5VVH5; Q6ZU52; Q6A162; P52954; Q9BRK4; Q9Y5V3; Q99750; Q6FHY5; Q6PF18; Q15742; Q9HBE1-4; Q9NR12; Q99471; Q4G0R1; P86480; Q8NC74; Q93062; Q93062-3; Q9H0W8; O60504; Q99932-2; Q12800; Q9UBB9; Q9NVV9; Q08117-2; Q63HR2; Q96NM4-3; Q05BL1; P36406; Q70EL1-9; Q08AM6; Q96DT7-3; Q05516; Q9NZV7; O60304; Q8TF50; P0C7X2; Q9NQZ8; Q9UGI0	TISSUE SPECIFICITY: Highest levels in heart, skeletal muscle, and pancreas, lower levels in brain, placenta, lung, liver and kidney.	GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006325; GO:0006355; GO:0006974; GO:0035064; GO:0035861; GO:0042802; GO:0046872; GO:0061086; GO:0061087; GO:1990226		9545646; 14574404; 15489334; 16397222; 18086877; 18285464; 18385154; 18669648; 20873783; 22761769; 23228662; 23150668; 23186163; 24275569; 23273982; 23142980	Polycomblike family
O43193	MTLR_HUMAN	Motilin receptor (G-protein coupled receptor 38)	MLNR GPR38 MTLR MTLR1	412	9606			Alternative splicing;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed only in thyroid, stomach, and bone marrow.	GO:0004930; GO:0005829; GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0042562		9441746; 10381885; 15057823; 11322507	G-protein coupled receptor 1 family
O43194	GPR39_HUMAN	G-protein coupled receptor 39	GPR39	453	9606			Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Metal-binding;Phosphoprotein;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix;Zinc	P08908	TISSUE SPECIFICITY: Expressed in many tissues, including the stomach, intestine and hypothalamus. {ECO:0000269|PubMed:9441746}.	GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0046872		9441746; 14702039; 15815621; 15489334; 18693759; 18588883; 23186163; 24275569	G-protein coupled receptor 1 family
O43196	MSH5_HUMAN	MutS protein homolog 5, hMSH5	MSH5	834	9606			Alternative splicing;ATP-binding;Disease variant;DNA damage;DNA repair;DNA-binding;Meiosis;Nucleotide-binding;Premature ovarian failure;Reference proteome	P00519; O15457; P50570-2; Q8TB36; P51608; Q16637; O14656-2; P28799; P42858; I6L9F6; O43933; O76024	TISSUE SPECIFICITY: Widely expressed, with high levels in testis and ovary, including granulosa cells (PubMed:9740671, PubMed:28175301). Also expressed in fetal ovary and adrenal gland (PubMed:28175301). {ECO:0000269|PubMed:28175301, ECO:0000269|PubMed:9740671}.	GO:0003690; GO:0005524; GO:0005634; GO:0006298; GO:0030983; GO:0051026		9740671; 10029069; 9787078; 14656967; 14574404; 15489334; 17823411; 28175301	DNA mismatch repair MutS family
O43236	SEPT4_HUMAN	Septin-4 (Bradeion beta) (Brain protein H5) (CE5B3 beta) (Cell division control-related protein 2, hCDCREL-2) (Peanut-like protein 2)	SEPTIN4 C17orf47 PNUTL2 SEP4 SEPT4 hucep-7	478	9606			3D-structure;Alternative splicing;Cell cycle;Cell division;Cell junction;Cell projection;Cilium;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Differentiation;Direct protein sequencing;Flagellum;GTP-binding;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Spermatogenesis;Synapse;Ubl conjugation	P05067; P63167; Q96FJ2; P42858; Q8IYM1; P37840; Q8IUQ4; P98170	TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues with highest expression in adult brain (at protein level), heart, liver and adrenal gland and fetal heart, kidney, liver and lung. Expressed in presynaptic terminals of dopaminergic neurons projecting from the substantia nigra pars compacta to the striatum (at protein level) (PubMed:17296554). Expressed in axonal varicosities in dopaminergic nerve terminals (at protein level) (PubMed:17296554). Expressed in the putamen and in the adjacent cerebral cortex (at protein level) (PubMed:17296554). Expressed in colonic crypts (at protein level) (PubMed:30389919). Also expressed in colorectal cancers and malignant melanomas. Expressed in platelets. {ECO:0000269|PubMed:11146656, ECO:0000269|PubMed:11167005, ECO:0000269|PubMed:11511094, ECO:0000269|PubMed:15116257, ECO:0000269|PubMed:15915442, ECO:0000269|PubMed:17296554, ECO:0000269|PubMed:30389919, ECO:0000269|PubMed:9889007}.; TISSUE SPECIFICITY: [Isoform ARTS]: Highly expressed in the brain and heart. {ECO:0000269|PubMed:11146656}.	GO:0000287; GO:0001764; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005940; GO:0006915; GO:0008021; GO:0015630; GO:0017157; GO:0030317; GO:0030424; GO:0030425; GO:0031105; GO:0031398; GO:0032153; GO:0034613; GO:0042802; GO:0042981; GO:0043065; GO:0043204; GO:0048515; GO:0060090; GO:0061484; GO:0061640; GO:0097227; GO:2001244	PTM: Phosphorylated by DYRK1A. {ECO:0000250|UniProtKB:P28661}.; PTM: Ubiquitinated by AREL1. {ECO:0000269|PubMed:23479728}.	9889007; 11167005; 11146656; 11511094; 14702039; 16625196; 15489334; 15116257; 15837787; 15915442; 17296554; 18318008; 21695558; 24275569; 17546647; 15029247; 23479728; 25588830; 29020630; 30389919	TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily, Septin GTPase family
O43237	DC1L2_HUMAN	Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic, LIC-2) (LIC53/55)	DYNC1LI2 DNCLI2 LIC2	492	9606			3D-structure;Alternative splicing;ATP-binding;Cytoplasm;Cytoskeleton;Dynein;Methylation;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Reference proteome;Transport			GO:0000226; GO:0000776; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0007018; GO:0016020; GO:0030286; GO:0042802; GO:0045504; GO:0051642; GO:1990090		14702039; 15616553; 15489334; 17081983; 16964243; 18691976; 18669648; 19413330; 20068231; 21269460; 21406692; 23186163; 24275569; 24129315	Dynein light intermediate chain family
O43242	PSMD3_HUMAN	26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58)	PSMD3	534	9606			3D-structure;Alternative splicing;Isopeptide bond;Phosphoprotein;Proteasome;Reference proteome;Ubl conjugation	Q9C0F1; P42858; P25963; P16885; O43395; P60900; P60896; O43298		GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813		9017604; 14702039; 16625196; 15489334; 1317798; 15147878; 17323924; 21269460; 22814378; 23186163; 24275569; 25114211; 26030138; 28112733; 27428775; 27342858	Proteasome subunit S3 family
O43248	HXC11_HUMAN	Homeobox protein Hox-C11 (Homeobox protein Hox-3H)	HOXC11 HOX3H	304	9606			Developmental protein;DNA-binding;Homeobox;Isopeptide bond;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	P22607; P01112; P42858; D3DTS7; P25786; Q15642-2		GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001656; GO:0001759; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007492; GO:0009952; GO:0009954; GO:0042733; GO:0045944; GO:0048856; GO:0060272; GO:1990837		9582375; 14702039; 15489334; 25218447; 25772364; 28112733; 11857506	Abd-B homeobox family
O43251	RFOX2_HUMAN	RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (Hexaribonucleotide-binding protein 2) (RNA-binding motif protein 9) (RNA-binding protein 9) (Repressor of tamoxifen transcriptional activity)	RBFOX2 FOX2 HRNBP2 RBM9 RTA	390	9606			3D-structure;Alternative splicing;Cytoplasm;Methylation;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;RNA-binding	P54253; Q8N9W6; Q6P1W5; Q13554; O75553; Q15038; P03372; P52597; Q9Y5V3; Q8NDC0; Q96HR8; P25788; Q96PU8; Q9NWB1; Q9BQY4; O76064; Q08AM6; P42858; A0A142I5B9; P54253; P0C7T5; Q8N9W6-4; Q9UQM7; Q8IWX8; Q15038; A1KXE4-2; P52597; P31943; Q3LI66; Q9Y5V3; Q8TDS5; Q15365; Q93062-3; Q6ZRY4; Q9BQY4; O76064; Q96LM6; Q9UHD9		GO:0000381; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007399; GO:0008380; GO:0010724; GO:0016070; GO:0021942; GO:0030520; GO:0042127; GO:0045892; GO:0048813; GO:0050885; GO:0140297		11875103; 12529303; 15461802; 14702039; 10591208; 15489334; 21269460; 24275569; 24129315	
O43252	PAPS1_HUMAN	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1, PAPS synthase 1, PAPSS 1 (Sulfurylase kinase 1, SK 1, SK1) [Includes: Sulfate adenylyltransferase, EC 2.7.7.4 (ATP-sulfurylase) (Sulfate adenylate transferase, SAT); Adenylyl-sulfate kinase, EC 2.7.1.25 (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase) ]	PAPSS1 ATPSK1 PAPSS	624	9606	PATHWAY: Sulfur metabolism; sulfate assimilation. {ECO:0000269|PubMed:14747722, ECO:0000269|PubMed:9576487, ECO:0000269|PubMed:9648242, ECO:0000269|PubMed:9668121}.	2.7.1.25; 2.7.7.4	3D-structure;Acetylation;ATP-binding;Kinase;Multifunctional enzyme;Nucleotide-binding;Nucleotidyltransferase;Reference proteome;Transferase		TISSUE SPECIFICITY: Expressed in testis, pancreas, kidney, thymus, prostate, ovary, small intestine, colon, leukocytes and liver. Also expressed in high endothelial venules (HEV) cells and in cartilage. {ECO:0000269|PubMed:9576487}.	GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016779; GO:0042803; GO:0050428		9576487; 9668121; 9648242; 10679223; 14702039; 15489334; 9915785; 14747722; 21269460; 22223895; 15755455; 17540769; 17276460	APS kinase family; Sulfate adenylyltransferase family
O43255	SIAH2_HUMAN	E3 ubiquitin-protein ligase SIAH2, EC 2.3.2.27 (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2, Siah-2, hSiah2)	SIAH2	324	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.27	3D-structure;Apoptosis;Biological rhythms;Cell cycle;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	O95835; Q9NRM7; P35372; Q7Z6J0	TISSUE SPECIFICITY: Widely expressed at low level. {ECO:0000269|PubMed:9403064}.	GO:0003714; GO:0004842; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006915; GO:0007049; GO:0007264; GO:0008270; GO:0031396; GO:0031624; GO:0042752; GO:0043005; GO:0043025; GO:0043066; GO:0043154; GO:0043161; GO:0043231; GO:0044257; GO:0048511; GO:0060070; GO:0061630; GO:0090090; GO:1990000; GO:2001237	PTM: Phosphorylated at Ser-28 by MAPK14, which mediates the degradation by the proteasome of EGLN3 (By similarity). Phosphorylated at Ser-28 by DYRK2; this increases the ubiquitin ligase activity and promotes degradation of EGLN3. {ECO:0000250|UniProtKB:Q06986, ECO:0000269|PubMed:22878263}.	9403064; 10207103; 15489334; 9334332; 11483518; 11389839; 12411493; 12810624; 16509823; 19224863; 22878263; 23186163; 26392558; 28546513	SINA (Seven in absentia) family
O43257	ZNHI1_HUMAN	Zinc finger HIT domain-containing protein 1 (Cyclin-G1-binding protein 1) (Zinc finger protein subfamily 4A member 1) (p18 Hamlet)	ZNHIT1 CGBP1 ZNFN4A1	154	9606			Coiled coil;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc;Zinc-finger	Q9GZN1; Q92870-2; P41182; Q8WUW1; P27658; A8MQ03; O00429-3; P29692-2; Q5TD97; Q06787-7; A6NEM1; P0C0S5; Q63ZY3; P60371; P60409; P59991; Q15759; Q16539; P45984; Q99750; Q9ULV0-2; P32243-2; D3DTS7; Q15025; Q12888	TISSUE SPECIFICITY: Expressed abundantly in liver, but weakly in skeletal muscle, ovary and small intestine. {ECO:0000269|PubMed:17892483}.	GO:0000786; GO:0000812; GO:0005634; GO:0005654; GO:0006355; GO:0031491; GO:0043486; GO:0046872	PTM: Phosphorylated on Thr by MAPK11 or MAPK14. {ECO:0000269|PubMed:17380123}.; PTM: Stres-induced ZNHIT1 is mainly regulated at the level of protein.	12853948; 15489334; 15647280; 17380123; 17892483; 22814378; 28561026; 16959974	ZNHIT1 family
O43264	ZW10_HUMAN	Centromere/kinetochore protein zw10 homolog	ZW10	779	9606			Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Direct protein sequencing;Endoplasmic reticulum;ER-Golgi transport;Kinetochore;Lipid droplet;Membrane;Mitosis;Phosphoprotein;Protein transport;Reference proteome;Transport	Q6NUQ1; O95229	TISSUE SPECIFICITY: Widely expressed.	GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0005828; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0007080; GO:0007094; GO:0007096; GO:0015031; GO:0016020; GO:0019237; GO:0034501; GO:0051301; GO:0051321; GO:0065003; GO:0070939; GO:1990423		9298984; 16554811; 15489334; 12665801; 11590237; 12686595; 15029241; 15272311; 15094189; 15485811; 15824131; 16732327; 19413330; 19369418; 19608861; 20462495; 21269460; 23186163; 25944712; 30970241	ZW10 family
O43272	PROD_HUMAN	Proline dehydrogenase 1, mitochondrial, EC 1.5.5.2 (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein)	PRODH PIG6 POX2 PRODH2	600	9606	PATHWAY: Amino-acid degradation; L-proline degradation into L-glutamate; L-glutamate from L-proline: step 1/2.	1.5.5.2	Acetylation;Alternative splicing;Disease variant;FAD;Flavoprotein;Mitochondrion;Oxidoreductase;Proline metabolism;Reference proteome;Schizophrenia;Transit peptide		TISSUE SPECIFICITY: Expressed in lung, skeletal muscle and brain, to a lesser extent in heart and kidney, and weakly in liver, placenta and pancreas.	GO:0004657; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006560; GO:0006562; GO:0008631; GO:0010133; GO:0010942; GO:0019470; GO:0043231; GO:0071949		9385373; 10192398; 15662599; 10591208; 15489334; 9305847; 12217952; 11891283; 16959974; 17135275	Proline oxidase family
O43278	SPIT1_HUMAN	Kunitz-type protease inhibitor 1 (Hepatocyte growth factor activator inhibitor type 1, HAI-1)	SPINT1 HAI1 UNQ223/PRO256	529	9606			3D-structure;Alternative splicing;Direct protein sequencing;Disulfide bond;Glycoprotein;Protease inhibitor;Reference proteome;Repeat;Secreted;Serine protease inhibitor;Signal	Q08AM2; Q8TD06; O75508; Q9BXN2-6; Q92520; Q8IUG1; P21145; Q9NVC3; Q9NRQ5; P02787; Q9BVC6; Q8WZ59; Q5BJF2; Q86UF1; Q9UHD9; O75841; O95183		GO:0001843; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0016020; GO:0030198; GO:0045687; GO:0060670; GO:0060674; GO:0070062; GO:0071773; GO:2000178		9045658; 12975309; 15489334; 10373425; 15340161; 18669648; 15713485	
O43280	TREA_HUMAN	Trehalase, EC 3.2.1.28 (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)	TREH TREA	583	9606		3.2.1.28	Alternative splicing;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Glycosidase;GPI-anchor;Hydrolase;Lipoprotein;Membrane;Reference proteome;Signal		TISSUE SPECIFICITY: Expressed in kidney, liver and small intestine. Also more weakly expressed in pancreas. {ECO:0000269|PubMed:9427547}.	GO:0004555; GO:0005991; GO:0005993; GO:0009887; GO:0031225; GO:0046658; GO:0070062		9427547; 15489334; 8773341; 28406212	Glycosyl hydrolase 37 family
O43281	EFS_HUMAN	Embryonal Fyn-associated substrate, hEFS (Cas scaffolding protein family member 3)	EFS CASS3	561	9606			Alternative splicing;Cell adhesion;Phosphoprotein;Reference proteome;SH3 domain;SH3-binding	Q9NYB9; P51451; P06241; O75694; Q92882; O94875; Q9BXA7; Q8TAU3; Q9NYB9-2; P21549; P51451; P06241-3; Q92990; O95872; Q68G74; Q8IVT4; Q8TDC0; A0A0S2Z4D7; A0A0S2Z4E4; E7ERP6; Q13526; Q8TEC5; O94875-10; O75865-2; Q9BXA7; Q8TF42; P07947	TISSUE SPECIFICITY: The protein has been detected in lung and placenta.	GO:0005737; GO:0005925; GO:0007155; GO:0007169; GO:0016477; GO:0017124; GO:0019904; GO:0035556; GO:0090527	PTM: Phosphorylated on multiple tyrosine residues. Phosphorylated on tyrosines by FYN and SRC (By similarity). {ECO:0000250}.	9349509; 14702039; 12508121; 15489334; 16959974	CAS family
O43283	M3K13_HUMAN	Mitogen-activated protein kinase kinase kinase 13, EC 2.7.11.25 (Leucine zipper-bearing kinase) (Mixed lineage kinase, MLK)	MAP3K13 LZK	966	9606		2.7.11.25	Alternative splicing;ATP-binding;Cytoplasm;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase	O43283	TISSUE SPECIFICITY: Expressed in the adult brain, liver, placenta and pancreas, with expression strongest in the pancreas. {ECO:0000269|PubMed:9353328}.	GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004712; GO:0005524; GO:0005737; GO:0006468; GO:0007254; GO:0014042; GO:0016020; GO:0018105; GO:0019899; GO:0019901; GO:0042802; GO:0042803; GO:0043507; GO:0043539; GO:0045773; GO:0046777; GO:0046872; GO:0051092; GO:0051403; GO:0106137; GO:0106310; GO:0150012; GO:1905492	PTM: Autophosphorylated on serine and threonine residues. {ECO:0000269|PubMed:9353328}.	9353328; 14702039; 16641997; 15489334; 8274451; 11163770; 11726277; 12492477; 17344846	Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase kinase subfamily
O43286	B4GT5_HUMAN	Beta-1,4-galactosyltransferase 5, Beta-1,4-GalTase 5, Beta4Gal-T5, b4Gal-T5, EC 2.4.1.- (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase, EC 2.4.1.274) (Lactosylceramide synthase, LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5)	B4GALT5	388	9606	PATHWAY: Protein modification; protein glycosylation.; PATHWAY: Sphingolipid metabolism.	2.4.1.-; 2.4.1.274	Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Lipid biosynthesis;Lipid metabolism;Manganese;Membrane;Metal-binding;Reference proteome;Signal-anchor;Sphingolipid metabolism;Transferase;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:9435216}.	GO:0000139; GO:0003945; GO:0005794; GO:0006486; GO:0008378; GO:0008489; GO:0009101; GO:0010706; GO:0016021; GO:0016266; GO:0021955; GO:0022010; GO:0030311; GO:0031647; GO:0032580; GO:0040019; GO:0042551; GO:0046872; GO:0070085		9435216; 9597550; 11780052; 15489334; 24498430; 10580128; 29415997	Glycosyltransferase 7 family
O43290	SNUT1_HUMAN	U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog, hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1, SART-1, hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1)	SART1	800	9606			3D-structure;Allergen;Alternative splicing;Coiled coil;Isopeptide bond;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Ubl conjugation	O75031; O43395; O94906; O75643; Q13573; P63165; P55854; Q9BZL1	TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:9449708}.	GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013	PTM: Sumoylated with SUMO2.	9449708; 11350945; 16554811; 15489334; 11410364; 9856836; 11991638; 17081983; 16723661; 17525332; 18220336; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 25218447; 25114211; 25772364; 25755297; 28112733	SNU66/SART1 family
O43291	SPIT2_HUMAN	Kunitz-type protease inhibitor 2 (Hepatocyte growth factor activator inhibitor type 2, HAI-2) (Placental bikunin)	SPINT2 HAI2 KOP	252	9606			3D-structure;Alternative splicing;Direct protein sequencing;Disease variant;Disulfide bond;Glycoprotein;Membrane;Protease inhibitor;Reference proteome;Repeat;Serine protease inhibitor;Signal;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Expressed in placenta, kidney, pancreas, prostate, testis, thymus, and trachea.	GO:0001843; GO:0004866; GO:0004867; GO:0005576; GO:0005737; GO:0005886; GO:0007163; GO:0016021; GO:0022408; GO:0060672; GO:0071711; GO:0071773; GO:2000146; GO:2000178		9346890; 9115294; 9434156; 14702039; 15057824; 15489334; 15340161; 19185281	
O43292	GPAA1_HUMAN	Glycosylphosphatidylinositol anchor attachment 1 protein, GPI anchor attachment protein 1 (GAA1 protein homolog, hGAA1)	GPAA1 GAA1	621	9606	PATHWAY: Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis.		Alternative splicing;Direct protein sequencing;Disease variant;Endoplasmic reticulum;Glycoprotein;GPI-anchor biosynthesis;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q92643; Q969N2; Q92993; Q8TAP4-4; P23284; Q15047-2; P61981	TISSUE SPECIFICITY: Ubiquitously expressed in fetal and adult tissues. Expressed at higher levels in fetal tissues than adult tissues. {ECO:0000269|PubMed:9468317}.	GO:0005739; GO:0005783; GO:0005789; GO:0005813; GO:0005829; GO:0006508; GO:0006621; GO:0015631; GO:0016020; GO:0016255; GO:0042765; GO:0065003		9468317; 10393431; 17974005; 15489334; 11483512; 21269460; 29100095	
O43293	DAPK3_HUMAN	Death-associated protein kinase 3, DAP kinase 3, EC 2.7.11.1 (DAP-like kinase, Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase, ZIP-kinase)	DAPK3 ZIPK	454	9606		2.7.11.1	3D-structure;Activator;Alternative splicing;Apoptosis;ATP-binding;Chromatin regulator;Cytoplasm;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Translation regulation;Tumor suppressor	O43293; Q9UBE8; O14974; Q8TDR4; Q10728	TISSUE SPECIFICITY: Widely expressed. Isoform 1 and isoform 2 are expressed in the bladder smooth muscle. {ECO:0000269|PubMed:15292222, ECO:0000269|PubMed:17126281}.	GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006355; GO:0006468; GO:0006915; GO:0006940; GO:0007088; GO:0007346; GO:0008140; GO:0008360; GO:0010506; GO:0016605; GO:0017148; GO:0030335; GO:0031267; GO:0035556; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043519; GO:0043522; GO:0046777; GO:0051893; GO:0071346; GO:0090263; GO:0097190; GO:0106310; GO:2000145; GO:2000249	PTM: The phosphorylation status is critical for kinase activity, oligomerization and intracellular localization. Phosphorylation at Thr-180, Thr-225 and Thr-265 is essential for activity. The phosphorylated form is localized in the cytoplasm promoted by phosphorylation at Thr-299; nuclear translocation or retention is maximal when it is not phosphorylated. Phosphorylation increases the trimeric form, and its dephosphorylation favors a kinase-inactive monomeric form. Both isoform 1 and isoform 2 can undergo autophosphorylation. {ECO:0000269|PubMed:15367680, ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:20854903}.	9488481; 10356987; 14702039; 15489334; 17126281; 11384979; 11781833; 12917339; 15292222; 15096528; 15367680; 16219639; 15910542; 15611134; 16756490; 17158456; 17953487; 18995835; 18084323; 21487036; 20854903; 21169990; 21454679; 21408167; 23454120; 23186163; 18239682; 17344846	Protein kinase superfamily, CAMK Ser/Thr protein kinase family, DAP kinase subfamily
O43294	TGFI1_HUMAN	Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor coactivator 55 kDa protein) (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein, Hic-5)	TGFB1I1 ARA55	461	9606			Acetylation;Activator;Alternative splicing;Cell junction;Cytoplasm;Cytoskeleton;Differentiation;LIM domain;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Wnt signaling pathway;Zinc	P13612; Q05397; Q9BUZ4; O68743	TISSUE SPECIFICITY: Expressed in platelets, smooth muscle and prostate stromal cells (at protein level). {ECO:0000269|PubMed:10075738, ECO:0000269|PubMed:10708479, ECO:0000269|PubMed:11311131, ECO:0000269|PubMed:12642630, ECO:0000269|PubMed:12772188, ECO:0000269|PubMed:16849583, ECO:0000269|PubMed:17166536, ECO:0000269|PubMed:17233630, ECO:0000269|PubMed:9664039}.	GO:0003712; GO:0003713; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007155; GO:0008285; GO:0010718; GO:0016055; GO:0016331; GO:0016363; GO:0030511; GO:0030512; GO:0030579; GO:0030855; GO:0045165; GO:0045599; GO:0045893; GO:0046872; GO:0048495; GO:0050681; GO:0070411	PTM: Phosphorylated by gonadotropin-releasing hormone-activated SRC. {ECO:0000269|PubMed:10838081, ECO:0000269|PubMed:11311131, ECO:0000269|PubMed:11856738, ECO:0000269|PubMed:17202804, ECO:0000269|PubMed:17233630}.	10075738; 14702039; 15489334; 9422762; 9032249; 9756887; 9664039; 10838081; 10708479; 11311131; 11313252; 11532379; 11463817; 11489729; 12445807; 12153727; 11856738; 12177201; 12714604; 12642630; 12631731; 12700349; 12772188; 15211577; 15687259; 15561701; 16330715; 16849583; 17081983; 16624805; 16803896; 16141357; 17202804; 17233630; 17166536; 18691976; 19369195; 21406692; 23145173; 22814378; 23186163; 24275569	Paxillin family
O43295	SRGP3_HUMAN	SLIT-ROBO Rho GTPase-activating protein 3, srGAP3 (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein, WRP)	SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2	1099	9606			Alternative splicing;Chromosomal rearrangement;Coiled coil;GTPase activation;Phosphoprotein;Reference proteome;SH3 domain	P62993; P42858; O08838; O35964; O35179	TISSUE SPECIFICITY: Highly expressed in adult and fetal brain. Expressed at low levels in kidney. Isoform 3 is expressed in the kidney but is absent in the brain. {ECO:0000269|PubMed:12195014, ECO:0000269|PubMed:12447388}.	GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0051056		12447388; 12195014; 9455477; 12168954; 11672528; 18088087; 18669648; 19807924; 16959974	
O43296	ZN264_HUMAN	Zinc finger protein 264	ZNF264 KIAA0412	627	9606			DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q8NHQ1; Q92997; A6NEM1; O15397; P60371; P60409; P60410; Q9BYR9; P23508; Q99750; Q9NRD5; Q8WV44; Q9Y473; Q8TF50	TISSUE SPECIFICITY: Relatively highly expressed in kidney, thymus, testis, ovary, brain, lung, placenta, and prostate, and relatively low expression in heart, liver, skeletal muscle, pancreas, spleen, and small intestine.	GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872		9455477; 14702039; 15057824; 15592455; 17525332; 18669648; 28112733	Krueppel C2H2-type zinc-finger protein family
O43298	ZBT43_HUMAN	Zinc finger and BTB domain-containing protein 43 (Zinc finger and BTB domain-containing protein 22B) (Zinc finger protein 297B) (ZnF-x)	ZBTB43 KIAA0414 ZBTB22B ZNF297B	467	9606			3D-structure;Acetylation;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q8WTP8; Q9BXS5; P36575; P49407; P54253; Q8IYE1; Q8IVW4; Q96Q77; P26196; Q14689-6; Q3B820; P25800; Q8TAP4-4; P61968; Q8TBB1; Q9UBU8-2; Q15014; O43242; Q5T7P8-2; Q15560; O43167; P15622-3; Q8TAU3; Q96SQ5		GO:0000785; GO:0000977; GO:0000981; GO:0001025; GO:0005634; GO:0006357; GO:0046872; GO:1990837		9455477; 15164053; 15489334; 16542149; 22814378; 23186163; 25218447; 25755297; 28112733	Krueppel C2H2-type zinc-finger protein family
O43299	AP5Z1_HUMAN	AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit, Zeta5)	AP5Z1 KIAA0415 SPG48	807	9606			Alternative splicing;Cytoplasm;DNA damage;DNA repair;Hereditary spastic paraplegia;Neurodegeneration;Nucleus;Protein transport;Reference proteome;Transport	Q8N1F7		GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0005770; GO:0015031; GO:0016192; GO:0016197; GO:0016607; GO:0030119; GO:0044599		12853948; 9455477; 15489334; 20613862; 22022230; 23186163	
O43300	LRRT2_HUMAN	Leucine-rich repeat transmembrane neuronal protein 2 (Leucine-rich repeat neuronal 2 protein)	LRRTM2 KIAA0416 LRRN2	516	9606			3D-structure;Cell junction;Cell membrane;Glycoprotein;Leucine-rich repeat;Membrane;Postsynaptic cell membrane;Reference proteome;Repeat;Signal;Synapse;Transmembrane;Transmembrane helix	A0PK00; P01375	TISSUE SPECIFICITY: Expressed in neuronal tissues. {ECO:0000269|PubMed:12676565}.	GO:0002091; GO:0005615; GO:0042043; GO:0050808; GO:0051965; GO:0060076; GO:0060291; GO:0098685; GO:0098686; GO:0098978; GO:0098982; GO:0099060; GO:0099061; GO:0099151		12676565; 9455477; 14702039; 15489334	LRRTM family
O43303	CP110_HUMAN	Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa, CP110, Cep110)	CCP110 CEP110 CP110 KIAA0419	1012	9606			Alternative splicing;Cell projection;Cilium;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Phosphoprotein;Reference proteome;Ubl conjugation	P62158; P41002; O15078; Q8IW35; P41208; Q9BVV6; Q5T7B8; Q96JN8	TISSUE SPECIFICITY: Highly expressed in testis. Detected at intermediate levels in spleen, thymus, prostate, small intestine, colon and peripheral blood leukocytes. {ECO:0000269|PubMed:12361598}.	GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007099; GO:0032053; GO:0032465; GO:0032991; GO:0045724; GO:0051298; GO:1902018; GO:1903723	PTM: Phosphorylated by CDKs. {ECO:0000269|PubMed:12361598}.; PTM: Ubiquitinated by the SCF(CCNF) during G2 phase, leading to its degradation by the proteasome and preventing centrosome reduplication. Deubiquitinated by USP33 in S and G2/M phase, leading to stabilize CCP110 during the period which centrioles duplicate and elongate. {ECO:0000269|PubMed:20596027, ECO:0000269|PubMed:23486064}.	9455477; 17974005; 10493829; 15616553; 15489334; 12361598; 14654843; 16760425; 17719545; 17681131; 18694559; 19413330; 19460342; 19369195; 20596027; 21620453; 22885064; 22441691; 22261722; 23186163; 23486064; 24421332; 26304236; 30375385	
O43306	ADCY6_HUMAN	Adenylate cyclase type 6, EC 4.6.1.1 (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase)	ADCY6 KIAA0422	1168	9606		4.6.1.1	Alternative splicing;ATP-binding;cAMP biosynthesis;Cell membrane;Cell projection;Cilium;Disease variant;Glycoprotein;Lyase;Magnesium;Manganese;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Detected in peripheral blood mononuclear leukocytes (at protein level) (PubMed:17916776). Detected in thyroid (PubMed:10978539). {ECO:0000269|PubMed:10978539}.	GO:0003091; GO:0004016; GO:0005080; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007193; GO:0007212; GO:0010977; GO:0016020; GO:0019901; GO:0031226; GO:0032420; GO:0035556; GO:0035811; GO:0046872; GO:0071380; GO:0071870; GO:0097746; GO:1904117; GO:1904322	PTM: Phosphorylation by RAF1 increases enzyme activity. Phosphorylation by PKA at Ser-662 inhibits the GNAS-mediated increase in catalytic activity. Phosphorylation by PKC at Ser-556, Ser-662 and Thr-919 inhibits catalytic activity. {ECO:0000250|UniProtKB:Q03343}.	10978539; 9455477; 12168954; 15489334; 8476432; 15385642; 18088087; 18669648; 23186163; 24275569; 17916776; 17110384; 24319099	Adenylyl cyclase class-4/guanylyl cyclase family
O43307	ARHG9_HUMAN	Rho guanine nucleotide exchange factor 9 (Collybistin) (PEM-2 homolog) (Rac/Cdc42 guanine nucleotide exchange factor 9)	ARHGEF9 ARHDH9 KIAA0424	516	9606			3D-structure;Alternative splicing;Cell junction;Cytoplasm;Disease variant;Epilepsy;Guanine-nucleotide releasing factor;Phosphoprotein;Reference proteome;SH3 domain;Synapse	Q86YD7; Q9NW38; Q92993; Q8TAP4-4; Q15047-2; Q9NU19; Q3SY00; Q14119; P61981; Q86VK4-3	TISSUE SPECIFICITY: Detected in brain. Detected at low levels in heart. {ECO:0000269|PubMed:10559246}.	GO:0005085; GO:0005829; GO:0014069; GO:0051056		9455477; 14702039; 15772651; 15489334; 10559246; 15215304; 22612257; 23033978; 25678704	
O43309	ZSC12_HUMAN	Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 305) (Zinc finger protein 96)	ZSCAN12 KIAA0426 ZNF305 ZNF96	611	9606			Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q8TD16-2; Q9H3R5; Q8NHQ1; Q3B820; P60410; P02545; Q9UJV3-2; Q5JR59; Q96JS3; P63244; P57086; Q7Z699; P78362; Q9Y2D8; Q9UBB9; P98155-2; O75436; Q9P0L1; P17028; Q8NF99-2; Q9NWS9-2; Q8WTR7; Q96IT1; Q9Y5A6; Q9NX65		GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872		9455477; 14702039; 14574404; 15489334; 28112733	Krueppel C2H2-type zinc-finger protein family
O43310	CTIF_HUMAN	CBP80/20-dependent translation initiation factor	CTIF KIAA0427	598	9606			Acetylation;Alternative splicing;Cytoplasm;Nonsense-mediated mRNA decay;Phosphoprotein;Reference proteome;Translation regulation	Q8N5M1; Q9NUU7; Q9UMR2; Q96MH2; Q86VS8; A9UHW6-2; Q6P9E2; Q9NZD8	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:19648179}.	GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0048471		9455477; 16177791; 15489334; 14702039; 18088087; 18669648; 19413330; 19648179; 19690332; 21269460; 22814378; 23186163; 24275569; 16959974	CTIF family
O43312	MTSS1_HUMAN	Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)	MTSS1 KIAA0429 MIM	755	9606			3D-structure;Actin-binding;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Phosphoprotein;Reference proteome;Tumor suppressor	P42858; O43312; Q60598	TISSUE SPECIFICITY: Expressed in many tissues, including spleen, thymus, prostate, testis, uterus, colon, and peripheral blood. {ECO:0000269|PubMed:12082544}.	GO:0001726; GO:0003779; GO:0003785; GO:0005102; GO:0005543; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0031235; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013		14702039; 16421571; 15489334; 9455477; 12082544; 12570871; 18088087	MTSS family
O43313	ATMIN_HUMAN	ATM interactor (ATM/ATR-substrate CHK2-interacting zinc finger protein, ASCIZ) (Zinc finger protein 822)	ATMIN KIAA0431 ZNF822	823	9606			Activator;Alternative splicing;DNA damage;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	Q13315	TISSUE SPECIFICITY: Ubiquitously expressed in normal tissues and cancer cell lines with highest levels in placenta and skeletal muscle. {ECO:0000269|PubMed:15933716}.	GO:0000976; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006974; GO:0010628; GO:0016604; GO:0044458; GO:0045893; GO:0045944; GO:0046872; GO:0070840; GO:1902857		9455477; 17974005; 15616553; 15489334; 14702039; 15933716; 17525732; 22167198	
O43314	VIP2_HUMAN	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, EC 2.7.4.24 (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2, hsVIP2)	PPIP5K2 HISPPD1 KIAA0433 VIP2	1243	9606		2.7.4.24	3D-structure;Alternative splicing;ATP-binding;Cytoplasm;Deafness;Disease variant;Hearing;Kinase;Non-syndromic deafness;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase	P14859-6; P78424; Q92922		GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092		9455477; 12168954; 15372022; 15489334; 17690096; 17702752; 18669648; 19690332; 21269460; 21222653; 23186163; 24275569; 29590114; 22119861	Histidine acid phosphatase family, VIP1 subfamily
O43315	AQP9_HUMAN	Aquaporin-9, AQP-9 (Aquaglyceroporin-9) (Small solute channel 1)	AQP9 SSC1	295	9606			Cell membrane;Membrane;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	Q08AM2; Q9NVV5-2; P05090; Q9P0B6; Q8N6F1-2; Q7Z7G2; Q4LDR2; Q9BV81; Q14802-3; O75084; P01350; Q9UM44; P24593; Q8TAF8; P30301; P09466; Q9NRX5; O95470; Q9NVC3; P02787; Q9BVK6; Q9BVC6	TISSUE SPECIFICITY: Highly expressed in peripheral leukocytes. Also expressed in liver, lung, and spleen. {ECO:0000269|PubMed:10564231, ECO:0000269|PubMed:9514918}.	GO:0005345; GO:0005350; GO:0005886; GO:0005887; GO:0006833; GO:0006863; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015722; GO:0015793; GO:0015837; GO:0015855; GO:0016323; GO:0043231; GO:0071320; GO:0071918		9514918; 10564231; 16572171; 15489334; 30420639	MIP/aquaporin (TC 1.A.8) family
O43316	PAX4_HUMAN	Paired box protein Pax-4	PAX4	350	9606			Alternative splicing;Developmental protein;Diabetes mellitus;Differentiation;Disease variant;DNA-binding;Homeobox;Nucleus;Paired box;Reference proteome;Repressor;Transcription;Transcription regulation			GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0005654; GO:0006357; GO:0009887; GO:0030154; GO:0031016; GO:0048856; GO:1990837		9439631; 9753306; 12853948; 15489334; 11263967; 11723072; 15509590; 15834548; 17426099	Paired homeobox family
O43318	M3K7_HUMAN	Mitogen-activated protein kinase kinase kinase 7, EC 2.7.11.25 (Transforming growth factor-beta-activated kinase 1, TGF-beta-activated kinase 1)	MAP3K7 TAK1	606	9606		2.7.11.25	3D-structure;Acetylation;Alternative splicing;Apoptosis;ATP-binding;Cell membrane;Cytoplasm;Disease variant;Host-virus interaction;Isopeptide bond;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Stress response;Transcription;Transcription regulation;Transferase;Ubl conjugation	Q16543; O14920; O14733; Q9UQF2; O00743; P40763; Q15750; Q9NYJ8; Q8N5C8; Q9UKE5; Q9Y4K3; P0CG48; B5Z6S0; P0DTC9; Q16543; P07900; Q15750; Q9NYJ8	TISSUE SPECIFICITY: Isoform 1A is the most abundant in ovary, skeletal muscle, spleen and blood mononuclear cells. Isoform 1B is highly expressed in brain, kidney and small intestine. Isoform 1C is the major form in prostate. Isoform 1D is the less abundant form. {ECO:0000269|PubMed:11118615}.	GO:0000165; GO:0000287; GO:0002223; GO:0002726; GO:0002753; GO:0002755; GO:0004672; GO:0004674; GO:0004707; GO:0004709; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007179; GO:0007249; GO:0007250; GO:0007252; GO:0007254; GO:0008349; GO:0010008; GO:0016239; GO:0030971; GO:0032743; GO:0038066; GO:0038095; GO:0042802; GO:0043123; GO:0043276; GO:0043507; GO:0043966; GO:0050852; GO:0051092; GO:0051403; GO:0070423; GO:0070498; GO:0097110; GO:0106310; GO:0140672	PTM: Association with TAB1/MAP3K7IP1 promotes autophosphorylation at Ser-192 and subsequent activation. Association with TAB2/MAP3K7IP2, itself associated with free unanchored Lys-63 polyubiquitin chain, promotes autophosphorylation and subsequent activation of MAP3K7. Dephosphorylation at Ser-192 by PPM1B/PP2CB and at Thr-187 by PP2A and PPP6C leads to inactivation. {ECO:0000269|PubMed:10702308, ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:17548520, ECO:0000269|PubMed:19675569, ECO:0000269|PubMed:21512573}.; PTM: 'Lys-48'-linked polyubiquitination at Lys-72 is induced by TNFalpha, and leads to proteasomal degradation. Undergoes 'Lys-48'-linked polyubiquitination catalyzed by ITCH (By similarity). Requires 'Lys-63'-linked polyubiquitination for autophosphorylation and subsequent activation. 'Lys-63'-linked ubiquitination does not lead to proteasomal degradation. Deubiquitinated by CYLD, a protease that selectively cleaves 'Lys-63'-linked ubiquitin chains. Deubiquitinated by Y.enterocolitica YopP. {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:17548520, ECO:0000269|PubMed:22406003}.; PTM: (Microbial infection) Cleaved and inactivated by the proteases 3C of coxsackievirus A16 and human enterovirus D68, allowing the virus to disrupt TRAF6-triggered NF-kappa-B induction. {ECO:0000269|PubMed:28424289}.; PTM: (Microbial infection) Acetylation of Thr-184 and Thr-187 by Yersinia YopJ prevents phosphorylation and activation, thus blocking the MAPK signaling pathway. {ECO:0000269|PubMed:22520462, ECO:0000269|PubMed:22802624}.	9480845; 11118615; 14702039; 14574404; 15489334; 8663074; 8638164; 9079627; 10094049; 10838074; 10702308; 11104763; 11460167; 12242293; 12804775; 12874243; 12589052; 14670075; 15894542; 17081983; 16845370; 16893890; 17079228; 17449468; 17548520; 18088087; 18691976; 18758450; 18286207; 18669648; 19413330; 19521662; 19369195; 19675569; 17496917; 19690332; 20060931; 20068231; 21269460; 22084099; 21512573; 21406692; 22520462; 22406003; 22802624; 23776175; 23186163; 24275569; 26334375; 27426733; 27426734; 28827540; 28424289; 29291351; 16289117; 28397838	Protein kinase superfamily, STE Ser/Thr protein kinase family, MAP kinase kinase kinase subfamily
O43320	FGF16_HUMAN	Fibroblast growth factor 16, FGF-16	FGF16	207	9606			Disease variant;Glycoprotein;Growth factor;Phosphoprotein;Reference proteome;Secreted	Q92989; Q92997; Q96ED9-2; Q0VD86; Q15323; P23508; Q9NRD5		GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008284; GO:0008543; GO:0009266; GO:0009887; GO:0010628; GO:0030154; GO:0030334; GO:2000546		9473496; 15772651; 16597617; 19690332; 20094046; 23709756; 25333065	Heparin-binding growth factors family
O43323	DHH_HUMAN	Desert hedgehog protein, DHH (HHG-3) [Cleaved into: Desert hedgehog protein N-product; Desert hedgehog protein C-product ]	DHH	396	9606			3D-structure;Autocatalytic cleavage;Calcium;Cell membrane;Developmental protein;Disease variant;Hydrolase;Lipoprotein;Membrane;Metal-binding;Palmitate;Protease;Reference proteome;Secreted;Signal;Zinc	Q9BWV1; Q4KMG0; Q96QV1-1		GO:0001649; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0007286; GO:0008233; GO:0008270; GO:0010468; GO:0016540; GO:0030238; GO:0032355; GO:0033327; GO:0042552; GO:0043627; GO:0050810	PTM: The C-terminal domain displays an autoproteolysis activity and a cholesterol transferase activity. Both activities result in the cleavage of the full-length protein and covalent attachment of a cholesterol moiety to the C-terminal of the newly generated N-terminal fragment (N-product). This covalent modification appears to play an essential role in restricting the spatial distribution of the protein activity to the cell surface. The N-product is the active species in both local and long-range signaling, whereas the C-product has no signaling activity (By similarity). {ECO:0000250}.	15489334; 11017805; 24784881; 19561611; 20519495; 15356051	Hedgehog family
O43324	MCA3_HUMAN	Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18)	EEF1E1 AIMP3 P18	174	9606			3D-structure;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Direct protein sequencing;Nucleus;Protein biosynthesis;Reference proteome	Q13137; Q9BTE0; PRO_0000038593 [P04591]	TISSUE SPECIFICITY: Down-regulated in various cancer tissues. {ECO:0000269|PubMed:15680327}.	GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0008285; GO:0017101; GO:0043065; GO:0043517; GO:1990830; GO:2000774; GO:2001235		9653160; 14574404; 15489334; 15680327; 19131329; 19289464; 19608861; 21269460; 18343821; 26472928	
O43353	RIPK2_HUMAN	Receptor-interacting serine/threonine-protein kinase 2, EC 2.7.11.1 (CARD-containing interleukin-1 beta-converting enzyme-associated kinase, CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2, RIP-2) (Tyrosine-protein kinase RIPK2, EC 2.7.10.2)	RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092	540	9606		2.7.10.2; 2.7.11.1	3D-structure;Acetylation;Adaptive immunity;Alternative splicing;Apoptosis;ATP-binding;Cytoplasm;Immunity;Innate immunity;Isopeptide bond;Kinase;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	Q13490; Q13489; Q9BX69; Q7Z434; Q9HC29; O43353; Q12933; Q13114; P98170	TISSUE SPECIFICITY: Detected in heart, brain, placenta, lung, peripheral blood leukocytes, spleen, kidney, testis, prostate, pancreas and lymph node.	GO:0001961; GO:0002250; GO:0002827; GO:0004672; GO:0004674; GO:0004706; GO:0004712; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006915; GO:0006954; GO:0007165; GO:0007249; GO:0010800; GO:0010942; GO:0030274; GO:0031398; GO:0031663; GO:0031982; GO:0032092; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032735; GO:0032743; GO:0032755; GO:0032760; GO:0032991; GO:0033091; GO:0033138; GO:0034134; GO:0034142; GO:0042098; GO:0042802; GO:0042803; GO:0043065; GO:0043123; GO:0043330; GO:0045087; GO:0045627; GO:0045944; GO:0046330; GO:0046641; GO:0050700; GO:0050731; GO:0050830; GO:0050852; GO:0051092; GO:0070374; GO:0070427; GO:0070431; GO:0070555; GO:0070671; GO:0070673; GO:0071223; GO:0071224; GO:0071225; GO:0089720; GO:0097202; GO:0106310; GO:1904417	PTM: Autophosphorylated. Autophosphorylation at Tyr-474 is necessary for effective NOD2 signaling. Phosphorylated. Phosphorylation at Tyr-381 by Src kinase CSK occurs in a ARHGEF2-dependent manner and is required for NOD2-dependent innate immune activation. {ECO:0000269|PubMed:16824733, ECO:0000269|PubMed:21123652, ECO:0000269|PubMed:21887730}.; PTM: Ubiquitinated on Lys-209; undergoes 'Lys-63'-linked polyubiquitination catalyzed by ITCH. Polyubiquitinated with 'Lys-48' and 'Lys-63'-linked chains by BIRC2/c-IAP1 and BIRC3/c-IAP2, leading to activation of NF-kappa-B. Also undergoes 'Met-1'-linked polyubiquitination; the head-to-tail linear polyubiquitination is mediated by the LUBAC complex in response to NOD2 stimulation. Linear polyubiquitination is restricted by FAM105B/otulin, probably to limit NOD2-dependent pro-inflammatory signaling activation of NF-kappa-B. Undergoes 'Lys-63'-linked deubiquitination by MYSM1 to attenuate NOD2-mediated inflammation and tissue damage (By similarity). {ECO:0000250|UniProtKB:P58801, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:19464198, ECO:0000269|PubMed:19592251, ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:23806334}.; PTM: (Microbial infection) Acetylation of Ser-174, Ser-176 and Ser-178 by Yersinia YopJ prevents phosphorylation and activation, thereby promoting cell death. {ECO:0000269|PubMed:22520462}.	9575181; 9642260; 9705938; 12975309; 14702039; 16421571; 15489334; 14638696; 16824733; 17054981; 18775659; 18079694; 18691976; 18669648; 19592251; 19464198; 19369195; 21123652; 20068231; 21269460; 21931591; 22520462; 22672233; 21887730; 23186163; 23806334; 24275569; 27812135; 28436939; 26646181; 17344846	Protein kinase superfamily, TKL Ser/Thr protein kinase family
O43364	HXA2_HUMAN	Homeobox protein Hox-A2 (Homeobox protein Hox-1K)	HOXA2 HOX1K	376	9606			Developmental protein;Disease variant;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation			GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0002076; GO:0005634; GO:0005654; GO:0006357; GO:0007379; GO:0008045; GO:0009952; GO:0009953; GO:0021568; GO:0021658; GO:0035284; GO:0042474; GO:0043231; GO:0045665; GO:0045668; GO:0045944; GO:0048703; GO:0060037; GO:0061061; GO:0071300; GO:1990837		12853948; 12690205; 15489334; 23775976; 18394579	Antp homeobox family, Proboscipedia subfamily
O43365	HXA3_HUMAN	Homeobox protein Hox-A3 (Homeobox protein Hox-1E)	HOXA3 HOX1E	443	9606			Developmental protein;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation	O15145; P23560-2; Q15437		GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001974; GO:0005634; GO:0005654; GO:0006357; GO:0008284; GO:0009952; GO:0010159; GO:0010467; GO:0021615; GO:0030878; GO:0048538; GO:0048645; GO:0048704; GO:0051216; GO:0060017; GO:0071837		12690205; 12853948; 15489334; 16959974	Antp homeobox family
O43374	RASL2_HUMAN	Ras GTPase-activating protein 4 (Calcium-promoted Ras inactivator) (Ras p21 protein activator 4) (RasGAP-activating-like protein 2)	RASA4 CAPRI GAPL KIAA0538	803	9606			Alternative splicing;Calcium;Cell membrane;Cytoplasm;GTPase activation;Membrane;Metal-binding;Reference proteome;Repeat;Zinc;Zinc-finger		TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11448776}.	GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046580; GO:0046872; GO:0071277		11448776; 9628581; 14702039; 12853948; 15489334	
O43379	WDR62_HUMAN	WD repeat-containing protein 62	WDR62 C19orf14	1518	9606			Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Disease variant;Mental retardation;Neurogenesis;Nucleus;Phosphoprotein;Primary microcephaly;Reference proteome;Repeat;WD repeat	Q92630; Q9H0I2; Q2KHM9; O15481; P45984; Q7Z4N8; Q9NUY8; Q9NUY8-2	TISSUE SPECIFICITY: Present in fetal brain, enriched within the ventricular and subventricular zone (at protein level). In the embryonic brain it is expressed in mitotic neural precursor cells. {ECO:0000269|PubMed:20890279}.	GO:0000922; GO:0002052; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0007052; GO:0007099; GO:0021987; GO:0022008; GO:0034451; GO:0045664; GO:0046605; GO:2001224		14702039; 17974005; 15057824; 15489334; 18220336; 18669648; 19413330; 19690332; 20890279; 20890278; 20729831; 20068231; 21496009; 21406692; 22814378; 23341463; 23186163; 26297806; 28089251; 28157543	
O43390	HNRPR_HUMAN	Heterogeneous nuclear ribonucleoprotein R, hnRNP R	HNRNPR HNRPR	633	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Isopeptide bond;Microsome;mRNA processing;mRNA splicing;Nucleus;Reference proteome;Repeat;Ribonucleoprotein;RNA-binding;Spliceosome;Ubl conjugation	Q5VWX1; P16333; Q99873; Q9Y5E9; Q9Y272; Q13148		GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0071013; GO:1990904		9421497; 15858414; 16710414; 15489334; 11991638; 17289661; 19413330; 19608861; 21269460; 21515746; 22223895; 23186163; 24275569; 25218447; 25772364; 25755297; 28112733	
O43395	PRPF3_HUMAN	U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3, hPrp3) (U4/U6 snRNP 90 kDa protein)	PRPF3 HPRP3 PRP3	683	9606			3D-structure;Alternative splicing;Direct protein sequencing;Disease variant;Isopeptide bond;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;Retinitis pigmentosa;Spliceosome;Ubl conjugation	Q9BWT7; Q86Z20; Q8NHQ1; Q92997; Q8IZU0; A0A0C3SFZ9; Q08379; Q96D09; O75031; Q9Y250; P55081; Q9UJV3-2; Q96RE7; Q8N5F7; Q6ZUT1; Q9H4L5; Q8IXK0-5; P78356-2; O43395; O94906; O43242; Q15276; Q2KHN1; O43290; Q13435; Q8TBC3; O95391; O75940; Q9Y2D8; Q9HCM9; Q9HCM9-2; Q6FI91; P40222; P26368; P26368-2; Q8WW38; Q9UGI0	TISSUE SPECIFICITY: Highly expressed in retina, liver, kidney and blood. Detected at lower levels in heart and brain. {ECO:0000269|PubMed:11773002}.	GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006397; GO:0008380; GO:0015030; GO:0016607; GO:0042802; GO:0046540; GO:0071005	PTM: Ubiquitinated. Undergoes 'Lys-63'-linked polyubiquitination by PRPF19 and deubiquitination by USP4. 'Lys-63'-linked ubiquitination increases the affinity for PRPF8 and may regulate the assembly of the U4/U6-U5 tri-snRNP complex. {ECO:0000269|PubMed:20595234}.	9328476; 9404889; 14702039; 16710414; 15489334; 15314151; 17081983; 16723661; 18669648; 18318008; 19413330; 19690332; 20595234; 20068231; 21269460; 21406692; 23186163; 24275569; 26030138; 28112733; 26912367; 28781166; 11773002; 12714658; 17932117	
O43396	TXNL1_HUMAN	Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein)	TXNL1 TRP32 TXL TXNL	289	9606			3D-structure;Cytoplasm;Direct protein sequencing;Disulfide bond;Electron transport;Nucleus;Phosphoprotein;Proteasome;Redox-active center;Reference proteome;Transport		TISSUE SPECIFICITY: Ubiquitous.	GO:0000502; GO:0005634; GO:0005737; GO:0005829; GO:0015036		9473519; 9668102; 10826702; 15489334; 12665801; 19349277; 21269460; 22814378; 23186163; 24275569; 11985582; 20455272	
O43399	TPD54_HUMAN	Tumor protein D54, hD54 (Tumor protein D52-like 2)	TPD52L2	206	9606			Acetylation;Alternative splicing;Coiled coil;Phosphoprotein;Reference proteome	Q8WTS1; Q8NI60; Q9Y371; Q62393		GO:0003723; GO:0005737; GO:0005975; GO:0042127; GO:0042803; GO:0048471		9838088; 14702039; 11780052; 15489334; 11549320; 17081983; 19367720; 18691976; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 25944712	TPD52 family
O43402	EMC8_HUMAN	ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B)	EMC8 C16orf2 C16orf4 COX4AL COX4NB FAM158B NOC4	210	9606			3D-structure;Alternative splicing;Endoplasmic reticulum;Membrane;Reference proteome	Q15006	TISSUE SPECIFICITY: Expressed in liver, pancreas, heart, lung, kidney, brain, skeletal muscle, and placenta. Expression levels are highest in pancreas and moderate in heart, skeletal muscle, and placenta.	GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0016020; GO:0045050; GO:0071816; GO:0072546		10337626; 15616553; 15489334; 21269460; 22119785; 25944712; 30415835; 29809151; 29242231; 32459176; 32439656	EMC8/EMC9 family
O43405	COCH_HUMAN	Cochlin (COCH-5B2)	COCH COCH5B2 UNQ257/PRO294	550	9606			3D-structure;Alternative splicing;Deafness;Disease variant;Disulfide bond;Extracellular matrix;Glycoprotein;Hearing;Non-syndromic deafness;Reference proteome;Repeat;Secreted;Signal	O76024	TISSUE SPECIFICITY: Expressed in inner ear structures; the cochlea and the vestibule.	GO:0005518; GO:0005576; GO:0007605; GO:0008360; GO:0042742; GO:0045089; GO:0062023	PTM: N-glycosylated. {ECO:0000269|PubMed:12843317}.; PTM: A 50 kDa form is created by proteolytic cleavage. {ECO:0000269|PubMed:12843317}.	9441737; 12975309; 14702039; 12508121; 15489334; 12843317; 17926100; 21886777; 11574466; 9806553; 9931344; 10400989; 11295836; 14512963; 12928864; 16835921; 17561763; 18312449; 22610276; 22931125; 23993205; 25388789; 29449721	
O43422	P52K_HUMAN	52 kDa repressor of the inhibitor of the protein kinase, p52rIPK (58 kDa interferon-induced protein kinase-interacting protein, p58IPK-interacting protein) (Death-associated protein 4) (THAP domain-containing protein 0) (THAP domain-containing protein 12)	THAP12 DAP4 P52RIPK PRKRIR THAP0	761	9606			Alternative splicing;DNA-binding;Metal-binding;Phosphoprotein;Reference proteome;Zinc;Zinc-finger	Q8N8K9; Q13228; O75410; O75410-7; Q8TF50		GO:0003677; GO:0007165; GO:0008285; GO:0046872; GO:0046983		9447982; 14702039; 15489334; 17974005; 21269460; 21406692; 23186163	
O43424	GRID2_HUMAN	Glutamate receptor ionotropic, delta-2, GluD2, GluR delta-2 subunit	GRID2 GLURD2	1007	9606			3D-structure;Alternative splicing;Cell junction;Cell membrane;Disulfide bond;Glycoprotein;Ion channel;Ion transport;Ligand-gated ion channel;Membrane;Neurodegeneration;Phosphoprotein;Postsynaptic cell membrane;Receptor;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix;Transport			GO:0004970; GO:0005886; GO:0005887; GO:0007157; GO:0007215; GO:0008066; GO:0008328; GO:0010975; GO:0015276; GO:0021707; GO:0030165; GO:0034613; GO:0035249; GO:0038023; GO:0043197; GO:0043523; GO:0045202; GO:0045211; GO:0050804; GO:0051965; GO:0060079; GO:0060134; GO:0097110; GO:0098688; GO:0098978; GO:0099061; GO:0099151; GO:1900454; GO:1904315; GO:1904861		9465309; 15815621; 15489334; 27418511; 23611888; 24078737; 16959974; 25841024	Glutamate-gated ion channel (TC 1.A.10.1) family, GRID2 subfamily
O43426	SYNJ1_HUMAN	Synaptojanin-1, EC 3.1.3.36 (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)	SYNJ1 KIAA0910	1573	9606		3.1.3.36	3D-structure;Alternative splicing;Cytoplasm;Disease variant;Endocytosis;Epilepsy;Hydrolase;Lipid metabolism;Methylation;Neurodegeneration;Parkinson disease;Parkinsonism;Phosphoprotein;Reference proteome;Repeat;RNA-binding		TISSUE SPECIFICITY: Concentrated at clathrin-coated endocytic intermediates in nerve terminals. Isoform 1 is more enriched than isoform 2 in developing brain as well as non-neuronal cells. Isoform 2 is very abundant in nerve terminals.	GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0005874; GO:0006661; GO:0006836; GO:0007420; GO:0007612; GO:0008022; GO:0012506; GO:0014015; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0032526; GO:0034097; GO:0034595; GO:0034596; GO:0043195; GO:0043647; GO:0043812; GO:0043813; GO:0044877; GO:0046488; GO:0046855; GO:0046856; GO:0048260; GO:0048471; GO:0048488; GO:0048489; GO:0052629; GO:0052658; GO:0061024; GO:0097060; GO:0098688; GO:0098793; GO:1904980; GO:1990175		9428629; 10048485; 12168954; 10830953; 15489334; 10542231; 17257598; 18669648; 19690332; 20068231; 23186163; 24275569; 27435091; 23804563; 23804577; 27496670	Synaptojanin family; Inositol 1,4,5-trisphosphate 5-phosphatase family
O43427	FIBP_HUMAN	Acidic fibroblast growth factor intracellular-binding protein, aFGF intracellular-binding protein (FGF-1 intracellular-binding protein)	FIBP	364	9606			Acetylation;Alternative splicing;Disease variant;Membrane;Nucleus;Reference proteome		TISSUE SPECIFICITY: Highly expressed in heart, skeletal muscle and pancreas. Expressed at lower levels in brain. Also found in placenta, liver and kidney.	GO:0005634; GO:0005739; GO:0008543; GO:0012505; GO:0016020; GO:0016607; GO:0017134; GO:0070527		9806903; 11104667; 14702039; 15489334; 11964394; 19369195; 21269460; 26660953; 27183861	
O43432	IF4G3_HUMAN	Eukaryotic translation initiation factor 4 gamma 3, eIF-4-gamma 3, eIF-4G 3, eIF4G 3 (eIF-4-gamma II, eIF4GII)	EIF4G3	1585	9606			3D-structure;Alternative splicing;Coiled coil;Initiation factor;Phosphoprotein;Protein biosynthesis;Reference proteome;Repeat;RNA-binding;Translation regulation	P06730; P06730		GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006413; GO:0006446; GO:0008135; GO:0016281	PTM: Following infection by certain enteroviruses, rhinoviruses and aphthoviruses, EIF4G1 is cleaved by the viral protease 2A, or the leader protease in the case of aphthoviruses. This shuts down the capped cellular mRNA transcription. {ECO:0000269|PubMed:12663812, ECO:0000269|PubMed:15016848}.	9418880; 16710414; 15489334; 9857202; 14507913; 12663812; 15016848; 10872469; 16964243; 17693683; 18088087; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 12975586; 11172724	Eukaryotic initiation factor 4G family
O43435	TBX1_HUMAN	T-box transcription factor TBX1, T-box protein 1 (Testis-specific T-box protein)	TBX1	398	9606			3D-structure;Alternative splicing;Developmental protein;Disease variant;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation	P57055		GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:1990837; GO:2000027; GO:2001037; GO:2001054		9268629; 11111039; 23186163; 14585638; 16959974; 17273972	
O43439	MTG8R_HUMAN	Protein CBFA2T2 (ETO homologous on chromosome 20) (MTG8-like protein) (MTG8-related protein 1) (Myeloid translocation-related protein 1) (p85)	CBFA2T2 EHT MTGR1	604	9606			Alternative splicing;Coiled coil;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q99750; Q9P0J1; Q9GZV8; P17987; O95429; Q9Y592-2; Q9BVG8-5; Q52LG2; P43360; Q9BSU1; Q9GZV8; Q9NQX0; Q9BRV8; O60504; P15884-3; Q96GY0	TISSUE SPECIFICITY: Ubiquitously expressed in fetal and adult tissues. Highly expressed in adult brain, heart, lung, kidney, lymph node, appendix, thymus, testis, uterus, small intestine, prostate and thymus. {ECO:0000269|PubMed:10675041, ECO:0000269|PubMed:9447981, ECO:0000269|PubMed:9787195, ECO:0000269|PubMed:9790752}.	GO:0000122; GO:0003714; GO:0005634; GO:0006351; GO:0010976; GO:0010977; GO:0045746; GO:0045892; GO:0046872; GO:0060575		9787195; 9447981; 10675041; 14702039; 11780052; 15489334; 9790752; 12242670; 14703694; 12559562; 15203199; 16616331; 19690332; 20520637; 20068231; 21406692; 23251453; 23186163; 24275569; 26115422; 27281218; 28112733	CBFA2T family
O43447	PPIH_HUMAN	Peptidyl-prolyl cis-trans isomerase H, PPIase H, EC 5.2.1.8 (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H, CypH) (U-snRNP-associated cyclophilin SnuCyp-20, USA-CYP)	PPIH CYP20 CYPH	177	9606		5.2.1.8	3D-structure;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Direct protein sequencing;Isomerase;mRNA processing;mRNA splicing;Nucleus;Reference proteome;Rotamase;Spliceosome	Q9NP55; Q7L591-3; P42858; Q8TBB1; Q92802; Q9GZT8; Q99633; O43172; Q9UHD9; P98170; PRO_0000037309 [P0C6X7]		GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0005681; GO:0005737; GO:0006457; GO:0016018; GO:0016607; GO:0043021; GO:0043231; GO:0045070; GO:0046540; GO:0065003; GO:0071001		9404889; 9570313; 14702039; 16710414; 15489334; 11823439; 16723661; 20676357; 21269460; 22814378; 25944712; 10713041; 12875835	Cyclophilin-type PPIase family, PPIase H subfamily
O43451	MGA_HUMAN	Maltase-glucoamylase (Alpha-1,4-glucosidase, EC 3.2.1.20)	MGAM MGA MGAML	2753	9606	PATHWAY: Carbohydrate degradation. {ECO:0000305|PubMed:18036614, ECO:0000305|PubMed:22058037, ECO:0000305|PubMed:27480812}.	3.2.1.20	3D-structure;Alternative splicing;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Glycosidase;Hydrolase;Membrane;Multifunctional enzyme;Reference proteome;Repeat;Signal-anchor;Sulfation;Transmembrane;Transmembrane helix	Q13520; Q7Z7G2; Q96BA8; O15529; P54219-3; Q9NUH8	TISSUE SPECIFICITY: Broadly expressed. Highly expressed in small intestine. Expressed in granulocytes. {ECO:0000269|PubMed:24309898, ECO:0000269|PubMed:9446624}.	GO:0000025; GO:0003824; GO:0004339; GO:0004553; GO:0004558; GO:0005886; GO:0005983; GO:0016021; GO:0016324; GO:0030246; GO:0032450; GO:0070062; GO:0070821; GO:0101003; GO:1901027	PTM: N- and O-glycosylated. {ECO:0000269|PubMed:18036614, ECO:0000269|PubMed:3143729}.; PTM: Does not undergo intracellular or extracellular proteolytic cleavage. {ECO:0000269|PubMed:3143729}.; PTM: Sulfated. {ECO:0000250}.	9446624; 12853948; 15489334; 24309898; 3121301; 3143729; 12547908; 18356321; 22058037; 27480812; 18036614	Glycosyl hydrolase 31 family
O43462	MBTP2_HUMAN	Membrane-bound transcription factor site-2 protease, EC 3.4.24.85 (Endopeptidase S2P) (Sterol regulatory element-binding proteins intramembrane protease, SREBPs intramembrane protease)	MBTPS2 S2P	519	9606		3.4.24.85	Cholesterol metabolism;Cytoplasm;Disease variant;Glycoprotein;Hydrolase;Ichthyosis;Lipid metabolism;Membrane;Metal-binding;Metalloprotease;Osteogenesis imperfecta;Palmoplantar keratoderma;Protease;Reference proteome;Steroid metabolism;Sterol metabolism;Transmembrane;Transmembrane helix;Zinc		TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, liver, muscle, kidney and pancreas. {ECO:0000269|PubMed:9659902}.	GO:0000139; GO:0004222; GO:0005737; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0046872; GO:0051091; GO:0070977; GO:1905897; GO:1990440		9659902; 15772651; 10419520; 11163209; 10805775; 19361614; 20672378; 22931912; 27380894	Peptidase M50A family
O43463	SUV91_HUMAN	Histone-lysine N-methyltransferase SUV39H1, EC 2.1.1.355 (Histone H3-K9 methyltransferase 1, H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1, Su(var)3-9 homolog 1)	SUV39H1 KMT1A SUV39H	412	9606		2.1.1.355	3D-structure;Acetylation;Alternative splicing;Biological rhythms;Cell cycle;Centromere;Chromatin regulator;Chromosome;Differentiation;Host-virus interaction;Metal-binding;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repressor;rRNA processing;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Zinc	O95260; Q86V38; Q9C0K0; Q6P047; P83916; Q13185; P45973; Q9BXL8; Q8NHQ1; P49761; Q5TAQ9; Q92997; Q15910; Q6ZNL6; A6NEM1; Q9NWQ4; Q9BX10; Q13547; Q92769; V9HWG0; Q96ED9; Q96ED9-2; P49639; P09017; Q8TBB5; Q92876; P60409; P60410; Q9BRK4; Q9UIS9; Q13133; A5D8V7; Q6TGC4; Q5T6S3; Q96I34; P62191; P54725; Q9NS23; P50749; O43159; P50454; Q96EB6; Q96BD6; Q8N4C7; Q8WW24; P37173; Q8WV44; Q01081; Q8N680; Q9Y2L8; Q8TAU3; Q9C0F3; Q7Z4V0; Q9BS31; Q9BS34; Q9UGI0; P68432		GO:0000122; GO:0000183; GO:0000775; GO:0000792; GO:0000794; GO:0000976; GO:0003682; GO:0005634; GO:0005652; GO:0005654; GO:0005677; GO:0005730; GO:0006325; GO:0006364; GO:0006974; GO:0007049; GO:0008270; GO:0008757; GO:0018024; GO:0030154; GO:0031062; GO:0031065; GO:0033553; GO:0034968; GO:0036123; GO:0036124; GO:0042054; GO:0042149; GO:0042754; GO:0045786; GO:0045892; GO:0046015; GO:0046974; GO:0047485; GO:0048511; GO:0061773; GO:0071456; GO:0097009	PTM: Phosphorylated on serine residues, and to a lesser degree, on threonine residues. The phosphorylated form is stabilized by SBF1 and is less active in its transcriptional repressor function. {ECO:0000269|PubMed:10671371}.; PTM: Acetylated at Lys-266, leading to inhibition of enzyme activity. SIRT1-mediated deacetylation relieves this inhibition. {ECO:0000269|PubMed:18004385}.	10202156; 14702039; 15772651; 15489334; 10671371; 10949293; 10848615; 11242053; 11484059; 12711603; 12101246; 12917624; 12789259; 14765126; 15107829; 16103223; 17081983; 16688220; 16818776; 16519522; 16858404; 16449642; 16652147; 16409643; 18004385; 18485871; 18669648; 19218236; 19690332; 20068231; 21406692; 23186163; 23695662	Class V-like SAM-binding methyltransferase superfamily, Histone-lysine methyltransferase family, Suvar3-9 subfamily
O43464	HTRA2_HUMAN	Serine protease HTRA2, mitochondrial, EC 3.4.21.108 (High temperature requirement protein A2, HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI)	HTRA2 OMI PRSS25	458	9606		3.4.21.108	3D-structure;Alternative splicing;Apoptosis;Autocatalytic cleavage;Direct protein sequencing;Disease variant;Endoplasmic reticulum;Epilepsy;Hydrolase;Membrane;Mitochondrion;Neurodegeneration;Parkinson disease;Parkinsonism;Protease;Reference proteome;Serine protease;Transit peptide;Transmembrane;Transmembrane helix;Zymogen	Q6ZTN6-2; Q86TN1; Q9Y575-3; Q96DX5-3; Q96FT7-4; Q96CA5; Q7Z7K6; P02489; Q5TAQ9-2; O00303; Q8TC29; Q13216-2; Q99871; Q02363; Q8IY31-2; Q8N5Z5; Q6P597; P57682; Q9Y2M5; P08727; Q14525; Q1L5Z9; Q99683; Q8NA82; Q8N594; Q8WY64; Q9P0J0; Q13562; O15381-5; Q96FW1; Q6GQQ9-2; Q9NUU6; Q9HBE1-4; Q9NV79; O14813; O75925; Q8WWB5; Q96T49; Q6ZMI0-5; P17980; P57052; Q8WVD3; Q96D59; Q96GQ5; Q8N488; Q8N6K7-2; Q9NR46; Q96GM5; Q16637-3; Q8WXH5; Q5VWN6; Q86WV5; O95150; Q6DKK2; Q495M9; O75604-3; Q8NEZ2; Q15007-2; O00308; P98170; P24278; Q9UNY5; Q8N0Y2-2; O60304; O15535; Q86V28; P02666; Q60855; P02666	TISSUE SPECIFICITY: [Isoform 1]: Ubiquitously expressed. {ECO:0000269|PubMed:10644717}.	GO:0000785; GO:0004252; GO:0005634; GO:0005739; GO:0005758; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006508; GO:0006672; GO:0007005; GO:0007568; GO:0007628; GO:0008233; GO:0008236; GO:0008630; GO:0009635; GO:0009898; GO:0010822; GO:0012501; GO:0016020; GO:0016540; GO:0019742; GO:0030900; GO:0031966; GO:0034599; GO:0034605; GO:0035458; GO:0035631; GO:0040014; GO:0042802; GO:0043065; GO:0043280; GO:0044257; GO:0045786; GO:0048666; GO:0051082; GO:0071300; GO:0071363; GO:0097194; GO:1901215; GO:1902176; GO:1903146; GO:1903955; GO:1904924; GO:1905370; GO:2001241; GO:2001269	PTM: Autoproteolytically activated. {ECO:0000269|PubMed:10873535}.	10644717; 10971580; 10995577; 15815621; 15489334; 11583623; 10873535; 15200957; 19502560; 21269460; 23479728; 24275569; 25944712; 11967569; 15961413; 18401856; 18364387; 25422467; 27208207; 27535533; 27696117	Peptidase S1C family
O43474	KLF4_HUMAN	Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor)	KLF4 EZF GKLF	513	9606			3D-structure;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q13363; Q92997; P13807; A0A024R8L2; O14964; O75031; O95983; P55771; Q08117-2		GO:0000122; GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001010; GO:0001228; GO:0002357; GO:0003700; GO:0005654; GO:0005667; GO:0005829; GO:0006351; GO:0006357; GO:0007500; GO:0008013; GO:0008270; GO:0008285; GO:0009913; GO:0010628; GO:0010629; GO:0015630; GO:0016525; GO:0019827; GO:0031077; GO:0032088; GO:0032270; GO:0032526; GO:0032717; GO:0034115; GO:0035166; GO:0043154; GO:0045429; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046985; GO:0048679; GO:0048730; GO:0050728; GO:0051247; GO:0051973; GO:0060070; GO:0060761; GO:0061629; GO:0071363; GO:0071499; GO:0090051; GO:0120222; GO:1902895; GO:1903672; GO:1904798; GO:1904998; GO:1990830; GO:1990837; GO:1990841; GO:2000134; GO:2000342	PTM: Ubiquitinated. 'Lys-48'-linked ubiquitinated and targeted for proteasomal degradation by the SCF(BTRC) E3 ubiquitin-protein ligase complex, thereby negatively regulating cell pluripotency maintenance and embryogenesis. {ECO:0000250|UniProtKB:Q60793}.; PTM: Polyglutamylated by TTLL1 and TTLL4 at Glu-411, which inhibits KLF4 binding with E3 ligase component BTRC, thereby impeding ubiquitination. Deglutamylated by CCP1 and CCP6; deglutamylation promotes KLF4 ubiquitination. KLF4 glutamylation state plays a critical role in the regulation of its function in cell reprogramming, pluripotency maintenance and embryogenesis. {ECO:0000250|UniProtKB:Q60793}.	9422764; 10392904; 23134681; 14702039; 15164053; 15489334; 17308127; 18035408; 17467953; 18669648; 18655026; 20071344; 20068231; 21746878; 21654807; 22814378; 23186163; 29593216; 31375868	Krueppel C2H2-type zinc-finger protein family
O43482	MS18B_HUMAN	Protein Mis18-beta (Cancer/testis antigen 86, CT86) (Opa-interacting protein 5, OIP-5)	OIP5 MIS18B	229	9606			Cell cycle;Cell division;Centromere;Chromosome;Metal-binding;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Zinc	Q9NQ94; Q9NYB9-2; Q9P2A4; P21549; Q92870-2; O75934; Q9BXY8; Q13515; Q8TDH9; Q6P1W5; Q9H1P6; Q8N865; Q8NA61-2; O60826; Q8N4L8; Q8TD31-3; Q86X02; Q96L14; Q86XR8-3; Q8TCT0; Q9Y6H1; P10606; Q9BSW2; Q9UI47-2; Q9NQL9; Q96EV8; Q86UW9; Q9H596; Q5JVL4; Q9NRA8; Q96DF8; Q9NYK6-3; Q96MY7; Q8WU58; P22607; A1L4K1; Q8TAE8; Q96CN9; P55040; Q9BZE0; O95872; Q13227; Q14957; P28799; Q9GZV7; O14964; P09067; P17482; P31273; P01112; Q9ULV5-2; Q14005-2; Q63ZY3; O60333-2; Q9HAQ2; O14901; Q2WGJ6; Q9P2K6; Q9Y448; P02533; P19012; Q7Z3Y8; P12035; Q92764; O76014; Q6A162; P04259; O95678; Q14533; P78385; O43790; Q52LG2; Q3LI72; Q3LI70; Q96BZ8; Q9NPJ6; O14770-4; Q5JXC2; Q9NYP9; Q6P0N0; Q8IVT2; Q6PF18; Q9P2K5-2; Q8NFW9; O14561; Q7Z6G3-2; P07196; Q7Z3B4; Q9BVL2; P37198; O43482; Q7Z4N8; Q9HBE1-4; Q8N4B1-4; Q99697-2; Q9UPG8; P52435; P78424; Q7Z5V6-2; P60891; P0CG20; P20618; Q9ULW5; Q9UJ41-4; P04049; Q8N443; Q06455-2; Q9BVN2; Q8WXG8; Q7Z3H4; Q8IYX7; Q6ZSJ9; P12757; Q969G3; Q9BV90; P14678-2; Q5JUK2; O60504; Q86W54-2; Q9BXF9; Q9BXU0; Q7Z6R9; Q9UBB9; O60220; O43711; P06753; Q5VU62; Q8N7U7-2; Q96RU7; Q86UV6-2; Q15654; Q12815; Q8N6Y0; O75604; Q70EL1-9; O76024; Q9BYJ9; Q15915; Q8TAU3; Q8N720; Q9Y649		GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0007049; GO:0007059; GO:0007154; GO:0010369; GO:0015030; GO:0016607; GO:0034080; GO:0042802; GO:0043231; GO:0046872; GO:0051301		9466265; 15489334; 17199038; 18691976; 18669648; 19690332; 20068231; 21406692; 23186163; 26921242	Mis18 family
O43488	ARK72_HUMAN	Aflatoxin B1 aldehyde reductase member 2, EC 1.1.1.n11 (AFB1 aldehyde reductase 1, AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase, SSA reductase)	AKR7A2 AFAR AFAR1 AKR7	359	9606		1.1.1.n11	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Golgi apparatus;Lipid metabolism;NADP;Oxidoreductase;Phosphoprotein;Reference proteome	O95154; Q92870-2; P54252; Q8WWM9; Q9Y2K1	TISSUE SPECIFICITY: Detected in brain, liver, small intestine and testis, and at lower levels in heart, prostate, skeletal muscle and spleen. Detected in kidney proximal and distal tubules, endothelial cells lining the Bowman's capsules and some cysts. Detected at low levels in lung and pancreas (at protein level). Widely expressed. {ECO:0000269|PubMed:10510318, ECO:0000269|PubMed:9576847}.	GO:0004032; GO:0004033; GO:0005737; GO:0005794; GO:0005829; GO:0005975; GO:0006081; GO:0006629; GO:0009055; GO:0019119; GO:0044597; GO:0044598; GO:0070062		16710414; 15489334; 9576847; 9823300; 10510318; 12071861; 17591773; 21269460; 23186163; 24275569; 25944712; 18752886	Aldo/keto reductase family, Aldo/keto reductase 2 subfamily
O43490	PROM1_HUMAN	Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133)	PROM1 PROML1 MSTP061	865	9606			Acetylation;Alternative splicing;Cell membrane;Cell projection;Cilium;Cone-rod dystrophy;Direct protein sequencing;Disease variant;Endoplasmic reticulum;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Retinitis pigmentosa;Signal;Stargardt disease;Transmembrane;Transmembrane helix	Q9UBN7; Q8VHP6; Q9UBN7	TISSUE SPECIFICITY: Isoform 1 is selectively expressed on CD34 hematopoietic stem and progenitor cells in adult and fetal bone marrow, fetal liver, cord blood and adult peripheral blood. Isoform 1 is not detected on other blood cells. Isoform 1 is also expressed in a number of non-lymphoid tissues including retina, pancreas, placenta, kidney, liver, lung, brain and heart. Found in saliva within small membrane particles. Isoform 2 is predominantly expressed in fetal liver, skeletal muscle, kidney, and heart as well as adult pancreas, kidney, liver, lung, and placenta. Isoform 2 is highly expressed in fetal liver, low in bone marrow, and barely detectable in peripheral blood. Isoform 2 is expressed on hematopoietic stem cells and in epidermal basal cells (at protein level). Expressed in adult retina by rod and cone photoreceptor cells (at protein level). {ECO:0000269|PubMed:12042327, ECO:0000269|PubMed:17874118}.	GO:0001750; GO:0005615; GO:0005783; GO:0005793; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0010842; GO:0015485; GO:0016324; GO:0031528; GO:0031982; GO:0042622; GO:0042805; GO:0045296; GO:0045494; GO:0060042; GO:0060219; GO:0070062; GO:0071914; GO:0072112; GO:0072139; GO:2000768	PTM: Isoform 1 and isoform 2 are glycosylated. {ECO:0000269|PubMed:12042327}.; PTM: Acetylation at Lys-225, Lys-257 and Lys-264 by NAT8 and NAT8B may control PROM1 protein expression and its function in cell apoptosis. {ECO:0000269|PubMed:24556617}.	9389721; 12042327; 14702039; 15815621; 15489334; 9389720; 17874118; 17498271; 18096722; 19302789; 20818439; 10587575; 17605048; 21406692; 24556617; 18654668	Prominin family
O43491	E41L2_HUMAN	Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1, 4.1G)	EPB41L2	1005	9606			Acetylation;Actin-binding;Alternative splicing;Cell cycle;Cell division;Cell membrane;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Membrane;Mitosis;Phosphoprotein;Reference proteome;Transport;Ubl conjugation	P12314	TISSUE SPECIFICITY: Widely expressed.	GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007049; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778		9598318; 14702039; 17974005; 14574404; 16254212; 17081983; 16964243; 18023480; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22361696; 22223895; 23870127; 23186163; 24275569; 25755297; 28112733	
O43493	TGON2_HUMAN	Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46, TGN38 homolog, hTGN46) (Trans-Golgi network glycoprotein 48, hTGN48) (Trans-Golgi network glycoprotein 51, hTGN51) (Trans-Golgi network protein 2)	TGOLN2 TGN46 TGN51	437	9606			3D-structure;Alternative splicing;Cell membrane;Glycoprotein;Golgi apparatus;Membrane;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	P60411; P16333; P01019; P78371; P03952; P06858; P40337-2	TISSUE SPECIFICITY: Isoform TGN46 is widely expressed. Isoform TGN51 is more abundant in fetal lung and kidney. Isoform TGN48 is barely expressed in embryonic kidney and promyelocytic cells.	GO:0005654; GO:0005768; GO:0005788; GO:0005794; GO:0005802; GO:0005886; GO:0016021; GO:0030133; GO:0030140; GO:0030669		9422759; 8907712; 14702039; 17974005; 15815621; 15489334; 18669648; 18318008; 20068231; 21269460; 21406692; 23186163; 24275569; 26091039; 25944712	
O43497	CAC1G_HUMAN	Voltage-dependent T-type calcium channel subunit alpha-1G (Cav3.1c) (NBR13) (Voltage-gated calcium channel subunit alpha Cav3.1)	CACNA1G KIAA1123	2377	9606			3D-structure;Alternative splicing;Calcium;Calcium channel;Calcium transport;Cell membrane;Cytoplasm;Disease variant;Glycoprotein;Ion channel;Ion transport;Membrane;Neurodegeneration;Phosphoprotein;Reference proteome;Repeat;Spinocerebellar ataxia;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel		TISSUE SPECIFICITY: Highly expressed in brain, in particular in the amygdala, subthalamic nuclei, cerebellum and thalamus. Moderate expression in heart; low expression in placenta, kidney and lung. Also expressed in colon and bone marrow and in tumoral cells to a lesser extent. Highly expressed in fetal brain, but also in peripheral fetal tissues as heart, kidney and lung, suggesting a developmentally regulated expression.	GO:0001518; GO:0003163; GO:0005248; GO:0005737; GO:0005886; GO:0005891; GO:0007268; GO:0008332; GO:0010045; GO:0019228; GO:0034765; GO:0042391; GO:0043005; GO:0045202; GO:0045956; GO:0060371; GO:0070509; GO:0070588; GO:0086002; GO:0086010; GO:0086015; GO:0086016; GO:0086018; GO:0086027; GO:0086045; GO:0086046; GO:0086056; GO:0086059; GO:0086091; GO:0097110	PTM: In response to raising of intracellular calcium, the T-type channels are activated by CaM-kinase II.	10493502; 10548410; 10648811; 10692398; 16671074; 16625196; 15489334; 10574461; 12168954; 9495342; 26456284; 26715324; 29878067	Calcium channel alpha-1 subunit (TC 1.A.1.11) family, CACNA1G subfamily
O43502	RA51C_HUMAN	DNA repair protein RAD51 homolog 3, R51H3 (RAD51 homolog C) (RAD51-like protein 2)	RAD51C RAD51L2	376	9606			Alternative splicing;ATP-binding;Cytoplasm;Disease variant;DNA damage;DNA recombination;DNA repair;DNA-binding;Fanconi anemia;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	Q8TDG4; Q86YC2; Q06609; O15315; O75771; Q6NVH7; O43543; O43542; Q9NZD8	TISSUE SPECIFICITY: Expressed in a variety of tissues, with highest expression in testis, heart muscle, spleen and prostate.	GO:0000707; GO:0000722; GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007062; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008094; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0043231; GO:0048471		9469824; 16625196; 15489334; 11751635; 11751636; 11744692; 11842112; 11842113; 12427746; 12966089; 14704354; 14716019; 16215984; 16395335; 19783859; 19451272; 20413593; 21269460; 21965664; 23108668; 24005041; 23186163; 23149936; 24141787; 20207730; 20400963; 20400964; 21990120	RecA family, RAD51 subfamily
O43504	LTOR5_HUMAN	Ragulator complex protein LAMTOR5 (Hepatitis B virus X-interacting protein, HBV X-interacting protein, HBX-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5)	LAMTOR5 HBXIP XIP	91	9606			3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Lysosome;Reference proteome	Q0VGL1; Q8NBW4; Q14765; PRO_0000037547 [Q9WMX2]	TISSUE SPECIFICITY: Highly expressed in skeletal and cardiac muscle, followed by pancreas, kidney, liver, brain, placenta and lung. Elevated levels in both cancerous and non-cancerous liver tissue of patients with chronic HBV infection compared with hepatic tissue without HBV infection.	GO:0005764; GO:0005765; GO:0005829; GO:0008361; GO:0009615; GO:0010628; GO:0019079; GO:0031902; GO:0032008; GO:0032757; GO:0032991; GO:0038202; GO:0043123; GO:0043154; GO:0051092; GO:0061462; GO:0071230; GO:0071986; GO:1900182; GO:1904263; GO:1905636		9499022; 16710414; 15489334; 12773388; 16176273; 17525332; 19413330; 21269460; 22980980; 24275569; 25561175; 25944712; 25567906; 21059355; 31704029; 31672913	LAMTOR5 family
O43505	B4GA1_HUMAN	Beta-1,4-glucuronyltransferase 1, EC 2.4.1.- (I-beta-1,3-N-acetylglucosaminyltransferase, iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)	B4GAT1 B3GNT1 B3GNT6	415	9606	PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:25279697, ECO:0000269|PubMed:25279699, ECO:0000269|PubMed:9405606}.	2.4.1.-	Congenital muscular dystrophy;Disease variant;Dystroglycanopathy;Glycoprotein;Glycosyltransferase;Golgi apparatus;Lissencephaly;Manganese;Membrane;Metal-binding;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	O95461-1; Q8N3Y3	TISSUE SPECIFICITY: In the adult, highly expressed in heart, brain, skeletal muscle and kidney and to a lesser extent in placenta, pancreas, spleen, prostate, testis, ovary, small intestine and colon. Very weak expression in lung, liver, thymus and peripheral blood leukocytes. In fetal highly expressed in brain and kidney and to a lesser extent in lung and liver. {ECO:0000269|PubMed:9405606}.	GO:0000139; GO:0005794; GO:0008532; GO:0015020; GO:0018146; GO:0030173; GO:0035269; GO:0046872; GO:0070062		9405606; 15489334; 19587235; 23359570; 23877401; 25279699; 25279697	Glycosyltransferase 49 family
O43506	ADA20_HUMAN	Disintegrin and metalloproteinase domain-containing protein 20, ADAM 20, EC 3.4.24.-	ADAM20	726	9606		3.4.24.-	Disulfide bond;EGF-like domain;Glycoprotein;Hydrolase;Membrane;Metal-binding;Metalloprotease;Protease;Reference proteome;Signal;Transmembrane;Transmembrane helix;Zinc;Zymogen		TISSUE SPECIFICITY: Testis specific.	GO:0004222; GO:0005886; GO:0007338; GO:0008237; GO:0008584; GO:0009897; GO:0016021; GO:0046872; GO:1990913	PTM: Has no obvious cleavage site for furin endopeptidase, suggesting that the proteolytic processing is regulated.	9469942; 10524237; 12508121; 15489334	
O43508	TNF12_HUMAN	Tumor necrosis factor ligand superfamily member 12 (APO3 ligand) (TNF-related weak inducer of apoptosis, TWEAK) [Cleaved into: Tumor necrosis factor ligand superfamily member 12, membrane form; Tumor necrosis factor ligand superfamily member 12, secreted form ]	TNFSF12 APO3L DR3LG UNQ181/PRO207	249	9606			3D-structure;Alternative splicing;Angiogenesis;Apoptosis;Cell membrane;Cleavage on pair of basic residues;Cytokine;Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Membrane;Reference proteome;Secreted;Signal-anchor;Transmembrane;Transmembrane helix	P05067; P06493; P35638; Q9UPY3; O43765; Q9NP84; Q6SIX7	TISSUE SPECIFICITY: Highly expressed in adult heart, pancreas, skeletal muscle, brain, colon, small intestine, lung, ovary, prostate, spleen, lymph node, appendix and peripheral blood lymphocytes. Low expression in kidney, testis, liver, placenta, thymus and bone marrow. Also detected in fetal kidney, liver, lung and brain.	GO:0001525; GO:0001938; GO:0005102; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0006915; GO:0006955; GO:0007165; GO:0030154; GO:0043542; GO:0045732; GO:0045766; GO:0048018; GO:0048471; GO:0097190; GO:0097191; GO:2001238	PTM: The soluble form derives from the membrane form by proteolytic processing.	9405449; 9560343; 12411489; 12975309; 16625196; 15489334; 10085077; 14961121; 12787562; 23667509	Tumor necrosis factor family
O43511	S26A4_HUMAN	Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4)	SLC26A4 PDS	780	9606			Alternative splicing;Cell membrane;Chloride;Deafness;Disease variant;Membrane;Non-syndromic deafness;Reference proteome;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: High expression in adult thyroid, lower expression in adult and fetal kidney and fetal brain. Not expressed in other tissues.	GO:0005886; GO:0005887; GO:0006811; GO:0006885; GO:0007605; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015111; GO:0015116; GO:0015301; GO:0015698; GO:0016021; GO:0016324; GO:0019531; GO:0031526; GO:0032880; GO:0070062		9398842; 14702039; 12853948; 10192399; 9618166; 9618167; 9500541; 10190331; 10602116; 10718825; 10878664; 10700480; 11375792; 11317356; 11748854; 12112665; 11932316; 11919333; 12974744; 14508505; 12788906; 12676893; 14679580; 15355436; 15531480; 15689455; 16684826; 17146393; 19204907; 20597900; 20108392; 24051746; 27535533; 28281779	SLC26A/SulP transporter (TC 2.A.53) family
O43513	MED7_HUMAN	Mediator of RNA polymerase II transcription subunit 7, hMED7 (Activator-recruited cofactor 34 kDa component, ARC34) (Cofactor required for Sp1 transcriptional activation subunit 9, CRSP complex subunit 9) (Mediator complex subunit 7) (RNA polymerase transcriptional regulation mediator subunit 7 homolog) (Transcriptional coactivator CRSP33)	MED7 ARC34 CRSP9	233	9606			3D-structure;Activator;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	Q9Y376; A0A0S2Z4Q4; O14964; Q15648; Q9BTT4; Q13503; O95402; Q9Y3C7; P03383		GO:0000151; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006367; GO:0016592; GO:0016604; GO:0019827; GO:0032968; GO:0051123; GO:0060261; GO:0061630; GO:0070847	PTM: Constitutively sumoylated. {ECO:0000269|PubMed:17709345}.	9671713; 9989412; 15489334; 10235267; 15175163; 15989967; 17709345; 19369195; 25218447; 25114211; 25772364; 25755297; 28112733	Mediator complex subunit 7 family
O43516	WIPF1_HUMAN	WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein, WASP-interacting protein)	WIPF1 WASPIP WIP	503	9606			3D-structure;Actin-binding;Alternative splicing;Cell projection;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Methylation;Phosphoprotein;Reference proteome;Repeat	Q9NYB9; P13196; Q14296; P62993; P08631; P14317; Q9NSC5; P16333; P53992; P42768; O00401; O00308; Q60598; Q9NYB9-2; Q9Y698; O43639; O15258; P42768	TISSUE SPECIFICITY: Highly expressed in peripheral blood mononuclear cells, spleen, placenta, small intestine, colon and thymus. Lower expression in ovary, heart, brain, lung, liver, skeletal muscle, kidney, pancreas, prostate and testis. {ECO:0000269|PubMed:9405671}.	GO:0001726; GO:0003779; GO:0005522; GO:0005829; GO:0005884; GO:0008154; GO:0015629; GO:0017124; GO:0030048; GO:0031410; GO:0051707; GO:0065003		9405671; 17974005; 15815621; 15489334; 10202051; 10878810; 19367720; 18669648; 19798448; 19690332; 19910490; 20068231; 21269460; 22231303; 23186163; 24275569; 25944712; 16275905	Verprolin family
O43520	AT8B1_HUMAN	Phospholipid-transporting ATPase IC, EC 7.6.2.1 (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1)	ATP8B1 ATPIC FIC1 PFIC	1251	9606		7.6.2.1	ATP-binding;Cell membrane;Cell projection;Disease variant;Endoplasmic reticulum;Golgi apparatus;Hearing;Intrahepatic cholestasis;Lipid transport;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport	Q9NV96; Q3MIR4	TISSUE SPECIFICITY: Found in most tissues except brain and skeletal muscle. Most abundant in pancreas and small intestine.	GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006855; GO:0007030; GO:0007605; GO:0008206; GO:0015721; GO:0016324; GO:0016604; GO:0016887; GO:0021650; GO:0032420; GO:0032534; GO:0034220; GO:0045176; GO:0045332; GO:0045892; GO:0060119; GO:0090554; GO:0090556; GO:0140326; GO:0140345; GO:0140346; GO:1901612; GO:1903729; GO:1990531; GO:2001225		9500542; 16177791; 9548971; 15489334; 17948906; 20510206; 20512993; 20947505; 20961850; 21914794; 25239307; 25315773; 27301931; 9918928; 11093741; 15239083; 15657619; 15888793; 16959974; 19731236; 20038848; 23197899	Cation transport ATPase (P-type) (TC 3.A.3) family, Type IV subfamily
O43521	B2L11_HUMAN	Bcl-2-like protein 11, Bcl2-L-11 (Bcl2-interacting mediator of cell death)	BCL2L11 BIM	198	9606			3D-structure;Alternative splicing;Apoptosis;Membrane;Mitochondrion;Phosphoprotein;Reference proteome;Ubl conjugation	Q92934; Q07812; P10415; Q16548; Q07817; Q07817-1; Q9HD36; Q92843; Q86UW9; P43364-2; Q07820; Q13064; P07237; P40855; P63244; Q9UHD9; Q8N6Y0; Q07813-1; Q07440; P68451; P97287; P03495; P10415; Q07817-1; Q9HD36; P10415; P14174	TISSUE SPECIFICITY: Isoform BimEL, isoform BimL and isoform BimS are the predominant isoforms and are widely expressed with tissue-specific variation. Isoform Bim-gamma is most abundantly expressed in small intestine and colon, and in lower levels in spleen, prostate, testis, heart, liver and kidney. {ECO:0000269|PubMed:12019181}.	GO:0001701; GO:0001782; GO:0001822; GO:0002262; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0006919; GO:0007127; GO:0007160; GO:0007283; GO:0007420; GO:0008017; GO:0008584; GO:0008630; GO:0012505; GO:0019898; GO:0019901; GO:0030879; GO:0031334; GO:0034263; GO:0034976; GO:0035148; GO:0042475; GO:0042981; GO:0043029; GO:0043065; GO:0043280; GO:0043525; GO:0043583; GO:0045787; GO:0046620; GO:0048066; GO:0048070; GO:0048536; GO:0048538; GO:0048563; GO:0070242; GO:0071385; GO:0071392; GO:0090200; GO:0097136; GO:0097140; GO:0097141; GO:0097192; GO:1902110; GO:1902237; GO:1902263; GO:1903896; GO:1904646; GO:2000271; GO:2001244	PTM: Phosphorylation at Ser-69 by MAPK1/MAPK3 leads to interaction with TRIM2 and polyubiquitination, followed by proteasomal degradation (PubMed:15486195, PubMed:21478148). Deubiquitination catalyzed by USP27X stabilizes the protein (By similarity). {ECO:0000250|UniProtKB:O54918, ECO:0000269|PubMed:15486195, ECO:0000269|PubMed:21478148}.; PTM: Ubiquitination by TRIM2 following phosphorylation by MAPK1/MAPK3 leads to proteasomal degradation. Conversely, deubiquitination catalyzed by USP27X stabilizes the protein. {ECO:0000250|UniProtKB:O54918}.	9430630; 11734221; 12019181; 11997495; 15147734; 17503221; 14702039; 15815621; 15489334; 15486195; 15661735; 16509771; 17289999; 19690332; 21478148; 22498477; 22761832; 23563182; 23186163; 27013495; 17389404; 18812174; 23235460	Bcl-2 family
O43524	FOXO3_HUMAN	Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1)	FOXO3 FKHRL1 FOXO3A	673	9606			3D-structure;Acetylation;Activator;Alternative splicing;Apoptosis;Chromosomal rearrangement;Cytoplasm;DNA-binding;Membrane;Methylation;Mitochondrion;Mitochondrion outer membrane;Nucleus;Phosphoprotein;Proto-oncogene;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	P31749; Q92974; P30260; Q92793; P03372; Q92731; P85037; Q08050; P51610; P01106; P11309-1; Q96T60; P06400; P28749; Q96EB6; P84022; Q13485; O75529; P63104; Q60987; P63101	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9479491}.	GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001227; GO:0001228; GO:0001542; GO:0001544; GO:0001547; GO:0001556; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005759; GO:0005829; GO:0006357; GO:0006390; GO:0006417; GO:0007568; GO:0008013; GO:0009410; GO:0010508; GO:0014737; GO:0019901; GO:0030330; GO:0030336; GO:0031490; GO:0032991; GO:0033209; GO:0034246; GO:0034599; GO:0042149; GO:0042594; GO:0043065; GO:0043525; GO:0043565; GO:0045591; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0048854; GO:0070542; GO:0071333; GO:0071386; GO:0071456; GO:0071548; GO:0090090; GO:0090571; GO:0097150; GO:0097192; GO:1901300; GO:1902895; GO:1903428; GO:1904646; GO:1990090; GO:1990785; GO:1990837; GO:2000177; GO:2000353	PTM: In the presence of survival factors such as IGF-1, phosphorylated on Thr-32 and Ser-253 by AKT1/PKB (PubMed:10102273). This phosphorylated form then interacts with 14-3-3 proteins and is retained in the cytoplasm (PubMed:10102273). Survival factor withdrawal induces dephosphorylation and promotes translocation to the nucleus where the dephosphorylated protein induces transcription of target genes and triggers apoptosis (PubMed:10102273). Although AKT1/PKB doesn't appear to phosphorylate Ser-315 directly, it may activate other kinases that trigger phosphorylation at this residue (PubMed:10102273, PubMed:11154281). Phosphorylated by STK4/MST1 on Ser-209 upon oxidative stress, which leads to dissociation from YWHAB/14-3-3-beta and nuclear translocation (PubMed:16751106). Phosphorylated by PIM1 (PubMed:18593906). Phosphorylation by AMPK leads to the activation of transcriptional activity without affecting subcellular localization (PubMed:17711846). In response to metabolic stress, phosphorylated by AMPK on Ser-30 which mediates FOXO3 mitochondrial translocation (PubMed:29445193). Phosphorylation by MAPKAPK5 promotes nuclear localization and DNA-binding, leading to induction of miR-34b and miR-34c expression, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent its translation (PubMed:21329882). Phosphorylated by CHUK/IKKA and IKBKB/IKKB (PubMed:15084260). TNF-induced inactivation of FOXO3 requires its phosphorylation at Ser-644 by IKBKB/IKKB which promotes FOXO3 retention in the cytoplasm, polyubiquitination and ubiquitin-mediated proteasomal degradation (PubMed:15084260). May be dephosphorylated by calcineurin A on Ser-299 which abolishes FOXO3 transcriptional activity (By similarity). In cancer cells, ERK mediated-phosphorylation of Ser-12 is required for mitochondrial translocation of FOXO3 in response to metabolic stress or chemotherapeutic agents (PubMed:29445193). Phosphorylation at Ser-253 promotes its degradation by the proteasome (PubMed:30513302). Dephosphorylation at Ser-253 by protein phosphatase 2A (PPP2CA) promotes its stabilization; interaction with PPP2CA is enhanced by AMBRA1 (PubMed:30513302). {ECO:0000250|UniProtKB:Q9WVH4, ECO:0000269|PubMed:10102273, ECO:0000269|PubMed:11154281, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:16751106, ECO:0000269|PubMed:17711846, ECO:0000269|PubMed:18593906, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:29445193, ECO:0000269|PubMed:30513302}.; PTM: Deacetylation by SIRT1 or SIRT2 stimulates interaction of FOXO3 with SKP2 and facilitates SCF(SKP2)-mediated FOXO3 ubiquitination and proteasomal degradation (PubMed:21841822). Deacetylation by SIRT2 stimulates FOXO3-mediated transcriptional activity in response to oxidative stress (By similarity). Deacetylated by SIRT3 (PubMed:23283301). Deacetylation by SIRT3 stimulates FOXO3-mediated mtDNA transcriptional activity in response to metabolic stress (PubMed:23283301). {ECO:0000250|UniProtKB:Q9WVH4, ECO:0000269|PubMed:21841822, ECO:0000269|PubMed:23283301}.; PTM: Heavily methylated by SET9 which decreases stability, while moderately increasing transcriptional activity. The main methylation site is Lys-271. Methylation doesn't affect subcellular location. {ECO:0000269|PubMed:22820736}.; PTM: Polyubiquitinated. Ubiquitinated by a SCF complex containing SKP2, leading to proteasomal degradation. {ECO:0000269|PubMed:21841822}.; PTM: The N-terminus is cleaved following import into the mitochondrion. {ECO:0000269|PubMed:29445193}.	9479491; 14702039; 14574404; 15489334; 9345057; 10102273; 11154281; 15084260; 16751106; 17711846; 18593906; 18220336; 18669648; 19413330; 19690332; 20181828; 21269460; 21329882; 22820736; 22313691; 21841822; 22761832; 23283301; 23805378; 23186163; 29445193; 30513302; 17940099	
O43525	KCNQ3_HUMAN	Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3)	KCNQ3	872	9606			3D-structure;Alternative splicing;Cell membrane;Disease variant;Epilepsy;Ion channel;Ion transport;Membrane;Phosphoprotein;Potassium;Potassium channel;Potassium transport;Reference proteome;Transmembrane;Transmembrane helix;Transport;Ubl conjugation;Voltage-gated channel		TISSUE SPECIFICITY: Predominantly expressed in brain.	GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0008076; GO:0009986; GO:0016021; GO:0033268; GO:0034765; GO:0043194; GO:0045202; GO:0060081; GO:0071805	PTM: KCNQ2/KCNQ3 are ubiquitinated by NEDD4L. Ubiquitination leads to protein degradation (Probable). Degradation induced by NEDD4L is inhibited by USP36 (PubMed:27445338). {ECO:0000269|PubMed:27445338, ECO:0000305|PubMed:27445338}.	9872318; 9677360; 14702039; 16421571; 15489334; 9425900; 10479678; 11034315; 10788442; 10684873; 10713961; 10908292; 10953053; 10713399; 11159685; 16319223; 27445338; 27564677; 10852552; 14534157; 22612257; 23360469; 25982755	Potassium channel family, KQT (TC 1.A.1.15) subfamily, Kv7.3/KCNQ3 sub-subfamily
O43526	KCNQ2_HUMAN	Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2)	KCNQ2	872	9606			3D-structure;Alternative splicing;Cell membrane;Disease variant;Epilepsy;Ion channel;Ion transport;Membrane;Mental retardation;Phosphoprotein;Potassium;Potassium channel;Potassium transport;Reference proteome;Transmembrane;Transmembrane helix;Transport;Ubl conjugation;Voltage-gated channel		TISSUE SPECIFICITY: In adult and fetal brain. Highly expressed in areas containing neuronal cell bodies, low in spinal cord and corpus callosum. Isoform 2 is preferentially expressed in differentiated neurons. Isoform 6 is prominent in fetal brain, undifferentiated neuroblastoma cells and brain tumors. {ECO:0000269|PubMed:10781098}.	GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0007399; GO:0008076; GO:0016021; GO:0030506; GO:0033268; GO:0034765; GO:0043194; GO:0045202; GO:0071805	PTM: KCNQ2/KCNQ3 heteromeric current can be increased by intracellular cyclic AMP, an effect that depends on phosphorylation of Ser-52 in the N-terminal region. {ECO:0000269|PubMed:16319223, ECO:0000269|PubMed:9872318}.; PTM: KCNQ2/KCNQ3 are ubiquitinated by NEDD4L. Ubiquitination leads to protein degradation (Probable). Degradation induced by NEDD4L is inhibited by USP36 (PubMed:27445338). {ECO:0000269|PubMed:27445338, ECO:0000305|PubMed:27445338}.	9039501; 9425895; 9430594; 9836639; 9827540; 9677360; 11160379; 11780052; 15489334; 9872318; 10479678; 11034315; 10788442; 10684873; 10713961; 10908292; 10953053; 10713399; 10781098; 14759258; 16319223; 27445338; 27564677; 10323247; 11175290; 11572947; 14534157; 12742592; 15249611; 17872363; 23360469; 24463883; 25818041; 25982755; 25740509; 26138355; 26993267; 27864847	Potassium channel family, KQT (TC 1.A.1.15) subfamily, Kv7.2/KCNQ2 sub-subfamily
O43529	CHSTA_HUMAN	Carbohydrate sulfotransferase 10, EC 2.8.2.- (HNK-1 sulfotransferase, HNK-1ST, HNK1ST, HuHNK-1ST)	CHST10	356	9606	PATHWAY: Steroid metabolism. {ECO:0000269|PubMed:23269668}.; PATHWAY: Protein modification; carbohydrate sulfation. {ECO:0000269|PubMed:32149355}.	2.8.2.-	Carbohydrate metabolism;Glycoprotein;Golgi apparatus;Lipid metabolism;Membrane;Reference proteome;Signal-anchor;Steroid metabolism;Transferase;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: In fetal tissues, it is predominantly expressed in brain, and weakly expressed in lung, kidney and liver. In adult, it is highly expressed in brain, testis, ovary, expressed at intermediate level in heart, pancreas, skeletal muscle, spleen and thymus, and weakly expressed in other tissues. In brain, it is expressed at higher level in the frontal lobe. {ECO:0000269|PubMed:32149355, ECO:0000269|PubMed:9478973}.	GO:0000139; GO:0005794; GO:0007155; GO:0007612; GO:0007616; GO:0008146; GO:0008209; GO:0008210; GO:0016020; GO:0016021; GO:0016051; GO:0016232; GO:0030166		9478973; 14702039; 15815621; 15489334; 10464296; 23269668; 32149355	Sulfotransferase 2 family
O43541	SMAD6_HUMAN	Mothers against decapentaplegic homolog 6, MAD homolog 6, Mothers against DPP homolog 6 (SMAD family member 6, SMAD 6, Smad6, hSMAD6)	SMAD6 MADH6	496	9606			Alternative splicing;Craniosynostosis;Disease variant;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc	P51817; Q13950; Q15797; O43541; O95630	TISSUE SPECIFICITY: Ubiquitous in various organs, with higher levels in lung. Isoform B is up-regulated in diseased heart tissue.	GO:0000785; GO:0000976; GO:0001657; GO:0003148; GO:0003180; GO:0003183; GO:0003184; GO:0003281; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0007179; GO:0007352; GO:0008285; GO:0009653; GO:0010991; GO:0016604; GO:0030154; GO:0030279; GO:0030509; GO:0030512; GO:0030514; GO:0031589; GO:0031625; GO:0032496; GO:0032991; GO:0034616; GO:0034713; GO:0035904; GO:0042802; GO:0043066; GO:0043627; GO:0045444; GO:0045668; GO:0046872; GO:0060394; GO:0060395; GO:0060976; GO:0070410; GO:0070411; GO:0070412; GO:0070698; GO:0071144; GO:0140416; GO:1902895	PTM: Phosphorylated by BMP type 1 receptor kinase and by PRKX. {ECO:0000269|PubMed:16491121}.; PTM: Monoubiquitinated at Lys-173 by the E2/E3 hybrid ubiquitin-protein ligase UBE2O, leading to reduced binding affinity for the activated BMP type I receptor ACVR1/ALK2, thereby enhancing BMP7 and regulating adipocyte differentiation (PubMed:23455153). Ubiquitinated by WWP1 (By similarity). Ubiquitinated by RNF165, promoting proteasomal degradation, leading to enhance the BMP-Smad signaling (By similarity). {ECO:0000250|UniProtKB:O35182, ECO:0000269|PubMed:23455153}.; PTM: Arginine methylation by PRMT1, which is recruited by BMPR2, initiates BMP-Induced signaling and induces dissociation from the BMPR1B receptor at the cell surface leading to derepress downstream Smad1/Smad5 signaling. {ECO:0000250|UniProtKB:O35182}.	8673135; 9436979; 9712726; 15489334; 9759503; 10647776; 10708948; 10708949; 10722652; 11284962; 11483516; 14657019; 16601693; 16951688; 16491121; 22275001; 23455153; 27606499; 31138930; 30796334; 30848080	Dwarfin/SMAD family
O43542	XRCC3_HUMAN	DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3)	XRCC3	346	9606			Acetylation;ATP-binding;Cytoplasm;Disease variant;DNA damage;DNA recombination;DNA repair;DNA-binding;Mitochondrion;Nucleotide-binding;Nucleus;Reference proteome	Q86YC2; Q06609; O43502; Q6NVH7		GO:0000722; GO:0000724; GO:0000781; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006974; GO:0008094; GO:0010033; GO:0010824; GO:0033065; GO:0036297; GO:0045003; GO:0048471; GO:0071140; GO:0090267; GO:0090656; GO:0090657; GO:0090737		9660962; 15489334; 11751635; 12023982; 11744692; 11842113; 14704354; 14716019; 16215984; 17525332; 20413593; 21269460; 21965664; 22814378; 23108668; 23149936; 24141787; 20207730; 11059748	RecA family, RAD51 subfamily
O43543	XRCC2_HUMAN	DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2)	XRCC2	280	9606			Cytoplasm;Cytoskeleton;Disease variant;DNA damage;DNA recombination;DNA repair;DNA-binding;Fanconi anemia;Nucleus;Phosphoprotein;Premature ovarian failure;Reference proteome	P50222; O43502; O75771		GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0008094; GO:0010165; GO:0010332; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:2000269		9660962; 9126486; 9628903; 14702039; 15489334; 11751635; 11744692; 11834724; 11842112; 11842113; 14704354; 21276791; 23186163; 23149936; 20207730; 22464251; 22232082; 23054243; 27233470; 30042186; 30489636; 30237576	RecA family, RAD51 subfamily
O43548	TGM5_HUMAN	Protein-glutamine gamma-glutamyltransferase 5, EC 2.3.2.13 (Transglutaminase X, TG(X), TGX, TGase X) (Transglutaminase-5, TGase-5)	TGM5 TGMX	720	9606		2.3.2.13	Acetylation;Acyltransferase;Alternative splicing;Calcium;Cytoplasm;Direct protein sequencing;Disease variant;Metal-binding;Reference proteome;Transferase	P55212; Q14451-3; O00291; Q63ZY3; P13473-2; Q6P4E2; P47929; O75400-2; Q96IZ5	TISSUE SPECIFICITY: Expressed in foreskin keratinocytes.	GO:0003810; GO:0005737; GO:0005886; GO:0006464; GO:0008544; GO:0018149; GO:0046872		9452468; 11390390; 15489334; 15290349; 16380904	Transglutaminase superfamily, Transglutaminase family
O43556	SGCE_HUMAN	Epsilon-sarcoglycan, Epsilon-SG	SGCE ESG UNQ433/PRO840	437	9606			Alternative splicing;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Disease variant;Dystonia;Glycoprotein;Golgi apparatus;Membrane;Reference proteome;Transmembrane;Transmembrane helix;Ubl conjugation		TISSUE SPECIFICITY: Ubiquitous.	GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0007160; GO:0007517; GO:0016010; GO:0016012; GO:0032590; GO:0042383	PTM: N-glycosylated. {ECO:0000250}.; PTM: Ubiquitinated, leading to its degradation by the proteasome. {ECO:0000250}.	9475163; 12975309; 14702039; 12853948; 15489334; 15193417; 9405466; 11528394; 19159218; 12402271; 15258227; 15079037; 16227522; 17853490; 18175340; 18362280; 19066193; 21796726	Sarcoglycan alpha/epsilon family
O43557	TNF14_HUMAN	Tumor necrosis factor ligand superfamily member 14 (Herpes virus entry mediator ligand, HVEM-L, Herpesvirus entry mediator ligand) (CD antigen CD258) [Cleaved into: Tumor necrosis factor ligand superfamily member 14, membrane form; Tumor necrosis factor ligand superfamily member 14, soluble form ]	TNFSF14 HVEML LIGHT UNQ391/PRO726	240	9606			3D-structure;Alternative splicing;Cell membrane;Cytokine;Cytoplasm;Disulfide bond;Glycoprotein;Membrane;Reference proteome;Secreted;Signal-anchor;Transmembrane;Transmembrane helix	Q08AM2; Q15848; O95393; O75508; Q8N6F1-2; Q07325; Q8N5M9; Q86UP9; P36941; P21145; Q6UX06; Q9Y342; P53801; Q96IW7; Q15436; Q8N2H4; P17152; Q92956; O95407; O00526; Q6UX98; P50284; Q71F55; O95407; O43557-1	TISSUE SPECIFICITY: Predominantly expressed in the spleen but also found in the brain. Weakly expressed in peripheral lymphoid tissues and in heart, placenta, liver, lung, appendix, and kidney, and no expression seen in fetal tissues, endocrine glands, or nonhematopoietic tumor lines. {ECO:0000269|PubMed:9462508}.	GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005737; GO:0005886; GO:0006915; GO:0006955; GO:0007165; GO:0010820; GO:0016021; GO:0031295; GO:0042098; GO:0042110; GO:0042802; GO:0043027; GO:0043029; GO:0045663; GO:0071260; GO:1901224; GO:1901741	PTM: N-glycosylated. {ECO:0000269|Ref.10}.; PTM: The soluble form of isoform 1 derives from the membrane form by proteolytic processing. {ECO:0000269|PubMed:11673523}.	9462508; 9765287; 11673523; 12975309; 14702039; 15057824; 10754304	Tumor necrosis factor family
O43559	FRS3_HUMAN	Fibroblast growth factor receptor substrate 3, FGFR substrate 3 (FGFR-signaling adaptor SNT2) (Suc1-associated neurotrophic factor target 2, SNT-2)	FRS3	492	9606			3D-structure;Lipoprotein;Membrane;Myristate;Phosphoprotein;Reference proteome	Q6UY14-3; Q9ULX6; Q9NYG5-2; Q3KP44; Q9Y6H3; Q9H2G9; Q9H5F2; Q8TAV5; Q5BKX5-3; Q6P5X5; Q8NEC5; Q8NA61; P48745; Q6NVV7; P27658; Q9UNS2; Q02930-3; A8MQ03; A2VCK2; Q9NQL9; A0A0U1RQF7; Q16610; Q9NQ30; O43559; P15976; P15976-2; P08631-2; P49639; P35452-2; Q02363; Q02535; Q9UKT9; Q0VD86; Q9ULR0-1; Q9H079; Q6ZU52; Q5T749; Q15323; Q14525; O76011; Q92764; Q01546; Q07627; P60410; Q8IUC1; Q9BYR8; Q9BYR7; Q3LI66; Q96FE5; Q8N456; Q8WWY6; Q5JXC2; Q6IA69; Q7Z3S9; P0DPK4; Q92824-2; Q9NR12; Q8WWB5; Q92569; Q6P1J6-2; Q9Y342; O15162; Q8WVV4-1; Q7Z5V6-2; Q9NQX0; Q8HWS3; Q9UFD9; Q9BWG6; Q8ND83; Q8N1D0-2; Q8WXH5; Q99932-2; Q7Z6I5; O43597; Q8IWL8; O75716; P15884; Q8TDR4; Q96PF1; Q08117; Q08117-2; Q9BUZ4; Q15654; Q86WV8; Q3SY00; O14817; Q9H9P5-5; A8MV65-2; Q9BRX9; Q9NZC7-5; Q8TF47; Q8NF64-3; Q15973; Q8TAU3; Q7Z4V0; Q9NWS9-2; Q9H707; Q9UC07-2; Q86W11; PRO_0000037548 [Q9WMX2]		GO:0005068; GO:0005104; GO:0005737; GO:0005886; GO:0007165; GO:0007169; GO:0008543; GO:0042802	PTM: Phosphorylated by ULK2 in vitro (By similarity). Phosphorylated on tyrosine residues upon stimulation by BFGF or NGFB. {ECO:0000250, ECO:0000269|PubMed:15094036, ECO:0000269|PubMed:9660748}.	9660748; 14574404; 15489334; 15485655; 15094036	
O43561	LAT_HUMAN	Linker for activation of T-cells family member 1 (36 kDa phospho-tyrosine adapter protein, pp36) (p36-38)	LAT	262	9606			Adaptive immunity;Alternative splicing;Cell membrane;Direct protein sequencing;Immunity;Lipoprotein;Mast cell degranulation;Membrane;Palmitate;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix	P00533; P62993; P06239; P27986; P19174; P18031; O43765; Q96BI3; P07307-3; Q9BXK5; J3KQ12; P49069; P09693; P19397; Q9H305; P57739; O00501; O95471; Q5JRM2; Q9BQA9; O15552; O14843; Q9Y680; P48165; P08034; O75712; Q8NBJ4; Q96P66; Q8TDV0; Q8TDT2; O15529; P62993-1; Q96MG2; Q8N5Z5; P43628; A8MZ59; Q86WI0; Q8TAF8; Q9BXW4; Q6FHY5; Q9GZY8-5; Q5SR56; Q6N075; Q9Y676; Q9GZW8; Q9H2K0; Q8N183; P35372-10; Q16378; Q9NR31; O43765; Q96EQ0; Q15849; P54219-3; Q9BZV2; Q9BXS9-3; Q9NQQ7-3; Q86UW2; P03973; Q8WWF3; Q8N9I0; Q8WY91; Q96CE8; Q96Q45-2; Q96B21; Q96HE8; Q9UBN6; Q9NXF8-2; P08487	TISSUE SPECIFICITY: Expressed in thymus, T-cells, NK cells, mast cells and, at lower levels, in spleen. Present in T-cells but not B-cells (at protein level). {ECO:0000269|PubMed:16160011, ECO:0000269|PubMed:9489702}.	GO:0001772; GO:0002250; GO:0002260; GO:0005794; GO:0005886; GO:0005911; GO:0006954; GO:0006955; GO:0007229; GO:0007265; GO:0008180; GO:0010467; GO:0016021; GO:0019722; GO:0019901; GO:0030159; GO:0035556; GO:0042110; GO:0043303; GO:0045121; GO:0045860; GO:0050863	PTM: Phosphorylated on tyrosines by ZAP70 upon TCR activation, or by SYK upon other immunoreceptor activation; which leads to the recruitment of multiple signaling molecules. Is one of the most prominently tyrosine-phosphorylated proteins detected following TCR engagement. May be dephosphorylated by PTPRJ. Phosphorylated by ITK leading to the recruitment of VAV1 to LAT-containing complexes.; PTM: Palmitoylation of Cys-26 and Cys-29 is required for raft targeting and efficient phosphorylation. {ECO:0000269|PubMed:9729044}.	9489702; 9529333; 15616553; 15489334; 9729044; 10488157; 10072481; 10811803; 10781611; 10942756; 11368773; 11259588; 12186560; 12913111; 15144186; 14696041; 16160011; 18088087; 19690332; 24275569; 27242165; 27522155	
O43566	RGS14_HUMAN	Regulator of G-protein signaling 14, RGS14	RGS14	566	9606			3D-structure;Alternative splicing;Cell cycle;Cell division;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;GTPase activation;Membrane;Microtubule;Nucleus;Phosphoprotein;Reference proteome;Repeat;Signal transduction inhibitor;Synapse	P08754; Q9BSI4		GO:0000278; GO:0000922; GO:0001965; GO:0003924; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005886; GO:0006913; GO:0006979; GO:0007051; GO:0007059; GO:0007186; GO:0007612; GO:0007616; GO:0008017; GO:0008277; GO:0008542; GO:0010070; GO:0014069; GO:0016604; GO:0016605; GO:0019901; GO:0030159; GO:0030425; GO:0031914; GO:0032794; GO:0035556; GO:0043197; GO:0043407; GO:0043547; GO:0043620; GO:0045744; GO:0048008; GO:0050769; GO:0051301; GO:0060291; GO:0070373; GO:0098978	PTM: Phosphorylated by PKC. Phosphorylation is increased in presence of forskolin and may enhance the GDI activity on G(i) alpha subunit GNAI1 (By similarity). {ECO:0000250}.	16819986; 14702039; 15372022; 15489334; 15917656; 17635935; 19690332; 17603074; 18434541; 21115486	
O43567	RNF13_HUMAN	E3 ubiquitin-protein ligase RNF13, EC 2.3.2.27 (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13)	RNF13 RZF	381	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.27	3D-structure;Alternative splicing;Disease variant;Endoplasmic reticulum;Endosome;Epilepsy;Glycoprotein;Golgi apparatus;Lysosome;Membrane;Metal-binding;Nucleus;Reference proteome;Signal;Transferase;Transmembrane;Transmembrane helix;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	P61088	TISSUE SPECIFICITY: Widely expressed (at protein level). In normal pancreas, expressed in islets, but not in ducts, nor in acini (at protein level). {ECO:0000269|PubMed:18794910}.	GO:0000139; GO:0004842; GO:0005637; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008432; GO:0016021; GO:0031902; GO:0043231; GO:0046872; GO:0051865; GO:0061630; GO:0070304	PTM: Auto-ubiquitinated. {ECO:0000269|PubMed:18794910}.	14702039; 16641997; 15489334; 17897319; 18794910; 23378536; 30595371	
O43570	CAH12_HUMAN	Carbonic anhydrase 12, EC 4.2.1.1 (Carbonate dehydratase XII) (Carbonic anhydrase XII, CA-XII) (Tumor antigen HOM-RCC-3.1.3)	CA12	354	9606		4.2.1.1	3D-structure;Alternative splicing;Cell membrane;Disease variant;Disulfide bond;Glycoprotein;Lyase;Membrane;Metal-binding;Reference proteome;Signal;Transmembrane;Transmembrane helix;Zinc		TISSUE SPECIFICITY: Highly expressed in colon, kidney, prostate, intestine and activated lymphocytes. Expressed at much higher levels in the renal cell cancers than in surrounding normal kidney tissue. Moderately expressed in pancreas, ovary and testis. Expressed in sweat glands and bronchiolar epithelium (PubMed:26911677). {ECO:0000269|PubMed:26911677}.	GO:0004089; GO:0005886; GO:0006730; GO:0008270; GO:0016021; GO:0016836; GO:0055064		9636197; 9770531; 14702039; 15489334; 17705204; 17314045; 17407288; 19186056; 19206230; 18618712; 26911677; 11493685; 21035102; 21184099	Alpha-carbonic anhydrase family
O43572	AKA10_HUMAN	A-kinase anchor protein 10, mitochondrial, AKAP-10 (Dual specificity A kinase-anchoring protein 2, D-AKAP-2) (Protein kinase A-anchoring protein 10, PRKA10)	AKAP10	662	9606			3D-structure;Cytoplasm;Membrane;Mitochondrion;Phosphoprotein;Reference proteome;Repeat;Transit peptide	P00514		GO:0005739; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0032991; GO:0051018		11248059; 14702039; 15489334; 18691976; 18669648; 23186163; 17485678	
O43581	SYT7_HUMAN	Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII, SytVII)	SYT7 PCANAP7	403	9606			3D-structure;Alternative splicing;Calcium;Calmodulin-binding;Cell junction;Cell membrane;Cell projection;Cytoplasmic vesicle;Exocytosis;Lipoprotein;Lysosome;Membrane;Metal-binding;Palmitate;Peroxisome;Phosphoprotein;Reference proteome;Repeat;Synapse;Transmembrane;Transmembrane helix	Q8IUQ4	TISSUE SPECIFICITY: Expressed in a variety of adult and fetal tissues.	GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042995; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098686; GO:0099056; GO:1990926; GO:1990927	PTM: Palmitoylated at its vesicular N-terminus; palmitoylation is required for localization to lysosome and phagocytosis in macrophages. {ECO:0000250|UniProtKB:Q9R0N7}.	9615227; 16554811; 15489334; 11342594; 12071850; 15811535; 22966849; 25437758; 26322740; 26333120	Synaptotagmin family
O43583	DENR_HUMAN	Density-regulated protein, DRP (Protein DRP1) (Smooth muscle cell-associated protein 3, SMAP-3)	DENR DRP1 H14	198	9606			3D-structure;Acetylation;Initiation factor;Phosphoprotein;Protein biosynthesis;Reference proteome	Q9NX47; Q9ULC4; Q8WX92; P0CG48	TISSUE SPECIFICITY: Highly expressed in heart and skeletal muscle and moderately expressed in the brain, placenta, liver and pancreas. Weakly expressed in the lung and kidney. {ECO:0000269|PubMed:9628587}.	GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0032790; GO:0075522		9628587; 16541075; 15489334; 10497265; 16982740; 17081983; 17878526; 18669648; 19413330; 19690332; 20713520; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569	DENR family
O43586	PPIP1_HUMAN	Proline-serine-threonine phosphatase-interacting protein 1, PEST phosphatase-interacting protein 1 (CD2-binding protein 1) (H-PIP)	PSTPIP1 CD2BP1	416	9606			3D-structure;Alternative splicing;Cell adhesion;Cell membrane;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Endocytosis;Immunity;Inflammatory response;Innate immunity;Membrane;Phosphoprotein;Reference proteome;SH3 domain	O15169; O43684; Q2TBE0; Q8IX18; Q08426; Q86YD7; P48023; Q96D16; Q9GZV7; Q03014; O75031; Q14005-2; Q63ZY3; Q96GY3; Q9Y4Z0; Q96EZ8; O15553; P00540; Q09161; Q9Y5E9; Q96T60; Q8WWY3; P0CG20; O43586; Q05209; Q99952; Q9Y2R2; Q15287; P32969; Q14D33; P28702-3; Q9BWG6; O00560; Q9H788; Q96GM5; Q9UQ90; P17752; Q9Y228; Q3SY00; O75386; Q96B02; Q53FD0-2; Q9Y473; Q9H9D4; Q9UK33; A0A0S2Z5X4	TISSUE SPECIFICITY: Highly expressed in the peripheral blood leukocytes, granulocytes and monocytes, namely in T-cells and natural killer cells, and in spleen. Weakly expressed in the thymus, small intestine, lung and placenta. {ECO:0000269|PubMed:14595024, ECO:0000269|PubMed:9857189}.	GO:0001931; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0030041; GO:0032154; GO:0042802; GO:0045087; GO:0048471; GO:0051015	PTM: Dephosphorylated on Tyr-345 by PTPN18, this event negatively regulates the association of PSTPIP1 with SH2 domain-containing proteins as tyrosine kinase. Phosphorylation of Tyr-345 is probably required for subsequent phosphorylation at other tyrosine residues. Phosphorylation is induced by activation of the EGFR and PDGFR in a ABL1 dependent manner. The phosphorylation regulates the interaction with WAS and with MEFV (By similarity). {ECO:0000250}.	9857189; 19054851; 15489334; 14595024; 17964261; 18480402; 19807924; 19109554; 19584923; 11971877; 22161697	
O43592	XPOT_HUMAN	Exportin-T (Exportin(tRNA)) (tRNA exportin)	XPOT	962	9606			Acetylation;Cytoplasm;Direct protein sequencing;Nucleus;Reference proteome;RNA-binding;Transport;tRNA-binding	O95678; P78424; P62826; Q13595		GO:0000049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0006886; GO:0016363; GO:0031267; GO:0071528		9660920; 9512417; 16541075; 15489334; 9857198; 12138183; 19413330; 19608861; 21269460; 22223895; 22814378	Exportin family
O43593	HAIR_HUMAN	Lysine-specific demethylase hairless, EC 1.14.11.65 ([histone H3]-dimethyl-L-lysine(9) demethylase hairless)	HR	1189	9606		1.14.11.65	Alternative splicing;Disease variant;DNA-binding;Hypotrichosis;Iron;Metal-binding;Nucleus;Oxidoreductase;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	Q8NFV4-4; Q9Y4X0-3; Q9Y6H3; Q9H5F2; Q5BKX5-3; Q9BYD5; A8MQ03; Q92567-2; P57678; P49639; Q0VD86; Q9BS75; Q8IUC1; Q52LG2; Q3LI76; Q9BYR8; Q9BYR6; O15496; P10745; Q99932-2; O43610; Q86WV8; Q9H0C1	TISSUE SPECIFICITY: Strongest expression of isoforms 1 and 2 is seen in the small intestine, weaker expression in brain and colon, and trace expression is found in liver, pancreas, spleen, thymus, stomach, salivary gland, appendix and trachea. Isoform 1 is always the most abundant. Isoform 1 is exclusively expressed at low levels in kidney and testis. Isoform 2 is exclusively expressed at high levels in the skin. {ECO:0000269|PubMed:10051399, ECO:0000269|PubMed:9736769}.	GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0140683		9445480; 10051399; 9736769; 15489334; 19122663; 24334705; 9758627; 11410842; 12406339; 16959974; 24961381	
O43597	SPY2_HUMAN	Protein sprouty homolog 2, Spry-2	SPRY2	315	9606			3D-structure;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Developmental protein;Disease variant;Membrane;Microtubule;Reference proteome	P29972; Q8WXE1; Q8NEC5; P22681; Q9H2X0; P07510-2; Q02930-3; O60573; Q9NVQ4; O43559; Q9Y223; P14770; O75791; P62993; P28799; Q96MH2; Q9H2F3; P60412; P60370; P60410; P60411; Q9BYQ6; Q9BQ66; Q9BYR0; Q6L8G9; P26371; Q9BYQ4; Q9BYQ2; Q14847; Q5T7P3; Q5TA82; Q5T5A8; Q5T5B0; Q5TA78; Q17RB8; O60336; Q99750; P50222; Q9UJV3-2; Q6P2C6; O43639; P32242; Q9UKS6; O43741; P43115-12; Q06455-4; Q96B97; Q9NUL5; O43609; O75716; Q9Y4C2; Q86UY0; P57075; Q8TF42; Q9Y2K6; Q8IUH5; Q8TAU3; Q96SQ5; Q5JPT6		GO:0000132; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007605; GO:0008285; GO:0010628; GO:0010719; GO:0010801; GO:0015629; GO:0015630; GO:0016020; GO:0016525; GO:0019901; GO:0030291; GO:0030335; GO:0030512; GO:0031345; GO:0031397; GO:0032587; GO:0033138; GO:0034260; GO:0035924; GO:0040037; GO:0042472; GO:0043066; GO:0043407; GO:0043539; GO:0045165; GO:0046580; GO:0048513; GO:0051387; GO:0051897; GO:0060437; GO:0060449; GO:0070373; GO:0070374; GO:1900747; GO:1902747; GO:1990752; GO:1990830	PTM: Cleaved at Pro-144 by the prolyl endopeptidase FAP (seprase) activity (in vitro). {ECO:0000269|PubMed:21288888}.	9458049; 14702039; 17974005; 15057823; 15489334; 10887178; 16877379; 12717443; 17974561; 19690332; 21288888; 23186163; 29408807; 25782674	Sprouty family
O43598	DNPH1_HUMAN	2'-deoxynucleoside 5'-phosphate N-hydrolase 1, EC 3.2.2.- (c-Myc-responsive protein RCL)	DNPH1 C6orf108 RCL	174	9606		3.2.2.-	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Glycosidase;Hydrolase;Nucleotide metabolism;Nucleus;Phosphoprotein;Reference proteome	Q96D03; O43598; Q92993; Q8TAP4-4; P17252; Q15047-2; P54274; P61981	TISSUE SPECIFICITY: Expressed at low levels in brain, colon, lung, peripheral blood leukocytes, placenta, small intestine, and thymus. Expressed at high levels in heart, kidney, liver, skeletal muscle and spleen. Overexpressed in a significant proportion of breast cancers. {ECO:0000269|PubMed:18726892}.	GO:0005634; GO:0005829; GO:0006195; GO:0009116; GO:0009159; GO:0030307; GO:0030855; GO:0042802; GO:0042803; GO:0070062; GO:0070694		9271375; 18726892; 14574404; 15489334; 17081983; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24260472; 24275569; 25944712; 25108359	2'-deoxynucleoside 5'-phosphate N-hydrolase 1 family
O43602	DCX_HUMAN	Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X, Lis-X)	DCX DBCN LISX	365	9606			3D-structure;Alternative splicing;Cell projection;Chromosomal rearrangement;Cytoplasm;Developmental protein;Differentiation;Disease variant;Epilepsy;Lissencephaly;Microtubule;Neurogenesis;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	Q13137; Q08379; Q13422; Q9BVG8; Q6A162; P60410; P50221; Q9UJV3-2; Q6NUQ1; Q96R06; Q9BSI4; P36406; P14373; O15062; Q8TD16-2; A1L4K1; Q08379; Q96ED9-2; Q13422-7; P45984; P50221; Q6FHY5; Q9UJV3-2; Q5JR59-3; Q8N1B4; Q96DT7-3; O15062; Q9UGI0	TISSUE SPECIFICITY: Highly expressed in neuronal cells of fetal brain (in the majority of cells of the cortical plate, intermediate zone and ventricular zone), but not expressed in other fetal tissues. In the adult, highly expressed in the brain frontal lobe, but very low expression in other regions of brain, and not detected in heart, placenta, lung, liver, skeletal muscles, kidney and pancreas.	GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0005930; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035082; GO:0035556; GO:0042461; GO:0043005; GO:0060041	PTM: Phosphorylation by MARK1, MARK2 and PKA regulates its ability to bind microtubules (By similarity). Phosphorylation at Ser-265 and Ser-297 seems to occur only in neonatal brain, the levels falling precipitously by postnatal day 21 (By similarity). {ECO:0000250|UniProtKB:O88809, ECO:0000250|UniProtKB:Q9ESI7}.; PTM: Ubiquitinated by MDM2, leading to its degradation by the proteasome. Ubiquitinated by MDM2 and subsequent degradation leads to reduce the dendritic spine density of olfactory bulb granule cells. {ECO:0000250|UniProtKB:O88809}.	9489699; 9489700; 15772651; 15489334; 17081983; 22359282; 24607389; 12692530; 9668176; 9817918; 9618162; 9989615; 10369164; 10441340; 10807542; 11601509; 11175293; 11468322; 12390976; 12027577; 12552055; 27292316	
O43603	GALR2_HUMAN	Galanin receptor type 2, GAL2-R, GALR-2	GALR2 GALNR2	387	9606			Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	PRO_0000010449 [P22466]	TISSUE SPECIFICITY: Expressed abundantly within the central nervous system in both hypothalamus and hippocampus. In peripheral tissues, the strongest expression was observed in heart, kidney, liver, and small intestine.	GO:0004966; GO:0005886; GO:0005887; GO:0005929; GO:0006936; GO:0007166; GO:0007188; GO:0007189; GO:0007194; GO:0007200; GO:0007204; GO:0007218; GO:0007275; GO:0007611; GO:0007631; GO:0008528; GO:0016021; GO:0017046; GO:0031175; GO:0042923; GO:0043647; GO:0045944; GO:0046488; GO:0090663; GO:1902608		9480833; 9880084; 9685625; 9832121; 15489334; 24517231; 25691535	G-protein coupled receptor 1 family
O43609	SPY1_HUMAN	Protein sprouty homolog 1, Spry-1	SPRY1	319	9606			Acetylation;Cytoplasm;Developmental protein;Membrane;Reference proteome	O43184-4; Q6UY14-3; X5D778; Q2TAC2-2; Q86X02; Q9H2X0; Q02930-3; A8MQ03; O95363; P23142-4; Q5TD97; P57678; Q9Y223-2; Q96NT3-2; Q96MH2; P49639; O75031; Q0VD86; Q5T749; Q15323; Q07627; Q8IUG1; P60412; P60370; P60409; P60410; P60411; Q8IUC1; P59991; P60328; Q9BYR7; Q9BQ66; Q9BYR5; P26371; Q9BYQ4; Q9BYQ3; Q5T7P2; Q5T7P3; Q5T751; Q5T752; Q5T754; Q5TA79; Q5TA81; Q5TA82; Q5TA76; Q5T5A8; Q9BYE3; Q5TA78; Q5TCM9; Q8IYB1; Q99750; P50222; Q6FHY5; Q7Z3S9; P0DPK4; Q9P121-3; P32242; Q92824-2; O15160; P54646; O43741; Q9Y2K5-2; Q04864-2; P49901; O43597; Q7Z6R9; Q96PF1; P57075-2; Q2TAL6; P17027; Q9Y3S2; Q8TAU3; Q8N8Z8; Q96EG3; P09022		GO:0000132; GO:0001656; GO:0001657; GO:0001759; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0008285; GO:0010719; GO:0030512; GO:0034260; GO:0040037; GO:0043407; GO:0046580; GO:0048513; GO:0051387; GO:0060449; GO:0060940; GO:0070373; GO:1902747		14533010; 15489334; 9458049; 22223895	Sprouty family
O43610	SPY3_HUMAN	Protein sprouty homolog 3, Spry-3 (Sprouty RTK signaling antagonist 3) (Sprouty3)	SPRY3	288	9606			Cytoplasm;Neurogenesis;Reference proteome	P29972; Q9BXY8; Q8NEC5; Q9H2X0; Q02930-3; Q9Y223-2; Q9Y4H4; P49639; O43593; Q5T749; O76011; Q5T7P2; Q5T7P3; Q5T754; O14633; Q5TA76; Q9BYE3; Q5T5B0; O60336; Q6FHY5; Q9HC98-4; Q9Y2K5; Q92504; P62760; Q8IUH5; Q96SQ5; Q8N720	TISSUE SPECIFICITY: Widely expressed; particularly in the fetal tissues. Expressed in the brain with expression the highest in Purkinje cells in the cerebellum (at protein level) (PubMed:26089202). Expressed in the myocardium of the heart (PubMed:30878395). {ECO:0000269|PubMed:26089202, ECO:0000269|PubMed:30878395}.	GO:0005829; GO:0016020; GO:0040037; GO:0043407; GO:0043409; GO:0046580; GO:0048513; GO:0061564; GO:0070373; GO:0150013		10655549; 14702039; 15772651; 15489334; 9458049; 17974561; 26089202; 29293652; 30878395	Sprouty family
O43612	OREX_HUMAN	Orexin (Hypocretin, Hcrt) [Cleaved into: Orexin-A (Hypocretin-1, Hcrt1); Orexin-B (Hypocretin-2, Hcrt2) ]	HCRT OX PPORX PPOX	131	9606			3D-structure;Amidation;Cell junction;Cleavage on pair of basic residues;Cytoplasmic vesicle;Disease variant;Disulfide bond;Endoplasmic reticulum;Neuropeptide;Pyrrolidone carboxylic acid;Reference proteome;Signal;Synapse		TISSUE SPECIFICITY: Abundantly expressed in subthalamic nucleus but undetectable in other brain regions tested (hypothalamus was not tested) and in heart, placenta, lung, liver, skeletal muscle, kidney and pancreas.	GO:0001659; GO:0005184; GO:0005576; GO:0005791; GO:0007200; GO:0007204; GO:0007205; GO:0007218; GO:0007268; GO:0008021; GO:0008156; GO:0030141; GO:0030431; GO:0031771; GO:0031772; GO:0042594; GO:0042755; GO:0043267; GO:0046928; GO:0048471; GO:0051928; GO:0051970; GO:0051971; GO:0060079; GO:0098794; GO:0120162	PTM: Specific enzymatic cleavages at paired basic residues yield the different active peptides.	9491897; 10364220; 10583376; 11340621; 11283317; 15479620; 14769912; 16429482; 10973318	Orexin family
O43613	OX1R_HUMAN	Orexin/Hypocretin receptor type 1 (Hypocretin receptor type 1) (Orexin receptor type 1, Ox-1-R, Ox1-R, Ox1R)	HCRTR1	425	9606			3D-structure;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix			GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0007268; GO:0007631; GO:0016499; GO:0017046; GO:0045202; GO:0051480; GO:0070374		9491897; 10973318; 11723285; 14702039; 16710414; 15489334; 11340621; 11283317; 26950369	G-protein coupled receptor 1 family
O43614	OX2R_HUMAN	Orexin receptor type 2, Ox-2-R, Ox2-R, Ox2R (Hypocretin receptor type 2)	HCRTR2	444	9606			3D-structure;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	P62937		GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0040011; GO:0045202; GO:0051480		9491897; 11723285; 14574404; 11340621; 11283317; 26950369; 25533960	G-protein coupled receptor 1 family
O43615	TIM44_HUMAN	Mitochondrial import inner membrane translocase subunit TIM44	TIMM44 MIMT44 TIM44	452	9606			3D-structure;ATP-binding;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleotide-binding;Phosphoprotein;Protein transport;Reference proteome;Transit peptide;Translocation;Transport	P10398; Q2TAC2-2; Q96DZ9; Q96DZ9-2; Q01658; Q00403; Q9Y5Q9; O95562; P57075-2		GO:0001650; GO:0005524; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0006626; GO:0006886; GO:0030150; GO:0051087		10339406; 14702039; 15489334; 21269460; 21406692; 23186163; 25944712; 18084070	Tim44 family
O43617	TPPC3_HUMAN	Trafficking protein particle complex subunit 3 (BET3 homolog)	TRAPPC3 BET3 CDABP0066	180	9606			3D-structure;Alternative splicing;Endoplasmic reticulum;ER-Golgi transport;Golgi apparatus;Lipoprotein;Palmitate;Reference proteome;Transport	Q9H8W4; Q9Y5R8; A5PLN9; P0DI81-3; Q9UL33; Q9UL33-2; Q8IUR0; O75865; O75865-2; Q86SZ2; Q9Y2L5		GO:0000139; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0033106; GO:0048208; GO:0099022; GO:1990071; GO:1990072		9564032; 14702039; 16710414; 15489334; 11805826; 19416478; 21269460; 21525244; 24275569; 25944712; 15692564; 16262728; 16828797	TRAPP small subunits family, BET3 subfamily
O43623	SNAI2_HUMAN	Zinc finger protein SNAI2 (Neural crest transcription factor Slug) (Protein snail homolog 2)	SNAI2 SLUG SLUGH	268	9606			Cytoplasm;Deafness;Developmental protein;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Waardenburg syndrome;Zinc;Zinc-finger	Q9NPB3; P68400; P21673; P36406; P36508	TISSUE SPECIFICITY: Expressed in most adult human tissues, including spleen, thymus, prostate, testis, ovary, small intestine, colon, heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Not detected in peripheral blood leukocyte. Expressed in the dermis and in all layers of the epidermis, with high levels of expression in the basal layers (at protein level). Expressed in osteoblasts (at protein level). Expressed in mesenchymal stem cells (at protein level). Expressed in breast tumor cells (at protein level). {ECO:0000269|PubMed:10866665, ECO:0000269|PubMed:16707493, ECO:0000269|PubMed:19756381, ECO:0000269|PubMed:21182836}.	GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001649; GO:0001837; GO:0003180; GO:0003198; GO:0003273; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006933; GO:0007219; GO:0007605; GO:0010839; GO:0010957; GO:0014032; GO:0030335; GO:0032331; GO:0032642; GO:0033629; GO:0035066; GO:0035921; GO:0043473; GO:0043518; GO:0043565; GO:0045600; GO:0045667; GO:0046872; GO:0050872; GO:0060021; GO:0060429; GO:0060536; GO:0060693; GO:0061314; GO:0070563; GO:0070888; GO:0071364; GO:0071479; GO:0090090; GO:1902230; GO:1990837; GO:2000647; GO:2000810; GO:2000811; GO:2001240	PTM: GSK3B-mediated phosphorylation results in cytoplasmic localization and degradation. {ECO:0000269|PubMed:22727060}.	10866665; 9721220; 10479723; 14702039; 15489334; 11912130; 12444107; 12955764; 15734731; 16707493; 19756381; 19386897; 21182836; 22727060; 25893292	Snail C2H2-type zinc-finger protein family
O43633	CHM2A_HUMAN	Charged multivesicular body protein 2a (Chromatin-modifying protein 2a, CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1, Vps2-1, hVps2-1)	CHMP2A BC2 CHMP2	222	9606			Acetylation;Coiled coil;Direct protein sequencing;Endosome;Host-virus interaction;Membrane;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transport;Ubl conjugation	Q9Y3E7; Q9Y3E7-1; Q9H444; Q8NF50-2; P42858; Q8WV92; Q9UN37		GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005635; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0010324; GO:0010458; GO:0010824; GO:0015031; GO:0016020; GO:0016236; GO:0019076; GO:0019904; GO:0030117; GO:0030496; GO:0031210; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0043162; GO:0045184; GO:0045324; GO:0046761; GO:0051258; GO:0051260; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1903543; GO:1903723; GO:1904903; GO:1904930	PTM: ISGylated in a CHMP5-dependent manner. Isgylation weakens and inhibits its interactions with VPS4A and VTA1 respectively. {ECO:0000269|PubMed:21543490}.	16533400; 14702039; 15489334; 12665801; 11559748; 14505570; 14519844; 16730941; 17853893; 17547705; 18385515; 18687924; 21269460; 21543490; 21310966; 23186163; 24275569; 26040712; 28242692	SNF7 family
O43639	NCK2_HUMAN	Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2, Nck-2) (SH2/SH3 adaptor protein NCK-beta)	NCK2 GRB4	380	9606			3D-structure;Acetylation;Cytoplasm;Endoplasmic reticulum;Phosphoprotein;Reference proteome;Repeat;SH2 domain;SH3 domain;Translation regulation	Q9NYB9; Q9NYB9-2; Q9P2A4; Q3KP44; Q7Z6G8-3; A7KAX9; P56945; Q9H165-2; P62324; Q53FE4; Q8N350-4; Q13191; Q96HB5; P07766; P15882; P52757; Q99828; Q9C0C6; Q6ZS10; Q16630-2; Q8N684; Q8N684-3; Q9NWM3; Q08345; Q8NES8; Q9NRI5-2; Q9Y2H0-1; Q14919; Q8N9I9; Q86TH3; Q5JST6; P52799; O15372; Q6IB98; P04626; P21860; Q86V42; B7ZLH0; A0A0C4DGW7; Q9NYF3; Q86UY5; P48023; Q6PCT2-2; Q96LA5; P53539; O15117; Q13480; Q9H706; Q86UU5; Q8IX15-3; P49639; P09017; Q86TF7; P13378; O75031; Q0VD86; Q9H0H0; Q8N5Z5; Q6ZU52; P10721; Q6TFL4; Q6PF15; Q5T749; Q13094; P48059; Q8TBB1; A6PVS8; Q9BRK4; P43360; Q96DN6; P50222; Q6FHY5; P08581; Q5JRA6; Q99583; Q86VE0; Q9NZQ3-3; Q9H3P2; Q7Z628; Q8NI38; Q5HYW2; Q99743; Q13285; O60422; Q13153; Q13177; Q9BYU1; Q8N4B1-4; Q6ZUJ8-3; Q9NQX0; Q569H4; P86479; P86480; O75832; Q02833; Q8NC74; Q5T8P6; Q9H6H4; Q04864; Q04864-2; Q7L0Q8; Q96L33; Q9NQC3; Q9UQR0; Q7RTU7; Q15637-4; Q15428; Q15427; Q96IW2; Q13573; O14512; O94875; Q8IUW3; Q9H0A9-2; O43597; Q9H3Y6; Q8TE77; Q96PV0; P15884; Q8TDR4; Q9BTD3; A1L306; P14373; Q8WV44; Q15654; P42681; P0CG48; Q8NFA0-2; Q5ST30; Q5ST30-4; Q9H9H4; P42768; Q92558; O00401; O43516-4; Q9Y330; B2RXF5; O15156; O15156-2; Q96GY0; Q5TFG8; Q9BYN7; Q8TF50; P0C7X2; Q7VLE8	TISSUE SPECIFICITY: Ubiquitous.	GO:0001771; GO:0001784; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0007165; GO:0007172; GO:0007173; GO:0007176; GO:0008093; GO:0008285; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030159; GO:0030838; GO:0030971; GO:0033137; GO:0035591; GO:0036493; GO:0042102; GO:0042110; GO:0044877; GO:0045944; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898; GO:1903912; GO:1990441	PTM: Phosphorylated. {ECO:0000269|PubMed:10026169}.	9737977; 9843575; 15489334; 10026169; 10330411; 11240126; 12470648; 16337946; 16835242; 18088087; 19807924; 19690332; 21406692; 22223895; 23186163	
O43653	PSCA_HUMAN	Prostate stem cell antigen	PSCA UNQ206/PRO232	114	9606			Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;GPI-anchor;Lipoprotein;Membrane;Reference proteome;Signal		TISSUE SPECIFICITY: Highly expressed in prostate (basal, secretory and neuroendocrine epithelium cells). Also found in bladder (transitional epithelium), placenta (trophoblasts), stomach (neuroendocrine cells), colon (neuroendocrine cells) and kidney (collecting ducts). Overexpressed in prostate cancers and expression is correlated with tumor stage, grade and androgen-independence. Highly expressed in prostate cancer bone metastases. Expressed in gastric epithelial cells, mainly in the isthmus (at protein level). Not detected in normal intestinal epithelium (at protein level). Expressed in brain cortex; expression is significantly increased in the front cortex of Alzheimer disease patients. {ECO:0000269|PubMed:10713670, ECO:0000269|PubMed:18488030, ECO:0000269|PubMed:25680266}.	GO:0005576; GO:0005886; GO:0031225; GO:0033130; GO:0070062; GO:0070373; GO:0099601	PTM: N-glycosylated. {ECO:0000269|PubMed:9465086}.	9465086; 10973799; 16421571; 12975309; 15489334; 15340161; 10713670; 18488030; 19648920; 25680266	
O43660	PLRG1_HUMAN	Pleiotropic regulator 1	PLRG1	514	9606			3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;WD repeat	O75934; Q99459; P52272; P54253		GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:1900087		9765207; 14702039; 15489334; 11101529; 11544257; 12176931; 19413330; 20176811; 23022480; 23186163; 28502770; 28076346	WD repeat PRL1/PRL2 family
O43663	PRC1_HUMAN	Protein regulator of cytokinesis 1	PRC1	620	9606			3D-structure;Alternative splicing;Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Nucleus;Oncogene;Phosphoprotein;Reference proteome	Q9BW66; P31153; P61925; O94972; O43663-1	TISSUE SPECIFICITY: Overexpressed in bladder cancer cells (PubMed:17409436). {ECO:0000269|PubMed:17409436}.	GO:0000022; GO:0000226; GO:0000922; GO:0001578; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051256; GO:0051301; GO:0070938; GO:1990023	PTM: Phosphorylation by CDK1 in early mitosis holds PRC1 in an inactive monomeric state, during the metaphase to anaphase transition, PRC1 is dephosphorylated, promoting interaction with KIF4A, which then translocates PRC1 along mitotic spindles to the plus ends of antiparallel interdigitating microtubules. Dephosphorylation also promotes MT-bundling activity by allowing dimerization. Phosphorylation by CDK1 prevents PLK1-binding: upon degradation of CDK1 at anaphase and dephosphorylation, it is then phosphorylated by PLK1, leading to cytokinesis. {ECO:0000269|PubMed:17351640, ECO:0000269|PubMed:17438553, ECO:0000269|PubMed:9885575}.	9885575; 14702039; 16572171; 15489334; 17974005; 12082078; 15297875; 14744859; 15625105; 16431929; 17409436; 17438553; 17351640; 18691976; 18669648; 19369195; 19468300; 20068231; 21269460; 22814378; 23186163; 29848660; 20691902	MAP65/ASE1 family
O43665	RGS10_HUMAN	Regulator of G-protein signaling 10, RGS10	RGS10	181	9606			3D-structure;Alternative splicing;Cytoplasm;GTPase activation;Lipoprotein;Nucleus;Palmitate;Phosphoprotein;Reference proteome;Signal transduction inhibitor	Q9H8W4		GO:0001965; GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0007213; GO:0008277; GO:0009968; GO:0043547; GO:0045202		8774883; 10791963; 11443111; 14702039; 15164054; 15489334; 10608901; 9353196; 21269460; 24275569; 18434541	
O43670	ZN207_HUMAN	BUB3-interacting and GLEBS motif-containing protein ZNF207, BuGZ, hBuGZ (Zinc finger protein 207)	ZNF207 BUGZ	478	9606			Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;Cytoskeleton;DNA-binding;Kinetochore;Metal-binding;Microtubule;Mitosis;Nucleus;Reference proteome;Repeat;Zinc;Zinc-finger		TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9799612}.	GO:0000070; GO:0000776; GO:0001578; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008201; GO:0008608; GO:0046785; GO:0046872; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047		9799612; 14702039; 16625196; 15489334; 21269460; 24462186; 24462187; 26388440	
O43674	NDUB5_HUMAN	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH, CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)	NDUFB5	189	9606			3D-structure;Alternative splicing;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Reference proteome;Respiratory chain;Transit peptide;Transmembrane;Transmembrane helix;Transport	P57086		GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776		9425316; 16641997; 15489334; 12611891; 21269460; 24275569; 25944712; 27626371	Complex I NDUFB5 subunit family
O43676	NDUB3_HUMAN	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12, CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit)	NDUFB3	98	9606			3D-structure;Acetylation;Disease variant;Electron transport;Membrane;Methylation;Mitochondrion;Mitochondrion inner membrane;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transmembrane;Transmembrane helix;Transport			GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776	PTM: Methylation at His residues by METTL9 enhances complex I-mediated mitochondrial respiration. {ECO:0000269|PubMed:33563959}.	9425316; 9878551; 15815621; 15489334; 12611891; 21269460; 22499348; 25944712; 27626371; 33563959; 27091925	Complex I NDUFB3 subunit family
O43678	NDUA2_HUMAN	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8, CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit)	NDUFA2	99	9606			3D-structure;Acetylation;Alternative splicing;Disulfide bond;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transport			GO:0001835; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776		9425316; 11042152; 15372022; 15489334; 12611891; 18513682; 19413330; 21269460; 25944712; 27626371; 15341729; 16959974	Complex I NDUFA2 subunit family
O43679	LDB2_HUMAN	LIM domain-binding protein 2, LDB-2 (Carboxyl-terminal LIM domain-binding protein 1, CLIM-1) (LIM domain-binding factor CLIM1)	LDB2 CLIM1	373	9606			Alternative splicing;Nucleus;Reference proteome;Ubl conjugation	Q9NWQ9; O15182; Q9BY27; Q9H6Z9; Q7L775; Q86VI1; Q9BVM4; Q8WUI4-6; Q68G74; P25800; P25791-3; Q8TAP4-4; P61968; Q8TBB1; Q969H8; Q96HA8; P20618; O00560; Q96GM5; Q9BWW4; Q99598; Q6DKK2		GO:0000122; GO:0001942; GO:0003712; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005886; GO:0007399; GO:0010669; GO:0019899; GO:0030274; GO:0030334; GO:0031252; GO:0035019; GO:0043549; GO:0044089; GO:0045944	PTM: Ubiquitinated by RLIM/RNF12, leading to its degradation by the proteasome. {ECO:0000250|UniProtKB:O55203}.	9799849; 9853615; 15489334; 16815859; 21406692	LDB family
O43680	TCF21_HUMAN	Transcription factor 21, TCF-21 (Capsulin) (Class A basic helix-loop-helix protein 23, bHLHa23) (Epicardin) (Podocyte-expressed 1, Pod-1)	TCF21 BHLHA23 POD1	179	9606			DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation	P05067; P15172; O00560; Q99081-3		GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001657; GO:0001658; GO:0001763; GO:0001822; GO:0001944; GO:0005634; GO:0005667; GO:0006357; GO:0007530; GO:0014707; GO:0030855; GO:0032502; GO:0032835; GO:0042826; GO:0043425; GO:0045944; GO:0046983; GO:0048286; GO:0048536; GO:0048557; GO:0048608; GO:0048732; GO:0050681; GO:0060008; GO:0060021; GO:0060425; GO:0060426; GO:0060435; GO:0060539; GO:0060541; GO:0060766; GO:0070888; GO:0072162; GO:0072277; GO:1990837		9733105; 10572052; 14574404; 15489334	
O43681	GET3_HUMAN	ATPase GET3, EC 3.6.-.- (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I)	GET3 ARSA ASNA1 TRC40	348	9606		3.6.-.-	3D-structure;Acetylation;ATP-binding;Cytoplasm;Endoplasmic reticulum;Hydrolase;Metal-binding;Nucleotide-binding;Nucleus;Reference proteome;Transport;Zinc	O95994; Q12797; Q12797-6; P49069; Q8TEY5; O95196-2; Q96D03; Q7Z589-5; Q96GL9; Q5JX71; Q9Y680; Q7L5D6; Q8NBJ4; Q96SL4; Q8TED1; Q9Y5L2; P24592; Q8WWG9; Q9UJ90; O15165-2; Q15084; O75381; O00264; O15173; Q04118; Q16378; Q15293; Q6ZWK4; Q96E16; P10451; Q8WWF3; Q5VXT5-2; Q6P9G4; Q9NW97; Q9H3N1; Q2TAL6; Q8IUB2; Q56975	TISSUE SPECIFICITY: Expressed in the epithelial cells of the liver, kidney, and stomach wall, in the adrenal medulla, in the islet cells of the pancreas, in the red pulp of the spleen, and in cardiac and skeletal muscle. {ECO:0000269|PubMed:9774623}.	GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0006620; GO:0015105; GO:0016887; GO:0043529; GO:0045048; GO:0046872; GO:0070062; GO:0071816		14702039; 15057824; 15489334; 8884272; 9712828; 9736449; 9774623; 17382883; 18477612; 19413330; 21269460; 21444755; 23041287; 24275569; 24392163; 25535373; 32910895	ArsA ATPase family
O43683	BUB1_HUMAN	Mitotic checkpoint serine/threonine-protein kinase BUB1, hBUB1, EC 2.7.11.1 (BUB1A)	BUB1 BUB1L	1085	9606		2.7.11.1	3D-structure;Alternative splicing;Apoptosis;ATP-binding;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Host-virus interaction;Kinase;Kinetochore;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	O95376; O60566; O43684; P46108; Q8NG31; Q8NG31-2; P03070	TISSUE SPECIFICITY: High expression in testis and thymus, less in colon, spleen, lung and small intestine. Expressed in fetal thymus, bone marrow, heart, liver, spleen and thymus. Expression is associated with cells/tissues with a high mitotic index.	GO:0000776; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005654; GO:0005829; GO:0006915; GO:0007063; GO:0007094; GO:0008283; GO:0016020; GO:0043231; GO:0051301; GO:0051754; GO:0051983; GO:0106310	PTM: Upon spindle-assembly checkpoint activation it is hyperphosphorylated and its kinase activity toward CDC20 is stimulated. Phosphorylation at Thr-609 is required for interaction with PLK1, phosphorylation at this site probably creates a binding site for the POLO-box domain of PLK1, thus enhancing the PLK1-BUB1 interaction. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:15525512, ECO:0000269|PubMed:16760428}.; PTM: Ubiquitinated and degraded during mitotic exit by APC/C-Cdh1. {ECO:0000269|PubMed:17158872}.	9521327; 9790499; 9660858; 10198256; 10366450; 15815621; 15489334; 9441741; 15020684; 15525512; 15723797; 16760428; 17981135; 17158872; 17525332; 18691976; 18669648; 19413330; 18922873; 19487456; 19369195; 19690332; 20739936; 20068231; 21269460; 21406692; 23186163; 26223641; 12655561; 17344846	Protein kinase superfamily, Ser/Thr protein kinase family, BUB1 subfamily
O43684	BUB3_HUMAN	Mitotic checkpoint protein BUB3	BUB3	328	9606			Acetylation;ADP-ribosylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Isopeptide bond;Kinetochore;Meiosis;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat	P54253; O43683; O60566; O43586; Q5XI90; A0A0H3NF38		GO:0000070; GO:0000776; GO:0005654; GO:0005829; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051444; GO:1990298	PTM: Poly-ADP-ribosylated by PARP1. {ECO:0000250}.	10198256; 9660858; 14702039; 15164054; 15489334; 15525512; 18199686; 18669648; 19608861; 21269460; 23186163; 24462186; 24462187	WD repeat BUB3 family
O43687	AKA7A_HUMAN	A-kinase anchor protein 7 isoforms alpha and beta, AKAP-7 isoforms alpha and beta (A-kinase anchor protein 18 kDa, AKAP 18) (Protein kinase A-anchoring protein 7 isoforms alpha/beta, PRKA7 isoforms alpha/beta)	AKAP7 AKAP15 AKAP18	104	9606			Alternative splicing;Cell membrane;Lipoprotein;Membrane;Myristate;Palmitate;Reference proteome	Q8TAP6; P10644; P31321; P13861-2; P31323; Q6DHZ2; Q9HAT0; Q96C74; Q15506	TISSUE SPECIFICITY: Expressed in brain, heart, lung, pancreas and skeletal muscle. {ECO:0000269|PubMed:9545239}.	GO:0001508; GO:0005886; GO:0006811; GO:0008104; GO:0016324; GO:0016328; GO:0035556; GO:0051018; GO:0060306; GO:0071320; GO:1901381; GO:1902261		9545239; 10613906; 14702039; 14574404; 15489334; 17244820; 24275569	
O43688	PLPP2_HUMAN	Phospholipid phosphatase 2, EC 3.1.3.-, EC 3.1.3.4 (Lipid phosphate phosphohydrolase 2) (PAP2-gamma, PAP2-G) (Phosphatidate phosphohydrolase type 2c) (Phosphatidic acid phosphatase 2c, PAP-2c, PAP2c)	PLPP2 LPP2 PPAP2C	288	9606	PATHWAY: Lipid metabolism; phospholipid metabolism. {ECO:0000269|PubMed:16467304, ECO:0000269|PubMed:9607309, ECO:0000269|PubMed:9705349}.	3.1.3.-; 3.1.3.4	Alternative splicing;Cell membrane;Endoplasmic reticulum;Endosome;Glycoprotein;Hydrolase;Lipid metabolism;Membrane;Reference proteome;Transmembrane;Transmembrane helix	P41235-3; Q8N5M9; Q7Z3S9; P42857; Q8N609; Q6UX27-3	TISSUE SPECIFICITY: Found mainly in brain, pancreas and placenta. {ECO:0000269|PubMed:9607309}.	GO:0005769; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005901; GO:0006644; GO:0006670; GO:0006672; GO:0007165; GO:0008195; GO:0016021; GO:0030148; GO:0031901; GO:0042392; GO:0042577; GO:0046839; GO:0106235	PTM: N-glycosylated. {ECO:0000269|PubMed:9705349}.	9570154; 9705349; 9607309; 15057824; 15489334; 16467304; 18215144	PA-phosphatase related phosphoesterase family
O43699	SIGL6_HUMAN	Sialic acid-binding Ig-like lectin 6, Siglec-6 (CD33 antigen-like 1) (CDw327) (Obesity-binding protein 1, OB-BP1) (CD antigen CD327)	SIGLEC6 CD33L CD33L1 OBBP1	453	9606			Alternative splicing;Cell adhesion;Cell membrane;Disulfide bond;Glycoprotein;Immunoglobulin domain;Lectin;Membrane;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix	Q14192; P15884; Q13021; P26367; O00206; Q8N720	TISSUE SPECIFICITY: Expressed at high levels in placenta (cyto- and syncytiotrophoblastic cells) and at lower levels in spleen, peripheral blood leukocytes (predominantly B-cells) and small intestine.	GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0007267; GO:0016020; GO:0030246; GO:0033691		9465907; 14702039; 15057824; 15489334; 10428856	Immunoglobulin superfamily, SIGLEC (sialic acid binding Ig-like lectin) family
O43704	ST1B1_HUMAN	Sulfotransferase 1B1, ST1B1, EC 2.8.2.1 (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase)	SULT1B1 ST1B2 SULT1B2	296	9606		2.8.2.1	3D-structure;Cytoplasm;Reference proteome;Transferase	Q9NUX5; O00560; Q06520; O00204; P26639; P31930; P61758	TISSUE SPECIFICITY: Highly expressed in the liver, peripheral blood leukocytes, colon (mucosal lining), small intestine (jejunum) and spleen. A lesser expression was observed in the lung, placenta and thymus. {ECO:0000269|PubMed:9463486}.	GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923		9443824; 9463486; 15489334; 35165440; 28084139; 16804942	Sulfotransferase 1 family
O43707	ACTN4_HUMAN	Alpha-actinin-4 (Non-muscle alpha-actinin 4)	ACTN4	911	9606			3D-structure;Acetylation;Actin-binding;Alternative splicing;Calcium;Cell junction;Cytoplasm;Cytoskeleton;Disease variant;Metal-binding;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	Q08043; A8K571; Q9NWQ9; P35222; P46940; O60294; Q8TBB1; P50222; Q8IY33; Q9NPC6; O00151; O94875-10; Q07157; B2R8Y4; P03466; Q5L4H4; P10276	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9508771}.	GO:0000977; GO:0001666; GO:0001725; GO:0001882; GO:0003713; GO:0003723; GO:0003779; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0015031; GO:0016604; GO:0016922; GO:0030018; GO:0030036; GO:0030050; GO:0030054; GO:0030335; GO:0030374; GO:0030864; GO:0031093; GO:0031143; GO:0031490; GO:0032417; GO:0032991; GO:0033209; GO:0035357; GO:0042803; GO:0042974; GO:0042981; GO:0042995; GO:0043005; GO:0044325; GO:0047485; GO:0048384; GO:0048471; GO:0051015; GO:0051272; GO:0055001; GO:0070062; GO:1900025; GO:1901224; GO:1903506; GO:1990904		10656685; 22567897; 15057824; 15489334; 17974005; 16344560; 9508771; 12042308; 15772161; 17289661; 19608861; 21269460; 24275569; 25944712; 33228246; 15988023; 18164029; 22351778; 10700177; 18436095; 22732337; 23890478; 23014460	Alpha-actinin family
O43708	MAAI_HUMAN	Maleylacetoacetate isomerase, MAAI, EC 5.2.1.2 (GSTZ1-1) (Glutathione S-transferase zeta 1, EC 2.5.1.18)	GSTZ1 MAAI	216	9606	PATHWAY: Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine: step 5/6.	2.5.1.18; 5.2.1.2	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Disease variant;Isomerase;Multifunctional enzyme;Phenylalanine catabolism;Phosphoprotein;Reference proteome;Transferase;Tyrosine catabolism	Q5SYC1; Q9H8Y8; O43708; P16333; Q58EX7; P47897; Q8WWU5-7; Q12933; Q9H0C1	TISSUE SPECIFICITY: Mostly expressed in liver followed by kidney, skeletal muscle and brain. Also expressed in melanocytes, synovium, placenta, breast and fetal liver and heart.	GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005829; GO:0006559; GO:0006572; GO:0006749; GO:0016034; GO:0042802; GO:0042803		9417084; 9396740; 9925947; 10373324; 14702039; 12508121; 15489334; 9531472; 19608861; 21269460; 22814378; 27876694; 10739172; 11327815	GST superfamily, Zeta family
O43709	BUD23_HUMAN	Probable 18S rRNA (guanine-N(7))-methyltransferase, EC 2.1.1.- (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)	BUD23 MERM1 WBSCR22 HUSSY-03 PP3381	281	9606		2.1.1.-	3D-structure;Alternative splicing;Chromatin regulator;Cytoplasm;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;rRNA processing;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Williams-Beuren syndrome	Q9UI30	TISSUE SPECIFICITY: Widely expressed, with high levels in heart, skeletal muscle and kidney. Detected at high levels in bronchial brushings and in normal lung (at protein level). In fetal lung tissue, expressed in the developing bronchial lumen lining cells (at protein level). Tends to be down-regulated in lungs affected by inflammatory diseases or neoplasia (at protein level). Expressed in immune cells, including B and T lymphocytes and macrophages. {ECO:0000269|PubMed:11978965, ECO:0000269|PubMed:12073013, ECO:0000269|PubMed:24488492}.	GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0016435; GO:0046982; GO:0048471; GO:0070476; GO:2000234	PTM: May be ubiquitinated and targeted to degradation in response to pro-inflammatory cytokine signaling. {ECO:0000305}.	11978965; 11124703; 12073013; 14702039; 15498874; 12853948; 15489334; 21269460; 23186163; 24086612; 24488492; 25851604; 34948388	Class I-like SAM-binding methyltransferase superfamily, BUD23/WBSCR22 family
O43711	TLX3_HUMAN	T-cell leukemia homeobox protein 3 (Homeobox protein Hox-11L2)	TLX3 HOX11L2	291	9606			Developmental protein;DNA-binding;Homeobox;Nucleus;Reference proteome	Q03154; Q6PJH3; Q9NXR5-2; Q7Z3H0-1; P19801; Q7Z5R6-2; Q96C12; Q8WXK4-2; P61421; Q9BPU9; Q9NP55; Q9H5F2; Q8TAV5; Q5BKX5-3; Q9NWW7; P40199; O43186; P67870; Q9UI47-2; O95967; Q7Z444; A8MTA8-2; A1KXE4-2; Q8N0W3; P49356; P53539; O75593; Q14390; A6NEM1; Q16082; Q6UWQ7-2; Q5TA45; Q6UXX5; O76011; Q8IUC1; Q3SY46; Q8IUB9; Q3SYF9; Q9BYR8; Q3LI64; Q3LI66; Q8IUC3; Q8IUC2; Q14847-2; Q9Y5V3; Q8N6F8; Q5VZ52; P35548; O14561; P0CG21; Q9BSH3; O43482; O15496; Q9HDD0; Q16633; P78424; P86480; A5LHX3; Q04864-2; Q01974; Q96LW2; P05121; Q16348; Q2TAY7; Q5T0L3; Q5W111-2; Q8IWL8; Q96PV0; Q9Y458; Q13488; Q96M29; Q96LM6; Q9BU02; Q69YG0; Q96NM4-3; Q12888; Q8IWZ5; Q6NVU6; Q9BRX9; A0A0C4DGF1; M0R160; G4XUV3; P27577		GO:0000785; GO:0000978; GO:0000981; GO:0001764; GO:0002087; GO:0005634; GO:0005654; GO:0006357; GO:0007417; GO:0007585; GO:0045665; GO:0048513; GO:0048665; GO:1990837		15489334	
O43715	TRIA1_HUMAN	TP53-regulated inhibitor of apoptosis 1 (Protein 15E1.1) (WF-1) (p53-inducible cell-survival factor, p53CSV)	TRIAP1 15E1.1 HSPC132	76	9606			3D-structure;Acetylation;Apoptosis;Coiled coil;Disulfide bond;Lipid transport;Mitochondrion;Reference proteome;Transport	P80188; Q9H8W4		GO:0002039; GO:0005654; GO:0005739; GO:0005758; GO:0006915; GO:0006977; GO:0015914; GO:0030330; GO:0032991; GO:0034644; GO:0043066; GO:0043154; GO:0045944; GO:0090201; GO:0097035; GO:0120009; GO:1902166; GO:2001140		15735003; 11042152; 14702039; 16541075; 15489334; 19413330; 21269460; 22814378; 23931759; 24275569; 26071602	TRIAP1/MDM35 family
O43716	GATC_HUMAN	Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial, Glu-AdT subunit C, EC 6.3.5.- (Protein 15E1.2)	GATC 15E1.2	136	9606		6.3.5.-	ATP-binding;Disease variant;Ligase;Mitochondrion;Nucleotide-binding;Primary mitochondrial disease;Protein biosynthesis;Reference proteome	P09917; P78358; O14964; Q9H0R6; Q05519; Q05519-2; Q6UXN7		GO:0005524; GO:0005739; GO:0006450; GO:0030956; GO:0032543; GO:0050567; GO:0070681		14702039; 16541075; 15489334; 19805282; 30283131	GatC family
O43719	HTSF1_HUMAN	HIV Tat-specific factor 1, Tat-SF1	HTATSF1	755	9606			3D-structure;Acetylation;Activator;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;RNA-binding;Transcription;Transcription regulation;Ubl conjugation	O75533-1	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:8849451}.	GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0006357; GO:0019079; GO:0032784		8849451; 15772651; 15489334; 9649438; 9765201; 9710584; 10393184; 10454543; 10913173; 11420046; 11780068; 15485897; 15905670; 17081983; 18669648; 18318008; 19413330; 19690332; 20068231; 21269460; 21406692; 22223895; 22814378; 23186163; 24275569; 28112733	HTATSF1 family
O43731	ERD23_HUMAN	ER lumen protein-retaining receptor 3 (KDEL endoplasmic reticulum protein retention receptor 3, KDEL receptor 3)	KDELR3	214	9606			Alternative splicing;Cytoplasmic vesicle;Endoplasmic reticulum;ER-Golgi transport;Golgi apparatus;Membrane;Protein transport;Receptor;Reference proteome;Transmembrane;Transmembrane helix;Transport	O60636		GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030133; GO:0030663; GO:0046923		12529303; 15461802; 14702039; 10591208; 15489334; 18086916	ERD2 family
O43734	CIKS_HUMAN	E3 ubiquitin ligase TRAF3IP2, EC 2.3.2.27 (Adapter protein CIKS) (Connection to IKK and SAPK/JNK) (E3 ubiquitin-protein ligase CIKS) (Nuclear factor NF-kappa-B activator 1, ACT1) (TRAF3-interacting protein 2)	TRAF3IP2 C6orf2 C6orf4 C6orf5 C6orf6	574	9606		2.3.2.27	Alternative splicing;Disease variant;Inflammatory response;Reference proteome;Transferase;Ubl conjugation pathway	Q96C98; Q13084; Q9UFD9; O75716; Q9Y4K3; Q15654	TISSUE SPECIFICITY: Widely expressed.	GO:0001768; GO:0001782; GO:0001783; GO:0001822; GO:0002230; GO:0002269; GO:0002334; GO:0002344; GO:0002447; GO:0005102; GO:0005634; GO:0006606; GO:0006954; GO:0006959; GO:0007507; GO:0009410; GO:0023019; GO:0023035; GO:0030217; GO:0031410; GO:0033209; GO:0035556; GO:0038173; GO:0042092; GO:0042119; GO:0043123; GO:0043588; GO:0048255; GO:0048535; GO:0048536; GO:0061630; GO:0070254; GO:0070534; GO:0072538; GO:0097400; GO:0110012; GO:1990959		10903453; 10962024; 10962033; 14702039; 17974005; 14574404; 15489334; 12459498; 19825828; 33723527; 20953186; 20953188; 24120361	
O43739	CYH3_HUMAN	Cytohesin-3 (ARF nucleotide-binding site opener 3, Protein ARNO3) (General receptor of phosphoinositides 1, Grp1) (PH, SEC7 and coiled-coil domain-containing protein 3)	CYTH3 ARNO3 GRP1 PSCD3	400	9606			3D-structure;Alternative splicing;Cell junction;Cell membrane;Coiled coil;Cytoplasm;Guanine-nucleotide releasing factor;Lipid-binding;Membrane;Reference proteome;Tight junction	Q96HB5-4; Q969H4; Q8N0S2; P53365; Q96HB5; Q969H4; P80217-2; Q8WWN9	TISSUE SPECIFICITY: Almost absent from liver, thymus and peripheral blood lymphocytes.	GO:0000139; GO:0001726; GO:0005085; GO:0005547; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0031234; GO:0032012; GO:0045785; GO:0048193; GO:0090162		9742223; 9707577; 12690205; 15489334; 10652308; 17398095; 23940353	
O43741	AAKB2_HUMAN	5'-AMP-activated protein kinase subunit beta-2, AMPK subunit beta-2	PRKAB2	272	9606			3D-structure;Alternative splicing;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Phosphoprotein;Reference proteome	Q8NFV4-4; Q6UY14-3; Q9NYG5-2; Q03989; Q9H7T9; P01185; Q8N9N5; Q8N9N5-2; Q7L4P6; Q6PI77; Q9H2G9; Q9H5F2; Q5BKX5-3; Q9NWW7; Q3SXR2; P42575; Q9BUN5-3; O60729; O14627; P27918; Q96BA8; O43186; A8MQ03; P14920; O95865; Q96D03; G5E9A7; Q7L591-3; O00472; Q9NQ30; P22607; P21333-2; P15976; P15976-2; Q8WXI9; Q5JQS6; Q7L5D6; Q08379; A6NEM1; Q9H8Y8; Q8TC17; Q14957; P28799; O15499; P06396; P04792; Q8IYA8; Q13422; Q9UKT9; Q9NZH6; Q5VVH5; Q9H079; Q7Z7F0-4; O60333-2; Q9UIH9; Q5JUW0-3; Q15323; Q6A162; Q07627; Q8IUG1; P60412; P60370; P60409; P60410; P60411; Q9BYP8; Q9BYR9; Q9BYR6; Q9BQ66; Q9BYR5; Q9BYR2; P26371; Q9BYQ4; Q9BYQ3; Q9BYQ2; Q9BYQ0; Q9UBR4-2; Q5T3J3; Q9Y250; Q9BRK4; Q9Y5V3; Q3KP22-3; P31153; Q99750; P50222; Q8N6F8; Q6PF18; Q15742; P0CG21; Q8TDS5; P18545; Q13956; Q99471; O75928; Q6ZR37; Q96KQ4; Q96I34; Q9GZV8; Q13131; P54646; P54619; Q9UGI9; O00231; P61289; P11217; Q96PU8; Q96QF0-7; Q5RL73; Q93062-3; Q04864-2; Q8TAI7; Q9UFD9; Q9Y3C5; Q01974; Q9UNE2; Q9UPU9-3; Q14140; Q12824-2; Q53HV7-2; Q7Z699; O43609; O43597; O75558; Q8N4C7; Q5VWN6-2; Q99081-3; Q9Y242; Q9NQB0-10; Q96PF1; Q08117-2; P19237; Q12933; Q96RU7; Q14142; Q9UPQ4-2; Q8IWZ5; Q9BYV2; Q969E8; Q5W5X9-3; Q9UMX0; Q5T124; Q70EL1-9; P61758; Q9UK41-2; Q9BRX9; Q53FD0-2; Q8TF47; Q96E35; Q13360-2; Q9UL36; Q6S9Z5; Q8TF50; Q9P0T4; A0A1U9X8X8; Q7Z783; Q9Y649		GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0007165; GO:0019901; GO:0031588; GO:0031669; GO:0050790; GO:0120162	PTM: Phosphorylated when associated with the catalytic subunit (PRKAA1 or PRKAA2). Phosphorylated by ULK1 and ULK2; leading to negatively regulate AMPK activity and suggesting the existence of a regulatory feedback loop between ULK1, ULK2 and AMPK. {ECO:0000269|PubMed:21460634}.	9575201; 12490143; 14702039; 16710414; 15489334; 18691976; 18669648; 18318008; 19413330; 19369195; 19690332; 20068231; 21460634; 17307971; 17712357; 21269460; 21406692; 23186163; 24275569; 17851531; 21399626	5'-AMP-activated protein kinase beta subunit family
O43745	CHP2_HUMAN	Calcineurin B homologous protein 2 (Hepatocellular carcinoma-associated antigen 520)	CHP2 HCA520	196	9606			3D-structure;Calcium;Cell membrane;Cytoplasm;Lipoprotein;Membrane;Metal-binding;Myristate;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	Q99750; P19634	TISSUE SPECIFICITY: Expressed in malignantly transformed cells but not detected in normal tissues. {ECO:0000269|PubMed:12097419, ECO:0000269|PubMed:12226101}.	GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0008284; GO:0010922; GO:0015031; GO:0042307; GO:0045944; GO:0070886; GO:0071277		12097419; 14702039; 16541075; 12226101; 18815128; 21392185; 16511206; 16710297	Calcineurin regulatory subunit family, CHP subfamily
O43747	AP1G1_HUMAN	AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1)	AP1G1 ADTG CLAPG1	822	9606			3D-structure;Alternative splicing;Cytoplasm;Cytoplasmic vesicle;Golgi apparatus;Membrane;Protein transport;Reference proteome;Transport	Q15276; Q6PD74; P56377; P54253; Q96S82	TISSUE SPECIFICITY: Widely expressed.	GO:0000139; GO:0005737; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0006896; GO:0006898; GO:0016020; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0031267; GO:0032438; GO:0032588; GO:0035615; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0048471; GO:0055037; GO:0060155; GO:0090160; GO:0110010; GO:0140312; GO:1903232		9653655; 9733768; 15616553; 17974005; 12773381; 14665628; 15775984; 15598649; 15758025; 21269460; 24275569; 25944712; 12042876	Adaptor complexes large subunit family
O43749	OR1F1_HUMAN	Olfactory receptor 1F1 (Olfactory receptor 16-35, OR16-35) (Olfactory receptor 1F10) (Olfactory receptor 1F4) (Olfactory receptor 1F5) (Olfactory receptor 1F6) (Olfactory receptor 1F7) (Olfactory receptor 1F8) (Olfactory receptor 1F9) (Olfactory receptor OR16-4)	OR1F1 OLFMF OR1F10 OR1F4 OR1F5 OR1F6 OR1F7 OR1F8 OR1F9	312	9606			Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Olfaction;Receptor;Reference proteome;Sensory transduction;Transducer;Transmembrane;Transmembrane helix			GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021		9288094; 9653642; 15489334; 9500546; 12213199; 14983052	G-protein coupled receptor 1 family
O43752	STX6_HUMAN	Syntaxin-6	STX6	255	9606			3D-structure;Acetylation;Alternative splicing;Coiled coil;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	P05067; Q13520; Q8IUR7-6; Q15125; P00533; Q96KR6; O14653; Q9H400; Q6FHY5; Q8N4V1; Q49AM1; Q9H2K0; Q9H115; P25788; Q9NY72; O95721; P27105; Q16623; P32856-2; Q12846; Q9NPL8; Q9NUH8; Q6UW68; Q8N661; Q9P0T7; O75379; Q9UID3-1		GO:0000139; GO:0000149; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0016189; GO:0019905; GO:0030136; GO:0030285; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048278; GO:0048471; GO:0090161		10080545; 14702039; 16710414; 15489334; 11384996; 19690332; 20068231; 20163565; 23186163; 23818989; 25944712; 28626000; 17159904	Syntaxin family
O43759	SNG1_HUMAN	Synaptogyrin-1	SYNGR1	233	9606			Acetylation;Alternative splicing;Cell junction;Cytoplasmic vesicle;Membrane;Reference proteome;Synapse;Transmembrane;Transmembrane helix	Q969F0; P29274; Q13520; O43889-2; Q96BA8; Q15125; Q08426; Q9Y282; Q5JX71; Q969F0; O15529; O00219-2; O15243; Q96E29; Q9HB07; Q9ULP0-2; Q96CS7; O60664; Q96T60; Q86VR2; O00560; Q3KNW5; Q13596; Q9NZD8; Q6ZMD2-2; Q9NUH8; Q96B21; Q96HE8; Q86WB7-2		GO:0005886; GO:0006605; GO:0016021; GO:0030285; GO:0030672; GO:0031594; GO:0035577; GO:0042470; GO:0045055; GO:0048169; GO:0048172; GO:0048499; GO:1990830		9760194; 15461802; 14702039; 10591208; 15489334; 17081065; 19413330; 17049558	Synaptogyrin family
O43760	SNG2_HUMAN	Synaptogyrin-2 (Cellugyrin)	SYNGR2 UNQ352/PRO615	224	9606			Acetylation;Alternative splicing;Cell junction;Cytoplasmic vesicle;Direct protein sequencing;Host-virus interaction;Lipid droplet;Membrane;Phosphoprotein;Reference proteome;Synapse;Transmembrane;Transmembrane helix	Q6AZY7	TISSUE SPECIFICITY: Ubiquitous; low expression in brain. {ECO:0000269|PubMed:9760194}.	GO:0005811; GO:0016021; GO:0030672; GO:0031594; GO:0045055; GO:0048499; GO:0070062	PTM: May be tyrosine phosphorylated by Src. {ECO:0000250|UniProtKB:O54980}.	9760194; 12975309; 16625196; 15489334; 17974005; 21269460; 22223895; 22814378; 23186163; 27226560	Synaptogyrin family
O43761	SNG3_HUMAN	Synaptogyrin-3	SYNGR3	229	9606			Acetylation;Cell junction;Cytoplasmic vesicle;Membrane;Reference proteome;Synapse;Transmembrane;Transmembrane helix	Q96CM8; P53367; Q08426; Q05329; C9JCN9; Q92993; Q8TAP4-4; Q504T8; Q00013; Q9ULP0-2; O60664; Q96T60; P17252; Q15047-2; Q9Y371; Q9NZD8; P49638; P61981	TISSUE SPECIFICITY: Expressed in brain and placenta. {ECO:0000269|PubMed:9760194}.	GO:0001504; GO:0008021; GO:0016021; GO:0021762; GO:0030672; GO:0031594; GO:0032411; GO:0042169; GO:0045055; GO:0047485		9760194; 14702039; 15489334; 22223895; 22814378	Synaptogyrin family
O43763	TLX2_HUMAN	T-cell leukemia homeobox protein 2 (Homeobox protein Hox-11L1) (Neural crest homeobox protein)	TLX2 HOX11L1 NCX	284	9606			3D-structure;Activator;Developmental protein;DNA-binding;Homeobox;Nucleus;Reference proteome;Transcription;Transcription regulation	Q3LI66; P78424		GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001707; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0048484; GO:0048513; GO:0050774; GO:1990837		10446220; 15815621; 15489334; 7518789; 20389279	
O43765	SGTA_HUMAN	Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein, UBP)	SGTA SGT SGT1	313	9606			3D-structure;Acetylation;Chaperone;Cytoplasm;Direct protein sequencing;Host-virus interaction;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat	Q9UKJ8; A8K660; Q15848; O95994; Q8TD06; Q16853; O95816; P46379; P46379-2; P35070; Q86Z23; Q9BXJ1; Q9BXJ0; Q9BXI9; Q6UWT4; P40259; Q8TCZ2; P55291; P07510-2; A0A0S2Z3K0; P08123; Q4VAQ0; Q68CJ9; P09603; P01037; P78358; P07711; Q9UHQ9; P59861; Q9UBP4; Q6E0U4; Q9HAV5; Q9UNE0-2; A0A0S2Z3V1; Q12805; O95967; Q96DN0; P30040; Q9HBU6; Q9NVM1; Q9Y624; Q96RJ6; Q9NSA1; Q9Y680; Q12841; P54710-2; P58549; O75084; P22466; Q9UBC7; P09681; Q14440; Q96SL4; P28799; Q02747; A0A0C4DFT7; B8Q183; P02724; P48723; P46695; P24592; Q6PIQ7; Q8N355; P40189; Q14653; Q13568; Q6GPH6; Q6GPH6-2; Q8N6L0; Q09470; Q16322; Q9UJ90; P02538; Q86UP2; Q86UP2-3; Q6ISS4; O43561; O43561-2; P80188; O15165-2; Q8N112; Q96G30; Q96HJ5; P08118; Q969H8; Q99972; Q8IW45; Q13232; Q9HCQ7; Q9GZP1; Q5JUK9; C3PTT6; Q96AQ6; Q9UN74; Q9Y5G9; Q96PD5-2; Q9UL19; Q969W9-2; P23284; P45877; Q96NZ9; Q8TAS3; Q9UIG4; Q15293; Q5GAN6; P50876; Q96K19-5; P04843; P31431; Q9HCN8; P05121; O75830; Q16586; Q16586-2; O43765; Q96EQ0; Q96DD7; Q8N114-3; P03973; Q0VAQ4; Q96QK8; Q71RC9; P08294; Q5DT21; P16150; P10451; Q8TCT8; P10124; Q86TD4-2; E0CX11; P51687; Q9BT88; Q9H2B2; Q07654; P02786; P01135; P01135-2; Q6P9G4; Q8WUU8; Q96A57-2; Q5JXX7; Q9Y2Y6; O60235; Q71RG4; O14798; O14836; O14836-2; Q9NS68-2; O75509; O43508; Q9C035-3; Q5BVD1; Q9GZX9; O95881; P11441; Q9UHD9; O75631; P01282; Q9NX94; Q8WWY7; Q8IUB5; Q8TCV5; Q8NAP8; O60844; Q96DA0; A0A1U9X8X8; P59635; P0DTD8; P0DTD3	TISSUE SPECIFICITY: Ubiquitous.	GO:0005634; GO:0005737; GO:0005829; GO:0006620; GO:0016020; GO:0030433; GO:0042802; GO:0043621; GO:0060090; GO:0071816; GO:0072380; GO:1903070; GO:1903071; GO:1904288; GO:2000059		9740675; 10567422; 9573291; 11230166; 15057824; 15489334; 15708368; 16580629; 16580632; 16964243; 17034881; 18669648; 19690332; 19608861; 20068231; 21269460; 21406692; 23129660; 23186163; 25179605; 24275569; 24675744; 25535373; 27193484; 28104892; 18759457	SGT family
O43766	LIAS_HUMAN	Lipoyl synthase, mitochondrial, EC 2.8.1.8 (Lipoate synthase, LS, Lip-syn) (Lipoic acid synthase)	LIAS LAS HUSSY-01	372	9606	PATHWAY: Protein modification; protein lipoylation via endogenous pathway; protein N(6)-(lipoyl)lysine from octanoyl-[acyl-carrier-protein]: step 2/2. {ECO:0000255|HAMAP-Rule:MF_03123}.	2.8.1.8	4Fe-4S;Alternative splicing;Disease variant;Iron;Iron-sulfur;Metal-binding;Mitochondrion;Reference proteome;S-adenosyl-L-methionine;Transferase;Transit peptide			GO:0001843; GO:0005739; GO:0005759; GO:0006954; GO:0006979; GO:0009107; GO:0009249; GO:0016992; GO:0032496; GO:0046872; GO:0051539; GO:0102552; GO:0102553		14702039; 15815621; 15489334; 11124703; 22152680	Radical SAM superfamily, Lipoyl synthase family
O43768	ENSA_HUMAN	Alpha-endosulfine (ARPP-19e)	ENSA	121	9606			Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Mitosis;Phosphoprotein;Protein phosphatase inhibitor;Reference proteome	Q96AP0; P22607; Q9UMX0; Q9Y649	TISSUE SPECIFICITY: Widely expressed with high levels in skeletal muscle and brain and lower levels in the pancreas. {ECO:0000269|PubMed:14728987, ECO:0000269|PubMed:9653196}.	GO:0000086; GO:0000278; GO:0004864; GO:0005102; GO:0005654; GO:0005737; GO:0007584; GO:0008200; GO:0019212; GO:0019870; GO:0019888; GO:0035308; GO:0050796; GO:0051301; GO:0051721	PTM: Phosphorylation at Ser-67 by GWL during mitosis is essential for interaction with PPP2R2D (PR55-delta) and subsequent inactivation of PP2A (By similarity). Phosphorylated by PKA. {ECO:0000250, ECO:0000269|PubMed:18973346, ECO:0000269|PubMed:9653196}.	9653196; 10480622; 14728987; 14702039; 17974005; 16710414; 15489334; 17081983; 17893145; 18973346; 20068231; 21269460; 21406692; 23186163; 24275569	Endosulfine family
O43772	MCAT_HUMAN	Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase, CAC) (Solute carrier family 25 member 20)	SLC25A20 CAC CACT	301	9606			Acetylation;Disease variant;Lipid transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	P13473-2		GO:0001701; GO:0005739; GO:0005743; GO:0005829; GO:0006853; GO:0015227; GO:0016021; GO:1902603		9399886; 9837782; 14702039; 15489334; 21269460; 24275569; 25944712; 12859414; 15057979; 15365988	Mitochondrial carrier (TC 2.A.29) family
O43776	SYNC_HUMAN	Asparagine--tRNA ligase, cytoplasmic, EC 6.1.1.22 (Asparaginyl-tRNA synthetase, AsnRS) (Asparaginyl-tRNA synthetase 1)	NARS1 NARS NRS	548	9606		6.1.1.22	3D-structure;Acetylation;Alternative splicing;Aminoacyl-tRNA synthetase;ATP-binding;Cytoplasm;Direct protein sequencing;Disease variant;Epilepsy;Ligase;Mental retardation;Neurodegeneration;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome	P54253		GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006421; GO:0016477; GO:0021987; GO:0031728; GO:0046983; GO:0070062		9421509; 9801298; 14702039; 16177791; 15489334; 9973509; 12235211; 19892738; 18669648; 19608861; 20068231; 21269460; 22814378; 23186163; 24275569; 25944712; 30171954; 32738225; 32788587; 33589599	Class-II aminoacyl-tRNA synthetase family
O43781	DYRK3_HUMAN	Dual specificity tyrosine-phosphorylation-regulated kinase 3, EC 2.7.12.1 (Regulatory erythroid kinase, REDK)	DYRK3	588	9606		2.7.12.1	3D-structure;Alternative splicing;ATP-binding;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Tyrosine-protein kinase;Ubl conjugation	Q9H8Y8	TISSUE SPECIFICITY: Isoform 1: Highly expressed in testis and in hematopoietic tissue such as fetal liver, and bone marrow (PubMed:10779429). Isoform 1: Predominant form in fetal liver and bone marrow (PubMed:10779429). Isoform 1: Present at low levels in heart, pancreas, lymph node and thymus (PubMed:10779429). Isoform 2: Highly expressed in testis and in hematopoietic tissue such as fetal liver, and bone marrow (PubMed:10779429). Isoform 2: Predominant form in testis. Isoform 2: Present at low levels in heart, pancreas, lymph node and thymus (PubMed:10779429). {ECO:0000269|PubMed:10779429}.	GO:0000242; GO:0000287; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007049; GO:0010494; GO:0016607; GO:0018105; GO:0018107; GO:0030218; GO:0035063; GO:0035617; GO:0043066; GO:0043231; GO:0043518; GO:0051301; GO:0080135; GO:0106310; GO:1902751; GO:1903008; GO:1903432	PTM: Ubiquitinated at anaphase by the anaphase-promoting complex (APC/C), leading to its degradation by the proteasome. {ECO:0000269|PubMed:29973724}.; PTM: Protein kinase activity is activated following autophosphorylation at Tyr-369 (Probable). Autophosphorylation at Ser-350 stabilizes the protein and enhances the protein kinase activity (PubMed:9748265). {ECO:0000269|PubMed:9748265, ECO:0000305|PubMed:9748265}.	9748265; 9845759; 10779429; 16710414; 15489334; 20167603; 23415227; 29973724; 29634919; 17344846	Protein kinase superfamily, CMGC Ser/Thr protein kinase family, MNB/DYRK subfamily
O43790	KRT86_HUMAN	Keratin, type II cuticular Hb6 (Hair keratin K2.11) (Keratin-86, K86) (Type II hair keratin Hb6) (Type-II keratin Kb26)	KRT86 KRTHB6	486	9606			Coiled coil;Disease variant;Intermediate filament;Isopeptide bond;Keratin;Reference proteome;Ubl conjugation	Q13554-3; Q8IYE0; Q07002; Q86XR8-3; Q02930-3; A8MQ03; Q9Y223-2; O14964; Q9H2F3; Q14005-2; Q15040; Q63ZY3; P02533; P19012; P08779; P08727; Q7Z3Z0; Q7Z3Y8; Q7Z3Y7; Q15323; Q14532; Q14525; O76011; Q92764; O76013-2; O76014; O76015; Q6A163; Q6A162; Q01546; O60336; P50222; Q13064; P61970; Q14990; O43482; Q7RTU3; Q9HCM1; Q14D33; Q92529; Q8WW24; Q3SY00; Q96IQ9; Q8N720	TISSUE SPECIFICITY: Synthesis begins slightly higher in the hair shaft than HB1 and HB3 and continues much farther up, ending in the keratogeneous zone. {ECO:0000269|PubMed:9084137}.	GO:0005615; GO:0005829; GO:0045095		9457912; 15489334; 9084137; 9402962; 10469314; 10504448; 10594761; 25557232	Intermediate filament family
O43791	SPOP_HUMAN	Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1)	SPOP	374	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:15897469, ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:19818708, ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:22632832, ECO:0000269|PubMed:32109420}.		3D-structure;Mental retardation;Nucleus;Reference proteome;Ubl conjugation pathway	Q13618; Q9UER7; Q16829; Q99836; Q9Y6Q9; P60484	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9414087}.	GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0016607; GO:0030162; GO:0031463; GO:0031625; GO:0043161		9414087; 14702039; 15489334; 14528312; 15240113; 15897469; 16651542; 16740475; 16524876; 22085717; 19818708; 22632832; 32109420	Tdpoz family
O43795	MYO1B_HUMAN	Unconventional myosin-Ib (MYH-1c) (Myosin I alpha, MMI-alpha, MMIa)	MYO1B	1136	9606			Actin-binding;Alternative splicing;ATP-binding;Calmodulin-binding;Isopeptide bond;Motor protein;Myosin;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	Q7Z3K3; P51687		GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0007015; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030050; GO:0030175; GO:0031982; GO:0045177; GO:0045296; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071944		15489334; 21269460; 24275569; 25218447; 25114211; 25755297; 28112733; 16959974	TRAFAC class myosin-kinesin ATPase superfamily, Myosin family
O43805	SSNA1_HUMAN	Sjoegren syndrome nuclear autoantigen 1 (Nuclear autoantigen of 14 kDa)	SSNA1 NA14	119	9606			Acetylation;Coiled coil;Cytoplasm;Cytoskeleton;Nucleus;Reference proteome	Q16543; Q08426; Q9HD26; Q86VQ0; Q8TBB1; Q96HA8; Q9NRD5; P78317; O00560; O43805; Q9P0N9; Q8N8B7; Q8N8B7-2; Q99757	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:9430706}.	GO:0005634; GO:0005813; GO:0005829; GO:0036064; GO:0042073; GO:0042802; GO:0060830		9430706; 15164053; 15489334; 14654843; 19413330; 21269460; 16959974	SSNA1 family
O43808	PM34_HUMAN	Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17)	SLC25A17 PMP34	307	9606			Cytoplasm;Membrane;Peroxisome;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	Q6FHY5; P40855	TISSUE SPECIFICITY: Ubiquitous. Expressed in liver. {ECO:0000269|PubMed:22185573}.	GO:0000295; GO:0001561; GO:0005347; GO:0005777; GO:0005778; GO:0005779; GO:0005829; GO:0006635; GO:0015217; GO:0015228; GO:0015230; GO:0015867; GO:0015908; GO:0016020; GO:0044610; GO:0051087; GO:0051724; GO:0080122		9874197; 15461802; 14702039; 10591208; 15489334; 10704444; 11121399; 11402059; 12445829; 14709540; 22185573	Mitochondrial carrier (TC 2.A.29) family
O43809	CPSF5_HUMAN	Cleavage and polyadenylation specificity factor subunit 5 (Cleavage and polyadenylation specificity factor 25 kDa subunit, CPSF 25 kDa subunit) (Cleavage factor Im complex 25 kDa subunit, CFIm25) (Nucleoside diphosphate-linked moiety X motif 21, Nudix motif 21) (Nudix hydrolase 21) (Pre-mRNA cleavage factor Im 68 kDa subunit)	NUDT21 CFIM25 CPSF25 CPSF5	227	9606			3D-structure;Acetylation;Cytoplasm;Differentiation;Direct protein sequencing;Methylation;mRNA processing;Nucleus;Phosphoprotein;Reference proteome;RNA-binding	P54253; Q86X55; Q16630; Q16630-1; Q16630-2; Q8N684; Q8N684-3; Q86YD7; P14136; Q08379; Q13422-7; O95678; P60660; Q96HA8; O43809; Q8WXF1-2; Q96BU1; Q99932-2; Q96N21; P36406; P14373; Q8N720; Q9UGI0	TISSUE SPECIFICITY: Expressed in the heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:17098938}.	GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016604; GO:0030154; GO:0031124; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051262; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975	PTM: Acetylated mainly by p300/CBP, recruited to the complex by CPSF6. Acetylation decreases interaction with PAPAO. Deacetylated by the class I/II HDACs, HDAC1, HDAC3 and HDAC10, and by the class III HDACs, SIRT1 AND SIRT2. {ECO:0000269|PubMed:17172643}.	9659921; 17974005; 15616553; 15489334; 8626397; 14690600; 14561889; 15169763; 15937220; 15592455; 17024186; 17098938; 17172643; 19864460; 19608861; 20695905; 21269460; 22813749; 23187700; 24275569; 24129315; 25944712; 29507755; 29276085; 18445629; 18767156; 20479262; 21295486	Nudix hydrolase family, CPSF5 subfamily
O43813	LANC1_HUMAN	Glutathione S-transferase LANCL1, EC 2.5.1.18 (40 kDa erythrocyte membrane protein, p40) (LanC-like protein 1)	LANCL1 GPR69A	399	9606		2.5.1.18	3D-structure;Acetylation;Cell membrane;Cytoplasm;Direct protein sequencing;Membrane;Metal-binding;Reference proteome;Transferase;Zinc	Q9UHR4; P42858; Q08509	TISSUE SPECIFICITY: Detected in erythrocytes, brain, kidney, testis, ovary, heart, lung, placenta and spleen (at protein level). Ubiquitous. Strongly expressed in brain, spinal cord, pituitary gland, kidney, heart, skeletal muscle, pancreas, ovary and testis. {ECO:0000269|PubMed:10944443, ECO:0000269|PubMed:15811525, ECO:0000269|PubMed:9512664}.	GO:0004364; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0005975; GO:0007186; GO:0008270; GO:0017124; GO:0043295; GO:0043523; GO:0050750; GO:1903203		9512664; 11474189; 15489334; 10944443; 15811525; 16979580; 19413330; 19608861; 21269460; 19528316	LanC-like protein family
O43815	STRN_HUMAN	Striatin	STRN	780	9606			Alternative splicing;Calmodulin-binding;Cell junction;Cell projection;Coiled coil;Cytoplasm;Membrane;Phosphoprotein;Reference proteome;Repeat;Synapse;WD repeat	Q9P2B4; Q9Y3A3; Q9BUL8; P67775; P30153; Q6NUQ1; Q9Y6E0; O00506; Q13033; Q9UBB9; Q9H2K2; Q9Y228; Q9BUL8; P30153	TISSUE SPECIFICITY: Preferentially expressed in brain. {ECO:0000269|PubMed:9693043}.	GO:0005516; GO:0005829; GO:0005923; GO:0007626; GO:0008285; GO:0014069; GO:0016020; GO:0016055; GO:0016358; GO:0030331; GO:0030425; GO:0043025; GO:0043197; GO:0044877; GO:0045211; GO:0051721; GO:0070016; GO:0070830; GO:0090443		9693043; 15815621; 15489334; 18669648; 19413330; 19369195; 19690332; 21269460; 23186163; 24275569; 25944712	WD repeat striatin family
O43818	U3IP2_HUMAN	U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein, U3 snoRNP-associated 55 kDa protein, U3-55K)	RRP9 RNU3IP2 U355K	475	9606			3D-structure;Acetylation;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribonucleoprotein;RNA-binding;rRNA processing;Ubl conjugation;WD repeat			GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0031428; GO:0032040; GO:0034511	PTM: Acetylation at Lys-12 and Lys-25 by KAT2B/PCAF under stress impairs pre-rRNA processing (PubMed:26867678). Deacetylation by SIRT7 enhances RRP9-binding to U3 snoRNA, which is a prerequisite for pre-rRNA processing (PubMed:26867678). {ECO:0000269|PubMed:26867678}.	9418896; 14702039; 15489334; 10982864; 12381732; 12429849; 18669648; 19690332; 21406692; 24129315; 28112733; 26867678; 16959974	WD repeat RRP9 family
O43819	SCO2_HUMAN	Protein SCO2 homolog, mitochondrial	SCO2	266	9606			3D-structure;Cardiomyopathy;Chaperone;Copper;Disease variant;Disulfide bond;Leigh syndrome;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Primary mitochondrial disease;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix	Q9UHD4	TISSUE SPECIFICITY: Ubiquitous.	GO:0001654; GO:0001701; GO:0003012; GO:0005507; GO:0005739; GO:0005759; GO:0006878; GO:0014823; GO:0015035; GO:0016531; GO:0022904; GO:0030016; GO:0031305; GO:0033617		10545952; 12529303; 15461802; 15489334; 15229189; 17189203; 19336478; 21269460; 24403053; 25959673; 25944712; 29154948; 28330871; 26741492; 29381136; 17850752; 10749987; 11673586; 14994243; 19353847; 23643385; 25525168	SCO1/2 family
O43820	HYAL3_HUMAN	Hyaluronidase-3, Hyal-3, EC 3.2.1.35 (Hyaluronoglucosaminidase-3) (Lung carcinoma protein 3, LuCa-3)	HYAL3 LUCA3	417	9606		3.2.1.35	Alternative splicing;Cell membrane;Cytoplasmic vesicle;Disulfide bond;EGF-like domain;Endoplasmic reticulum;Endosome;Fertilization;Glycoprotein;Glycosidase;Hydrolase;Membrane;Reference proteome;Secreted;Signal	Q8N9W6-4; Q9UQM7; O75553	TISSUE SPECIFICITY: Expressed in sperm (PubMed:20586096). Highly expressed in epidermis of the skin, where it is expressed intracellularily in the deep horny layer (at protein level) (PubMed:21699545). Bone marrow, testis and kidney (PubMed:10493834). {ECO:0000269|PubMed:10493834, ECO:0000269|PubMed:20586096, ECO:0000269|PubMed:21699545}.	GO:0001552; GO:0001669; GO:0002080; GO:0004415; GO:0005576; GO:0005764; GO:0005769; GO:0005783; GO:0005886; GO:0005975; GO:0006954; GO:0007341; GO:0009615; GO:0030214; GO:0031410; GO:0033906; GO:0046677; GO:0051216; GO:0071347; GO:0071356; GO:0071493; GO:0097225; GO:2000355; GO:2000368	PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q8VEI3}.	10493834; 12084718; 16641997; 15489334; 20586096; 21699545	Glycosyl hydrolase 56 family
O43822	CF410_HUMAN	Cilia- and flagella-associated protein 410 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2)	CFAP410 C21orf2 LRRC76	256	9606			Alternative splicing;Cell projection;Ciliopathy;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Disease variant;DNA damage;Dwarfism;Leucine-rich repeat;Mitochondrion;Phosphoprotein;Reference proteome;Repeat	O00244; Q53SE7; Q96IK5; Q9NZD8	TISSUE SPECIFICITY: Widely expressed (PubMed:26974433, PubMed:9325172). Expressed in the retina (PubMed:26294103).	GO:0001750; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006974; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0043231; GO:0060271		9465297; 10830953; 15489334; 9325172; 19369195; 21834987; 23186163; 26290490; 26294103; 26167768; 27548899; 26974433; 28422394	
O43823	AKAP8_HUMAN	A-kinase anchor protein 8, AKAP-8 (A-kinase anchor protein 95 kDa, AKAP 95)	AKAP8 AKAP95	692	9606			Cytoplasm;DNA-binding;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transcription;Transcription regulation;Transport;Ubl conjugation;Zinc;Zinc-finger	Q9UBL3; P42574; Q9C005; O15379; P49736; P13861; Q15418; P61964	TISSUE SPECIFICITY: Highly expressed in heart, liver, skeletal muscle, kidney and pancreas. Expressed in mature dendritic cells. {ECO:0000269|PubMed:19277197}.	GO:0000278; GO:0000793; GO:0001939; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005794; GO:0007076; GO:0007165; GO:0008270; GO:0015031; GO:0016020; GO:0016363; GO:0031065; GO:0032720; GO:0033127; GO:0034237; GO:0042826; GO:0044839; GO:0045087; GO:0051059; GO:0071222; GO:0071380	PTM: Phosphorylated on tyrosine residues probably by SRC subfamily protein kinases; multiple phosphorylation is leading to dissociation from nuclear structures implicated in chromatin structural changes. {ECO:0000269|PubMed:25770215}.	9473338; 15057824; 10601332; 10791967; 10764601; 11591814; 11964380; 12740381; 14641107; 15470020; 16227597; 17081983; 16980585; 18691976; 18669648; 19413330; 19277197; 19690332; 20068231; 21269460; 21406692; 22130794; 23186163; 23995757; 24275569; 24129315; 25770215; 26683827; 26880274; 28112733; 16959974	AKAP95 family
O43825	B3GT2_HUMAN	Beta-1,3-galactosyltransferase 2, Beta-1,3-GalTase 2, Beta3Gal-T2, Beta3GalT2, EC 2.4.1.86 (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2)	B3GALT2	422	9606	PATHWAY: Protein modification; protein glycosylation.	2.4.1.86	Glycoprotein;Glycosyltransferase;Golgi apparatus;Lipid metabolism;Manganese;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Detected in heart and brain. {ECO:0000269|PubMed:9417100, ECO:0000269|PubMed:9582303}.	GO:0000139; GO:0006486; GO:0006682; GO:0008194; GO:0008499; GO:0009312; GO:0016021; GO:0016757; GO:0047275		9417100; 9582303; 11318611; 14702039; 16710414; 15489334	Glycosyltransferase 31 family
O43826	G6PT1_HUMAN	Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein, TRG-19)	SLC37A4 G6PT G6PT1 PRO0685 TRG19	429	9606			Alternative splicing;Antiport;Disease variant;Endoplasmic reticulum;Glycogen storage disease;Membrane;Reference proteome;Sugar transport;Transmembrane;Transmembrane helix;Transport	Q13323	TISSUE SPECIFICITY: Mostly expressed in liver and kidney.	GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0008643; GO:0015152; GO:0015760; GO:0016020; GO:0016021; GO:0030176; GO:0035435; GO:0042593; GO:0061513		9428641; 9856496; 10026167; 10023055; 10323254; 15489334; 21949678; 11949931; 9758626; 9781688; 10482962; 10518030; 9675154; 10482875; 11071391; 10874322; 10923042; 10931421; 12409273; 15669677; 15059622; 15953877; 19579760; 21629566	Major facilitator superfamily, Organophosphate:Pi antiporter (OPA) (TC 2.A.1.4) family
O43827	ANGL7_HUMAN	Angiopoietin-related protein 7 (Angiopoietin-like factor) (Angiopoietin-like protein 7) (Cornea-derived transcript 6 protein)	ANGPTL7 CDT6 UNQ313/PRO356	346	9606			Coiled coil;Direct protein sequencing;Disulfide bond;Glycoprotein;Reference proteome;Secreted;Signal	P35609	TISSUE SPECIFICITY: Higly expressed in the cornea (at protein level) (PubMed:11682471). Expression is restricted to the stromal layer (PubMed:11682471). Also detected at the junction between the corneal stromal layer and the conjuctiva. Not detected in the sclera (PubMed:11682471). {ECO:0000269|PubMed:11682471, ECO:0000269|PubMed:9727400}.	GO:0005102; GO:0005576; GO:0005615; GO:0006979; GO:0042802; GO:0062023; GO:1901346; GO:1903053		9727400; 11426320; 12975309; 14702039; 21697133; 16710414; 15489334; 15340161; 11682471; 16541013; 21199193; 25622036	
O43829	ZBT14_HUMAN	Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog, Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog, ZF5, Zfp-5, hZF5)	ZBTB14 ZFP161 ZNF478	449	9606			Activator;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q9BXS5; P48047; Q9UIF8-2; Q13895; Q2NKX9; Q9Y6Q1; P55212; Q9HC52; Q00536; Q00536-3; Q8IVW4; Q96LK0; P99999; P26196; Q96JC9; Q8N9N8; Q9H0I2; Q7L775; Q3B820; Q86YD7; P22607; Q9H8Y8; Q14957; P06396; O00291; P01112; Q68E01; Q92993; O14901; Q5T3J3; Q15013; P55081; Q15014; Q9Y3B7; P41227; Q9BSU3; Q96CV9; Q9BRL4; Q13526; Q96T60; P62875; O75400-2; P62826; Q8N451; D3DU92; P32969; P62851; P62081; Q9BWG6; O00560; Q9Y371; P08579; Q17RD7; Q8N8B7; Q8N8B7-2; Q5T7W7; Q99757; Q9UMX0; O14904; Q8TBK6; Q96NC0; Q96BH6		GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001822; GO:0003170; GO:0003279; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0016235; GO:0043565; GO:0045892; GO:0046872; GO:0060976; GO:1990837		9244432; 9177479; 17714511; 15489334; 14706637; 15629158; 28112733	Krueppel C2H2-type zinc-finger protein family
O43837	IDH3B_HUMAN	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)	IDH3B	385	9606			3D-structure;Acetylation;Alternative splicing;Disease variant;Mitochondrion;Reference proteome;Retinitis pigmentosa;Transit peptide;Tricarboxylic acid cycle	PRO_0000014436 [P50213]		GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0009055; GO:0051287		10601238; 14702039; 11780052; 15489334; 17974005; 19608861; 21269460; 25944712; 28098230; 28139779; 18806796	Isocitrate and isopropylmalate dehydrogenases family
O43847	NRDC_HUMAN	Nardilysin, EC 3.4.24.61 (N-arginine dibasic convertase, NRD convertase, NRD-C) (Nardilysin convertase)	NRDC NRD1	1151	9606		3.4.24.61	Alternative splicing;Hydrolase;Metal-binding;Metalloprotease;Phosphoprotein;Protease;Reference proteome;Signal;Zinc	P04637	TISSUE SPECIFICITY: Primarily in adult heart, skeletal muscle, and testis and at much lower levels in other tissues.	GO:0004222; GO:0005739; GO:0005829; GO:0009986; GO:0046872; GO:0048408; GO:0051044; GO:0052548; GO:0120163		9581555; 9479496; 16710414; 15489334; 11042131; 18669648; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569	Peptidase M16 family
O43852	CALU_HUMAN	Calumenin (Crocalbin) (IEF SSP 9302)	CALU	315	9606			Acetylation;Alternative splicing;Calcium;Direct protein sequencing;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Sarcoplasmic reticulum;Secreted;Signal	Q9UMX0-2; P13569; P05067	TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at high levels in heart, placenta and skeletal muscle, at lower levels in lung, kidney and pancreas and at very low levels in brain and liver.	GO:0005509; GO:0005576; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016020; GO:0033018; GO:0042470		9675259; 9598325; 14702039; 12853948; 15489334; 12665801; 10222138; 12643545; 17081065; 16964243; 18691976; 19159218; 19139490; 20068231; 21269460; 23186163; 24275569; 26091039; 25944712	CREC family
O43854	EDIL3_HUMAN	EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)	EDIL3 DEL1	480	9606			3D-structure;Alternative splicing;Calcium;Cell adhesion;Developmental protein;Disulfide bond;EGF-like domain;Glycoprotein;Metal-binding;Reference proteome;Repeat;Secreted;Signal			GO:0005178; GO:0005509; GO:0007155; GO:0010811; GO:0062023; GO:0070062; GO:1903561		9420328; 14702039; 15489334; 22601780	
O43861	ATP9B_HUMAN	Probable phospholipid-transporting ATPase IIB, EC 7.6.2.1 (ATPase class II type 9B)	ATP9B ATPIIB NEO1L HUSSY-20	1147	9606		7.6.2.1	Alternative splicing;ATP-binding;Golgi apparatus;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Reference proteome;Translocase;Transmembrane;Transmembrane helix			GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0016887; GO:0045332; GO:0048471; GO:0140326		16177791; 15489334; 14702039; 9548971; 11124703; 21914794	Cation transport ATPase (P-type) (TC 3.A.3) family, Type IV subfamily
O43865	SAHH2_HUMAN	S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3), IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2, AdoHcyase 2)	AHCYL1 DCAL IRBIT XPVKONA	530	9606			3D-structure;Acetylation;Alternative splicing;Cell membrane;Cytoplasm;Endoplasmic reticulum;Membrane;Microsome;NAD;One-carbon metabolism;Phosphoprotein;Reference proteome;RNA-binding	O43865; Q9HD36; P55957; P55957-2; P42773; Q9UI36-2; P55040; P09105; Q96MH2; P17066; Q14643; Q8TAC2; Q5S007; P43356; P50222; Q8NCR3; Q8N323; Q8N2W9; O94827-4; O14829; O60437; Q9NQX0; O00233; A0A0S2Z4G9; Q9UHI7; Q9UHI7-3; Q02978; O94993; P48775; Q9BZF9; P49910; Q53Z40; P04608	TISSUE SPECIFICITY: Expressed in dendritic cells. {ECO:0000269|PubMed:11904675}.	GO:0003723; GO:0005737; GO:0005789; GO:0005829; GO:0006378; GO:0006611; GO:0006730; GO:0006915; GO:0010765; GO:0016324; GO:0031440; GO:0032412; GO:0033353; GO:0038166; GO:0042045; GO:0042802; GO:0044070; GO:0044233; GO:0051592; GO:0070062; GO:1990456	PTM: Phosphorylated at Ser/Thr residues between Ser-68 and Thr-72 in the PEST region: required for interaction with dATP-bound RRM1 and ITPR1. Phosphorylation at Ser-68 by PRKD1 and CAMK4 is required for further phosphorylations by CSNK1A1 (PubMed:16793548). Phosphorylation is induced by oxidative stress (PubMed:19224921). Probably phosphorylated by CAMK2A; phosphorylation at Ser-68 may be required for interaction with SLC9A3 (PubMed:20584908). Dephosphorylated in response to apoptotic stress conditions which causes translocation of both AHCYL1 and BCL2L10 from mitochondria-associated endoplasmic reticulum membranes and promotes apoptosis (PubMed:27995898). {ECO:0000269|PubMed:16793548, ECO:0000269|PubMed:19224921, ECO:0000269|PubMed:25237103, ECO:0000269|PubMed:27995898, ECO:0000305|PubMed:20584908}.	11904675; 14702039; 17974005; 16710414; 15489334; 12878157; 7782076; 16754674; 16793548; 16769890; 18829453; 18669648; 19224921; 19220705; 20584908; 21269460; 21406692; 22814378; 23186163; 27995898; 31799605; 25237103	Adenosylhomocysteinase family
O43866	CD5L_HUMAN	CD5 antigen-like (Apoptosis inhibitor expressed by macrophages, hAIM) (CT-2) (IgM-associated peptide) (SP-alpha)	CD5L API6 UNQ203/PRO229	347	9606			Apoptosis;Cytoplasm;Direct protein sequencing;Disulfide bond;Glycoprotein;Immunity;Inflammatory response;Reference proteome;Repeat;Secreted;Signal		TISSUE SPECIFICITY: Expressed in spleen, lymph node, thymus, bone marrow, and fetal liver, but not in non-lymphoid tissues. {ECO:0000269|PubMed:9045627}.	GO:0002376; GO:0004252; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006915; GO:0006954; GO:0006968; GO:0009986; GO:0030449; GO:0031638; GO:0072562; GO:1903661	PTM: Not N-glycosylated (PubMed:23236605). Probably not O-glycosylated (PubMed:23236605). {ECO:0000269|PubMed:23236605}.	9045627; 12975309; 14702039; 16710414; 15489334; 8034987; 11981870; 15340161; 16030018; 23236605; 24223991; 24583716; 24295828; 24275569; 24804991; 25713983	
O43868	S28A2_HUMAN	Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2, CNT 2, hCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside co-transporter, SPNT) (Solute carrier family 28 member 2)	SLC28A2 CNT2	658	9606			Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Expressed in heart and skeletal muscle followed by liver, kidney, intestine, pancreas, placenta and brain (PubMed:9435697). Weak expression in lung (PubMed:9435697). {ECO:0000269|PubMed:9435697}.	GO:0001895; GO:0005326; GO:0005337; GO:0005345; GO:0005415; GO:0005886; GO:0005887; GO:0006139; GO:0006836; GO:0012506; GO:0015211; GO:0015213; GO:0015293; GO:0015389; GO:0015860; GO:0015862; GO:0016020; GO:0030135; GO:0031526; GO:0032238; GO:0035340; GO:0045117; GO:0072531; GO:0150104; GO:1901474; GO:1901642; GO:1904823		9435697; 10087507; 14702039; 15489334; 10455109; 15861032; 17700367	Concentrative nucleoside transporter (CNT) (TC 2.A.41) family
O43889	CREB3_HUMAN	Cyclic AMP-responsive element-binding protein 3, CREB-3, cAMP-responsive element-binding protein 3 (Leucine zipper protein) (Luman) (Transcription factor LZIP-alpha) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3, N-terminal Luman, Transcriptionally active form ]	CREB3 LZIP	371	9606			Activator;Alternative splicing;Chemotaxis;Cytoplasm;DNA-binding;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Host-virus interaction;Membrane;Nucleus;Reference proteome;Repeat;Repressor;Signal-anchor;Transcription;Transcription regulation;Transmembrane;Transmembrane helix;Unfolded protein response	Q92685; O43889; Q68CJ9; Q9NS37; P35638; P51610; P05412; O00268; Q15109; Q92685; Q9BVK2; P05090; P29972; P41181; P55087; P09871; P06681; P32246; Q9UJ71; Q9BXR6; Q8N6F1-2; Q8IUR6; P78329; Q9H295; Q15125; P50402; P37268; Q01740; P31513; P17302; A0A0C4DFT7; P51610; P24593; Q8TAF8; Q6FG55; Q99735; Q99519; P26678; P60201-2; Q01453; P05155; P11686; Q9BZD2; P11166; P14672; Q9BRI3; P82251; O43759-2; Q8TAA9; Q9Y397; P29846	TISSUE SPECIFICITY: Ubiquitously expressed (PubMed:9271389, PubMed:19779205). Expressed in dendritic cells (DC). Weakly expressed in monocytes (at protein level) (PubMed:20546900). {ECO:0000269|PubMed:19779205, ECO:0000269|PubMed:20546900, ECO:0000269|PubMed:9271389}.	GO:0000139; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0001558; GO:0002230; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006351; GO:0006357; GO:0006935; GO:0006990; GO:0008140; GO:0016020; GO:0016021; GO:0016604; GO:0019043; GO:0019046; GO:0030176; GO:0030335; GO:0031726; GO:0034976; GO:0035497; GO:0042127; GO:0042802; GO:0042803; GO:0042981; GO:0042994; GO:0043025; GO:0045786; GO:0045893; GO:0045944; GO:0046983; GO:0050930; GO:0051928; GO:0090026; GO:0090045; GO:0090575; GO:0140467; GO:1902236; GO:1990837	PTM: First proteolytically cleaved by site-1 protease (S1P) that generates membrane-associated N-terminus and a luminal C-terminus forms. The membrane-associated N-terminus form is further proteolytically processed probably by the site-2 protease (S2P) through a regulated intramembrane proteolysis (RIP), releasing the transcriptional active processed cyclic AMP-responsive element-binding protein 3 form, which is transported to the nucleus. The proteolytic cleavage is strongly induced during dendritic cell (DC) maturation and inhibited by DCSTAMP. That form is rapidly degraded. {ECO:0000269|PubMed:12138176, ECO:0000269|PubMed:16940180, ECO:0000269|PubMed:17054986, ECO:0000269|PubMed:18391022, ECO:0000269|PubMed:20546900}.; PTM: N-glycosylated. {ECO:0000269|PubMed:12138176, ECO:0000269|PubMed:16940180}.	9271389; 9389645; 10675342; 19779205; 15164053; 15489334; 10623756; 10629049; 10984507; 12138176; 15001559; 15845366; 15705566; 17054986; 16940180; 17296613; 18587271; 18391022; 20546900	BZIP family, ATF subfamily
O43895	XPP2_HUMAN	Xaa-Pro aminopeptidase 2, EC 3.4.11.9 (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P, Membrane-bound APP, Membrane-bound AmP, mAmP) (X-Pro aminopeptidase 2)	XPNPEP2	674	9606		3.4.11.9	Aminopeptidase;Cell membrane;Glycoprotein;GPI-anchor;Hydrolase;Lipoprotein;Membrane;Metal-binding;Metalloprotease;Protease;Reference proteome;Signal;Zinc		TISSUE SPECIFICITY: Expressed in kidney, lung, heart, placenta, liver, small intestine and colon. No expression in brain, skeletal muscle, pancreas, spleen, thymus, prostate, testis and ovary. {ECO:0000269|PubMed:9375790}.	GO:0004177; GO:0005576; GO:0005886; GO:0016020; GO:0031225; GO:0046872; GO:0070006; GO:0070062	PTM: N-glycosylated. {ECO:0000269|PubMed:15361070}.	9375790; 15772651; 15489334; 16175507; 15361070; 20625347; 21898657	Peptidase M24B family
O43896	KIF1C_HUMAN	Kinesin-like protein KIF1C	KIF1C KIAA0706	1103	9606			3D-structure;ATP-binding;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Methylation;Microtubule;Motor protein;Neurodegeneration;Nucleotide-binding;Phosphoprotein;Reference proteome	A0JNT9	TISSUE SPECIFICITY: Expressed in all tissues examined, with most abundant expression in heart and skeletal muscle. {ECO:0000269|PubMed:9685376}.	GO:0003723; GO:0003774; GO:0003777; GO:0005524; GO:0005783; GO:0005794; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0030705; GO:1904115; GO:1990048; GO:1990049	PTM: Phosphorylated on tyrosine residues. {ECO:0000269|PubMed:9685376}.	9685376; 9734811; 15489334; 17081983; 16964243; 18669648; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 24129315; 24482476; 24319291	TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, Unc-104 subfamily
O43897	TLL1_HUMAN	Tolloid-like protein 1, EC 3.4.24.-	TLL1 TLL	1013	9606		3.4.24.-	3D-structure;Alternative splicing;Atrial septal defect;Calcium;Developmental protein;Differentiation;Disease variant;Disulfide bond;EGF-like domain;Glycoprotein;Hydrolase;Metal-binding;Metalloprotease;Protease;Reference proteome;Repeat;Secreted;Signal;Zinc;Zymogen			GO:0001501; GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0008270; GO:0030154; GO:0030199		15489334; 10479448; 10896944; 11313359; 18824173; 16959974; 18830233	
O43900	PRIC3_HUMAN	Prickle planar cell polarity protein 3 (LIM domain only protein 6, LMO-6) (Prickle-like protein 3, Pk3) (Triple LIM domain protein 6)	PRICKLE3 LMO6	615	9606			Alternative splicing;Cell membrane;Cilium biogenesis/degradation;Cytoplasm;Developmental protein;Disease variant;Leber hereditary optic neuropathy;LIM domain;Membrane;Metal-binding;Mitochondrion;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Repeat;Zinc	P00519; P06241; O00204	TISSUE SPECIFICITY: Widely expressed.	GO:0005739; GO:0005886; GO:0008270; GO:0030030		14702039; 15772651; 15489334; 9344658; 18669648; 23186163; 16959974; 32516135	Prickle / espinas / testin family
O43903	GAS2_HUMAN	Growth arrest-specific protein 2, GAS-2	GAS2	313	9606			Alternative splicing;Apoptosis;Cell cycle;Cell shape;Cytoplasm;Cytoskeleton;Growth arrest;Membrane;Phosphoprotein;Reference proteome	Q8IYX1	TISSUE SPECIFICITY: Ubiquitously expressed with highest levels in liver, lung, and kidney. Not found in spleen.	GO:0001544; GO:0001547; GO:0005829; GO:0005884; GO:0006915; GO:0007049; GO:0008017; GO:0008093; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051764; GO:0071711	PTM: Cleaved, during apoptosis, on a specific aspartic residue by caspases.; PTM: Phosphorylated on serine residues during the G0-G1 transition phase. {ECO:0000250}.	9521882; 14702039; 16554811; 15489334; 18669648; 24706950; 24275569	GAS2 family
O43909	EXTL3_HUMAN	Exostosin-like 3, EC 2.4.1.223 (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3)	EXTL3 EXTL1L EXTR1 KIAA0519	919	9606	PATHWAY: Glycan metabolism; heparan sulfate biosynthesis. {ECO:0000269|PubMed:28132690, ECO:0000269|PubMed:28148688}.	2.4.1.223	Disease variant;Disulfide bond;Dwarfism;Endoplasmic reticulum;Glycoprotein;Glycosyltransferase;Golgi apparatus;Manganese;Membrane;Mental retardation;Metal-binding;Phosphoprotein;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	P54253	TISSUE SPECIFICITY: Ubiquitous. Expressed in keratinocytes. {ECO:0000269|PubMed:22727489}.	GO:0001888; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0015012; GO:0016021; GO:0016757; GO:0030307; GO:0046872		9479495; 9473480; 9628581; 15489334; 10639137; 22727489; 28132690; 28148688; 28397838	Glycosyltransferase 47 family
O43913	ORC5_HUMAN	Origin recognition complex subunit 5	ORC5 ORC5L	435	9606			3D-structure;Alternative splicing;ATP-binding;Chromosome;DNA replication;Nucleotide-binding;Nucleus;Reference proteome;Ubl conjugation	Q13415; Q13416; Q9UBD5; O43929	TISSUE SPECIFICITY: Abundant in spleen, ovary, prostate, testis, and colon mucosa. {ECO:0000269|PubMed:9765232}.	GO:0000166; GO:0000781; GO:0000785; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0006275	PTM: Multi-mono-ubiquitinated by OBI1; ubiquitination is important for efficient DNA replication origin site activation. Ubiquitination levels are low in mitotic and early G1-phAse cells and are induced in late G1-/early S-phase, peaking in S-phase and decrease toward the end of the cell cycle. {ECO:0000269|PubMed:31160578}.	9829972; 9417919; 9765232; 12853948; 12690205; 15489334; 12909626; 17716973; 21269460; 31160578	ORC5 family
O43914	TYOBP_HUMAN	TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein, KAR-associated protein)	TYROBP DAP12 KARAP	113	9606			3D-structure;Alternative splicing;Calcium;Cell membrane;Disulfide bond;Immunity;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Signal;Transmembrane;Transmembrane helix	Q14953; O95944; O00241; Q969S0; Q8N2M4; Q9NZC2; O43914	TISSUE SPECIFICITY: Expressed at low levels in the early development of the hematopoietic system and in the promonocytic stage and at high levels in mature monocytes. Expressed in hematological cells and tissues such as peripheral blood leukocytes and spleen. Also found in bone marrow, lymph nodes, placenta, lung and liver. Expressed at lower levels in different parts of the brain especially in the basal ganglia and corpus callosum. {ECO:0000269|PubMed:11922939}.	GO:0002222; GO:0002223; GO:0002274; GO:0002282; GO:0002283; GO:0005102; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0009986; GO:0010628; GO:0016021; GO:0030036; GO:0030316; GO:0030667; GO:0030889; GO:0030900; GO:0032693; GO:0032731; GO:0032755; GO:0032760; GO:0032816; GO:0032911; GO:0032930; GO:0034241; GO:0035556; GO:0042802; GO:0042803; GO:0043277; GO:0046872; GO:0048678; GO:0050821; GO:0097190; GO:0110090; GO:1900272; GO:1901216; GO:1902685; GO:1904151; GO:2000010; GO:2001206	PTM: Following ligand binding by associated receptors, tyrosine phosphorylated in the ITAM domain which leads to activation of additional tyrosine kinases and subsequent cell activation. {ECO:0000269|PubMed:9490415}.	9490415; 14702039; 16344560; 15057824; 15489334; 9655483; 10449773; 10604985; 10888890; 10799849; 11602640; 12370476; 11922939; 15557162; 15940674; 17012248; 16920917; 17928527; 18624290; 18957693; 19369195; 21727189; 23715743; 25957402; 26221034; 25944712; 20890284; 25981043; 27658901; 28716534	TYROBP family
O43915	VEGFD_HUMAN	Vascular endothelial growth factor D, VEGF-D (c-Fos-induced growth factor, FIGF)	VEGFD FIGF	354	9606			3D-structure;Angiogenesis;Cleavage on pair of basic residues;Developmental protein;Differentiation;Direct protein sequencing;Disulfide bond;Glycoprotein;Growth factor;Mitogen;Reference proteome;Repeat;Secreted;Signal	Q15836	TISSUE SPECIFICITY: Highly expressed in lung, heart, small intestine and fetal lung, and at lower levels in skeletal muscle, colon, and pancreas.	GO:0001666; GO:0001934; GO:0001938; GO:0002040; GO:0005161; GO:0005172; GO:0005576; GO:0005615; GO:0008083; GO:0008283; GO:0008284; GO:0009617; GO:0016020; GO:0031093; GO:0038084; GO:0042056; GO:0042802; GO:0043185; GO:0045766; GO:0048010; GO:0050930; GO:0051781; GO:0060754; GO:0071542	PTM: Undergoes a complex proteolytic maturation which generates a variety of processed secreted forms with increased activity toward VEGFR-3 and VEGFR-2. VEGF-D first form an antiparallel homodimer linked by disulfide bonds before secretion. The fully processed VEGF-D is composed mostly of two VEGF homology domains (VHDs) bound by non-covalent interactions. {ECO:0000269|PubMed:10542248}.	9205122; 9479493; 9435229; 14702039; 15489334; 10542248; 21148085	PDGF/VEGF growth factor family
O43916	CHST1_HUMAN	Carbohydrate sulfotransferase 1 (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1, GST-1) (Keratan sulfate Gal-6 sulfotransferase, KS6ST, KSGal6ST, KSST, EC 2.8.2.21)	CHST1	411	9606	PATHWAY: Glycan metabolism. {ECO:0000269|PubMed:17690104}.	2.8.2.21	Carbohydrate metabolism;Glycoprotein;Golgi apparatus;Inflammatory response;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	Q8TED1; P27105	TISSUE SPECIFICITY: Widely expressed at low level. Expressed in brain and skeletal muscle. Expressed by high endothelial cells (HEVs) and leukocytes. {ECO:0000269|PubMed:11310842, ECO:0000269|PubMed:9405439}.	GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0042339; GO:0045130		9405439; 9639683; 10049591; 15489334; 10642612; 10330415; 11310842; 17690104	Sulfotransferase 1 family, Gal/GlcNAc/GalNAc subfamily
O43918	AIRE_HUMAN	Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)	AIRE APECED	545	9606			3D-structure;Activator;Alternative splicing;Cytoplasm;Direct protein sequencing;Disease variant;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	O43918; Q9UER7; P68431; P16333; P78527	TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in thymus (medullary epithelial cells and monocyte-dendritic cells), pancreas, adrenal cortex and testis. Expressed at lower level in the spleen, fetal liver and lymph nodes. In secondary lymphoid organs, expressed in a discrete population of bone marrow-derived toleregenic antigen presenting cells (APCs) called extrathymic AIRE expressing cells (eTAC)(at protein level) (PubMed:23993652). Isoform 2 and isoform 3 seem to be less frequently expressed than isoform 1, if at all. {ECO:0000269|PubMed:23993652}.	GO:0000977; GO:0002458; GO:0002509; GO:0003682; GO:0005634; GO:0005737; GO:0006355; GO:0006955; GO:0006959; GO:0008270; GO:0016604; GO:0032722; GO:0042393; GO:0042802; GO:0045060; GO:0045182; GO:0045893; GO:0045944; GO:0097536; GO:2000410	PTM: Phosphorylated. Phosphorylation could trigger oligomerization. {ECO:0000269|PubMed:11533054}.	9398839; 9398840; 10830953; 15489334; 9931333; 11533054; 10677297; 11274163; 14974083; 18292755; 19302042; 23993652; 26972725; 15649886; 19293276; 19446523; 9888391; 9717837; 11275943; 11524731; 11524733; 11600535; 12173302; 12625412; 11836330; 12050215; 15712268; 16114041; 26084028; 27426947	
O43920	NDUS5_HUMAN	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa, CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit)	NDUFS5	106	9606			3D-structure;Disulfide bond;Electron transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Reference proteome;Respiratory chain;Transport	Q9NP61; P42858; Q2NKQ1-4; Q496A3		GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776		9653160; 10070614; 15489334; 12611891; 21269460; 21310150; 22814378; 24275569; 25944712; 27626371; 20818383	Complex I NDUFS5 subunit family
O43921	EFNA2_HUMAN	Ephrin-A2 (EPH-related receptor tyrosine kinase ligand 6, LERK-6) (HEK7 ligand, HEK7-L)	EFNA2 EPLG6 LERK6	213	9606			3D-structure;Cell membrane;Disulfide bond;Glycoprotein;GPI-anchor;Lipoprotein;Membrane;Reference proteome;Signal	P54764		GO:0005886; GO:0007267; GO:0007411; GO:0021772; GO:0030316; GO:0031225; GO:0031594; GO:0043204; GO:0046849; GO:0046875; GO:0048013		9465306; 9826538; 15057824; 19836338	Ephrin family
O43924	PDE6D_HUMAN	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta, GMP-PDE delta (Protein p17)	PDE6D PDED	150	9606			3D-structure;Cell projection;cGMP;Ciliopathy;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Joubert syndrome;Membrane;Reference proteome;Sensory transduction;Vision	Q9NXU5; Q0P5N6; P36404; P36405; Q5XKR4; P51153; PRO_0000082708 [Q15382]; Q92834; Q92834-2; Q9D0J4; Q9WUL7; Q7DB77	TISSUE SPECIFICITY: Widely expressed. Detected in various tissues including spleen, prostate gland, testis, ovary, small intestine, colon, retina, and peripheral blood. {ECO:0000269|PubMed:9712853}.	GO:0005095; GO:0005737; GO:0005829; GO:0005856; GO:0005929; GO:0007601; GO:0030659; GO:0031267; GO:0031410; GO:0050896		9570951; 9533031; 9781033; 9712853; 15489334; 10518933; 9990021; 21269460; 24166846; 11980706; 22002721; 23559067; 23698361	PDE6D/unc-119 family
O43927	CXL13_HUMAN	C-X-C motif chemokine 13 (Angie) (B cell-attracting chemokine 1, BCA-1) (B lymphocyte chemoattractant) (CXC chemokine BLC) (Small-inducible cytokine B13)	CXCL13 BCA1 BLC SCYB13	109	9606			3D-structure;Chemotaxis;Cytokine;Disulfide bond;Inflammatory response;Reference proteome;Secreted;Signal		TISSUE SPECIFICITY: Highest levels in liver, followed by spleen, lymph node, appendix and stomach. Low levels in salivary gland, mammary gland and fetal spleen.	GO:0002467; GO:0002518; GO:0002544; GO:0002920; GO:0005576; GO:0005615; GO:0006954; GO:0006955; GO:0007166; GO:0007204; GO:0007267; GO:0008009; GO:0008201; GO:0010820; GO:0017134; GO:0030593; GO:0031640; GO:0031724; GO:0031735; GO:0033625; GO:0033634; GO:0035754; GO:0035768; GO:0042742; GO:0045236; GO:0045765; GO:0048018; GO:0048248; GO:0061844; GO:0070098; GO:0071222; GO:0090630; GO:2000545		9486651; 9463416; 15489334	Intercrine alpha (chemokine CxC) family
O43929	ORC4_HUMAN	Origin recognition complex subunit 4	ORC4 ORC4L	436	9606			3D-structure;Alternative splicing;ATP-binding;Disease variant;DNA replication;DNA-binding;Dwarfism;Methylation;Nucleotide-binding;Nucleus;Reference proteome	Q13416; Q9UBD5; O43913; Q9Y5N6; Q7LG56; P15884		GO:0000166; GO:0000781; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005730; GO:0005829; GO:0006270		9353276; 14702039; 15815621; 15489334; 12909626; 17716973; 20068231; 21269460; 22427655; 24129315; 24989122; 21358632; 21358631	ORC4 family
O43933	PEX1_HUMAN	Peroxisome biogenesis factor 1 (Peroxin-1) (Peroxisome biogenesis disorder protein 1)	PEX1	1283	9606			Alternative splicing;Amelogenesis imperfecta;ATP-binding;Cytoplasm;Deafness;Disease variant;Membrane;Nucleotide-binding;Peroxisome;Peroxisome biogenesis;Peroxisome biogenesis disorder;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport;Zellweger syndrome	Q9NYG5; P13928; Q9NP61; Q16520; Q9UNS2; Q5TAQ9-2; Q9BPU6; O60841; Q8TE68-3; Q8NCL4; P68431; A0A024R1L7; Q8IY31-3; Q9UNL4; Q9NVX7-2; P57682; Q8N1A0; Q68G74; Q9NS73-5; P41218; O43196-4; Q96A32; Q13608; O75925; Q8TBJ4; Q8TCX5; Q8N488; Q9C0C4; Q9NTN9-3; Q13530; Q6RVD6; Q9UJZ1; Q8WUA7-2; Q96EI5; P19429; P45880; Q9GZS3; O00308; Q8TBF4; Q9UJW8-4; Q8N895; Q86V28		GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016887; GO:0044877; GO:0060152; GO:0070062		9398848; 9398847; 9539740; 11439091; 14702039; 12690205; 12853948; 15489334; 12717447; 18669648; 19413330; 19105186; 19690332; 20068231; 21269460; 21406692; 23186163; 26387595; 16088892; 27302843	AAA ATPase family
O60216	RAD21_HUMAN	Double-strand-break repair protein rad21 homolog, hHR21 (Nuclear matrix protein 1, NXP-1) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product) (65-kDa carboxy-terminal product) ]	RAD21 HR21 KIAA0078 NXP1 SCC1	631	9606			3D-structure;Activator;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;Cytoskeleton;Developmental protein;Direct protein sequencing;Disease variant;DNA damage;DNA repair;DNA-binding;Isopeptide bond;Mental retardation;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	Q13643; Q29RF7; Q9NTI5; Q14683; Q9UQE7; Q9NP77; Q8N3U4; Q7Z5K2	TISSUE SPECIFICITY: Expressed in the gut (at protein level). {ECO:0000269|PubMed:25575569}.	GO:0000775; GO:0000785; GO:0000795; GO:0000922; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006302; GO:0006310; GO:0006357; GO:0006915; GO:0007064; GO:0007130; GO:0007131; GO:0008278; GO:0010972; GO:0016020; GO:0016363; GO:0030496; GO:0034089; GO:0034990; GO:0034991; GO:0045841; GO:0045876; GO:0051301; GO:0071168; GO:1990414	PTM: Cleaved by separase/ESPL1 at the onset of anaphase; this cleavage is required for sister chromatid separation and cytokinesis (PubMed:11509732). Cleaved by caspase-3/CASP3 or caspase-7/CASP7 at the beginning of apoptosis (PubMed:12417729, PubMed:11875078). {ECO:0000269|PubMed:11509732, ECO:0000269|PubMed:11875078, ECO:0000269|PubMed:12417729}.; PTM: Phosphorylated; becomes hyperphosphorylated in M phase of cell cycle. The large dissociation of cohesin from chromosome arms during prophase may be partly due to its phosphorylation by PLK1. {ECO:0000269|PubMed:11073952}.	8812457; 7584044; 14702039; 15489334; 10931856; 11590136; 11931760; 12417729; 10623634; 11073952; 11509732; 11875078; 12198550; 15837422; 17105772; 18669648; 19696148; 11483345; 19690332; 20068231; 21269460; 22628566; 23186163; 24275569; 28112733; 22633399; 25575569; 31334757	Rad21 family
O60218	AK1BA_HUMAN	Aldo-keto reductase family 1 member B10, EC 1.1.1.300, EC 1.1.1.54 (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein, ARP, hARP) (Small intestine reductase, SI reductase)	AKR1B10 AKR1B11	316	9606	PATHWAY: Cofactor metabolism; retinol metabolism. {ECO:0000269|PubMed:12732097, ECO:0000269|PubMed:18087047}.	1.1.1.300; 1.1.1.54	3D-structure;Acetylation;Lipid metabolism;Lysosome;NADP;Oxidoreductase;Reference proteome;Secreted	Q13085; Q9NYB0	TISSUE SPECIFICITY: Found in many tissues. Highly expressed in small intestine, colon and adrenal gland. {ECO:0000269|PubMed:9565553}.	GO:0001523; GO:0001758; GO:0004032; GO:0004033; GO:0005576; GO:0005739; GO:0005764; GO:0005829; GO:0008106; GO:0016488; GO:0044597; GO:0044598; GO:0045550; GO:0047655; GO:0047718; GO:0052650; GO:0110095		9565553; 9765596; 12853948; 12690205; 15489334; 9537432; 12732097; 15755999; 19608861; 21585341; 19563777; 19013440; 18087047; 21269460	Aldo/keto reductase family
O60220	TIM8A_HUMAN	Mitochondrial import inner membrane translocase subunit Tim8 A (Deafness dystonia protein 1) (X-linked deafness dystonia protein)	TIMM8A DDP DDP1 TIM8A	97	9606			Chaperone;Deafness;Disease variant;Disulfide bond;Dystonia;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transport;Zinc	Q99856; Q8WUW1; Q9BXJ5; Q969G5; P48643; Q53GS7; P42858; P19012; O43482; Q7Z699; O75886; Q9Y5L4; O60220; O76024	TISSUE SPECIFICITY: Highly expressed in fetal and adult brain, followed by fetal lung, liver and kidney. Also expressed in heart, placenta, lung, liver, kidney, pancreas, skeletal muscle and heart.	GO:0005739; GO:0005743; GO:0005758; GO:0007399; GO:0042719; GO:0042802; GO:0045039; GO:0046872		8841189; 14702039; 15772651; 15489334; 10051608; 10051550; 11489896; 15254020; 11803487; 18669648; 21269460; 21406692; 23186163; 24275569; 10878669; 11875042; 11956200	Small Tim family
O60229	KALRN_HUMAN	Kalirin, EC 2.7.11.1 (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)	KALRN DUET DUO HAPIP TRAD	2986	9606		2.7.11.1	3D-structure;Alternative splicing;ATP-binding;Cytoplasm;Cytoskeleton;Disulfide bond;Guanine-nucleotide releasing factor;Immunoglobulin domain;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Serine/threonine-protein kinase;SH3 domain;Transferase	PRO_0000449631 [P0DTD1]; PRO_0000449633 [P0DTD1]; Q9Y6H5-1	TISSUE SPECIFICITY: Isoform 2 is brain specific. Highly expressed in cerebral cortex, putamen, amygdala, hippocampus and caudate nucleus. Weakly expressed in brain stem and cerebellum. Isoform 4 is expressed in skeletal muscle. {ECO:0000269|PubMed:10023074}.	GO:0004674; GO:0004712; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0007417; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310	PTM: Autophosphorylated.	9285789; 10023074; 14702039; 16641997; 15489334; 17974005; 18088087; 18669648; 19807924; 22738176; 16959974; 17344846	Protein kinase superfamily, CAMK Ser/Thr protein kinase family
O60231	DHX16_HUMAN	Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, EC 3.6.4.13 (ATP-dependent RNA helicase #3) (DEAH-box protein 16)	DHX16 DBP2 DDX16 KIAA0577 PRP2	1041	9606		3.6.4.13	3D-structure;ATP-binding;Disease variant;Helicase;Hydrolase;mRNA processing;mRNA splicing;Neuropathy;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Spliceosome	Q92620; Q92917; Q13435; Q9HCS7	TISSUE SPECIFICITY: Expressed in the spleen, thyroid and testis. Also expressed in the brain and cerebellum. {ECO:0000269|PubMed:31256877}.	GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0008380; GO:0016887; GO:0071005		9547260; 9628581; 14574404; 15489334; 17081983; 16964243; 18669648; 18318008; 19413330; 19690332; 20423332; 20841358; 20068231; 21269460; 21406692; 23186163; 25296192; 31256877; 29360106	DEAD box helicase family, DEAH subfamily, DDX16/PRP8 sub-subfamily
O60232	ZNRD2_HUMAN	Protein ZNRD2 (Autoantigen p27) (Sjoegren syndrome/scleroderma autoantigen 1) (Zinc ribbon domain-containing protein 2)	ZNRD2 SSSCA1	199	9606			3D-structure;Acetylation;Cell cycle;Cell division;Mitosis;Phosphoprotein;Reference proteome	P35609; P51946; P78371; P49368; P48643; Q99832; V9HW96; V9HW37; Q0VD86; O75928-2; P78317; O75971; G2XKQ0; Q9Y228; Q7KZS0; Q9UJ78-2; Q9Q2G4		GO:0000278; GO:0051301		9486406; 15489334; 17525332; 19413330; 21269460; 22814378	
O60235	TM11D_HUMAN	Transmembrane protease serine 11D, EC 3.4.21.- (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain ]	TMPRSS11D HAT	418	9606		3.4.21.-	Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Hydrolase;Membrane;Protease;Reference proteome;Secreted;Serine protease;Signal-anchor;Transmembrane;Transmembrane helix;Zymogen	O43765	TISSUE SPECIFICITY: Located in the cells of the submucosal serous glands of the bronchi and trachea.	GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0007585; GO:0008233; GO:0070062		9565616; 15489334; 9070615; 23536651; 24227843	Peptidase S1 family
O60237	MYPT2_HUMAN	Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2, Myosin phosphatase target subunit 2)	PPP1R12B MYPT2	982	9606			Alternative promoter usage;Alternative splicing;ANK repeat;Cytoplasm;Cytoskeleton;Phosphoprotein;Reference proteome;Repeat	Q14204; P22607; Q14957; P06396; Q92569	TISSUE SPECIFICITY: Detected in skeletal muscle, fetal and adult heart, brain, placenta, kidney, spleen, thymus, pancreas and lung. Isoform 3 and isoform 4 are heart specific. {ECO:0000269|PubMed:11067852, ECO:0000269|PubMed:9570949}.	GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006937; GO:0007165; GO:0008047; GO:0019208; GO:0019901; GO:0030018; GO:0031672		9570949; 11067852; 16710414; 15489334; 12923170; 20068231; 23186163	
O60238	BNI3L_HUMAN	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X, NIP3L)	BNIP3L BNIP3A BNIP3H NIX	219	9606			Alternative splicing;Apoptosis;Endoplasmic reticulum;Host-virus interaction;Membrane;Mitochondrion;Mitochondrion outer membrane;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	Q15848; Q9NQ11; Q92934; P10415; Q12983; O60238; Q9BXN2; Q9BXN2-6; O43169; Q969F0; Q9H0R8; P60520; Q5T700; Q13021; Q9H492; P22736-1; Q9NRQ5; P17152; A0PK00; Q9NRS4; Q9H2S6-2; P03247; A0A663DJA2		GO:0005521; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005783; GO:0016021; GO:0016239; GO:0016607; GO:0031224; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043067; GO:0051607; GO:0060548; GO:0071456; GO:0097345; GO:1903146; GO:1903214	PTM: Undergoes progressive proteolysis to an 11 kDa C-terminal fragment, which is blocked by the proteasome inhibitor lactacystin.	9523198; 9867803; 10381623; 12663450; 14702039; 17974005; 16421571; 15489334; 12606722; 17081983; 20068231; 21264228; 23186163; 24275569	NIP3 family
O60239	3BP5_HUMAN	SH3 domain-binding protein 5, SH3BP-5 (SH3 domain-binding protein that preferentially associates with BTK)	SH3BP5 SAB	455	9606			3D-structure;Alternative splicing;Coiled coil;Cytoplasmic vesicle;Guanine-nucleotide releasing factor;Membrane;Mitochondrion;Phosphoprotein;Reference proteome;SH3-binding	Q06187; Q8IY31-3; Q9ULW6	TISSUE SPECIFICITY: Highly expressed in testis and ovaries. It is also expressed in a variety of tissues including spleen, lymph node, thymus, bone marrow, fetal liver, colon, small intestine and prostate. {ECO:0000269|PubMed:9571151}.	GO:0004860; GO:0005085; GO:0005654; GO:0005737; GO:0005739; GO:0007165; GO:0016604; GO:0017124; GO:0030659; GO:0035556; GO:0061099		17974005; 14702039; 16641997; 15489334; 9571151; 10339589; 12167088; 16964243; 18669648; 19413330; 20068231; 23186163; 26506309; 30217979	SH3BP5 family
O60240	PLIN1_HUMAN	Perilipin-1 (Lipid droplet-associated protein)	PLIN1 PERI PLIN	522	9606			Endoplasmic reticulum;Lipid droplet;Lipid metabolism;Phosphoprotein;Reference proteome	O14520	TISSUE SPECIFICITY: Detected in adipocytes from white adipose tissue (at protein level) (PubMed:27832861). Detected in visceral adipose tissue and mammary gland (PubMed:9521880). {ECO:0000269|PubMed:27832861, ECO:0000269|PubMed:9521880}.	GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0008289; GO:0016042; GO:0070417	PTM: Major cAMP-dependent protein kinase-substrate in adipocytes, also dephosphorylated by PP1. When phosphorylated, may be maximally sensitive to HSL and when unphosphorylated, may play a role in the inhibition of lipolysis, by acting as a barrier in lipid droplet (By similarity). {ECO:0000250}.	9521880; 16572171; 15489334; 21345103; 23399566; 24275569; 26357594; 27832861	Perilipin family
O60241	AGRB2_HUMAN	Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2)	ADGRB2 BAI2	1585	9606			Alternative splicing;Cell membrane;Direct protein sequencing;Disease variant;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transducer;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Strongly expressed in brain. Also detected in heart, thymus, skeletal muscle, and different cell lines.	GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016021; GO:0016525; GO:0033173	PTM: Autoproteolytic processes at the GPS domain; this cleavage modulates receptor activity. Additionally, furin is involved in the cleavage at another site, in the middle of the extracellular domain, generating a soluble fragment. {ECO:0000269|PubMed:20367554}.; PTM: Glycosylated. {ECO:0000269|PubMed:20367554}.	9533023; 16710414; 15489334; 20367554; 21787750; 25713288; 28891236	G-protein coupled receptor 2 family, Adhesion G-protein coupled receptor (ADGR) subfamily
O60242	AGRB3_HUMAN	Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3)	ADGRB3 BAI3 KIAA0550	1522	9606			3D-structure;Alternative splicing;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transducer;Transmembrane;Transmembrane helix	Q8N954; O60883; P15941-11; P30825; Q96MV1; Q9ESN4	TISSUE SPECIFICITY: Strongly expressed in brain. Also detected in heart. Reduced expression in some glioblastoma cell lines. {ECO:0000269|PubMed:9533023}.	GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558	PTM: The endogenous protein is proteolytically cleaved into 2 subunits, an extracellular subunit and a seven-transmembrane subunit. {ECO:0000269|PubMed:22333914}.	9533023; 9628581; 12168954; 14702039; 14574404; 15489334; 18669648; 21262840; 24567399; 22333914; 25713288	G-protein coupled receptor 2 family, Adhesion G-protein coupled receptor (ADGR) subfamily
O60243	H6ST1_HUMAN	Heparan-sulfate 6-O-sulfotransferase 1, HS6ST-1, EC 2.8.2.-	HS6ST1 HS6ST	411	9606		2.8.2.-	Alternative splicing;Coiled coil;Disease variant;Glycoprotein;Hypogonadotropic hypogonadism;Kallmann syndrome;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix	Q15323; P60410	TISSUE SPECIFICITY: Expressed in fetal brain. {ECO:0000269|PubMed:9535912}.	GO:0000139; GO:0001525; GO:0005887; GO:0006024; GO:0008146; GO:0015015; GO:0017095; GO:0048286; GO:0048666; GO:0060716	PTM: N-glycosylated. {ECO:0000250}.	9535912; 14702039; 15815621; 15489334; 21700882; 25077900	Sulfotransferase 6 family
O60244	MED14_HUMAN	Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component, ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2, CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog, hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component, Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component, DRIP150)	MED14 ARC150 CRSP2 CXorf4 DRIP150 EXLM1 RGR1 TRAP170	1454	9606			3D-structure;Activator;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	Q96RN5; Q9Y2X0; Q9ULK4; Q71SY5	TISSUE SPECIFICITY: Ubiquitous.	GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0019827; GO:0030374; GO:0032968; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847		9598311; 9989412; 10235266; 10024883; 15489334; 9734358; 10235267; 12218053; 11867769; 12509459; 15175163; 15340088; 15625066; 15989967; 16595664; 18691976; 18669648; 19369195; 19690332; 20068231; 21269460; 23186163; 16959974	Mediator complex subunit 14 family
O60248	SOX15_HUMAN	Protein SOX-15 (Protein SOX-12) (Protein SOX-20)	SOX15 SOX12 SOX20 SOX26 SOX27	233	9606			Activator;Alternative splicing;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	O14503; Q96LI6	TISSUE SPECIFICITY: Widely expressed in fetal and adult tissues examined, highest level found in fetal spinal cord and adult brain and testis. {ECO:0000269|PubMed:8978787, ECO:0000269|PubMed:9880678}.	GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006325; GO:0006355; GO:0006357; GO:0008584; GO:0009653; GO:0014718; GO:0030154; GO:0043403; GO:0045843; GO:0045944; GO:0048627; GO:0060707; GO:0070318; GO:2000288		9540826; 14702039; 16625196; 15489334; 8978787; 8332506; 9880678; 21406692	
O60256	KPRB_HUMAN	Phosphoribosyl pyrophosphate synthase-associated protein 2, PRPP synthase-associated protein 2 (41 kDa phosphoribosypyrophosphate synthetase-associated protein, PAP41)	PRPSAP2	369	9606			3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Nucleotide biosynthesis;Phosphoprotein;Reference proteome	P60891; P11908-2; Q14558; O60256; Q8IYF3-3	TISSUE SPECIFICITY: Ubiquitous.	GO:0000287; GO:0002189; GO:0004749; GO:0004857; GO:0005737; GO:0006015; GO:0006139; GO:0006164; GO:0042802; GO:0060348		9545573; 14702039; 16625196; 15489334; 17081983; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569	Ribose-phosphate pyrophosphokinase family
O60258	FGF17_HUMAN	Fibroblast growth factor 17, FGF-17	FGF17 UNQ161/PRO187	216	9606			Alternative splicing;Developmental protein;Disease variant;Glycoprotein;Growth factor;Hypogonadotropic hypogonadism;Kallmann syndrome;Reference proteome;Secreted;Signal	Q9UHD9	TISSUE SPECIFICITY: Preferentially expressed in the embryonic brain.	GO:0001934; GO:0005104; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0030154; GO:0030334		9514906; 12975309; 15489334; 16597617; 20094046; 23643382	Heparin-binding growth factors family
O60259	KLK8_HUMAN	Kallikrein-8, hK8, EC 3.4.21.118 (Neuropsin, NP) (Ovasin) (Serine protease 19) (Serine protease TADG-14) (Tumor-associated differentially expressed gene 14 protein)	KLK8 NRPN PRSS19 TADG14 UNQ283/PRO322	260	9606		3.4.21.118	3D-structure;Alternative splicing;Cytoplasm;Disulfide bond;Glycoprotein;Hydrolase;Protease;Reference proteome;Secreted;Serine protease;Signal;Zymogen	A8MQ03; P42858; Q92876; Q15323; O76011; Q07627; P60410; P26371; Q7Z3S9; P0DPK4; P50454; P37173; Q8IUH5	TISSUE SPECIFICITY: Isoform 1 is predominantly expressed in the pancreas. Isoform 2 is expressed in adult brain and hippocampus. Isoform 1 and isoform 2 are found in fetal brain and placenta. Detected in salivary gland, uterus, thymus, breast, testis and kidney but not in spleen, liver, lung or normal ovarian tissue. Displays an 11.5-fold increase in Alzheimer disease hippocampus compared to controls and is overexpressed in some ovarian carcinomas. Expressed at low levels in normal skin while high levels are found in psoriasis vulgaris, seborrheic keratosis, lichen planus and squamous cell carcinoma skin samples. Expressed in the keratinocytes. {ECO:0000269|PubMed:11309326, ECO:0000269|PubMed:11522960, ECO:0000269|PubMed:12147714, ECO:0000269|PubMed:17761692}.	GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0007613; GO:0008219; GO:0009611; GO:0030141; GO:0031642; GO:0043616; GO:0048681; GO:0048812; GO:0050807; GO:0050808; GO:0097180		9714609; 10485494; 10102990; 11054574; 11309326; 12975309; 15057824; 15489334; 15282331; 11522960; 12147714; 12782581; 16337200; 17487847; 17761692; 19194479	Peptidase S1 family, Kallikrein subfamily
O60260	PRKN_HUMAN	E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)	PRKN PARK2	465	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.31	3D-structure;Alternative splicing;Autophagy;Cell junction;Cell projection;Cytoplasm;Disease variant;Endoplasmic reticulum;Membrane;Metal-binding;Mitochondrion;Mitochondrion outer membrane;Neurodegeneration;Nucleus;Parkinson disease;Parkinsonism;Phosphoprotein;Reference proteome;Repeat;S-nitrosylation;Synapse;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	P54252-2; Q8IZ52-2; Q9Y3I1; Q9Y3I1-1; Q9UBN7; P08238; Q5S007; O95140; Q16342; Q9BXM7; Q9BXM7-1; O60260; P49792; Q8IXI2; Q15645; Q6NUN9; Q9Z2Q6; P68510; PRO_0000045592 [Q99IB8]; Q6ZTN6-2; Q86WR3; P63010-2; P05067; Q0P5N6; Q86TN1; Q8WXK3; Q8WXK3-2; Q9Y575-3; Q9H672-2; Q96DX5; Q96DX5-3; Q9H0Y0; P54253; O14867; P46379-2; A8KA13; Q8WUW1; P29466-3; Q13939; P78396-2; Q00535; Q9UNS2; Q9UBU7; Q5QP82-2; P61962; Q5TAQ9-2; Q9BW61; Q8NDP9; P78352-2; P31689; A0A024RCP2; O75530-2; Q8TC29; Q6P1L5; O00757; P57775; Q9UHY8; P22607; Q9H2C0; Q9NXC2; Q96IK5; P62879; Q7Z602; P06396; P68431; Q86YM7; P0DMV8; P11142; Q6DN90-2; Q8NA54; P05161; Q9UKP3-2; Q9NVX7-2; Q9UIH9; Q6TDP4; O94889; Q9Y2M5; Q8WZ60; Q3SY46; Q9BYQ4; Q9BYZ2; Q8TBB1; O95777; Q9GZQ8; P10636-6; P61244-4; Q8TDB4; A4FUJ8; P51948; Q8N594; Q9Y483-4; Q9NPC7; Q96FW1; Q6GQQ9-2; P68402; Q9NR21-5; Q9HBE1-4; Q96MG8; Q9NV79; Q13113; Q96LB9; Q6ZR37; P25786; P40306; P28070; O60671; Q8NDN9-2; P41220; A0A087WUY2; O94844; Q8N5U6; Q9Y3C5; Q6ZNA4-2; Q9ULX5; Q8WVD3; Q9UBS8; Q96A37; Q96D59; Q96BH1; P08865; Q8N488; Q15393; Q2NKQ1-4; Q14190-2; Q9HCE7-2; P37840; Q9Y6H5-5; Q96DI7; O14544; Q99932-2; Q8IUW3; Q8TCT7-2; Q7Z699; Q9C004; Q96BD6; Q99619; O75886; O95630; Q9UNE7; Q9BT88; Q13148; Q16650; Q15554-4; Q04724; Q71RG4-4; Q9H0E2; P19474; Q9UPQ4-2; Q8NBM4-4; P57075-2; P0CG47; O15205; Q9Y385; P68036; P61081; Q9C0C9; Q13404; Q04323-2; Q9Y3C8; Q96RL1-2; O75604-3; P18206-2; P45880; P40337-2; Q9UBQ0-2; Q9GZS3; O00308; Q04917; O43167-2; Q15916; Q9Y649	TISSUE SPECIFICITY: Highly expressed in the brain including the substantia nigra (PubMed:9560156, PubMed:19501131). Expressed in heart, testis and skeletal muscle (PubMed:9560156). Expression is down-regulated or absent in tumor biopsies, and absent in the brain of PARK2 patients (PubMed:14614460, PubMed:12719539). Overexpression protects dopamine neurons from kainate-mediated apoptosis (PubMed:12628165). Found in serum (at protein level) (PubMed:19501131). {ECO:0000269|PubMed:12628165, ECO:0000269|PubMed:12719539, ECO:0000269|PubMed:14614460, ECO:0000269|PubMed:19501131, ECO:0000269|PubMed:9560156}.	GO:0000122; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0001664; GO:0001933; GO:0001964; GO:0003714; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007417; GO:0007612; GO:0008013; GO:0008270; GO:0008344; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010906; GO:0010994; GO:0014059; GO:0014069; GO:0015631; GO:0016235; GO:0016236; GO:0016567; GO:0016579; GO:0016607; GO:0017124; GO:0019899; GO:0019900; GO:0019901; GO:0030165; GO:0030544; GO:0031072; GO:0031396; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032368; GO:0032436; GO:0033132; GO:0034620; GO:0034976; GO:0035249; GO:0035519; GO:0036503; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043123; GO:0043130; GO:0043161; GO:0043274; GO:0043388; GO:0043524; GO:0044257; GO:0044314; GO:0044828; GO:0044877; GO:0045732; GO:0045944; GO:0046329; GO:0046676; GO:0048471; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051865; GO:0051881; GO:0055069; GO:0060548; GO:0060828; GO:0061630; GO:0061734; GO:0070050; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0071287; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0097237; GO:0097413; GO:0097602; GO:0098779; GO:0098793; GO:0099074; GO:1900407; GO:1901215; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1902803; GO:1903202; GO:1903214; GO:1903265; GO:1903351; GO:1903377; GO:1903382; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1905281; GO:1905366; GO:1905477; GO:1990000; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378	PTM: Auto-ubiquitinates in an E2-dependent manner leading to its own degradation (PubMed:19229105, PubMed:25474007, PubMed:23770917). Also polyubiquitinated by RNF41 for proteasomal degradation (PubMed:19229105). {ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:23770917, ECO:0000269|PubMed:25474007}.; PTM: S-nitrosylated. The inhibition of PRKN ubiquitin E3 ligase activity by S-nitrosylation could contribute to the degenerative process in PD by impairing the ubiquitination of PRKN substrates. {ECO:0000269|PubMed:15105460}.; PTM: Phosphorylated (PubMed:23754282, PubMed:24660806, PubMed:24784582, PubMed:18957282, PubMed:25474007). Activation requires phosphorylation at Ser-65 by PINK1 and binding to PINK1 phosphorylated ubiquitin (PubMed:23754282, PubMed:24660806, PubMed:24784582, PubMed:18957282, PubMed:25474007). Phosphorylation at Thr-175 by PINK1 and at Thr-217 is important for mitochondrial localization (PubMed:18957282). {ECO:0000269|PubMed:18957282, ECO:0000269|PubMed:23754282, ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25474007}.	9560156; 19501131; 14702039; 14574404; 15489334; 10319893; 10973942; 10888878; 11078524; 11439185; 11590439; 11431533; 12446796; 12150907; 12925569; 14532270; 12628165; 14614460; 12719539; 15229644; 15105460; 15987638; 15728840; 16135753; 16352719; 16332688; 16955485; 17846173; 18957282; 19029340; 18541373; 19229105; 19801972; 20798600; 20889974; 19966284; 21376232; 20889486; 21753002; 21532592; 22082830; 22396657; 23754282; 23933751; 24270810; 23770917; 23620051; 24660806; 24898855; 25474007; 24751536; 24784582; 24896179; 25527291; 25621951; 32047033; 33499712; 12634850; 17360614; 23727886; 23770887; 14976155; 9731209; 10072423; 10511432; 10939576; 10965160; 10824074; 11179010; 11487568; 11163284; 12116199; 12112109; 12056932; 12114481; 12397156; 11971093; 12362318; 12730996; 12629236; 12781599; 15584030; 20404107; 22956510; 27535533; 29311685	RBR family, Parkin subfamily
O60264	SMCA5_HUMAN	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5, EC 3.6.4.- (Sucrose nonfermenting protein 2 homolog, hSNF2H)	SMARCA5 SNF2H WCRF135	1052	9606		3.6.4.-	3D-structure;Acetylation;ATP-binding;Chromatin regulator;Chromosome;Helicase;Host-virus interaction;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	Q9NRL2; Q9UIG0; P62805; Q96T23	TISSUE SPECIFICITY: Ubiquitously expressed.	GO:0000183; GO:0000793; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005730; GO:0006275; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0006357; GO:0008094; GO:0008623; GO:0016479; GO:0016584; GO:0016589; GO:0016590; GO:0016887; GO:0031062; GO:0031065; GO:0031213; GO:0031491; GO:0031497; GO:0035066; GO:0042766; GO:0044030; GO:0045740; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0090536; GO:0110016; GO:0140658; GO:1905213; GO:1990164; GO:1990830; GO:2001020		9730600; 15489334; 10880450; 10914549; 10655480; 11435432; 11980720; 12434153; 12198550; 12972596; 15284901; 14759371; 15543136; 17081983; 16603771; 17693683; 18691976; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 23186163; 23911928; 24275569; 26100909; 28801535; 28112733; 33092197	SNF2/RAD54 helicase family, ISWI subfamily
O60266	ADCY3_HUMAN	Adenylate cyclase type 3, EC 4.6.1.1 (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III, AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3, AC3)	ADCY3 KIAA0511	1144	9606		4.6.1.1	Alternative splicing;ATP-binding;Calmodulin-binding;cAMP biosynthesis;Cell membrane;Cell projection;Cytoplasm;Glycoprotein;Golgi apparatus;Isopeptide bond;Lyase;Magnesium;Manganese;Membrane;Metal-binding;Nucleotide-binding;Obesity;Olfaction;Phosphoprotein;Reference proteome;Repeat;Sensory transduction;Transmembrane;Transmembrane helix;Ubl conjugation		TISSUE SPECIFICITY: Detected in zona glomerulosa and zona fasciculata in the adrenal gland (at protein level) (PubMed:11549699). Expressed in brain, heart, kidney, liver, lung, pancreas islets, placenta, and skeletal muscle (PubMed:9920776). Detected in testis (PubMed:15705663). {ECO:0000269|PubMed:11549699, ECO:0000269|PubMed:15705663, ECO:0000269|PubMed:9920776}.	GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0016021; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322	PTM: Sumoylated. Sumoylation is required for targeting ot olfactory cilia. {ECO:0000250|UniProtKB:P21932}.; PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q8VHH7}.; PTM: Rapidly phosphorylated after stimulation by odorants or forskolin. Phosphorylation by CaMK2 at Ser-1076 down-regulates enzyme activity. {ECO:0000250|UniProtKB:Q8VHH7}.	9920776; 14702039; 15815621; 15489334; 9628581; 8476432; 11549699; 15705663; 23186163; 29311636; 29311637	Adenylyl cyclase class-4/guanylyl cyclase family
O60269	GRIN2_HUMAN	G protein-regulated inducer of neurite outgrowth 2, GRIN2	GPRIN2 KIAA0514	458	9606			Reference proteome	Q13639; P31947	TISSUE SPECIFICITY: Expressed specifically in the cerebellum. {ECO:0000269|PubMed:10480904}.	GO:0005886; GO:0031175		9628581; 15164054; 15489334; 10480904	
O60271	JIP4_HUMAN	C-Jun-amino-terminal kinase-interacting protein 4, JIP-4, JNK-interacting protein 4 (Cancer/testis antigen 89, CT89) (Human lung cancer oncogene 6 protein, HLC-6) (JNK-associated leucine-zipper protein, JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis, PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1)	SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6	1321	9606			3D-structure;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Lysosome;Membrane;Phosphoprotein;Reference proteome	P84077; P62330; Q96A65; P61006; P62331	TISSUE SPECIFICITY: Expressed only in testis on the round spermatids of stage I, II and II. Absent in spermatogonia and spermatocyte. {ECO:0000269|PubMed:9480848}.; TISSUE SPECIFICITY: [Isoform 4]: Expressed in testis and in acute myeloid leukemia (AML) patients. {ECO:0000269|PubMed:16112646}.; TISSUE SPECIFICITY: [Isoform 3]: Expressed in testis. {ECO:0000269|PubMed:14662895}.	GO:0001669; GO:0001933; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0045665; GO:0045666; GO:0048471; GO:0051146; GO:0070062; GO:1903860	PTM: Phosphorylated by MAPK8 and MAPK14. {ECO:0000250}.	12391307; 16112646; 9628581; 12168954; 14702039; 16625196; 15489334; 9480848; 14662895; 15144186; 14743216; 15693750; 17081983; 17525332; 18220336; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 29146937; 19644450	JIP scaffold family
O60281	ZN292_HUMAN	Zinc finger protein 292	ZNF292 KIAA0530	2723	9606			3D-structure;Acetylation;Alternative splicing;Autism spectrum disorder;Coiled coil;Disease variant;DNA-binding;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger			GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872		14574404; 14702039; 9628581; 19690332; 31723249	Krueppel C2H2-type zinc-finger protein family
O60282	KIF5C_HUMAN	Kinesin heavy chain isoform 5C (Kinesin heavy chain neuron-specific 2)	KIF5C KIAA0531 NKHC2	957	9606			Alternative splicing;ATP-binding;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Disease variant;Microtubule;Motor protein;Nucleotide-binding;Reference proteome;Transport	P68400; P19784; Q8IXI2; Q6FHY5	TISSUE SPECIFICITY: Highest expression in brain, prostate and testis, and moderate expression in kidney, small intestine and ovary.	GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0006996; GO:0007018; GO:0007411; GO:0008017; GO:0008045; GO:0008574; GO:0016887; GO:0030705; GO:0032839; GO:0035253; GO:0043025; GO:0044295; GO:0048489; GO:0051028; GO:0098971; GO:0099641; GO:0150034; GO:1904115		9628581; 15815621; 15489334; 9361024; 15644324; 21269460; 24812067; 23033978; 23603762; 29048727	TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, Kinesin subfamily
O60284	ST18_HUMAN	Suppression of tumorigenicity 18 protein (Zinc finger protein 387)	ST18 KIAA0535 ZNF387	1047	9606			3D-structure;Coiled coil;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger		TISSUE SPECIFICITY: Detected at low levels in heart, liver, kidney, skeletal muscle, pancreas, testis, ovary and prostate. Detected at even lower levels in mammary epithelial cells and breast cancer cells. {ECO:0000269|PubMed:15489893}.	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0008285; GO:0032993; GO:0033209; GO:0045944; GO:0070102; GO:0070498; GO:2001269		9628581; 15489334; 15489893	MYT1 family
O60285	NUAK1_HUMAN	NUAK family SNF1-like kinase 1, EC 2.7.11.1 (AMPK-related protein kinase 5, ARK5) (Omphalocele kinase 1)	NUAK1 ARK5 KIAA0537 OMPHK1	661	9606		2.7.11.1	Acetylation;Alternative splicing;ATP-binding;Cell adhesion;Cytoplasm;DNA damage;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	O95835; Q9UQ35; P04637; Q93008	TISSUE SPECIFICITY: Expressed at high levels in heart and brain, and at lower levels in skeletal muscle, kidney, ovary, placenta, lung and liver. Highly up-regulated in colorectal cancer cell lines. {ECO:0000269|PubMed:14982852}.	GO:0001650; GO:0002039; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0042149; GO:0046872; GO:0106310; GO:1901796; GO:2000772	PTM: Ubiquitinated with 'Lys-29'- and 'Lys-33'-linked polyubiquitins which appear to impede LKB1-mediated phosphorylation. Deubiquitinated by USP9X. {ECO:0000269|PubMed:18254724}.; PTM: Phosphorylated at Thr-211 by STK11/LKB1 in complex with STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39. Not dephosphorylated by the myosin PP1 complex when regulating its activity, due to the presence of PPP1R12A, which prevents myosin PP1 from dephosphorylating NUAK1. Phosphorylated by STK38L upon stimulation with IGF1. {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:20354225}.	14976552; 9628581; 14702039; 16541075; 15489334; 12409306; 14982852; 15060171; 15273717; 16044163; 16424013; 16488889; 18254724; 19369195; 19927127; 20354225; 21317932; 25329316; 17344846	Protein kinase superfamily, CAMK Ser/Thr protein kinase family, SNF1 subfamily
O60291	MGRN1_HUMAN	E3 ubiquitin-protein ligase MGRN1, EC 2.3.2.27 (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1)	MGRN1 KIAA0544 RNF156	552	9606	PATHWAY: Protein modification; protein ubiquitination.	2.3.2.27	Alternative splicing;Cell membrane;Cytoplasm;Endosome;Lipoprotein;Membrane;Metal-binding;Myristate;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	Q99816		GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006513; GO:0008333; GO:0016020; GO:0016567; GO:0043231; GO:0043951; GO:0045744; GO:0045879; GO:0046872; GO:0061630; GO:0070062	PTM: Autoubiquitinated in vitro. {ECO:0000250}.	19737927; 9628581; 15616553; 15489334; 17229889; 18669648; 19703557; 20213681; 20068231; 22814378; 23186163	
O60292	SI1L3_HUMAN	Signal-induced proliferation-associated 1-like protein 3, SIPA1-like protein 3 (SPA-1-like protein 3)	SIPA1L3 KIAA0545 SPAL3	1781	9606			Acetylation;Cataract;Cell membrane;Chromosomal rearrangement;Coiled coil;GTPase activation;Membrane;Phosphoprotein;Reference proteome	P63104		GO:0001654; GO:0001725; GO:0002244; GO:0003382; GO:0005096; GO:0005615; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0007010; GO:0016324; GO:0045177; GO:0051056; GO:0061689; GO:0090162; GO:0090630		15057824; 9628581; 12168954; 18669648; 19690332; 19608861; 23186163; 24275569; 25804400; 26231217	
O60293	ZC3H1_HUMAN	Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)	ZFC3H1 CCDC131 KIAA0546 PSRC2	1989	9606			Acetylation;Alternative splicing;Coiled coil;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Zinc;Zinc-finger	P10242; P23560-2		GO:0000178; GO:0005615; GO:0005634; GO:0006396; GO:0046872		9628581; 15489334; 14702039; 17525332; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 27871484	
O60294	TYW4_HUMAN	tRNA wybutosine-synthesizing protein 4, tRNA yW-synthesizing protein 4, EC 2.1.1.290, EC 2.3.1.231 (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase)	LCMT2 KIAA0547 TYW4	686	9606	PATHWAY: tRNA modification; wybutosine-tRNA(Phe) biosynthesis.	2.1.1.290; 2.3.1.231	Methyltransferase;Reference proteome;S-adenosyl-L-methionine;Transferase;tRNA processing	O43707		GO:0005737; GO:0006400; GO:0008175; GO:0030488; GO:0031591		9628581; 15489334; 12853982	Methyltransferase superfamily, LCMT family
O60296	TRAK2_HUMAN	Trafficking kinesin-binding protein 2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 3 protein)	TRAK2 ALS2CR3 KIAA0549	914	9606			Alternative splicing;Coiled coil;Cytoplasm;Endosome;Glycoprotein;Mitochondrion;Phosphoprotein;Reference proteome;Transport		TISSUE SPECIFICITY: Widely expressed, with highest expression in heart.	GO:0005102; GO:0005737; GO:0005739; GO:0005769; GO:0005829; GO:0005886; GO:0006605; GO:0017022; GO:0022008; GO:0030425; GO:0031410; GO:0032839; GO:0047496; GO:0048311; GO:0050811; GO:0098957; GO:0098972; GO:1904115	PTM: O-glycosylated. {ECO:0000250}.	11161814; 14702039; 15815621; 9628581; 15489334; 16630562; 23186163; 24275569	Milton family
O60303	KATIP_HUMAN	Katanin-interacting protein	KATNIP KIAA0556	1618	9606			Cell projection;Ciliopathy;Coiled coil;Cytoplasm;Cytoskeleton;Joubert syndrome;Phosphoprotein;Reference proteome			GO:0005615; GO:0005737; GO:0005856; GO:0042995; GO:0090660		9628581; 12168954; 15616553; 15489334; 18669648; 23186163; 26714646; 30237576	
O60304	ZN500_HUMAN	Zinc finger protein 500 (Zinc finger protein with KRAB and SCAN domains 18)	ZNF500 KIAA0557 ZKSCAN18	480	9606			Alternative splicing;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	O95363; P14136; Q96MH2; O43464; P42858; Q8WXH2; O43189; Q7Z699		GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0046872		9628581; 14702039; 15616553; 15489334	Krueppel C2H2-type zinc-finger protein family
O60306	AQR_HUMAN	RNA helicase aquarius, EC 3.6.4.13 (Intron-binding protein of 160 kDa, IBP160)	AQR KIAA0560	1485	9606		3.6.4.13	3D-structure;Acetylation;ATP-binding;Helicase;Hydrolase;mRNA processing;mRNA splicing;Nucleotide-binding;Nucleus;Reference proteome;RNA-binding;Spliceosome	Q9ULR0; Q9UNP9; Q9HCS7; Q96NB3		GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013		9628581; 17974005; 15489334; 11991638; 16949364; 17981804; 19608861; 21269460; 24275569; 25599396; 28502770; 28076346	CWF11 family
O60307	MAST3_HUMAN	Microtubule-associated serine/threonine-protein kinase 3, EC 2.7.11.1	MAST3 KIAA0561	1309	9606		2.7.11.1	3D-structure;ATP-binding;Kinase;Magnesium;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase	P60484		GO:0000287; GO:0004674; GO:0004712; GO:0005524; GO:0007010; GO:0018105; GO:0035556; GO:0106310		15057824; 9628581; 15951562; 18669648; 19413330; 19369195; 19690332; 23186163; 24275569; 17344846	Protein kinase superfamily, AGC Ser/Thr protein kinase family
O60308	CE104_HUMAN	Centrosomal protein of 104 kDa, Cep104	CEP104 KIAA0562	925	9606			3D-structure;Alternative splicing;Cell projection;Ciliopathy;Coiled coil;Cytoplasm;Cytoskeleton;Joubert syndrome;Reference proteome;Repeat	Q15637		GO:0000922; GO:0005737; GO:0005814; GO:0005929; GO:0016594; GO:0016595; GO:0016596		9628581; 16710414; 15489334; 21399614; 22885064; 23970417; 26477546; 32453716	
O60312	AT10A_HUMAN	Phospholipid-transporting ATPase VA, EC 7.6.2.1 (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A)	ATP10A ATP10C ATPVA ATPVC KIAA0566	1499	9606		7.6.2.1	Alternative splicing;ATP-binding;Cell membrane;Endoplasmic reticulum;Lipid transport;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport	Q9NV96	TISSUE SPECIFICITY: Widely expressed, with highest levels in kidney, followed by lung, brain, prostate, testis, ovary and small intestine.	GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0008360; GO:0016021; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:0140351; GO:1903527; GO:1990531	PTM: Autophosphorylated at the conserved aspartate of the P-type ATPase signature sequence. {ECO:0000250|UniProtKB:O94823}.	11326269; 11353404; 16572171; 15489334; 9628581; 21914794; 25947375; 26637798; 29599178; 30530492	Cation transport ATPase (P-type) (TC 3.A.3) family, Type IV subfamily
O60313	OPA1_HUMAN	Dynamin-like 120 kDa protein, mitochondrial, EC 3.6.5.5 (Optic atrophy protein 1) [Cleaved into: Dynamin-like 120 kDa protein, form S1 ]	OPA1 KIAA0567	960	9606		3.6.5.5	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cardiomyopathy;Coiled coil;Deafness;Disease variant;GTP-binding;Hydrolase;Lipid-binding;Membrane;Mitochondrion;Mitochondrion inner membrane;Neurodegeneration;Nucleotide-binding;Primary mitochondrial disease;Reference proteome;Sensory transduction;Transit peptide;Transmembrane;Transmembrane helix;Vision	Q12983; Q5S007; Q9NTG7	TISSUE SPECIFICITY: Highly expressed in retina. Also expressed in brain, testis, heart and skeletal muscle. Isoform 1 expressed in retina, skeletal muscle, heart, lung, ovary, colon, thyroid gland, leukocytes and fetal brain. Isoform 2 expressed in colon, liver, kidney, thyroid gland and leukocytes. Low levels of all isoforms expressed in a variety of tissues. {ECO:0000269|PubMed:11017079, ECO:0000269|PubMed:11017080, ECO:0000269|PubMed:11810270}.	GO:0000002; GO:0000266; GO:0000287; GO:0001843; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0005874; GO:0006915; GO:0007005; GO:0007007; GO:0007601; GO:0008017; GO:0008053; GO:0016020; GO:0016021; GO:0019896; GO:0030061; GO:0030425; GO:0031966; GO:0043066; GO:0046039; GO:0051259; GO:0070300; GO:0090201; GO:0090398; GO:0097749; GO:1901612; GO:1902236; GO:1904115	PTM: PARL-dependent proteolytic processing releases an antiapoptotic soluble form not required for mitochondrial fusion. Cleaved by OMA1 at position S1 following stress conditions. {ECO:0000269|PubMed:20038677}.; PTM: [Isoform 2]: Cleavage at position S2 is mediated by YME1L (PubMed:17709429, PubMed:24616225, PubMed:27495975). Cleavage may occur in the sequence motif Leu-Gln-Gln-Gln-Ile-Gln (LQQQIQ) (PubMed:16778770). {ECO:0000269|PubMed:16778770, ECO:0000269|PubMed:17709429, ECO:0000269|PubMed:24616225, ECO:0000269|PubMed:27495975}.; PTM: [Isoform 3]: Cleavage at position S2 is mediated by YME1L (PubMed:17709429, PubMed:24616225, PubMed:27495975). Cleavage may occur in the sequence motif Leu-Gln-Gln-Gln-Ile-Gln (LQQQIQ) (PubMed:16778770). {ECO:0000269|PubMed:16778770, ECO:0000269|PubMed:17709429, ECO:0000269|PubMed:24616225, ECO:0000269|PubMed:27495975}.; PTM: [Isoform 4]: Cleavage at position S2 is mediated by YME1L (PubMed:17709429, PubMed:24616225, PubMed:27495975). Cleavage may occur in the sequence motif Leu-Gln-Gln-Gln-Ile-Gln (LQQQIQ) (PubMed:16778770). {ECO:0000269|PubMed:16778770, ECO:0000269|PubMed:17709429, ECO:0000269|PubMed:24616225, ECO:0000269|PubMed:27495975}.	9628581; 20843780; 16641997; 15489334; 11810270; 11017079; 11017080; 16778770; 17709429; 20038677; 19608861; 21364629; 20185555; 21269460; 21112924; 20974897; 21081504; 21636302; 25012220; 24616225; 24275569; 25146916; 25944712; 27495975; 26561570; 28746876; 11440988; 11440989; 12036970; 12566046; 14961560; 15531309; 15948788; 16240368; 16617242; 16513463; 18360822; 18195150; 18065439; 18158317; 18204809; 19319978; 19325939; 19969356; 22382025; 22857269; 23387428; 23401657	TRAFAC class dynamin-like GTPase superfamily, Dynamin/Fzo/YdjA family
O60315	ZEB2_HUMAN	Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1, SMADIP1) (Zinc finger homeobox protein 1b)	ZEB2 KIAA0569 SIP1 ZFHX1B ZFX1B HRIHFB2411	1214	9606			3D-structure;Acetylation;Alternative splicing;Chromosome;Disease variant;DNA-binding;Epilepsy;Hirschsprung disease;Homeobox;Isopeptide bond;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	Q96KQ7; Q13330; O94776		GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007399; GO:0019208; GO:0030511; GO:0043565; GO:0045636; GO:0045944; GO:0046872; GO:0048023; GO:0048066; GO:0048856; GO:0090263; GO:0097324; GO:1903056	PTM: Sumoylation on Lys-391 and Lys-866 is promoted by the E3 SUMO-protein ligase CBX4, and impairs interaction with CTBP1 and transcription repression activity. {ECO:0000269|PubMed:16061479}.	11448942; 11279515; 9628581; 14702039; 15815621; 15489334; 9853615; 16061479; 19608861; 23186163; 24275569; 25218447; 25772364; 28112733; 12451214; 15384097; 16688751; 16959974; 20516212	Delta-EF1/ZFH-1 C2H2-type zinc-finger family
O60318	GANP_HUMAN	Germinal-center associated nuclear protein, GANP, EC 2.3.1.48 (80 kDa MCM3-associated protein) (MCM3 acetylating protein, MCM3AP, EC 2.3.1.-) (MCM3 acetyltransferase)	MCM3AP GANP KIAA0572 MAP80	1980	9606		2.3.1.-; 2.3.1.48	3D-structure;Acetylation;Acyltransferase;Alternative promoter usage;Chromosome;Coiled coil;Cytoplasm;Immunity;Mental retardation;Methylation;mRNA transport;Neuropathy;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transferase;Translocation;Transport		TISSUE SPECIFICITY: Widely expressed (PubMed:11024281). Up-regulated in germinal center B-cells in tonsils (at protein level) (PubMed:11024281). {ECO:0000269|PubMed:11024281}.	GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390		11024281; 10830953; 15489334; 9628581; 9712829; 11258703; 12226073; 16914116; 18669648; 19413330; 19690332; 20005110; 20384790; 20507984; 20068231; 21195085; 21406692; 23591820; 23186163; 23652018; 22307388; 16959974; 24123876; 28633435; 28969388; 29982295	SAC3 family
O60331	PI51C_HUMAN	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma, PIP5K1gamma, PtdIns(4)P-5-kinase 1 gamma, EC 2.7.1.68 (Type I phosphatidylinositol 4-phosphate 5-kinase gamma)	PIP5K1C KIAA0589	668	9606		2.7.1.68	3D-structure;Acetylation;Alternative splicing;ATP-binding;Cell adhesion;Cell junction;Cell membrane;Cell projection;Chemotaxis;Cytoplasm;Disease variant;Endocytosis;Exocytosis;Kinase;Lipid metabolism;Membrane;Methylation;Nucleotide-binding;Nucleus;Phagocytosis;Phosphoprotein;Reference proteome;Transferase	Q9Y490; P46940	TISSUE SPECIFICITY: [Isoform 1]: Isoform 1 is strongly expressed in brain and also detected in heart and lung. {ECO:0000269|PubMed:19548880}.; TISSUE SPECIFICITY: [Isoform 2]: Isoform 2 is strongly expressed in pancreas and liver and in lesser quantities in brain, heart, lung and kidney. {ECO:0000269|PubMed:19548880}.; TISSUE SPECIFICITY: [Isoform 3]: Isoform 3 is detected in large amounts in heart and large intestine, is also present in lung, pancreas and thyroid, and to a lesser extent in brain, stomach and kidney. {ECO:0000269|PubMed:19548880}.	GO:0001891; GO:0001931; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0006661; GO:0006909; GO:0010008; GO:0014066; GO:0016079; GO:0016308; GO:0030036; GO:0030593; GO:0032587; GO:0034333; GO:0046854; GO:0048488; GO:0052812; GO:0061024; GO:0072583; GO:0098609; GO:0098793	PTM: Phosphorylation on Ser-650 negatively regulates binding to TLN2 and is strongly stimulated in mitosis. Phosphorylation on Tyr-649 is necessary for targeting to focal adhesions. Phosphorylation on Ser-650 and Tyr-649 are mutually exclusive. Phosphorylated by SYK and CSK (By similarity). Tyrosine phosphorylation is enhanced by PTK2 signaling. Phosphorylated at Tyr-639 upon EGF stimulation. Some studies suggest that phosphorylation on Tyr-649 enhances binding to tailins (TLN1 and TLN2). According to PubMed:15738269 phosphorylation at Tyr-649 does not directly enhance binding to tailins (TLN1 and TLN2) but may act indirectly by inhibiting phosphorylation at Ser-650. {ECO:0000250, ECO:0000269|PubMed:15738269}.; PTM: Acetylation at Lys-265 and Lys-268 seems to decrease lipid 1-phosphatidylinositol-4-phosphate 5-kinase activity. Deacetylation of these sites by SIRT1 positively regulates the exocytosis of TSH-containing granules from pituitary cells. {ECO:0000269|PubMed:20668706}.	19548880; 9628581; 14702039; 15057824; 12422219; 12847086; 15738269; 17261850; 17635937; 20668706; 19889969; 22942276; 25588945; 17701898	
O60333	KIF1B_HUMAN	Kinesin-like protein KIF1B, Klp	KIF1B KIAA0591 KIAA1448	1816	9606			3D-structure;Acetylation;Alternative splicing;Apoptosis;ATP-binding;Cell junction;Cell projection;Charcot-Marie-Tooth disease;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Disease variant;Microtubule;Mitochondrion;Motor protein;Neurodegeneration;Neuropathy;Nucleotide-binding;Phosphoprotein;Reference proteome;Synapse	Q7Z460; Q8IUQ4; Q6UY14-3; P20933; Q6ZTN6-2; Q92688; P13928; D3DTF8; P05067; O94778; Q86TN1; Q9Y575-3; Q96DX5; Q96DX5-3; Q6XD76; Q96FT7-4; Q9H0Y0; P15313; P46379-2; Q9UQB8-6; Q16611; Q8IXM2; Q16520; Q9BXK5; Q14457; Q96LC9; Q8WUW1; Q0VDD7; Q9NSI6-4; Q9H0W9-4; Q8TAB5; Q8N865; Q96LL4; Q96NX5; Q8N5S9-2; Q6ZP82; Q96LX7-5; A0A1B0GWI1; Q9Y3X0; Q9UJX2; Q494V2-2; Q9Y3D0; Q14677; Q96DZ5; Q6PJW8-3; Q96MW5; Q8IUI8; P02489; Q8TB03; P00167; Q7L576; Q5TAQ9-2; Q8NDP9; Q9P1A6-3; Q5VZB9; Q7L591-3; A0A024RCP2; O14531; Q9BPU6; Q92997; O75530-2; O00303; Q9H6S3; Q13216-2; Q9NQ30; Q6NXG1; Q99504; O15540; Q6P1L5; Q49AJ0-4; Q96GL9; Q17RN3; Q8IZU1; O15287; Q8TC84; Q53R41; O00757; Q9UHY8; P15407; Q8NCL4; P15976-2; Q9NXC2; P10075; Q9HBQ8; O95872; Q7Z602; Q9Y4H4; Q6NXT2; A8K0U2; A0A024R1L7; P49639; P09017; Q96EW2-2; Q8IY31-3; P22692; Q14005-2; Q9NXX0; Q8WYH8-2; Q8IXL9; Q8NA54; Q86U28; Q9UKP3-2; P0C870; Q9NVX7-2; Q8WZ19; Q96SI1-2; Q06136; Q6ZU52; Q12756; Q9UIH9; P57682; Q9Y2M5; Q8N1A0; Q14525; Q3SY46; Q3SYF9; Q8IUC2; Q14847-2; O95447; Q5T7P3; Q96PV6; Q68G74; Q8N448; A2RU56; Q96JB6; Q14693; Q9UDY8-2; Q99683; P61244-4; Q9NS73-5; Q03112-9; Q8N6F8; Q9NYP9; Q15049; A0A0A0MR05; Q8N594; Q9Y605; Q96HT8; Q8IXL7-2; Q9NPC7; P28331-5; O76041; I6L9F6; Q8N5V2; Q8NBF2-2; Q14995; Q96MF7; Q6X4W1-6; P36639-4; Q7Z417; O15381-5; Q5BJF6-2; O43482; Q96FW1; Q6GQQ9-2; Q9NR21-5; Q9HBE1-4; P22061-2; Q9NV79; Q9BRX2; O15534; Q96FX8; Q96LB9; Q7RTV0; O75925; Q9UF11-2; Q58EX7-2; Q6ZR37; Q99541; Q8TBJ4; Q8NA72-3; Q9H1D9; O43741; P60891; P11908; P28062-2; P47897; Q9Y5P3; Q96PK6; Q9P2K3-2; Q6NTF9-3; Q8TDP1; Q8N5U6; Q8WVD3; Q96D59; Q9H0X6; P62244; P08865; Q66K80; Q8N488; Q8N6K7-2; Q7Z3H4; P34741; O00560; Q9NTN9-3; Q96B97; Q9NUL5-3; Q8IYI0; O60902-3; P12757; P08195-4; Q9NSD5-3; Q92966; Q13573; Q99932-2; A0A024R4B0; Q8TCT7-2; Q7Z698; Q9C004; Q99619; Q8IXS7; O75886; Q8NBJ7; Q9H7C4; Q17RD7-3; Q86TJ2-3; Q5VWN6; Q8IYN2; Q9BQ70; Q13569; Q86WV5; Q96A09; Q8NA77; P21980-2; O60830; Q8N0U2; Q8IUR5-4; Q71RG4-4; P36406; Q9UPQ4-2; L8E9Q5; Q86WT6-2; Q9C026; Q86WV8; Q9Y3Q8; Q9BUF5; Q9UGJ1-2; Q5VYS8-5; Q9BSL1; Q8NBM4-4; Q969T4; Q13404; Q04323-2; O75604-3; P45880; P40337-2; Q8NEZ2; P58304; Q9BQA1; Q9BRX9; Q15007-2; Q9NZC7-5; O43167-2; Q53FD0-2; Q15776; Q9UJW8-4; Q8N895; Q9C0F3; Q8N0Y2-2; Q96MN9-2; Q6ZNH5; Q96C55; Q68EA5; Q7Z3I7; Q96N77-2; Q9BS34; Q3KNS6-3; Q15695; O15535; Q2QGD7; A0A384ME25; B4DLR9; B7Z3E8; Q7L8T7; Q7Z783; Q86V28; Q12959; P78352; Q96QZ7; Q63622	TISSUE SPECIFICITY: Isoform 3 is abundant in the skeletal muscle. It is also expressed in fetal brain, lung and kidney, and adult heart, placenta, testis, ovary and small intestine. Isoform 2 is abundant in the brain and also expressed in fetal heart, lung, liver and kidney, and adult skeletal muscle, placenta, liver, kidney, heart, spleen, thymus, prostate, testis, ovary, small intestine, colon and pancreas. {ECO:0000269|PubMed:10762626, ECO:0000269|PubMed:11526494, ECO:0000269|PubMed:12888911}.	GO:0003777; GO:0005524; GO:0005739; GO:0005871; GO:0005874; GO:0005875; GO:0006915; GO:0007018; GO:0007270; GO:0007274; GO:0008017; GO:0008021; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030659; GO:0030705; GO:0031410; GO:0043005; GO:1904115		10762626; 11526494; 12888911; 9628581; 10819331; 16710414; 15489334; 14702039; 16225668; 18334619; 18669648; 19413330; 19690332; 20068231; 21269460; 21406692; 22814378; 23186163; 24275569; 11389829	TRAFAC class myosin-kinesin ATPase superfamily, Kinesin family, Unc-104 subfamily
O60336	MABP1_HUMAN	Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1, JNKBP-1)	MAPKBP1 JNKBP1 KIAA0596	1514	9606			Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Disease variant;Nephronophthisis;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat	O43184-4; Q6UY14-3; Q9NP73-4; Q9GZU7; A8MQ03; O15353; O76003; P49639; Q14145; Q5T749; Q15323; O76011; Q92764; O76015; Q6A162; O43790; Q07627; Q8IUG1; P60409; P60410; P60411; P60328; Q6PEX3; Q9BYR8; Q9BYR7; Q9BQ66; Q6L8G9; Q6L8G8; P26371; Q9BYQ4; Q9BYQ3; Q9BYQ2; Q99750; P50222; Q6FHY5; A6NJ78-4; P15173; Q7Z3S9; P0DPK4; O15496; Q9NRY6; Q9BYM8; O76081; O76081-6; Q8IUQ4; O43597; O43610; Q99081; P15884; P15884-3; Q96M29; Q8IYF3; Q8IYF3-3; P14373; Q8IWZ5; Q15654; P62699; Q7Z783	TISSUE SPECIFICITY: Expressed in intestinal mucosa, where it is detected in epithelial cells, endothelial cells, smooth muscle cells and immune cells, such as lymphocytes (PubMed:22700971). Expressed in kidney (PubMed:28089251). {ECO:0000269|PubMed:22700971, ECO:0000269|PubMed:28089251}.	GO:0005654; GO:0005730; GO:0005737; GO:0032717; GO:0043124; GO:0097431; GO:1900425		15491607; 9628581; 12168954; 14702039; 17974005; 16572171; 15489334; 22700971; 22814378; 23341463; 23186163; 28089251; 28157543	
O60337	MARH6_HUMAN	E3 ubiquitin-protein ligase MARCHF6, EC 2.3.2.27 (Doa10 homolog) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI, MARCH-VI) (Protein TEB-4) (RING finger protein 176) (RING-type E3 ubiquitin transferase MARCHF6)	MARCHF6 KIAA0597 MARCH6 RNF176 TEB4	910	9606	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:15673284}.	2.3.2.27	Acetylation;Alternative splicing;Endoplasmic reticulum;Epilepsy;Membrane;Metal-binding;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	Q9UHX3; P41220-1	TISSUE SPECIFICITY: Present in brain (at protein level). {ECO:0000269|PubMed:15673284}.	GO:0000835; GO:0004842; GO:0005783; GO:0005789; GO:0008270; GO:0010498; GO:0016020; GO:0016021; GO:0016567; GO:0019899; GO:0030176; GO:0030433; GO:0031624; GO:0036503; GO:0043161; GO:0044322; GO:0061630; GO:0070936; GO:1904380; GO:1990381	PTM: Auto-ubiquitinated, which results in proteasomal degradation. {ECO:0000269|PubMed:15673284}.	9628581; 14702039; 15372022; 15489334; 11641273; 15673284; 16373356; 19651899; 22814378; 24449766; 31664039	
O60341	KDM1A_HUMAN	Lysine-specific histone demethylase 1A, EC 1.14.99.66 (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)	KDM1A AOF2 KDM1 KIAA0601 LSD1	852	9606		1.14.99.66	3D-structure;Alternative splicing;Chromatin regulator;Coiled coil;Developmental protein;Direct protein sequencing;Disease variant;FAD;Flavoprotein;Isopeptide bond;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	Q9BYF1; Q99996; Q86SG2; Q13490; Q6P047; Q8TC20-4; Q9BWT7; Q49A88-3; Q99459; Q9BXL8; Q86XR8-3; Q8NHQ1; Q8TAP6; Q12873; P38432; Q96EY1; P26378-2; Q9UPT5-1; Q3B820; Q9H8W3; Q8IZU1; Q9BQS8; O95995; Q96CN9; Q08379; Q9NYA3; Q8NEC7; Q9BX10; Q16695; Q96CS2; O15379; Q9UBX0; Q9NSC5; Q16891; O75564-2; Q9BVG8-5; Q8TBB5; P19012; Q15323; Q14525; Q92764; Q6A163; Q6A162; Q96JB6; Q9Y250; O95983; P01106; Q3BBV0; Q7Z6G3-2; P35240; Q16236; P46531; Q13133; Q96F24; A5D8V7; Q8IZS5; Q9BYU1; Q8IZL8; Q99471; Q5T6S3; Q03181; P62191; Q9NS23; P50749; Q86WH2; Q06330; Q9UKL0; Q8IZ40; Q9P2K3-2; Q96P16-3; Q8N6K7; Q9UGK8; Q13435; O15198; O95863; Q96H20; Q8N0Z3; Q96BD6; Q8N4C7; Q8N6V9; Q9UBB9; Q08117-2; Q2M3C6; P45379-11; Q05BL1; Q9BUZ4; Q5W5X9-3; Q8TF42; Q9H9H4; Q9Y3C0; O96006; O15060; Q92618; O14646; Q96KQ7; Q96KQ7-1; P05771-1; Q9UKL0; P17542; P04637; P22091	TISSUE SPECIFICITY: Ubiquitously expressed. {ECO:0000269|PubMed:16079795}.	GO:0000122; GO:0000380; GO:0000781; GO:0000785; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0006357; GO:0006482; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032880; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034720; GO:0035563; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060765; GO:0060992; GO:0061629; GO:0061752; GO:0071320; GO:0071480; GO:0090308; GO:0120162; GO:0140297; GO:0140682; GO:1902166; GO:1990391; GO:1990841; GO:2000179; GO:2000648	PTM: Polyubiquitinated by JADE2; which leads to its proteasomal degradation. {ECO:0000269|PubMed:25018020}.	9628581; 16710414; 15489334; 17974005; 12032298; 11102443; 12493763; 15620353; 15811342; 16140033; 16079794; 16079795; 16223729; 17081983; 17805299; 18220336; 18691976; 18669648; 19413330; 19369195; 19690332; 20389281; 19880879; 25750265; 20228790; 20562920; 20068231; 21269460; 21406692; 23186163; 24275569; 25018020; 28112733; 33980486; 16885027; 16956976; 16531230; 21300290; 23721412; 23020937; 24838796; 26656649	Flavin monoamine oxidase family
O60343	TBCD4_HUMAN	TBC1 domain family member 4 (Akt substrate of 160 kDa, AS160)	TBC1D4 AS160 KIAA0603	1298	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Diabetes mellitus;GTPase activation;Methylation;Phosphoprotein;Reference proteome;Repeat	P63104	TISSUE SPECIFICITY: Widely expressed. Isoform 2 is the highest overexpressed in most tissues. Isoform 1 is highly expressed in skeletal muscle and heart, but was not detectable in the liver nor in adipose tissue. Isoform 2 is strongly expressed in adrenal and thyroid gland, and also in lung, kidney, colon, brain and adipose tissue. Isoform 2 is moderately expressed in skeletal muscle. Expressed in pancreatic Langerhans islets, including beta cells (at protein level). Expression is decreased by twofold in pancreatic islets in type 2 diabetes patients compared to control subjects. Up-regulated in T-cells from patients with atopic dermatitis. {ECO:0000269|PubMed:15304337, ECO:0000269|PubMed:18276765, ECO:0000269|PubMed:18771725}.	GO:0005096; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869; GO:0090630	PTM: Phosphorylated by AKT1; insulin-induced. Also phosphorylated by AMPK in response to insulin. Insulin-stimulated phosphorylation is required for SLC2A4/GLUT4 translocation. Has no effect on SLC2A4/GLUT4 internalization. Physiological hyperinsulinemia increases phosphorylation in skeletal muscle. Insulin-stimulated phosphorylation is reduced by 39% in type 2 diabetic patients. {ECO:0000269|PubMed:11994271, ECO:0000269|PubMed:15919790, ECO:0000269|PubMed:18771725}.	18771725; 19077034; 9628581; 14702039; 15057823; 15489334; 17974005; 11994271; 12637568; 15971998; 17081983; 16964243; 18276765; 15304337; 15919790; 18220336; 18669648; 19413330; 19690332; 19608861; 20068231; 21269460; 21406692; 22908308; 23186163; 24275569; 25043022; 21454505	
O60346	PHLP1_HUMAN	PH domain leucine-rich repeat-containing protein phosphatase 1, EC 3.1.3.16 (Pleckstrin homology domain-containing family E member 1, PH domain-containing family E member 1) (Suprachiasmatic nucleus circadian oscillatory protein, hSCOP)	PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP	1717	9606		3.1.3.16	Acetylation;Alternative splicing;Apoptosis;Cell membrane;Cytoplasm;Hydrolase;Leucine-rich repeat;Manganese;Membrane;Metal-binding;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome;Repeat;Tumor suppressor	P05771-2; Q14160; O14745; Q80U72; O14745	TISSUE SPECIFICITY: In colorectal cancer tissue, expression is highest in the surface epithelium of normal colonic mucosa adjacent to the cancer tissue but is largely excluded from the crypt bases. Expression is lost or significantly decreased in 78% of tested tumors (at protein level). Ubiquitously expressed in non-cancerous tissues. {ECO:0000269|PubMed:15808505, ECO:0000269|PubMed:19079341}.	GO:0002667; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0009649; GO:0042981; GO:0043231; GO:0043408; GO:0046328; GO:0046872; GO:0051898; GO:1900744		16177791; 9628581; 12168954; 15489334; 14702039; 15808505; 17081983; 17386267; 18162466; 19732725; 19079341; 20513427; 21701506; 21986499; 21804599; 22814378; 24145035; 23186163; 24892992; 24530606; 25820252	
O60353	FZD6_HUMAN	Frizzled-6, Fz-6, hFz6	FZD6	706	9606			Alternative splicing;Cell membrane;Cytoplasmic vesicle;Developmental protein;Disease variant;Disulfide bond;Endoplasmic reticulum;G-protein coupled receptor;Glycoprotein;Membrane;Phosphoprotein;Receptor;Reference proteome;Signal;Transducer;Transmembrane;Transmembrane helix;Ubl conjugation;Wnt signaling pathway	P47972; Q8N474; Q9ULT6	TISSUE SPECIFICITY: Detected in adult heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, thymus, prostate, testis, ovary, small intestine and colon. In the fetus, expressed in brain, lung, liver and kidney.	GO:0001843; GO:0001942; GO:0004930; GO:0005789; GO:0005886; GO:0005887; GO:0009986; GO:0016021; GO:0016324; GO:0016327; GO:0017147; GO:0030168; GO:0030659; GO:0031625; GO:0033278; GO:0035567; GO:0035880; GO:0042472; GO:0042813; GO:0043433; GO:0048105; GO:0060070; GO:0060071; GO:0090090; GO:1904693	PTM: Ubiquitinated by ZNRF3, leading to its degradation by the proteasome. {ECO:0000250}.	9480858; 11707601; 14702039; 17974005; 16421571; 15489334; 18669648; 22045688; 22575959; 21665003	G-protein coupled receptor Fz/Smo family
O60356	NUPR1_HUMAN	Nuclear protein 1 (Candidate of metastasis 1) (Protein p8)	NUPR1 COM1	82	9606			Activator;Alternative splicing;Cytoplasm;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	P17655; Q494V2-2; O15534; P06454	TISSUE SPECIFICITY: Widely expressed, with high levels in liver, pancreas, prostate, ovary, colon, thyroid, spinal cord, trachea and adrenal gland, moderate levels in heart, placenta, lung, skeletal muscle, kidney, testis, small intestine, stomach and lymph node, and low levels in brain, spleen, thymus and bone marrow. Not detected in peripheral blood leukocytes. {ECO:0000269|PubMed:10092851}.	GO:0002526; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006473; GO:0008285; GO:0008584; GO:0009636; GO:0010506; GO:0010507; GO:0010667; GO:0010698; GO:0031401; GO:0032993; GO:0035914; GO:0042771; GO:0043066; GO:0043433; GO:0043525; GO:0045171; GO:0045786; GO:0045787; GO:0045820; GO:0048147; GO:0048471; GO:0050680; GO:0062099; GO:0065003; GO:0150078; GO:1901800; GO:1902902; GO:1903862; GO:1904036; GO:1904691; GO:1905897; GO:2000194; GO:2001244	PTM: Phosphorylated in vitro by PKA and CK. Phosphorylation promotes DNA-binding activity. {ECO:0000269|PubMed:11056169}.; PTM: Acetylated by EP300 in vitro. {ECO:0000269|PubMed:11940591}.	10092851; 10493524; 14702039; 16341674; 10493829; 15489334; 11056169; 11940591; 16300740; 16478804; 18690848; 19650074; 19723804; 20181828; 22858377; 22565310; 28720707; 30451898	NUPR family
O60359	CCG3_HUMAN	Voltage-dependent calcium channel gamma-3 subunit (Neuronal voltage-gated calcium channel gamma-3 subunit) (Transmembrane AMPAR regulatory protein gamma-3, TARP gamma-3)	CACNG3	315	9606			Calcium;Calcium channel;Calcium transport;Ion channel;Ion transport;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport;Voltage-gated channel			GO:0005245; GO:0005886; GO:0005891; GO:0006605; GO:0006816; GO:0008104; GO:0016247; GO:0019226; GO:0030165; GO:0030425; GO:0030666; GO:0032281; GO:0035255; GO:0036477; GO:0051968; GO:0060076; GO:0098685; GO:0098839; GO:0098943; GO:0098970; GO:0098978; GO:0099061; GO:0099590; GO:0099645; GO:2000311; GO:2000969		10221464; 10493829; 15489334	PMP-22/EMP/MP20 family, CACNG subfamily
O60381	HBP1_HUMAN	HMG box-containing protein 1 (HMG box transcription factor 1) (High mobility group box transcription factor 1)	HBP1	514	9606			3D-structure;Alternative splicing;DNA-binding;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Wnt signaling pathway	P06400		GO:0000785; GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0016055; GO:0016607; GO:0051726	PTM: Ubiquitinated by the CTLH E3 ubiquitin-protein ligase complex, leading to subsequent proteasomal degradation. {ECO:0000269|PubMed:29911972}.	10958660; 14702039; 12853948; 15489334; 10562551; 11500377; 21406692; 23186163; 24275569; 29911972	
O60383	GDF9_HUMAN	Growth/differentiation factor 9, GDF-9	GDF9	454	9606			Cleavage on pair of basic residues;Cytokine;Disulfide bond;Glycoprotein;Growth factor;Phosphoprotein;Premature ovarian failure;Reference proteome;Secreted;Signal		TISSUE SPECIFICITY: Expressed in ovarian granulosa cells. Present in oocytes of primary follicles (at protein level). {ECO:0000269|PubMed:10443672, ECO:0000269|PubMed:12050262}.	GO:0005125; GO:0005615; GO:0007179; GO:0007292; GO:0008083; GO:0008284; GO:0010862; GO:0030509; GO:0060395; GO:0070698; GO:2000870	PTM: Phosphorylated; phosphorylation is critical for GDF9 function. In vitro, can be phosphorylated by CK at Ser-325. {ECO:0000269|PubMed:18006624, ECO:0000269|PubMed:20067794}.	15372022; 15489334; 10443672; 12050262; 18006624; 19366876; 20067794; 20660033; 21632818; 21829661; 21970812; 29044499; 16278619; 16645022; 16954162; 17156781; 17482612; 19438907	TGF-beta family
O60391	NMD3B_HUMAN	Glutamate receptor ionotropic, NMDA 3B, GluN3B (N-methyl-D-aspartate receptor subtype 3B, NMDAR3B, NR3B)	GRIN3B	1043	9606			Calcium;Cell junction;Cell membrane;Glycoprotein;Ion channel;Ion transport;Ligand-gated ion channel;Magnesium;Membrane;Postsynaptic cell membrane;Receptor;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix;Transport			GO:0004970; GO:0005261; GO:0005262; GO:0005886; GO:0015276; GO:0016594; GO:0017146; GO:0030594; GO:0035235; GO:0038023; GO:0042165; GO:0043025; GO:0045211; GO:0051205; GO:0051924		15057824; 11735224; 11717388; 15722182; 22833210	Glutamate-gated ion channel (TC 1.A.10.1) family, NR3B/GRIN3B subfamily
O60393	NOBOX_HUMAN	Homeobox protein NOBOX	NOBOX	691	9606			Alternative splicing;Developmental protein;Differentiation;Disease variant;DNA-binding;Homeobox;Nucleus;Oogenesis;Premature ovarian failure;Reference proteome;Transcription;Transcription regulation		TISSUE SPECIFICITY: Expressed in ovaries, testes and pancreas. Expressed within all stages of the adult female germline, from primordial follicles through to MII oocytes. {ECO:0000269|PubMed:16597639}.	GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0048477		12853948; 16597639; 17701902; 21837770; 25514101; 27798098	
O60423	AT8B3_HUMAN	Phospholipid-transporting ATPase IK, EC 7.6.2.1 (ATPase class I type 8B member 3)	ATP8B3 ATP1K FOS37502_2	1300	9606		7.6.2.1	Alternative splicing;ATP-binding;Cytoplasmic vesicle;Endoplasmic reticulum;Lipid transport;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Reference proteome;Translocase;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Isoform 3 was only detected in testis. {ECO:0000269|PubMed:12880872}.	GO:0000287; GO:0002080; GO:0005524; GO:0005789; GO:0005802; GO:0005886; GO:0007030; GO:0007339; GO:0016020; GO:0016021; GO:0016887; GO:0045332; GO:0090556; GO:0140326; GO:1990531		12880872; 15057824; 15489334; 14702039; 20947505	Cation transport ATPase (P-type) (TC 3.A.3) family, Type IV subfamily
O60427	FADS1_HUMAN	Acyl-CoA (8-3)-desaturase, EC 1.14.19.44 (Delta(5) fatty acid desaturase, D5D, Delta(5) desaturase, Delta-5 desaturase) (Fatty acid desaturase 1)	FADS1 FADSD5	444	9606	PATHWAY: Lipid metabolism; polyunsaturated fatty acid biosynthesis.	1.14.19.44	Acetylation;Alternative splicing;Electron transport;Endoplasmic reticulum;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Membrane;Mitochondrion;Oxidoreductase;Reference proteome;Transmembrane;Transmembrane helix;Transport		TISSUE SPECIFICITY: Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. {ECO:0000269|PubMed:10601301, ECO:0000269|PubMed:10769175, ECO:0000269|PubMed:10860662}.	GO:0000248; GO:0005739; GO:0005789; GO:0006355; GO:0006629; GO:0006636; GO:0007267; GO:0008654; GO:0009267; GO:0016020; GO:0016021; GO:0016213; GO:0016491; GO:0016717; GO:0036109; GO:0042759; GO:0043231; GO:0043651; GO:0045485; GO:0045595; GO:0046456; GO:0062076		10601301; 10769175; 10860662; 14702039; 17974005; 16554811; 15489334; 22619218; 22814378; 25732826	Fatty acid desaturase type 1 family
O60437	PEPL_HUMAN	Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein)	PPL KIAA0568	1756	9606			3D-structure;Cell junction;Cell membrane;Coiled coil;Cytoplasm;Cytoskeleton;Keratinization;Membrane;Phosphoprotein;Reference proteome;Repeat;SH3 domain	Q9H9F9; O43865; P31749; P13196; O76027; O00481; O00481-2; Q5SZD1; Q8IYX8-2; P17661; Q5T447; P42858; Q13422-7; Q4G0X4; Q9Y448; Q7Z3Z0; Q6A163; Q13084; Q9BYU1; Q9NRD5; Q6IQ23-2; Q8WVV4-1; Q96QF0; Q96QF0-7; Q15311; Q12933; P14373; Q9Y3Q8; Q96BW1; P08670; Q9HCK0; P49910; O14771; O14978; Q6S9Z5; Q8NBB4; Q8NBB4-2; Q9H4T2	TISSUE SPECIFICITY: Expressed in stratified squamous epithelia and in some other epithelia. {ECO:0000269|PubMed:9412476, ECO:0000269|PubMed:9521878}.	GO:0001533; GO:0005198; GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0009612; GO:0016020; GO:0030057; GO:0031424; GO:0042060; GO:0045104; GO:0045296; GO:0070062		9412476; 9521878; 10051401; 15616553; 15489334; 9628581; 12244133; 12853457; 15229321; 21269460; 21406692; 23186163; 24275569	Plakin or cytolinker family
O60443	GSDME_HUMAN	Gasdermin-E (Inversely correlated with estrogen receptor expression 1, ICERE-1) (Non-syndromic hearing impairment protein 5) [Cleaved into: Gasdermin-E, N-terminal, GSDME-NT; Gasdermin-E, C-terminal, GSDME-CT ]	GSDME DFNA5 ICERE1	496	9606			Alternative splicing;Cell membrane;Cytoplasm;Deafness;Membrane;Necrosis;Non-syndromic deafness;Reference proteome;Transmembrane;Transmembrane beta strand;Tumor suppressor	Q96CG3	TISSUE SPECIFICITY: Expressed in cochlea (PubMed:9771715). Low level of expression in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas, with highest expression in placenta (PubMed:9771715). {ECO:0000269|PubMed:9771715}.	GO:0002839; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0007605; GO:0008219; GO:0008285; GO:0016020; GO:0016021; GO:0022829; GO:0043410; GO:0060113; GO:0070265; GO:0070269; GO:0071356; GO:0098586; GO:0140507; GO:1901612; GO:2001244	PTM: Cleavage at Asp-270 by CASP3 (mature and uncleaved precursor forms) or granzyme B (GZMB) relieves autoinhibition and is sufficient to initiate pyroptosis. {ECO:0000269|PubMed:28045099, ECO:0000269|PubMed:28459430, ECO:0000269|PubMed:31953257, ECO:0000269|PubMed:32188940}.; PTM: [Gasdermin-E]: Succination by the Krebs cycle intermediate fumarate, which leads to S-(2-succinyl)cysteine residues, inhibits processing by caspases, and ability to initiate pyroptosis (PubMed:32820063). Succination modification is catalyzed by a non-enzymatic reaction caused by an accumulation of fumarate (PubMed:32820063). {ECO:0000269|PubMed:32820063}.	9771715; 14702039; 12853948; 12690205; 15489334; 9523727; 16897187; 18223688; 19690332; 21269460; 21522185; 22814378; 19911014; 24506266; 26236191; 27281216; 28459430; 28045099; 32188940; 32820063; 31953257	Gasdermin family
O60447	EVI5_HUMAN	Ecotropic viral integration site 5 protein homolog, EVI-5 (Neuroblastoma stage 4S gene protein)	EVI5 NB4S	810	9606			Alternative splicing;Cell cycle;Cell division;Chromosomal rearrangement;Coiled coil;Cytoplasm;Cytoskeleton;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	P40617; Q8N715; Q96LK0; P48730; Q12959; Q14241; Q3B820; Q9UKT4; Q9NV31; Q96BZ8; P25800; Q8IYB1; Q96EZ8; Q15014; P53350; Q8WWY3; P62491; Q6BDI9; Q8N8B7-2; Q8WVP5; Q9NWS9-2	TISSUE SPECIFICITY: Expressed in various cell lines (at protein level). Expressed in a wide range of tissues including brain and adrenal. {ECO:0000269|PubMed:16033705, ECO:0000269|PubMed:9618176}.	GO:0005096; GO:0005634; GO:0005815; GO:0005819; GO:0005829; GO:0007049; GO:0031267; GO:0042147; GO:0043547; GO:0051301; GO:0090630	PTM: Probably phosphorylated by PLK1; may be required for degradation during mitosis. {ECO:0000269|PubMed:16439210}.; PTM: Ubiquitinated. Degradation during prophase is ubiquitin-dependent. {ECO:0000269|PubMed:16439210}.	9618176; 19077034; 16710414; 16033705; 16439210; 16764853; 18669648; 19413330; 23186163; 24275569	
O60449	LY75_HUMAN	Lymphocyte antigen 75, Ly-75 (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205)	LY75 CD205 CLEC13B	1722	9606			3D-structure;Alternative splicing;Direct protein sequencing;Disulfide bond;Endocytosis;Glycoprotein;Lectin;Membrane;Phosphoprotein;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	Q969F0	TISSUE SPECIFICITY: Expressed in spleen, thymus, colon and peripheral blood lymphocytes. Detected in myeloid and B-lymphoid cell lines. Isoform 2 and isoform 3 are expressed in malignant Hodgkin lymphoma cells called Hodgkin and Reed-Sternberg (HRS) cells. {ECO:0000269|PubMed:12824192, ECO:0000269|PubMed:9862343}.	GO:0005887; GO:0006897; GO:0006954; GO:0006955; GO:0009897; GO:0030246; GO:0038023; GO:0070062	PTM: N-glycosylated. {ECO:0000269|PubMed:9862343}.	9862343; 9553150; 12824192; 15815621; 18669648	
O60462	NRP2_HUMAN	Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2)	NRP2 VEGF165R2	931	9606			3D-structure;Alternative splicing;Calcium;Developmental protein;Differentiation;Disulfide bond;Glycoprotein;Heparin-binding;Host-virus interaction;Membrane;Metal-binding;Neurogenesis;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix	P97953-1; O60462-6		GO:0001525; GO:0001938; GO:0002116; GO:0003148; GO:0005021; GO:0005576; GO:0005886; GO:0007155; GO:0007411; GO:0008201; GO:0010595; GO:0016020; GO:0016021; GO:0017154; GO:0019838; GO:0019955; GO:0021612; GO:0021649; GO:0021675; GO:0021828; GO:0030424; GO:0036486; GO:0038023; GO:0042802; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099055; GO:0099175; GO:1901166; GO:1902285; GO:1903375; GO:1904835; GO:1990830		9331348; 9529250; 11112349; 15815621; 15489334; 10748121; 10520995; 30057110; 17989695; 22365152	Neuropilin family
O60469	DSCAM_HUMAN	Down syndrome cell adhesion molecule (CHD2)	DSCAM	2012	9606			3D-structure;Alternative splicing;Cell adhesion;Cell junction;Cell membrane;Cell projection;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Neurogenesis;Phosphoprotein;Reference proteome;Repeat;Secreted;Signal;Synapse;Transmembrane;Transmembrane helix	Q8WWB5	TISSUE SPECIFICITY: Primarily expressed in brain.	GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007162; GO:0007399; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0016020; GO:0030424; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070593; GO:0098632; GO:1990782; GO:1990890	PTM: Phosphorylated at tyrosine residues. Phosphorylation is enhanced by NTN1. {ECO:0000269|PubMed:19196994}.	9426258; 10925149; 10830953; 15169762; 18585357; 19196994; 22685302	
O60476	MA1A2_HUMAN	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB, EC 3.2.1.113 (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB, Alpha-1,2-mannosidase IB)	MAN1A2 MAN1B	641	9606	PATHWAY: Protein modification; protein glycosylation. {ECO:0000250|UniProtKB:P32906}.	3.2.1.113	Acetylation;Calcium;Disulfide bond;Glycoprotein;Glycosidase;Golgi apparatus;Hydrolase;Membrane;Metal-binding;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Highest levels of expression in placenta and testis.	GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0016021; GO:0048286; GO:0070062; GO:1904381		9592125; 16710414; 15489334; 22223895; 22814378	Glycosyl hydrolase 47 family
O60477	BRNP1_HUMAN	BMP/retinoic acid-inducible neural-specific protein 1 (Deleted in bladder cancer protein 1)	BRINP1 DBC1 DBCCR1 FAM5A IB3089A	761	9606			Alternative splicing;Cell cycle;Cytoplasm;Glycoprotein;Growth arrest;Reference proteome;Signal	Q5BKZ1	TISSUE SPECIFICITY: Highly expressed in brain. Weakly expressed in heart, lung, skeletal muscle, kidney, thymus, prostate, testis and small intestine. {ECO:0000269|PubMed:9545632}.	GO:0001662; GO:0005737; GO:0005783; GO:0007049; GO:0007614; GO:0008219; GO:0030425; GO:0035176; GO:0035640; GO:0042711; GO:0043025; GO:0045666; GO:0045786; GO:0045930; GO:0050768; GO:0071300; GO:0071625		9545632; 15164053; 15489334; 11420708; 14712213; 16369496; 16959974	BRINP family
O60478	G137B_HUMAN	Integral membrane protein GPR137B (Transmembrane 7 superfamily member 1 protein)	GPR137B TM7SF1	399	9606			Autophagy;Glycoprotein;Lysosome;Membrane;Reference proteome;Transmembrane;Transmembrane helix	Q13049	TISSUE SPECIFICITY: Expressed in kidney, heart, brain and placenta. {ECO:0000269|PubMed:9521871}.	GO:0005765; GO:0005887; GO:0006914; GO:0010506; GO:0016020; GO:0043030; GO:0043087; GO:0045671; GO:0045779; GO:0150032; GO:1904263		9521871; 16710414; 15489334; 22729905; 31036939	GPR137 family
O60479	DLX3_HUMAN	Homeobox protein DLX-3	DLX3	287	9606			3D-structure;Amelogenesis imperfecta;Developmental protein;DNA-binding;Homeobox;Nucleus;Reference proteome	Q92870-2; P54253; B4DE54; Q8N9N5-2; Q8N9N5-7; P55212; Q14203-5; P22607; Q9NP62; P42858; P13473-2; Q12837; O75400-2; P37840; Q9UMX0		GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001890; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0010467; GO:0016055; GO:0030154; GO:0030509; GO:0030855; GO:0031069; GO:0035315; GO:0042475; GO:0071335; GO:0071895; GO:1990837		9467018; 11792834; 16303743; 15489334; 15666299; 26550823	Distal-less homeobox family
O60481	ZIC3_HUMAN	Zinc finger protein ZIC 3 (Zinc finger protein 203) (Zinc finger protein of the cerebellum 3)	ZIC3 ZNF203	467	9606			3D-structure;Activator;Alternative splicing;Cytoplasm;Developmental protein;Differentiation;Disease variant;DNA-binding;Heterotaxy;Isopeptide bond;Metal-binding;Neurogenesis;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Triplet repeat expansion;Ubl conjugation;Zinc;Zinc-finger			GO:0000978; GO:0000981; GO:0001228; GO:0001947; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007368; GO:0007417; GO:0009952; GO:0030154; GO:0030324; GO:0035469; GO:0035545; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0071907; GO:0071910; GO:1990837		9354794; 19266028; 15772651; 15489334; 17764085; 21858219; 21406692; 28112733; 18716025; 14681828; 16959974; 17295247; 20452998; 24123890	GLI C2H2-type zinc-finger protein family
O60486	PLXC1_HUMAN	Plexin-C1 (Virus-encoded semaphorin protein receptor) (CD antigen CD232)	PLXNC1 VESPR	1568	9606			3D-structure;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Signal;Transmembrane;Transmembrane helix	O75326; Q8JL80	TISSUE SPECIFICITY: Detected in heart, brain, lung, spleen and placenta. {ECO:0000269|PubMed:9586637}.	GO:0002116; GO:0005102; GO:0005886; GO:0005887; GO:0007155; GO:0007162; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:1902287	PTM: N-glycosylated. {ECO:0000269|PubMed:20727575, ECO:0000269|PubMed:9586637}.	9586637; 20727575	Plexin family
O60487	MPZL2_HUMAN	Myelin protein zero-like protein 2 (Epithelial V-like antigen 1)	MPZL2 EVA EVA1 UNQ606/PRO1192	215	9606			Cell adhesion;Deafness;Disease variant;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Non-syndromic deafness;Reference proteome;Signal;Transmembrane;Transmembrane helix	Q6UWV2	TISSUE SPECIFICITY: Widely expressed. In fetal tissues, highest expression in the inner ear. In adult tissues, highest levels in thymus and lung. {ECO:0000269|PubMed:29961571}.	GO:0005856; GO:0005886; GO:0007156; GO:0009653; GO:0016021; GO:0098609		9585423; 12975309; 14702039; 15489334; 19159218; 29961571; 29982980	Myelin P0 protein family
O60488	ACSL4_HUMAN	Long-chain-fatty-acid--CoA ligase 4, EC 6.2.1.3 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4, LACS 4)	ACSL4 ACS4 FACL4 LACS4	711	9606		6.2.1.15; 6.2.1.3	Alport syndrome;Alternative splicing;ATP-binding;Cell membrane;Deafness;Disease variant;Elliptocytosis;Endoplasmic reticulum;Fatty acid metabolism;Hereditary hemolytic anemia;Ligase;Lipid metabolism;Magnesium;Membrane;Mental retardation;Microsome;Mitochondrion;Mitochondrion outer membrane;Nucleotide-binding;Peroxisome;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix			GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0008610; GO:0016020; GO:0016021; GO:0030182; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0044233; GO:0047676; GO:0060136; GO:0070062; GO:0090433		9598324; 9480748; 14702039; 15489334; 18669648; 21269460; 21242590; 22633490; 24269233; 23186163; 25944712; 11889465; 16959974; 29961568	ATP-dependent AMP-binding enzyme family
O60493	SNX3_HUMAN	Sorting nexin-3 (Protein SDP3)	SNX3	162	9606			3D-structure;Acetylation;Alternative splicing;Chromosomal rearrangement;Cytoplasmic vesicle;Direct protein sequencing;Endosome;Isopeptide bond;Lipid-binding;Methylation;Microphthalmia;Phosphoprotein;Protein transport;Reference proteome;Transport;Ubl conjugation	Q15041; P46108; Q9NS64		GO:0005737; GO:0005769; GO:0005829; GO:0009617; GO:0010008; GO:0010314; GO:0010324; GO:0010976; GO:0015031; GO:0019903; GO:0022615; GO:0030111; GO:0030136; GO:0030904; GO:0031901; GO:0032009; GO:0032266; GO:0032456; GO:0034499; GO:0042177; GO:0046597; GO:0050765; GO:0051224; GO:0070062; GO:0070273; GO:0070676; GO:0080025; GO:1905394; GO:2000642	PTM: Ubiquitinated, leading to its proteasomal degradation. Deubiquitinated by USP10 (By similarity). {ECO:0000250|UniProtKB:O70492}.	9819414; 11433298; 14702039; 14574404; 15489334; 12665801; 12471201; 17081983; 17622474; 18767904; 18669648; 19413330; 20482551; 20068231; 21269460; 21725319; 23237080; 23186163; 24275569; 24866125; 24129315; 24344282; 25944712; 28112733; 30213940	Sorting nexin family
O60494	CUBN_HUMAN	Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)	CUBN IFCR	3623	9606			3D-structure;Calcium;Cell membrane;Cholesterol metabolism;Cleavage on pair of basic residues;Coated pit;Cobalamin;Cobalt;Direct protein sequencing;Disease variant;Disulfide bond;EGF-like domain;Endocytosis;Endosome;Glycoprotein;Lipid metabolism;Lysosome;Membrane;Metal-binding;Phosphoprotein;Protein transport;Receptor;Reference proteome;Repeat;Signal;Steroid metabolism;Sterol metabolism;Transport	Q9BXJ7; P27352	TISSUE SPECIFICITY: Detected in kidney cortex (at protein level) (PubMed:9572993). Expressed in kidney proximal tubule cells, placenta, visceral yolk-sac cells and in absorptive intestinal cells. Expressed in the epithelium of intestine and kidney. {ECO:0000269|PubMed:9572993}.	GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0070062	PTM: The precursor is cleaved by a trans-Golgi proteinase furin, removing a propeptide. {ECO:0000269|PubMed:9572993}.; PTM: N-glycosylated. {ECO:0000269|PubMed:14576052, ECO:0000269|PubMed:20237569, ECO:0000269|PubMed:29402915}.	9572993; 15164054; 10371504; 10080186; 11717447; 11606717; 14576052; 17124247; 29402915; 31613795; 20237569; 30523278; 10887099; 16959974; 17668238; 21355061; 21248752; 23114252; 24156255	
O60496	DOK2_HUMAN	Docking protein 2 (Downstream of tyrosine kinase 2) (p56(dok-2))	DOK2	412	9606			3D-structure;Direct protein sequencing;Host-virus interaction;Phosphoprotein;Reference proteome	Q9NUX5; P42681; P07947	TISSUE SPECIFICITY: Highly expressed in peripheral blood leukocytes, lymph nodes and spleen. Lower expression in thymus, bone marrow and fetal liver. {ECO:0000269|PubMed:9478921}.	GO:0005068; GO:0005737; GO:0005829; GO:0007165; GO:0007166; GO:0007169; GO:0007265	PTM: On immunoreceptor stimulation, phosphorylated on C-terminal tyrosine residues. Phosphorylation on Tyr-345 is required for binding to the SH2 domain of NCK. Phosphorylation on both Tyr-271 and Tyr-299 is required for interaction with RASGAP. Phosphorylated on tyrosine residues by TEK/TIE2 (By similarity). {ECO:0000250}.	9478921; 15489334; 15144186; 15592455; 19690332; 23186163; 28841444	DOK family, Type A subfamily
O60499	STX10_HUMAN	Syntaxin-10, Syn10	STX10 SYN10	249	9606			3D-structure;Acetylation;Alternative splicing;Coiled coil;Golgi apparatus;Membrane;Phosphoprotein;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport	Q9UID3-1; Q8NI60; Q5JRM2; Q16623; Q12846; Q96IK0	TISSUE SPECIFICITY: Expressed at high levels in heart, skeletal muscle and pancreas.	GO:0000139; GO:0000149; GO:0005484; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031982; GO:0032588; GO:0032880; GO:0042147; GO:0048193; GO:0048278; GO:0048471		9446797; 15057824; 15489334; 15878329; 18195106; 18691976; 18669648; 19690332; 20068231; 21269460; 22814378; 23186163; 24275569; 25944712	Syntaxin family
O60500	NPHN_HUMAN	Nephrin (Renal glomerulus-specific cell adhesion receptor)	NPHS1 NPHN	1241	9606			3D-structure;Alternative splicing;Cell adhesion;Cell membrane;Developmental protein;Disease variant;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Myogenesis;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	P46940; P16333	TISSUE SPECIFICITY: Specifically expressed in podocytes of kidney glomeruli.	GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007254; GO:0007519; GO:0007520; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0036060; GO:0042995; GO:0050839; GO:0070062; GO:0072015; GO:0098609	PTM: Phosphorylated at Tyr-1193 by FYN, leading to the recruitment and activation of phospholipase C-gamma-1/PLCG1. {ECO:0000250}.	9660941; 19309778; 15057824; 10550324; 10393930; 11562357; 18088087; 9915943; 10652016; 11726550; 11317351; 17290294; 18614772; 18503012; 20172850; 22009864; 20798252; 22732337; 22565185; 25804400; 26560236	Immunoglobulin superfamily
O60502	OGA_HUMAN	Protein O-GlcNAcase, OGA, EC 3.2.1.169 (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase, NCOAT)	OGA HEXC KIAA0679 MEA5 MGEA5	916	9606		3.2.1.169	3D-structure;Alternative splicing;Cytoplasm;Glycosidase;Host-virus interaction;Hydrolase;Nucleus;Phosphoprotein;Reference proteome		TISSUE SPECIFICITY: Ubiquitous. Shows highest expression in the brain, placenta and pancreas. {ECO:0000269|PubMed:11148210, ECO:0000269|PubMed:11341771}.	GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0016020; GO:0016231; GO:0102166; GO:0102167; GO:0102571	PTM: Proteolytically cleaved by caspase-3 during apoptosis. The fragments interact with each other; cleavage does not decrease enzyme activity. {ECO:0000269|PubMed:11788610, ECO:0000269|PubMed:18586680}.	9811929; 11341771; 11148210; 9734811; 12168954; 15164054; 15489334; 11788610; 16533067; 18586680; 18669648; 19413330; 19690332; 20863279; 20673219; 20068231; 21269460; 21406692; 22814378; 23186163; 24088714; 28742148; 22365600	Glycosyl hydrolase 84 family
O60503	ADCY9_HUMAN	Adenylate cyclase type 9, EC 4.6.1.1 (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX, ACIX) (Adenylyl cyclase 9, AC9)	ADCY9 KIAA0520	1353	9606		4.6.1.1	ATP-binding;cAMP biosynthesis;Cell membrane;Glycoprotein;Lyase;Magnesium;Manganese;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Detected in skeletal muscle, pancreas, lung, heart, kidney, liver, brain and placenta (PubMed:9628827, PubMed:10987815). Expressed in multiple cells of the lung, with expression highest in airway smooth muscle (PubMed:12972952). {ECO:0000269|PubMed:10987815, ECO:0000269|PubMed:12972952, ECO:0000269|PubMed:9628827}.	GO:0001701; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007165; GO:0007189; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0046872; GO:0071880		9628827; 12972952; 15879435; 10987815; 9628581; 12168954; 15489334; 18669648; 20068231; 23186163; 24275569	Adenylyl cyclase class-4/guanylyl cyclase family
O60504	VINEX_HUMAN	Vinexin (SH3-containing adapter molecule 1, SCAM-1) (Sorbin and SH3 domain-containing protein 3)	SORBS3 SCAM1	671	9606			3D-structure;Acetylation;Alternative splicing;Cell adhesion;Cell junction;Cytoplasm;Cytoskeleton;Nucleus;Phosphoprotein;Reference proteome;Repeat;SH3 domain	Q9NYB9-2; Q96EY9; Q53H80; P31751; Q49AR9; Q9NX04; Q8NEC5; O43439-4; Q68D86; Q96HB5; Q2TAC2-2; Q16204; Q8TD31-3; P51946; Q9UK58; Q9UJX2; P42773; Q8IYR0; Q8IWX8; Q9H9E3; Q99829; Q96FN4; Q86YQ8; Q9BSW2; P26196; Q14689-6; Q92997; Q5JVL4; O15372; Q6IB98; Q9H0I2; Q7L5A3; Q9NYF3; Q6PCT2-2; Q9BVV2; O95995; P55040; P23415; O95872; Q92917; P13807; A0A024R8L2; O14964; P52597; P61978; P61978-2; Q9BUJ2; Q9NV31; Q1MX18; Q8NA54; Q63ZY3; Q6ZU52; Q9BVG8-5; Q8IVT4; Q13064; Q15742; Q96HR8; A0A0S2Z4D7; Q9NZQ3; Q9HC98-4; Q8NI38; Q5HYW2; Q9UHY1; O43482; Q9UJX0; Q13177; Q9P286; Q8N4B1-4; O43189; Q4G0R1; Q494U1-3; O60568; Q96PV4; P56282; O15160; O75145; Q8IXY8; Q6NYC8; P47897; O75771; Q13671; Q9HAT0; Q9BST9; Q06455-2; Q8IYX7; Q9BWG6; Q9C0A6-3; Q9H788; Q9H788-2; O14512; Q9NZD8; Q9H987-2; Q9NU19; Q8N8B7-2; Q15561; Q96N21; Q63HR2; P36406; P14373; Q8WV44; Q9BZW7; Q3SY00; P40222; O75604; Q5ST30; Q5ST30-4; P18206-2; Q9H9H4; A5D8V6; Q8TF74; O15156; Q53FD0-2; Q9NQZ6; Q96IQ9; O15357; P00519; P13631; Q9BST9; Q14151; Q9Y6W5; O00401; Q9QWI6-2	TISSUE SPECIFICITY: Both isoforms are expressed in different tissues like heart, placenta, brain, skeletal muscle and pancreas. Isoform beta is especially found in liver.	GO:0000122; GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0007015; GO:0007155; GO:0017166; GO:0030055; GO:0031589; GO:0043410; GO:0051495; GO:0051496	PTM: Phosphorylated at Ser-530 by MAPK1/ERK2 during cell spreading. {ECO:0000250}.	9885244; 16421571; 15489334; 10585480; 12660241; 15242778; 16302969; 17081983; 16964243; 18662323; 18669648; 19807924; 19369195; 19690332; 20068231; 21406692; 22223895; 22814378; 23186163; 24275569; 18220336; 18691976; 19413330	
O60506	HNRPQ_HUMAN	Heterogeneous nuclear ribonucleoprotein Q, hnRNP Q (Glycine- and tyrosine-rich RNA-binding protein, GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)	SYNCRIP HNRPQ NSAP1	623	9606			3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Host-virus interaction;Isopeptide bond;Methylation;Microsome;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribonucleoprotein;RNA-binding;Spliceosome;Translation regulation;Ubl conjugation	P07814; Q5JVS0; Q14103-4; Q99873; Q9NR22; Q9NR22-2; Q86V38; P55212; P02489; Q01658; Q14204; P41091; Q0VDC6; Q00403; O00291; P54652; Q92876; P13473-2; Q86VE0; Q13153; P16284; Q8N2W9; Q99873-3; Q9NR22; P20339; P62826; Q6NXR8; P34741; Q9Y371; Q13148; P61086; P08670	TISSUE SPECIFICITY: Ubiquitously expressed. Detected in heart, brain, pancreas, placenta, spleen, lung, liver, skeletal muscle, kidney, thymus, prostate, uterus, small intestine, colon, peripheral blood and testis. {ECO:0000269|PubMed:11352648}.	GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006396; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0045293; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990904; GO:2000623; GO:2000767	PTM: Phosphorylated on tyrosine. The membrane-bound form found in microsomes is phosphorylated in vitro by insulin receptor tyrosine kinase (INSR). Phosphorylation is inhibited upon binding to RNA, whereas the cytoplasmic form is poorly phosphorylated (By similarity). {ECO:0000250}.	9847309; 11574476; 14574404; 15489334; 12601080; 11051545; 11352648; 11134005; 9731529; 12376575; 11991638; 15479637; 16765914; 17289661; 17525332; 19413330; 19523114; 19647514; 19029303; 19608861; 21269460; 21515746; 23071094; 23186163; 23455924; 24275569; 25944712; 28112733	
O60507	TPST1_HUMAN	Protein-tyrosine sulfotransferase 1, EC 2.8.2.20 (Tyrosylprotein sulfotransferase 1, TPST-1)	TPST1	370	9606		2.8.2.20	3D-structure;Disulfide bond;Glycoprotein;Golgi apparatus;Membrane;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Ubiquitous. Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269|PubMed:9501187}.	GO:0000139; GO:0005794; GO:0006478; GO:0006954; GO:0008146; GO:0008476; GO:0016020; GO:0030173; GO:0042803; GO:0050427	PTM: N-glycosylated. {ECO:0000269|PubMed:16859706, ECO:0000269|PubMed:9501187}.	9501187; 14702039; 12690205; 15489334; 9733778; 16859706; 25660941; 28821720	Protein sulfotransferase family
O60508	PRP17_HUMAN	Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3, Ehb3) (PRP17 homolog, hPRP17)	CDC40 EHB3 PRP17 PRPF17	579	9606			3D-structure;Disease variant;Mental retardation;mRNA processing;mRNA splicing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;WD repeat	Q9UMS4		GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0016607; GO:0071007; GO:0071013; GO:1990403	PTM: Undergoes isomerization of the peptide bond between Gly-94 and Pro-95. The reaction is catalyzed by PPIL1. {ECO:0000269|PubMed:33220177}.	9524131; 9830021; 14702039; 14574404; 15489334; 9769104; 9303539; 11991638; 18669648; 19690332; 20068231; 21406692; 23186163; 24275569; 33220177; 28502770; 28076346; 29361316; 29360106; 29301961; 30705154	
O60512	B4GT3_HUMAN	Beta-1,4-galactosyltransferase 3, Beta-1,4-GalTase 3, Beta4Gal-T3, b4Gal-T3, EC 2.4.1.- (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase, EC 2.4.1.38) (N-acetyllactosamine synthase, EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase, EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3)	B4GALT3	393	9606	PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:11588157, ECO:0000269|PubMed:9405390}.	2.4.1.-; 2.4.1.275; 2.4.1.38; 2.4.1.90	Alternative splicing;Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Lipid metabolism;Manganese;Membrane;Metal-binding;Reference proteome;Signal-anchor;Transferase;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Found in various tissues. Highest expression in placenta, prostate, testis, ovary, intestine and muscle, and in fetal brain. {ECO:0000269|PubMed:9405390}.	GO:0000139; GO:0003831; GO:0003945; GO:0005794; GO:0005829; GO:0005975; GO:0006486; GO:0006682; GO:0008378; GO:0016021; GO:0032580; GO:0046872; GO:0070062; GO:0070085		9405390; 9597550; 11588157; 16710414; 14702039; 15489334; 10580128	Glycosyltransferase 7 family
O60513	B4GT4_HUMAN	Beta-1,4-galactosyltransferase 4, Beta-1,4-GalTase 4, Beta4Gal-T4, b4Gal-T4, EC 2.4.1.- (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Lactotriaosylceramide beta-1,4-galactosyltransferase, EC 2.4.1.275) (N-acetyllactosamine synthase, EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4)	B4GALT4 UNQ552/PRO1109	344	9606	PATHWAY: Protein modification; protein glycosylation. {ECO:0000305|PubMed:12511560}.; PATHWAY: Glycolipid biosynthesis. {ECO:0000305|PubMed:9792633}.	2.4.1.-; 2.4.1.275; 2.4.1.90	Disulfide bond;Glycoprotein;Glycosyltransferase;Golgi apparatus;Lipid metabolism;Manganese;Membrane;Metal-binding;Reference proteome;Secreted;Signal-anchor;Transferase;Transmembrane;Transmembrane helix		TISSUE SPECIFICITY: Highest expression is observed in placenta, pancreas, kidney and heart (PubMed:9792633). Expressed in corneal epithelial cells (PubMed:17690104). {ECO:0000269|PubMed:17690104, ECO:0000269|PubMed:9792633}.	GO:0000139; GO:0001572; GO:0003945; GO:0005794; GO:0005975; GO:0006486; GO:0006643; GO:0008378; GO:0016021; GO:0018146; GO:0032580; GO:0035250; GO:0046872; GO:0070085	PTM: N-glycosylated. {ECO:0000269|PubMed:32827291}.	9597550; 9792633; 11588157; 12975309; 17974005; 15489334; 10580128; 12511560; 17690104; 32827291	Glycosyltransferase 7 family
O60519	CRBL2_HUMAN	cAMP-responsive element-binding protein-like 2	CREBL2	120	9606			Activator;Cell cycle;Differentiation;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Tumor suppressor	Q8IUR6; P35638; Q16236; Q96KN3; Q7KZS0		GO:0000785; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0007049; GO:0007165; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821	PTM: Phosphorylated by AMPK. {ECO:0000269|PubMed:18063805}.	9693048; 19054851; 16541075; 15489334; 18063805	BZIP family, ATF subfamily
O60524	NEMF_HUMAN	Ribosome quality control complex subunit NEMF (Antigen NY-CO-1) (Nuclear export mediator factor) (Serologically defined colon cancer antigen 1)	NEMF SDCCAG1	1076	9606			3D-structure;Alternative splicing;Coiled coil;Cytoplasm;Disease variant;Mental retardation;Neuropathy;Nucleus;Phosphoprotein;Reference proteome		TISSUE SPECIFICITY: Expressed in brain, heart, liver, lung, spleen, and skeletal muscle. Also expressed at lower levels in stomach and testis. {ECO:0000269|PubMed:16103875, ECO:0000269|PubMed:33048237}.	GO:0000049; GO:0005634; GO:0005829; GO:0043023; GO:0051168; GO:0065003; GO:0072344; GO:0140708; GO:1990112; GO:1990116		14702039; 17974005; 12508121; 15489334; 9610721; 16103875; 17081983; 18669648; 19690332; 20068231; 21269460; 21406692; 23186163; 24275569; 27431290; 33048237; 25578875; 32934225	NEMF family
O60543	CIDEA_HUMAN	Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A)	CIDEA	219	9606			3D-structure;Activator;Apoptosis;Lipid droplet;Nucleus;Reference proteome;Transcription;Transcription regulation		TISSUE SPECIFICITY: Expressed in omental and subcutaneous adipose tissue (at protein level). {ECO:0000269|PubMed:18509062}.	GO:0001659; GO:0001818; GO:0005634; GO:0005737; GO:0005739; GO:0005740; GO:0005811; GO:0005829; GO:0006629; GO:0006915; GO:0008219; GO:0010890; GO:0019915; GO:0030512; GO:0032720; GO:0035634; GO:0042803; GO:0042981; GO:0050995; GO:0070417; GO:0120163; GO:1900118; GO:1902510		9564035; 18509062; 19843876	
O60547	GMDS_HUMAN	GDP-mannose 4,6 dehydratase, EC 4.2.1.47 (GDP-D-mannose dehydratase, GMD)	GMDS	372	9606	PATHWAY: Nucleotide-sugar biosynthesis; GDP-L-fucose biosynthesis via de novo pathway; GDP-L-fucose from GDP-alpha-D-mannose: step 1/2. {ECO:0000305|PubMed:9525924}.	4.2.1.47	3D-structure;Acetylation;Alternative splicing;Lyase;NADP;Phosphoprotein;Reference proteome	O60547; O43448; Q96HA8	TISSUE SPECIFICITY: Highly expressed in pancreas and small intestine. Expressed in thymus, protstate, colon, heart, placenta, liver and kidney. Expressed at low levels in spleen, testis, brain and lung. {ECO:0000269|PubMed:9525924}.	GO:0005737; GO:0005829; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070062; GO:0070401		9525924; 9603974; 14574404; 15489334; 19413330; 21269460; 23186163	NAD(P)-dependent epimerase/dehydratase family, GDP-mannose 4,6-dehydratase subfamily
O60548	FOXD2_HUMAN	Forkhead box protein D2 (Forkhead-related protein FKHL17) (Forkhead-related transcription factor 9, FREAC-9)	FOXD2 FKHL17 FREAC9	495	9606			DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	Q03989; A2RRN7; A8MQ03; O75593; Q3LI76; Q3LHN2; Q3SYF9; Q3LI59; Q9BYR7; Q3LI66; Q8IUC2; Q9Y5V3; A8MTQ0; Q16633; Q96LM6; Q08117-2	TISSUE SPECIFICITY: Kidney specific. {ECO:0000269|PubMed:9403061}.	GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0009653; GO:0030154; GO:0043565; GO:0045944; GO:1990837		9403061; 16710414; 23186163	
O60551	NMT2_HUMAN	Glycylpeptide N-tetradecanoyltransferase 2, EC 2.3.1.97 (Myristoyl-CoA:protein N-myristoyltransferase 2, NMT 2) (Peptide N-myristoyltransferase 2) (Protein-lysine myristoyltransferase NMT2, EC 2.3.1.-) (Type II N-myristoyltransferase)	NMT2	498	9606		2.3.1.-; 2.3.1.97	3D-structure;Acyltransferase;Cytoplasm;Membrane;Phosphoprotein;Reference proteome;Transferase	Q9BR61; P20290-2; P42574; Q8N2W9		GO:0004379; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0018008; GO:0019898; GO:0022400; GO:0043657; GO:0075733		9506952; 15164054; 15489334; 21269460; 23186163; 24275569; 25255805; 32103017	NMT family
O60563	CCNT1_HUMAN	Cyclin-T1, CycT1, Cyclin-T	CCNT1	726	9606			3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Coiled coil;Cyclin;Direct protein sequencing;Host-virus interaction;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	Q9UHB7; O60885-1; P50750; O94992; P04608; P04610	TISSUE SPECIFICITY: Ubiquitously expressed.	GO:0000079; GO:0000976; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0006468; GO:0007049; GO:0008024; GO:0016538; GO:0019901; GO:0032786; GO:0032968; GO:0043923; GO:0045944; GO:0051301; GO:0061575; GO:0070063; GO:0070691; GO:0097322; GO:0140297; GO:1900364; GO:1903654; GO:1903655		9491887; 9499409; 16541075; 10393184; 10329125; 10329126; 9832504; 10364329; 10913173; 12065898; 12944466; 14972556; 16109376; 16109377; 17643375; 18691976; 19369195; 19608861; 20068231; 21269460; 24360279; 23186163; 27292648; 27189267; 28112733; 23033978	Cyclin family, Cyclin C subfamily
O60565	GREM1_HUMAN	Gremlin-1 (Cell proliferation-inducing gene 2 protein) (Cysteine knot superfamily 1, BMP antagonist 1) (DAN domain family member 2) (Down-regulated in Mos-transformed cells protein) (Increased in high glucose protein 2, IHG-2)	GREM1 CKTSF1B1 DAND2 DRM PIG2	184	9606			3D-structure;Alternative splicing;Cytokine;Direct protein sequencing;Disulfide bond;Glycoprotein;Reference proteome;Secreted;Signal	P35968; P59991; Q99750; Q04917	TISSUE SPECIFICITY: Highly expressed in small intestine, fetal brain and colon. Expression is restricted to intestinal subepithelial myofibroblasts (ISEMFs) at the crypt base. In subjects with HMPS1, by contrast, GREM1 is expressed, not only in basal ISEMFs, but also at very high levels in epithelial cells (predominantly colonocytes), with expression extending most of the way up the sides of the crypt. Weakly expressed in brain, ovary, prostate, pancreas and skeletal muscle. In brain found in the region localized around the internal capsule in the large subcortical nuclei, including caudate, putamen, substantia nigra, thalamus and subthalamus. Predominantly expressed in normal cells including neurons, astrocytes and fibroblasts. {ECO:0000269|PubMed:10894942, ECO:0000269|PubMed:22561515}.	GO:0000902; GO:0002042; GO:0002092; GO:0003257; GO:0003337; GO:0005125; GO:0005615; GO:0006915; GO:0007165; GO:0007267; GO:0008284; GO:0009887; GO:0009954; GO:0009986; GO:0010717; GO:0016015; GO:0030199; GO:0030297; GO:0030308; GO:0030326; GO:0030502; GO:0030514; GO:0032331; GO:0033689; GO:0036122; GO:0038098; GO:0042803; GO:0043066; GO:0043184; GO:0045668; GO:0045766; GO:0045892; GO:0045944; GO:0046851; GO:0048018; GO:0048263; GO:0051092; GO:0051893; GO:0051973; GO:0060173; GO:0060394; GO:0060676; GO:0062023; GO:0090027; GO:0090090; GO:0090190; GO:0090291; GO:1900086; GO:1900155; GO:1900158; GO:1901224; GO:2000273; GO:2000727		9660951; 10744662; 10894942; 14702039; 15489334; 15340161; 22561515; 27036124	DAN family
